COMPOUND_ID	BIOACTIVITY_IN_BRIEF
CMNPD1	antibiotic
CMNPD2	antibiotic
CMNPD3	antibiotic
CMNPD4	antibiotic
CMNPD5	antibiotic
CMNPD6	antibiotic
CMNPD7	insecticidal | neurotoxic
CMNPD18	antimicrobial | antifungal
CMNPD19	antimicrobial | antifungal
CMNPD20	antimicrobial | antifungal
CMNPD21	antimicrobial | antifungal
CMNPD29	antiviral
CMNPD87	antibiotic
CMNPD90	antibiotic
CMNPD91	antibiotic
CMNPD140	toxic
CMNPD141	cytotoxicity
CMNPD142	cytotoxicity
CMNPD164	antibiotics
CMNPD179	analgesic
CMNPD188	inhibit human immunodeficiency virus (HIV) in vitro
CMNPD229	cytotoxic | markedly inhibit growth of the P-388 leukemia
CMNPD230	cytotoxic | markedly inhibit growth of the P-388 leukemia
CMNPD237	antibiotic | cytotoxic | antimicrobial
CMNPD238	antibiotic
CMNPD239	antibiotic
CMNPD240	antibiotic
CMNPD245	antifungal
CMNPD256	antibiotic
CMNPD262	antimicrobial
CMNPD263	antimicrobial
CMNPD264	antibiotic | antimicrobial
CMNPD287	toxic
CMNPD288	toxic
CMNPD291	toxin
CMNPD292	toxin
CMNPD293	toxin
CMNPD294	antimicrobial
CMNPD295	toxin
CMNPD296	toxin
CMNPD297	toxin
CMNPD298	toxin
CMNPD299	toxin
CMNPD300	toxin
CMNPD301	toxin
CMNPD302	toxin
CMNPD303	toxin
CMNPD304	toxin
CMNPD305	toxin
CMNPD306	toxin
CMNPD307	ichthyotoxin
CMNPD328	antimicrobial
CMNPD330	toxic
CMNPD331	toxic
CMNPD332	toxic
CMNPD333	toxic
CMNPD346	antimicrobial | toxic to marine ciliates
CMNPD347	toxic
CMNPD348	toxic
CMNPD362	inhibit the growth of two marine bacteria
CMNPD366	antimicrobial
CMNPD367	antimicrobial
CMNPD368	inhibition of the growth of marine bacteria and fungi | inhibition of cell division in fertilized sea-urchin eggs | inhibition of the motility of sea-urchin sperm | ichthyotoxicity | inhibition of feeding by fish
CMNPD370	ichthyotoxicity
CMNPD371	ichthyotoxicity
CMNPD372	ichthyotoxicity
CMNPD373	plant growth regulator
CMNPD388	antibacterial | toxic
CMNPD405	anti-inflammatory
CMNPD406	anti-inflammatory
CMNPD407	anti-inflammatory
CMNPD409	antibacterial
CMNPD446	toxic ichthyotoxin
CMNPD447	inhibitor of cell division
CMNPD450	antimicrobial
CMNPD451	antimicrobial
CMNPD497	antimicrobial
CMNPD526	antimicrobial
CMNPD528	potent inhibitor of cell division
CMNPD533	antimicrobial
CMNPD557	antimicrobial
CMNPD558	antimicrobial
CMNPD559	antimicrobial
CMNPD560	antimicrobial
CMNPD561	antimicrobial
CMNPD562	antimicrobial
CMNPD563	antimicrobial
CMNPD582	pheromone
CMNPD632	apoptotic
CMNPD633	apoptotic
CMNPD653	antifungal | molluscicidal activities | toxicity to brine shrimp
CMNPD655	antimicrobial
CMNPD656	antimicrobial
CMNPD668	anti-algal
CMNPD677	toxic
CMNPD678	toxic
CMNPD683	toxic
CMNPD686	inhibitor of feeding by fish
CMNPD687	toxic, inhibitor of feeding by fish
CMNPD725	powerful inhibitor of cell division and of assembly of microtubules
CMNPD793	ecdysone
CMNPD795	antimicrobial
CMNPD796	antimicrobial
CMNPD800	ichthyotoxic
CMNPD801	ichthyotoxic
CMNPD802	ichthyotoxic
CMNPD819	antifungal
CMNPD822	antimicrobial
CMNPD823	antimicrobial
CMNPD824	antimicrobial
CMNPD825	antimicrobial
CMNPD826	antimicrobial
CMNPD838	potent inhibitor of feeding by fish
CMNPD839	potent inhibitor of feeding by fish
CMNPD840	potent inhibitor of feeding by fish
CMNPD870	antimicrobial
CMNPD871	antimicrobial
CMNPD872	antibiotic
CMNPD873	antibiotic
CMNPD874	antibiotic
CMNPD875	antibiotic | inhibit in vitro settlement of barnacle (Balanus amphitrite) larvae | moderate antibacterial properties
CMNPD876	antibiotic
CMNPD895	anti-tumour | CNS activity in vivo
CMNPD901	inhibit cell division in fertilized eggs of the sea urchin Pseudocentrotus depressus
CMNPD902	antibiotic
CMNPD920	antifungal
CMNPD921	antifungal
CMNPD922	antifungal
CMNPD938	antimicrobial
CMNPD939	antimicrobial
CMNPD942	cytotoxic
CMNPD943	cytotoxic
CMNPD944	ichthyotoxin
CMNPD945	ichthyotoxin
CMNPD946	ichthyotoxin
CMNPD947	antiviral | antimicrobial
CMNPD948	antiviral | antimicrobial
CMNPD949	antiviral | antimicrobial
CMNPD950	antimicrobial | cytotoxic
CMNPD951	antimicrobial | cytotoxic
CMNPD965	serotonergic agent | potential antidepressant
CMNPD973	potential bronchodilator | CNS activity | cardiovascular activity
CMNPD976	potent muscle-relaxant | anti-inflammatory | anti-allergic activity
CMNPD977	α-adrenoceptor-blocking activity
CMNPD978	cytotoxic
CMNPD983	antagonist of serotonergic receptors
CMNPD992	moderately antimicrobial
CMNPD1014	antimicrobial
CMNPD1015	antimicrobial
CMNPD1016	antimicrobial
CMNPD1017	antimicrobial
CMNPD1018	antimicrobial
CMNPD1019	antimicrobial
CMNPD1020	antimicrobial
CMNPD1021	antimicrobial
CMNPD1022	antimicrobial
CMNPD1023	antimicrobial
CMNPD1024	antibiotic
CMNPD1032	antimicrobial
CMNPD1033	antimicrobial
CMNPD1066	inhibit fish feeding
CMNPD1067	inhibit fish feeding
CMNPD1088	cytotoxic
CMNPD1089	cytotoxic
CMNPD1095	cytotoxic
CMNPD1105	antimicrobial
CMNPD1116	ictithyotoxic
CMNPD1136	antimicrobial
CMNPD1137	antimicrobial
CMNPD1145	antimicrobial
CMNPD1146	antimicrobial
CMNPD1147	ichthyotoxic
CMNPD1148	ichthyotoxic
CMNPD1149	ichthyotoxic
CMNPD1161	antimicrobial | anti-inflammatory | inhibitor of phospholipase A2
CMNPD1162	antimicrobial
CMNPD1163	antimicrobial
CMNPD1164	antimicrobial
CMNPD1165	antimicrobial
CMNPD1167	ichthyotoxicity
CMNPD1168	ichthyotoxicity
CMNPD1169	ichthyotoxicity
CMNPD1170	antimicrobial
CMNPD1172	cytotoxin
CMNPD1193	anti-inflammatory
CMNPD1199	anti-inflammatory
CMNPD1200	potent anti-inflammatory
CMNPD1201	potent anti-inflammatory
CMNPD1202	potent anti-inflammatory
CMNPD1203	potent anti-inflammatory
CMNPD1204	potent anti-inflammatory
CMNPD1209	antimicrobial | cytotoxic | ichthyotoxic | larvicidal
CMNPD1210	antimicrobial | cytotoxic | ichthyotoxic | larvicidal
CMNPD1211	antimicrobial | cytotoxic | ichthyotoxic | larvicidal
CMNPD1212	weakly cytotoxic
CMNPD1238	mild antimicrobial
CMNPD1265	anti-tumour
CMNPD1269	cytotoxicity
CMNPD1282	antiinflammatory
CMNPD1297	ichthyotoxin
CMNPD1305	ichthyotoxic
CMNPD1311	ichthyotoxic
CMNPD1318	modest cytotoxicity towards a panel of tumour cell lines
CMNPD1321	antineoplastic
CMNPD1322	antineoplastic
CMNPD1396	cytotoxic
CMNPD1397	cytotoxic
CMNPD1398	antimicrobial | cytotoxic
CMNPD1399	antimicrobial | cytotoxic
CMNPD1400	anti-inflammatory
CMNPD1401	anti-inflammatory
CMNPD1402	anti-inflammatory
CMNPD1403	anti-inflammatory
CMNPD1404	anti-inflammatory
CMNPD1405	anti-inflammatory
CMNPD1410	cytotoxic
CMNPD1411	cytotoxic
CMNPD1435	significant anti-inflammatory activity
CMNPD1436	significant anti-inflammatory activity
CMNPD1437	significant anti-inflammatory activity
CMNPD1438	significant anti-inflammatory activity
CMNPD1441	anticancer
CMNPD1443	anticancer
CMNPD1451	mildly cytotoxic
CMNPD1453	antimicrobial
CMNPD1454	antimicrobial
CMNPD1455	antimicrobial
CMNPD1463	ichthyotoxic
CMNPD1464	antineoplastic
CMNPD1466	neuromuscular toxin
CMNPD1470	cytotoxic
CMNPD1489	toxic to grasshoppers
CMNPD1492	mild toxin
CMNPD1494	toxic to copepod larvae
CMNPD1519	lethal non-proteinous toxin
CMNPD1520	causative agent of Dogger Bank itch
CMNPD1535	inhibitor of cell division in the fertilized-sea-urchin-egg assay
CMNPD1537	antimicrobial | cytotoxic | ichthyodeterrent
CMNPD1538	antimicrobial and cytotoxic
CMNPD1539	antimicrobial | cytotoxic | ichthyodeterrent
CMNPD1540	antimicrobial | cytotoxic
CMNPD1541	good activity in the P388 lymphocytic leukaemia assay
CMNPD1542	good activity in the P388 lymphocytic leukaemia assay
CMNPD1543	good activity in the P388 lymphocytic leukaemia assay
CMNPD1548	ichthyotoxic
CMNPD1549	ichthyotoxic
CMNPD1583	feeding inhibitor
CMNPD1584	feeding inhibitor
CMNPD1603	antimicrobial, toxic
CMNPD1606	antibiotic
CMNPD1607	antibiotic
CMNPD1612	ichthyotoxin
CMNPD1613	ichthyotoxin
CMNPD1623	antineoplastic
CMNPD1625	antibacterial | inhibitor of eukaryotic DNA polymerase α
CMNPD1626	antibacterial
CMNPD1627	toxin
CMNPD1640	activity against P388 lymphocytic leukaemia in vivo | cancer-protective agent
CMNPD1641	activity against P388 lymphocytic leukaemia in vivo | cancer-protective agent
CMNPD1642	activity against P388 lymphocytic leukaemia in vivo | cancer-protective agent
CMNPD1643	antimicrobial | antiviral | cytotoxic
CMNPD1644	cytotoxic
CMNPD1648	cytotoxic
CMNPD1665	cytotoxicity
CMNPD1666	cytotoxicity
CMNPD1667	cytotoxicity
CMNPD1668	cytotoxicity
CMNPD1669	cytotoxicity
CMNPD1674	antiviral | cytotoxic
CMNPD1675	antiviral | cytotoxic
CMNPD1676	antiviral | cytotoxic
CMNPD1677	antimicrobial | cytotoxic
CMNPD1678	antimicrobial | cytotoxic
CMNPD1679	antimicrobial | cytotoxic
CMNPD1680	antimicrobial | cytotoxic
CMNPD1681	antimicrobial | cytotoxic
CMNPD1682	antimicrobial | cytotoxic
CMNPD1683	antimicrobial | cytotoxic
CMNPD1712	antifungal
CMNPD1713	antifungal
CMNPD1731	antibacterial agent
CMNPD1745	bronchodilator activity in vitro
CMNPD1746	bronchodilator activity in vitro
CMNPD1747	bronchodilator activity in vitro
CMNPD1748	antibiotic
CMNPD1749	antibiotic
CMNPD1757	toxin
CMNPD1765	inhibit the growth of fungal plant pathogens
CMNPD1766	antimicrobial and cytotoxic
CMNPD1767	antimicrobial and cytotoxic
CMNPD1768	antimicrobial and cytotoxic
CMNPD1793	antimicrobial
CMNPD1794	antimicrobial
CMNPD1812	ichthyotoxic and phytotoxic
CMNPD1813	ichthyotoxic and phytotoxic
CMNPD1814	ichthyotoxic and phytotoxic
CMNPD1815	significant cytotoxicity
CMNPD1823	inhibit the growth of insects
CMNPD1824	ichthyotoxic
CMNPD1851	potent neurophysiological activity in mammals
CMNPD1877	antifungal and molluscicidal activities and toxicity to brine shrimp
CMNPD1900	toxic to the damselfish Pomacentrus coeruleus
CMNPD1901	toxic to the damselfish Pomacentrus coeruleus
CMNPD1917	cytotoxic
CMNPD1921	potent cytotoxin
CMNPD1922	antibacterial and antifungal, cytotoxic
CMNPD1927	ichthyotoxicity
CMNPD1928	ichthyotoxicity
CMNPD1939	cytotoxic
CMNPD1978	inhibit the growth of Bacillus subtilis, Staphylococcus aureus, and Candida albicans
CMNPD1979	inhibit the growth of Bacillus subtilis, Staphylococcus aureus, and Candida albicans
CMNPD1980	inhibit the growth of Bacillus subtilis, Staphylococcus aureus, and Candida albicans
CMNPD1982	inhibit the growth of Bacillus subtilis, Staphylococcus aureus, and Candida albicans
CMNPD1983	toxic to corals
CMNPD1988	antimicrobial
CMNPD1989	antimicrobial
CMNPD2004	inhibit cell division in fertilized starfish eggs
CMNPD2005	inhibit cell division in fertilized starfish eggs
CMNPD2016	antimicrobial
CMNPD2017	antimicrobial
CMNPD2018	antimicrobial
CMNPD2050	cytotoxic
CMNPD2051	cytotoxic
CMNPD2052	cytotoxic
CMNPD2053	cytotoxic
CMNPD2059	cardiotoxic
CMNPD2072	inhibit the growth of diatoms
CMNPD2073	inhibit the growth of diatoms
CMNPD2074	inhibit the growth of diatoms
CMNPD2075	inhibit the growth of diatoms
CMNPD2087	antimicrobial
CMNPD2088	toxin
CMNPD2089	toxin
CMNPD2090	toxin
CMNPD2091	toxin
CMNPD2104	antimicrobial
CMNPD2133	antibacterial
CMNPD2137	toxic
CMNPD2138	cytotoxic
CMNPD2140	cytotoxic
CMNPD2182	ichthyotoxic
CMNPD2183	ichthyotoxic
CMNPD2184	ichthyotoxic
CMNPD2185	ichthyotoxic
CMNPD2186	ichthyotoxic
CMNPD2187	ichthyotoxic
CMNPD2188	toxicity
CMNPD2189	toxicity
CMNPD2191	toxin
CMNPD2195	ichthyotoxic | brine-shrimp toxic
CMNPD2197	cytotoxic | inhibit the growth of P388 lymphocytic leukaemia and HL-60 human promyelocytic leukaemia cell lines | inhibit the synthesis of RNA
CMNPD2198	inhibit the growth of Staphylococcus aureus and Bacillus subtilis | inhibit cell division in fertilized sea-urchin eggs
CMNPD2199	inhibit the growth of Staphylococcus aureus and Bacillus subtilis | inhibit the growth of two marine bacteria | inhibit cell division in fertilized sea-urchin eggs
CMNPD2200	inhibit the growth of Staphylococcus aureus and Bacillus subtilis | inhibit the growth of two marine bacteria | inhibit cell division in fertilized sea-urchin eggs
CMNPD2201	inhibit the growth of Staphylococcus aureus and Bacillus subtilis
CMNPD2218	inhibitor of mitotic cell division
CMNPD2219	cytotoxic
CMNPD2246	moderate antimicrobial
CMNPD2247	moderate antimicrobial
CMNPD2272	cytotoxic
CMNPD2273	cytotoxic
CMNPD2277	anti-tumour
CMNPD2278	anti-tumour | cytotoxin
CMNPD2280	toxin | ichthyotoxic
CMNPD2281	α-adrenoceptor-blocking activity
CMNPD2285	inhibit cell division in the fertilized starfish-egg assay
CMNPD2286	inhibit cell division in the fertilized starfish-egg assay
CMNPD2288	significant activity on the isolated guinea-pig ileum
CMNPD2289	antimicrobial
CMNPD2296	moderate the enzymic reactions of ATPase
CMNPD2297	ATPase inhibitor
CMNPD2298	ATPase inhibitor
CMNPD2299	ATPase inhibitor
CMNPD2302	insecticidal | antifungal
CMNPD2320	mildly cytotoxic
CMNPD2330	antimicrobial
CMNPD2331	antimicrobial
CMNPD2336	antimicrobial
CMNPD2337	antimicrobial
CMNPD2343	inhibit cell division in the fertilized-starfish-egg assay
CMNPD2344	inhibit cell division in the fertilized-starfish-egg assay
CMNPD2345	antispasmodic | inhibit cell division of fertilized starfish eggs
CMNPD2353	ichthyotoxic
CMNPD2354	ichthyotoxic
CMNPD2374	ichthyotoxic
CMNPD2377	inhibit LPS-induced TNF-α production by murine macrophage-like cells in a dose-dependent manner
CMNPD2384	anti-tumour activity against HL-60 cells
CMNPD2398	potent inhibitor of chemically induced inflammation
CMNPD2404	inhibit cell division in fertilized starfish eggs
CMNPD2406	antimicrobial
CMNPD2407	antimicrobial
CMNPD2408	antimicrobial
CMNPD2409	antimicrobial
CMNPD2436	ichthyotoxic | antibacterial | antifungal
CMNPD2437	ichthyotoxic | antibacterial
CMNPD2438	ichthyotoxic | antibacterial | antifungal
CMNPD2439	ichthyotoxic | antibacterial | antifungal
CMNPD2450	toxic
CMNPD2453	mildly cytotoxic
CMNPD2454	mildly cytotoxic
CMNPD2455	mildly cytotoxic
CMNPD2456	mildly cytotoxic
CMNPD2457	mildly cytotoxic
CMNPD2458	mildly cytotoxic
CMNPD2459	mildly cytotoxic
CMNPD2460	mildly cytotoxic
CMNPD2468	cytotoxic
CMNPD2473	potent inhibitor of feeding by fish
CMNPD2479	anti-tumour
CMNPD2480	anti-tumour
CMNPD2481	antifungal
CMNPD2482	antagonist of the ubiquitous calcium-ion-binding protein calmodulin
CMNPD2483	potent antimicrobial | insecticidal | cytotoxic
CMNPD2488	cytotoxic
CMNPD2489	cytotoxic
CMNPD2490	cytotoxic
CMNPD2491	cytotoxic
CMNPD2561	toxin
CMNPD2564	antimicrobial
CMNPD2566	antineoplastic
CMNPD2567	antineoplastic
CMNPD2569	antimicrobial
CMNPD2571	potent tumour promoter
CMNPD2572	plant growth regulator
CMNPD2573	toxic to damselfish | antimicrobial
CMNPD2574	toxic to damselfish | antimicrobial
CMNPD2575	toxic to damselfish | antimicrobial
CMNPD2576	toxic to damselfish | antimicrobial
CMNPD2607	cell division inhibitor
CMNPD2647	significant antiviral
CMNPD2648	significant antiviral
CMNPD2649	significant antiviral
CMNPD2651	cytotoxic
CMNPD2652	cytotoxic
CMNPD2653	cytotoxic
CMNPD2654	cytotoxic
CMNPD2655	cytotoxic
CMNPD2662	neuroexcitatory agent | anthelmintic
CMNPD2687	cytotoxic | inhibit the growth of P388 murine leukaemia and of colon, lung and mammary human tumour cell lines
CMNPD2688	inhibit HIV reverse transcriptase
CMNPD2690	gastric H+/K+-transporting ATPase inhibitor
CMNPD2691	gastric H+/K+-transporting ATPase inhibitor
CMNPD2692	gastric H+/K+-transporting ATPase inhibitor
CMNPD2709	cytotoxic
CMNPD2710	cytotoxic
CMNPD2712	significant antileukaemic
CMNPD2713	significant antileukaemic
CMNPD2714	significant antileukaemic
CMNPD2715	significant antileukaemic
CMNPD2716	significant antileukaemic
CMNPD2717	anti-tumour
CMNPD2719	significant antifungal
CMNPD2722	anti-tumour | antimicrobial.
CMNPD2723	antimicrobial
CMNPD2724	cytotoxic
CMNPD2725	potent antileukaemic agent
CMNPD2726	cytotoxic | antimicrobial
CMNPD2727	cytotoxic | antimicrobial
CMNPD2729	cytotoxic | antimicrobial | anthelmintic
CMNPD2730	cytotoxic | antimicrobial | anthelmintic
CMNPD2731	plant growth regulator
CMNPD2733	antimicrobial
CMNPD2734	antimicrobial
CMNPD2735	antimicrobial
CMNPD2736	antimicrobial
CMNPD2737	antimicrobial
CMNPD2738	mildly toxic to fish
CMNPD2739	mildly toxic to fish
CMNPD2740	mildly toxic to fish
CMNPD2745	antifungal
CMNPD2746	antifungal
CMNPD2747	cytotoxic
CMNPD2748	cytotoxic
CMNPD2750	α-adrenoceptor-blocking agent
CMNPD2754	cytotoxic
CMNPD2758	modest antimicrobial
CMNPD2760	inhibit human immunodeficiency virus (HIV) in vitro
CMNPD2761	antimicrobial
CMNPD2762	antimicrobial
CMNPD2763	antimicrobial
CMNPD2765	antimicrobial
CMNPD2766	antimicrobial
CMNPD2771	toxin
CMNPD2772	toxin
CMNPD2773	toxin
CMNPD2779	inhibit H,K-ATPase | antimicrobial
CMNPD2789	ichthyotoxic | antimalarial
CMNPD2790	ichthyotoxic
CMNPD2793	antibacterial | antifungal
CMNPD2795	antibacterial | antifungal
CMNPD2831	antiviral | cytotoxic
CMNPD2832	antiviral | cytotoxic
CMNPD2833	antiviral | cytotoxic
CMNPD2835	inhibit the growth of Bacillus subtilis, Staphylococcus aureus and Candida albicans
CMNPD2836	inhibit the growth of Bacillus subtilis, Staphylococcus aureus and Candida albicans
CMNPD2837	inhibit the growth of Bacillus subtilis, Staphylococcus aureus and Candida albicans
CMNPD2838	inhibit the growth of Bacillus subtilis, Staphylococcus aureus and Candida albicans
CMNPD2839	inhibit the growth of Bacillus subtilis, Staphylococcus aureus and Candida albicans
CMNPD2840	inhibit the growth of Bacillus subtilis, Staphylococcus aureus and Candida albicans
CMNPD2845	significant antimicrobial
CMNPD2847	significant antimicrobial
CMNPD2853	inhibit cell division of fertilized starfish eggs
CMNPD2856	antiinflammatory
CMNPD2857	antiinflammatory
CMNPD2858	inhibitor of the enzyme phospholipase A2
CMNPD2865	inhibition of aggregation of blood platelets | antimicrobial
CMNPD2866	inhibition of aggregation of blood platelets | antimicrobial
CMNPD2867	inhibition of aggregation of blood platelets | antimicrobial
CMNPD2880	inhibit the activity of Na+/K+-transporting ATPase
CMNPD2883	cytotoxin
CMNPD2940	inhibit larval settlement in the barnacle
CMNPD2954	antitumour | antifungal
CMNPD2955	anti-inflammatory | analgesicory
CMNPD2956	anti-inflammatory | analgesicory
CMNPD2957	anti-inflammatory | analgesicory
CMNPD2958	anti-inflammatory | analgesicory
CMNPD2959	anti-inflammatory | analgesicory
CMNPD2960	anti-inflammatory | analgesicory
CMNPD2961	anti-inflammatory | analgesicory
CMNPD2962	anti-inflammatory | analgesicory
CMNPD2963	inhibit the development of fertilized sea-urchin eggs
CMNPD2964	inhibit the development of fertilized sea-urchin eggs
CMNPD2965	antimicrobial
CMNPD2967	toxic to larvae of tobacco hornworm
CMNPD2973	inhibit larval settlement in the barnacle
CMNPD2974	inhibit larval settlement in the barnacle
CMNPD2976	ichthyotoxic
CMNPD2977	ichthyotoxic | cytotoxic
CMNPD2980	antiviral
CMNPD2982	antioxidant
CMNPD3001	lyso-platelet-activating factor, inhibit ascidian, barnacle, bryozoan and algal settling
CMNPD3007	inhibit the growth of 3T3 and CEF cell lines
CMNPD3020	antineoplastic
CMNPD3021	antineoplastic
CMNPD3022	antineoplastic
CMNPD3023	antineoplastic
CMNPD3024	antineoplastic
CMNPD3025	toxin
CMNPD3028	cytotoxic
CMNPD3029	cytotoxin
CMNPD3057	cytotoxic
CMNPD3058	antineoplastic
CMNPD3063	antineoplastic | calmodulinantagonistic
CMNPD3064	antineoplastic | calmodulinantagonistic
CMNPD3065	anti-tumour
CMNPD3066	anti-tumour | antimicrobial | cytotoxic
CMNPD3067	cytotoxic
CMNPD3068	cytotoxic | antimicrobial
CMNPD3078	cytotoxic
CMNPD3086	cytotoxic | immunosuppressive
CMNPD3088	antineoplastic
CMNPD3135	activity against P388 in vitro
CMNPD3137	juvenile hormone
CMNPD3139	boxfish toxin
CMNPD3143	toxin
CMNPD3144	antifungal
CMNPD3145	potent antineoplastic
CMNPD3146	activator of sarcoplasmic reticulum Ca2+-ATPase
CMNPD3147	cytotoxic
CMNPD3148	cytotoxic
CMNPD3150	fish-feeding inhibitor
CMNPD3151	fish-feeding inhibitor
CMNPD3152	spermatozoid-releasing and attracting factor
CMNPD3160	cytotoxin
CMNPD3161	cytotoxin | inhibit microtubule polymerization
CMNPD3166	antitumour
CMNPD3167	antitumour
CMNPD3168	antitumour
CMNPD3169	antitumour
CMNPD3170	antimicrobial
CMNPD3178	inhibit feeding by young abalone
CMNPD3185	inhibit both 5-lipoxygenase and Na+/K+ATPase
CMNPD3186	potent inhibitor of platelet aggregation
CMNPD3241	active against the intestinal protozoan Giardia
CMNPD3244	cytotoxic
CMNPD3245	cytotoxin
CMNPD3246	cytotoxin
CMNPD3247	cytotoxin
CMNPD3248	cytotoxic
CMNPD3249	cytotoxic
CMNPD3255	antiviral
CMNPD3262	anthelmintic
CMNPD3263	anthelmintic
CMNPD3264	anthelmintic
CMNPD3265	antifungal
CMNPD3269	cytotoxic
CMNPD3271	cytotoxic
CMNPD3272	cytotoxic
CMNPD3273	cytotoxic
CMNPD3277	in vitro activity against P388 cells and against human lung, colonand mammary cancer cell lines
CMNPD3278	antiviral | antitumour
CMNPD3282	strong contractile activity in the guinea-pig ileum assay
CMNPD3283	strong contractile activity in the guinea-pig ileum assay
CMNPD3284	strong contractile activity in the guinea-pig ileum assay
CMNPD3286	antimicrobial
CMNPD3287	cytotoxic
CMNPD3288	antimicrobial | cytotoxic
CMNPD3290	antitumour | antiviral | immunomodulatory properties in vitro and in vivo antitumour activity
CMNPD3291	potent antineoplastic
CMNPD3292	potent antineoplastic
CMNPD3293	potent antineoplastic
CMNPD3294	cytotoxic
CMNPD3295	cytotoxic
CMNPD3296	cytotoxic
CMNPD3297	cytotoxic | antitumor
CMNPD3298	cytotoxic
CMNPD3299	cytotoxic | antimicrobial
CMNPD3300	in vitro activity against L1210 leukaemia cells | potent coronary vasodilating activity
CMNPD3301	in vitro activity against L1210 leukaemia cells | potent coronary vasodilating activity
CMNPD3306	mildly cytotoxic
CMNPD3308	H, K-ATPase inhibitor
CMNPD3316	inhibit H,K-ATPase
CMNPD3352	antiviral
CMNPD3353	antiviral
CMNPD3354	cytotoxic
CMNPD3355	cytotoxic
CMNPD3368	antibacterial
CMNPD3371	cytotoxic
CMNPD3372	antiinflammatory
CMNPD3374	aldose reductase inhibitor
CMNPD3375	acetyl cholinesterase inhibitor
CMNPD3376	antimicrobial | anti-inflammatory
CMNPD3377	antimicrobial | anti-inflammatory
CMNPD3378	antimicrobial | anti-inflammatory
CMNPD3379	antimicrobial | anti-inflammatory
CMNPD3380	antimicrobial | anti-inflammatory
CMNPD3381	antimicrobial | anti-inflammatory
CMNPD3387	ichthyotoxic | cytotoxic
CMNPD3388	ichthyotoxic | cytotoxic
CMNPD3389	ichthyotoxic | cytotoxic
CMNPD3397	potent antileukemic
CMNPD3399	barnacle hatching factor
CMNPD3401	antiproliferative
CMNPD3418	potent antitumour-promoter
CMNPD3419	cytotoxic
CMNPD3420	cytotoxic
CMNPD3428	cytotoxic
CMNPD3429	cytotoxic
CMNPD3430	cytotoxic
CMNPD3432	cytotoxic
CMNPD3433	cytotoxic
CMNPD3435	inhibit insect growth in the silkworm Bombyx mori
CMNPD3436	inhibit insect growth in the silkworm Bombyx mori
CMNPD3437	inhibit insect growth in the silkworm Bombyx mori
CMNPD3448	cytotoxic
CMNPD3449	cytotoxic
CMNPD3453	antiviral | anti-inflammatory
CMNPD3456	antiviral | anti-inflammatory
CMNPD3457	antiviral | anti-inflammatory
CMNPD3458	anti-inflammatory
CMNPD3463	cytotoxic | antiviral
CMNPD3514	inhibitor of eukaryotic DNA polymerase α
CMNPD3515	ichthyotoxic
CMNPD3516	ichthyotoxic
CMNPD3525	ichthyotoxic
CMNPD3526	ichthyotoxic
CMNPD3534	cytotoxic
CMNPD3535	cytotoxic
CMNPD3536	cytotoxic
CMNPD3537	cytotoxic
CMNPD3538	cytotoxin
CMNPD3539	cytotoxin
CMNPD3540	cytotoxin
CMNPD3541	cytotoxic
CMNPD3542	cytotoxic
CMNPD3543	cytotoxic
CMNPD3547	cytotoxic | antiviraland immunosuppressive agent
CMNPD3548	cytotoxic | antiviraland immunosuppressive agent
CMNPD3549	cytotoxic | antiviraland immunosuppressive agent
CMNPD3550	cytotoxic | antiviraland immunosuppressive agent
CMNPD3551	cytotoxic | antiviraland immunosuppressive agent
CMNPD3553	antiviral
CMNPD3561	cytotoxic
CMNPD3562	cytotoxic
CMNPD3563	potent antineoplastic
CMNPD3564	potent antineoplastic
CMNPD3565	potent antineoplastic
CMNPD3601	inhibit growth of the pathogenic fungus Lagenidium callinectes
CMNPD3602	significant antiviral
CMNPD3623	mod. inhib. NO prod.
CMNPD3628	toxin
CMNPD3636	potent sarcoplasmic reticulum Ca-releasing activity
CMNPD3638	cytotoxic | phytotoxic
CMNPD3639	cytotoxic | phytotoxic
CMNPD3640	cytotoxic | phytotoxic
CMNPD3641	inhibit the activity of 3-hydroxy-3-methylglutaryl coenzyme A (HMG-CoA) reductase
CMNPD3642	antimutagenic
CMNPD3643	antimutagenic
CMNPD3647	feeding-inhibition
CMNPD3648	feeding-inhibition
CMNPD3650	feeding deterrent activity against the abalone Haliotis discus hannai
CMNPD3651	feeding deterrent activity against the abalone Haliotis discus hannai
CMNPD3655	cytotoxic
CMNPD3666	antiplasmin inhibitor
CMNPD3667	antiplasmin inhibitor
CMNPD3668	antiplasmin inhibitor
CMNPD3673	antimicrobial
CMNPD3696	insecticidal
CMNPD3697	insecticidal
CMNPD3714	cytotoxicity
CMNPD3715	cytotoxicity
CMNPD3716	cytotoxicity
CMNPD3737	antibacterial
CMNPD3740	antifungal
CMNPD3741	antifungal
CMNPD3742	antimicrobial
CMNPD3747	potent sarcoplasmic reticulum Ca2+-ATPase activator
CMNPD3748	cytotoxic in the brine shrimp Artemia salina and fertilized sea-urchin egg assays
CMNPD3749	cytotoxic in the brine shrimp Artemia salina and fertilized sea-urchin egg assays
CMNPD3750	cytotoxic in the brine shrimp Artemia salina and fertilized sea-urchin egg assays
CMNPD3751	cytotoxic in the brine shrimp Artemia salina and fertilized sea-urchin egg assays
CMNPD3752	cytotoxin
CMNPD3753	toxin | ichthyotoxic
CMNPD3756	antifungal | cytotoxic
CMNPD3757	antifungal | cytotoxic
CMNPD3758	antifungal | cytotoxic
CMNPD3759	cytotoxic
CMNPD3764	cytotoxic | inhibit the growth of L1210 and P388 leukaemia cells in vitro and active in the sea-urchin cell division assay
CMNPD3765	cytotoxic | inhibit the growth of L1210 and P388 leukaemia cells in vitro and active in the sea-urchin cell division assay
CMNPD3773	toxic
CMNPD3774	toxic
CMNPD3775	toxic
CMNPD3776	antitumour | antiviral | antifungal
CMNPD3777	antimicrobial
CMNPD3778	antimicrobial
CMNPD3779	antimicrobial
CMNPD3780	antimicrobial
CMNPD3781	antimicrobial
CMNPD3782	antimicrobial
CMNPD3786	antifungal | cytotoxicity
CMNPD3787	antifungal
CMNPD3788	cytotoxic
CMNPD3789	cytotoxic
CMNPD3790	cytotoxic | antifungal
CMNPD3792	anthelmintic
CMNPD3795	anthelmintic
CMNPD3798	stimulate antibiotic production | potent inhibitor of the pathogenic marine bacterium Listonella anguillara
CMNPD3812	antitumour
CMNPD3817	cytotoxic
CMNPD3818	cytotoxic
CMNPD3830	cytotoxic
CMNPD3831	toxicity in the brine shrimp assay
CMNPD3849	bind to the human leukotriene B4 receptor
CMNPD3852	ichthyotoxic
CMNPD3864	antiviral
CMNPD3865	antimicrobiol
CMNPD3870	antifungal
CMNPD3871	inhibit the hydrolysis of phosphatidylcholine by bee-venom phospholipase A2
CMNPD3874	cytotoxicity | anti-thrombocyte activity | vasodilative activity
CMNPD3884	antitumour | antifungal
CMNPD3891	potent immunosuppressive activity
CMNPD3892	cytotoxic
CMNPD3909	inhibit biofilm formation by P. aeruginosa, Vibrio harveyi and S. aureus | interfere with quorum sensing in Chromobacterium violaceum without affecting organism growth
CMNPD3928	cytotoxic
CMNPD3929	cytotoxic
CMNPD3930	anti-inflammatory
CMNPD3935	cytotoxic
CMNPD3936	cytotoxic
CMNPD3937	cytotoxic
CMNPD3938	cytotoxic
CMNPD3948	inhibit cell division in fertilized starfish eggs
CMNPD3949	inhibit cell division in fertilized starfish eggs
CMNPD3958	significant anti-inflammatory
CMNPD3959	significant anti-inflammatory
CMNPD3960	significant anti-inflammatory
CMNPD3961	significant anti-inflammatory | IA vs 4 HTCLs.
CMNPD3962	significant anti-inflammatory
CMNPD3981	antileukaemic
CMNPD3982	antileukaemic
CMNPD3983	inhibit cell division in fertilized starfish eggs
CMNPD3996	antifungal | molluscicidal | toxicity to brine shrimp
CMNPD4007	tumour promoter
CMNPD4012	antineoplastic agent
CMNPD4014	antifertility agent
CMNPD4015	antifertility agent
CMNPD4016	antifertility agent
CMNPD4018	potential alarm pheromone
CMNPD4019	potential alarm pheromone
CMNPD4020	antitumour
CMNPD4034	causative agent
CMNPD4035	toxic
CMNPD4036	anti-inflammatory
CMNPD4037	anti-inflammatory
CMNPD4038	anti-inflammatory
CMNPD4043	cytotoxic
CMNPD4044	cytotoxic
CMNPD4045	cytotoxic | antimicrobial
CMNPD4046	antifungal
CMNPD4054	cytotoxic
CMNPD4055	cytotoxic
CMNPD4056	cytotoxic
CMNPD4057	cytotoxic against the KB cell line
CMNPD4059	cytotoxic
CMNPD4060	cytotoxic
CMNPD4061	cytotoxic
CMNPD4098	antifungal
CMNPD4099	antifungal
CMNPD4100	antifungal
CMNPD4102	inhibit the growth of P388 lymphocytic leukemia cells
CMNPD4103	inhibit the growth of P388 lymphocytic leukemia cells
CMNPD4106	toxin
CMNPD4117	shellfish poisoning
CMNPD4118	shellfish poisoning
CMNPD4119	anthelmintic
CMNPD4120	antileukaemic
CMNPD4124	antileukaemic | Ca2+ ATPase activator
CMNPD4127	antibacterial | antimycotic
CMNPD4128	antibacterial | antimycotic
CMNPD4129	antibacterial | antimycotic
CMNPD4130	antibacterial | antimycotic
CMNPD4138	hepatotoxic
CMNPD4141	cytokynin
CMNPD4170	cytotoxic
CMNPD4171	cytotoxic
CMNPD4172	cytotoxic
CMNPD4188	inhibitor of mitotic cell division
CMNPD4189	cytotoxin
CMNPD4190	anti-plasmin inhibitor
CMNPD4197	aldose reductase inhibitor
CMNPD4198	aldose reductase inhibitor
CMNPD4205	antifungal | molluscicidal | toxicity to brine shrimp
CMNPD4222	plant growth regulator
CMNPD4224	growth stimulation in lettuce and rice seedlings
CMNPD4228	anthelmintic
CMNPD4229	anthelmintic
CMNPD4230	anthelmintic
CMNPD4244	cytotoxic | antifungal
CMNPD4245	cytotoxic | antifungal
CMNPD4246	in vitro immunosuppressive | antitumour
CMNPD4247	in vitro immunosuppressive | antitumour
CMNPD4248	in vitro immunosuppressive | antitumour
CMNPD4249	in vitro immunosuppressive | antitumour
CMNPD4250	in vitro immunosuppressive | antitumour
CMNPD4256	potent cytotoxic
CMNPD4257	cytotoxic
CMNPD4258	cytotoxic
CMNPD4259	cytotoxic
CMNPD4260	cytotoxic
CMNPD4261	cytotoxic | antifungal
CMNPD4266	potent antineoplastic
CMNPD4267	potent antineoplastic
CMNPD4268	potent antineoplastic
CMNPD4269	potent antineoplastic
CMNPD4273	cytotoxicity against KB cells
CMNPD4277	antifungal
CMNPD4280	ichthyotoxic
CMNPD4281	ichthyotoxic
CMNPD4282	ichthyotoxic
CMNPD4283	ichthyotoxic
CMNPD4284	ichthyotoxic
CMNPD4285	ichthyotoxic
CMNPD4286	ichthyotoxic
CMNPD4287	ichthyotoxic
CMNPD4288	cytotoxic | antifungal
CMNPD4289	cytotoxic | antifungal
CMNPD4290	cytotoxic | antifungal
CMNPD4291	cytotoxic | antifungal
CMNPD4292	cytotoxic | antifungal
CMNPD4293	potent thrombin inhibitor
CMNPD4294	potent thrombin inhibitor
CMNPD4295	cytotoxic
CMNPD4296	potent calcium-releasing activity in sarcoplasmic reticulum
CMNPD4299	cytotoxic | significant ichthyodeterrent
CMNPD4300	cytotoxic | significant ichthyodeterrent
CMNPD4301	cytotoxic | significant ichthyodeterrent
CMNPD4304	significant cytotoxicity in the L1210 assay
CMNPD4306	cytotoxin
CMNPD4313	anthelmintic
CMNPD4314	anthelmintic
CMNPD4315	cytotoxicity
CMNPD4316	cytotoxic
CMNPD4318	potent actomyosin ATPase activator
CMNPD4319	potent actomyosin ATPase activator
CMNPD4320	potent actomyosin ATPase activator
CMNPD4321	antimicrobial | inhibit Na+/K+ ATPase
CMNPD4322	antimicrobial | inhibit Na+/K+ ATPase
CMNPD4326	cytotoxic | antiinflammatory
CMNPD4327	cytotoxic | antiinflammatory
CMNPD4331	cytotoxic | antiinflammatory
CMNPD4332	cytotoxic
CMNPD4352	cytotoxic
CMNPD4358	cardiotonic
CMNPD4372	antimicrobial
CMNPD4383	cytotoxic
CMNPD4384	cytotoxic
CMNPD4385	potent antiviral agent
CMNPD4394	cytotoxic
CMNPD4395	cytotoxic
CMNPD4419	inhibit cell division of fertilized starfish eggs
CMNPD4423	ichthyotoxic | antimicrobial
CMNPD4424	ichthyotoxic | antimicrobial
CMNPD4425	ichthyotoxic | antimicrobial
CMNPD4426	ichthyotoxic | antimicrobial
CMNPD4429	in vitro cytotoxicity against L1210 cells
CMNPD4430	in vitro cytotoxicity against L1210 cells
CMNPD4431	cytokynin
CMNPD4454	cardiotoxic
CMNPD4467	platelet aggregation factor (PAF) antagonist
CMNPD4470	toxic to brine shrimp
CMNPD4504	cytotoxic
CMNPD4507	steatotic | cytotoxic
CMNPD4513	activate the enzyme phospholipase A2
CMNPD4514	cytotoxic
CMNPD4515	cytotoxic
CMNPD4516	cytotoxic
CMNPD4519	cytostatic
CMNPD4520	minor cytotoxic, inhibitor of HIV-1 integrase
CMNPD4523	ichthyotoxic
CMNPD4524	ichthyotoxic
CMNPD4525	ichthyotoxic
CMNPD4526	ichthyotoxic
CMNPD4527	ichthyotoxic
CMNPD4531	chthyotoxic
CMNPD4532	chthyotoxic
CMNPD4538	cytotoxic
CMNPD4539	ichthyodeterrent
CMNPD4540	ichthyodeterrent
CMNPD4543	insecticidal activity and cytotoxicity
CMNPD4544	insecticidal activity and cytotoxicity
CMNPD4548	antioxidative
CMNPD4550	antimicrobial
CMNPD4551	antifungal
CMNPD4552	antifungal
CMNPD4553	antifungal
CMNPD4554	antifungal
CMNPD4555	antifungal
CMNPD4560	antiviral
CMNPD4563	calmodulin antagonist activity
CMNPD4568	antitumour activity
CMNPD4569	antitumour activity
CMNPD4570	antitumour activity
CMNPD4571	antitumour activity
CMNPD4572	antitumour activity
CMNPD4573	antitumour activity
CMNPD4577	antimicrobial, inhibit the growth of fish RNA viruses and marine bacteria
CMNPD4579	cytotoxic | immunosuppressive
CMNPD4580	cytotoxic | immunosuppressive
CMNPD4611	cytotoxic
CMNPD4612	cytotoxic
CMNPD4613	cytotoxic and antifungal
CMNPD4628	antifungal
CMNPD4631	cytotoxicity, antifungal, and antiprotozoal activities
CMNPD4632	cytotoxicity, antifungal, and antiprotozoal activities
CMNPD4633	cytotoxicity, antifungal, and antiprotozoal activities
CMNPD4634	cytotoxicity, antifungal, and antiprotozoal activities
CMNPD4635	cytotoxicity, antifungal, and antiprotozoal activities
CMNPD4636	cytotoxicity, antifungal, and antiprotozoal activities
CMNPD4642	antimicrobial
CMNPD4647	cytotoxic
CMNPD4648	cytotoxic
CMNPD4659	PAF (platelet activating factor) antagonist
CMNPD4660	cytotoxic
CMNPD4661	cytotoxic
CMNPD4662	cytotoxic
CMNPD4663	cytotoxic
CMNPD4664	cytotoxic
CMNPD4665	cytotoxic
CMNPD4666	toxin
CMNPD4667	antifungal
CMNPD4670	inhibit the development of fertilized echinoderm eggs
CMNPD4673	antiviral
CMNPD4680	pollen germination and growth inhibitor
CMNPD4722	cytotoxic
CMNPD4728	cytotoxic
CMNPD4773	insecticidal | acaricidal
CMNPD4774	insecticidal | acaricidal
CMNPD4775	insecticidal | acaricidal
CMNPD4776	insecticidal | acaricidal
CMNPD4800	potent actomyosin ATPase activator
CMNPD4801	potent actomyosin ATPase activator
CMNPD4802	inhibit histidine decarboxylase
CMNPD4806	significant anti-inflammatory
CMNPD4807	significant anti-inflammatory
CMNPD4808	significant anti-inflammatory
CMNPD4827	cytotoxic
CMNPD4828	cytotoxic
CMNPD4829	cytotoxic
CMNPD4830	cytotoxic
CMNPD4831	cytotoxic
CMNPD4832	cytotoxic
CMNPD4833	cytotoxic
CMNPD4834	cytotoxic
CMNPD4835	cytotoxic
CMNPD4836	cytotoxic
CMNPD4837	cytotoxic
CMNPD4838	cytotoxic
CMNPD4839	antifungal | cytotoxic
CMNPD4840	inhibitor of protein phosphatases 1 and 2A
CMNPD4841	inhibitor of protein phosphatases 1 and 2A
CMNPD4842	inhibitor of protein phosphatases 1 and 2A
CMNPD4843	inhibitor of protein phosphatases 1 and 2A
CMNPD4844	potent cytotoxin
CMNPD4845	cytotoxic
CMNPD4846	cytotoxic
CMNPD4847	antiviral | peripheral analgesic
CMNPD4851	cytotoxin
CMNPD4852	cytotoxin
CMNPD4854	thrombin-inhibitory
CMNPD4855	cytotoxic
CMNPD4856	calmodulin antagonist
CMNPD4879	anti-tumour agent
CMNPD4880	potent actomyosin ATPase activator
CMNPD4891	antimicrobial | genotoxicity | cytotoxicity in the E. coli PQ37 SOS chromotest
CMNPD4895	antimicrobial | mild tyrosine kinase inhibition
CMNPD4897	cytotoxic
CMNPD4898	antimicrobial
CMNPD4899	antifungal | antineoplastic
CMNPD4906	cytotoxic
CMNPD4907	cytotoxicity | antifungal
CMNPD4908	cytotoxicity | antifungal
CMNPD4909	cytotoxicity | antifungal
CMNPD4918	in vivo anti-inflammatory
CMNPD4926	antitumor
CMNPD4927	antiviral | cytotoxic
CMNPD4928	antiviral | cytotoxic
CMNPD4929	antiviral | cytotoxic
CMNPD4930	antiviral | cytotoxic
CMNPD4933	antimicrobial
CMNPD4934	antimicrobial
CMNPD4935	antimicrobial
CMNPD4937	antimicrobial
CMNPD4939	cytotoxicity | antimicrobial | anti-HIV- 1 reverse transcriptase activities
CMNPD4940	cytotoxicity | antimicrobial | anti-HIV- 1 reverse transcriptase activities
CMNPD4941	cytotoxicity | antimicrobial | anti-HIV- 1 reverse transcriptase activities
CMNPD4942	cytotoxicity | antimicrobial | anti-HIV- 1 reverse transcriptase activities
CMNPD4943	cytotoxicity | antimicrobial | anti-HIV- 1 reverse transcriptase activities
CMNPD4944	cytotoxicity | antimicrobial | anti-HIV- 1 reverse transcriptase activities
CMNPD4945	in vitro cytotoxicity | antiviral
CMNPD4946	antimicrobial | cytotoxic
CMNPD4947	antiviral agent
CMNPD4964	antiparasitic
CMNPD5003	anti-inflammatory
CMNPD5013	cytotoxicity against the P-388 cell line
CMNPD5017	aldose reductase inhibitor
CMNPD5018	mildly cytotoxic
CMNPD5019	mildly cytotoxic
CMNPD5020	antineoplastic
CMNPD5021	antineoplastic
CMNPD5022	antineoplastic
CMNPD5023	antineoplastic
CMNPD5024	antineoplastic
CMNPD5025	antineoplastic
CMNPD5036	antiviral
CMNPD5037	antiviral
CMNPD5038	antiviral
CMNPD5039	antiviral
CMNPD5040	antiviral
CMNPD5060	antifouling activity
CMNPD5083	inhibit insect growth
CMNPD5084	inhibit insect growth
CMNPD5101	anti-inflammatory | inhibit chemically-induced inflammation in the mouse ear assay
CMNPD5102	anti-inflammatory | inhibit chemically-induced inflammation in the mouse ear assay | inhibit leukotriene synthesis
CMNPD5103	anti-inflammatory
CMNPD5104	anti-inflammatory
CMNPD5113	anti-inflammatory
CMNPD5114	anti-inflammatory
CMNPD5115	anti-inflammatory
CMNPD5116	anti-inflammatory
CMNPD5117	anti-inflammatory
CMNPD5122	anti-inflammatory
CMNPD5133	toxic to brine shrimp
CMNPD5134	toxic to brine shrimp
CMNPD5135	cytotoxic
CMNPD5150	cytotoxic
CMNPD5152	cytostatic
CMNPD5157	cytotoxic
CMNPD5160	mildly active against the P-388 cell line
CMNPD5165	antineoplastic
CMNPD5172	ichthyotoxic
CMNPD5173	ichthyotoxic
CMNPD5174	ichthyotoxic
CMNPD5175	ichthyotoxic
CMNPD5176	ichthyotoxic
CMNPD5177	ichthyotoxic
CMNPD5178	ichthyotoxic
CMNPD5209	inhibit 5- and 15-lipoxygenases | bind weakly to leukotriene B4 receptors
CMNPD5210	inhibit 5- and 15-lipoxygenases | bind weakly to leukotriene B4 receptors
CMNPD5211	cytotoxic | antifungal
CMNPD5212	cytotoxic | antifungal
CMNPD5213	cytotoxic | antifungal
CMNPD5214	cytotoxic | antifungal
CMNPD5215	antineoplastic
CMNPD5216	antineoplastic
CMNPD5217	antimicrobial
CMNPD5218	cytotoxic
CMNPD5221	antimicrobial
CMNPD5222	antimicrobial
CMNPD5223	antimicrobial
CMNPD5224	antimicrobial
CMNPD5225	antimicrobial
CMNPD5226	antimicrobial
CMNPD5227	antimicrobial
CMNPD5228	antimicrobial
CMNPD5232	ichthyodeterrent
CMNPD5236	cytotoxic
CMNPD5237	cytotoxic
CMNPD5238	cytotoxic
CMNPD5239	cytotoxic
CMNPD5240	cytotoxic
CMNPD5241	cytotoxic
CMNPD5242	cytotoxic | antifungal
CMNPD5244	cytotoxic
CMNPD5248	antimicrobial | cytotoxic
CMNPD5249	antimicrobial | cytotoxic
CMNPD5252	cytotoxic
CMNPD5253	cytotoxic
CMNPD5257	cytotoxic
CMNPD5258	HIV-1 protease inhibitor
CMNPD5259	HIV-1 protease inhibitor
CMNPD5268	cytotoxic
CMNPD5300	antiviral | cytotoxic
CMNPD5301	antiviral | cytotoxic
CMNPD5302	antiviral | cytotoxic
CMNPD5303	antimicrobial
CMNPD5304	antimicrobial
CMNPD5306	antibiotic
CMNPD5307	antibiotic
CMNPD5308	moderate antimicrobial
CMNPD5309	moderate antimicrobial
CMNPD5310	moderate antimicrobial
CMNPD5311	moderate antimicrobial
CMNPD5313	mildly cytotoxic
CMNPD5314	mildly cytotoxic
CMNPD5315	mildly cytotoxic
CMNPD5316	toxin
CMNPD5317	toxin
CMNPD5321	potent antifungal
CMNPD5322	potent antifungal
CMNPD5323	potent antifungal
CMNPD5324	potent antifungal
CMNPD5332	immunosuppressive
CMNPD5333	immunosuppressive
CMNPD5334	toxic
CMNPD5336	provide in vivo protection against Semeliki Forest Virus (SFV) in mouse
CMNPD5337	fish feeding inhibitor
CMNPD5349	cytokinin
CMNPD5361	cytotoxic
CMNPD5362	cytotoxic
CMNPD5363	cytotoxic
CMNPD5370	insecticidal properties
CMNPD5388	cytotoxicity | antitumour
CMNPD5403	antimicrobial
CMNPD5404	antimicrobial | inhibited Na+/K+-ATPase
CMNPD5405	inhibit the activity of HIV-1 protease
CMNPD5406	inhibit the activity of HIV-1 protease
CMNPD5407	inhibit the activity of HIV-1 protease
CMNPD5408	inhibit the activity of HIV-1 protease
CMNPD5409	inhibit the activity of HIV-1 protease
CMNPD5410	inhibit the activity of HIV-1 protease
CMNPD5411	toxic in the brine shrimp assay
CMNPD5412	toxic in the brine shrimp assay
CMNPD5413	toxic in the brine shrimp assay
CMNPD5414	toxic in the brine shrimp assay
CMNPD5416	cytotoxic
CMNPD5425	weakly cytotoxic
CMNPD5426	cytotoxic
CMNPD5427	cytotoxic
CMNPD5428	cytotoxic
CMNPD5429	cytotoxic
CMNPD5430	cytotoxic
CMNPD5431	cytotoxic
CMNPD5432	cytotoxic
CMNPD5433	cytotoxic
CMNPD5434	cytotoxic
CMNPD5435	cytotoxic
CMNPD5436	cytotoxic
CMNPD5437	cytotoxic
CMNPD5438	cytotoxic
CMNPD5439	ichthyotoxic
CMNPD5440	ichthyotoxic
CMNPD5441	antibacterial | cytotoxic | antiplasmodial activity against chloroquine-resistant Plasmodium falciparum
CMNPD5442	antibacterial | cytotoxic
CMNPD5449	antitumour agent
CMNPD5450	antitumour agent
CMNPD5452	potent protein phosphatase inhibitor
CMNPD5454	cytotoxic
CMNPD5455	cytotoxic
CMNPD5456	cytotoxic
CMNPD5457	cytotoxic
CMNPD5458	cytotoxic
CMNPD5460	cytotoxic
CMNPD5461	potent thrombin inhibitor
CMNPD5462	thrombin-inhibitory
CMNPD5463	cytotoxic
CMNPD5464	cytotoxic
CMNPD5465	cytotoxic
CMNPD5466	cytotoxic | antimicrobial
CMNPD5467	cytotoxic | antimicrobial
CMNPD5468	cytotoxic | antimicrobial
CMNPD5469	cytotoxic | antimicrobial
CMNPD5470	ichthyotoxic | cytotoxic
CMNPD5471	ichthyotoxic | cytotoxic
CMNPD5473	cytotoxic
CMNPD5474	cytotoxic
CMNPD5475	cytotoxic
CMNPD5476	cytotoxic
CMNPD5477	cytotoxic
CMNPD5478	antimicrobial | cytotoxic
CMNPD5487	antimicrobial | cytotoxic
CMNPD5491	cytotoxic
CMNPD5492	antiviral
CMNPD5493	antiviral
CMNPD5494	cytotoxic
CMNPD5500	antimicrobial
CMNPD5504	cause the differentiation of K562 leukemia cells into erythrocytes
CMNPD5513	cytotoxic
CMNPD5514	cytotoxin
CMNPD5515	cytotoxin
CMNPD5516	cytotoxin
CMNPD5517	cytotoxin
CMNPD5518	cytotoxin
CMNPD5520	protein tyrosine kinase inhibitory activity
CMNPD5522	Na+/K+-ATPase inhibitor
CMNPD5523	Na+/K+-ATPase inhibitor
CMNPD5524	Na+/K+-ATPase inhibitor
CMNPD5525	Na+/K+-ATPase inhibitor
CMNPD5526	Na+/K+-ATPase inhibitor
CMNPD5527	Na+/K+-ATPase inhibitor
CMNPD5529	antifungal
CMNPD5530	antifungal
CMNPD5545	cytotoxic
CMNPD5546	cytotoxic
CMNPD5547	cytotoxic
CMNPD5548	cytotoxic
CMNPD5553	cytotoxic
CMNPD5556	toxic to brine shrimp
CMNPD5557	toxic to brine shrimp
CMNPD5558	toxic to brine shrimp
CMNPD5559	toxic to brine shrimp
CMNPD5560	cytotoxic
CMNPD5561	cytotoxic
CMNPD5562	cytotoxic
CMNPD5564	antileukaemic
CMNPD5572	Ca2+-ATPase activator
CMNPD5577	antibacterial
CMNPD5578	antibacterial
CMNPD5579	antibacterial
CMNPD5580	antibacterial
CMNPD5581	cytotoxic
CMNPD5582	cytotoxic
CMNPD5583	cytotoxic
CMNPD5584	cytotoxic
CMNPD5585	cytotoxic
CMNPD5616	ichthyotoxic | fish feeding inhibitor
CMNPD5630	moderate cytotoxicity against KB cells
CMNPD5631	moderate cytotoxicity against KB cells
CMNPD5635	inhibit the release of anti-IgE induced histamine release from rat peritoneal mast cells
CMNPD5636	inhibit the release of anti-IgE induced histamine release from rat peritoneal mast cells
CMNPD5652	inhibit the anti-IgE-induced release of histamine from rat mast cells
CMNPD5653	inhibit the anti-IgE-induced release of histamine from rat mast cells
CMNPD5654	cytotoxic
CMNPD5655	cytotoxic
CMNPD5658	antifungal | antithrombin
CMNPD5659	antifungal | antithrombin
CMNPD5660	antifungal | antithrombin
CMNPD5661	antifungal | antithrombin
CMNPD5662	antifungal | antithrombin
CMNPD5664	toxic
CMNPD5665	toxic
CMNPD5666	toxic
CMNPD5667	antifungal | cytotoxic
CMNPD5668	antifungal | cytotoxic
CMNPD5669	antifungal | cytotoxic
CMNPD5670	inhibitor of cell division in the fertilized sea-urchin egg assay
CMNPD5683	cytotoxic
CMNPD5706	toxic
CMNPD5707	toxic
CMNPD5710	cytotoxic to P388 murine leukaemia cells
CMNPD5712	cytotoxic to P388 murine leukaemia cells
CMNPD5729	cytotoxic to P388 murine leukaemia cells
CMNPD5744	lethal to brine shrimp
CMNPD5745	lethal to brine shrimp
CMNPD5746	lethal to brine shrimp
CMNPD5747	lethal to brine shrimp
CMNPD5775	cytotoxic
CMNPD5784	cytotoxic
CMNPD5785	cytotoxic
CMNPD5786	cytotoxic
CMNPD5787	fish feeding deterrent
CMNPD5790	ichthyotoxic
CMNPD5791	ichthyotoxic
CMNPD5792	antioxidant
CMNPD5794	antineoplastic
CMNPD5795	anti-microbial
CMNPD5796	anti-microbial
CMNPD5797	anti-microbial
CMNPD5798	anti-microbial
CMNPD5799	anti-microbial
CMNPD5800	anti-microbial
CMNPD5801	cytotoxic
CMNPD5803	cytotoxic protein kinase C inhibitor
CMNPD5806	cytotoxic
CMNPD5807	cytotoxic
CMNPD5808	cytotoxic
CMNPD5809	cytotoxic
CMNPD5812	cytotoxic
CMNPD5814	central nervous system depressant
CMNPD5845	ichthyotoxic
CMNPD5846	cytotoxin
CMNPD5847	cytotoxin
CMNPD5848	cytotoxin
CMNPD5852	cytotoxic against KB and LoVo cells | exhibit antiviral activity against HSV-1
CMNPD5853	cytotoxic against KB and LoVo cells | exhibit antiviral activity against HSV-1
CMNPD5856	antimicrobial | antibiotic
CMNPD5857	antimycin | antibiotic
CMNPD5858	antimycin | antibiotic
CMNPD5859	exceptional affinity for ferric ion
CMNPD5860	exceptional affinity for ferric ion
CMNPD5861	cytotoxic
CMNPD5862	cytotoxic
CMNPD5864	important in controlling the growth of potential competitors
CMNPD5865	important in controlling the growth of potential competitors
CMNPD5866	cause amnesic shellfish poisoning
CMNPD5867	cause amnesic shellfish poisoning
CMNPD5869	cytotoxic
CMNPD5870	cytotoxic
CMNPD5871	toxin
CMNPD5872	toxin
CMNPD5873	toxin
CMNPD5889	cytotoxic | antiviral | antifungal
CMNPD5892	deter fish feeding
CMNPD5893	deter fish feeding
CMNPD5896	prevent fouling
CMNPD5911	cytotoxic
CMNPD5915	inhibit cell division in fertilized sea urchin eggs
CMNPD5927	possible vasopressin VI receptor antagonist
CMNPD5928	cytotoxic
CMNPD5934	causative agent of an outbreak of human illness and death
CMNPD5972	toxic to the aphid Schizuphis graminum
CMNPD5981	antitumour | immunostimulatory
CMNPD5982	antitumour | immunostimulatory
CMNPD5983	antitumour | immunostimulatory
CMNPD5984	antitumour | immunostimulatory
CMNPD6007	antimicrobial
CMNPD6008	antimicrobial
CMNPD6009	block the interleukin-6 receptor
CMNPD6010	inhibit thombin
CMNPD6011	inhibit thombin
CMNPD6012	inhibit thombin
CMNPD6013	inhibit thombin
CMNPD6014	inhibit HIV reverse transcriptase
CMNPD6022	antifungal
CMNPD6023	antifungal
CMNPD6024	antifungal
CMNPD6025	antifungal
CMNPD6026	antifungal
CMNPD6027	antifungal
CMNPD6028	antifungal
CMNPD6029	antifungal
CMNPD6030	antifungal
CMNPD6031	antifungal
CMNPD6034	inhibit cell division in fertilized starfish eggs
CMNPD6035	inhibit cell division in fertilized starfish eggs
CMNPD6036	inhibit cell division in fertilized starfish eggs
CMNPD6039	antifungal
CMNPD6040	antifungal
CMNPD6041	antifungal
CMNPD6042	antifungal
CMNPD6043	antifungal
CMNPD6044	cytotoxic
CMNPD6045	cytotoxic
CMNPD6046	cytotoxic
CMNPD6049	cytotoxic
CMNPD6050	cytotoxic
CMNPD6058	potent antitumour
CMNPD6059	potent antitumour
CMNPD6060	potent antitumour
CMNPD6066	cytotoxin
CMNPD6067	cytotoxic
CMNPD6068	cytotoxic
CMNPD6069	cytotoxic
CMNPD6070	cytotoxic
CMNPD6081	potent cytotoxic and immunosuppressive agent
CMNPD6083	cytotoxic
CMNPD6085	cytotoxic
CMNPD6091	potent serine protease inhibitor, thrombin inhibition activity
CMNPD6106	calcium channel blocker
CMNPD6114	inhibit ATP-citratelyase
CMNPD6115	aldose reductase inhibitor
CMNPD6116	aldose reductase inhibitor
CMNPD6117	aldose reductase inhibitor
CMNPD6122	leukotriene B4 receptor antagonist
CMNPD6125	potent insecticide
CMNPD6127	cytotoxic
CMNPD6128	potent cytotoxicity | inhibit topoisomerase II in vitro
CMNPD6129	potent cytotoxicity | inhibit topoisomerase II in vitro
CMNPD6130	potent cytotoxicity | inhibit topoisomerase II in vitro
CMNPD6131	potent cytotoxicity | inhibit topoisomerase II in vitro
CMNPD6132	potent cytotoxicity | inhibit topoisomerase II in vitro
CMNPD6133	potent cytotoxicity | inhibit topoisomerase II in vitro
CMNPD6136	cytotoxin
CMNPD6145	antimicrobial
CMNPD6149	antifungal
CMNPD6150	antifungal
CMNPD6151	protein kinase C inhibitor
CMNPD6161	cytotoxic
CMNPD6162	cytotoxic | immunosuppressive
CMNPD6163	mildly antimicrobial | cytotoxic
CMNPD6164	mildly antimicrobial | cytotoxic
CMNPD6165	mildly antimicrobial | cytotoxic
CMNPD6170	antimicrobial
CMNPD6171	antimicrobial
CMNPD6172	antimicrobial
CMNPD6173	antimicrobial
CMNPD6174	antimicrobial
CMNPD6175	antimicrobial
CMNPD6176	antimicrobial
CMNPD6177	antimicrobial
CMNPD6178	antimicrobial
CMNPD6179	cytotoxin
CMNPD6180	cytotoxin
CMNPD6181	inhibit settlement and metamorphosis of barnacle larvae
CMNPD6183	inhibitor of the endothelin A receptor
CMNPD6193	antimicrobial
CMNPD6194	antifungal
CMNPD6196	topoisomerase II inhibitor
CMNPD6199	protein tyrosine kinase inhibitory activity
CMNPD6200	protein tyrosine kinase inhibitory activity
CMNPD6201	protein tyrosine kinase inhibitory activity
CMNPD6206	antifungal
CMNPD6207	antifungal
CMNPD6208	antifungal
CMNPD6209	antifungal
CMNPD6210	antifungal
CMNPD6223	toxic to brine shrimp
CMNPD6224	toxic to brine shrimp
CMNPD6235	cytotoxic
CMNPD6238	mild protein phosphatase inhibitor
CMNPD6246	stimulate synthesis of nerve growth factor
CMNPD6247	stimulate synthesis of nerve growth factor
CMNPD6248	cytotoxic | antiviral
CMNPD6249	cytotoxic | antiviral
CMNPD6262	cytotoxic
CMNPD6266	potent antitumour agent
CMNPD6270	cytoprotective against HIV-1 in the NCI primary screen
CMNPD6271	antifungal | cytotoxic
CMNPD6272	antimicrobial
CMNPD6273	cytotoxic
CMNPD6279	Inhib. expression iNOS
CMNPD6287	toxic to brine shrimp | inhibit cell division in fertilized sea urchin eggs
CMNPD6308	cytotoxic
CMNPD6309	cytotoxic
CMNPD6311	acetylcholinesterase activity
CMNPD6312	inhibit LPS-induced TNF-α production by murine macrophage-like cells in a dose-dependent manner
CMNPD6333	antiinflammatory
CMNPD6334	antiinflammatory
CMNPD6343	mildly cytotoxic
CMNPD6352	inhibit cell division in fertilized ascidian eggs
CMNPD6353	inhibit cell division in fertilized ascidian eggs
CMNPD6354	inhibit cell division in fertilized ascidian eggs
CMNPD6355	antiviral
CMNPD6356	antiviral
CMNPD6357	cytotoxic
CMNPD6358	cytotoxic
CMNPD6359	cytotoxic
CMNPD6360	cytotoxic
CMNPD6361	cytotoxic
CMNPD6374	in vitro cytotoxicity
CMNPD6376	calmodulin-related antagonist activity
CMNPD6387	antioxidant
CMNPD6388	antioxidant
CMNPD6390	cytotoxic
CMNPD6391	cytotoxic
CMNPD6392	cytotoxic
CMNPD6395	cytotoxic
CMNPD6396	cytotoxic
CMNPD6399	Ichthyotoxic
CMNPD6426	exhibit weak inhibition of a serine protease
CMNPD6427	exhibit weak inhibition of a serine protease
CMNPD6428	exhibit weak inhibition of a serine protease
CMNPD6431	phospholipase A2 inhibitor
CMNPD6432	phospholipase A2 inhibitor
CMNPD6433	antifungal
CMNPD6439	cytotoxic
CMNPD6440	cytotoxin | phosphodiesterase inhibitor
CMNPD6441	cytotoxin | phosphodiesterase inhibitor
CMNPD6447	cytotoxic
CMNPD6451	moderate cytotoxicity
CMNPD6452	Larval settlement/metamorphosis-promoting
CMNPD6453	Larval settlement/metamorphosis-promoting
CMNPD6454	cytotoxic
CMNPD6497	cytotoxic
CMNPD6498	cytotoxic
CMNPD6499	cytotoxic
CMNPD6500	cytotoxic
CMNPD6501	cytotoxic
CMNPD6502	cytotoxic
CMNPD6503	cytotoxic
CMNPD6504	cytotoxic
CMNPD6505	cytotoxic
CMNPD6512	potent cytotoxin
CMNPD6513	cytoprotective against HIV-1
CMNPD6524	ichthyocrinotoxic
CMNPD6525	antimicrobial | antifungal
CMNPD6528	antimicrobial
CMNPD6529	antimicrobial
CMNPD6536	antimicrobial
CMNPD6539	antimicrobial antibiotic
CMNPD6541	antiinflammatory
CMNPD6542	antiinflammatory
CMNPD6543	cytotoxic
CMNPD6549	inhibit the binding of platelet aggregation factor(PAF) to its receptors | inhibit PAF-induced platelet aggregation
CMNPD6550	inhibit the binding of platelet aggregation factor(PAF) to its receptors | inhibit PAF-induced platelet aggregation
CMNPD6551	inhibit the binding of platelet aggregation factor(PAF) to its receptors | inhibit PAF-induced platelet aggregation
CMNPD6552	inhibit the binding of platelet aggregation factor(PAF) to its receptors | inhibit PAF-induced platelet aggregation
CMNPD6553	inhibit the binding of platelet aggregation factor(PAF) to its receptors | inhibit PAF-induced platelet aggregation
CMNPD6554	cytotoxic
CMNPD6555	cytotoxic
CMNPD6556	cytotoxic
CMNPD6557	cytotoxic
CMNPD6558	cytotoxic
CMNPD6559	cytotoxic
CMNPD6560	antimitotic | antiproliferative agent | cytotoxic
CMNPD6561	potent cytotoxin
CMNPD6572	toxic
CMNPD6573	toxic
CMNPD6581	inosine 5'-monophosphate dehydrogenase inhibitor
CMNPD6583	inhibit protein tyrosine kinase pp60v-src
CMNPD6584	inhibit protein tyrosine kinase pp60v-src
CMNPD6585	inhibit protein tyrosine kinase pp60v-src
CMNPD6587	antimicrobial
CMNPD6632	antitumour
CMNPD6633	antitumour
CMNPD6634	antitumour
CMNPD6635	antitumour
CMNPD6636	antitumour
CMNPD6637	antitumour
CMNPD6638	antitumour
CMNPD6639	antitumour
CMNPD6640	antitumour
CMNPD6641	antitumour
CMNPD6649	inhibit HIV reverse transcriptase
CMNPD6650	inhibit HIV reverse transcriptase
CMNPD6667	IL-6 receptor antagonist
CMNPD6668	IL-6 receptor antagonist
CMNPD6669	IL-6 receptor antagonist
CMNPD6670	IL-6 receptor antagonist
CMNPD6671	IL-6 receptor antagonist
CMNPD6672	antitumour | immunostimulatory
CMNPD6673	antitumour | immunostimulatory
CMNPD6674	antitumour | immunostimulatory
CMNPD6682	antifungal
CMNPD6683	antifungal
CMNPD6684	antifungal
CMNPD6685	toxic to brine shrimp | inhibit cell division in fertilized ascidian eggs
CMNPD6686	toxic to brine shrimp | inhibit cell division in fertilized ascidian eggs
CMNPD6687	toxic to brine shrimp | inhibit cell division in fertilized ascidian eggs | cytotoxic | activity in an in vitro endothelial cell–neutrophil leukocyte adhesion assay
CMNPD6688	toxic to brine shrimp | inhibit cell division in fertilized ascidian eggs
CMNPD6691	cytotoxic
CMNPD6692	cytotoxic | potent inhibitor of glutamate-induced tubulin polymerization
CMNPD6693	cytotoxic | potent inhibitor of glutamate-induced tubulin polymerization
CMNPD6694	cytotoxic
CMNPD6695	cytotoxic
CMNPD6696	cytotoxic
CMNPD6697	cytotoxic
CMNPD6698	potent cytotoxic
CMNPD6699	potent cytotoxic
CMNPD6700	potent cytotoxic
CMNPD6701	potent cytotoxic
CMNPD6702	potent cytotoxic
CMNPD6706	cytotoxin
CMNPD6707	cytotoxic
CMNPD6708	cytotoxic
CMNPD6709	cytotoxic
CMNPD6710	cytotoxic
CMNPD6711	cytotoxic
CMNPD6717	mild anti-HIV activity
CMNPD6732	cytotoxic against KB cells | fish antifeedant
CMNPD6733	cytotoxic against KB cells | fish antifeedant
CMNPD6734	cytotoxic against KB cells | fish antifeedant
CMNPD6735	antimicrobial
CMNPD6738	antifungal
CMNPD6739	antifungal
CMNPD6742	antifungal
CMNPD6747	antibiotic | cytotoxic
CMNPD6748	antibiotic | cytotoxic | antiplasmodial activity against chloroquine-resistant Plasmodium falciparum
CMNPD6749	antibiotic | cytotoxic
CMNPD6750	antibiotic | cytotoxic | antiplasmodial activity against chloroquine-resistant Plasmodium falciparum
CMNPD6751	antibiotic | cytotoxic
CMNPD6752	antibiotic | cytotoxic
CMNPD6753	antibiotic | cytotoxic | antiplasmodial activity against chloroquine-resistant Plasmodium falciparum
CMNPD6754	antibiotic | cytotoxic
CMNPD6755	antibiotic | cytotoxic
CMNPD6758	cytotoxic
CMNPD6759	cytotoxic
CMNPD6760	cytotoxic
CMNPD6761	cytotoxic
CMNPD6762	cytotoxic
CMNPD6763	potent cytotoxic
CMNPD6764	antifungal
CMNPD6765	antifungal
CMNPD6768	cytotoxic
CMNPD6769	cytotoxic
CMNPD6770	cytotoxic
CMNPD6771	cytotoxic
CMNPD6774	antifungal
CMNPD6775	antifungal
CMNPD6779	antifungal
CMNPD6780	prevent fertilization of sea urchin eggs
CMNPD6781	cytotoxic | antimicrobial
CMNPD6782	cytotoxic | antimicrobial
CMNPD6783	cytotoxic | antimicrobial
CMNPD6784	cytotoxic | antimicrobial
CMNPD6785	cytotoxic | antimicrobial
CMNPD6786	cytotoxic | antimicrobial
CMNPD6787	cytotoxic | antimicrobial
CMNPD6788	cytotoxic | antimicrobial
CMNPD6789	muscarinic receptor binding inhibitor
CMNPD6790	muscarinic receptor binding inhibitor
CMNPD6791	muscarinic receptor binding inhibitor
CMNPD6792	muscarinic receptor binding inhibitor
CMNPD6793	muscarinic receptor binding inhibitor
CMNPD6794	muscarinic receptor binding inhibitor
CMNPD6796	cytotoxic
CMNPD6797	cytotoxic
CMNPD6798	cytotoxic
CMNPD6799	cytotoxic
CMNPD6800	PKC inhibitor
CMNPD6801	PKC inhibitor
CMNPD6803	cytotoxic
CMNPD6815	cytotoxic | insecticidal activity
CMNPD6830	histamine-H3 antagonist | inhibit the settling of barnacle larvae
CMNPD6835	antimicrobial
CMNPD6837	antifungal
CMNPD6846	cytotoxic
CMNPD6847	cytotoxic
CMNPD6848	cytotoxic
CMNPD6849	cytotoxicity
CMNPD6850	inhibitory activities against topoisomerase II
CMNPD6851	inhibitory activities against topoisomerase II
CMNPD6852	inhibitory activities against topoisomerase II
CMNPD6857	inhibitor of HIV- 1
CMNPD6862	cytotoxic, antitumour
CMNPD6867	protein kinase C inhibitor
CMNPD6868	protein kinase C inhibitor
CMNPD6910	Antibiotic
CMNPD6911	Antibiotic
CMNPD6917	ichthyotoxic | inhibit fish feeding
CMNPD6918	ichthyotoxic | inhibit fish feeding
CMNPD6919	ichthyotoxic | inhibit fish feeding
CMNPD6920	cytotoxic
CMNPD6921	cytotoxic
CMNPD6922	cytotoxic
CMNPD6923	cytotoxic
CMNPD6927	antibacterial
CMNPD6928	antibacterial
CMNPD6930	cytotoxic
CMNPD6941	inhibit HIV in vitro
CMNPD6942	inhibit HIV in vitro
CMNPD6943	inhibit HIV in vitro
CMNPD6944	inhibition in the guanosine diphosphate/G-protein RAS exchange assay
CMNPD6945	antihistaminic
CMNPD6946	antihistaminic
CMNPD6947	antihistaminic
CMNPD6948	antihistaminic
CMNPD6949	antihistaminic
CMNPD6950	antihistaminic
CMNPD6951	antihistaminic
CMNPD6952	antihistaminic
CMNPD6953	antihistaminic
CMNPD6954	antihistaminic
CMNPD6955	antifungal
CMNPD7002	cytotoxic
CMNPD7003	cytotoxic
CMNPD7004	mildly cytotoxic
CMNPD7005	mildly cytotoxic
CMNPD7006	mildly cytotoxic
CMNPD7015	toxic to brine shrimp
CMNPD7048	toxic to brine shrimp | inhibit cell division in fertilized ascidian eggs
CMNPD7049	toxic to brine shrimp | inhibit cell division in fertilized ascidian eggs
CMNPD7050	toxic to brine shrimp | inhibit cell division in fertilized ascidian eggs
CMNPD7051	toxic to brine shrimp | inhibit cell division in fertilized ascidian eggs
CMNPD7055	cytotoxic
CMNPD7056	cytotoxic
CMNPD7057	cytotoxic
CMNPD7062	cytotoxic
CMNPD7085	cytotoxicity against P388, L1210 or KB cell lines
CMNPD7086	cytotoxicity against P388, L1210 or KB cell lines
CMNPD7087	cytotoxicity against P388, L1210 or KB cell lines
CMNPD7088	cytotoxicity against P388, L1210 or KB cell lines
CMNPD7089	cytotoxicity against P388, L1210 or KB cell lines
CMNPD7090	cytotoxicity against P388, L1210 or KB cell lines
CMNPD7091	cytotoxicity against P388, L1210 or KB cell lines
CMNPD7092	cytotoxicity against P388, L1210 or KB cell lines
CMNPD7093	cytotoxicity against P388, L1210 or KB cell lines
CMNPD7094	cytotoxicity against P388, L1210 or KB cell lines
CMNPD7095	cytotoxicity against P388, L1210 or KB cell lines
CMNPD7099	toxic to brine shrimp
CMNPD7100	toxic to brine shrimp
CMNPD7101	toxic to brine shrimp
CMNPD7102	toxic to brine shrimp
CMNPD7104	potent antitumour agent
CMNPD7105	potent antitumour agent
CMNPD7106	potent antitumour agent
CMNPD7107	potent antitumour agent
CMNPD7108	cytotoxic
CMNPD7126	cytotoxic
CMNPD7127	exhibit weak inhibition of a serine protease
CMNPD7128	exhibit weak inhibition of a serine protease
CMNPD7129	exhibit weak inhibition of a serine protease
CMNPD7131	antimicrobial
CMNPD7132	antimicrobial
CMNPD7133	antimicrobial
CMNPD7134	antimicrobial
CMNPD7135	inhibit 5- and 15-lipoxygenases | bind weakly to leukotriene B4 receptors
CMNPD7141	cytotoxic
CMNPD7142	cytotoxic
CMNPD7143	cytotoxic
CMNPD7144	cytotoxic
CMNPD7145	cytotoxic
CMNPD7146	cytotoxic
CMNPD7162	inhibition of topoisomerase II catalytic activity
CMNPD7163	inhibition of topoisomerase II catalytic activity
CMNPD7164	inhibition of topoisomerase II catalytic activity
CMNPD7165	cytotoxic
CMNPD7169	cytotoxic
CMNPD7170	cytotoxicity | protein kinase C activity
CMNPD7171	cytotoxicity | protein kinase C activity
CMNPD7174	cytotoxic
CMNPD7176	cytotoxic
CMNPD7177	cytotoxic
CMNPD7187	cytotoxic
CMNPD7188	cytotoxic
CMNPD7189	cytotoxic
CMNPD7190	cytotoxic
CMNPD7195	toxic to brine shrimp
CMNPD7198	inhibitor of protein tyrosine kinase pp60v-src
CMNPD7228	inhibit calf thymus DNA polymerase α
CMNPD7229	inhibit calf thymus DNA polymerase α
CMNPD7230	antimicrobial
CMNPD7231	antimicrobial
CMNPD7236	antibiotic
CMNPD7237	N-acetyl-β-D-glucosaminidase inhibitor
CMNPD7238	N-acetyl-β-D-glucosaminidase inhibitor
CMNPD7246	cytotoxic
CMNPD7247	cytotoxin
CMNPD7251	platelet activation factor (PAF) antagonist
CMNPD7252	platelet activation factor (PAF) antagonist
CMNPD7253	platelet activation factor (PAF) antagonist
CMNPD7262	moderate cytotoxicity against cultured P388 cells
CMNPD7263	moderate cytotoxicity against cultured P388 cells
CMNPD7264	moderate cytotoxicity against cultured P388 cells
CMNPD7265	moderate cytotoxicity against cultured P388 cells
CMNPD7272	ichthyotoxic
CMNPD7273	ichthyotoxic
CMNPD7275	ichthyotoxic | molluscicidal
CMNPD7276	cytotoxic
CMNPD7277	cytotoxic
CMNPD7278	cytotoxic
CMNPD7279	cytotoxic
CMNPD7280	ichthyotoxin
CMNPD7281	ichthyotoxin
CMNPD7282	ichthyotoxin
CMNPD7285	cytotoxin
CMNPD7286	cytotoxin
CMNPD7287	cytotoxic
CMNPD7288	cytotoxic
CMNPD7289	cytotoxic
CMNPD7290	potent haemolytic agent
CMNPD7291	phosphatase inhibitor
CMNPD7297	toxin
CMNPD7298	cytotoxic
CMNPD7299	inhibit feeding by the copepod Tigriopus californicus
CMNPD7300	inhibit feeding by the copepod Tigriopus californicus
CMNPD7301	inhibit feeding by the copepod Tigriopus californicus
CMNPD7302	inhibit feeding by the copepod Tigriopus californicus
CMNPD7316	inhibit the development of fertilized sea urchin eggs
CMNPD7329	toxic
CMNPD7330	toxic
CMNPD7331	toxic
CMNPD7332	toxic
CMNPD7333	toxic
CMNPD7340	cytotoxic
CMNPD7349	cytotoxic
CMNPD7352	cytotoxic | antifungal
CMNPD7353	cytotoxic | antifungal
CMNPD7354	cytotoxic | antifungal
CMNPD7355	cytotoxic | antifungal
CMNPD7356	cytotoxic | antifungal
CMNPD7357	cytotoxic | antifungal
CMNPD7358	cytotoxic | antifungal
CMNPD7359	cytotoxic | antifungal
CMNPD7360	cytotoxic | antifungal
CMNPD7361	cytotoxic | antifungal
CMNPD7466	antimicrobial
CMNPD7467	antimicrobial
CMNPD7469	antitumour
CMNPD7470	antitumour
CMNPD7471	brine shrimp toxicity
CMNPD7472	brine shrimp toxicity
CMNPD7473	brine shrimp toxicity
CMNPD7474	brine shrimp toxicity
CMNPD7475	brine shrimp toxicity
CMNPD7476	brine shrimp toxicity
CMNPD7477	brine shrimp toxicity
CMNPD7478	brine shrimp toxicity
CMNPD7479	brine shrimp toxicity
CMNPD7480	brine shrimp toxicity
CMNPD7481	brine shrimp toxicity
CMNPD7482	brine shrimp toxicity
CMNPD7500	selective cytotoxicity against melanoma and breast tumour cell lines
CMNPD7502	cytotoxic
CMNPD7503	cytotoxic
CMNPD7504	topoisomerase II inhibitor
CMNPD7508	protein phosphatase inhibitor
CMNPD7509	cytotoxic
CMNPD7511	cytostatic
CMNPD7512	cytostatic
CMNPD7513	antiviral
CMNPD7516	antifungal
CMNPD7517	cytotoxic
CMNPD7518	cytotoxic
CMNPD7519	cytotoxic
CMNPD7520	cytotoxic
CMNPD7521	cytotoxic
CMNPD7522	thrombin inhibitor
CMNPD7523	thrombin inhibitor
CMNPD7524	thrombin inhibitor
CMNPD7531	cytotoxic
CMNPD7532	cytotoxic
CMNPD7533	cytotoxic
CMNPD7534	cytotoxic
CMNPD7535	cytotoxic
CMNPD7536	cytotoxic
CMNPD7538	cytotoxic
CMNPD7539	cytotoxic
CMNPD7540	cytotoxic
CMNPD7541	cytotoxic
CMNPD7542	cytotoxic
CMNPD7543	antifungal | cytotoxic
CMNPD7544	antifungal | cytotoxic
CMNPD7545	antifungal | cytotoxic
CMNPD7555	moderate immunosuppressive activity
CMNPD7556	potential inhibitor of AIDS
CMNPD7557	potential inhibitor of AIDS
CMNPD7558	potential inhibitor of AIDS
CMNPD7559	potential inhibitor of AIDS
CMNPD7560	potential inhibitor of AIDS
CMNPD7561	potential inhibitor of AIDS
CMNPD7586	active in receptor binding assays
CMNPD7587	active in receptor binding assays
CMNPD7588	active in receptor binding assays
CMNPD7589	active in receptor binding assays
CMNPD7591	inhibit moulting of the cyprid larvae of barnacles
CMNPD7592	inhibit moulting of the cyprid larvae of barnacles
CMNPD7593	inhibit moulting of the cyprid larvae of barnacles
CMNPD7617	weak thrombin receptor antagonist
CMNPD7626	cytotoxic
CMNPD7628	inhibitor of cholesteryl ester transfer protein
CMNPD7629	inhibitor of cholesteryl ester transfer protein
CMNPD7630	inhibit c-erbB-2 kinase | selective inhibitor of the Her-2/Neu protooncogene
CMNPD7631	inhibit c-erbB-2 kinase
CMNPD7633	inhibit binding of LTB4 to human netrophils
CMNPD7634	significant differential antitumour | antimalarial
CMNPD7635	significant differential antitumour | antimalarial
CMNPD7639	topoisomerase II inhibitor
CMNPD7640	topoisomerase II inhibitor
CMNPD7641	topoisomerase II inhibitor
CMNPD7642	topoisomerase II inhibitor
CMNPD7643	topoisomerase II inhibitor
CMNPD7644	topoisomerase II inhibitor
CMNPD7647	toxic to brine shrimp
CMNPD7648	toxic to brine shrimp
CMNPD7667	inhibit settlement and metamorphosis of barnacle larvae
CMNPD7668	inhibit settlement and metamorphosis of barnacle larvae
CMNPD7669	inhibit settlement and metamorphosis of barnacle larvae
CMNPD7677	moderately cytotoxic
CMNPD7678	cytotoxic
CMNPD7679	cytotoxic
CMNPD7680	cytotoxic
CMNPD7686	ichthyotoxic | antifeedant
CMNPD7687	ichthyotoxic | antifeedant
CMNPD7688	ichthyotoxic | antifeedant
CMNPD7695	cytotoxic
CMNPD7696	cytotoxic
CMNPD7697	cytotoxic
CMNPD7707	inhibit glucanase activity
CMNPD7721	mild cytotoxic
CMNPD7722	mild cytotoxic
CMNPD7733	cytotoxic
CMNPD7774	toxic to fish and brine shrimp
CMNPD7806	ichthyotoxic
CMNPD7817	potent antiviral
CMNPD7819	moderate inhibitory activity against protein kinase C
CMNPD7820	moderate inhibitory activity against protein kinase C
CMNPD7821	moderate inhibitory activity against protein kinase C
CMNPD7824	moderate cytotoxicity | antiviral
CMNPD7825	moderate cytotoxicity | antiviral
CMNPD7834	potent activity in the differentiation of HL-60 cells
CMNPD7835	potent activity in the differentiation of HL-60 cells
CMNPD7836	potent activity in the differentiation of HL-60 cells
CMNPD7837	potent activity in the differentiation of HL-60 cells
CMNPD7842	cytotoxic
CMNPD7843	ichthyotoxic
CMNPD7846	cytotoxic
CMNPD7847	cytotoxic
CMNPD7848	cytotoxic
CMNPD7861	cytotoxic
CMNPD7864	calcium channel activator
CMNPD7870	antimicrobial
CMNPD7871	antimicrobial | mildly cytotox. and AB
CMNPD7872	antimicrobial
CMNPD7873	antimicrobial | mildly cytotox.
CMNPD7877	cytotoxic
CMNPD7878	cytotoxic
CMNPD7879	cytotoxic
CMNPD7880	cytotoxic
CMNPD7885	antimicrobial
CMNPD7887	cytotoxic
CMNPD7891	weakly cytotoxic
CMNPD7900	antimicrobial
CMNPD7901	antimicrobial
CMNPD7902	antimicrobial
CMNPD7923	cytotoxic
CMNPD7924	cytotoxic
CMNPD7925	cytotoxic
CMNPD7926	cytotoxic
CMNPD7927	cytotoxic
CMNPD7928	cytotoxic
CMNPD7929	cytotoxic
CMNPD7930	cytotoxic
CMNPD7931	cytotoxic
CMNPD7932	cytotoxic
CMNPD7933	cytotoxic
CMNPD7935	cytotoxic
CMNPD7972	cytotoxic
CMNPD7973	cytotoxic
CMNPD7974	cytotoxic
CMNPD7975	cytotoxic
CMNPD7980	neurotoxic
CMNPD7981	neurotoxic
CMNPD7982	tetrodotoxin
CMNPD7983	tetrodotoxin
CMNPD7984	antimicrobial | antiviral
CMNPD7985	antifungal | cytotoxin
CMNPD7986	cytotoxic
CMNPD7987	cytotoxic
CMNPD7988	cytotoxic
CMNPD7993	chitinase inhibitor
CMNPD7996	inhibitor of superoxide anion generation
CMNPD7997	antimicrobial
CMNPD7998	arrest the cell cycle in the G2 phase
CMNPD7999	cytotoxic
CMNPD8001	antifungal | weakly inhibit microtubule assembly
CMNPD8002	cytotoxic
CMNPD8003	cytotoxic
CMNPD8004	cytotoxic
CMNPD8005	cytotoxicity against P338 cells
CMNPD8006	cytotoxicity against P338 cells
CMNPD8007	cytotoxicity against P338 cells
CMNPD8012	antibiotic
CMNPD8015	antimicrobial
CMNPD8016	potent inhibitor of cysteine proteases
CMNPD8017	potent inhibitor of cysteine proteases
CMNPD8018	potent inhibitor of cysteine proteases
CMNPD8019	broad-acting feeding deterrent
CMNPD8020	brine shrimp toxicity
CMNPD8021	potent antimitotic agent
CMNPD8022	immunosuppressive agent
CMNPD8023	moderately cytotoxic
CMNPD8024	fast-acting toxin
CMNPD8025	toxin
CMNPD8026	potent ichthyotoxic | hemolytic polyether glycoside
CMNPD8027	weakly toxic to other ciliates
CMNPD8028	weakly toxic to other ciliates
CMNPD8029	weakly toxic to other ciliates
CMNPD8032	antiviral
CMNPD8043	inhibit the feeding of young abalone Haliotis discus
CMNPD8046	potent feeding deterrent against temperate and tropical fishes and sea urchins
CMNPD8047	potent feeding deterrent against temperate and tropical fishes and sea urchins
CMNPD8048	potent feeding deterrent against temperate and tropical fishes and sea urchins
CMNPD8049	antibacterial
CMNPD8050	inhibit growth of the green alga Monostroma oxyspermum
CMNPD8071	antitumour
CMNPD8072	antitumour
CMNPD8073	cytotoxic
CMNPD8074	cytotoxic
CMNPD8075	cytotoxic
CMNPD8077	antibacterial
CMNPD8078	cytotoxic
CMNPD8079	cytotoxic
CMNPD8080	cytotoxic
CMNPD8123	inhibit binding of ω-conotoxin GVIA to N-type Ca2+ channels
CMNPD8124	inhibit binding of ω-conotoxin GVIA to N-type Ca2+ channels
CMNPD8125	inhibit binding of ω-conotoxin GVIA to N-type Ca2+ channels
CMNPD8126	inhibit binding of ω-conotoxin GVIA to N-type Ca2+ channels
CMNPD8127	inhibit binding of ω-conotoxin GVIA to N-type Ca2+ channels
CMNPD8128	potent actomyosin ATPase inhibitor
CMNPD8130	inhibit protein kinase C
CMNPD8134	cytotoxic
CMNPD8135	cytotoxin
CMNPD8136	cytotoxic | active against leukemia and colon tumour lines
CMNPD8137	cytotoxic | active against leukemia and colon tumour lines
CMNPD8138	cytotoxic | active against leukemia and colon tumour lines
CMNPD8139	cytotoxic | active against leukemia and colon tumour lines
CMNPD8140	cytotoxic | active against leukemia and colon tumour lines
CMNPD8141	cytotoxic | active against leukemia and colon tumour lines
CMNPD8142	cytotoxic | active against leukemia and colon tumour lines
CMNPD8143	cytotoxic | active against leukemia and colon tumour lines
CMNPD8144	cytotoxic | active against leukemia and colon tumour lines
CMNPD8145	cytotoxic | activity in an in vitro endothelial cell–neutrophil leukocyte adhesion assay
CMNPD8146	cytotoxic | activity in an in vitro endothelial cell–neutrophil leukocyte adhesion assay
CMNPD8147	cytotoxic | activity in an in vitro endothelial cell–neutrophil leukocyte adhesion assay
CMNPD8148	inhibit fertilization of starfish (Asterias amurensis) gametes
CMNPD8149	inhibit fertilization of starfish (Asterias amurensis) gametes
CMNPD8163	cytotoxic
CMNPD8164	cytotoxic
CMNPD8165	cytotoxic
CMNPD8166	inhibitor of vasicular cell adhesion molecule-1 (VCAM-1) induction
CMNPD8167	antifungal | cytotoxic
CMNPD8168	cytotoxic
CMNPD8169	cytotoxic
CMNPD8170	cytotoxic
CMNPD8173	antifungal | cytotoxic
CMNPD8177	cytotoxic
CMNPD8178	cytotoxic
CMNPD8179	cytotoxic
CMNPD8180	cytotoxic
CMNPD8181	protect cells infected with HIV | significant cytotoxicity
CMNPD8182	significant cytotoxicity
CMNPD8184	antifungal | cytotoxic
CMNPD8185	antifungal | cytotoxic
CMNPD8186	antifungal | cytotoxic
CMNPD8187	calmodulin antagonist
CMNPD8194	immunosuppressive
CMNPD8195	inhibit microfouling
CMNPD8196	inhibit microfouling
CMNPD8197	inhibit microfouling
CMNPD8198	cytotoxic
CMNPD8199	cytotoxic
CMNPD8200	cytotoxic
CMNPD8204	antitrypanosomal | antimalarial
CMNPD8216	cytotoxicity
CMNPD8217	cytotoxicity
CMNPD8218	cytotoxicity
CMNPD8219	cytotoxicity
CMNPD8225	highly cytotoxic
CMNPD8226	antifungal
CMNPD8227	antimicrobial
CMNPD8228	antimicrobial
CMNPD8229	antimicrobial
CMNPD8230	antimicrobial
CMNPD8245	antifouling | inhibit settlement and metamorphosis of barnacle larvae
CMNPD8246	selective antihistamine activity in the guinea pig ileum
CMNPD8247	selective antihistamine activity in the guinea pig ileum
CMNPD8248	mildly antifungal
CMNPD8249	mildly antifungal
CMNPD8250	inhibit the metamorphosis of barnacle larvae
CMNPD8261	cytotoxic | antifouling agent
CMNPD8262	inhibit settlement and metamorphosis of barnacle larvae
CMNPD8264	moderate differential activity as SR-Ca2+-channel agonists of the Ry1R FKBP12 complex
CMNPD8265	moderate differential activity as SR-Ca2+-channel agonists of the Ry1R FKBP12 complex
CMNPD8266	moderate differential activity as SR-Ca2+-channel agonists of the Ry1R FKBP12 complex
CMNPD8277	topoisomerase II inhibitor
CMNPD8282	mildly cytotoxic
CMNPD8285	induce larval metamorphosis in ascidians
CMNPD8295	inhibit the settlement and metamorphosis of barnacle larvae
CMNPD8296	inhibit the settlement and metamorphosis of barnacle larvae
CMNPD8297	inhibit the settlement and metamorphosis of barnacle larvae
CMNPD8298	inhibit the settlement and metamorphosis of barnacle larvae
CMNPD8299	inhibit the settlement and metamorphosis of barnacle larvae
CMNPD8300	inhibit the settlement and metamorphosis of barnacle larvae
CMNPD8301	antifouling agent
CMNPD8302	antifouling agent
CMNPD8336	cytotoxic | inhibit gastrulation of starfish embryos
CMNPD8337	cytotoxic
CMNPD8338	antiinflammatory
CMNPD8339	inhibit the cdc25A protein phosphatase
CMNPD8340	cytotoxic
CMNPD8341	cytotoxic
CMNPD8342	cytotoxic
CMNPD8345	inhibit fish feeding
CMNPD8346	inhibit fish feeding
CMNPD8347	inhibit fish feeding
CMNPD8349	inhibit gastrulation of starfish embryos
CMNPD8350	cytotoxic
CMNPD8351	cytotoxic
CMNPD8352	cytotoxic
CMNPD8353	cytotoxic
CMNPD8358	cytotoxic
CMNPD8359	cytotoxic
CMNPD8360	cytotoxic
CMNPD8361	cytotoxic
CMNPD8362	cytotoxic
CMNPD8363	cytotoxic
CMNPD8364	cytotoxic
CMNPD8369	cytotoxic
CMNPD8370	cytotoxic
CMNPD8380	inhibit endothelin converting enzyme
CMNPD8381	mildly cytotoxic
CMNPD8382	mildly cytotoxic
CMNPD8386	proposed intermediate on the pathway to prostanoids in coelenterates
CMNPD8389	inhibit farnesyl protein transferase
CMNPD8390	inhibit farnesyl protein transferase
CMNPD8393	inhibit farnesyl protein transferase
CMNPD8396	cytotoxic
CMNPD8397	cytotoxic
CMNPD8404	potent cytotoxic
CMNPD8410	antimicrobial
CMNPD8412	cytotoxic
CMNPD8425	ichthyotoxic
CMNPD8435	cytotoxic
CMNPD8442	cytotoxic
CMNPD8447	cytotoxic
CMNPD8495	cytotoxic
CMNPD8506	mild cytotoxicity
CMNPD8507	mild cytotoxicity | inhibit phospholipase A2
CMNPD8508	mild cytotoxicity
CMNPD8509	inhibit phospholipase A2
CMNPD8514	cytotoxic
CMNPD8515	cytotoxic
CMNPD8526	cytotoxic
CMNPD8530	inhibit feeding by the planehead filefish
CMNPD8531	inhibit feeding by the planehead filefish
CMNPD8532	inhibit feeding by the planehead filefish
CMNPD8547	cytotoxic
CMNPD8548	cytotoxic
CMNPD8549	cytotoxic
CMNPD8550	cytotoxic
CMNPD8551	cytotoxic | inhibit polymerization of G-actin to F-actin
CMNPD8552	cytotoxic
CMNPD8553	cytotoxic
CMNPD8554	cytotoxic
CMNPD8555	cytotoxic
CMNPD8556	potent in vitro cytotoxicity | toxicity in in vivo evaluation | strongly stabilises microtubules
CMNPD8557	cytotoxic
CMNPD8562	cytotoxic
CMNPD8563	cytotoxic
CMNPD8570	cytotoxic
CMNPD8588	cytotoxic
CMNPD8589	cytotoxic
CMNPD8590	cytosolic phospholipase A2 inhibitor
CMNPD8591	cytosolic phospholipase A2 inhibitor
CMNPD8592	potent shellfish toxin
CMNPD8593	toxin
CMNPD8596	toxin | diarrhetic shellfish poisoning
CMNPD8599	in vitro anti-HIV activity
CMNPD8600	microbial
CMNPD8604	antitumour antibiotic
CMNPD8609	anticancer agent
CMNPD8610	cytotoxic
CMNPD8619	cytotoxic
CMNPD8620	cytotoxic
CMNPD8621	cytotoxic
CMNPD8622	cytotoxic
CMNPD8623	cytotoxic
CMNPD8624	mildly cytotoxic
CMNPD8625	mildly cytotoxic
CMNPD8626	mildly cytotoxic
CMNPD8634	cytotoxic
CMNPD8637	cytotoxic
CMNPD8638	cytotoxic
CMNPD8679	moderate cytotoxicity
CMNPD8680	moderate cytotoxicity
CMNPD8681	moderate cytotoxicity
CMNPD8682	moderate cytotoxicity
CMNPD8683	moderate cytotoxicity
CMNPD8684	moderate cytotoxicity
CMNPD8685	moderate cytotoxicity
CMNPD8686	moderate cytotoxicity
CMNPD8687	moderate cytotoxicity
CMNPD8688	moderate cytotoxicity
CMNPD8689	moderate cytotoxicity
CMNPD8690	moderate cytotoxicity
CMNPD8691	moderate cytotoxicity
CMNPD8692	moderate cytotoxicity
CMNPD8693	moderate cytotoxicity
CMNPD8694	moderate cytotoxicity
CMNPD8695	moderate cytotoxicity
CMNPD8696	moderate cytotoxicity
CMNPD8697	moderate cytotoxicity
CMNPD8698	moderate cytotoxicity
CMNPD8699	moderate cytotoxicity
CMNPD8700	moderate cytotoxicity
CMNPD8701	moderate cytotoxicity
CMNPD8702	moderate cytotoxicity
CMNPD8703	moderate cytotoxicity
CMNPD8704	moderate cytotoxicity
CMNPD8705	moderate cytotoxicity
CMNPD8706	moderate cytotoxicity
CMNPD8707	moderate cytotoxicity
CMNPD8708	moderate cytotoxicity
CMNPD8709	moderate cytotoxicity
CMNPD8712	weak cytotoxicity
CMNPD8713	weak cytotoxicity
CMNPD8727	antifungal
CMNPD8737	inhibit the growth of marine bacteria
CMNPD8738	N-type calcium channel blocker
CMNPD8739	N-type calcium channel blocker
CMNPD8740	N-type calcium channel blocker
CMNPD8741	antibiotic
CMNPD8742	antitumour agent
CMNPD8743	antimicrobial agent
CMNPD8744	antimicrobial agent
CMNPD8745	antimicrobial agent
CMNPD8748	anticancer | antibiotic
CMNPD8749	anticancer | antibiotic
CMNPD8750	anticancer | antibiotic
CMNPD8751	anticancer | antibiotic
CMNPD8752	weakly antimicrobial
CMNPD8753	xanthine oxidase inhibitor
CMNPD8755	mildly cytotoxic
CMNPD8756	mildly cytotoxic
CMNPD8757	mildly cytotoxic
CMNPD8758	mildly cytotoxic
CMNPD8759	antimicrobial agent
CMNPD8760	antimicrobial agent
CMNPD8761	antimicrobial agent
CMNPD8762	antimicrobial agent
CMNPD8763	antimicrobial agent
CMNPD8764	antimicrobial agent
CMNPD8765	antimicrobial agent
CMNPD8766	antimicrobial agent
CMNPD8767	cytotoxic
CMNPD8768	cytotoxic | significant growth inhibitor of P388 cells
CMNPD8769	inhibit the adhesion of HL-60 cells to human umbilical vein endothelial cells (HUVEC)
CMNPD8772	inhibit the adhesion of HL-60 cells to human umbilical vein endothelial cells (HUVEC)
CMNPD8778	significant cytotoxicity against tumour cell lines
CMNPD8779	significant cytotoxicity against tumour cell lines
CMNPD8780	significant cytotoxicity against tumour cell lines
CMNPD8781	cytotoxic
CMNPD8782	antitumour activity
CMNPD8783	cytotoxic
CMNPD8784	cytotoxic | mammalian cell cycle inhibitor
CMNPD8786	ichthyotoxic | brine-shrimp toxic
CMNPD8787	ichthyotoxic | brine-shrimp toxic
CMNPD8791	cytotoxic
CMNPD8792	cytotoxic
CMNPD8793	weak antimicrobial activity
CMNPD8796	neurotoxin
CMNPD8797	causative agent of diarrhetic shellfish poisoning
CMNPD8801	inhibitor of VZV and CMV proteases
CMNPD8802	P-selectrin receptor inhibitor
CMNPD8805	anthelmintic
CMNPD8813	fish deterrent
CMNPD8814	mildly cytotoxic
CMNPD8815	mildly cytotoxic
CMNPD8816	mildly cytotoxic
CMNPD8817	mildly cytotoxic
CMNPD8818	mildly cytotoxic
CMNPD8819	mildly cytotoxic
CMNPD8820	mildly cytotoxic
CMNPD8824	antifungal and antibacterial
CMNPD8836	inhibit morphogenesis in the foliaceous green alga Monostroma oxyspermum
CMNPD8843	toxin
CMNPD8844	toxin | tumour promoter
CMNPD8851	cytotoxic
CMNPD8854	antifouling
CMNPD8862	mildly cytotoxic
CMNPD8863	mildly cytotoxic
CMNPD8868	cytotoxic
CMNPD8869	cytotoxic
CMNPD8870	cytotoxic
CMNPD8871	cytotoxic
CMNPD8872	neurotoxin
CMNPD8873	neurotoxin
CMNPD8875	inhibit human DNA topoisomerase I
CMNPD8877	inhibit human DNA topoisomerase I
CMNPD8880	cytotoxic | selective inhibition of the fecal opportunist Enterococcus faecalis
CMNPD8884	immunosuppressive
CMNPD8885	immunosuppressive
CMNPD8886	potent cytotoxin
CMNPD8887	induce metamorphosis in larvae of the ascidian Halocynthia roretzi
CMNPD8888	induce metamorphosis in larvae of the ascidian Halocynthia roretzi
CMNPD8889	induce metamorphosis in larvae of the ascidian Halocynthia roretzi, antifouling activity against the barnacle Balanus amphitrite
CMNPD8890	induce metamorphosis in larvae of the ascidian Halocynthia roretzi, antifouling activity against the barnacle Balanus amphitrite
CMNPD8891	induce metamorphosis in larvae of the ascidian Halocynthia roretzi, antifouling activity against the barnacle Balanus amphitrite
CMNPD8892	induce metamorphosis in larvae of the ascidian Halocynthia roretzi, antifouling activity against the barnacle Balanus amphitrite
CMNPD8893	induce metamorphosis in larvae of the ascidian Halocynthia roretzi, antifouling activity against the barnacle Balanus amphitrite
CMNPD8895	inhibit inosine monophosphate dehydrogenase in vitro
CMNPD8901	inhibit both DNA polymerase b and HIV reverse transcriptase
CMNPD8902	inhibit protein kinase C
CMNPD8903	cytotoxic
CMNPD8908	significant in vitro cytotoxicity
CMNPD8909	significant in vitro cytotoxicity
CMNPD8910	significant in vitro cytotoxicity
CMNPD8911	significant in vitro cytotoxicity
CMNPD8912	significant in vitro cytotoxicity
CMNPD8913	significant in vitro cytotoxicity
CMNPD8914	significant in vitro cytotoxicity
CMNPD8915	significant in vitro cytotoxicity
CMNPD8916	significant in vitro cytotoxicity
CMNPD8917	significant in vitro cytotoxicity
CMNPD8918	significant in vitro cytotoxicity
CMNPD8919	significant in vitro cytotoxicity
CMNPD8920	significant in vitro cytotoxicity
CMNPD8921	significant in vitro cytotoxicity
CMNPD8922	specifically inhibit blastulation of starfish (Asterina pectinifera) embryos
CMNPD8924	inhibit protein phosphatase 2A
CMNPD8925	inhibit protein phosphatase 2A
CMNPD8928	inhibit protein phosphatase 2A
CMNPD8929	cytotoxin
CMNPD8930	cytotoxin
CMNPD8931	antitumour
CMNPD8932	antitumour
CMNPD8933	antitumour
CMNPD8934	antitumour
CMNPD8935	antitumour agent
CMNPD8936	antitumour agent
CMNPD8937	cytotoxic
CMNPD8938	cytotoxic
CMNPD8939	cytotoxic
CMNPD8940	cytotoxic
CMNPD8941	cytotoxic
CMNPD8942	cytotoxic
CMNPD8943	protein phosphatase inhibitor
CMNPD8949	neurotoxic
CMNPD8956	cytotoxic
CMNPD8959	cytotoxic
CMNPD8960	cytotoxic
CMNPD8961	potent cytotoxic agent
CMNPD8965	induce p56lck-CD4 dissociation
CMNPD8966	induce p56lck-CD4 dissociation
CMNPD8967	induce p56lck-CD4 dissociation
CMNPD8968	induce p56lck-CD4 dissociation
CMNPD8973	anticholinesterase
CMNPD8974	cytotoxicity | antimicrobial
CMNPD8976	cytotoxic
CMNPD8977	topoisomerase II inhibitor
CMNPD8980	mild cytotoxicity
CMNPD8983	cytotoxic
CMNPD8984	inhibit macrophagic NO synthase induced by LPS without significant cytotoxicity
CMNPD8986	protein kinase C inhibitor
CMNPD8987	protein kinase C inhibitor
CMNPD8988	cytotoxin
CMNPD8989	antihistaminic activity
CMNPD8990	antihistaminic activity
CMNPD8991	tyrosine kinase inhibitor
CMNPD8992	tyrosine kinase inhibitor
CMNPD8993	tyrosine kinase inhibitor
CMNPD8994	tyrosine kinase inhibitor
CMNPD8996	inhibit cyclin dependent kinase 4 (cdk4)
CMNPD8998	antagonist of serotonergic receptors of the rabbit aorta
CMNPD9000	inhibit larval settlement and metamorphosis of the barnacle Balanus amphitrite
CMNPD9017	inhibitor of interleukin-8 receptors and protein kinase C
CMNPD9018	inhibitor of interleukin-8 receptors and protein kinase C
CMNPD9019	inhibitor of interleukin-8 receptors and protein kinase C
CMNPD9020	inhibitor of interleukin-8 receptors and protein kinase C
CMNPD9021	inhibitor of interleukin-8 receptors and protein kinase C
CMNPD9022	cytotoxic
CMNPD9023	cytotoxic
CMNPD9031	moderate antimicrobial | inhibite Na+/K+-ATPase PLA2
CMNPD9032	moderate antimicrobial | inhibite Na+/K+-ATPase PLA2
CMNPD9033	moderate antimicrobial | inhibite Na+/K+-ATPase PLA2
CMNPD9034	moderate antimicrobial | inhibite Na+/K+-ATPase PLA2
CMNPD9035	moderate antimicrobial | inhibite Na+/K+-ATPase PLA2
CMNPD9036	moderate antimicrobial | inhibite Na+/K+-ATPase PLA2
CMNPD9037	moderate antimicrobial | inhibite Na+/K+-ATPase PLA2
CMNPD9042	modest in vitro antimalarial activity
CMNPD9046	antifungal | cleave both single- and double-stranded RNA
CMNPD9047	antifungal
CMNPD9077	inhibitor of algal fouling
CMNPD9079	weakly cytotoxic
CMNPD9080	weakly cytotoxic
CMNPD9081	weakly cytotoxic
CMNPD9087	toxic to brine shrimp Artemia salina
CMNPD9088	toxic to brine shrimp Artemia salina
CMNPD9091	cytotoxic
CMNPD9092	cytotoxic
CMNPD9093	cytotoxic
CMNPD9094	macrophage activation inhibitor
CMNPD9095	macrophage activation inhibitor
CMNPD9096	cytotoxic
CMNPD9097	cytotoxic
CMNPD9098	cytotoxic
CMNPD9099	cytotoxic
CMNPD9100	cytotoxic
CMNPD9101	cytotoxic
CMNPD9102	cytotoxic
CMNPD9103	cytotoxic
CMNPD9104	cytotoxic
CMNPD9105	cytotoxic
CMNPD9119	cdc25A protein phosphatase inhibitor
CMNPD9123	antileukemia activity
CMNPD9124	phospholipase C inhibitor
CMNPD9150	antimicrobial
CMNPD9151	cytotoxic
CMNPD9152	inhibit the growth of Gram positive bacteria
CMNPD9167	promising treatment for osteoporosis
CMNPD9174	inhibitor of macrophage scavenger receptors
CMNPD9175	insecticidal towards larvae of the pest insect Spodoptera littoralis
CMNPD9176	insecticidal towards larvae of the pest insect Spodoptera littoralis
CMNPD9193	ichthyotoxicity | brine shrimp lethality
CMNPD9194	antimicrobial
CMNPD9198	antiinflammatory | cytotoxic
CMNPD9199	antiinflammatory | cytotoxic
CMNPD9200	antiinflammatory | cytotoxic
CMNPD9201	cytotoxic
CMNPD9202	cytotoxic
CMNPD9204	cytotoxin
CMNPD9205	inhibit superoxide production in rabbit-cell neutrophils
CMNPD9217	cytotoxic
CMNPD9218	cytotoxic
CMNPD9219	cytotoxic
CMNPD9220	cytotoxic
CMNPD9236	potent DNA topoisomerase I inhibitor
CMNPD9237	potent DNA topoisomerase I inhibitor
CMNPD9238	antibiotics
CMNPD9239	antibiotics
CMNPD9240	antibiotics
CMNPD9241	antibiotics
CMNPD9245	ichthyotoxic
CMNPD9246	ichthyotoxic
CMNPD9247	ichthyotoxic
CMNPD9248	ichthyotoxic
CMNPD9249	ichthyotoxic
CMNPD9255	cytotoxic
CMNPD9256	cytotoxic
CMNPD9257	cytotoxic
CMNPD9258	cytotoxic
CMNPD9259	cytotoxic
CMNPD9260	cytotoxic
CMNPD9261	cytotoxic
CMNPD9284	ichthyotoxic
CMNPD9285	ichthyotoxic
CMNPD9286	mildly cytotoxic
CMNPD9287	mildly cytotoxic
CMNPD9288	mildly cytotoxic
CMNPD9289	mildly cytotoxic
CMNPD9305	cytotoxic
CMNPD9306	cytotoxic
CMNPD9309	potent inhibitor of the Macrophage Scavenger Receptor
CMNPD9310	cytotoxic
CMNPD9311	cytotoxic
CMNPD9312	active in a yeast-based assay for DNA damaging activity
CMNPD9313	active in a yeast-based assay for DNA damaging activity
CMNPD9314	active in a yeast-based assay for DNA damaging activity
CMNPD9315	active in a DNA damaging assay
CMNPD9319	inhibit interleukin-8 receptors
CMNPD9335	inhibit predation by fish
CMNPD9336	inhibit predation by fish
CMNPD9337	inhibit predation by fish
CMNPD9338	inhibit predation by fish
CMNPD9341	cytotoxicity
CMNPD9342	cytotoxicity
CMNPD9343	cytotoxicity
CMNPD9344	cytotoxicity
CMNPD9345	cytotoxicity
CMNPD9346	cytotoxicity
CMNPD9347	cytotoxicity
CMNPD9348	cytotoxicity
CMNPD9349	cytotoxicity
CMNPD9350	cytotoxicity
CMNPD9351	cytotoxicity
CMNPD9352	cytotoxicity
CMNPD9353	cytotoxicity
CMNPD9369	inhibit the growth of marine bacteria
CMNPD9370	inhibit the growth of marine bacteria
CMNPD9371	inhibit the growth of marine bacteria
CMNPD9372	inhibit the growth of marine bacteria
CMNPD9373	inhibit the growth of marine bacteria
CMNPD9374	inhibit the growth of marine bacteria
CMNPD9375	inhibit the growth of marine bacteria
CMNPD9376	inhibit the growth of marine bacteria
CMNPD9383	cytotoxic
CMNPD9384	cytotoxic
CMNPD9386	cause human intoxication
CMNPD9390	phytotoxic | antimicroalgal agent
CMNPD9398	antibiotic
CMNPD9399	antibiotic
CMNPD9400	plant growth promotion activity
CMNPD9401	inhibit endothelin converting enzyme
CMNPD9402	antiviral agent
CMNPD9404	significant cytotoxicity against the HCT-116 cell line | moderately selective cytotoxicity against a panel of renal tumor cell lines
CMNPD9413	cytotoxic
CMNPD9414	cytotoxic
CMNPD9416	cytotoxic
CMNPD9417	cytotoxic
CMNPD9418	cytotoxic
CMNPD9421	inhibit CD45 protein tyrosine phosphatase
CMNPD9423	inhibit P388 leukemia cells
CMNPD9424	antialgal agent
CMNPD9425	antialgal agent
CMNPD9426	antialgal agent
CMNPD9428	cytotoxic
CMNPD9429	cytotoxic
CMNPD9430	cytotoxic
CMNPD9431	cytotoxic
CMNPD9434	antimicrobial
CMNPD9435	significant activity against P388 cells
CMNPD9436	significant activity against P388 cells
CMNPD9437	significant activity against P388 cells
CMNPD9438	significant activity against P388 cells
CMNPD9439	significant activity against P388 cells
CMNPD9440	significant activity against P388 cells
CMNPD9441	significant activity against P388 cells
CMNPD9442	significant activity against P388 cells
CMNPD9443	cytotoxic
CMNPD9444	cytotoxic
CMNPD9445	antifungal
CMNPD9446	antifungal
CMNPD9447	antifungal
CMNPD9448	cytotoxic
CMNPD9449	cytotoxic
CMNPD9450	inhibit the growth of the unicellular alga Dunaliella sp.
CMNPD9451	inhibit the growth of the unicellular alga Dunaliella sp.
CMNPD9452	fungistatic
CMNPD9456	antimitotic agent
CMNPD9458	modestcannabinoid receptor binding activity
CMNPD9459	modestcannabinoid receptor binding activity
CMNPD9460	toxin
CMNPD9467	moderately cytotoxic
CMNPD9482	inhibit the growth of the co-occurring thaustrochytrid Schizochytrium aggregatum
CMNPD9498	antifungal
CMNPD9499	ichthyotoxic agent
CMNPD9508	potent inhibitor of eukaryotic DNA polymerases and HIV-1 reverse transcriptase type 1
CMNPD9528	moderate in vitro anthelmintic activity against the parasitant stage of Nippostrongylus brasiliensis
CMNPD9536	anthelmintic
CMNPD9537	anthelmintic
CMNPD9538	inhibitor of lipid peroxidation
CMNPD9544	inhibit fouling by macroalgae
CMNPD9550	inhibit phospholipase A2 or show evidence of cytotoxicity
CMNPD9551	inhibit phospholipase A2 or show evidence of cytotoxicity
CMNPD9552	inhibit phospholipase A2 or show evidence of cytotoxicity
CMNPD9553	inhibit phospholipase A2 or show evidence of cytotoxicity
CMNPD9554	inhibit phospholipase A2 or show evidence of cytotoxicity
CMNPD9555	inhibit phospholipase A2 or show evidence of cytotoxicity
CMNPD9556	inhibit phospholipase A2 or show evidence of cytotoxicity
CMNPD9557	inhibit phospholipase A2 or show evidence of cytotoxicity
CMNPD9558	inhibit phospholipase A2 or show evidence of cytotoxicity
CMNPD9559	inhibit phospholipase A2 or show evidence of cytotoxicity
CMNPD9560	inhibit phospholipase A2 or show evidence of cytotoxicity
CMNPD9561	inhibit phospholipase A2 or show evidence of cytotoxicity
CMNPD9562	inhibit phospholipase A2 or show evidence of cytotoxicity
CMNPD9563	inhibit phospholipase A2 or show evidence of cytotoxicity
CMNPD9564	inhibit phospholipase A2 or show evidence of cytotoxicity
CMNPD9567	cytotoxin
CMNPD9568	cytotoxin
CMNPD9569	cytotoxin
CMNPD9570	cytotoxin
CMNPD9571	cytotoxin
CMNPD9572	cytotoxin
CMNPD9575	cytotoxic
CMNPD9576	cytotoxic
CMNPD9577	cytotoxin
CMNPD9578	cytotoxic
CMNPD9584	antileishmanial
CMNPD9585	antileishmanial
CMNPD9593	cytotoxic
CMNPD9594	in vitro activity against solid tumors but lacked in vivo activity
CMNPD9595	cytotoxic
CMNPD9603	moderately cytotoxic
CMNPD9604	cytotoxic
CMNPD9605	cytotoxic
CMNPD9609	cytotoxin | potent inhibitor of types 1 and 2A serine/threonine protein phosphatases
CMNPD9610	cytotoxin | potent inhibitor of types 1 and 2A serine/threonine protein phosphatases
CMNPD9611	cytotoxin | potent inhibitor of types 1 and 2A serine/threonine protein phosphatases
CMNPD9612	potent inhibitor of tumor cell proliferation
CMNPD9613	serine-threonine phosphatase inhibitor
CMNPD9614	serine-threonine phosphatase inhibitor
CMNPD9615	serine-threonine phosphatase inhibitor
CMNPD9616	potent but scarce antitumor agent
CMNPD9617	potent immunosuppressive agent
CMNPD9618	potent antitumor agent
CMNPD9621	histamine-H3 antagonist
CMNPD9622	antifouling agent
CMNPD9623	cytotoxic
CMNPD9636	cytotoxic
CMNPD9642	antimicrobial
CMNPD9643	antiproliferative
CMNPD9644	antiproliferative
CMNPD9645	antiifungal
CMNPD9646	antiifungal
CMNPD9647	antiifungal
CMNPD9648	potent serine protease inhibitor
CMNPD9649	potent serine protease inhibitor
CMNPD9651	cytotoxic
CMNPD9652	cytotoxic
CMNPD9653	antifungal
CMNPD9654	cytotoxic
CMNPD9655	cytotoxin
CMNPD9656	cytotoxic
CMNPD9657	potent inhibitor of vascular cell adhesion molecule-1 (VCAM-1)
CMNPD9672	serine-threonine protein phosphatase inhibitor
CMNPD9673	insecticidal | cytotoxicity
CMNPD9674	antimicrobial
CMNPD9675	antimicrobial
CMNPD9678	cytotoxic
CMNPD9679	cytotoxic
CMNPD9680	cytotoxic
CMNPD9681	cytotoxic
CMNPD9707	inhibit c-erbB-2 kinase and cyclindependent kinase 4
CMNPD9708	inhibit c-erbB-2 kinase and cyclindependent kinase 4
CMNPD9721	moderate antibacterial
CMNPD9722	moderate antibacterial
CMNPD9724	cystein protease inhibitor
CMNPD9726	cytotoxic | interfering with or damaging DNA
CMNPD9728	inhibit HIV-1 in the NCI primary screen
CMNPD9729	inhibit HIV-1 in the NCI primary screen
CMNPD9734	active in the brine shrimp lethality assay
CMNPD9735	inhibit activity of the motor protein kinesin by interfering with the binding of kinesin to microtubules.
CMNPD9736	cytotoxic
CMNPD9737	cytotoxic
CMNPD9739	potentantifouling activity against larvae of the barnacle Balanus amphitrite
CMNPD9740	potentantifouling activity against larvae of the barnacle Balanus amphitrite
CMNPD9741	potentantifouling activity against larvae of the barnacle Balanus amphitrite
CMNPD9742	potentantifouling activity against larvae of the barnacle Balanus amphitrite
CMNPD9747	cytotoxic
CMNPD9766	antimicrobial
CMNPD9767	antimicrobial
CMNPD9769	cytotoxic
CMNPD9770	cytotoxic
CMNPD9771	cytotoxic
CMNPD9772	cytotoxicity
CMNPD9773	cytotoxicity
CMNPD9774	cytotoxicity
CMNPD9775	cytotoxicity | Antimalarial (IC50 = 1.6, 2.2 μM vs P. falciparum strain W2 and D6), selectivity = 7.0, 5.1
CMNPD9776	cytotoxicity
CMNPD9777	cytotoxicity
CMNPD9778	antimalarial
CMNPD9779	antimalarial
CMNPD9785	potent inhibitor of gastrulation in starfish (Asterina pectinifera) embryos
CMNPD9786	potent inhibitor of gastrulation in starfish (Asterina pectinifera) embryos
CMNPD9787	serine protease inhibitor
CMNPD9788	serine protease inhibitor
CMNPD9791	inhibitor of human secretory phospholipase A2
CMNPD9792	potent and selective phospholipase A2 inhibitor
CMNPD9793	potent and selective phospholipase A2 inhibitor
CMNPD9794	potent and selective phospholipase A2 inhibitor
CMNPD9795	potent and selective phospholipase A2 inhibitor
CMNPD9796	potent and selective phospholipase A2 inhibitor
CMNPD9799	cytotoxic
CMNPD9800	cytotoxic
CMNPD9801	cytotoxic
CMNPD9802	cytotoxic
CMNPD9803	cytotoxic
CMNPD9804	cytotoxic
CMNPD9805	cytotoxic
CMNPD9806	cytotoxic
CMNPD9807	cytotoxic
CMNPD9816	cdc25A protein phosphatase inhibitor
CMNPD9818	reverse multidrug resistance in carcinoma cells caused by overexpression of two membrane glycoproteins
CMNPD9829	antifungal activity against Saccharomyces cervisiae A364A and its mutants at 0.1 mg per disk
CMNPD9830	antifungal activity against Saccharomyces cervisiae A364A and its mutants at 0.1 mg per disk
CMNPD9831	cytotoxic
CMNPD9833	inhibitor of gastrulation of starfish embryos
CMNPD9834	inhibitor of gastrulation of starfish embryos
CMNPD9840	significant inhibition of osteoporosis
CMNPD9841	significant inhibition of osteoporosis
CMNPD9842	significant inhibition of osteoporosis
CMNPD9843	significant inhibition of osteoporosis
CMNPD9867	cytotoxic
CMNPD9868	cytotoxic
CMNPD9869	cytotoxic
CMNPD9877	cytotoxic
CMNPD9908	significant antitumor activity
CMNPD9911	cytotoxic
CMNPD9917	ichthyotoxic
CMNPD9918	ichthyotoxic
CMNPD9919	cytotoxic
CMNPD9920	cytotoxic
CMNPD9921	cytotoxic
CMNPD9922	cytotoxic
CMNPD9923	cytotoxic
CMNPD9928	cytotoxic
CMNPD9929	cytotoxic
CMNPD9930	cytotoxic
CMNPD9931	cytotoxic
CMNPD9932	cytotoxic
CMNPD9933	cytotoxic
CMNPD9934	cytotoxic
CMNPD9935	cytotoxic
CMNPD9937	cytotoxic | PLA2 inhibitory
CMNPD9938	cytotoxic | PLA2 inhibitory
CMNPD9939	cytotoxic | PLA2 inhibitory
CMNPD9940	cytotoxic | PLA2 inhibitory | inhibitor of cell division in fertilized starfish eggs
CMNPD9951	antineoplastic agent
CMNPD9952	cytotoxic
CMNPD9953	cytotoxic
CMNPD9965	antimicrobial
CMNPD9966	antimicrobial
CMNPD9967	antimicrobial
CMNPD9968	cytotoxic
CMNPD9969	cytotoxic
CMNPD9970	cytotoxic
CMNPD9971	cytotoxic
CMNPD9972	cytotoxic
CMNPD9973	cytotoxic
CMNPD9975	antifouling agent
CMNPD9981	diarrhetic shellfish toxin
CMNPD9984	toxin
CMNPD9991	cytotoxic
CMNPD9992	cytotoxic
CMNPD9993	cytotoxic
CMNPD9994	cytotoxic
CMNPD10007	weakly cytotoxic
CMNPD10013	inhibit cyclin dependent kinase 4 and c-erbB-2 kinase
CMNPD10015	antibacterial agent
CMNPD10016	G2 cell cycle checkpoint inhibitor
CMNPD10017	G2 cell cycle checkpoint inhibitor
CMNPD10020	cytotoxic
CMNPD10021	cytotoxic
CMNPD10022	cytotoxic
CMNPD10023	cytotoxic
CMNPD10024	cytotoxic
CMNPD10028	mildly cytotoxic
CMNPD10029	mildly cytotoxic
CMNPD10030	mildly cytotoxic
CMNPD10031	mildly cytotoxic
CMNPD10035	cytotoxic
CMNPD10036	cytotoxic
CMNPD10038	cytotoxic
CMNPD10039	cytotoxic
CMNPD10045	toxic to brine shrimp
CMNPD10046	toxic to brine shrimp
CMNPD10047	toxic to brine shrimp
CMNPD10048	toxic to brine shrimp
CMNPD10049	euritogenic activity toward the rat pheochromocytoma PC-12 cell line
CMNPD10050	neuritogenic activity
CMNPD10051	neuritogenic activity
CMNPD10052	neuritogenic activity
CMNPD10070	moderately cytotoxic
CMNPD10071	moderately cytotoxic
CMNPD10072	moderately cytotoxic
CMNPD10073	moderately cytotoxic
CMNPD10074	moderately cytotoxic
CMNPD10075	moderately cytotoxic
CMNPD10076	moderately cytotoxic
CMNPD10077	moderately cytotoxic
CMNPD10078	moderately cytotoxic
CMNPD10079	moderately cytotoxic
CMNPD10084	cytotoxin
CMNPD10085	cytotoxin
CMNPD10086	potent cytotoxin
CMNPD10104	antifungal agent
CMNPD10105	antifungal agent
CMNPD10112	antiinflammatory
CMNPD10113	antiinflammatory
CMNPD10116	cytotoxic
CMNPD10117	antibiotic | inhibit methicillin-resistant Staphylococcus aureus, vancomycin-resistant enterococci and drug-resistant Streptococcus pneumoniae
CMNPD10118	antibiotic | inhibit methicillin-resistant Staphylococcus aureus, vancomycin-resistant enterococci and drug-resistant Streptococcus pneumoniae
CMNPD10119	antibiotic | inhibit methicillin-resistant Staphylococcus aureus, vancomycin-resistant enterococci and drug-resistant Streptococcus pneumoniae
CMNPD10120	antibiotic | inhibit methicillin-resistant Staphylococcus aureus, vancomycin-resistant enterococci and drug-resistant Streptococcus pneumoniae
CMNPD10121	minor antiinflammatory
CMNPD10122	minor antiinflammatory
CMNPD10123	minor antiinflammatory
CMNPD10124	minor antiinflammatory
CMNPD10125	minor antiinflammatory
CMNPD10126	cytotoxin | significant antiinflammatory
CMNPD10127	cytotoxin
CMNPD10128	cytotoxin
CMNPD10131	antibiotic
CMNPD10132	inhibit the enzyme diacylglycerol acyl transferase (DGAT)
CMNPD10133	inhibit the enzyme diacylglycerol acyl transferase (DGAT)
CMNPD10134	inhibit the enzyme diacylglycerol acyl transferase (DGAT)
CMNPD10135	inhibit the enzyme diacylglycerol acyl transferase (DGAT)
CMNPD10136	significant cytotoxicity against cultured P388 cells
CMNPD10143	significant cytotoxicity against cultured P388 cells
CMNPD10144	significant cytotoxicity against cultured P388 cells
CMNPD10145	significant cytotoxicity against cultured P388 cells
CMNPD10146	mild antibacterial activity
CMNPD10147	DNA cleaving | antitumour | antibiotic
CMNPD10148	DNA cleaving | antitumour | antibiotic
CMNPD10149	DNA cleaving | antitumour | antibiotic
CMNPD10150	DNA cleaving | antitumour | antibiotic
CMNPD10151	DNA cleaving | antitumour | antibiotic
CMNPD10152	mild antimicrobial activity
CMNPD10153	tyrosine kinase (p56lck) inhibitor
CMNPD10158	potent in vitro cytotoxicity against the HCT-116 cell line
CMNPD10159	potent in vitro cytotoxicity against the HCT-116 cell line
CMNPD10160	selective cytotoxicity against the COLO 205 and SK-MEL-2 cell lines, inhibit molluscum contagiosum virus (MCV) topoisomerase
CMNPD10163	potent antifungal
CMNPD10165	significant cytotoxicity
CMNPD10174	toxic and antifungal
CMNPD10183	cytotoxic
CMNPD10184	cytotoxic
CMNPD10185	cytotoxic
CMNPD10186	cytotoxic
CMNPD10188	ichthyotoxic
CMNPD10197	inhibit DNA polymerases α and β
CMNPD10199	cytotoxicity
CMNPD10202	toxic
CMNPD10203	hemolytic | icthyotoxic
CMNPD10204	hemolytic | icthyotoxic
CMNPD10206	potent serine/threonine-specific protein phosphatase inhibitor
CMNPD10210	active in the constitutive nitric oxide synthetase assay
CMNPD10219	tyrosine kinase inhibitor
CMNPD10258	inhibitor of cholesterol biosynthesis
CMNPD10259	inhibitor of cholesterol biosynthesis
CMNPD10260	inhibitor of cholesterol biosynthesis
CMNPD10261	inhibitor of cholesterol biosynthesis
CMNPD10262	inhibit in vitro SV40 DNA replication
CMNPD10263	antifungal
CMNPD10264	inhibit proliferation of activated T-cells by a non-cytotoxic mechanism
CMNPD10265	inhibit proliferation of activated T-cells by a non-cytotoxic mechanism
CMNPD10266	inhibit proliferation of activated T-cells by a non-cytotoxic mechanism
CMNPD10267	inhibit proliferation of activated T-cells by a non-cytotoxic mechanism
CMNPD10268	inhibit proliferation of activated T-cells by a non-cytotoxic mechanism
CMNPD10269	cytotoxic
CMNPD10270	cytotoxic
CMNPD10271	cytotoxic
CMNPD10272	cytotoxic
CMNPD10273	reverse the phenotype of melanoma H-ras transformed NIH3T3 cells
CMNPD10274	reverse the phenotype of melanoma H-ras transformed NIH3T3 cells
CMNPD10276	weak cytotoxicity against a human leukemia cell-line (K-562)
CMNPD10277	weak cytotoxicity against a human leukemia cell-line (K-562)
CMNPD10278	weak cytotoxicity against a human leukemia cell-line (K-562)
CMNPD10279	weak cytotoxicity against a human leukemia cell-line (K-562)
CMNPD10280	weak cytotoxicity against a human leukemia cell-line (K-562)
CMNPD10281	weak cytotoxicity against a human leukemia cell-line (K-562)
CMNPD10282	weak cytotoxicity against a human leukemia cell-line (K-562)
CMNPD10283	cytotoxic
CMNPD10284	cytotoxic
CMNPD10285	cytotoxic
CMNPD10286	cytotoxic
CMNPD10287	cytotoxic
CMNPD10288	cytotoxic
CMNPD10289	cytotoxic
CMNPD10296	cytotoxic
CMNPD10305	significantly reduce proliferation of rheumatoid synovial fibroblasts
CMNPD10306	significantly reduce proliferation of rheumatoid synovial fibroblasts
CMNPD10307	significantly reduce proliferation of rheumatoid synovial fibroblasts
CMNPD10308	significantly reduce proliferation of rheumatoid synovial fibroblasts
CMNPD10310	antifungal | cytotoxic
CMNPD10311	antifungal | cytotoxic
CMNPD10312	antifungal | cytotoxic
CMNPD10313	antifungal | cytotoxic
CMNPD10314	antifungal | cytotoxic
CMNPD10315	antimitotic agent
CMNPD10320	nematocidal activity
CMNPD10321	cytotoxic
CMNPD10322	cytotoxic
CMNPD10323	cytotoxic
CMNPD10324	cytotoxic
CMNPD10325	cytotoxic
CMNPD10326	antifungal and cytotoxic
CMNPD10327	cytotoxic
CMNPD10328	cytotoxic
CMNPD10329	cytotoxic
CMNPD10330	cytotoxic
CMNPD10331	antifungal | cytotoxic
CMNPD10333	antifungal activity
CMNPD10334	antifungal activity
CMNPD10335	antifungal activity
CMNPD10336	induce large intracellular vacuoles in 3Y1 rat fibroblasts
CMNPD10337	induce large intracellular vacuoles in 3Y1 rat fibroblasts
CMNPD10338	induce large intracellular vacuoles in 3Y1 rat fibroblasts
CMNPD10339	induce large intracellular vacuoles in 3Y1 rat fibroblasts
CMNPD10340	induce large intracellular vacuoles in 3Y1 rat fibroblasts
CMNPD10341	induce large intracellular vacuoles in 3Y1 rat fibroblasts
CMNPD10342	induce large intracellular vacuoles in 3Y1 rat fibroblasts
CMNPD10343	induce large intracellular vacuoles in 3Y1 rat fibroblasts
CMNPD10344	weakly cytotoxic
CMNPD10345	inhibitor of VCAM-1 expression
CMNPD10346	serine-threonine phosphatase inhibitor
CMNPD10347	serine-threonine phosphatase inhibitor
CMNPD10348	serine-threonine phosphatase inhibitor
CMNPD10362	cytotoxic
CMNPD10363	weak immunosuppressive activity
CMNPD10364	weak immunosuppressive activity
CMNPD10365	weak immunosuppressive activity
CMNPD10366	striking differential cytotoxicity patterns against a panel of human tumour cell lines
CMNPD10367	striking differential cytotoxicity patterns against a panel of human tumour cell lines
CMNPD10368	striking differential cytotoxicity patterns against a panel of human tumour cell lines
CMNPD10376	antifungal agent
CMNPD10377	inhibit the hepatitis B virus
CMNPD10378	inhibit the hepatitis B virus
CMNPD10379	inhibit the hepatitis B virus
CMNPD10381	induce p56lck-CD4 dissociation
CMNPD10382	induce p56lck-CD4 dissociation
CMNPD10385	potent antitumor activity
CMNPD10386	cytotoxic
CMNPD10389	cytotoxic | inhibit calcineurin | inhibit the peptidase activity of CPP32
CMNPD10390	cytotoxic | inhibit calcineurin
CMNPD10392	cytotoxic
CMNPD10394	cytotoxic
CMNPD10395	pyridoacridine topoisomerase II inhibitor
CMNPD10397	moderately active cytotoxic agent
CMNPD10398	moderately active cytotoxic agent
CMNPD10407	cytotoxic
CMNPD10408	cathepsin B inhibitor with potential anticancer activity
CMNPD10409	cytotoxic
CMNPD10410	serine protease inhibitor
CMNPD10411	serine protease inhibitor
CMNPD10412	serine protease inhibitor
CMNPD10413	serine protease inhibitor
CMNPD10414	serine protease inhibitor
CMNPD10415	serine protease inhibitor
CMNPD10422	cytotoxic | HIV-inhibitory
CMNPD10423	cytotoxic | HIV-inhibitory
CMNPD10424	cytotoxic | HIV-inhibitory
CMNPD10425	cytotoxic | HIV-inhibitory
CMNPD10433	cytotoxic
CMNPD10436	Na,K-ATPase inhibitor
CMNPD10447	antibacterial agent
CMNPD10448	antibacterial agent
CMNPD10449	antibacterial agent
CMNPD10450	antibacterial agent
CMNPD10452	cytotoxic
CMNPD10454	antibacterial
CMNPD10455	antibacterial
CMNPD10456	antibacterial
CMNPD10457	antibacterial
CMNPD10459	toxin to brine shrimp
CMNPD10460	β-adrenoceptor agonist
CMNPD10468	inhibitor of α1,3-fucosyltransferase VII
CMNPD10469	inhibitor of α1,3-fucosyltransferase VII
CMNPD10472	inhibitor of kinesin motor proteins
CMNPD10473	inhibitor of kinesin motor proteins
CMNPD10474	inhibitor of kinesin motor proteins
CMNPD10475	inhibitor of kinesin motor proteins
CMNPD10476	inhibitor of kinesin motor proteins
CMNPD10477	inhibitor of kinesin motor proteins
CMNPD10478	inhibit vacuolar H+-ATPase
CMNPD10479	inhibit vacuolar H+-ATPase
CMNPD10481	inhibitor of phosphatidylinositol-specific phospholipase C
CMNPD10485	antifouling agent
CMNPD10490	moderately cytotoxic
CMNPD10491	moderately cytotoxic
CMNPD10492	moderately cytotoxic
CMNPD10493	moderately cytotoxic
CMNPD10500	antibacterial | Ca2/calmodulin-dependent phosphodiesterase inhibitor
CMNPD10501	inhibit Ca2/calmodulin-dependent phosphodiesterase
CMNPD10502	inhibit Ca2/calmodulin-dependent phosphodiesterase
CMNPD10503	inhibit Ca2/calmodulin-dependent phosphodiesterase
CMNPD10504	inhibit Ca2/calmodulin-dependent phosphodiesterase
CMNPD10505	inhibit Ca2/calmodulin-dependent phosphodiesterase
CMNPD10506	cytotoxic
CMNPD10507	cytotoxic
CMNPD10533	cytotoxic
CMNPD10534	cytotoxic
CMNPD10543	cytotoxic
CMNPD10544	antifouling agent
CMNPD10545	antifouling agent
CMNPD10556	toxic to brine shrimp
CMNPD10557	significant cytotoxicity
CMNPD10558	significant cytotoxicity
CMNPD10559	significant cytotoxicity
CMNPD10560	significant cytotoxicity
CMNPD10561	significant cytotoxicity
CMNPD10565	inhibitor of HIV-1 integrase
CMNPD10566	inhibitor of HIV-1 integrase
CMNPD10567	inhibitor of HIV-1 integrase
CMNPD10568	inhibitor of HIV-1 integrase
CMNPD10569	cytotoxic
CMNPD10570	cytotoxic
CMNPD10571	cytotoxic
CMNPD10572	cytotoxic
CMNPD10573	cytotoxic
CMNPD10574	cytotoxic
CMNPD10575	cytotoxic
CMNPD10576	cytotoxic
CMNPD10577	cytotoxic
CMNPD10578	cytotoxic
CMNPD10579	cytotoxic
CMNPD10580	cytotoxic | antimicrobial
CMNPD10581	cytotoxic | antimicrobial
CMNPD10582	cytotoxic | antimicrobial
CMNPD10583	moderate cytotoxicity
CMNPD10584	moderate cytotoxicity
CMNPD10585	inhibit the release of histamine from rat mast cells
CMNPD10617	H,K-ATPase inhibitor
CMNPD10629	fish feeding deterrent
CMNPD10631	cytotoxic
CMNPD10636	cytotoxic
CMNPD10646	toxic to brine shrimp
CMNPD10647	toxic to brine shrimp
CMNPD10648	toxic to brine shrimp
CMNPD10649	toxic to brine shrimp
CMNPD10669	cytotoxic
CMNPD10670	cytotoxic
CMNPD10671	cytotoxic
CMNPD10690	cytotoxic
CMNPD10691	cytotoxic
CMNPD10692	cytotoxic
CMNPD10693	cytotoxic
CMNPD10694	cytotoxic
CMNPD10695	cytotoxic
CMNPD10696	cytotoxic
CMNPD10697	cytotoxic
CMNPD10698	cytotoxic
CMNPD10699	cytotoxic
CMNPD10700	cytotoxic
CMNPD10701	cytotoxic
CMNPD10702	cytotoxic
CMNPD10722	cytotoxic
CMNPD10723	inhibitor of Mycobacterium tuberculosis H37Rv
CMNPD10724	inhibitor of Mycobacterium tuberculosis H37Rv
CMNPD10740	inhibit settlement of the cyprid larvae of the barnacle Balanus amphitrite
CMNPD10741	inhibit settlement of the cyprid larvae of the barnacle Balanus amphitrite
CMNPD10742	inhibit settlement of the cyprid larvae of the barnacle Balanus amphitrite
CMNPD10743	inhibit settlement of the cyprid larvae of the barnacle Balanus amphitrite
CMNPD10744	toxic to the cyprid larvae of B. amphitrite
CMNPD10745	toxic to the cyprid larvae of B. amphitrite
CMNPD10746	toxic to the cyprid larvae of B. amphitrite
CMNPD10747	toxic to the cyprid larvae of B. amphitrite
CMNPD10757	cytotoxic
CMNPD10766	cytotoxic
CMNPD10784	cytotoxic
CMNPD10785	cytotoxic
CMNPD10786	cytotoxic
CMNPD10797	cytotoxic
CMNPD10798	toxic
CMNPD10799	toxic
CMNPD10800	moderate cytotoxicity
CMNPD10801	moderate cytotoxicity
CMNPD10802	toxin
CMNPD10803	toxin
CMNPD10805	toxin
CMNPD10811	inhibit cell division in fertilized sea urchin eggs
CMNPD10822	weakly cytotoxic
CMNPD10823	weakly cytotoxic
CMNPD10824	weakly cytotoxic
CMNPD10830	inhibitor of HIV-1 integrase
CMNPD10831	cytotoxic and antimicrobial agent
CMNPD10834	cytotoxic
CMNPD10835	cytotoxic
CMNPD10851	cytotoxic
CMNPD10863	inhibitor of cell division in fertilized sea urchin eggs
CMNPD10864	inhibitor of cell division in fertilized sea urchin eggs
CMNPD10865	inhibitor of cell division in fertilized sea urchin eggs
CMNPD10866	inhibitor of cell division in fertilized sea urchin eggs
CMNPD10886	inhibitor of sphingosine kinase
CMNPD10887	inhibitor of sphingosine kinase
CMNPD10888	inhibitor of sphingosine kinase
CMNPD10889	mildly antimicrobial
CMNPD10890	mildly antimicrobial
CMNPD10895	antibacterial
CMNPD10896	antibacterial
CMNPD10897	cytotoxic
CMNPD10898	cytotoxin
CMNPD10899	cytotoxin
CMNPD10900	cytotoxin
CMNPD10901	cytotoxin
CMNPD10905	activity against methicillin-resistant Staphylococcus aureus and Burkholderia cepacia
CMNPD10906	potent antitumor | antibiotic
CMNPD10907	cytotoxic
CMNPD10908	cytotoxic
CMNPD10920	tyrosine kinase inhibitor
CMNPD10921	tyrosine kinase inhibitor
CMNPD10922	tyrosine kinase inhibitor
CMNPD10923	tyrosine kinase inhibitor
CMNPD10924	tyrosine kinase inhibitor
CMNPD10925	inhibitor of microtubule assembly
CMNPD10926	potent anti-microtubule activity in a microtubule assembly assay utilising purified porcine brain microtubule proteins
CMNPD10949	weak antibacterial | cytotoxic
CMNPD10950	antimicrobial
CMNPD10951	antimicrobial
CMNPD10952	antimicrobial
CMNPD10953	good anti-inflammatory
CMNPD10961	ichthyotoxic | cytotoxic | neurotoxic | inhibits IL-1β-induced sPLA2 secretion from HepG2 cells
CMNPD10965	toxic to brine shrimp | mildly toxic to goldfish
CMNPD10966	toxic to brine shrimp | mildly toxic to goldfish
CMNPD10971	inhibit hypoxia-induced activation of the VEGF gene promotor in Hep3B human liver tumour cells in vitro
CMNPD10982	cytotoxic | antifungal
CMNPD10983	cytotoxic | antifungal
CMNPD10992	potent cytotoxic
CMNPD10993	potent cytotoxic
CMNPD10997	neurotoxic shellfish poisoning
CMNPD10998	potent antifungal
CMNPD10999	potent antifungal
CMNPD11000	potent antifungal
CMNPD11001	potent antifungal
CMNPD11011	antiinflammatory agent
CMNPD11022	radical scavenger
CMNPD11036	cytotoxic
CMNPD11047	protein phosphatase 2A inhibitor
CMNPD11049	moderate cytotoxicity
CMNPD11050	lipoxygenase inhibitor
CMNPD11051	3-heptacosoxypropane-1,2-diol
CMNPD11054	immunosuppressive agent
CMNPD11055	immunosuppressive agent
CMNPD11057	antifungal agent
CMNPD11062	antimicrobial
CMNPD11063	cytotoxic
CMNPD11064	cytotoxic
CMNPD11065	cytotoxic
CMNPD11066	cytotoxic
CMNPD11067	cytotoxic
CMNPD11068	cytotoxic
CMNPD11077	induce neuritogenesis in pheochromocytoma PC12 and neuroblastoma Neuro 2A cells
CMNPD11084	reverse the phenotype of ras-transformed cells
CMNPD11085	reverse the phenotype of ras-transformed cells
CMNPD11086	cytotoxin
CMNPD11087	cytotoxin
CMNPD11091	potent cytotoxic
CMNPD11092	tumor cell growth inhibitor
CMNPD11093	tumor cell growth inhibitor
CMNPD11094	α-glucosidase inhibitor
CMNPD11095	α-glucosidase inhibitor
CMNPD11096	cytotoxin
CMNPD11098	antifungal | cytotoxic
CMNPD11102	inhibit the protease cathepsin B
CMNPD11103	selectivity in the National Cancer Institute's 60 cell-line panel
CMNPD11104	selectivity in the National Cancer Institute's 60 cell-line panel
CMNPD11105	cytotoxic | antifungal
CMNPD11106	cytotoxic | antifungal
CMNPD11107	cytotoxic | antifungal
CMNPD11108	cytotoxic | antifungal
CMNPD11120	antifungal | inhibit nitric oxide synthase
CMNPD11123	significant reduction of molting and increased mortality when fed to sympatric predatory amphipods
CMNPD11124	protein kinase C inhibitor
CMNPD11125	moderately active antifungal agent
CMNPD11128	moderately cytotoxic
CMNPD11129	moderately cytotoxic
CMNPD11130	moderately cytotoxic
CMNPD11131	moderately cytotoxic
CMNPD11132	moderately cytotoxic | 85.9% inhib. of delayed rectifier K+ currents in rat dissociated hippocampal neurons at 100 μM
CMNPD11133	moderately cytotoxic
CMNPD11134	potent cytotoxic
CMNPD11135	potent cytotoxic
CMNPD11136	potent cytotoxic
CMNPD11143	cytotoxic agent
CMNPD11144	cytotoxic agent
CMNPD11151	antihistaminic agent
CMNPD11155	mildly cytotoxic | antimicrobial
CMNPD11166	antiviral
CMNPD11167	antibacterial agent
CMNPD11168	minor antimicrobial agent
CMNPD11169	minor antimicrobial agent
CMNPD11170	minor antimicrobial agent
CMNPD11185	inhibit HIV-1
CMNPD11186	inhibit HIV-1
CMNPD11187	inhibit HIV-1
CMNPD11190	potent Na,K-ATPase activity
CMNPD11191	potent Na,K-ATPase activity
CMNPD11192	potent Na,K-ATPase activity
CMNPD11193	potent Na,K-ATPase activity
CMNPD11199	inhibit [3H]-1,3-dipropyl-8-cyclopentylxanthine binding to rat-brain adenosine A1 receptors
CMNPD11200	inhibit [3H]-1,3-dipropyl-8-cyclopentylxanthine binding to rat-brain adenosine A1 receptors
CMNPD11209	selectively inhibit phospholipase A2
CMNPD11216	inhibit the kinesin family of motor proteins
CMNPD11236	moderately cytotoxic
CMNPD11237	moderately cytotoxic
CMNPD11238	in vitro antiviral activity
CMNPD11239	moderately cytotoxic
CMNPD11240	moderately cytotoxic
CMNPD11241	moderately cytotoxic
CMNPD11242	moderately cytotoxic
CMNPD11243	moderately cytotoxic
CMNPD11244	cytotoxic
CMNPD11245	cytotoxic
CMNPD11246	cytotoxic
CMNPD11247	cytotoxic
CMNPD11248	cytotoxic
CMNPD11252	cytotoxic
CMNPD11256	antiinflammatory agent
CMNPD11257	antiinflammatory agent
CMNPD11258	antiinflammatory agent
CMNPD11259	antiinflammatory agent
CMNPD11260	antiinflammatory agent
CMNPD11261	antiinflammatory agent
CMNPD11262	cytotoxic
CMNPD11263	cytotoxic
CMNPD11264	cytotoxic
CMNPD11265	cytotoxic
CMNPD11280	cytotoxic
CMNPD11281	mildly cytotoxic
CMNPD11285	cytotoxic
CMNPD11286	cytotoxic
CMNPD11287	cytotoxic
CMNPD11288	cytotoxic
CMNPD11289	cytotoxic
CMNPD11290	cytotoxic
CMNPD11291	cytotoxic
CMNPD11292	cytotoxic
CMNPD11293	cytotoxic
CMNPD11294	cytotoxic
CMNPD11295	inhibit the binding of IL-8 to the human recombinant IL-8 receptor type A
CMNPD11296	inhibit the binding of IL-8 to the human recombinant IL-8 receptor type A
CMNPD11297	inhibit the binding of IL-8 to the human recombinant IL-8 receptor type A
CMNPD11301	potent thrombin receptor antagonist that inhibits human platelet aggregation in vitro
CMNPD11304	cytotoxic
CMNPD11310	induce morphological changes in rat fibroblasts
CMNPD11311	induce morphological changes in rat fibroblasts
CMNPD11312	induce morphological changes in rat fibroblasts
CMNPD11337	potent fish feeding inhibitor
CMNPD11338	potent fish feeding inhibitor
CMNPD11339	cytotoxic
CMNPD11340	cytotoxic
CMNPD11341	cytotoxic
CMNPD11342	cytotoxic
CMNPD11343	cytotoxic
CMNPD11361	antifungal
CMNPD11372	antimicrobial
CMNPD11373	antimicrobial
CMNPD11377	cytotoxic
CMNPD11378	HIV-inhibitory agent
CMNPD11379	cytotoxic
CMNPD11380	cytotoxic
CMNPD11381	cytotoxic
CMNPD11382	significant cytotoxicity
CMNPD11393	cytotoxic
CMNPD11400	cytotoxic
CMNPD11412	strong in vitro anti-tuberculosis activity
CMNPD11425	modest anti-cancer activity
CMNPD11430	fish feeding inhibitor
CMNPD11431	fish feeding inhibitor
CMNPD11442	mildly cytotoxic | inhibit phospholipase A2
CMNPD11459	inhibit the binding of [3H]-1,3-dipropyl-8-cyclopentylxanthine on adenosine A1 receptors
CMNPD11460	inhibit the binding of [3H]-1,3-dipropyl-8-cyclopentylxanthine on adenosine A1 receptors
CMNPD11466	moderate cytotoxicity
CMNPD11481	cytotoxic
CMNPD11482	cytotoxic
CMNPD11483	cytotoxic
CMNPD11484	cytotoxic
CMNPD11486	cytotoxic
CMNPD11487	cytotoxic
CMNPD11488	cytotoxic
CMNPD11489	cytotoxic
CMNPD11490	antifungal agent
CMNPD11500	mildly cytotoxic
CMNPD11504	cytotoxic
CMNPD11505	cytotoxic
CMNPD11506	cytotoxic
CMNPD11507	cytotoxic
CMNPD11511	mildly cytotoxic
CMNPD11533	cytotoxic
CMNPD11535	inhibitor of phospholipase A2
CMNPD11542	diarrhetic shellfish poisoning
CMNPD11552	inhibit phospholipase A2
CMNPD11560	potent inhibitor of the mitochondrial respiratory chain
CMNPD11562	cytotoxic
CMNPD11563	cytotoxic
CMNPD11564	cytotoxic
CMNPD11565	cytotoxic
CMNPD11566	inhibitor of HIV-1 integrase
CMNPD11567	cytotoxic against P388 murine leukemia cells
CMNPD11568	cytotoxic
CMNPD11573	significant cytotoxicity
CMNPD11574	significant cytotoxicity
CMNPD11575	significant cytotoxicity
CMNPD11576	significant cytotoxicity
CMNPD11577	significant cytotoxicity
CMNPD11578	significant cytotoxicity
CMNPD11581	anti-HIV active
CMNPD11586	in vitro antiproliferative activity
CMNPD11590	cytotoxic
CMNPD11591	cytotoxic
CMNPD11594	cytotoxic agent
CMNPD11607	neuritogenic activity toward the PC-12 rat pheochromocytoma cell line
CMNPD11614	significantly inhibit settlement of the biofouling alga Hincksia irregulatus
CMNPD11615	significantly inhibit settlement of the biofouling alga Hincksia irregulatus
CMNPD11616	significantly inhibit settlement of the biofouling alga Hincksia irregulatus
CMNPD11630	antimicrobial agent
CMNPD11631	antimicrobial agent
CMNPD11632	antimicrobial agent
CMNPD11633	antimicrobial agent
CMNPD11634	antimicrobial agent
CMNPD11635	antimicrobial agent
CMNPD11636	antimicrobial agent
CMNPD11640	selective antimicrobial activity
CMNPD11648	induce both the acylated homoserine lactone (AHL) regulatory system in Agrobacterium tumefaciens and bioluminescence in Vibrio harveyi
CMNPD11649	selective antimicrobial activity
CMNPD11650	selective antimicrobial activity
CMNPD11651	selective antimicrobial activity
CMNPD11652	selective antimicrobial activity
CMNPD11653	selective antimicrobial activity
CMNPD11654	selective antimicrobial activity
CMNPD11655	selective antimicrobial activity
CMNPD11656	reasonably potent activity against both methicillin-resistant Staphylococcus aureus (MRSA) and vancomycin-resistant enterococcal strains (VRE) of bacteria
CMNPD11657	inhibit growth of a wide range of fungi but was inactive against bacteria
CMNPD11658	inhibit the gastrulation of starfish (Asterina pectinifera) embryos
CMNPD11659	inhibit the gastrulation of starfish (Asterina pectinifera) embryos
CMNPD11660	inhibit the gastrulation of starfish (Asterina pectinifera) embryos
CMNPD11661	potent DNA-damaging agent, cytotoxicity, potent antibacterial activity against S. aureus and Enterococcus faecium
CMNPD11662	potent DNA-damaging agent, potent antibacterial activity against S. aureus and Enterococcus faecium
CMNPD11663	slight inhibition of B. subtilis in a disc-diffusion assay
CMNPD11668	potent inhibitor of acetylcholine esterase
CMNPD11675	inhibit sphingomyelinase activity of rat brain membranes
CMNPD11686	inhibitor of anaerobic electron transport, highly selective inhibitor of NADH-fumarate reductase (NFRD) from the pig roundworm Ascaris suum
CMNPD11688	active against human leukaemia HL-60 and murine L1210 cell lines
CMNPD11689	inhibit the adhesion of HL-60 cells to human umbilical vein endothelial cells (HUVEC)
CMNPD11690	inhibit the adhesion of HL-60 cells to human umbilical vein endothelial cells (HUVEC)
CMNPD11693	moderate in vitro cytotoxicity in the National Cancer Institute's (NCI) 60 human tumour cell line panel, potent activity against MRSA and VCE
CMNPD11694	moderate antimalarial activity against Plasmodium falciparum but only weak antimycobacterial activity
CMNPD11697	inhibit cyclin-dependent kinase 4
CMNPD11702	inhibit the growth of B. subtilis and S. aureus in an agar plate diffusion assay
CMNPD11703	moderately cytotoxic to P388 murine leukaemia cells
CMNPD11704	moderately cytotoxic to P388 murine leukaemia cells
CMNPD11705	moderately cytotoxic to P388 murine leukaemia cells
CMNPD11706	moderately cytotoxic to P388 murine leukaemia cells
CMNPD11707	moderately cytotoxic to P388 murine leukaemia cells
CMNPD11708	potent cytotoxicity in vitro against KB and LoVo cell lines, toxic in vivo to mice, poorly tolerated
CMNPD11709	weak cytotoxicity against LoVo cells, active in the antimycobacterial diffusion susceptibility assay
CMNPD11710	weak cytotoxicity against LoVo cells, active in the antimycobacterial diffusion susceptibility assay
CMNPD11711	ichthyotoxic to goldfish and activate sodium channels in mouse neuro-2a neuroblastoma cells
CMNPD11729	modestly cytotoxic (L1210 and KB cell lines)
CMNPD11730	modestly cytotoxic (L1210 and KB cell lines)
CMNPD11731	modestly cytotoxic (L1210 and KB cell lines)
CMNPD11735	“fast-acting” toxicity in the traditional mouse bioassay
CMNPD11736	“fast-acting” toxicity in the traditional mouse bioassay
CMNPD11737	“fast-acting” toxicity in the traditional mouse bioassay
CMNPD11738	“fast-acting” toxicity in the traditional mouse bioassay
CMNPD11739	“fast-acting” toxicity in the traditional mouse bioassay
CMNPD11740	toxic
CMNPD11754	weakly cytotoxic (to P388 cells)
CMNPD11755	weakly cytotoxic (to P388 cells)
CMNPD11756	weakly cytotoxic (to P388 cells)
CMNPD11769	antibacterial
CMNPD11770	antibacterial
CMNPD11771	antibacterial
CMNPD11778	cytotoxicity in the NCI 60-cell line human tumour screen, potent activity against the NCI/ADR-RES breast cancer cell line.
CMNPD11780	moderate in vitro anthelmintic activity against the parasitant stage of Nippostrongylus brasiliensis
CMNPD11788	modest antibacterial activity against a range of marine bacteria
CMNPD11790	active against a range of marine bacteria
CMNPD11791	active against a range of marine bacteria
CMNPD11810	antibacterial activity against S. aureus
CMNPD11812	neuraminidase inhibition activity
CMNPD11813	neuraminidase inhibition activity
CMNPD11814	neuraminidase inhibition activity
CMNPD11815	DNA-damaging properties
CMNPD11819	antifungal
CMNPD11820	antifungal
CMNPD11821	antifungal
CMNPD11822	antifungal
CMNPD11830	inhibitory effect on the biosynthesis of cholesterol
CMNPD11831	inhibitory effect on the biosynthesis of cholesterol
CMNPD11838	antimicrobial
CMNPD11839	antimicrobial
CMNPD11840	nematocidal activity
CMNPD11841	nematocidal activity
CMNPD11842	nematocidal activity
CMNPD11845	cytotoxic
CMNPD11846	cytotoxic
CMNPD11847	cytotoxic
CMNPD11848	cytotoxic
CMNPD11849	cytotoxic
CMNPD11850	cytotoxic
CMNPD11851	cytotoxic
CMNPD11852	cytotoxic
CMNPD11853	cytotoxic
CMNPD11854	cytotoxic
CMNPD11855	cytotoxic
CMNPD11856	cytotoxic
CMNPD11857	cytotoxic
CMNPD11875	inhibitor of membrane type 1 matrix metalloproteinase
CMNPD11876	inhibitor of membrane type 1 matrix metalloproteinase
CMNPD11877	inhibitor of membrane type 1 matrix metalloproteinase
CMNPD11878	moderately antifungal
CMNPD11879	moderately antifungal
CMNPD11880	moderately antifungal
CMNPD11883	cytotoxic
CMNPD11887	moderate cytotoxicity
CMNPD11888	moderate cytotoxicity
CMNPD11893	mildly active against Plasmodium falciparum
CMNPD11897	potent nematocide
CMNPD11898	varying in vitro antitumour activity
CMNPD11899	varying in vitro antitumour activity
CMNPD11900	varying in vitro antitumour activity
CMNPD11901	varying in vitro antitumour activity
CMNPD11902	varying in vitro antitumour activity
CMNPD11903	varying in vitro antitumour activity
CMNPD11904	cytotoxic
CMNPD11905	cytotoxic
CMNPD11907	cytotoxic
CMNPD11908	cytotoxic
CMNPD11910	in vitro antitumour
CMNPD11911	weakly cytotoxic
CMNPD11914	HIV-inhibitory
CMNPD11915	potent anti-inflammatory
CMNPD11916	potent anti-inflammatory
CMNPD11919	potent neurologically-active
CMNPD11936	antifungal
CMNPD11937	antifungal
CMNPD11942	inhibit the settling of larvae of the barnacle Balanus amphitrite
CMNPD11944	selective inhibitor of neuronal nitric oxide synthase
CMNPD11945	selective inhibitor of neuronal nitric oxide synthase
CMNPD11948	potent in vivo activity against Plasmodium berghei
CMNPD11949	potent in vivo activity against Plasmodium berghei
CMNPD11950	potent in vivo activity against Plasmodium berghei
CMNPD11956	cytotoxic | antioxidant
CMNPD11957	DNA-cleaving agent
CMNPD11958	feeding deterrent to the reef fish Thalassoma bifasciatum
CMNPD11960	antifungal | cytotoxic
CMNPD11961	antifungal | cytotoxic
CMNPD11962	inhibit the feeding of the reef fish T. bifasciatum
CMNPD11963	weakly cytotoxic
CMNPD11965	weak inhibitor of CDC2 kinase
CMNPD11967	Inhibitor of the novel mycobacterial enzyme mycothiol S-conjugate amidase
CMNPD11968	Inhibitor of the novel mycobacterial enzyme mycothiol S-conjugate amidase
CMNPD11969	growth inhibitor of the adherent bacterium Rhodospirillum salexigens
CMNPD11971	cytotoxic
CMNPD11972	cytotoxic
CMNPD11973	antihistamine activity in isolated guinea pig ileum
CMNPD11974	toxic to the crab Hemigrapsus sanguineus
CMNPD11975	toxic to the crab Hemigrapsus sanguineus
CMNPD11976	toxic to the crab Hemigrapsus sanguineus
CMNPD11979	toxic to a variety of micro- and macro-algae
CMNPD11980	toxic to a variety of micro- and macro-algae
CMNPD11981	toxic to a variety of micro- and macro-algae
CMNPD11982	toxic to a variety of micro- and macro-algae
CMNPD11985	Na/K-ATPase inhibitor
CMNPD11990	selective PLA2 inhibitor
CMNPD11994	human lipoxygenase inhibitory activity
CMNPD11995	moderate cytotoxicity
CMNPD11996	moderate cytotoxicity
CMNPD11997	CDC25 phosphatase inhibitor
CMNPD12009	weakly cytotoxic
CMNPD12010	weakly cytotoxic
CMNPD12011	weakly cytotoxic
CMNPD12017	moderate cytotoxicity
CMNPD12018	inhibit the development of fertilised sea urchin eggs
CMNPD12019	inhibit the development of fertilised sea urchin eggs
CMNPD12025	cytotoxic
CMNPD12026	cytotoxic
CMNPD12027	cytotoxic
CMNPD12028	cytotoxic
CMNPD12029	cytotoxic
CMNPD12030	antiviral | cytotoxic
CMNPD12032	cytotoxic
CMNPD12033	cytotoxic
CMNPD12034	cytotoxic
CMNPD12035	cytotoxic
CMNPD12036	inhibitor of MSK1 and MAPKAPK-2 protein kinases
CMNPD12037	inhibitor of MSK1 and MAPKAPK-2 protein kinases
CMNPD12038	inhibitor of MSK1 and MAPKAPK-2 protein kinases
CMNPD12039	inhibitor of MSK1 and MAPKAPK-2 protein kinases
CMNPD12040	inhibitor of in vitro HIV-1 envelope-mediated fusion
CMNPD12041	inhibitor of in vitro HIV-1 envelope-mediated fusion
CMNPD12042	inhibitor of in vitro HIV-1 envelope-mediated fusion
CMNPD12043	inhibitor of in vitro HIV-1 envelope-mediated fusion
CMNPD12044	moderately cytotoxic
CMNPD12045	moderately cytotoxic
CMNPD12046	moderately cytotoxic
CMNPD12049	cytotoxic and apoptosis-inducing
CMNPD12051	moderate cytotoxicity | antifungal | nucleic acid-cleaving properties
CMNPD12052	moderate cytotoxicity | antifungal | nucleic acid-cleaving properties
CMNPD12053	anti-HIV-1 reverse transcriptase activity
CMNPD12054	inhibitor of membrane-type matrix metalloproteinase
CMNPD12055	inhibitor of membrane-type matrix metalloproteinase
CMNPD12058	inhibitor of HIV-1 integrase
CMNPD12059	inhibitor of HIV-1 integrase
CMNPD12060	inhibitor of HIV-1 integrase
CMNPD12064	cytotoxic
CMNPD12065	cytotoxic
CMNPD12066	cytotoxic
CMNPD12077	anti-feedant against the ecologically relevant reef fish Thalassoma bifasciatum
CMNPD12078	moderately cytotoxic
CMNPD12079	moderately cytotoxic
CMNPD12080	moderately cytotoxic
CMNPD12081	moderately cytotoxic
CMNPD12082	norlanostane glycoside
CMNPD12083	norlanostane glycoside
CMNPD12094	reverse MDR in a human carcinoma cell line
CMNPD12108	cytotoxic
CMNPD12109	cytotoxic
CMNPD12110	cytotoxic
CMNPD12111	cytotoxic
CMNPD12112	cytotoxic
CMNPD12113	mildly cytotoxic
CMNPD12114	mildly cytotoxic
CMNPD12115	mildly cytotoxic
CMNPD12116	mildly cytotoxic
CMNPD12117	mildly cytotoxic
CMNPD12118	mildly cytotoxic
CMNPD12119	mildly cytotoxic
CMNPD12120	potent cytotoxicity
CMNPD12135	mild cytotoxicity | inhibit PLA2
CMNPD12136	mild cytotoxicity | inhibit PLA2
CMNPD12137	antimycobacterial
CMNPD12138	antimycobacterial
CMNPD12139	antimycobacterial
CMNPD12140	colombiasin A
CMNPD12141	antibacterial
CMNPD12143	antimycobacterial
CMNPD12150	in vitro antitumour activity towards the HT-29 cell-line
CMNPD12151	in vitro antitumour activity towards the HT-29 cell-line
CMNPD12152	in vitro antitumour activity towards the HT-29 cell-line
CMNPD12153	in vitro antitumour activity towards the HT-29 cell-line
CMNPD12154	in vitro antitumour activity towards the HT-29 cell-line
CMNPD12155	in vitro antitumour activity towards the HT-29 cell-line
CMNPD12156	mildly cytotoxic
CMNPD12184	cytotoxic
CMNPD12185	cytotoxic
CMNPD12186	cytotoxic
CMNPD12187	cytotoxic
CMNPD12188	cytotoxic
CMNPD12189	cytotoxic
CMNPD12198	mildly cytotoxic
CMNPD12199	mildly cytotoxic
CMNPD12200	mildly cytotoxic
CMNPD12201	mildly cytotoxic
CMNPD12202	mildly cytotoxic
CMNPD12203	mildly cytotoxic
CMNPD12204	mildly cytotoxic
CMNPD12205	mildly cytotoxic
CMNPD12209	reduce expression of pro-inflammatory inducible nitric oxide synthetase (iNOS) in a murine macrophage cell line
CMNPD12219	in vitro antitumour activity
CMNPD12220	in vitro antitumour activity | inhibit CYP450 1A | induce glutathione-S-transferase and quinone reductase activity
CMNPD12224	cytotoxic
CMNPD12225	cytotoxic
CMNPD12226	cytotoxic
CMNPD12227	cytotoxic
CMNPD12228	cytotoxic
CMNPD12229	cytotoxic
CMNPD12230	cytotoxic
CMNPD12231	cytotoxic
CMNPD12232	cytotoxic
CMNPD12233	cytotoxic
CMNPD12234	cytotoxic
CMNPD12235	cytotoxic
CMNPD12236	cytotoxic
CMNPD12246	cytotoxic
CMNPD12256	cytotoxicity towards MDR tumour cell lines
CMNPD12279	toxin
CMNPD12280	toxin
CMNPD12281	toxin
CMNPD12282	toxin
CMNPD12299	cytotoxic
CMNPD12304	cytotoxic
CMNPD12305	cytotoxic
CMNPD12306	cytotoxic
CMNPD12307	cytotoxic
CMNPD12308	cytotoxic
CMNPD12309	cytotoxic
CMNPD12310	cytotoxic
CMNPD12311	cytotoxic
CMNPD12312	cytotoxic
CMNPD12313	cytotoxic
CMNPD12338	potent inhibitor of microtubule assembly
CMNPD12371	anti-HSV (Herpes simplex virus) activity
CMNPD12372	anti-HSV (Herpes simplex virus) activity
CMNPD12377	acute toxicity-exhibiting
CMNPD12378	acute toxicity-exhibiting
CMNPD12379	potent antifungal activity towards the pathogen Cladosporium cucumerinum
CMNPD12380	antifungal | potent in vitro activity against Candida albicans
CMNPD12381	antifungal | potent in vitro activity against Candida albicans
CMNPD12382	antifungal
CMNPD12383	antifungal
CMNPD12390	moderate antifungal activity against C. albicans, T. rubrum and four crop-threatening fungi | moderate activity against the human gastric tumour BGC cell line
CMNPD12391	moderate antifungal activity against C. albicans, T. rubrum and four crop-threatening fungi | moderate activity against the human gastric tumour BGC cell line
CMNPD12392	moderate antifungal activity against C. albicans, T. rubrum and four crop-threatening fungi | moderate activity against the human gastric tumour BGC cell line
CMNPD12393	antibiotic | activity against a variety of microorganisms and microalgae
CMNPD12394	appreciable cytotoxicity towards KB cell lines
CMNPD12397	significant cytotoxic activity against the P388 cell line | appreciable cytotoxicity against a disease-oriented panel of 39 human cancer cell lines | specifically inhibit two protein kinases and topoisomerase II
CMNPD12398	significant cytotoxic activity against the P388 cell line
CMNPD12399	significant cytotoxic activity against the P388 cell line
CMNPD12400	significant cytotoxic activity against the P388 cell line
CMNPD12408	active against S. aureus, E. coli and B. subtilis | inactive against C. albicans
CMNPD12409	activity in the brine shrimp assay
CMNPD12410	activity in the brine shrimp assay
CMNPD12412	increased potency toward some renal, CNS and breast cancer cell lines in the NCI's 60-cell line panel
CMNPD12415	antimicrobial activity against a range of bacteria
CMNPD12416	inhibit the adhesion of human-leukemia HL-60 cells to human-umbilical-vein endothelial cells (HUVEC)
CMNPD12417	inhibit the adhesion of human-leukemia HL-60 cells to human-umbilical-vein endothelial cells (HUVEC)
CMNPD12419	potent cytotoxicity against the murine P388 cell line and 39 human cancer cell lines
CMNPD12423	antimalarial activity in vitro against Plasmodium falciparum | moderate cytotoxicity against the KB, BC-1 and Vero cell lines
CMNPD12431	antiplasmodial activity against two strains of P. falciparum
CMNPD12433	antiplasmodial activity against two strains of P. falciparum
CMNPD12437	cytotoxic against Ehrlich carcinoma cells in vitro
CMNPD12438	cytotoxic against Ehrlich carcinoma cells in vitro | cytotoxic to developing eggs of the sea urchin Strongylocentrotus intermedius
CMNPD12439	cytotoxic against Ehrlich carcinoma cells in vitro
CMNPD12440	modest activity against the phytopathogenic fungus Neurospora crassa
CMNPD12441	modest activity against the phytopathogenic fungus Neurospora crassa
CMNPD12448	active against C. albicans
CMNPD12450	moderately active against Arthrobacter citreus, B. brevis, B. subtilis, B. licheniformis, Corynebacterium insidiosum, Micrococcus luteus, Mycobacterium phlei, Streptomyces sp. and Acinetobacter calcoaceticus
CMNPD12451	moderately active against Arthrobacter citreus, B. brevis, B. subtilis, B. licheniformis, Corynebacterium insidiosum, Micrococcus luteus, Mycobacterium phlei, Streptomyces sp. and Acinetobacter calcoaceticus
CMNPD12455	moderate antimycobacterial activity
CMNPD12460	antifungal in vitro against C. albicans, T. rubrum and A. niger
CMNPD12462	weak cytotoxicity against KB cells
CMNPD12463	modest cytotoxicity to neuro-2a neuroblastoma cells
CMNPD12464	cytotoxicity against KB and LoVo cells
CMNPD12465	appreciable cytotoxicity against KB and LoVo cells
CMNPD12466	cytotoxicity to both KB and LoVo cell lines
CMNPD12469	cytotoxic to KB and LoVo cells
CMNPD12470	weakly cytotoxic against KB and LoVo cells in vitro
CMNPD12471	weakly cytotoxic against KB and LoVo cells in vitro
CMNPD12472	weakly cytotoxic against KB and LoVo cells in vitro
CMNPD12473	weakly cytotoxic against KB and LoVo cells in vitro
CMNPD12474	weakly cytotoxic against KB and LoVo cells in vitro
CMNPD12480	cytotoxicity against human colon tumour cells (HCT-116) in vitro
CMNPD12481	potent stimulator of actin polymerisation | show a unique profile of cytotoxicity by the COMPARE algorithm in the NCI panel | strongly inhibitory towards C. albicans
CMNPD12482	cytotoxic
CMNPD12483	cytotoxic to KB cells
CMNPD12484	antifungal activity against fluconazole-resistant C. albicans
CMNPD12486	strong in vitro cytotoxicity towards a range of human tumour cell lines and disrupt microtubules
CMNPD12487	toxicity against P388, A-549, HT-29 and MEL-28 cell lines in the sub-nanomolar range
CMNPD12488	cytotoxic against KB and LoVo cells
CMNPD12489	potent brine shrimp toxin
CMNPD12490	cytotoxic in a cell-based assay but only weakly toxic to fish
CMNPD12492	varying levels of cytotoxicity against murine L1210 cells and human epidermoid carcinoma KB cells
CMNPD12493	varying levels of cytotoxicity against murine L1210 cells and human epidermoid carcinoma KB cells
CMNPD12494	varying levels of cytotoxicity against murine L1210 cells and human epidermoid carcinoma KB cells
CMNPD12495	varying levels of cytotoxicity against murine L1210 cells and human epidermoid carcinoma KB cells
CMNPD12496	varying levels of cytotoxicity against murine L1210 cells and human epidermoid carcinoma KB cells
CMNPD12498	cytotoxic
CMNPD12499	cytolytic activity towards oyster heart cells
CMNPD12507	moderate activity against a range of bacteria
CMNPD12514	weak cytotoxicity in vitro against the A-549 and H-116 cell lines
CMNPD12515	antifeedant activity against young abalone
CMNPD12516	antifeedant activity against young abalone
CMNPD12517	induce morphological abnormality in the plant pathogenic fungus Pyricularia oryzae | cytotoxic activity against several cultured cancer cell lines
CMNPD12518	induce morphological abnormality in the plant pathogenic fungus Pyricularia oryzae | cytotoxic activity against several cultured cancer cell lines
CMNPD12520	activity against NINH3T3 fibroblast and KA3IT murine cancer cell lines
CMNPD12526	in vitro cytotoxic activity against HT-29 H-116 and A-549
CMNPD12541	toxic to brine shrimp | active against the marine bacteria Alcaligenes aquamarinus and E. coli
CMNPD12542	toxic to brine shrimp
CMNPD12547	moderate activity in the brine shrimp bioassay
CMNPD12549	strong toxicity to ants with considerable knockdown effect on the first day
CMNPD12550	gradual toxicity to ants that escalated at the fourth day with > 70% mortality
CMNPD12551	gradual toxicity to ants that escalated at the fourth day with > 70% mortality
CMNPD12552	strong toxicity to ants with considerable knockdown effect on the first day
CMNPD12565	anti-elastase activity against porcine pancreas elastase (PPE
CMNPD12576	cytotoxic
CMNPD12577	inhibit elastase
CMNPD12578	cytotoxic
CMNPD12591	antimicrobial | potent inhibitor of the bacterial type III secretion system
CMNPD12592	neuritogenic activity against neuroblastoma cells
CMNPD12593	neuritogenic activity against neuroblastoma cells
CMNPD12594	α-glucosidase inhibitor
CMNPD12595	geranylgeranyltransferase type I inhibitor
CMNPD12596	geranylgeranyltransferase type I inhibitor
CMNPD12597	cytotoxic
CMNPD12598	moderately cytotoxic
CMNPD12599	moderately cytotoxic
CMNPD12600	moderately cytotoxic
CMNPD12601	moderately cytotoxic
CMNPD12602	moderately cytotoxic
CMNPD12603	inhibit the growth of HCT-116 cells
CMNPD12604	inhibit the growth of HCT-116 cells
CMNPD12605	inhibit the growth of HCT-116 cells
CMNPD12606	inhibit the growth of HCT-116 cells
CMNPD12607	antifungal activity
CMNPD12608	antifungal activity
CMNPD12609	moderate antifungal activity
CMNPD12611	selective toxicity towards murine macrophage cells (RAW 264–7)
CMNPD12612	selective toxicity towards murine macrophage cells (RAW 264–7)
CMNPD12613	selective toxicity towards murine macrophage cells (RAW 264–7)
CMNPD12614	selective toxicity towards murine macrophage cells (RAW 264–7)
CMNPD12615	selective toxicity towards murine macrophage cells (RAW 264–7)
CMNPD12616	selective toxicity towards murine macrophage cells (RAW 264–7)
CMNPD12617	selective toxicity towards murine macrophage cells (RAW 264–7)
CMNPD12618	weakly inhibit dual-specificity phosphatase
CMNPD12619	weakly inhibit dual-specificity phosphatase
CMNPD12620	weakly inhibit dual-specificity phosphatase
CMNPD12621	weakly inhibit dual-specificity phosphatase
CMNPD12622	weakly inhibit dual-specificity phosphatase
CMNPD12623	weakly inhibit dual-specificity phosphatase
CMNPD12625	cytotoxic
CMNPD12628	cytotoxic
CMNPD12629	cytotoxic
CMNPD12630	cytotoxic
CMNPD12631	cytotoxic
CMNPD12632	cytotoxic
CMNPD12633	cytotoxic
CMNPD12634	potent cytotoxicity
CMNPD12635	potently cytotoxic
CMNPD12636	potently cytotoxic
CMNPD12637	inhibitor of factor VIIa and thrombin
CMNPD12638	immunomodulatory activity
CMNPD12639	cytotoxic
CMNPD12640	potent tryptase inhibitor
CMNPD12641	potent tryptase inhibitor
CMNPD12642	weakly cytotoxic
CMNPD12643	weak cytotoxicity
CMNPD12646	repel the settlement of Mytilus edulis adults
CMNPD12647	repel the settlement of Mytilus edulis adults
CMNPD12648	repel the settlement of Mytilus edulis adults
CMNPD12649	nematocidal activity
CMNPD12650	nematocidal activity
CMNPD12654	antibacterial
CMNPD12661	potent cytotoxicity
CMNPD12662	cytotoxicity and antiproliferative properties similar to those of the chondropsins
CMNPD12663	inhibit the division of fertilised sea urchin eggs
CMNPD12664	inhibit the division of fertilised sea urchin eggs
CMNPD12665	moderately cytotoxic
CMNPD12666	inhibit the invasion of breast carcinoma cells into new tissues
CMNPD12667	inhibit the invasion of breast carcinoma cells into new tissues
CMNPD12668	inhibit the invasion of breast carcinoma cells into new tissues
CMNPD12669	inhibit the invasion of breast carcinoma cells into new tissues
CMNPD12679	nematocidal activity
CMNPD12680	cathepsin inhibitor
CMNPD12681	high affinity for the human serotonin 5-HT2 receptor
CMNPD12699	inhibit the cell fusion of HIV-1
CMNPD12700	weak cytotoxicity
CMNPD12701	cytotoxic
CMNPD12702	cytotoxic
CMNPD12703	cytotoxic
CMNPD12704	cytotoxic
CMNPD12706	inhibit feeding by the reef fish Thalassoma bifasciatum
CMNPD12715	moderately cytotoxic
CMNPD12716	moderately cytotoxic
CMNPD12727	modest cytoprotection against HIV-1
CMNPD12728	toxic to brine shrimp
CMNPD12729	inhibit sea urchin embryogenesis
CMNPD12733	cytotoxic to P388, HT-29 and A-549 cell lines and the polyps of the scleractinian coral Madracis mirabilis
CMNPD12736	widely varying cytotoxicity
CMNPD12737	widely varying cytotoxicity
CMNPD12738	widely varying cytotoxicity
CMNPD12739	widely varying cytotoxicity
CMNPD12740	widely varying cytotoxicity
CMNPD12741	widely varying cytotoxicity
CMNPD12742	widely varying cytotoxicity
CMNPD12743	cytotoxic and anti-HIV–1 activity
CMNPD12744	cytotoxic and anti-HIV–1 activity
CMNPD12745	cytotoxic and anti-HIV–1 activity
CMNPD12746	cytotoxic and anti-HIV–1 activity
CMNPD12747	cytotoxic and anti-HIV–1 activity
CMNPD12748	cytotoxic and anti-HIV–1 activity
CMNPD12749	cytotoxic and anti-HIV–1 activity
CMNPD12750	cytotoxic and anti-HIV–1 activity
CMNPD12751	cytotoxic and anti-HIV–1 activity
CMNPD12752	cytotoxic and anti-HIV–1 activity
CMNPD12753	cytotoxic and anti-HIV–1 activity
CMNPD12754	cytotoxic and anti-HIV–1 activity
CMNPD12755	cytotoxic and anti-HIV–1 activity
CMNPD12756	cytotoxic and anti-HIV–1 activity
CMNPD12757	cytotoxic and anti-HIV–1 activity
CMNPD12758	cytotoxic and anti-HIV–1 activity
CMNPD12759	cytotoxic and anti-HIV–1 activity
CMNPD12760	cytotoxic and anti-HIV–1 activity
CMNPD12761	cytotoxic and anti-HIV–1 activity
CMNPD12762	cytotoxic and anti-HIV–1 activity
CMNPD12763	cytotoxic and anti-HIV–1 activity
CMNPD12764	cytotoxic and anti-HIV–1 activity
CMNPD12765	cytotoxic and anti-HIV–1 activity
CMNPD12767	weak cytotoxicity
CMNPD12768	weak cytotoxicity
CMNPD12769	cytotoxicity
CMNPD12770	cytotoxicity
CMNPD12771	cytotoxicity
CMNPD12772	cytotoxicity
CMNPD12773	cytotoxicity
CMNPD12774	cytotoxicity
CMNPD12775	cytotoxicity
CMNPD12776	cytotoxicity
CMNPD12777	cytotoxicity
CMNPD12778	cytotoxicity
CMNPD12779	cytotoxicity
CMNPD12780	cytotoxicity
CMNPD12781	cytotoxicity
CMNPD12782	cytotoxicity
CMNPD12785	inhibit the protease activity of human RAS converting enzyme (hRCE1)
CMNPD12786	inhibit the protease activity of human RAS converting enzyme (hRCE1)
CMNPD12787	inhibit the protease activity of human RAS converting enzyme (hRCE1)
CMNPD12788	inhibit the protease activity of human RAS converting enzyme (hRCE1)
CMNPD12789	inhibit the protease activity of human RAS converting enzyme (hRCE1)
CMNPD12790	cytotoxic | antimicrobial
CMNPD12791	cytotoxic | antimicrobial
CMNPD12792	cytotoxic
CMNPD12793	cytotoxic
CMNPD12794	cytotoxic
CMNPD12795	significant cytotoxicity in human cancer cell lines
CMNPD12796	significant cytotoxicity in human cancer cell lines
CMNPD12797	significant cytotoxicity in human cancer cell lines
CMNPD12798	significant cytotoxicity in human cancer cell lines
CMNPD12810	inhibit the growth of several human cancer cell lines
CMNPD12811	significant cytotoxicity to a range of human and murine cancer cell lines
CMNPD12812	significant cytotoxicity to a range of human and murine cancer cell lines
CMNPD12815	anti-inflammatory activity
CMNPD12826	ichthyotoxic | cytotoxic
CMNPD12827	ichthyotoxic | cytotoxic
CMNPD12828	ichthyotoxic | cytotoxic
CMNPD12829	ichthyotoxic | cytotoxic
CMNPD12830	ichthyotoxic | cytotoxic
CMNPD12831	ichthyotoxic | cytotoxic
CMNPD12832	ichthyotoxic | cytotoxic
CMNPD12833	ichthyotoxic | cytotoxic
CMNPD12834	neuraminidase inhibitor
CMNPD12835	moderately antibacterial
CMNPD12841	cytotoxicity towards the A-549 and P388 tumour cell lines
CMNPD12845	cytotoxicity towards the A-549 and P388 tumour cell lines
CMNPD12865	mild cytotoxicity towards MCF-7 and OVCAR-3 tumour cell lines
CMNPD12866	Variable potency and selectivity towards tumour cell lines A-549, HT-29 and P388
CMNPD12867	Variable potency and selectivity towards tumour cell lines A-549, HT-29 and P388
CMNPD12868	Variable potency and selectivity towards tumour cell lines A-549, HT-29 and P388
CMNPD12869	Variable potency and selectivity towards tumour cell lines A-549, HT-29 and P388
CMNPD12870	Variable potency and selectivity towards tumour cell lines A-549, HT-29 and P388
CMNPD12871	Variable potency and selectivity towards tumour cell lines A-549, HT-29 and P388
CMNPD12872	Variable potency and selectivity towards tumour cell lines A-549, HT-29 and P388
CMNPD12873	Variable potency and selectivity towards tumour cell lines A-549, HT-29 and P388
CMNPD12875	Moderate in vitro cytotoxicity towards tumour cell lines
CMNPD12876	cytotoxicity to a wide range of tumour cell lines
CMNPD12879	cytotoxic
CMNPD12902	inhibit ligand binding to rat-brain adenosine A1 receptors
CMNPD12903	inhibit ligand binding to rat-brain adenosine A1 receptors
CMNPD12908	mild cytotoxicity towards KB and Hepa59T/VGH tumour cell lines
CMNPD12922	antimitotic agent
CMNPD12929	mildly cytotoxic
CMNPD12930	mild haemolytic activity towards mice blood erythrocytes
CMNPD12931	mild haemolytic activity towards mice blood erythrocytes
CMNPD12935	mild cytotoxicity
CMNPD12945	mildly cytotoxic
CMNPD12946	mildly cytotoxic
CMNPD12947	mildly cytotoxic
CMNPD12948	mildly cytotoxic
CMNPD12949	mildly cytotoxic
CMNPD12950	mildly cytotoxic
CMNPD12951	mildly cytotoxic
CMNPD12957	cytotoxic
CMNPD12965	moderate cytotoxicity towards drug-resistant cells expressing P-gp | not cytotoxic against cells expressing multidrug resistance protein-1 (MRP-1)
CMNPD12966	moderate cytotoxicity towards drug-resistant cells expressing P-gp | not cytotoxic against cells expressing multidrug resistance protein-1 (MRP-1)
CMNPD12967	moderate cytotoxicity towards drug-resistant cells expressing P-gp | not cytotoxic against cells expressing multidrug resistance protein-1 (MRP-1)
CMNPD12968	moderate cytotoxicity towards drug-resistant cells expressing P-gp | not cytotoxic against cells expressing multidrug resistance protein-1 (MRP-1)
CMNPD12969	moderate cytotoxicity towards drug-resistant cells expressing P-gp | not cytotoxic against cells expressing multidrug resistance protein-1 (MRP-1)
CMNPD12970	moderate cytotoxicity towards drug-resistant cells expressing P-gp | not cytotoxic against cells expressing multidrug resistance protein-1 (MRP-1)
CMNPD12971	moderate cytotoxicity towards drug-resistant cells expressing P-gp | not cytotoxic against cells expressing multidrug resistance protein-1 (MRP-1)
CMNPD12972	moderate cytotoxicity towards drug-resistant cells expressing P-gp | not cytotoxic against cells expressing multidrug resistance protein-1 (MRP-1)
CMNPD12973	moderate cytotoxicity towards drug-resistant cells expressing P-gp | not cytotoxic against cells expressing multidrug resistance protein-1 (MRP-1)
CMNPD12974	moderate cytotoxicity towards drug-resistant cells expressing P-gp | not cytotoxic against cells expressing multidrug resistance protein-1 (MRP-1)
CMNPD12975	moderate cytotoxicity towards drug-resistant cells expressing P-gp | not cytotoxic against cells expressing multidrug resistance protein-1 (MRP-1)
CMNPD12976	moderate cytotoxicity towards drug-resistant cells expressing P-gp | not cytotoxic against cells expressing multidrug resistance protein-1 (MRP-1)
CMNPD12977	moderate cytotoxicity towards drug-resistant cells expressing P-gp | not cytotoxic against cells expressing multidrug resistance protein-1 (MRP-1)
CMNPD12980	potent cytotoxin towards a range of tumour cell lines
CMNPD12989	moderate cytotoxicity against the HCT-116 cell line
CMNPD12991	potent and selective activity against Haemonchus contortus, a parasitic nematode of ruminants
CMNPD12992	potent and selective activity against Haemonchus contortus, a parasitic nematode of ruminants
CMNPD12993	potent antiangiogenic activity on bovine aorta endothelial cell (BAEC) proliferation
CMNPD12994	anthelmintic activity against Trichinella spiralis
CMNPD12995	anthelmintic activity against Trichinella spiralis
CMNPD12996	anthelmintic activity against Trichinella spiralis
CMNPD13003	Mild cytotoxicity to murine fibrosarcoma and monocyte/macrophage cell lines
CMNPD13006	mild cytotoxicity | anti-inflammatory
CMNPD13007	moderately cytotoxic
CMNPD13020	inhibitor of matrix metalloproteinase 2 (MMP2)
CMNPD13021	cytotoxic
CMNPD13040	mild antibacterial activity as well as toxicity towards brine shrimp
CMNPD13041	mild antibacterial activity as well as toxicity towards brine shrimp
CMNPD13042	cytotoxic
CMNPD13048	antiplasmodial | antitrypanosomal
CMNPD13049	antiplasmodial | antitrypanosomal
CMNPD13056	cytotoxic
CMNPD13057	cytotoxic | anti-inflammatory
CMNPD13058	cytotoxic | anti-inflammatory
CMNPD13059	cytotoxic | anti-inflammatory
CMNPD13060	cytotoxic | anti-inflammatory
CMNPD13061	cytotoxic
CMNPD13062	cytotoxic
CMNPD13069	mildly cytotoxic
CMNPD13075	potent cytotoxicity towards tumour cell lines | growth inhibition of M. tuberculosis H37Ra
CMNPD13076	potent cytotoxicity towards tumour cell lines | growth inhibition of M. tuberculosis H37Ra
CMNPD13077	potent cytotoxicity towards the P388 cell line
CMNPD13078	potent cytotoxicity towards the P388 cell line
CMNPD13083	responsible for sperm activation and attraction
CMNPD13084	potent cytotoxicity against P388 murine leukemia cells
CMNPD13162	mild antiviral potency
CMNPD13163	mild antiviral potency
CMNPD13164	induce neuronal differentiation in PC12 cells | significant synergistic effects on NGF-induced neuronal differentiation in PC12 cells
CMNPD13165	induce neuronal differentiation in PC12 cells | significant synergistic effects on NGF-induced neuronal differentiation in PC12 cells
CMNPD13166	antifungal activity towards the plant pathogen Cladosporium cucumerinum
CMNPD13171	cytotoxic | antifungal
CMNPD13172	cytotoxic | antifungal
CMNPD13173	inhibitory activity in a CCR5 | no activity towards the related receptor CXCR2
CMNPD13174	inhibitory activity in a CCR5 | no activity towards the related receptor CXCR2
CMNPD13175	HIV integrase inhibitor
CMNPD13176	HIV integrase inhibitor
CMNPD13177	HIV integrase inhibitor
CMNPD13178	potent proteasome inhibitor | potent and selective in vitro cytotoxicity against cell lines in the NCI panel | highly potent inhibition of the proteasomal chymotrypsin-like proteolytic activity of purified 20S proteasome
CMNPD13179	potent in vitro activity against a wide range of bacteria, including several multiple-drug resistant pathogens | exhibit excellent in vivo efficacy in a systemic Staphylococcus aureus infection mouse model
CMNPD13180	potent in vitro activity against a wide range of bacteria, including several multiple-drug resistant pathogens | exhibit excellent in vivo efficacy in a systemic Staphylococcus aureus infection mouse model
CMNPD13181	potent in vitro activity against a wide range of bacteria, including several multiple-drug resistant pathogens | exhibit excellent in vivo efficacy in a systemic Staphylococcus aureus infection mouse model
CMNPD13182	potent antibacterial activities against Staphylococci and Enterococci sp. | active against multiple-drug resistant strains
CMNPD13183	potent antibacterial activities against Staphylococci and Enterococci sp. | active against multiple-drug resistant strains
CMNPD13184	active against a wide range of dinoflagellates and raphidophytes
CMNPD13186	antibacterial | antifungal
CMNPD13187	moderate activity against B. subtilis, Streptomyces viridochromogenes, S. aureus and E. coli | activity against a number of human tumour cell lines
CMNPD13188	cytotoxic | moderate activity against a panel of 14 tumour cell lines
CMNPD13189	cytotoxic | moderate activity against a panel of 14 tumour cell lines
CMNPD13190	cytotoxic | moderate activity against a panel of 14 tumour cell lines
CMNPD13191	dose-dependent neuritogenic activity against the neuroblastoma cell line Neuro 2A
CMNPD13197	antifungal antibiotic | active against the phytopathogenic fungus Phytophthora capsici
CMNPD13198	antifungal antibiotic | active against the phytopathogenic fungus Phytophthora capsici
CMNPD13199	antifungal antibiotic | active against the phytopathogenic fungus Phytophthora capsici
CMNPD13200	antifungal antibiotic | active against the phytopathogenic fungus Phytophthora capsici
CMNPD13201	antifungal antibiotic | active against the phytopathogenic fungus Phytophthora capsici
CMNPD13202	antifungal antibiotic | active against the phytopathogenic fungus Phytophthora capsici
CMNPD13203	antifungal antibiotic | active against the phytopathogenic fungus Phytophthora capsici
CMNPD13205	strong binding affinity for the ferric ion in the chrome azurol S (CAS) assay
CMNPD13206	strong binding affinity for the ferric ion in the chrome azurol S (CAS) assay
CMNPD13207	potent activity against methicillin-resistant S. aureus (MRSA) | strongly active against Enterococcus serolicida, E. faecium and E. faecalis
CMNPD13208	potent inhibitor of the pathogenic marine bacterium Vibrio anguillarum
CMNPD13209	potent inhibitor of the pathogenic marine bacterium Vibrio anguillarum
CMNPD13210	potent inhibitor of the pathogenic marine bacterium Vibrio anguillarum
CMNPD13211	cytotoxic
CMNPD13212	active against human tumour cell lines
CMNPD13213	active against human tumour cell lines
CMNPD13214	active against human tumour cell lines | potent activity against the fungus Mucor meihei and the bacteria B. subtilis and E. coli | antialgal activity against the microalga, Chlorella vulgaris, C. sorokiniana and Scenedesmus suspicatus
CMNPD13215	inhibitory activity against histone deacetylase | antibacterial activity against Micrococcus luteus
CMNPD13216	inhibiting the growth of the marine bacterium Ruegeria atlantica and that of E. coli and S. aureus to a lesser extent
CMNPD13217	antibiotics
CMNPD13218	antibiotics
CMNPD13219	modest cytotoxicity against Haemonchus contortus
CMNPD13220	modest cytotoxicity against Haemonchus contortus
CMNPD13221	modest cytotoxicity against Haemonchus contortus
CMNPD13222	modest cytotoxicity against Haemonchus contortus
CMNPD13223	modest cytotoxicity against Haemonchus contortus
CMNPD13225	cytotoxic | moderate activity against the HCT-116 cell line
CMNPD13226	cytotoxic | moderate activity against the HCT-116 cell line
CMNPD13227	cytotoxic | moderate activity against the HCT-116 cell line
CMNPD13228	weak antibacterial activity against Staphylococcus epidermidis and Enterococcus durans
CMNPD13229	weak antibacterial activity against Staphylococcus epidermidis and Enterococcus durans
CMNPD13231	potent in vitro inhibitor of Herpes simplex viruses 1 and 2
CMNPD13232	potent in vitro inhibitor of Herpes simplex viruses 1 and 2
CMNPD13233	potent in vitro inhibitor of Herpes simplex viruses 1 and 2
CMNPD13234	potent in vitro inhibitor of Herpes simplex viruses 1 and 2
CMNPD13235	potent in vitro inhibitor of Herpes simplex viruses 1 and 2
CMNPD13236	moderate cytotoxicity to the HCT-116 cell line in vitro
CMNPD13237	moderate cytotoxicity to the HCT-116 cell line in vitro
CMNPD13239	significant in vitro cytotoxicity against HCT-116 | moderate antimicrobial activity against amphoterocin-resistant C. albicans, MRSA and vancomycin-resistant E. faecium
CMNPD13240	modest antibacterial activity against Micrococcus luteus and Neurospora crassa
CMNPD13241	modest antibacterial activity against Micrococcus luteus and Neurospora crassa
CMNPD13243	weakly antimicrobial | significant tyrosine kinase p56lck enzyme inhibitor activity | antioxidative
CMNPD13244	weakly antimicrobial
CMNPD13246	antiproliferative activity towards KB and NCI-H460 cells
CMNPD13258	moderately cytotoxic to a mouse neuroblastoma cell line
CMNPD13259	moderately cytotoxic to a mouse neuroblastoma cell line
CMNPD13264	moderate activity against oesophageal and cervical cancer cell lines
CMNPD13265	activity against KB and LoVo cell lines in vitro | poorly tolerated in vivo with little antitumour activity
CMNPD13269	moderately cytotoxic against KB cells in vitro
CMNPD13271	activity against the KB cell line
CMNPD13272	potent cytotoxicity against KB cells
CMNPD13273	toxicity in the brine shrimp assay | weak affinity for the rat cannabinoid CB1 receptor | moderate inhibitor of the anandamide membrane transporter (AMT)
CMNPD13274	toxicity in the brine shrimp assay | weak affinity for the rat cannabinoid CB1 receptor
CMNPD13275	toxicity in the brine shrimp assay
CMNPD13276	toxicity in the brine shrimp assay
CMNPD13277	toxicity in the brine shrimp assay
CMNPD13278	toxicity in the brine shrimp assay
CMNPD13279	toxicity in the brine shrimp assay | weak affinity for the rat cannabinoid CB1 receptor
CMNPD13280	moderate cytotoxicity towards KB cells in vitro
CMNPD13281	moderate cytotoxicity towards KB cells in vitro
CMNPD13282	cytotoxic
CMNPD13288	moderately cytotoxic against murine lymphoma L1210 and human epidermoid carcinoma KB cells in vitro
CMNPD13289	moderately cytotoxic against murine lymphoma L1210 and human epidermoid carcinoma KB cells in vitro
CMNPD13290	moderately cytotoxic against murine lymphoma L1210 and human epidermoid carcinoma KB cells in vitro
CMNPD13291	moderate growth-inhibitory activity in vitro against a range of human cancer cell lines
CMNPD13292	moderate growth-inhibitory activity in vitro against a range of human cancer cell lines
CMNPD13304	lead compound against prostate cancer
CMNPD13305	moderate to significant activity against three unidentified strains of marine bacteria | strong growth inhibitory effects on the fouling microalga Phaeodactylum tricornutum
CMNPD13306	moderate to significant activity against three unidentified strains of marine bacteria | strong growth inhibitory effects on the fouling microalga Phaeodactylum tricornutum
CMNPD13307	moderate to significant activity against three unidentified strains of marine bacteria | strong growth inhibitory effects on the fouling microalga Phaeodactylum tricornutum
CMNPD13308	moderate to significant activity against three unidentified strains of marine bacteria | strong growth inhibitory effects on the fouling microalga Phaeodactylum tricornutum
CMNPD13309	moderate to significant activity against three unidentified strains of marine bacteria | strong growth inhibitory effects on the fouling microalga Phaeodactylum tricornutum
CMNPD13310	moderate to significant activity against three unidentified strains of marine bacteria | strong growth inhibitory effects on the fouling microalga Phaeodactylum tricornutum
CMNPD13311	moderate to significant activity against three unidentified strains of marine bacteria | strong growth inhibitory effects on the fouling microalga Phaeodactylum tricornutum
CMNPD13312	moderate to significant activity against three unidentified strains of marine bacteria | strong growth inhibitory effects on the fouling microalga Phaeodactylum tricornutum
CMNPD13313	moderate to significant activity against three unidentified strains of marine bacteria | strong growth inhibitory effects on the fouling microalga Phaeodactylum tricornutum
CMNPD13314	moderate to significant activity against three unidentified strains of marine bacteria | strong growth inhibitory effects on the fouling microalga Phaeodactylum tricornutum
CMNPD13315	moderate to significant activity against three unidentified strains of marine bacteria | strong growth inhibitory effects on the fouling microalga Phaeodactylum tricornutum
CMNPD13316	moderate to significant activity against three unidentified strains of marine bacteria | strong growth inhibitory effects on the fouling microalga Phaeodactylum tricornutum
CMNPD13317	potent radical-scavenging effects in test for antioxidative properties in the α,α-diphenyl-β-picrylhydrazyl radical (DPPH) and thiobarbituric acid reactive substances (TBARS) assay systems | moderately cytotoxic against several carcinoma cell lines
CMNPD13318	potent radical-scavenging effects in test for antioxidative properties in the α,α-diphenyl-β-picrylhydrazyl radical (DPPH) and thiobarbituric acid reactive substances (TBARS) assay systems | moderately cytotoxic against several carcinoma cell lines
CMNPD13319	potent radical-scavenging effects in test for antioxidative properties in the α,α-diphenyl-β-picrylhydrazyl radical (DPPH) and thiobarbituric acid reactive substances (TBARS) assay systems | moderately cytotoxic against several carcinoma cell lines
CMNPD13320	potent radical-scavenging effects in test for antioxidative properties in the α,α-diphenyl-β-picrylhydrazyl radical (DPPH) and thiobarbituric acid reactive substances (TBARS) assay systems | moderately cytotoxic against several carcinoma cell lines
CMNPD13321	potent radical-scavenging effects in test for antioxidative properties in the α,α-diphenyl-β-picrylhydrazyl radical (DPPH) and thiobarbituric acid reactive substances (TBARS) assay systems | moderately cytotoxic against several carcinoma cell lines
CMNPD13322	potent radical-scavenging effects in test for antioxidative properties in the α,α-diphenyl-β-picrylhydrazyl radical (DPPH) and thiobarbituric acid reactive substances (TBARS) assay systems | moderately cytotoxic against several carcinoma cell lines
CMNPD13323	potent radical-scavenging effects in test for antioxidative properties in the α,α-diphenyl-β-picrylhydrazyl radical (DPPH) and thiobarbituric acid reactive substances (TBARS) assay systems | moderately cytotoxic against several carcinoma cell lines
CMNPD13324	potent radical-scavenging effects in test for antioxidative properties in the α,α-diphenyl-β-picrylhydrazyl radical (DPPH) and thiobarbituric acid reactive substances (TBARS) assay systems | moderately cytotoxic against several carcinoma cell lines
CMNPD13325	significantly less active in test for antioxidative properties in the α,α-diphenyl-β-picrylhydrazyl radical (DPPH) and thiobarbituric acid reactive substances (TBARS) assay systems
CMNPD13326	significantly less active in test for antioxidative properties in the α,α-diphenyl-β-picrylhydrazyl radical (DPPH) and thiobarbituric acid reactive substances (TBARS) assay systems
CMNPD13327	moderate cytotoxicity against the murine cancer cell line KA3IT | reduce cytotoxicity against normal NIH3T3 cells
CMNPD13328	moderate cytotoxicity against the murine cancer cell line KA3IT | reduce cytotoxicity against normal NIH3T3 cells
CMNPD13329	moderate cytotoxicity against the murine cancer cell line KA3IT | reduce cytotoxicity against normal NIH3T3 cells
CMNPD13330	moderate cytotoxicity against the murine cancer cell line KA3IT | reduce cytotoxicity against normal NIH3T3 cells
CMNPD13348	potent and highly specific activity against the marine filamentous fungi Dendryphiella salina and Lindra thalassiae | potent activity against C. albicans | antineoplastic activity against the HCT-116 cell line
CMNPD13351	potent DPPH radical scavenging activity
CMNPD13357	active against D6 and W2 clones of the malaria parasite Plasmodium falciparum
CMNPD13362	significant cytotoxicity against HeLa and A431 cell lines
CMNPD13363	moderately active against all cell lines
CMNPD13365	significant cytotoxicity against the human tumour cell lines MCF7, PC3, HeLa, A431 and K562
CMNPD13366	significant cytotoxicity against the human tumour cell lines MCF7, PC3, HeLa, A431 and K562
CMNPD13376	moderate activity against five strains of bacteria
CMNPD13385	cytotoxic
CMNPD13387	cytotoxic
CMNPD13388	cytotoxic
CMNPD13389	inhibit DNA polymerases α and γ
CMNPD13390	anti-feedant activity against goldfish
CMNPD13391	anti-feedant activity against goldfish
CMNPD13392	inhibitor of membrane type 1 matrix metalloproteinase (MT1-MMP)
CMNPD13393	marginal to moderate toxicity to five human tumour cell lines
CMNPD13394	marginal to moderate toxicity to five human tumour cell lines
CMNPD13395	marginal to moderate toxicity to five human tumour cell lines
CMNPD13396	marginal to moderate toxicity to five human tumour cell lines
CMNPD13397	mildly cytotoxic
CMNPD13403	mildly cytotoxic to human leukemia cells
CMNPD13404	mildly cytotoxic to human leukemia cells
CMNPD13405	toxic in the brine shrimp assay | active against HeLa
CMNPD13417	moderately cytotoxic
CMNPD13418	antifungal
CMNPD13419	antifungal
CMNPD13420	antifungal
CMNPD13421	antifungal
CMNPD13422	mildly cytotoxic
CMNPD13423	cytotoxic against a range of human tumour cell lines
CMNPD13424	cytotoxic against a range of human tumour cell lines
CMNPD13425	cytotoxic against a range of human tumour cell lines
CMNPD13426	antimicrobial
CMNPD13427	antimicrobial
CMNPD13428	antimicrobial
CMNPD13429	antimicrobial
CMNPD13430	antimicrobial
CMNPD13431	antimicrobial
CMNPD13432	antimicrobial
CMNPD13433	antimicrobial
CMNPD13434	antimicrobial
CMNPD13435	antimicrobial
CMNPD13436	antimicrobial
CMNPD13437	antimicrobial
CMNPD13438	antimicrobial
CMNPD13439	potent cytotoxicity to an array of human tumour cell lines
CMNPD13440	potent cytotoxicity to an array of human tumour cell lines
CMNPD13445	potent G2 checkpoint inhibitor and highly cytotoxic
CMNPD13446	potent G2 checkpoint inhibitor and highly cytotoxic
CMNPD13447	cytotoxic | inhibitor of tubulin polymerisation
CMNPD13448	cytotoxic to P388 murine leukemia cells
CMNPD13449	cytotoxic to P388 murine leukemia cells
CMNPD13450	cytotoxic to P388 murine leukemia cells
CMNPD13451	inhibit the settlement of larvae of the blue mussel (Mytilus edulis galloprovincialis)
CMNPD13456	growth inhibitory
CMNPD13457	very cytotoxic
CMNPD13461	N-Methyl-D-aspartate (NMDA) receptor ligand
CMNPD13476	inducer of neuronal differentiation
CMNPD13477	antimicrobial
CMNPD13478	antimicrobial
CMNPD13479	antimicrobial
CMNPD13480	antimicrobial
CMNPD13481	antimicrobial
CMNPD13484	inhibit telomerase activity
CMNPD13485	inhibit telomerase activity
CMNPD13486	inhibit telomerase activity
CMNPD13487	inhibit telomerase activity
CMNPD13488	inhibit telomerase activity
CMNPD13489	mildly antimicrobial
CMNPD13490	mildly antimicrobial
CMNPD13494	MT1-MMP inhibitor
CMNPD13497	geranylgeranyltransferase type I inhibitor
CMNPD13498	potent inhibitor of HIV-1 envelope-mediated fusion
CMNPD13499	weak inhibitor of HIV-1 envelope-mediated fusion
CMNPD13500	antibacterial
CMNPD13501	antimitotic
CMNPD13502	antimitotic
CMNPD13510	potent protein kinase inhibitor
CMNPD13515	cytotoxic
CMNPD13520	moderately cytotoxic to murine Ehrlich carcinoma cells
CMNPD13524	inhibit the settling of the cyprid (barnacle) larvae Balanus ainphitrite
CMNPD13528	mildly cytotoxic
CMNPD13532	cytotoxic
CMNPD13533	cytotoxic
CMNPD13534	cytotoxic
CMNPD13542	moderately cytotoxic
CMNPD13543	moderately cytotoxic
CMNPD13544	moderately cytotoxic
CMNPD13545	moderately cytotoxic
CMNPD13546	moderately cytotoxic
CMNPD13547	inhibit the cell division of sea urchin eggs | not cytotoxic to human leukemia cells
CMNPD13548	inhibit the cell division of sea urchin eggs | not cytotoxic to human leukemia cells
CMNPD13549	inhibit the cell division of sea urchin eggs | not cytotoxic to human leukemia cells
CMNPD13557	proteasome inhibitor
CMNPD13558	proteasome inhibitor
CMNPD13559	proteasome inhibitor
CMNPD13560	proteasome inhibitor
CMNPD13561	proteasome inhibitor
CMNPD13562	proteasome inhibitor
CMNPD13563	proteasome inhibitor
CMNPD13564	inhibit the production of superoxide from human neutrophils
CMNPD13565	bind to P2Y12 receptors
CMNPD13567	inhibitor of the fertilisation of sea urchin eggs
CMNPD13568	inhibitor of the fertilisation of sea urchin eggs
CMNPD13569	inhibitor of the fertilisation of sea urchin eggs
CMNPD13570	inhibitor of the fertilisation of sea urchin eggs
CMNPD13571	inhibitor of the fertilisation of sea urchin eggs
CMNPD13572	inhibitor of the fertilisation of sea urchin eggs
CMNPD13573	inhibitor of the fertilisation of sea urchin eggs
CMNPD13574	inhibitor of the fertilisation of sea urchin eggs
CMNPD13575	significantly cytotoxic
CMNPD13576	significantly cytotoxic
CMNPD13577	significantly cytotoxic
CMNPD13578	significantly cytotoxic
CMNPD13579	cytotoxic to murine P388 leukemia cells
CMNPD13580	mildly cytotoxic
CMNPD13581	mildly cytotoxic
CMNPD13583	antimicrobial
CMNPD13584	antimicrobial
CMNPD13585	antimicrobial
CMNPD13586	potently cytotoxic towards A431 cells
CMNPD13587	potently cytotoxic towards A431 cells | potent inhibitor of plant vacuolar H+-pyrophosphatase
CMNPD13588	potently cytotoxic towards A431 cells | potent inhibitor of plant vacuolar H+-pyrophosphatase
CMNPD13593	biological activity towards bacteria, brine shrimp, sea urchin egg development and crown gall potato tumours
CMNPD13594	biological activity towards bacteria, brine shrimp, sea urchin egg development and crown gall potato tumours
CMNPD13595	biological activity towards bacteria, brine shrimp, sea urchin egg development and crown gall potato tumours
CMNPD13596	biological activity towards bacteria, brine shrimp, sea urchin egg development and crown gall potato tumours
CMNPD13597	biological activity towards bacteria, brine shrimp, sea urchin egg development and crown gall potato tumours
CMNPD13598	biological activity towards bacteria, brine shrimp, sea urchin egg development and crown gall potato tumours
CMNPD13599	biological activity towards bacteria, brine shrimp, sea urchin egg development and crown gall potato tumours
CMNPD13600	biological activity towards bacteria, brine shrimp, sea urchin egg development and crown gall potato tumours
CMNPD13619	activity in a number of ecologically-relevant assays, including antibiotic and feeding deterrence properties
CMNPD13637	modest cytotoxicity towards a panel of tumour cell lines
CMNPD13639	arrest the cell cycle at G2/M
CMNPD13640	arrest the cell cycle at G2/M
CMNPD13641	cytotoxic
CMNPD13642	modest cytotoxicity towards two tumour cell lines
CMNPD13645	mild cytotoxicity towards two tumour cell lines
CMNPD13646	modest cytotoxicity towards two tumour cell lines
CMNPD13651	mild cytotoxicity towards human tumour cell lines
CMNPD13652	selective cytotoxicity towards the KB cell line
CMNPD13653	selective cytotoxicity towards the KB cell line
CMNPD13654	selective towards the Hepa cell line
CMNPD13655	selective cytotoxicity towards the KB cell line
CMNPD13658	P388 cell line growth inhibition
CMNPD13664	potently cytotoxic
CMNPD13670	Antimalarial against Plasmodium falciparum
CMNPD13675	Antimalarial against Plasmodium falciparum
CMNPD13676	Antimalarial against Plasmodium falciparum
CMNPD13689	mild cytotoxicity towards Hepa and KB cell lines
CMNPD13699	cytotoxicity towards Vero and MDCK cell lines
CMNPD13700	cytotoxicity towards Vero and MDCK cell lines
CMNPD13701	cytotoxicity towards Vero and MDCK cell lines
CMNPD13702	cytotoxicity towards Vero and MDCK cell lines
CMNPD13703	cytotoxicity towards Vero and MDCK cell lines
CMNPD13704	cytotoxicity towards Vero and MDCK cell lines
CMNPD13716	cytotoxic against P388D1 cells
CMNPD13718	cytotoxicity towards a panel of human tumour cell lines
CMNPD13719	cytotoxicity towards a panel of human tumour cell lines
CMNPD13726	weak antifungal activity
CMNPD13727	weak antifungal activity
CMNPD13728	weak antifungal activity
CMNPD13729	weak antifungal activity | weakly inhibit tyrosine kinase p56lck
CMNPD13730	weak antifungal activity | weakly inhibit tyrosine kinase p56lck
CMNPD13732	mildly cytotoxic
CMNPD13733	weakly cytotoxic
CMNPD13734	weakly cytotoxic
CMNPD13736	potent antimicrobial and antitumour activity in vitro
CMNPD13737	potent antimicrobial and antitumour activity in vitro
CMNPD13751	channel-gating antagonist of voltage-gated potassium channels
CMNPD13752	potent inhibitors of glycogen synthase kinase-3 (GSK-3)
CMNPD13753	potent inhibitors of glycogen synthase kinase-3 (GSK-3)
CMNPD13768	mildly cytotoxic
CMNPD13769	mildly cytotoxic
CMNPD13774	moderately cytotoxic
CMNPD13775	moderately cytotoxic
CMNPD13776	moderately cytotoxic
CMNPD13777	antitumour agent
CMNPD13779	modest cytotoxicity towards a panel of tumour cell lines
CMNPD13780	modest cytotoxicity towards a panel of tumour cell lines
CMNPD13781	weak to moderate activity towards the HCT-116 tumour cell line
CMNPD13782	weak to moderate activity towards the HCT-116 tumour cell line
CMNPD13783	weak to moderate activity towards the HCT-116 tumour cell line
CMNPD13784	weak to moderate activity towards the HCT-116 tumour cell line
CMNPD13785	weak to moderate activity towards the HCT-116 tumour cell line
CMNPD13786	weak to moderate activity towards the HCT-116 tumour cell line
CMNPD13787	antifungal
CMNPD13789	histamine antagonist
CMNPD13791	mild cytotoxicity against LOVO-DOX colon carcinoma (with a GI50 value of 0.9 g/mL)
CMNPD13793	cytotoxicity towards a rat glioma cell line
CMNPD13794	cytotoxicity towards a rat glioma cell line
CMNPD13796	mildly cytotoxic
CMNPD13797	mildly cytotoxic
CMNPD13798	mildly cytotoxic towards the L1210 murine leukemia cell line
CMNPD13799	mildly cytotoxic towards the L1210 murine leukemia cell line
CMNPD13800	mildly cytotoxic towards the L1210 murine leukemia cell line
CMNPD13801	not cytotoxic towards A431 and wild-type and p53 deficient HCT-116 human tumour cell lines
CMNPD13804	extraordinarily potent cytotoxic enediyne antibiotics
CMNPD13805	extraordinarily potent cytotoxic enediyne antibiotics
CMNPD13806	extraordinarily potent cytotoxic enediyne antibiotics
CMNPD13809	potent inhibitor of microtubule assembly
CMNPD13810	cytotoxic
CMNPD13811	cytotoxic
CMNPD13820	neuritogenic activity against PC12 cells in the presence of nerve growth factor
CMNPD13821	neuritogenic activity against PC12 cells in the presence of nerve growth factor
CMNPD13822	neuritogenic activity against PC12 cells in the presence of nerve growth factor
CMNPD13823	neuritogenic activity
CMNPD13824	neuritogenic activity
CMNPD13825	neuritogenic activity
CMNPD13826	neuritogenic activity
CMNPD13827	neuritogenic activity
CMNPD13828	neuritogenic activity
CMNPD13829	neuritogenic activity
CMNPD13830	neuritogenic activity
CMNPD13831	neuritogenic activity
CMNPD13832	neuritogenic activity
CMNPD13833	neuritogenic activity
CMNPD13834	neuritogenic activity
CMNPD13835	neuritogenic activity
CMNPD13836	neuritogenic activity
CMNPD13837	neuritogenic activity
CMNPD13838	neuritogenic activity
CMNPD13839	neuritogenic activity
CMNPD13840	neuritogenic activity
CMNPD13841	neuritogenic activity
CMNPD13842	neuritogenic activity
CMNPD13843	neuritogenic activity
CMNPD13844	neuritogenic activity
CMNPD13845	neuritogenic activity
CMNPD13846	neuritogenic activity
CMNPD13847	modest in vitro cytotoxicity towards a panel of human tumour cell lines
CMNPD13848	modest in vitro cytotoxicity towards a panel of human tumour cell lines
CMNPD13849	modest in vitro cytotoxicity towards a panel of human tumour cell lines
CMNPD13850	modest in vitro cytotoxicity towards a panel of human tumour cell lines
CMNPD13851	modest in vitro cytotoxicity towards a panel of human tumour cell lines
CMNPD13852	modest in vitro cytotoxicity towards a panel of human tumour cell lines
CMNPD13853	modest in vitro cytotoxicity towards a panel of human tumour cell lines
CMNPD13854	modest in vitro cytotoxicity towards a panel of human tumour cell lines
CMNPD13855	modest in vitro cytotoxicity towards a panel of human tumour cell lines
CMNPD13856	modest in vitro cytotoxicity towards a panel of human tumour cell lines
CMNPD13857	modest in vitro cytotoxicity towards a panel of human tumour cell lines
CMNPD13858	modest in vitro cytotoxicity towards a panel of human tumour cell lines
CMNPD13860	modest in vitro cytotoxicity towards a panel of human tumour cell lines
CMNPD13866	varied biological activity towards a range of tumour cell lines and bacteria
CMNPD13867	varied biological activity towards a range of tumour cell lines and bacteria
CMNPD13868	varied biological activity towards a range of tumour cell lines and bacteria
CMNPD13869	varied biological activity towards a range of tumour cell lines and bacteria
CMNPD13870	mildly inhibit division of fertilised sea urchin eggs
CMNPD13871	mildly inhibit division of fertilised sea urchin eggs
CMNPD13872	in vitro cytotoxicity towards a panel of human tumour cell lines | in vivo activity towards Lewis lung and mouse S180 sarcoma tumour models
CMNPD13873	in vitro cytotoxicity towards a panel of human tumour cell lines
CMNPD13874	in vitro cytotoxicity towards a panel of human tumour cell lines
CMNPD13881	mildly cytotoxic
CMNPD13882	mildly cytotoxic
CMNPD13886	modest antimicrobial activity against selected Gram-positive bacteria
CMNPD13888	antitumour | antiplasmodial
CMNPD13893	moderate activity against human tumour cell lines
CMNPD13894	moderate phytotoxicity and concentration-dependent inhibition of human cancer cell lines | low general cytotoxicity
CMNPD13895	moderate phytotoxicity and concentration-dependent inhibition of human cancer cell lines | low general cytotoxicity
CMNPD13896	inhibite the growth of human colon tumour cells (HCT-116)
CMNPD13897	inhibite the growth of human colon tumour cells (HCT-116)
CMNPD13898	inhibite the growth of human colon tumour cells (HCT-116)
CMNPD13901	inhibitor of the pathway between chorismic and para-aminobenzoic acids | strongly active against Gram-positive bacteria
CMNPD13903	moderate activity against B. subtilis | Streptococcus viridochromogenes and Staphylococcus aureus
CMNPD13905	moderate activity against B. subtilis
CMNPD13906	moderate activity against B. subtilis
CMNPD13910	active against a range of tumour cell lines
CMNPD13915	modest cytotoxicity against L1210 and KB cell lines
CMNPD13916	moderate antiproliferative activity against several human leukemia cell lines and | active against brine shrimp
CMNPD13917	moderate antiproliferative activity against several human leukemia cell lines and | active against brine shrimp
CMNPD13918	induce neurite outgrowth in rat pheochromocytoma cells
CMNPD13920	cytotoxic against human cancer cell lines
CMNPD13924	strongly neuroprotective
CMNPD13929	moderate activities against the KB cell line
CMNPD13930	moderate activities against the KB cell line
CMNPD13933	moderately cytotoxic
CMNPD13934	moderately cytotoxic
CMNPD13935	moderately cytotoxic
CMNPD13936	moderately cytotoxic
CMNPD13937	cytotoxic
CMNPD13938	cytotoxic
CMNPD13939	cytotoxic
CMNPD13940	cytotoxic
CMNPD13945	significant cytotoxicity against P388 cells | moderately cytotoxic to 39 human tumour cell lines
CMNPD13946	significant cytotoxicity against P388 cells
CMNPD13949	moderately cytotoxic to 39 human tumour cell lines
CMNPD13950	cytotoxic against a neuroblastoma cell line
CMNPD13951	cytotoxic against a neuroblastoma cell line
CMNPD13952	modestly cytotoxic
CMNPD13953	modestly cytotoxic
CMNPD13954	modestly cytotoxic
CMNPD13955	modestly cytotoxic
CMNPD13956	inhibitor of adhesion of human leukaemia HL-61 cells to human umbilical vein endothelial cells (HUVEC)
CMNPD13958	potent inhibitors of the adhesion of HL-60 cells to HUVEC
CMNPD13959	potent inhibitors of the adhesion of HL-60 cells to HUVEC
CMNPD13960	cytotoxic towards a variety of cancer cell lines | with some selectivity for the CCRFCEM leukemia line
CMNPD13964	cytotoxic | moderately antifungal against a range of organisms | active against Micrococcus luteus
CMNPD13965	cytotoxic | active against Micrococcus luteus
CMNPD13966	moderate antimicrobial activity and | cytotoxic against sea urchin eggs
CMNPD13967	cytotoxic | sodium channel blocking | ichthyotoxic
CMNPD13968	cytotoxic | sodium channel blocking | ichthyotoxic
CMNPD13969	cytotoxic | sodium channel blocking | ichthyotoxic
CMNPD13975	relatively potent brine shrimp toxicity
CMNPD13976	relatively potent brine shrimp toxicity
CMNPD13980	relatively potent brine shrimp toxicity
CMNPD13981	cytotoxic
CMNPD13982	cytotoxic
CMNPD13983	inhibit osteoclastogenesis of the murine monocytic cell line RAW264 | potential for use as an antiresorptive for prevention and treatment of osteoporosis in postmenopausal women | inhibit cyclooxygenase-2 (COX-2) activity
CMNPD13987	potent cytotoxin
CMNPD13994	modestly cytotoxic against two human squamous cell carcinomas
CMNPD13996	potent thrombin inhibitor
CMNPD13998	potent antifungal activity against the marine algal pathogen Lindra thallasiae
CMNPD13999	potent antifungal activity against the marine algal pathogen Lindra thallasiae
CMNPD14000	inhibit glycation and α-amylase | have an effect on complications of diabetes
CMNPD14006	cytotoxic
CMNPD14007	cytotoxic
CMNPD14014	strong anti-HSV-1 activity in vitro | little inhibition of HIV-1 reverse transcriptase
CMNPD14027	moderately selective cytotoxicity
CMNPD14033	radical-scavenging activity | potent inhibitor of α-glucosidase and α-amylase | possible potential as a functional food or nutraceutical for diabetes
CMNPD14039	potent inhibitor of hypoxia-activated hypoxia-inducible factor-1 and of the angiogenic factor hypoxia-induced VEGF in T47D cells
CMNPD14040	antifeedant activity against the sea urchin Strongylocentrotus intermedius
CMNPD14041	antifeedant activity against the sea urchin Strongylocentrotus intermedius
CMNPD14043	activity at a similar level in a DNA methyltransferase enzyme inhibition assay
CMNPD14044	activity at a similar level in a DNA methyltransferase enzyme inhibition assay
CMNPD14045	activity at a similar level in a DNA methyltransferase enzyme inhibition assay
CMNPD14053	anthelmintic activity | antitumour activity against Ehrlich ascites carcinoma in vitro
CMNPD14098	inhibitor of bacterial proteases
CMNPD14099	α-glycosidase inhibitor
CMNPD14100	cytotoxic
CMNPD14101	cytotoxic
CMNPD14102	cytotoxic
CMNPD14103	cytotoxic
CMNPD14104	cytotoxic
CMNPD14105	cytotoxic
CMNPD14106	cytotoxic
CMNPD14107	cytotoxic
CMNPD14108	cytotoxic
CMNPD14109	cytotoxic
CMNPD14110	cytotoxic
CMNPD14111	inhibit HIF-1 activation in human breast tumour cells
CMNPD14114	weakly cytotoxic
CMNPD14115	weakly cytotoxic
CMNPD14116	weakly cytotoxic
CMNPD14117	moderately cytotoxic
CMNPD14119	potent nematocide
CMNPD14120	potent nematocide
CMNPD14121	potent nematocide
CMNPD14122	potent nematocide
CMNPD14124	inhibit inducible nitric oxide synthase activity
CMNPD14125	cytotoxic
CMNPD14126	cytotoxic
CMNPD14133	potent cytotoxin
CMNPD14135	potent inhibitor of protein phosphatase 2A
CMNPD14136	potent inhibitor of protein phosphatase 2A
CMNPD14137	potent inhibitor of protein phosphatase 2A
CMNPD14138	inhibitor of serine protease factor VIIa and thrombin
CMNPD14139	inhibitor of serine protease factor VIIa and thrombin
CMNPD14140	inhibitor of serine protease factor VIIa and thrombin
CMNPD14143	potent antimitotic
CMNPD14145	cytotoxic | antitubercular
CMNPD14146	cytotoxic | antitubercular
CMNPD14149	reverse P-glycoprotein-mediated multi-drug resistance in mammalian cells
CMNPD14150	potent cytoprotective activity against HIV-1
CMNPD14156	strongly inhibit growth of the murine P388 lymphocytic leukaemia
CMNPD14157	antiproliferative
CMNPD14158	antiproliferative
CMNPD14159	antiproliferative
CMNPD14160	antiproliferative
CMNPD14161	antiproliferative
CMNPD14163	potent cytotoxicity against various human carcinoma cells
CMNPD14164	inhibitory activity towards the assembly of microtubules
CMNPD14165	inhibitory activity towards the assembly of microtubules
CMNPD14169	moderately antifungal
CMNPD14174	antiplasmodial activity against chloroquine-resistant Plasmodium falciparum
CMNPD14175	antiplasmodial activity against chloroquine-resistant Plasmodium falciparum
CMNPD14176	antiplasmodial activity against chloroquine-resistant Plasmodium falciparum
CMNPD14177	antiplasmodial activity against chloroquine-resistant Plasmodium falciparum
CMNPD14178	antiplasmodial activity against chloroquine-resistant Plasmodium falciparum
CMNPD14179	antiplasmodial activity against chloroquine-resistant Plasmodium falciparum
CMNPD14180	antiplasmodial activity against chloroquine-resistant Plasmodium falciparum
CMNPD14181	antiplasmodial activity against chloroquine-resistant Plasmodium falciparum
CMNPD14182	antiplasmodial activity against chloroquine-resistant Plasmodium falciparum
CMNPD14183	antiplasmodial activity against chloroquine-resistant Plasmodium falciparum
CMNPD14184	antiplasmodial activity against chloroquine-resistant Plasmodium falciparum
CMNPD14185	antiplasmodial activity against chloroquine-resistant Plasmodium falciparum
CMNPD14186	antiplasmodial activity against chloroquine-resistant Plasmodium falciparum
CMNPD14187	antiplasmodial activity against chloroquine-resistant Plasmodium falciparum
CMNPD14188	antiplasmodial activity against chloroquine-resistant Plasmodium falciparum
CMNPD14189	antiplasmodial activity against chloroquine-resistant Plasmodium falciparum
CMNPD14193	inhibitor of histone deacetylase
CMNPD14194	inhibitor of histone deacetylase
CMNPD14195	inhibitor of histone deacetylase
CMNPD14196	cytotoxic
CMNPD14201	inhibit the growth of mammalian cells
CMNPD14202	inhibit the growth of mammalian cells
CMNPD14204	potent antiinflammatory | antifungal | anti-HIV-1 agent
CMNPD14205	potent antiinflammatory | antifungal | anti-HIV-1 agent
CMNPD14206	potent antiinflammatory | antifungal | anti-HIV-1 agent
CMNPD14207	significant antihistamine activity
CMNPD14208	significant antihistamine activity
CMNPD14209	significant antihistamine activity
CMNPD14210	weakly cytotoxic
CMNPD14211	antifouling
CMNPD14214	moderate cytotoxicity
CMNPD14223	moderately cytotoxic | inhibit division of fertilised sea urchin eggs
CMNPD14236	cytotoxic
CMNPD14240	cytotoxic activity
CMNPD14241	antibacterial activity against Enterococcus durans
CMNPD14243	strongly antifungal
CMNPD14250	active as human lipoxygenase inhibitor
CMNPD14251	active as human lipoxygenase inhibitor
CMNPD14252	antibacterial
CMNPD14253	antibacterial
CMNPD14254	antibacterial
CMNPD14255	antibacterial
CMNPD14256	antibacterial
CMNPD14257	antibacterial
CMNPD14258	antibacterial | inhibit protein phosphatase 2A activity
CMNPD14259	antibacterial
CMNPD14265	antibacterial
CMNPD14271	potent antagonist of the sarcoplasmic reticulum calcium channel RyR1-FKBP12
CMNPD14272	potent antagonist of the sarcoplasmic reticulum calcium channel RyR1-FKBP12
CMNPD14278	inactivator of human 15-lipoxygenase
CMNPD14279	inactivator of human 15-lipoxygenase
CMNPD14280	inactivator of human 15-lipoxygenase
CMNPD14281	inactivator of human 15-lipoxygenase
CMNPD14282	inactivator of human 15-lipoxygenase
CMNPD14283	inhibitor of MAPKAP kinase 2
CMNPD14284	inhibitor of MAPKAP kinase 2
CMNPD14285	anti-invasion
CMNPD14288	weakly antibacterial
CMNPD14289	weakly antibacterial
CMNPD14292	antimicrobial
CMNPD14293	antimicrobial
CMNPD14303	inhibit the lyase activity of DNA polymerase β
CMNPD14304	inhibit the lyase activity of DNA polymerase β
CMNPD14305	inhibit the lyase activity of DNA polymerase β
CMNPD14306	cytotoxic | nematocidal
CMNPD14307	inhibit bacterial folate biosynthesis
CMNPD14308	inhibit bacterial folate biosynthesis
CMNPD14320	weak cytotoxicity
CMNPD14321	weak cytotoxicity
CMNPD14322	weak cytotoxicity
CMNPD14323	weak cytotoxicity
CMNPD14324	weak cytotoxicity
CMNPD14325	cytotoxic
CMNPD14326	cytotoxic
CMNPD14327	cytotoxic
CMNPD14328	cytotoxic
CMNPD14329	cytotoxic | antimicrobial | phosphatase Cdc25B inhibitory activity
CMNPD14330	cytotoxic
CMNPD14331	cytotoxic
CMNPD14332	cytotoxic
CMNPD14338	potently antitubercular
CMNPD14339	moderately cytotoxic
CMNPD14340	moderately cytotoxic
CMNPD14341	moderately cytotoxic
CMNPD14342	moderately cytotoxic
CMNPD14343	moderately cytotoxic
CMNPD14348	cytotoxic
CMNPD14349	cytotoxic
CMNPD14352	potent HIV-1 reverse transcriptase inhibitory activity
CMNPD14362	cytotoxic
CMNPD14363	cytotoxic
CMNPD14364	cytotoxic
CMNPD14365	cytotoxic
CMNPD14366	moderately cytotoxic
CMNPD14367	moderately cytotoxic
CMNPD14368	moderately cytotoxic
CMNPD14369	moderately cytotoxic
CMNPD14370	potent cytotoxin
CMNPD14371	potently cytotoxic
CMNPD14372	potently cytotoxic
CMNPD14374	selectively active against a yeast strain defective in double stranded DNA repair
CMNPD14384	mildly antibacterial
CMNPD14385	mildly antibacterial
CMNPD14404	moderately cytotoxic
CMNPD14413	potent cytotoxin
CMNPD14420	mildly cytotoxic
CMNPD14421	mildly cytotoxic
CMNPD14422	mildly cytotoxic
CMNPD14423	mildly cytotoxic
CMNPD14431	moderate in vitro cytotoxicity towards tumour cell lines
CMNPD14432	mild inhibitor of acetylcholinesterase
CMNPD14451	antibacterial activity towards Gram-positive bacteria
CMNPD14452	antibacterial activity towards Gram-positive bacteria
CMNPD14456	activity in a number of biological assays | antiinflammatory | cytotoxicity | antiinfective
CMNPD14457	activity in a number of biological assays | antiinflammatory | cytotoxicity | antiinfective
CMNPD14464	activity in a number of biological assays | antiinflammatory | cytotoxicity | antiinfective
CMNPD14465	activity in a number of biological assays | antiinflammatory | cytotoxicity | antiinfective
CMNPD14466	activity in a number of biological assays | antiinflammatory | cytotoxicity | antiinfective
CMNPD14467	activity in a number of biological assays | antiinflammatory | cytotoxicity | antiinfective
CMNPD14470	activity in a number of biological assays | antiinflammatory | cytotoxicity | antiinfective
CMNPD14471	activity in a number of biological assays | antiinflammatory | cytotoxicity | antiinfective
CMNPD14473	potent antiproliferative activity towards tumour cell lines
CMNPD14476	mild growth inhibition of Plasmodium falciparum
CMNPD14477	mild growth inhibition of Plasmodium falciparum
CMNPD14479	mild growth inhibition of Plasmodium falciparum
CMNPD14481	modestly potent growth inhibitor against two tumour cell lines
CMNPD14488	modestly cytotoxic
CMNPD14489	modest cytotoxicity towards tumour cell lines
CMNPD14490	modest cytotoxicity towards tumour cell lines
CMNPD14491	modest cytotoxicity towards tumour cell lines
CMNPD14493	modest biological activity towards Plasmodium falciparum and human tumour cell lines
CMNPD14506	inhibitor of cytokinesis
CMNPD14507	inhibitor of cytokinesis
CMNPD14519	moderately potent inhibitor of the mitochondrial respiratory chain
CMNPD14520	moderately potent inhibitor of the mitochondrial respiratory chain
CMNPD14532	modest cytotoxicity towards a panel of mouse and human tumour cell lines
CMNPD14533	modest cytotoxicity towards a panel of mouse and human tumour cell lines
CMNPD14536	modestly cytotoxic
CMNPD14537	modestly cytotoxic
CMNPD14538	modestly cytotoxic
CMNPD14539	modestly cytotoxic
CMNPD14540	modestly cytotoxic
CMNPD14541	modestly cytotoxic
CMNPD14542	modestly cytotoxic
CMNPD14543	mild cytotoxicity
CMNPD14548	mildly cytotoxic
CMNPD14555	cytotoxicity against murine IC-2WT tumour cells in vitro
CMNPD14556	cytotoxicity against murine IC-2WT tumour cells in vitro
CMNPD14557	cytotoxicity against murine IC-2WT tumour cells in vitro
CMNPD14558	cytotoxicity against murine IC-2WT tumour cells in vitro
CMNPD14559	cytotoxicity against murine IC-2WT tumour cells in vitro
CMNPD14560	cytotoxicity against murine IC-2WT tumour cells in vitro
CMNPD14564	inhibitory to L1210 murine leukemia cells
CMNPD14565	inhibitory to L1210 murine leukemia cells
CMNPD14566	cytotoxic
CMNPD14570	cytotoxic
CMNPD14571	cytotoxic
CMNPD14572	cytotoxic
CMNPD14575	antimicrobial
CMNPD14583	antifungal
CMNPD14598	relatively potent partial agonist of human A3 adenosine receptors
CMNPD14600	weakly cytotoxic
CMNPD14601	weakly cytotoxic
CMNPD14602	weakly cytotoxic
CMNPD14603	weakly cytotoxic
CMNPD14605	mildly antibacterial
CMNPD14619	neuritogenic activity against PC12 cells in the presence of nerve growth factor
CMNPD14620	neuritogenic activity
CMNPD14621	neuritogenic activity
CMNPD14622	neuritogenic activity
CMNPD14625	modest in vitro cytotoxicity towards a panel of human tumour cell lines
CMNPD14626	modest in vitro cytotoxicity towards a panel of human tumour cell lines
CMNPD14627	modest in vitro cytotoxicity towards a panel of human tumour cell lines
CMNPD14628	modest in vitro cytotoxicity towards a panel of human tumour cell lines
CMNPD14629	modest in vitro cytotoxicity towards a panel of human tumour cell lines
CMNPD14630	modest in vitro cytotoxicity towards a panel of human tumour cell lines
CMNPD14631	modest in vitro cytotoxicity towards a panel of human tumour cell lines
CMNPD14632	modest in vitro cytotoxicity towards a panel of human tumour cell lines
CMNPD14633	modest in vitro cytotoxicity towards a panel of human tumour cell lines
CMNPD14634	modest in vitro cytotoxicity towards a panel of human tumour cell lines
CMNPD14635	modest in vitro cytotoxicity towards a panel of human tumour cell lines
CMNPD14636	modest in vitro cytotoxicity towards a panel of human tumour cell lines
CMNPD14637	modest in vitro cytotoxicity towards a panel of human tumour cell lines
CMNPD14638	modest in vitro cytotoxicity towards a panel of human tumour cell lines
CMNPD14660	mildly bioactive
CMNPD14666	induce neurite outgrowth in PC12 cells
CMNPD14667	induce neurite outgrowth in PC12 cells
CMNPD14668	induce neurite outgrowth in PC12 cells
CMNPD14675	inhibit human colon carcinoma HCT-116 cells
CMNPD14679	significant activity against methicillin-resistant Staphylococcus aureus (MRSA) | vancomycin-resistant Enterococcus faecium (VREF) | cytotoxic to human colon carcinoma HCT-116 cells
CMNPD14680	significant activity against methicillin-resistant Staphylococcus aureus (MRSA) | vancomycin-resistant Enterococcus faecium (VREF) | cytotoxic to human colon carcinoma HCT-116 cells
CMNPD14681	significant activity against methicillin-resistant Staphylococcus aureus (MRSA) | vancomycin-resistant Enterococcus faecium (VREF) | cytotoxic to human colon carcinoma HCT-116 cells
CMNPD14682	significant activity against methicillin-resistant Staphylococcus aureus (MRSA) | vancomycin-resistant Enterococcus faecium (VREF) | cytotoxic to human colon carcinoma HCT-116 cells
CMNPD14683	potent differentiation inducer of M. oxyspermum | induce germination in other green macroalgae
CMNPD14684	active against A-549 lung and Jurkat human leukaemia cell lines
CMNPD14689	antioxidant activity in the 1,1-diphenyl-2-picrylhydrazyl (DPPH) free radical scavenging assay
CMNPD14690	active against both drug-sensitive and drug-resistant Gram positive microorganisms | inhibit growth of the murine melanoma cell line B16-F10
CMNPD14691	antitumour activity against a number of human cancer cell lines
CMNPD14692	antitumour activity against a number of human cancer cell lines
CMNPD14693	weak inhibitor of the recombinant enzyme sortase B
CMNPD14694	weak inhibitor of the recombinant enzyme sortase B
CMNPD14695	activity against HT-29 and B16-F10 cell lines
CMNPD14698	active against E. coli, S. aureus and Streptomyces viridochromogenes | cytotoxic to HMO2 (gastric adenocarcinoma) and HePG2 (hepatic carcinoma) cell lines
CMNPD14710	inhibitor of the proliferation of a variety of murine and human cancer cell lines
CMNPD14714	inhibit the ubiquitin-activating enzyme E1
CMNPD14717	active against the sea urchin Strongylocentrus intermedius | cytotoxic to embryos and spermatoxic to sperm
CMNPD14719	weak antifungal activity against Cryptococcus neoformans | antibacterial activity against Micrococcus luteus
CMNPD14720	weak antifungal activity against Cryptococcus neoformans | antibacterial activity against Micrococcus luteus
CMNPD14725	weakly active against L1210 cells | antibacterial against M. luteus and B. subtilis
CMNPD14726	modestly cytotoxic against L1210 cells
CMNPD14728	active against HIV | neuroprotective potential | selectively active against L5178y cells
CMNPD14730	weak cytotoxicity
CMNPD14731	weakly cytotoxic to A-549 cells only
CMNPD14734	antiproliferative
CMNPD14735	antiproliferative
CMNPD14736	cytotoxic to P388 and A-549 cell lines
CMNPD14737	cytotoxic to P388 and A-549 cell lines
CMNPD14738	cytotoxic to a range of human tumour cell lines
CMNPD14739	cytotoxic to a range of human tumour cell lines | strongly cytotoxic to SKOV-3 cells (human ovarian carcinoma)
CMNPD14740	cytotoxic agent against tsFT210 cells
CMNPD14742	motility inhibitor of the dinoflagellate Prorocentrum micans
CMNPD14743	motility inhibitor of the dinoflagellate Prorocentrum micans
CMNPD14744	modest growth inhibition of alga | antibacterial | antifungal
CMNPD14745	modest growth inhibition of alga | antibacterial | antifungal
CMNPD14746	modest growth inhibition of alga | antibacterial | antifungal
CMNPD14747	modest growth inhibition of alga | antibacterial | antifungal
CMNPD14748	modest growth inhibition of alga | antibacterial | antifungal
CMNPD14749	modest growth inhibition of alga | antibacterial | antifungal
CMNPD14750	modest growth inhibition of alga | antibacterial | antifungal
CMNPD14751	modest growth inhibition of alga | antibacterial | antifungal
CMNPD14752	modest growth inhibition of alga | antibacterial | antifungal
CMNPD14753	modest growth inhibition of alga | antibacterial | antifungal
CMNPD14754	modest growth inhibition of alga | antibacterial | antifungal
CMNPD14755	inhibit tyrosinase
CMNPD14757	moderately cytotoxic to L1210 and KB cells
CMNPD14758	induce neuritogenesis in neuroblastoma neuro-2a cells at low concentration | cytotoxic at higher concentration
CMNPD14759	inhibitor of adhesion of human leukaemia HL-60 cells to human umbilical vein endothelial cells (HUVEC)
CMNPD14760	inhibitor of adhesion of human leukaemia HL-60 cells to human umbilical vein endothelial cells (HUVEC)
CMNPD14761	inhibitor of adhesion of human leukaemia HL-60 cells to human umbilical vein endothelial cells (HUVEC)
CMNPD14762	cytotoxicity against HCT-116 cells
CMNPD14763	cytotoxicity against HCT-116 cells
CMNPD14764	cytotoxicity against HCT-116 cells
CMNPD14765	cytotoxicity against HCT-116 cells
CMNPD14771	antimicrofilament activity | cytotoxic towards L1210 and C38 cell lines
CMNPD14773	potent L-calcium channel blocker
CMNPD14774	cytotoxic against the KB and Raji cell lines
CMNPD14775	cytotoxic to NCI-H460 and neuro-2a cell lines
CMNPD14776	cytotoxic to NCI-H460 and neuro-2a cell lines
CMNPD14777	cytotoxic to NCI-H460 and neuro-2a cell lines
CMNPD14778	cytotoxic to NCI-H460 and neuro-2a cell lines
CMNPD14779	cytotoxic to NCI-H460 and neuro-2a cell lines
CMNPD14780	cytotoxic to brine shrimp and to the NCI-H460 and neuro-2a cell lines
CMNPD14781	cytotoxic to brine shrimp and to the NCI-H460 and neuro-2a cell lines
CMNPD14782	cytotoxic to brine shrimp and to the NCI-H460 and neuro-2a cell lines
CMNPD14783	cytotoxic to brine shrimp and to the NCI-H460 and neuro-2a cell lines
CMNPD14784	comparable activity to swinholide A | inhibiting proliferation in NCI-H460, neuro-2a and MDA-MB-435 cell lines and inhibiting cytokinesis
CMNPD14788	modest antifungal
CMNPD14792	active towards Aspergillus niger | haemolytic activity
CMNPD14793	haemolytic against mouse erythrocytes, cytotoxic against P388 cells | antifungal towards Aspergillus niger to varying degrees
CMNPD14794	haemolytic against mouse erythrocytes, cytotoxic against P388 cells | antifungal towards Aspergillus niger to varying degrees
CMNPD14795	haemolytic against mouse erythrocytes, cytotoxic against P388 cells | antifungal towards Aspergillus niger to varying degrees
CMNPD14796	haemolytic against mouse erythrocytes, cytotoxic against P388 cells | antifungal towards Aspergillus niger to varying degrees
CMNPD14797	haemolytic against mouse erythrocytes, cytotoxic against P388 cells | antifungal towards Aspergillus niger to varying degrees
CMNPD14798	weakly antibacterial
CMNPD14799	potently cytotoxic against L1210 and KB cell lines
CMNPD14800	potently cytotoxic against L1210 and KB cell lines
CMNPD14807	brevetoxin from the binding site in rat brain synaptosomes | antagonise toxic effects of brevetoxins in fish | itself non-toxic to fish
CMNPD14812	inhibitor of DLD-1 and RP-MI7951 cell lines
CMNPD14846	significant activity in the DPPH assay
CMNPD14847	significant activity in the DPPH assay
CMNPD14848	significant activity in the DPPH assay
CMNPD14849	significant activity in the DPPH assay
CMNPD14850	significant activity in the DPPH assay
CMNPD14851	significant activity in the DPPH assay
CMNPD14852	significant activity in the DPPH assay | inhibitor of butylcholine esterase
CMNPD14853	significant activity in the DPPH assay
CMNPD14854	significant activity in the DPPH assay
CMNPD14855	significant activity in the DPPH assay
CMNPD14856	significant activity in the DPPH assay
CMNPD14857	significant activity in the DPPH assay
CMNPD14858	significant activity in the DPPH assay
CMNPD14859	significant activity in the DPPH assay
CMNPD14860	significant activity in the DPPH assay | inhibitor of butylcholine esterase
CMNPD14861	significant activity in the DPPH assay
CMNPD14862	significant antioxidant activity
CMNPD14863	potently active against human cytomegalovirus (HCMV) in vitro
CMNPD14864	strongly antioxidant
CMNPD14865	strongly antioxidant | antiproliferative effects against 26-L5 cells
CMNPD14866	strongly antioxidant | antiproliferative effects against 26-L5 cells
CMNPD14867	strongly antioxidant | antiproliferative effects against 26-L5 cells
CMNPD14868	cytotoxic agent against the NSCLC-N6 and A-549 cell lines
CMNPD14869	cytotoxic agent against the NSCLC-N6 and A-549 cell lines
CMNPD14870	anti-inflammatory agents by inhibition of leukotriene biosynthesis
CMNPD14871	anti-inflammatory agents by inhibition of leukotriene biosynthesis
CMNPD14872	variously active in a range of bioassays | cytotoxicity | sodium channels | modulation of intracellular calcium concentrations
CMNPD14873	variously active in a range of bioassays | cytotoxicity | sodium channels | modulation of intracellular calcium concentrations
CMNPD14874	variously active in a range of bioassays | cytotoxicity | sodium channels | modulation of intracellular calcium concentrations
CMNPD14875	variously active in a range of bioassays | cytotoxicity | sodium channels | modulation of intracellular calcium concentrations
CMNPD14876	variously active in a range of bioassays | cytotoxicity | sodium channels | modulation of intracellular calcium concentrations
CMNPD14890	active against P388 cells and HT-29 cells
CMNPD14891	active against P388 cells
CMNPD14907	cytotoxic against the NSCLC-N6 and A-549 cancer cell lines
CMNPD14908	cytotoxic against the NSCLC-N6 and A-549 cancer cell lines
CMNPD14909	cytotoxic against the NSCLC-N6 and A-549 cancer cell lines
CMNPD14932	significant aldose reductase inhibitor
CMNPD14933	significant aldose reductase inhibitor
CMNPD14934	significant aldose reductase inhibitor
CMNPD14940	moderate activity against the human oesophageal cancer cell line WHCO1
CMNPD14941	moderate activity against the human oesophageal cancer cell line WHCO1
CMNPD14951	toxic to larvae of the scleractinian coral Pseudosiderastrea tayamai
CMNPD14952	toxic to larvae of the scleractinian coral Pseudosiderastrea tayamai
CMNPD14953	antibacterial | antifungal | anti-HIV active | cytotoxic to several human tumour cell lines by specific induction of apoptosis
CMNPD14954	antibacterial | antifungal
CMNPD14955	antibacterial | antifungal
CMNPD15027	antifungal against Candida glabrata
CMNPD15028	inhibitor of Raf kinase
CMNPD15029	inhibitor of Raf kinase
CMNPD15030	inhibitor of Raf kinase
CMNPD15031	telomerase inhibitory activity
CMNPD15044	cytotoxic to cancer cell lines
CMNPD15046	cytotoxic to cancer cell lines
CMNPD15047	cytotoxic
CMNPD15048	cytotoxic
CMNPD15049	cytotoxic to brine shrimp
CMNPD15050	cytotoxic to brine shrimp
CMNPD15053	weakly cytotoxic
CMNPD15055	cytotoxic
CMNPD15056	cytotoxic
CMNPD15057	cytotoxic
CMNPD15058	cytotoxic
CMNPD15059	cytotoxic
CMNPD15060	cytotoxic
CMNPD15061	cytotoxic
CMNPD15064	antimalarial
CMNPD15065	antimalarial
CMNPD15074	cytotoxic
CMNPD15079	cytotoxic
CMNPD15085	inhibit amoeboid invasion by human tumour cells
CMNPD15086	inhibit amoeboid invasion by human tumour cells
CMNPD15087	potently cytotoxic
CMNPD15088	potently cytotoxic
CMNPD15089	potently cytotoxic
CMNPD15090	potently cytotoxic
CMNPD15091	potently cytotoxic
CMNPD15092	potently cytotoxic
CMNPD15093	inhibitor of proteasome activity
CMNPD15107	agonist activity against chemokine receptor CXCR3
CMNPD15108	cytotoxic
CMNPD15109	cytotoxic
CMNPD15111	cytotoxic
CMNPD15112	cytotoxic
CMNPD15116	activity against Staphylococcus epidermis
CMNPD15117	activity against Staphylococcus epidermis
CMNPD15118	activity against Staphylococcus epidermis
CMNPD15119	activity against Staphylococcus epidermis
CMNPD15120	activity against Staphylococcus epidermis
CMNPD15121	activity against Staphylococcus epidermis
CMNPD15122	cytotoxic
CMNPD15123	antimicrobial activity
CMNPD15129	moderately cytotoxic
CMNPD15130	moderately cytotoxic
CMNPD15131	moderately cytotoxic
CMNPD15132	antibacterial
CMNPD15135	antimalarial and antituberculosis activity
CMNPD15136	inhibit Ca2+ uptake by neurons
CMNPD15137	inhibitor of the Helicobacter pylori enzyme aspartyl semialdehyde dehydrogenase
CMNPD15144	antibacterial activity against the fish pathogen Aeromonas hydrophila
CMNPD15145	antibacterial activity against the fish pathogen Aeromonas hydrophila
CMNPD15146	antibacterial activity against the fish pathogen Aeromonas hydrophila
CMNPD15156	cytotoxic
CMNPD15159	cytotoxic
CMNPD15160	inhibit superoxide production by human neutrophils
CMNPD15161	inhibit the division of fertilised sea urchin eggs
CMNPD15162	inhibit the maturation of starfish oocytes
CMNPD15163	inhibit the maturation of starfish oocytes
CMNPD15164	inhibit the maturation of starfish oocytes
CMNPD15165	inhibit the maturation of starfish oocytes
CMNPD15166	inhibit the maturation of starfish oocytes
CMNPD15167	inhibit the maturation of starfish oocytes
CMNPD15168	inhibit the maturation of starfish oocytes
CMNPD15169	inhibitor of leucotriene production in porcine leukocytes
CMNPD15170	inhibitor of leucotriene production in porcine leukocytes
CMNPD15196	phosphatase Cdc25B inhibitory activity
CMNPD15197	phosphatase Cdc25B inhibitory activity
CMNPD15204	cytotoxic
CMNPD15206	cytotoxic
CMNPD15207	cytotoxic
CMNPD15208	cytotoxic
CMNPD15209	cytotoxic
CMNPD15219	active against Candida albicans
CMNPD15220	active against Candida albicans
CMNPD15226	moderately cytotoxic
CMNPD15227	moderately cytotoxic
CMNPD15232	cytotoxic
CMNPD15234	selectively active against a yeast strain defective in double stranded DNA repair
CMNPD15237	cytotoxic
CMNPD15238	antimicrobial to B. subtilis and S. cerevisae
CMNPD15239	antimicrobial to B. subtilis and S. cerevisae
CMNPD15240	antimicrobial to B. subtilis and S. cerevisae
CMNPD15241	antimicrobial to B. subtilis and S. cerevisae
CMNPD15242	cytotoxic
CMNPD15249	mild activity towards Plasmodium falciparum | cytotoxicity towards a panel of tumour cell lines
CMNPD15252	mild activity towards Plasmodium falciparum
CMNPD15255	mildly cytotoxic
CMNPD15256	mildly cytotoxic
CMNPD15257	mildly cytotoxic
CMNPD15258	mildly cytotoxic
CMNPD15259	mildly cytotoxic
CMNPD15260	mildly cytotoxic
CMNPD15261	mildly cytotoxic
CMNPD15262	mildly cytotoxic
CMNPD15264	mild cytotoxicity
CMNPD15270	mildly antiplasmodial
CMNPD15271	mildly antiplasmodial
CMNPD15272	mildly antiplasmodial
CMNPD15273	mildly antiplasmodial
CMNPD15274	mildly antiplasmodial
CMNPD15275	mildly antiplasmodial
CMNPD15276	mildly antiplasmodial
CMNPD15286	mildly cytotoxic
CMNPD15287	mildly cytotoxic
CMNPD15288	mildly cytotoxic
CMNPD15291	cytotoxic (mild)
CMNPD15296	cytotoxic (mild)
CMNPD15299	cytotoxic
CMNPD15310	mildly cytotoxic
CMNPD15311	mildly cytotoxic
CMNPD15312	mildly cytotoxic
CMNPD15313	mildly cytotoxic
CMNPD15320	mildly cytotoxic
CMNPD15321	mildly cytotoxic
CMNPD15322	mildly cytotoxic
CMNPD15324	mild cytotoxicity
CMNPD15325	mild cytotoxicity
CMNPD15327	mild cytotoxicity
CMNPD15331	mild cytotoxicity
CMNPD15346	mild cytotoxicity
CMNPD15348	mild cytotoxicity
CMNPD15349	mild cytotoxicity
CMNPD15350	mild cytotoxicity
CMNPD15353	mild cytotoxicity
CMNPD15386	mildly cytotoxic
CMNPD15389	mildly cytotoxic
CMNPD15390	mildly cytotoxic
CMNPD15391	mildly cytotoxic
CMNPD15392	mildly cytotoxic
CMNPD15394	mildly cytotoxic
CMNPD15396	mildly cytotoxic
CMNPD15399	mildly cytotoxic
CMNPD15402	mildly cytotoxic
CMNPD15403	mildly cytotoxic
CMNPD15404	mildly cytotoxic
CMNPD15405	mildly cytotoxic
CMNPD15406	mildly cytotoxic
CMNPD15407	mildly cytotoxic
CMNPD15408	mildly cytotoxic
CMNPD15455	moderate inhibitor of recombinant human cdc25B phosphatase
CMNPD15456	moderate inhibitor of recombinant human cdc25B phosphatase
CMNPD15457	moderate inhibitor of recombinant human cdc25B phosphatase
CMNPD15458	cytotoxic
CMNPD15459	cytotoxic
CMNPD15460	cytotoxic
CMNPD15461	cytotoxic
CMNPD15478	potently cytotoxic
CMNPD15487	modestly cytotoxic towards a panel of tumour cell lines
CMNPD15489	modestly cytotoxic towards a panel of tumour cell lines
CMNPD15501	induce the intracellular production of reactive oxygen species leading to disruption of mitochondrial potential and cell death by apoptosis
CMNPD15502	induce the intracellular production of reactive oxygen species leading to disruption of mitochondrial potential and cell death by apoptosis
CMNPD15505	modestly α-glucosidase inhibitory
CMNPD15508	potent cytotoxicity towards colorectal tumour cells
CMNPD15509	potent cytotoxicity towards colorectal tumour cells
CMNPD15510	potent cytotoxicity towards colorectal tumour cells
CMNPD15511	potent cytotoxicity towards colorectal tumour cells
CMNPD15517	promot plant growth in sprouts of Brassica campestris
CMNPD15609	mild cytotoxicity towards, and apoptotic induction of, Ehrlich carcinoma cells
CMNPD15610	mild cytotoxicity towards, and apoptotic induction of, Ehrlich carcinoma cells
CMNPD15611	modestly antifungal
CMNPD15612	modestly antifungal
CMNPD15619	moderately cytotoxic
CMNPD15632	cytotoxic
CMNPD15633	cytotoxic
CMNPD15634	cytotoxic
CMNPD15635	cytotoxic
CMNPD15636	cytotoxic
CMNPD15637	cytotoxic
CMNPD15648	modestly cytotoxic
CMNPD15649	modestly cytotoxic
CMNPD15652	moderately active towards a range of microorganisms
CMNPD15657	mildly cytotoxic towards mouse fibroblast cells
CMNPD15664	mildly cytotoxic
CMNPD15665	mildly cytotoxic
CMNPD15666	antibiotics | antibacterial activity against methicillin-resistant Staphylococcus aureus (MRSA) | active against vancomycin-resistant Streptococcus faecium (VREF) and Candida albicans (weakly)
CMNPD15667	antibiotics | antibacterial activity against methicillin-resistant Staphylococcus aureus (MRSA)
CMNPD15668	antibiotics | antibacterial activity against methicillin-resistant Staphylococcus aureus (MRSA)
CMNPD15669	antibiotics | antibacterial activity against methicillin-resistant Staphylococcus aureus (MRSA)
CMNPD15672	effective tumour promoter | inhibiting 12-O-tetradecanoylphorbol-13-acetate (TPA)-induced activation of Epstein–Barr virus early antigen
CMNPD15673	effective tumour promoter | inhibiting 12-O-tetradecanoylphorbol-13-acetate (TPA)-induced activation of Epstein–Barr virus early antigen
CMNPD15674	growth inhibitor of Gram-positive bacteria | moderately cytotoxic against human tumour cell lines
CMNPD15675	growth inhibitor of Gram-positive bacteria | moderately cytotoxic against human tumour cell lines
CMNPD15682	weak to moderately cytotoxic to HCT-116 | weakly active against Candida albicans
CMNPD15683	weak to moderately cytotoxic to HCT-116 | weakly active against Candida albicans
CMNPD15684	weak to moderately cytotoxic to HCT-116 | weakly active against Candida albicans
CMNPD15685	weak to moderately cytotoxic to HCT-116 | weakly active against Candida albicans
CMNPD15686	selectively active against a number of solid tumour derived human tumour cell lines | weakly active against Streptomyces viridochromogenes
CMNPD15695	cytotoxic
CMNPD15696	moderate activity against Staphylococcus aureus and Streptomyces viridochromogenes
CMNPD15697	moderate activity against Staphylococcus aureus and Streptomyces viridochromogenes
CMNPD15699	moderately active against HL-60, BCTC-823 and MDA-MB-435 cell lines
CMNPD15700	cytotoxic to mammalian cell lines, sperm and egg cells of S. intermedius
CMNPD15701	potent inhibitor of MRSA | less potent against vancomycin-resistant Enterococcus faecalis (VCE)
CMNPD15702	potent inhibitor of MRSA | less potent against vancomycin-resistant Enterococcus faecalis (VCE)
CMNPD15706	varying levels of antibacterial activity
CMNPD15707	varying levels of antibacterial activity
CMNPD15708	cytotoxic to L1210 cells
CMNPD15709	cytotoxic to L1210 cells
CMNPD15710	cytotoxic to L1210 cells
CMNPD15711	active against Saccharomyces cerevisiae
CMNPD15713	inhibitor of the human lung adenocarcinoma cell line A549
CMNPD15714	inhibit growth of A549 cells | moderate antibacterial | antifungal
CMNPD15715	weakly cytotoxic to L1210 cells | active against Staphylococcus epidermidis
CMNPD15716	weakly cytotoxic to L1210 cells
CMNPD15720	weakly cytotoxic to HCT-116 cells
CMNPD15721	weakly cytotoxic to HCT-116 cells
CMNPD15722	weakly cytotoxic to HCT-116 cells
CMNPD15726	cytotoxic to the human chronic myelogenous leukaemia cell line K5672 through S-phase blockage and apoptosis
CMNPD15727	moderately cytotoxic (A375-S2 melanoma cell line)
CMNPD15728	weak antibacterial activity against Staphylococcus epidermidis and Enterococcus durans | cytotoxic to neuroblastoma cells
CMNPD15729	weak antibacterial activity against Staphylococcus epidermidis and Enterococcus durans | cytotoxic to neuroblastoma cells
CMNPD15735	potent activity against several human tumour cell lines including LN-caP (prostrate), SK-BR3 (breast), HT29 (colon) and HELA (cervix) cell lines
CMNPD15736	highly selective cytotoxicity in the NCI cell line assay | inhibiting the SF-268 cell line (CNS) and the RXF 393 cell line (renal) cancer
CMNPD15740	radical scavenging activity against 1,1-diphenyl-2-picrylhydrazyl (DPPH) | moderate activity against MRSA and multidrug-resistant Staphylococcus aureus (MDRSA)
CMNPD15742	cytotoxic (human A375-S2 and HELA cell lines)
CMNPD15744	active against the fungus Mycotypha microspora and the green alga Chlorella fusca
CMNPD15745	modestly active against several human tumour cell lines | DPPH radical-scavenging properties
CMNPD15746	active against MRSA and MDRSA
CMNPD15749	inhibitor of the P388 cell line
CMNPD15750	inhibitor of the P388 cell line
CMNPD15753	modest activity against 3α-hydroxysteroid dehydrogenase (3α-HSD)
CMNPD15756	moderate activity against C. albicans
CMNPD15760	inhibit adhesion of HL-60 cells to human-umbilical-vein endothelial cells (HUVECs)
CMNPD15761	inhibit adhesion of HL-60 cells to human-umbilical-vein endothelial cells (HUVECs)
CMNPD15762	induce neuritogenesis in neuroblastoma neuro 2a cells at a low concentration
CMNPD15763	moderately active against Aspergillus clavatus
CMNPD15764	moderately active against Aspergillus clavatus
CMNPD15765	moderately active against Aspergillus clavatus
CMNPD15769	mild icthyotoxicity and weak toxicity to brine shrimp
CMNPD15772	cytotoxic to NCI-H460 human lung tumour and neuro-2a mouse neuroblastoma cell lines
CMNPD15773	cytotoxic to NCI-H460 human lung tumour and neuro-2a mouse neuroblastoma cell lines
CMNPD15774	disrupt the microtubule network in A-10 cells | cytotoxic to the MCF7 breast cancer and HCT-116 cell lines
CMNPD15778	moderate chymotrypsin inhibitory activity
CMNPD15779	moderate chymotrypsin inhibitory activity
CMNPD15780	moderate chymotrypsin inhibitory activity
CMNPD15781	moderate chymotrypsin inhibitory activity
CMNPD15785	modest inhibitor of DNA polymerase α
CMNPD15787	potent antifungal activity against Aspergillus niger | antiprotozoan activity against Trichomonas foetus
CMNPD15799	moderately cytotoxic to human leukaemia K562 cells and murine lymphoma P388 cell lines
CMNPD15800	moderately cytotoxic to human leukaemia K562 cells and murine lymphoma P388 cell lines
CMNPD15801	potent differentiation inducer of M. oxyspermum | induce germination in other green macroalgae
CMNPD15805	modest inhibitor of the HL-60 cell line
CMNPD15806	modest inhibitor of the HL-60 cell line
CMNPD15809	significantly enhance fluconazole activity in Saccharomyces cerevisiae
CMNPD15810	significantly enhance fluconazole activity in Saccharomyces cerevisiae
CMNPD15811	scavenger of the DPPH radical and of ONOO- from morpholinosydnonimine (SIN-1)
CMNPD15812	scavenger of the DPPH radical and of ONOO- from morpholinosydnonimine (SIN-1)
CMNPD15824	algicidal to the bloom-forming species Heterosigma akashiwo and Karenia mikimotoi
CMNPD15827	anti-allergic | inhibitor of histamine release from rat basophile leukaemia (RBL) cells
CMNPD15829	affinity for N-methyl-D-aspartate (NMDA) receptors | δ-opioid receptor antagonist
CMNPD15830	moderately active against NCI-H460 human lung tumour and MDA-MB-435 breast cancer cell lines | inhibitor of microtubules
CMNPD15835	moderate inhibitor of DNA methyl transferase-1
CMNPD15836	modest activity against a range of human tumour cell lines
CMNPD15837	modest activity against a range of human tumour cell lines
CMNPD15838	modest activity against a range of human tumour cell lines
CMNPD15839	modest activity against a range of human tumour cell lines | weakly active against Candida albicans
CMNPD15840	modest activity against a range of human tumour cell lines
CMNPD15841	modest activity against a range of human tumour cell lines
CMNPD15842	modest activity against a range of human tumour cell lines | weakly active against Candida albicans
CMNPD15850	weak in vitro anthelmintic activity against Nippostrongylus brasiliensis
CMNPD15856	weak activity against five human tumour cell lines and the Chinese hamster ovary (CHO) cell line
CMNPD15857	strong activity against five human tumour cell lines and the Chinese hamster ovary (CHO) cell line
CMNPD15858	weak activity against five human tumour cell lines and the Chinese hamster ovary (CHO) cell line
CMNPD15859	moderately cytotoxic to NSCLC-N6 and A549 lung cancer cell lines
CMNPD15864	moderate cytotoxicity against several human cancer cell lines
CMNPD15865	moderate cytotoxicity against several human cancer cell lines
CMNPD15866	moderate cytotoxicity against several human cancer cell lines
CMNPD15867	moderate cytotoxicity against several human cancer cell lines
CMNPD15872	mildly cytotoxic to the human A375-S2 melanoma cell line
CMNPD15873	mildly cytotoxic to the human A375-S2 melanoma cell line
CMNPD15874	mildly cytotoxic to the human A375-S2 melanoma cell line
CMNPD15890	cytotoxic
CMNPD15891	cytotoxic
CMNPD15893	reverse MDR in mammalian cancer cells
CMNPD15894	reverse MDR in mammalian cancer cells
CMNPD15906	inhibitory against L1210 cells
CMNPD15907	inhibitory against L1210 cells
CMNPD15908	inhibitory against L1210 cells
CMNPD15909	inhibitory against L1210 cells
CMNPD15910	inhibit inducible nitric oxide synthase (iNOS) activity
CMNPD15914	HIV-1 active
CMNPD15916	antifungal
CMNPD15918	human histone deacetylase inhibitor
CMNPD15919	human histone deacetylase inhibitor
CMNPD15920	human histone deacetylase inhibitor
CMNPD15921	human histone deacetylase inhibitor
CMNPD15922	human histone deacetylase inhibitor
CMNPD15923	cytotoxic | cause multi-nucleation in mammalian cells | promote the polymerisation of G-actin and stabilised F-actin filaments
CMNPD15924	cytotoxic | cause multi-nucleation in mammalian cells
CMNPD15925	cytotoxic | cause multi-nucleation in mammalian cells
CMNPD15926	cytotoxic | cause multi-nucleation in mammalian cells
CMNPD15927	cytotoxic | cause multi-nucleation in mammalian cells
CMNPD15931	antifungal
CMNPD15932	antifungal
CMNPD15933	antifungal
CMNPD15934	antifungal
CMNPD15937	cytotoxic
CMNPD15940	inhibit the fertilisation of sea urchin eggs but not their embryogenesis
CMNPD15942	cytotoxic
CMNPD15943	cytotoxic
CMNPD15944	potently cytotoxic | causing S phase arrest suggestive of protein synthesis inhibition
CMNPD15945	cytotoxic
CMNPD15946	cytotoxic
CMNPD15947	cytotoxic
CMNPD15948	cytotoxic
CMNPD15949	cytotoxic to human colon cancer cells
CMNPD15950	cytotoxic to human colon cancer cells
CMNPD15954	cytotoxic
CMNPD15955	cytotoxic
CMNPD15963	cytotoxic
CMNPD15964	cytotoxic
CMNPD15965	cytotoxic
CMNPD15966	cytotoxic
CMNPD15967	cytotoxic
CMNPD15968	cytotoxic
CMNPD15969	cytotoxic
CMNPD15970	cytotoxic
CMNPD15971	cytotoxic
CMNPD15972	cytotoxic
CMNPD15974	potent inhibitor of indolamine-2,3-dioxygenase
CMNPD15988	neuroprotective activity against agonists serotonin and glutamate in primary neurons
CMNPD15989	neuroprotective activity against agonists serotonin and glutamate in primary neurons
CMNPD15990	neuroprotective activity against agonists serotonin and glutamate in primary neurons
CMNPD15991	neuroprotective activity against agonists serotonin and glutamate in primary neurons
CMNPD15994	cytotoxic
CMNPD15995	cytotoxic
CMNPD16014	cytotoxic
CMNPD16015	cytotoxic
CMNPD16016	antiinvasion activity in a cell-based assay
CMNPD16019	cytotoxic
CMNPD16020	cytotoxic
CMNPD16021	selective phosphatidylinositol-3-kinase (PI3K) inhibitor
CMNPD16022	inhibitor of Leishmania sp. adenosine phosphoribosyl transferase
CMNPD16038	inhibitor of the first cell division of fertilised sea urchin eggs
CMNPD16039	inhibitor of the first cell division of fertilised sea urchin eggs
CMNPD16040	inhibitor of the first cell division of fertilised sea urchin eggs
CMNPD16041	inhibitor of the first cell division of fertilised sea urchin eggs
CMNPD16042	inhibitor of human protein tyrosine phosphatase 1B
CMNPD16043	cytotoxic to human gastric adenocarcinoma cells
CMNPD16044	cytotoxic to human gastric adenocarcinoma cells
CMNPD16051	mildly cytotoxic
CMNPD16052	mildly cytotoxic
CMNPD16055	cytotoxic
CMNPD16056	inhibitor of human farnesoid X-activated receptor
CMNPD16057	inhibitor of human farnesoid X-activated receptor
CMNPD16058	inhibitor of human farnesoid X-activated receptor
CMNPD16059	cytotoxic
CMNPD16060	cytotoxic
CMNPD16061	cytotoxic
CMNPD16062	cytotoxic
CMNPD16063	cytotoxic
CMNPD16064	cytotoxic
CMNPD16065	mildly cytotoxic
CMNPD16068	mildly cytotoxic
CMNPD16073	mildly cytotoxic
CMNPD16075	mildly cytotoxic
CMNPD16084	cytotoxic
CMNPD16085	cytotoxic
CMNPD16086	cytotoxic
CMNPD16087	cytotoxic
CMNPD16105	mildly cytotoxic to P388 cells | growth inhibitor of yeast
CMNPD16106	mildly cytotoxic to P388 cells | growth inhibitor of yeast
CMNPD16110	antiangiogenic
CMNPD16120	stabilise the binding of DNA to DNA polymerase β
CMNPD16122	stabilise the binding of DNA to DNA polymerase β
CMNPD16123	selectively cytotoxic to mouse lymphoma cells
CMNPD16124	selectively cytotoxic to mouse lymphoma cells
CMNPD16125	selectively cytotoxic to mouse lymphoma cells
CMNPD16126	selectively cytotoxic to mouse lymphoma cells
CMNPD16127	selectively cytotoxic to mouse lymphoma cells
CMNPD16128	selectively cytotoxic to mouse lymphoma cells
CMNPD16129	selectively cytotoxic to mouse lymphoma cells
CMNPD16130	selectively cytotoxic to mouse lymphoma cells
CMNPD16131	selectively cytotoxic to mouse lymphoma cells
CMNPD16132	selectively cytotoxic to mouse lymphoma cells
CMNPD16133	selectively cytotoxic to mouse lymphoma cells
CMNPD16143	mild cytotoxicity
CMNPD16144	mild cytotoxicity
CMNPD16151	mildly cytotoxic
CMNPD16152	mildly cytotoxic
CMNPD16153	mildly cytotoxic
CMNPD16154	antiplasmodial activity
CMNPD16155	antiplasmodial activity
CMNPD16156	mildly cytotoxic
CMNPD16157	mildly cytotoxic
CMNPD16160	potent inhibitor (sub-micromolar) of indoleamine-2,3-dioxygenase
CMNPD16164	antioxidant | antiproliferative
CMNPD16165	antioxidant | antiproliferative
CMNPD16166	antioxidant | antiproliferative
CMNPD16167	antioxidant | antiproliferative
CMNPD16168	antioxidant | antiproliferative
CMNPD16169	antioxidant | antiproliferative
CMNPD16170	antioxidant | antiproliferative
CMNPD16171	antioxidant | antiproliferative
CMNPD16176	mildly bioactive
CMNPD16177	mildly bioactive
CMNPD16178	mildly bioactive
CMNPD16179	cytotoxin
CMNPD16180	cytotoxic
CMNPD16188	mildly antimycobacterial
CMNPD16189	mildly cytotoxic
CMNPD16190	mildly cytotoxic
CMNPD16191	mildly cytotoxic
CMNPD16192	modestly cytotoxic towards two tumour cell lines
CMNPD16200	mild cytotoxicity
CMNPD16201	mildly cytotoxic | IA PTP1B
CMNPD16206	mildly cytotoxic
CMNPD16207	mildly cytotoxic
CMNPD16209	mildly cytotoxic
CMNPD16211	mildly cytotoxic
CMNPD16212	mildly cytotoxic
CMNPD16213	mildly cytotoxic
CMNPD16214	mildly cytotoxic
CMNPD16225	modest antimycobacterial | antiplasmodial
CMNPD16226	modest antimycobacterial | antiplasmodial
CMNPD16227	modest antimycobacterial | antiplasmodial
CMNPD16228	modest antimycobacterial | antiplasmodial
CMNPD16229	modest antimycobacterial | antiplasmodial
CMNPD16230	modest antimycobacterial | antiplasmodial
CMNPD16231	modest antimycobacterial | antiplasmodial
CMNPD16232	cytotoxic
CMNPD16235	cytotoxicity towards a panel of tumour cell lines
CMNPD16236	cytotoxicity towards a panel of tumour cell lines
CMNPD16237	cytotoxicity towards a panel of tumour cell lines (TGI <10 µM)
CMNPD16238	cytotoxicity towards a panel of tumour cell lines (TGI <10 µM)
CMNPD16239	cytotoxicity towards a panel of tumour cell lines (TGI <10 µM)
CMNPD16247	cytotoxicity (mild)
CMNPD16248	cytotoxicity (mild)
CMNPD16252	mild cytotoxicity
CMNPD16253	mild cytotoxicity
CMNPD16254	non-toxic settlement inhibition of larvae of the barnacle Balanus amphitrite
CMNPD16255	non-toxic settlement inhibition of larvae of the barnacle Balanus amphitrite
CMNPD16256	non-toxic settlement inhibition of larvae of the barnacle Balanus amphitrite
CMNPD16257	non-toxic settlement inhibition of larvae of the barnacle Balanus amphitrite
CMNPD16258	non-toxic settlement inhibition of larvae of the barnacle Balanus amphitrite
CMNPD16259	non-toxic settlement inhibition of larvae of the barnacle Balanus amphitrite
CMNPD16260	non-toxic settlement inhibition of larvae of the barnacle Balanus amphitrite
CMNPD16261	non-toxic settlement inhibition of larvae of the barnacle Balanus amphitrite
CMNPD16262	non-toxic settlement inhibition of larvae of the barnacle Balanus amphitrite
CMNPD16263	non-toxic settlement inhibition of larvae of the barnacle Balanus amphitrite
CMNPD16288	induce apoptosis in transformed mammalian cells
CMNPD16291	antibacterial activity
CMNPD16295	mild cytotoxicity
CMNPD16296	mild cytotoxicity
CMNPD16298	mildly cytotoxic
CMNPD16299	mildly cytotoxic (P388)
CMNPD16300	mildly cytotoxic (P388)
CMNPD16301	mildly cytotoxic (P388)
CMNPD16302	mildly cytotoxic (P388)
CMNPD16303	mildly cytotoxic (P388)
CMNPD16304	mildly cytotoxic (P388)
CMNPD16305	mildly cytotoxic (P388)
CMNPD16306	mildly cytotoxic (P388)
CMNPD16307	mildly cytotoxic (P388)
CMNPD16308	mildly cytotoxic (P388)
CMNPD16309	mildly cytotoxic (P389)
CMNPD16359	mildly cytotoxic
CMNPD16360	mildly cytotoxic
CMNPD16362	mildly cytotoxic
CMNPD16365	mildly cytotoxic
CMNPD16381	mildly cytotoxic
CMNPD16382	mildly cytotoxic
CMNPD16383	mildly cytotoxic
CMNPD16384	mildly cytotoxic
CMNPD16385	mildly cytotoxic
CMNPD16386	mildly cytotoxic
CMNPD16387	mildly cytotoxic
CMNPD16388	mildly cytotoxic
CMNPD16389	mildly cytotoxic
CMNPD16392	mildly antimalarial | antitrypanosomal
CMNPD16393	mildly antimalarial | antitrypanosomal
CMNPD16420	moderately cytotoxic
CMNPD16424	cytotoxic | inhibit vacuolar ATPase with an IC50 of 2 nM | active in the NCI hollow-fibre assay
CMNPD16425	cytotoxic
CMNPD16428	cytotoxic
CMNPD16431	cytotoxic
CMNPD16432	cytotoxic
CMNPD16433	cytotoxic
CMNPD16445	promot plant growth in sprouts of Brassica campestris
CMNPD16479	induce haemolysis of erythrocytes
CMNPD16482	induce haemolysis of erythrocytes
CMNPD16483	enhance the neuritogenic activity of NGF with PC-12 cells
CMNPD16484	enhance the neuritogenic activity of NGF with PC-12 cells
CMNPD16485	enhance the neuritogenic activity of NGF with PC-12 cells
CMNPD16486	enhance the neuritogenic activity of NGF with PC-12 cells
CMNPD16487	enhance the neuritogenic activity of NGF with PC-12 cells
CMNPD16488	enhance the neuritogenic activity of NGF with PC-12 cells
CMNPD16489	moderately cytostatic towards fertilised sea urchin eggs
CMNPD16490	moderately cytostatic towards fertilised sea urchin eggs
CMNPD16491	mild cytotoxicity
CMNPD16492	cytotoxicity towards a panel of tumour cell lines
CMNPD16493	cytotoxicity towards a panel of tumour cell lines
CMNPD16494	cytotoxicity towards a panel of tumour cell lines
CMNPD16496	moderately cytotoxic towards a panel of tumour cell lines
CMNPD16497	cytotoxic
CMNPD16513	mild cytotoxicity
CMNPD16514	mild cytotoxicity
CMNPD16515	mild cytotoxicity
CMNPD16516	mild cytotoxicity
CMNPD16531	activate antioxidant response element with micromolar potency
CMNPD16532	activate antioxidant response element with micromolar potency
CMNPD16533	activate antioxidant response element with micromolar potency
CMNPD16534	moderately cytotoxic to eggs of the sea urchin Strongylocentrotus intermedius
CMNPD16535	moderately cytotoxic to eggs of the sea urchin Strongylocentrotus intermedius
CMNPD16536	broad-spectrum activity against Gram-positive bacteria
CMNPD16537	broad-spectrum activity against Gram-positive bacteria
CMNPD16538	broad-spectrum activity against Gram-positive bacteria | moderately active against Haemophilus influenza
CMNPD16546	inhibit ornithine decarboxylase induction, an important target in cancer chemoprevention
CMNPD16547	inhibit ornithine decarboxylase induction, an important target in cancer chemoprevention
CMNPD16548	moderately active against the human colon adenocarcinoma cell line HCT-116
CMNPD16551	cytotoxicity against HCT-116 cells
CMNPD16552	cytotoxicity against HCT-116 cells
CMNPD16555	potent and quite selective inhibitor of a pathogenic Enterococcus sp
CMNPD16556	cytotoxic (P388)
CMNPD16561	potently cytotoxic against a panel of human tumour cell lines
CMNPD16563	selectively cytotoxic to transformed rat glia cells and to Neuro-2a mouse neuroblastoma cells
CMNPD16564	selectively cytotoxic to transformed rat glia cells and to Neuro-2a mouse neuroblastoma cells
CMNPD16565	significantly cytotoxic (HCT-116) | potent in the 60-cell-line panel of the National Cancer Institute | especially against solid tumour cell lines
CMNPD16566	significantly cytotoxic (HCT-116)
CMNPD16567	significantly cytotoxic (HCT-116)
CMNPD16568	inhibitor of S. aureus N315 (MRSA) and 4-amino-4-deoxychorismate synthase
CMNPD16571	iron-chelating activity
CMNPD16572	iron-chelating activity
CMNPD16573	iron-chelating activity
CMNPD16574	iron-chelating activity
CMNPD16575	immunosuppressive activity in an interleukin-5 production inhibition assay
CMNPD16576	immunosuppressive activity in an interleukin-5 production inhibition assay
CMNPD16577	active against Bacillus brevis and cytotoxic to Jurkat and HeLa S3 cell lines
CMNPD16583	potent activity against a panel of human tumour cell lines, notably lung and ovarian cancer cell lines
CMNPD16592	potent antioxidative activity in a lipid model
CMNPD16595	moderate cytotoxicity (P388 and HL-60)
CMNPD16598	moderately cytotoxic to tumour cell lines
CMNPD16599	moderately cytotoxic to tumour cell lines
CMNPD16600	moderately cytotoxic to tumour cell lines
CMNPD16608	inhibitor of both xanthin oxidase and 3α-hydroxysteroid dehydrogenase
CMNPD16609	inhibitor of both xanthin oxidase and 3α-hydroxysteroid dehydrogenase
CMNPD16610	significant blocking activity on large-conductance calcium-activated potassium channels
CMNPD16611	significant blocking activity on large-conductance calcium-activated potassium channels
CMNPD16613	significant blocking activity on large-conductance calcium-activated potassium channels
CMNPD16618	induce apoptosis in HL-60 cells | inhibit EGF-induced malignant transformation of murine epidermal JB6 P+ Cl 41 cells
CMNPD16619	induce apoptosis in HL-60 cells | inhibit EGF-induced malignant transformation of murine epidermal JB6 P+ Cl 41 cells
CMNPD16627	cytotoxic to several mammalian cell lines
CMNPD16628	modest activity against Staphylococcus aureus, methicillin-resistant S. aureus and multidrug-resistant S. aureus
CMNPD16629	inhibit the growth of the fungus Pyricularia oryzae
CMNPD16636	weakly active against Candida albicans | moderate DPPH radical scavenging activity
CMNPD16637	moderate activity against Candida albicans
CMNPD16640	moderate activity against Candida albicans
CMNPD16641	selectively inhibit a Hof1 deletion sp. of the yeast Saccharomyces cerevisiae
CMNPD16642	moderately cytotoxic (HeLa and L1210)
CMNPD16643	moderately cytotoxic (HeLa and L1210)
CMNPD16644	moderately cytotoxic (HeLa and L1210)
CMNPD16645	moderately cytotoxic (HeLa and L1210)
CMNPD16647	cytotoxic to human epidermoid carcinoma KB (KB3-1) cells
CMNPD16648	cytotoxic to human epidermoid carcinoma KB (KB3-1) cells
CMNPD16649	cytotoxic to human epidermoid carcinoma KB (KB3-1) cells
CMNPD16650	significant cytotoxicity (P388 and HL-60)
CMNPD16651	moderately cytotoxic (K562)
CMNPD16652	moderately cytotoxic (K562)
CMNPD16653	modestly active against methicillin-resistant S. aureus | weak cytotoxicity (HCT-116)
CMNPD16654	modestly active against methicillin-resistant S. aureus | weak cytotoxicity (HCT-116)
CMNPD16655	cytotoxic (H125)
CMNPD16659	active against B. subtilis, E. coli and C. albicans
CMNPD16660	weak activity against Hep-2 and HepG2 cells
CMNPD16661	inhibitory to S. aureus, E. coli, the fungusFusarium oxysporum and the HepG2 cell line
CMNPD16662	significant growth inhibitor of P388 cells | moderately inhibitory to a panel of human tumour cell lines | significant in vivo inhibitory activity against P388 in mice and inhibit protein kinase EGFR and topoisomerase II
CMNPD16664	significant growth inhibitor of P388 cells | moderately inhibitory to a panel of human tumour cell lines
CMNPD16667	inhibitor of the adhesion of HL-60 cells to human-umbilical-vein endothelial cells (HUVECs)
CMNPD16668	significant growth inhibitor of P388
CMNPD16669	significant growth inhibitor of P388
CMNPD16670	significant growth inhibitor of P388
CMNPD16671	modestly cytotoxic (KB and KBv200)
CMNPD16673	cytotoxic to the human A375-S2 melanoma cell line
CMNPD16684	inhibit cytochrome P450 1A activity
CMNPD16685	moderately active as inducers of NAD(P)H quinone reductase (QR) in cultured mouse Hepa 1c1c7 cells | weak aromatase inhibitor
CMNPD16688	active against the fungus Phytophthora infestans
CMNPD16691	weak tyrosinase inhibitor
CMNPD16692	potent inhibitor of histone deacetylase (HDAC) | cytotoxic to HCT-116 cells and active in the NCI 60 cancer cell line panel
CMNPD16693	potent inhibitor of histone deacetylase (HDAC) | cytotoxic to HCT-116 cells and active in the NCI 60 cancer cell line panel
CMNPD16696	moderately cytotoxic to HeLa cells
CMNPD16701	weak cytotoxicity against Hep-2 and HepG2 cells
CMNPD16702	selectively inhibit elastase and chymotrypsin in vitro
CMNPD16703	good antimalarial activity against the W2 chloroquine-resistant malaria sp.
CMNPD16709	cell growth inhibitory
CMNPD16710	cell growth inhibitory
CMNPD16711	strong activity against NCI-H460 human lung tumour cells
CMNPD16712	selective antimalarial activity against Plasmodium falciparum | modest activity only against Trypanosoma cruzi, Leishmania donovani and MCF-7 cancer cells
CMNPD16713	selective antimalarial activity against Plasmodium falciparum | modest activity only against Trypanosoma cruzi, Leishmania donovani and MCF-7 cancer cells
CMNPD16714	potent cytotoxicity to human B lymphocyte DG-75 cells and Epstein–Barr virus infected human B lymphocyte Raji cells
CMNPD16716	potent cytotoxicity to human B lymphocyte DG-75 cells and Epstein–Barr virus infected human B lymphocyte Raji cells
CMNPD16717	cytotoxic to human B lymphocyte DG-75 cells
CMNPD16718	cytotoxic to human B lymphocyte DG-75 cells
CMNPD16720	modestly cytotoxic to L1210 murine leukemia and KB human epidermoid carcinoma cells
CMNPD16723	moderately cytotoxic to the human tumour cell lines A431 (vulva-derived epidermoid carcinoma) and Nakata oral squamous cell carcinoma
CMNPD16724	potent voltage-dependent N-type Ca2+ channel-opening activity | relatively weak acute toxicity to mice (i.p. injection) | significant cyclooxygenase-1 (COX-1) inhibition
CMNPD16727	highly selective inhibitor of the protein phosphatase PP2A
CMNPD16731	antibacterial | weak cytotoxicity
CMNPD16737	potent antimitotic agent | acting by stimulating the polymerisation of tubulin and inhibiting the proliferation of both MCF-7 (breast) and HCT-116 cells
CMNPD16739	protein tyrosine phosphatase 1B (PTPa1B) inhibitor
CMNPD16740	protein tyrosine phosphatase 1B (PTPa1B) inhibitor
CMNPD16741	moderate inhibitor of tumour necrosis factor alpha | induce nuclear factor-κB activation
CMNPD16745	inhibitor of superoxide production in human neutrophils in vitro and of proliferation of HL-60 cells
CMNPD16746	antiproliferative activities
CMNPD16747	weak antituberculosis activity
CMNPD16748	strongly cytotoxic (NCI-H187) | potent antimalarial activity | activity against HSV-1 and the malarial parasite Plasmodium falciparum
CMNPD16749	free radical scavenger (DPPH assay)
CMNPD16752	strong radical scavenger (DPPH assay)
CMNPD16753	modest antibacterial activity
CMNPD16756	modest antibacterial activity
CMNPD16768	selective cytotoxicity to the HeLa cell line
CMNPD16788	potent DPPH radical scavenger
CMNPD16789	potent DPPH radical scavenger
CMNPD16790	potent DPPH radical scavenger
CMNPD16791	potent radical scavenger in the DPPH assay
CMNPD16792	potent radical scavenger in the DPPH assay
CMNPD16793	potent radical scavenger in the DPPH assay
CMNPD16794	potent radical scavenger in the DPPH assay
CMNPD16795	modest antibacterial | antimalarial | antitumour | antifungal
CMNPD16796	modest antibacterial | antimalarial | antitumour | antifungal
CMNPD16797	modest antibacterial | antimalarial | antitumour | antifungal
CMNPD16798	modest antibacterial | antimalarial | antitumour | antifungal
CMNPD16799	modest antibacterial | antimalarial | antitumour | antifungal
CMNPD16800	modest antibacterial | antimalarial | antitumour | antifungal
CMNPD16801	modest antibacterial | antimalarial | antitumour | antifungal
CMNPD16802	modest antibacterial | antimalarial | antitumour | antifungal
CMNPD16803	modest antibacterial | antimalarial | antitumour | antifungal
CMNPD16804	modest antibacterial | antimalarial | antitumour | antifungal
CMNPD16805	significantly cytotoxic against an esophageal cell line
CMNPD16824	significant antifungal activity against the pathogenic, Fluconazole-resistant yeast, Candida glabrata
CMNPD16839	inhibit the growth of the HIV opportunistic fungus Cryptococcus neoformans
CMNPD16852	α-glucosidase inhibitor
CMNPD16853	α-glucosidase inhibitor
CMNPD16856	inhibit the SARS coronovirus 3CL protease
CMNPD16857	inhibit the hypoxia-induced activation of T47D breast tumour cells by hypoxia-inducible factor-1 (HIF-1)
CMNPD16858	cytotoxic
CMNPD16859	cytotoxic
CMNPD16860	cytotoxic
CMNPD16861	cytotoxic
CMNPD16862	inhibit growth of Candida albicans
CMNPD16865	inhibit growth of Candida albicans
CMNPD16869	potent cytotoxin | promoter of actin polymerisation
CMNPD16870	potent cytotoxin | promoter of actin polymerisation
CMNPD16871	potent cytotoxin | promoter of actin polymerisation
CMNPD16872	potent cytotoxin | promoter of actin polymerisation
CMNPD16885	cytotoxic | potent inhibitor of actin polymerisation
CMNPD16888	cytotoxic
CMNPD16889	cytotoxic
CMNPD16890	cytotoxic
CMNPD16891	cytotoxic
CMNPD16892	cytotoxic
CMNPD16893	cytotoxic
CMNPD16894	cytotoxic
CMNPD16895	cytotoxic
CMNPD16896	cytotoxic
CMNPD16897	cytotoxic
CMNPD16898	cytotoxic
CMNPD16899	cytotoxic
CMNPD16900	cytotoxic
CMNPD16906	cytotoxic
CMNPD16909	antibacterial
CMNPD16910	antibacterial
CMNPD16911	antibacterial | mild inhibitor of Bcl-2 activity
CMNPD16912	antibacterial
CMNPD16914	a modulator of rat neuronal cell serotonin receptors by the reduction of calcium influx at concentrations 100 times less than the cytotoxic values
CMNPD16916	antibacterial and antifungal (C. albicans)
CMNPD16917	cytotoxic P2X7 receptor agonist
CMNPD16918	cytotoxic
CMNPD16919	cytotoxic
CMNPD16920	cytotoxic
CMNPD16921	cytotoxic
CMNPD16922	cytotoxic
CMNPD16923	cytotoxic
CMNPD16924	cytotoxic
CMNPD16925	cytotoxic
CMNPD16926	cytotoxic
CMNPD16927	cytotoxic
CMNPD16928	cytotoxic
CMNPD16929	cytotoxic
CMNPD16930	cytotoxic
CMNPD16931	cytotoxic
CMNPD16945	cytotoxic
CMNPD16946	antibacterial | weakly cytotoxic
CMNPD16948	weakly antimalarial
CMNPD16949	cytotoxic
CMNPD16950	inhibit HIF-1 activation and secrete VEGF production
CMNPD16951	inhibit HIF-1 activation and secrete VEGF production
CMNPD16952	inhibit HIF-1 activation and secrete VEGF production
CMNPD16953	inhibit HIF-1 activation and secrete VEGF production
CMNPD16958	moderately cytotoxic
CMNPD16959	antifungal | antitumor | immunosuppressive
CMNPD16961	inhibit neutrophil chemotaxis
CMNPD16962	antifungal | antitumor | immunosuppressive
CMNPD16966	mildly cytotoxic
CMNPD16967	mildly cytotoxic
CMNPD16969	cytotoxic
CMNPD16970	cytotoxic
CMNPD16974	antimicrobial to the AIDS opportunistic pathogens Candida albicans, Cryptococcus neoformans, methicillin-resistant Staphylococcus aureus, Mycobacterium intracellulare and Aspergillus fumigatus
CMNPD16975	antimicrobial to the AIDS opportunistic pathogens Candida albicans, Cryptococcus neoformans, methicillin-resistant Staphylococcus aureus, Mycobacterium intracellulare and Aspergillus fumigatus
CMNPD16981	isoprenylcysteine carboxyl methyltransferase (Icmt) inhibitor
CMNPD16982	cytotoxic
CMNPD16986	agonists of the human P2Y11 receptor
CMNPD16987	agonists of the human P2Y11 receptor
CMNPD16991	antifungal to C. albicans and Erg6 mutant Saccharomyces cerevisiae, but not wild S. cerevisiae
CMNPD16992	antifungal to C. albicans and Erg6 mutant Saccharomyces cerevisiae, but not wild S. cerevisiae
CMNPD16996	radical scavenging activity
CMNPD16997	radical scavenging activity
CMNPD17003	cytotoxic
CMNPD17004	cytotoxic
CMNPD17010	cytotoxic
CMNPD17011	cytotoxic
CMNPD17012	inhibit the growth of Staphylococcus aureus
CMNPD17025	cytotoxic
CMNPD17036	cytotoxic and farnesyl transferase inhibiting
CMNPD17037	cytotoxic and farnesyl transferase inhibiting
CMNPD17038	cytotoxic and farnesyl transferase inhibiting
CMNPD17039	inhibitor of HIF-1
CMNPD17042	cytotoxic | increase activity under hypoxic conditions
CMNPD17043	cytotoxic | increase activity under hypoxic conditions
CMNPD17044	cytotoxic | increase activity under hypoxic conditions
CMNPD17045	cytotoxic | increase activity under hypoxic conditions
CMNPD17046	antimicrobial activity (Streptomyces)
CMNPD17047	antimicrobial activity (Streptomyces)
CMNPD17048	potent inhibitor of calcineurin
CMNPD17055	inhibitor of the farnesoid X activated receptor
CMNPD17056	inhibitor of the farnesoid X activated receptor
CMNPD17057	inhibitor of the farnesoid X activated receptor
CMNPD17064	cytotoxic
CMNPD17070	active against Mycobacterium tuberculosis, low cytotoxicity
CMNPD17071	active against Mycobacterium tuberculosis, low cytotoxicity
CMNPD17075	cytotoxic | antifungal to amphotericin-B-resistant Candida albicans
CMNPD17076	cytotoxic | antifungal to amphotericin-B-resistant Candida albicans
CMNPD17077	antiangiogenic against HUVECs | inhibit VEGF-induced phosphorylation of ERK1/2 and p38
CMNPD17078	antiangiogenic against HUVECs | inhibit VEGF-induced phosphorylation of ERK1/2 and p38
CMNPD17079	antiangiogenic against HUVECs | inhibit VEGF-induced phosphorylation of ERK1/2 and p38
CMNPD17080	antiangiogenic against HUVECs | inhibit VEGF-induced phosphorylation of ERK1/2 and p38
CMNPD17081	antiangiogenic against HUVECs | inhibit VEGF-induced phosphorylation of ERK1/2 and p38
CMNPD17082	antiangiogenic against HUVECs | inhibit VEGF-induced phosphorylation of ERK1/2 and p38
CMNPD17083	antiangiogenic against HUVECs | inhibit VEGF-induced phosphorylation of ERK1/2 and p38
CMNPD17084	acetylcholinesterase inhibitor
CMNPD17088	cytotoxic
CMNPD17089	cytotoxic
CMNPD17092	selectively cytotoxic to HUVECs | antiangiogenic
CMNPD17093	selectively cytotoxic to HUVECs | antiangiogenic
CMNPD17099	cause early apoptosis
CMNPD17102	activate Ca2+ influx in mouse spleenocytes
CMNPD17108	cytotoxic
CMNPD17109	cytotoxic
CMNPD17110	cytotoxic
CMNPD17111	cytotoxic
CMNPD17112	cytotoxic
CMNPD17113	cytotoxic
CMNPD17114	cytotoxic
CMNPD17115	cytotoxic
CMNPD17120	mildly cytotoxic
CMNPD17123	mildly cytotoxic
CMNPD17124	mildly cytotoxic
CMNPD17125	mildly cytotoxic
CMNPD17126	mild antiproliferative | apoptosis-inducing
CMNPD17127	mild antiproliferative | apoptosis-inducing
CMNPD17128	mild antiproliferative | apoptosis-inducing
CMNPD17129	mild antiproliferative | apoptosis-inducing
CMNPD17130	mild antiproliferative | apoptosis-inducing
CMNPD17131	mild antiproliferative | apoptosis-inducing
CMNPD17132	mild antiproliferative | apoptosis-inducing
CMNPD17133	mild antiproliferative | apoptosis-inducing
CMNPD17134	mild antiproliferative | apoptosis-inducing
CMNPD17135	mild antiproliferative | apoptosis-inducing
CMNPD17136	mild antiproliferative | apoptosis-inducing
CMNPD17137	mildly antibacterial
CMNPD17138	mildly antibacterial
CMNPD17139	mildly antibacterial
CMNPD17161	moderate cytotoxicity
CMNPD17164	moderate cytotoxicity
CMNPD17165	mild cytotoxicity
CMNPD17167	mild cytotoxicity
CMNPD17171	moderately potent inhibitor of the mitochondrial respiratory electron chain
CMNPD17172	moderately potent inhibitor of the mitochondrial respiratory electron chain
CMNPD17173	weakly antimycobacterial
CMNPD17174	weakly antimycobacterial
CMNPD17175	mild cytotoxicity (P388)
CMNPD17176	mild cytotoxicity (P388)
CMNPD17182	active in a hyphae formation inhibition assay | acting as a pre-screen for cytotoxins and potential protein kinase inhibitor
CMNPD17183	active in a hyphae formation inhibition assay | acting as a pre-screen for cytotoxins and potential protein kinase inhibitor
CMNPD17197	potently cytotoxic
CMNPD17198	potently cytotoxic
CMNPD17199	potently cytotoxic
CMNPD17200	potently cytotoxic
CMNPD17201	potently cytotoxic
CMNPD17202	potently cytotoxic
CMNPD17203	potently cytotoxic
CMNPD17204	potently cytotoxic
CMNPD17205	potently cytotoxic
CMNPD17206	potently cytotoxic
CMNPD17207	potently cytotoxic
CMNPD17214	cytotoxic activity towards tumour cell lines
CMNPD17242	mild in vitro cytotoxic activity
CMNPD17252	mild in vitro cytotoxic activity
CMNPD17255	active in the inhibition of superoxide production and elastase release by activated human neutrophils
CMNPD17258	mild antibacterial activity
CMNPD17259	mild antibacterial activity
CMNPD17279	(modestly) cytotoxic
CMNPD17280	(modestly) cytotoxic
CMNPD17290	stimulate growth of pre-osteoblastic MC3T3-E1 cells, suggesting potential use in the prevention of osteoporosis
CMNPD17291	mildly antibacterial
CMNPD17292	mildly antibacterial
CMNPD17301	mildly cytotoxic
CMNPD17302	mildly cytotoxic
CMNPD17303	mildly cytotoxic
CMNPD17304	mildly cytotoxic
CMNPD17305	mildly cytotoxic
CMNPD17306	mildly cytotoxic
CMNPD17307	mildly cytotoxic
CMNPD17308	mildly cytotoxic
CMNPD17309	mildly cytotoxic
CMNPD17310	mildly cytotoxic
CMNPD17311	mild cytotoxicity
CMNPD17312	mild cytotoxicity
CMNPD17313	mild cytotoxicity
CMNPD17314	mild cytotoxicity
CMNPD17316	moderately cytotoxic
CMNPD17321	reduce the expression of iNOS and COX-2 proteins in LPS-stimulated murine macrophages
CMNPD17329	mild cytotoxicity
CMNPD17331	minimal cytotoxicity
CMNPD17338	minimal cytotoxicity
CMNPD17342	antiinflammatory
CMNPD17360	toxic
CMNPD17361	toxic
CMNPD17379	mild cytotoxicity
CMNPD17382	inhibit high cell density-induced apoptosis in two tumour cell lines
CMNPD17386	cytotoxic
CMNPD17387	cytotoxic
CMNPD17388	cytotoxic
CMNPD17394	antibacterial
CMNPD17395	cytotoxicity through activation of apoptosis
CMNPD17396	cytotoxicity through activation of apoptosis
CMNPD17397	cytotoxicity through activation of apoptosis
CMNPD17398	cytotoxicity through activation of apoptosis
CMNPD17399	cytotoxicity through activation of apoptosis
CMNPD17400	cytotoxicity through activation of apoptosis
CMNPD17409	mildly antiinflammatory
CMNPD17410	mildly antiinflammatory
CMNPD17411	antiinflammatory | in vivo activity towards a model of acute gouty arthritis
CMNPD17412	antiinflammatory | in vivo activity towards a model of acute gouty arthritis
CMNPD17415	mildly cytotoxic
CMNPD17416	mildly cytotoxic
CMNPD17417	mildly cytotoxic
CMNPD17418	mild antibacterial activity | nanomolar growth inhibitor of Chinese hamster V79 cells
CMNPD17419	mild antibacterial activity | nanomolar growth inhibitor of Chinese hamster V79 cells
CMNPD17420	mild antibacterial activity | nanomolar growth inhibitor of Chinese hamster V79 cells
CMNPD17421	mild antibacterial activity | nanomolar growth inhibitor of Chinese hamster V79 cells
CMNPD17423	mildly cytotoxic
CMNPD17424	mildly cytotoxic
CMNPD17425	Mild cytotoxicity
CMNPD17427	mild cytotoxicity
CMNPD17429	mild cytotoxicity
CMNPD17441	neuritogenic activity toward the rat pheochromocytoma cell line PC-12 in the presence of nerve growth factor
CMNPD17445	inhibitor of HIF-1 reporter activity | mild cytotoxin
CMNPD17446	inhibitor of HIF-1 reporter activity | mild cytotoxin
CMNPD17447	inhibit hyphae formation in Streptomyces 85E
CMNPD17453	varying effects in a sea urchin embryo development assay
CMNPD17454	varying effects in a sea urchin embryo development assay
CMNPD17455	varying effects in a sea urchin embryo development assay
CMNPD17456	induce neuronal differentiation and to enhance the neuritogenic activity of NGF
CMNPD17457	induce neuronal differentiation and to enhance the neuritogenic activity of NGF
CMNPD17462	weakly inhibit urchin egg-cell fertilisation and division
CMNPD17463	induce neuronal differentiation and to enhance the neuritogenic activity of NGF
CMNPD17464	induce neuronal differentiation and to enhance the neuritogenic activity of NGF
CMNPD17465	induce neuronal differentiation and to enhance the neuritogenic activity of NGF
CMNPD17466	induce neuronal differentiation and to enhance the neuritogenic activity of NGF
CMNPD17468	mild activity (9 µM) in the target bioassay
CMNPD17476	modestly cytotoxic
CMNPD17477	modestly cytotoxic
CMNPD17479	moderately cytotoxic
CMNPD17480	moderately cytotoxic
CMNPD17482	moderate cytotoxicity towards a panel of tumour cell lines
CMNPD17485	nanomolar cytotoxic
CMNPD17486	cytotoxic
CMNPD17502	antiproliferative | antibacterial
CMNPD17503	antiproliferative | antibacterial
CMNPD17514	mildly cytotoxic (P388)
CMNPD17518	mildly cytotoxic (P388)
CMNPD17527	moderate inhibition of interleukin-5 production without cytotoxicity to HCT-116 cells
CMNPD17535	broad-spectrum activity against Gram-positive and Gram-negative organisms | activity against methicillin-resistant Staphylococcus aureus (MRSA) and vancomycin-resistant Enterococcus faecium (VREF)
CMNPD17536	broad-spectrum activity against Gram-positive and Gram-negative organisms | activity against methicillin-resistant Staphylococcus aureus (MRSA) and vancomycin-resistant Enterococcus faecium (VREF)
CMNPD17537	broad-spectrum activity against Gram-positive and Gram-negative organisms | activity against methicillin-resistant Staphylococcus aureus (MRSA) and vancomycin-resistant Enterococcus faecium (VREF)
CMNPD17538	broad-spectrum activity against Gram-positive and Gram-negative organisms | activity against methicillin-resistant Staphylococcus aureus (MRSA) and vancomycin-resistant Enterococcus faecium (VREF)
CMNPD17539	broad-spectrum activity against Gram-positive and Gram-negative organisms | activity against methicillin-resistant Staphylococcus aureus (MRSA) and vancomycin-resistant Enterococcus faecium (VREF)
CMNPD17540	potent activity against MRSA | moderate activity against HCT-116 cancer cells
CMNPD17541	potent activity against MRSA | moderate activity against HCT-116 cancer cells
CMNPD17544	weakly active against B. subtilis
CMNPD17545	active against a range of Gram-positive and Gram-negative bacteria
CMNPD17546	weak to moderate activity against B. subtilis and Staphylococcus lentus
CMNPD17547	weak to moderate activity against B. subtilis and Staphylococcus lentus
CMNPD17548	weak to moderate activity against B. subtilis and Staphylococcus lentus
CMNPD17549	weak to moderate activity against B. subtilis and Staphylococcus lentus
CMNPD17550	weak to moderate activity against B. subtilis and Staphylococcus lentus
CMNPD17551	weak to moderate activity against B. subtilis and Staphylococcus lentus
CMNPD17552	weak to moderate activity against B. subtilis and Staphylococcus lentus
CMNPD17553	weak to moderate activity against B. subtilis and Staphylococcus lentus
CMNPD17554	weak inhibitor of acetylcholinesterase
CMNPD17555	antiprotozoal activity against both chloroquine-susceptible and chloroquine-resistant clones of Plasmodium falciparum | without cytotoxicity to normal (Vero) cells
CMNPD17558	weak to modest cytotoxicity against the HeLa cell line
CMNPD17559	weak to modest cytotoxicity against the HeLa cell line
CMNPD17560	weak to modest cytotoxicity against the HeLa cell line
CMNPD17561	selective inhibitor of HCT-116 cells
CMNPD17562	selective inhibitor of HCT-116 cells | selective cytotoxicity against melanoma and leukaemia cell lines
CMNPD17563	growth inhibitor of barnyard millet
CMNPD17564	growth inhibitor of barnyard millet
CMNPD17565	activity against E. coli, S. aureus and B. subtilis
CMNPD17566	antibiotics | inhibitory to carcinoma cell lines (gastric adenocarcinoma, hepatocellular carcinoma (Hep G2) and breast carcinoma (MCF 7)) | inducing upregulation of p53 and the cyclin kinase inhibitor p21
CMNPD17567	antibiotics | moderate growth inhibition of Gram-positive bacteria | inhibitory to carcinoma cell lines (gastric adenocarcinoma, hepatocellular carcinoma (Hep G2) and breast carcinoma (MCF 7)) | inducing upregulation of p53 and the cyclin kinase inhibitor p21
CMNPD17568	antibiotics | slightly inhibitory to Brevibacillus brevis | inhibitory to carcinoma cell lines (gastric adenocarcinoma, hepatocellular carcinoma (Hep G2) and breast carcinoma (MCF 7)) | inducing upregulation of p53 and the cyclin kinase inhibitor p21
CMNPD17573	modest antibacterial activity
CMNPD17574	modest antibacterial activity
CMNPD17575	modest antibacterial activity
CMNPD17580	broad-spectrum antibiotic
CMNPD17581	selectively inhibit two Pseudovibrio bacterial strains
CMNPD17582	selectively inhibit two Pseudovibrio bacterial strains
CMNPD17583	selectively inhibit Gram-positive bacteria | slightly cytotoxic to A549 human lung cancer cells and baby hamster kidney cells
CMNPD17584	selectively inhibit Gram-positive bacteria | slightly cytotoxic to A549 human lung cancer cells and baby hamster kidney cells
CMNPD17586	identical activity to prodigiosin in human topoisomerase I inhibition and against human adenocarcinoma cells
CMNPD17587	weak inhibitor of protein tyrosine phosphatase 1B
CMNPD17588	weak inhibitor of protein tyrosine phosphatase 1B
CMNPD17589	potent antioxidant activity (superoxide suppression)
CMNPD17590	moderate cytotoxicity to several cancer cell lines | moderate radical scavenging activity against DPPH
CMNPD17591	moderate cytotoxicity to several cancer cell lines | moderate radical scavenging activity against DPPH
CMNPD17592	moderate cytotoxicity to several cancer cell lines | moderate radical scavenging activity against DPPH
CMNPD17593	moderate cytotoxicity to several cancer cell lines | moderate radical scavenging activity against DPPH
CMNPD17594	moderate cytotoxicity to several cancer cell lines | moderate radical scavenging activity against DPPH
CMNPD17595	moderate cytotoxicity to several cancer cell lines | moderate radical scavenging activity against DPPH
CMNPD17596	moderate cytotoxicity to several cancer cell lines | moderate radical scavenging activity against DPPH | moderately inhibitory to protein tyrosine kinases
CMNPD17597	moderate cytotoxicity to several cancer cell lines | moderate radical scavenging activity against DPPH
CMNPD17598	moderate cytotoxicity to several cancer cell lines | moderate radical scavenging activity against DPPH
CMNPD17601	moderately active against Pyricularia oryzae
CMNPD17602	activity against several cancer cell lines
CMNPD17603	modest activity against B. subtilis, S. aureus and Salinivibrio costicola
CMNPD17604	broad-spectrum antimicrobial activity
CMNPD17607	strong UV-A protecting activity
CMNPD17611	induce cyclic adenosine monophosphate production in GPR12-transfected CHO and HEK293 cells
CMNPD17616	susceptibility to several cancer cell lines
CMNPD17617	susceptibility to several cancer cell lines
CMNPD17618	susceptibility to several cancer cell lines
CMNPD17620	weak activity against the A549 cell line
CMNPD17621	weak activity against the A549 cell line
CMNPD17622	weak activity against the A549 cell line
CMNPD17623	significant activity against E. coli, B. subtilis and Micrococcus lysoleikticus
CMNPD17624	significant activity against E. coli, B. subtilis and Micrococcus lysoleikticus
CMNPD17628	weak cytotoxicity to HeLa cells
CMNPD17631	cytotoxic to L1210 cells
CMNPD17632	cytotoxic to L1210 cells
CMNPD17633	cytotoxic to L1210 cells
CMNPD17634	weak activity against Mycobacterium tuberculosis
CMNPD17635	weak activity against Mycobacterium tuberculosis
CMNPD17636	weakly active against S. aureus and E. coli
CMNPD17637	active against S. aureus
CMNPD17638	cytotoxic to P388 cells | inhibit growth of BSY-1 (breast) and MKN7 (stomach) human cancer cell lines
CMNPD17639	cytotoxic to P388 cells
CMNPD17640	cytotoxic to P388 cells
CMNPD17641	cytotoxic to P388 cells
CMNPD17646	cytotoxic against several cancer cell lines
CMNPD17647	cytotoxic against several cancer cell lines
CMNPD17648	cytotoxic against several cancer cell lines
CMNPD17649	cytotoxic against several cancer cell lines
CMNPD17650	cytotoxic against several cancer cell lines
CMNPD17651	cytotoxic against several cancer cell lines
CMNPD17653	selective inhibitor of a selection of eukaryotic DNA polymerases
CMNPD17654	strong inhibition of Gram-positive bacteria and C. albicans | cytotoxicity to A549 and Jurkat cancer cells
CMNPD17655	inhibit the polymerisation of a tubulin homologue in vitro | slightly active against multi-drug-resistant bacteria
CMNPD17663	significant antibacterial | antifungal
CMNPD17664	significant antibacterial | antifungal
CMNPD17665	significant antibacterial | antifungal
CMNPD17666	inhibitor of several tumour cell lines | weak inhibitor of Gram-positive bacteria
CMNPD17667	inhibitor of several tumour cell lines | weak inhibitor of Gram-positive bacteria
CMNPD17668	inhibitory to P388 and HL-60 cells | selectively cytotoxic to a panel of 39 human cancer cell lines
CMNPD17669	inhibitory to P388 and HL-60 cells
CMNPD17670	inhibitory to P388 and HL-60 cells | selectively cytotoxic to a panel of 39 human cancer cell lines
CMNPD17671	inhibitory to P388 and HL-60 cells
CMNPD17672	inhibitory to P388 and HL-60 cells
CMNPD17673	inhibitory to P388 and HL-60 cells | selectively cytotoxic to a panel of 39 human cancer cell lines
CMNPD17674	moderately cytototoxic to A549 cells
CMNPD17675	moderately cytototoxic to A549 cells
CMNPD17680	down-regulator of the molecular chaperone GRP78
CMNPD17681	modest activity against S. aureus and MRSA
CMNPD17685	mild activity against S. aureus and MRSA
CMNPD17686	mild activity against S. aureus and MRSA
CMNPD17688	selective effects against the protozoan Plasmodium falciparum
CMNPD17689	selective effects against Trypanosoma cruzi
CMNPD17694	cytotoxic to a number of human tumour cell lines
CMNPD17695	cytotoxic to a number of human tumour cell lines
CMNPD17698	cytotoxic to a number of human tumour cell lines
CMNPD17699	cytotoxic to a number of human tumour cell lines
CMNPD17701	tyrosine kinase inhibitor
CMNPD17702	moderate antiplasmodial activity | cytotoxic to a number of cancer cell lines
CMNPD17703	moderate antiplasmodial activity | cytotoxic to a number of cancer cell lines
CMNPD17707	inhibitor of cytochrome P450 1A and the estrogen biosynthetic enzyme CYP19 (aromatase) | moderate inducer of quinone reductase activity
CMNPD17708	inhibitor of cytochrome P450 1A and the estrogen biosynthetic enzyme CYP19 (aromatase) | moderate inducer of quinone reductase activity
CMNPD17709	weak cytotoxicity to the A375-S2 melanoma cell line
CMNPD17710	weak cytotoxicity to the A375-S2 melanoma cell line
CMNPD17711	weak cytotoxicity to the A375-S2 melanoma cell line
CMNPD17712	weak cytotoxicity to the A375-S2 melanoma cell line
CMNPD17713	weak cytotoxic activity against a range of human tumour cell lines
CMNPD17714	weak cytotoxic activity against a range of human tumour cell lines
CMNPD17715	antiproliferative towards L5178Y mouse lymphoma cells
CMNPD17718	potent cytotoxicity to the H-460 human lung cancer cell line
CMNPD17719	strongly cytotoxic to several cancer cell lines
CMNPD17720	moderately toxic in the brine shrimp bioassay
CMNPD17722	moderate broad-spectrum antiproliferative activity against four human cancer cell lines
CMNPD17723	selective inhibitor of trypsin in vitro
CMNPD17725	weakly cytotoxic against several cancer cell lines
CMNPD17726	weakly cytotoxic against several cancer cell lines
CMNPD17728	inhibitor of elastase and chymotrypsin
CMNPD17729	inhibit trypsin
CMNPD17730	potent cytotoxin to cancer cells with an unprecedented selectivity profile in the NCI 60 cell line panel
CMNPD17731	highly selective cytotoxicity towards transformed mammalian cell lines
CMNPD17732	potent chymotrypsin inhibitor and an inhibitor of H-460 lung cancer and neuro-2a neuroblastoma cells
CMNPD17733	ion channel inhibitor of Ca2+-release-activated Ca2+ channels
CMNPD17734	strong antitrypanosomal and antileishmanial activity
CMNPD17736	modest antimalarial activity | quorum-sensing inhibitory properties
CMNPD17737	modest antimalarial activity | quorum-sensing inhibitory properties
CMNPD17738	modest antimalarial activity | quorum-sensing inhibitory properties
CMNPD17739	modest antimalarial activity | quorum-sensing inhibitory properties
CMNPD17740	modest antimalarial activity | quorum-sensing inhibitory properties
CMNPD17741	modest antimalarial activity | quorum-sensing inhibitory properties
CMNPD17742	potently cytotoxic towards human B lymphocyte DG-75 cells and Epstein–Barr virus (EBV) infected Raji cells
CMNPD17743	proposed as a possible model for ladder-frame initiation of biosynthesis of related polyether metabolites
CMNPD17745	potent protein phosphatase 1 inhibitor
CMNPD17746	powerful haemolytic icthyotoxin
CMNPD17747	cytolytic activity towards oyster heart and gill cells
CMNPD17748	cytolytic activity towards oyster heart and gill cells
CMNPD17749	cytolytic activity towards oyster heart and gill cells
CMNPD17757	modest cytotoxicity against a panel of twelve human tumour cell lines
CMNPD17758	modest cytotoxicity against a panel of twelve human tumour cell lines
CMNPD17759	Weak to modest cytotoxicity (31–6 µM)
CMNPD17760	Weak to modest cytotoxicity (31–6 µM)
CMNPD17761	Weak to modest cytotoxicity (31–6 µM)
CMNPD17762	Weak to modest cytotoxicity (31–6 µM) | significant antifungal properties
CMNPD17763	cytotoxicity against a panel of human tumour cell lines
CMNPD17764	cytotoxicity against a panel of human tumour cell lines
CMNPD17765	cytotoxicity against a panel of human tumour cell lines
CMNPD17768	COX-2 inhibition
CMNPD17779	moderate to significant radical-scavenging activities (DPPH assay)
CMNPD17780	moderate to significant radical-scavenging activities (DPPH assay)
CMNPD17781	moderate to significant radical-scavenging activities (DPPH assay)
CMNPD17782	moderate to significant radical-scavenging activities (DPPH assay)
CMNPD17783	moderate to significant radical-scavenging activities (DPPH assay)
CMNPD17784	moderate to significant radical-scavenging activities (DPPH assay)
CMNPD17785	moderate to significant radical-scavenging activities (DPPH assay)
CMNPD17786	moderate to significant radical-scavenging activities (DPPH assay)
CMNPD17787	moderate to significant radical-scavenging activities (DPPH assay)
CMNPD17788	moderate to significant radical-scavenging activities (DPPH assay)
CMNPD17794	modest activity against a range of Hela cells
CMNPD17808	anti-inflammatory
CMNPD17809	anti-inflammatory
CMNPD17810	anti-inflammatory
CMNPD17811	anti-inflammatory
CMNPD17812	anti-inflammatory
CMNPD17813	anti-inflammatory
CMNPD17814	anti-inflammatory
CMNPD17815	modestly cytotoxic against a panel of twelve human cell lines | weakly antimalarial
CMNPD17831	modest cytotoxic activity against P388 tumour cells
CMNPD17832	exist as interconverting atropisomers arising from restricted rotation about the α-pyrone ring system | moderate activity against MRSA and VREF
CMNPD17833	modest MRSA activity
CMNPD17835	modest potency in the DPPH radical-scavenging assay
CMNPD17836	modest potency in the DPPH radical-scavenging assay
CMNPD17837	modest potency in the DPPH radical-scavenging assay
CMNPD17838	significant DPPH radical-scavenging activity
CMNPD17841	cytotoxic
CMNPD17842	cytotoxic
CMNPD17843	cytotoxic
CMNPD17855	moderately cytotoxic
CMNPD17870	inhibit the Helicobacter pylori enzyme glutamate racemase, an enzyme which interconverts L- and D-glucose and so is of importance in constructing bacterial cell walls
CMNPD17871	modestly cytotoxic
CMNPD17873	antileishmanial
CMNPD17874	antileishmanial
CMNPD17879	brine-shrimp-toxic
CMNPD17880	cytotoxic to human UT-7 leukaemic cells
CMNPD17881	potently cytotoxic and cause microfilament disruption
CMNPD17882	potently cytotoxic and cause microfilament disruption
CMNPD17883	potently cytotoxic and cause microfilament disruption
CMNPD17884	potently cytotoxic and cause microfilament disruption
CMNPD17886	inactive vs M. tuberculosis and 2 HTCL
CMNPD17888	inhibit HIV-1 infection in the nanomolar range with cytotoxicity at micromolar levels
CMNPD17889	Potent agonists of human sensory neuron-specific G protein coupled receptor (SNSR)
CMNPD17890	Potent agonists of human sensory neuron-specific G protein coupled receptor (SNSR)
CMNPD17891	Potent agonists of human sensory neuron-specific G protein coupled receptor (SNSR)
CMNPD17892	cytotoxic
CMNPD17893	cytotoxic
CMNPD17894	cytotoxic
CMNPD17895	cytotoxic
CMNPD17896	cytotoxic
CMNPD17897	cytotoxic
CMNPD17898	cytotoxic
CMNPD17899	cytotoxic
CMNPD17900	cytotoxic
CMNPD17901	cytotoxic
CMNPD17902	cytotoxic
CMNPD17904	cytotoxic to leukaemia cells
CMNPD17906	cytotoxic to leukaemia cells
CMNPD17907	cytotoxic
CMNPD17908	cytotoxic
CMNPD17909	cytotoxic | antibacterial
CMNPD17911	antioxidant activity
CMNPD17912	antioxidant activity
CMNPD17914	inhibit the androgen receptor of prostrate cancer cells
CMNPD17918	moderately cytotoxic
CMNPD17919	moderately cytotoxic
CMNPD17920	moderately cytotoxic
CMNPD17926	weakly cytotoxic
CMNPD17927	cytotoxic | antibacterial
CMNPD17928	moderately cytotoxic
CMNPD17929	moderately cytotoxic
CMNPD17930	moderately cytotoxic
CMNPD17932	cytotoxic
CMNPD17933	cytotoxic
CMNPD17936	cytotoxic
CMNPD17937	cytotoxic
CMNPD17938	cytotoxic
CMNPD17939	cytotoxic
CMNPD17940	cytotoxic
CMNPD17941	cytotoxic
CMNPD17942	cytotoxic
CMNPD17943	cytotoxic to both mammalian cancer cells and brine shrimp larvae
CMNPD17950	moderately cytotoxic
CMNPD17951	moderately cytotoxic
CMNPD17953	antimicrobial
CMNPD17954	antimicrobial
CMNPD17955	antifungal
CMNPD17956	antifungal
CMNPD17969	isoprenylcysteine carboxyl methyltransferase inhibitor
CMNPD17970	inhibitor of blood coagulation factor XIa
CMNPD17971	inhibitor of blood coagulation factor XIa
CMNPD17972	weakly cytotoxic
CMNPD17973	adenosine A1 receptor antagonist | moderately cytotoxic
CMNPD17974	cytotoxic
CMNPD17975	cytotoxic
CMNPD17976	cytotoxic
CMNPD17977	selectively cytotoxic towards a selection of human tumour cell lines
CMNPD17978	cytotoxic
CMNPD17979	cytotoxic
CMNPD17984	cathepsin B inhibition activity
CMNPD17986	inhibitor of protein farnesyl transferase and active against several strains of Plasmodium falciparum
CMNPD17987	inhibitor of protein farnesyl transferase and active against several strains of Plasmodium falciparum
CMNPD17988	inhibitor of protein farnesyl transferase and active against several strains of Plasmodium falciparum | active against P. vinkei infection in mice
CMNPD17989	inhibitor of protein farnesyl transferase and active against several strains of Plasmodium falciparum
CMNPD17994	modestly cytotoxic | HER2 kinase inhibitor
CMNPD17995	modestly cytotoxic | HER2 kinase inhibitor
CMNPD17996	modestly cytotoxic | HER2 kinase inhibitor
CMNPD17997	proteasome inhibitor
CMNPD18006	mildly cytotoxic
CMNPD18012	mildly cytotoxic
CMNPD18017	cytotoxic
CMNPD18018	cytotoxic
CMNPD18019	toxic to brine shrimp
CMNPD18020	toxic to brine shrimp
CMNPD18021	toxic to brine shrimp
CMNPD18022	toxic to brine shrimp
CMNPD18023	toxic to brine shrimp
CMNPD18025	cytotoxic
CMNPD18027	cytotoxic
CMNPD18035	cytotoxic
CMNPD18039	cytotoxic
CMNPD18044	cytotoxic
CMNPD18045	cytotoxic
CMNPD18046	cytotoxic
CMNPD18047	cytotoxic
CMNPD18048	cytotoxic
CMNPD18049	ligand of thyrotropin-releasing hormone receptor 2
CMNPD18050	ligand of thyrotropin-releasing hormone receptor 2
CMNPD18051	ligand of thyrotropin-releasing hormone receptor 2
CMNPD18052	ligand of thyrotropin-releasing hormone receptor 2
CMNPD18053	antimalarial in tests against Plasmodium falciparum
CMNPD18054	antimalarial in tests against Plasmodium falciparum
CMNPD18055	antimalarial in tests against Plasmodium falciparum
CMNPD18056	moderately cytotoxic | weakly inhibitory towards isocitrate lyase
CMNPD18057	moderately cytotoxic | weakly inhibitory towards isocitrate lyase
CMNPD18058	moderately cytotoxic | weakly inhibitory towards isocitrate lyase
CMNPD18059	moderately cytotoxic | weakly inhibitory towards isocitrate lyase
CMNPD18060	moderately cytotoxic | weakly inhibitory towards isocitrate lyase
CMNPD18061	moderately cytotoxic | weakly inhibitory towards isocitrate lyase
CMNPD18062	moderately cytotoxic | weakly inhibitory towards isocitrate lyase
CMNPD18063	moderately cytotoxic | weakly inhibitory towards isocitrate lyase
CMNPD18064	moderately cytotoxic | weakly inhibitory towards isocitrate lyase
CMNPD18065	moderately cytotoxic | weakly inhibitory towards isocitrate lyase
CMNPD18068	cytotoxic
CMNPD18077	cytotoxic
CMNPD18078	cytotoxic
CMNPD18080	inhibitory towards isocitrate lyase
CMNPD18086	antibacterial
CMNPD18087	antibacterial
CMNPD18097	cytotoxic
CMNPD18098	cytotoxic
CMNPD18099	cytotoxic
CMNPD18102	cytotoxic
CMNPD18103	cytotoxic
CMNPD18105	antibacterial
CMNPD18107	antibacterial
CMNPD18108	antibacterial
CMNPD18109	antibacterial
CMNPD18113	antibacterial
CMNPD18115	cytotoxic
CMNPD18116	inhibitor of the settling of Balanus albicostatus larvae
CMNPD18117	inhibitor of the settling of Balanus albicostatus larvae
CMNPD18118	inhibitor of the settling of Balanus albicostatus larvae
CMNPD18119	moderately cytotoxic
CMNPD18120	moderately cytotoxic
CMNPD18121	moderately cytotoxic
CMNPD18129	inhibitor of molluscan endo-1,3-β-D-glucanase
CMNPD18136	moderately cytotoxic
CMNPD18143	mildly cytotoxic
CMNPD18144	mildly cytotoxic
CMNPD18145	mildly cytotoxic
CMNPD18146	mildly cytotoxic
CMNPD18147	mildly cytotoxic
CMNPD18164	mild inhibition of human neutrophil elastase release
CMNPD18168	modest cytotoxicity in vitro
CMNPD18169	modest cytotoxicity in vitro
CMNPD18170	anti-inflammatory activity (iNOS and COX-2)
CMNPD18171	anti-inflammatory activity (iNOS and COX-2)
CMNPD18172	anti-inflammatory activity (iNOS and COX-2)
CMNPD18173	anti-inflammatory activity (iNOS and COX-2)
CMNPD18174	anti-inflammatory activity (iNOS and COX-2)
CMNPD18185	moderate toxicity to brine shrimp larvae
CMNPD18189	moderate toxicity to brine shrimp larvae
CMNPD18192	moderate toxicity to brine shrimp larvae
CMNPD18198	exhibit antiproliferative activity | decrease disaggregation and cell migration in an in vitro model of metastasis
CMNPD18199	exhibit antiproliferative activity | decrease disaggregation and cell migration in an in vitro model of metastasis
CMNPD18200	anti-inflammatory
CMNPD18209	cytotoxic (moderate)
CMNPD18219	mildly COX-2-inhibiting
CMNPD18220	mildly COX-2-inhibiting
CMNPD18222	effects on the expression of iNOS and COX-2 in macrophage cells
CMNPD18224	(modest) cytotoxicity | effects on the expression of iNOS and COX-2 in macrophage cells
CMNPD18229	mildly cytotoxic
CMNPD18230	mildly cytotoxic
CMNPD18231	a stimulatory effect on osteoblastic cells in vitro
CMNPD18262	absolute configuration
CMNPD18284	mild levels of cytotoxicity
CMNPD18285	mild levels of cytotoxicity
CMNPD18286	mild levels of cytotoxicity
CMNPD18287	mild levels of cytotoxicity
CMNPD18288	mild levels of cytotoxicity
CMNPD18289	mild levels of cytotoxicity
CMNPD18290	mild levels of cytotoxicity
CMNPD18292	inhibit iNOS and COX-2 protein expression
CMNPD18304	modest cytotoxicity | nACh receptor activity | modest inhibitor of the function of protein tyrosine phosphatase 1B
CMNPD18305	modest cytotoxicity | nACh receptor activity
CMNPD18306	modest cytotoxicity | nACh receptor activity
CMNPD18307	modest cytotoxicity | nACh receptor activity | modest inhibitor of the function of protein tyrosine phosphatase 1B
CMNPD18308	modest cytotoxicity | nACh receptor activity
CMNPD18309	modest cytotoxicity | nACh receptor activity
CMNPD18342	modest cytotoxicity
CMNPD18350	mild growth inhibitory effects towards breast MCF-7 cells in vitro
CMNPD18351	mild growth inhibitory effects towards breast MCF-7 cells in vitro
CMNPD18352	mild growth inhibitory effects towards breast MCF-7 cells in vitro
CMNPD18353	mild growth inhibitory effects towards breast MCF-7 cells in vitro
CMNPD18364	combinations of weak cytotoxicity | moderate anti-inflammatory activity
CMNPD18365	combinations of weak cytotoxicity | moderate anti-inflammatory activity
CMNPD18366	combinations of weak cytotoxicity | moderate anti-inflammatory activity
CMNPD18367	combinations of weak cytotoxicity | moderate anti-inflammatory activity
CMNPD18368	combinations of weak cytotoxicity | moderate anti-inflammatory activity
CMNPD18369	combinations of weak cytotoxicity | moderate anti-inflammatory activity
CMNPD18370	combinations of weak cytotoxicity | moderate anti-inflammatory activity
CMNPD18371	combinations of weak cytotoxicity | moderate anti-inflammatory activity
CMNPD18372	combinations of weak cytotoxicity | moderate anti-inflammatory activity
CMNPD18373	mildly cytotoxic
CMNPD18374	mildly cytotoxic
CMNPD18375	mildly cytotoxic
CMNPD18376	mildly cytotoxic
CMNPD18378	variable effects on gene expression of pro-inflammatory marker proteins
CMNPD18379	variable effects on gene expression of pro-inflammatory marker proteins
CMNPD18380	variable effects on gene expression of pro-inflammatory marker proteins
CMNPD18381	variable effects on gene expression of pro-inflammatory marker proteins
CMNPD18382	variable effects on gene expression of pro-inflammatory marker proteins
CMNPD18383	variable effects on gene expression of pro-inflammatory marker proteins
CMNPD18384	variable effects on gene expression of pro-inflammatory marker proteins
CMNPD18385	variable effects on gene expression of pro-inflammatory marker proteins
CMNPD18386	variable effects on gene expression of pro-inflammatory marker proteins
CMNPD18387	variable effects on gene expression of pro-inflammatory marker proteins
CMNPD18388	variable effects on gene expression of pro-inflammatory marker proteins
CMNPD18389	variable effects on gene expression of pro-inflammatory marker proteins
CMNPD18390	mildly cytotoxic
CMNPD18391	variable levels of activity against B. subtilis
CMNPD18392	variable levels of activity against B. subtilis | modest activity against P388 cells and Trichophyton mentagrophytes
CMNPD18393	variable levels of activity against B. subtilis
CMNPD18394	variable levels of activity against B. subtilis
CMNPD18417	modest cytotoxicity
CMNPD18418	modest cytotoxicity
CMNPD18429	cytotoxic
CMNPD18438	mildly cytotoxic
CMNPD18439	mildly cytotoxic
CMNPD18444	inhibit the division of fertilised sea urchin eggs
CMNPD18447	inhibitor of human neutrophil respiratory burst
CMNPD18448	inhibitor of human neutrophil respiratory burst
CMNPD18449	inhibitor of human neutrophil respiratory burst
CMNPD18450	inhibitor of human neutrophil respiratory burst
CMNPD18451	inhibitor of human neutrophil respiratory burst
CMNPD18452	inhibitor of human neutrophil respiratory burst
CMNPD18453	inhibitor of human neutrophil respiratory burst
CMNPD18456	submicromolar growth inhibitor
CMNPD18458	submicromolar growth inhibitor
CMNPD18460	submicromolar growth inhibitor | potent antimitotic activity
CMNPD18466	mild antibacterial activity
CMNPD18471	cytotoxic
CMNPD18474	nanomolar potency growth inhibition of three human tumour cell lines in vitro
CMNPD18475	nanomolar potency growth inhibition of three human tumour cell lines in vitro
CMNPD18479	mild cytotoxicity
CMNPD18480	mild cytotoxicity
CMNPD18481	mild cytotoxicity
CMNPD18483	inhibit TNF-α-induced NF-κB activation by inhibiting IKKβ kinase
CMNPD18484	inhibit TNF-α-induced NF-κB activation by inhibiting IKKβ kinase
CMNPD18486	promote proliferation of osteoblast cells in vitro
CMNPD18489	induce murine neuroblast cell differentiation
CMNPD18490	induce murine neuroblast cell differentiation
CMNPD18491	inhibit sea-urchin egg fertilisation
CMNPD18492	inhibit sea-urchin egg fertilisation
CMNPD18493	inhibit sea-urchin egg fertilisation
CMNPD18494	inhibit sea-urchin egg fertilisation
CMNPD18495	inhibit sea-urchin egg fertilisation
CMNPD18496	inhibit sea-urchin egg fertilisation
CMNPD18497	modest antifungal properties
CMNPD18507	cytotoxicity (mild)
CMNPD18508	modest cytotoxicity towards a panel of tumour cell lines
CMNPD18509	modest cytotoxicity towards a panel of tumour cell lines
CMNPD18510	cytotoxic
CMNPD18511	cytotoxic
CMNPD18512	cytotoxic
CMNPD18513	cytotoxic
CMNPD18522	modest antifouling activity towards Balanus albicostatus cyprids without toxicity
CMNPD18527	radical scavenging (DPPH assay)
CMNPD18528	radical scavenging (DPPH assay)
CMNPD18530	mild cytotoxicity | Gram-positive antibacterial
CMNPD18531	mild cytotoxicity | Gram-positive antibacterial
CMNPD18551	mild antibacterial
CMNPD18552	mild antibacterial
CMNPD18553	mild antibacterial
CMNPD18562	inhibitor of the human hepatoma SMMC-7721 cell line
CMNPD18563	inhibitor of the human hepatoma SMMC-7721 cell line
CMNPD18564	modestly cytotoxic against A549 cells
CMNPD18565	modestly cytotoxic against A549 cells
CMNPD18566	potent cytotoxicity to HL-60 and A549 cells
CMNPD18572	moderately cytotoxic to HL-60 and A549 cells
CMNPD18573	moderately cytotoxic to HL-60 and A549 cells
CMNPD18580	moderate inhibition of KB and KBv cells
CMNPD18587	inhibitory to MRSA
CMNPD18588	inhibitory to MRSA
CMNPD18589	cytotoxic to A549 cells
CMNPD18590	cytotoxic to P388 cells
CMNPD18593	cytotoxic to the HL-60 cell line
CMNPD18595	cytotoxic to the HL-60 cell line
CMNPD18600	cytotoxic to hepG2 cells, Curvularia lunata, E. coli and Candida albicans | acetylcholinesterase activity
CMNPD18602	modestly active against Fusarium oxysporum
CMNPD18603	weakly active against KB and KBv200 cell lines
CMNPD18604	strong radical-scavenging activity
CMNPD18605	strong radical-scavenging activity
CMNPD18609	antibiotics
CMNPD18610	antibiotics
CMNPD18611	antibiotics
CMNPD18612	antibiotics
CMNPD18613	selective inhibitor of the phytopathogenic microorganism Phytophthora capsici
CMNPD18618	very mild cathepsin B-inhibiting
CMNPD18619	very mild cathepsin B-inhibiting
CMNPD18620	very mild cathepsin B-inhibiting
CMNPD18621	modest activity against Candida albicans
CMNPD18622	modest activity against Candida albicans
CMNPD18623	modest cytotoxicity to HCT-116 cells
CMNPD18624	active against a selection of human cancer cell lines
CMNPD18625	block tumour necrosis factor (TNF)-induced activation | inhibit nitric oxide and prostaglandin E2 production | moderately cytotoxic to HCT-116 cells
CMNPD18626	block tumour necrosis factor (TNF)-induced activation | inhibit nitric oxide and prostaglandin E2 production | moderately cytotoxic to HCT-116 cells
CMNPD18628	inhibit growth of A549 cells | activity against Bacillus subtilis and Staphylococcus aureus
CMNPD18629	activity against methicillin-resistant Staphylococcus aureus (MRSA)
CMNPD18632	strongly inhibitory against a number of human cancer cell lines | active against Streptococcus pyrogenes and antibiotic-resistant S. pneumoniae
CMNPD18633	strongly inhibitory against a number of human cancer cell lines | active against Streptococcus pyrogenes and antibiotic-resistant S. pneumoniae
CMNPD18635	potent activity against Enterococcus hirae and Micrococcus luteus
CMNPD18636	potent activity against Enterococcus hirae and Micrococcus luteus
CMNPD18644	bacteriocidal or bacteriostatic properties
CMNPD18645	bacteriocidal or bacteriostatic properties
CMNPD18646	bacteriocidal or bacteriostatic properties
CMNPD18647	bacteriocidal or bacteriostatic properties
CMNPD18648	inhibit P-glycoprotein and reverse daunorubicin resistance in A2780 ovarian cancer cells
CMNPD18651	cytotoxic to HT-29 cells
CMNPD18652	cytotoxic to HT-29 cells
CMNPD18653	cytotoxic to HT-29 cells
CMNPD18654	cytotoxic to HT-29 cells
CMNPD18655	cytotoxic to HT-29 cells
CMNPD18656	cytotoxic to HT-29 cells
CMNPD18657	potent cytotoxicity against a number of cancer cell lines
CMNPD18658	potent cytotoxicity against a number of cancer cell lines
CMNPD18659	potential for development for asthma treatment | suppression of cytokine production with minimal mammalian cell cytotoxicity
CMNPD18660	potential for development for asthma treatment | suppression of cytokine production with minimal mammalian cell cytotoxicity
CMNPD18661	potential for development for asthma treatment | suppression of cytokine production with minimal mammalian cell cytotoxicity
CMNPD18662	potential for development for asthma treatment | suppression of cytokine production with minimal mammalian cell cytotoxicity
CMNPD18663	potential for development for asthma treatment | suppression of cytokine production with minimal mammalian cell cytotoxicity
CMNPD18664	potential for development for asthma treatment | suppression of cytokine production with minimal mammalian cell cytotoxicity
CMNPD18665	potential for development for asthma treatment | suppression of cytokine production with minimal mammalian cell cytotoxicity
CMNPD18666	potential for development for asthma treatment | suppression of cytokine production with minimal mammalian cell cytotoxicity
CMNPD18667	potential for development for asthma treatment | suppression of cytokine production with minimal mammalian cell cytotoxicity
CMNPD18668	potential for development for asthma treatment | suppression of cytokine production with minimal mammalian cell cytotoxicity
CMNPD18669	moderate inhibitor of protein-tyrosine phosphatase B
CMNPD18670	moderately active against S. aureus, B. subtilis and E. coli | a strong inhibitor of the microalgae Chlorella vulgaris, C. sorokiniana and Scenedesmus subspicatus | high cytotoxicity when tested in a panel of 36 tumour cell lines
CMNPD18671	high cytotoxicity when tested in a panel of 36 tumour cell lines
CMNPD18672	high cytotoxicity when tested in a panel of 36 tumour cell lines
CMNPD18673	high cytotoxicity when tested in a panel of 36 tumour cell lines
CMNPD18674	strongly cytotoxic to A549, HT-29 and MDA-MB-231 cells
CMNPD18677	inhibit human platelet phosphodiesterase 5 (PDE5)
CMNPD18678	inhibit human platelet phosphodiesterase 5 (PDE5)
CMNPD18679	activity against vancomycin-resistant Enterococcus faecalis (VRE) with varying degrees of potency
CMNPD18680	activity against vancomycin-resistant Enterococcus faecalis (VRE) with varying degrees of potency
CMNPD18714	selectively inhibit α-glucosidase from Saccharomyces cerevisiae
CMNPD18715	modestly cytotoxic to several human tumour cell lines
CMNPD18717	inhibitor of the mammalian mitochondrial respiratory chain
CMNPD18718	inhibitor of the mammalian mitochondrial respiratory chain
CMNPD18719	significant 1,1-diphenyl-2-picrylhydrazyl (DPPH) radical-scavenging activity
CMNPD18722	moderate activity against C. albicans
CMNPD18723	moderate activity against C. albicans | weakly cytotoxic to HL-60 cells | inhibit P. aeruginosagrowth
CMNPD18729	cytotoxic to several tumour cell lines
CMNPD18730	cytotoxic to several tumour cell lines | moderate growth inhibition of A549 and HL-60 cells
CMNPD18735	weak growth inhibition of HL-60 and A549 cells
CMNPD18737	moderate growth inhibition of A549 and HL-60 cells
CMNPD18743	strong growth inhibition of HL-60 cells
CMNPD18745	inhibitor of Tobacco Mosaic Virus (TMV) replication
CMNPD18746	inhibitor of Tobacco Mosaic Virus (TMV) replication
CMNPD18759	inhibit growth of B. subtilis, E. coli and S. aureus.
CMNPD18760	cytotoxic
CMNPD18761	cytotoxic
CMNPD18762	cytotoxic
CMNPD18763	selectively cytotoxic against a panel of 39 human cancer cell lines
CMNPD18764	cytotoxic
CMNPD18765	cytotoxic
CMNPD18766	cytotoxic
CMNPD18768	cytotoxic
CMNPD18769	cytotoxic
CMNPD18770	cytotoxic
CMNPD18771	cytotoxic
CMNPD18772	cytotoxic
CMNPD18774	modest DPPH radical-scavenging activity
CMNPD18775	modest DPPH radical-scavenging activity
CMNPD18776	modest DPPH radical-scavenging activity
CMNPD18778	moderately cytotoxic to HL-60, U937 and T47D cells
CMNPD18779	moderately cytotoxic to HL-60, U937 and T47D cells
CMNPD18780	moderately active against S. aureus
CMNPD18790	moderate inhibitor of HeLa cells | inhibit HIV-1 replication in C8166 cells
CMNPD18791	moderate inhibitor of HeLa cells
CMNPD18792	moderate inhibitor of HeLa cells
CMNPD18798	moderately cytotoxic to HeLa cells
CMNPD18799	cytotoxic against a panel of four cancer cell lines
CMNPD18800	cytotoxic against a panel of four cancer cell lines
CMNPD18801	cytotoxic against a panel of four cancer cell lines
CMNPD18802	cytotoxic against a panel of four cancer cell lines
CMNPD18803	cytotoxic against a panel of four cancer cell lines
CMNPD18804	cytotoxic against a panel of four cancer cell lines | potently cytotoxic to HL-60 and BEL-7402 cells
CMNPD18805	cytotoxic against a panel of four cancer cell lines
CMNPD18806	cytotoxic against a panel of four cancer cell lines
CMNPD18807	cytotoxic against a panel of four cancer cell lines
CMNPD18808	cytotoxic against a panel of four cancer cell lines
CMNPD18809	moderately active against K562 tumour cells
CMNPD18811	a range of biological activities | cytochrome P450 1A (CYP1A) inhibition | glutathione S-transferases (GST) and epoxide hydrolase (mEH) induction | potent radical-scavenging activity against hydroxyl radicals
CMNPD18812	moderately active radical scavengers of the DPPH free radical
CMNPD18813	moderately active radical scavengers of the DPPH free radical | active against PC-3 prostate cancer cells
CMNPD18818	active against a panel of 36 human tumour cell lines | significant selectivity toward 12 of the cell lines and possess a unique cytotoxic selectivity pattern as determined by COMPARE analyses
CMNPD18819	active against a panel of 36 human tumour cell lines
CMNPD18820	cytotoxic to HEp-2 and HepG2 cells
CMNPD18821	modest DPPH radical scavenger
CMNPD18822	modest DPPH radical scavenger
CMNPD18823	inhibitor of indoleamine 2,3-dioxygenase (IDO)
CMNPD18824	inhibitor of indoleamine 2,3-dioxygenase (IDO)
CMNPD18825	inhibitor of indoleamine 2,3-dioxygenase (IDO)
CMNPD18831	cytotoxic to L5178Y murine cancer cells
CMNPD18840	moderate cytotoxicity to HepG2 cells | strong inhibitor of acetylcholinesterase
CMNPD18841	moderate cytotoxicity to HepG2 cells
CMNPD18843	moderate activities against HL-60 cells
CMNPD18844	moderate activities against HL-60 cells
CMNPD18854	strong DNA-binding affinity to calf thymus (CT) DNA
CMNPD18855	weak inhibitor of both S. aureus and MRSA
CMNPD18860	a unique calcium influx activation profile in murine cerebrocortical neurons
CMNPD18861	selectively inhibit cathepsins D and E
CMNPD18862	selectively inhibit cathepsins D and E
CMNPD18863	selective for cathepsin E
CMNPD18864	moderate inhibitor of porcine pancreatic elastase activity in vitro
CMNPD18865	moderate inhibitor of porcine pancreatic elastase activity in vitro
CMNPD18866	moderate inhibitor of porcine pancreatic elastase activity in vitro
CMNPD18867	moderate inhibitor of porcine pancreatic elastase in vitro
CMNPD18868	moderate inhibitor of porcine pancreatic elastase in vitro
CMNPD18869	moderate inhibitor of porcine pancreatic elastase in vitro
CMNPD18871	selective inhibitor of the NAD+-dependent cytoplasmic protein, human sirtuin type 2 (SIRT2)
CMNPD18872	cytotoxic to MOLT-4 and MCF-7 cells
CMNPD18873	potent and selective agent against HCT-116 through disruption of cellular microfilament networks | active in vivo in HCT-116-bearing mice with severe combined immunodeficiency
CMNPD18874	marginal insecticidal activity against the beet armyworm (Spodoptera exigua)
CMNPD18875	marginal insecticidal activity against the beet armyworm (Spodoptera exigua)
CMNPD18877	cytotoxic to HEK293 cells
CMNPD18879	growth inhibitor of HT-29 and IMR-32 cells
CMNPD18880	inhibitor of porcine pancreatic elastase
CMNPD18881	inhibitor of porcine pancreatic elastase
CMNPD18882	inhibitor of porcine pancreatic elastase
CMNPD18883	broad-spectrum cytotoxicity in a human tumour cell line panel
CMNPD18884	cytotoxic to HeLa S3cells and a panel of human cancer cell lines | potent protein kinase inhibition
CMNPD18885	a partial agonist of site 2 on the voltage-gated sodium channel
CMNPD18886	modest activity only against HeLa and HT-29 cells | moderate activity against Plasmodium falciparum, Leishmania donovani and mammalian Vero cells
CMNPD18887	extremely weak toxicity in a mouse bioassay
CMNPD18889	potent ichthyotoxin, in addition to being active against Aspergillus niger
CMNPD18891	nhibit the binding of brevetoxin-3 to voltage-sensitive sodium channels in rat brain synaptosomes
CMNPD18892	significant antiproliferative activities against several human solid tumour cell lines
CMNPD18893	significant antiproliferative activities against several human solid tumour cell lines
CMNPD18896	inhibitory against L-phosphatidylserine-induced PKC activation
CMNPD18899	cytotoxic
CMNPD18916	low cytotoxicity
CMNPD18923	antifouling properties of the more abundant of this series against Pseudoalteromonas sp.
CMNPD18924	antifouling properties of the more abundant of this series against Pseudoalteromonas sp.
CMNPD18925	antifouling properties of the more abundant of this series against Pseudoalteromonas sp.
CMNPD18926	antifouling properties of the more abundant of this series against Pseudoalteromonas sp.
CMNPD18934	cytotoxic activity of the extract against two human cancer cell lines
CMNPD18947	modest antistaphylococcal activity
CMNPD18948	modest antistaphylococcal activity
CMNPD18949	modest antistaphylococcal activity
CMNPD18950	modest antistaphylococcal activity
CMNPD18951	modest antistaphylococcal activity
CMNPD18958	antiplasmodial
CMNPD18959	antiplasmodial
CMNPD18972	analgesic
CMNPD18979	antimicrobial
CMNPD18984	moderate to strong antimicrobial | anticancer
CMNPD18985	moderate to strong antimicrobial | anticancer
CMNPD18986	moderate to strong antimicrobial | anticancer
CMNPD18987	moderate to strong antimicrobial | anticancer
CMNPD18988	moderate to strong antimicrobial | anticancer
CMNPD18989	moderate to strong antimicrobial | anticancer
CMNPD18990	moderate to strong antimicrobial | anticancer
CMNPD18991	moderate to strong antimicrobial | anticancer
CMNPD19020	active against MRSA
CMNPD19021	active against MRSA
CMNPD19022	active against MRSA
CMNPD19023	active against MRSA
CMNPD19024	active against MRSA
CMNPD19025	active against MRSA
CMNPD19026	active against MRSA
CMNPD19027	inhibitor of the kinase GSK-3β
CMNPD19028	inhibitor of the kinase GSK-3β
CMNPD19029	inhibitor of the kinase GSK-3β
CMNPD19030	inhibit HIF-1 activation in human breast tumour cells
CMNPD19031	inhibit HIF-1 activation in human breast tumour cells
CMNPD19032	inhibit HIF-1 activation in human breast tumour cells
CMNPD19033	inhibit HIF-1 activation in human breast tumour cells
CMNPD19034	inhibit HIF-1 activation in human breast tumour cells
CMNPD19035	inhibit HIF-1 activation in human breast tumour cells
CMNPD19036	inhibit HIF-1 activation in human breast tumour cells
CMNPD19037	inhibit HIF-1 activation in human breast tumour cells
CMNPD19038	inhibit HIF-1 activation in human breast tumour cells
CMNPD19039	inhibit HIF-1 activation in human breast tumour cells
CMNPD19040	inhibit HIF-1 activation in human breast tumour cells
CMNPD19041	inhibit HIF-1 activation in human breast tumour cells
CMNPD19042	inhibit HIF-1 activation in human breast tumour cells
CMNPD19043	inhibit HIF-1 activation in human breast tumour cells
CMNPD19044	inhibit HIF-1 activation in human breast tumour cells
CMNPD19045	inhibit HIF-1 activation in human breast tumour cells
CMNPD19046	inhibit HIF-1 activation in human breast tumour cells
CMNPD19047	cytotoxic
CMNPD19048	cytotoxic
CMNPD19049	cytotoxic
CMNPD19050	weakly cytotoxic | weakly antimicrobial
CMNPD19055	active against Trypanosoma brucei (African sleeping sickness)
CMNPD19056	active against Trypanosoma brucei (African sleeping sickness)
CMNPD19057	weakly active against S. aureus
CMNPD19058	weakly active against S. aureus
CMNPD19059	weakly active against S. aureus
CMNPD19060	weakly active against S. aureus
CMNPD19066	generally cytotoxic | active against Leishmania major
CMNPD19067	generally cytotoxic
CMNPD19071	moderately active against S. cerevisiae (baker's yeast)
CMNPD19072	moderately active against S. cerevisiae (baker's yeast)
CMNPD19073	cytotoxic
CMNPD19075	mod. activity vs HTCL
CMNPD19078	anti-inflammatory in a mouse oedema model | lacking cytotoxicity
CMNPD19079	anti-inflammatory in a mouse oedema model | lacking cytotoxicity
CMNPD19080	inibited HIV-1 proliferation
CMNPD19083	cytotoxic
CMNPD19084	cytotoxic
CMNPD19085	cytotoxic
CMNPD19086	potently antiproliferative to HL60 cells
CMNPD19087	potently antiproliferative to HL60 cells
CMNPD19088	potently antiproliferative to HL60 cells
CMNPD19089	potently antiproliferative to HL60 cells
CMNPD19090	potently antiproliferative to HL60 cells
CMNPD19091	potently antiproliferative to HL60 cells
CMNPD19092	potently antiproliferative to HL60 cells
CMNPD19093	potently antiproliferative to HL60 cells
CMNPD19094	potently antiproliferative to HL60 cells
CMNPD19095	cytotoxic
CMNPD19096	cytotoxic
CMNPD19097	cytotoxic
CMNPD19098	cytotoxic
CMNPD19099	anti-proliferative towards leukaemia cells
CMNPD19107	mild inhibitor of Bcl-3 activity
CMNPD19108	mild inhibitor of Bcl-3 activity
CMNPD19109	mild inhibitor of Bcl-3 activity
CMNPD19121	cytotoxic
CMNPD19122	cytotoxic
CMNPD19124	weak cytotoxicity
CMNPD19126	active against TB-causing Mycobacterium smegmatis and M. bovis under both aerobic and hypoxic conditions
CMNPD19127	active against TB-causing Mycobacterium smegmatis and M. bovis under both aerobic and hypoxic conditions
CMNPD19128	active against TB-causing Mycobacterium smegmatis and M. bovis under both aerobic and hypoxic conditions
CMNPD19129	moderately cytotoxic and antibacterial
CMNPD19132	antitrypanosomal | antimalarial
CMNPD19133	antitrypanosomal | antimalarial
CMNPD19137	inibitor of EGF-induced malignant transformation of murine epidermal cells
CMNPD19143	cytotoxic
CMNPD19144	cytotoxic
CMNPD19151	antibacterial | antifungal
CMNPD19152	antibacterial | antifungal
CMNPD19153	weakly antibacterial
CMNPD19156	weakly antifungal
CMNPD19162	activity against bacteria, Plasmodium falciparum (malaria) and Trypanosoma brucei brucei (sleeping sickness)
CMNPD19163	activity against bacteria, Plasmodium falciparum (malaria) and Trypanosoma brucei brucei (sleeping sickness)
CMNPD19164	cytotoxic
CMNPD19165	cytotoxic
CMNPD19166	cytotoxic
CMNPD19167	cytotoxic
CMNPD19168	cytotoxic
CMNPD19169	cytotoxic
CMNPD19170	cytotoxic
CMNPD19171	weakly inhibit serine protease factor XIa
CMNPD19172	weakly inhibit serine protease factor XIa
CMNPD19173	weakly inhibit serine protease factor XIa
CMNPD19174	cytotoxic
CMNPD19175	non-selective pyruvate phosphate dikinase (PPDK) inhibitor
CMNPD19181	antimicrobial
CMNPD19182	cytotoxic
CMNPD19183	neuroprotective against iodoacetic acid-induced cell death in mouse neurons
CMNPD19184	human protein tyrosine phosphatase 1B (hPTB1B) inhibitor
CMNPD19193	moderately active against Trypanosoma brucei
CMNPD19194	moderately active against Trypanosoma brucei
CMNPD19201	cytotoxic
CMNPD19202	cytotoxic
CMNPD19203	cytotoxic | active against protein tyrosine kinase EGF-R
CMNPD19205	cytotoxic
CMNPD19206	anti-inflammatory in mice
CMNPD19208	cytotoxic
CMNPD19212	cytotoxic
CMNPD19213	cytotoxic
CMNPD19217	antiplasmodial
CMNPD19218	antiplasmodial
CMNPD19219	antiplasmodial
CMNPD19220	antiplasmodial
CMNPD19221	antiplasmodial
CMNPD19227	inhibit peripheral blood mononuclear cell proliferation
CMNPD19231	activate the cAMP cell signalling pathway
CMNPD19232	activate the cAMP cell signalling pathway
CMNPD19233	moderately cytotoxic
CMNPD19234	moderately cytotoxic
CMNPD19235	moderately cytotoxic
CMNPD19237	moderately anti-inflammatory | inhibit PGE2 and NO production in cells
CMNPD19238	moderately anti-inflammatory | inhibit PGE2 and NO production in cells
CMNPD19240	inhibit human Ras-converting enzyme (hRCE protease)
CMNPD19242	inhibit human Ras-converting enzyme (hRCE protease)
CMNPD19243	inhibit human Ras-converting enzyme (hRCE protease)
CMNPD19247	weakly cytotoxic
CMNPD19249	cytotoxic
CMNPD19262	cytotoxic | cause apoptosis
CMNPD19263	cytotoxic | cause apoptosis
CMNPD19264	weakly antimicrobial and antifeedants to mesograzers
CMNPD19265	weakly antimicrobial and antifeedants to mesograzers
CMNPD19266	weakly antimicrobial and antifeedants to mesograzers
CMNPD19267	weakly antimicrobial and antifeedants to mesograzers
CMNPD19268	weakly antimicrobial and antifeedants to mesograzers
CMNPD19269	reverse efflux pump-mediated fluconazole resistance in the yeasts S. cerevisiae and C. albicans but had no antimicrobial activity
CMNPD19270	reverse efflux pump-mediated fluconazole resistance in the yeasts S. cerevisiae and C. albicans but had no antimicrobial activity
CMNPD19283	inhibit protein kinase C ζ (PKCζ)
CMNPD19284	inhibit protein kinase C ζ (PKCζ)
CMNPD19285	inhibit protein kinase C ζ (PKCζ)
CMNPD19298	inhibit tube-formation in a human endothelial cell line model of angiogenesis
CMNPD19299	reduce expression of pro-inflammatory inducible nitric oxide synthetase (iNOS) in a murine macrophage cell line
CMNPD19300	mildly toxic to Artemia salina
CMNPD19301	mildly toxic to Artemia salina
CMNPD19302	mildly toxic to Artemia salina
CMNPD19303	mildly toxic to Artemia salina
CMNPD19304	cytotoxic
CMNPD19306	micromolar antimalarial activity towards both chloroquine-sensitive and chloroquine-resistant strains of Plasmodium falciparum
CMNPD19311	antibacterial
CMNPD19314	mildly cytotoxic
CMNPD19315	mildly cytotoxic
CMNPD19316	mildly cytotoxic
CMNPD19336	mildly cytotoxic
CMNPD19342	mildly antimalarial with no significant cytotoxicity
CMNPD19344	modestly antimycobacterial with antineuroinflammatory activities
CMNPD19345	effect on iNOS protein expression
CMNPD19348	effect on iNOS protein expression
CMNPD19349	reduce iNOS and COX-2 protein expression in macrophage cells
CMNPD19362	moderate antimalarial activity
CMNPD19364	activity against a range of marine Gram-positive and -negative bacteria | active in an anti-quorum-sensing bioassay
CMNPD19365	activity against a range of marine Gram-positive and -negative bacteria
CMNPD19366	activity against a range of marine Gram-positive and -negative bacteria | active in an anti-quorum-sensing bioassay
CMNPD19367	weak inhib. iNOS and COX-2 expression
CMNPD19378	mild cytotoxicity
CMNPD19379	mild cytotoxicity
CMNPD19380	mild cytotoxicity
CMNPD19381	mild cytotoxicity
CMNPD19382	mild cytotoxicity
CMNPD19383	mild cytotoxicity
CMNPD19384	mild cytotoxicity
CMNPD19390	mild biological activities
CMNPD19391	mild biological activities
CMNPD19392	mild biological activities
CMNPD19393	mild cytotoxicity
CMNPD19400	moderate cytotoxicity
CMNPD19401	moderate cytotoxicity
CMNPD19402	moderate cytotoxicity
CMNPD19403	moderate cytotoxicity towards the Hep2 cell line
CMNPD19404	moderate cytotoxicity
CMNPD19405	moderate cytotoxicity
CMNPD19406	moderate cytotoxicity
CMNPD19407	moderate cytotoxicity
CMNPD19408	moderate cytotoxicity
CMNPD19409	moderate cytotoxicity
CMNPD19416	potent inhibitor of iNOS expression in stimulated macrophage cells
CMNPD19417	potent inhibitor of iNOS expression in stimulated macrophage cells
CMNPD19418	potent inhibitor of iNOS expression in stimulated macrophage cells
CMNPD19419	moderate levels of cytotoxicity towards a glioma cell line
CMNPD19420	moderate levels of cytotoxicity towards a glioma cell line
CMNPD19421	moderate levels of cytotoxicity towards a glioma cell line
CMNPD19441	potent antifouling activity (Balanus amphitrite)
CMNPD19454	modest inhibitor of elastase release from human neutrophils
CMNPD19455	modest inhibitor of elastase release from human neutrophils
CMNPD19456	modest inhibitor of elastase release from human neutrophils
CMNPD19457	modest inhibitor of elastase release from human neutrophils
CMNPD19458	modest inhibitor of elastase release from human neutrophils
CMNPD19459	modest inhibitor of elastase release from human neutrophils
CMNPD19460	generally inhibit elastase release and superoxide production by human neutrophils
CMNPD19461	generally inhibit elastase release and superoxide production by human neutrophils
CMNPD19462	generally inhibit elastase release and superoxide production by human neutrophils
CMNPD19463	generally inhibit elastase release and superoxide production by human neutrophils
CMNPD19464	generally inhibit elastase release and superoxide production by human neutrophils
CMNPD19465	generally inhibit elastase release and superoxide production by human neutrophils
CMNPD19466	moderate levels of in vitro cytotoxicity towards human prostate and breast adenocarcinoma cell lines
CMNPD19467	moderate levels of in vitro cytotoxicity towards human prostate and breast adenocarcinoma cell lines
CMNPD19468	moderate levels of in vitro cytotoxicity towards human prostate and breast adenocarcinoma cell lines
CMNPD19469	moderate levels of in vitro cytotoxicity towards human prostate and breast adenocarcinoma cell lines
CMNPD19470	moderate levels of in vitro cytotoxicity towards human prostate and breast adenocarcinoma cell lines
CMNPD19471	moderate levels of in vitro cytotoxicity towards human prostate and breast adenocarcinoma cell lines
CMNPD19472	moderate levels of in vitro cytotoxicity towards human prostate and breast adenocarcinoma cell lines
CMNPD19473	moderate levels of in vitro cytotoxicity towards human prostate and breast adenocarcinoma cell lines
CMNPD19474	moderate levels of in vitro cytotoxicity towards human prostate and breast adenocarcinoma cell lines
CMNPD19475	moderate levels of in vitro cytotoxicity towards human prostate and breast adenocarcinoma cell lines
CMNPD19482	reduce the expression of iNOS and COX-2 proteins in LPS-stimulated murine macrophages
CMNPD19486	reduce the levels of expression of iNOS and COX-2 proteins in stimulated murine macrophages
CMNPD19487	reduce the levels of expression of iNOS and COX-2 proteins in stimulated murine macrophages
CMNPD19489	reduce the levels of expression of iNOS and COX-2 proteins in stimulated murine macrophages
CMNPD19490	reduce the levels of expression of iNOS and COX-2 proteins in stimulated murine macrophages
CMNPD19499	micromolar-active in the Microtox assay
CMNPD19502	broad-spectrum antimicrobial activity
CMNPD19505	broad-spectrum antimicrobial activity
CMNPD19508	broad-spectrum antimicrobial activity
CMNPD19513	moderate inhibition of P388 murine leukaemia cells | growth inhibition of B. subtilis, C. albicans and T. mentagrophytes
CMNPD19527	moderate antimicrobial activity | potent inhibitor of PLA2
CMNPD19528	moderate antimicrobial activity | potent inhibitor of PLA2
CMNPD19529	potent in vitro antifungal activity
CMNPD19530	potent in vitro antifungal activity
CMNPD19544	mildly cytotoxic
CMNPD19545	mildly cytotoxic
CMNPD19546	mildly cytotoxic
CMNPD19547	mildly cytotoxic
CMNPD19548	mildly cytotoxic
CMNPD19549	mildly cytotoxic
CMNPD19550	mildly cytotoxic
CMNPD19551	mild cytotoxicity towards a panel of human tumour cell lines
CMNPD19552	mild cytotoxicity towards a panel of human tumour cell lines
CMNPD19553	mild cytotoxicity towards a panel of human tumour cell lines
CMNPD19554	mild cytotoxicity towards a panel of human tumour cell lines
CMNPD19555	mild cytotoxicity towards a panel of human tumour cell lines
CMNPD19556	mild cytotoxicity towards a panel of human tumour cell lines
CMNPD19557	anti-inflammatory | antiproliferative
CMNPD19558	anti-inflammatory | antiproliferative
CMNPD19568	modest toxicity to brine shrimp
CMNPD19569	modest toxicity to brine shrimp
CMNPD19573	cytotoxic
CMNPD19574	cytotoxic
CMNPD19575	cytotoxic
CMNPD19576	cytotoxic
CMNPD19577	cytotoxic
CMNPD19578	cytotoxic
CMNPD19582	inhibitor of C. albicans growth
CMNPD19584	potently cytotoxic (A2780, IC50 0.34 μM)
CMNPD19585	mildly cytotoxic
CMNPD19586	mildly cytotoxic
CMNPD19595	increase reactive oxygen species formation by mouse macrophages
CMNPD19596	increase reactive oxygen species formation by mouse macrophages
CMNPD19607	mildly cytotoxic towards a panel of three human tumour cell lines | promote tubulin polymerisation
CMNPD19612	less potent cytotoxins
CMNPD19613	less potent cytotoxins
CMNPD19618	broad-spectrum antifungal activity
CMNPD19623	moderate antifungal activities
CMNPD19624	moderate antifungal activities
CMNPD19647	potent activity against methicillin-resistant Staphylococcus aureus (MRSA) | moderate activity against HCT-116 cells
CMNPD19651	modest radical scavenging activity
CMNPD19654	antibacterial
CMNPD19655	a variety of activities against human tumour cell lines
CMNPD19656	activity against K562 (human chronic myelogenous leukaemia) cells
CMNPD19657	activity against K562 (human chronic myelogenous leukaemia) cells
CMNPD19658	activity against K562 (human chronic myelogenous leukaemia) cells
CMNPD19659	activity against K562 (human chronic myelogenous leukaemia) cells
CMNPD19660	activity against K562 (human chronic myelogenous leukaemia) cells
CMNPD19661	activity against K562 (human chronic myelogenous leukaemia) cells
CMNPD19662	activity against K562 (human chronic myelogenous leukaemia) cells
CMNPD19663	inhibitor of the TNF-α-induced transcription factor NFκB and induced quinone reductase activity
CMNPD19664	inhibit NFκB to a lesser extent and had no effect on quinone reductase activity
CMNPD19665	active against a range of Gram-positive bacteria including vancomycin resistant strains
CMNPD19672	activity against MRSA
CMNPD19673	activity against MRSA
CMNPD19674	active against human lymphoblastoid namalva cells
CMNPD19677	potent inhibition of HCT-116 cells | weak activity against MRSA
CMNPD19683	potent activity against HCT-116 cells, drug-resistant Staphylococci and other Gram-positive pathogens | activity against Mycobacterium bacille
CMNPD19688	induce reporter gene expression under the control of the insulin-degrading enzyme (IDE) promoter
CMNPD19693	DPPH activity
CMNPD19694	DPPH activity
CMNPD19695	active against HeLa and human malignant pleural mesothelioma (MPM) ACC-MESO-1 cells
CMNPD19696	cytotoxicity to the HeLa and HL-60 cells
CMNPD19698	toxicity to HeLa cells
CMNPD19699	activity against several human cancer cell lines | inhibit growth of a number of bacteria including antibiotic-resistant strains
CMNPD19700	inhibitor of murine carcinoma colon 26-L5 cell invasion (metastasis inhibitor)
CMNPD19703	pronounced, reversible and non-cytotoxic effect on mammalian cell morphology
CMNPD19704	display binding to a series of human receptors | selective binding to the human serotonin 5-HT2B receptor
CMNPD19705	display binding to a series of human receptors | selective binding to the human serotonin 5-HT3B receptor
CMNPD19706	display binding to a series of human receptors | selective binding to the human serotonin 5-HT4B receptor
CMNPD19707	display binding to a series of human receptors | selective binding to the human serotonin 5-HT5B receptor
CMNPD19708	display binding to a series of human receptors | selective binding to the human serotonin 5-HT6B receptor
CMNPD19710	active against Gram-positive bacteria
CMNPD19711	active against Gram-positive bacteria
CMNPD19712	active against Gram-positive bacteria
CMNPD19713	cytotoxic to HCT-116 cells
CMNPD19714	cytotoxic to HCT-116 cells
CMNPD19716	cytotoxic to HCT-116 cells
CMNPD19718	inhibitor of binding of dihydroxytestosterone (DHT) to the androgen receptor
CMNPD19739	activity in a panel of cytotoxicity assays | selective anti-HIV activity | specifically blocking the R5 strain but having no effect on the X4 tropic HIV-1 strain
CMNPD19740	activity in a panel of cytotoxicity assays
CMNPD19744	inhibitor of P388 and HL-60 cells
CMNPD19745	inhibitor of P388 and HL-60 cells
CMNPD19749	anti-inflammatory activity (via inhibition of NF-κB luciferase and nitrite production)
CMNPD19755	activity against E. coli
CMNPD19757	cytotoxic to several human tumour cells, especially SK-MEL-2 (skin), XF498 (CNS) and HCT15 (colon)
CMNPD19758	weak cytostatic and membranolytic activities in embryos of the sea urchin Strongylocentrotus nudus
CMNPD19766	strong radical scavenger as measured by the protective effect against L-glutamate toxicity
CMNPD19767	strong radical scavenger as measured by the protective effect against L-glutamate toxicity
CMNPD19776	fat-accumulation inhibitory activity against 3T3-L1 murine adipocytes
CMNPD19779	activity against A-549 cells
CMNPD19780	activity against A-549 cells
CMNPD19784	active against P388 and HL-60 cells
CMNPD19787	inhibitor of the protein Mcl-1 (a cancer drug target implicated in apoptosis) | significantly cytotoxic against HCT-116 cells
CMNPD19788	inhibit growth of B. subtilis, Microbotryum violaceum, Septoria tritici and Chlorella fusca
CMNPD19789	inhibit growth of B. subtilis, Microbotryum violaceum, Septoria tritici and Chlorella fusca
CMNPD19799	inhibitor of P388 cells
CMNPD19800	inhibitor of P388 cells
CMNPD19801	inhibitor of P388 cells | inhibit other human tumour cell lines
CMNPD19802	inhibitor of P388 cells | inhibit other human tumour cell lines
CMNPD19803	inhibitor of tyrosine kinase and of human umbilical vein endothelial cell (HUVEC) proliferation, migration and tubule formation
CMNPD19804	inhibitor of tyrosine kinase and of human umbilical vein endothelial cell (HUVEC) proliferation, migration and tubule formation
CMNPD19806	cytotoxic to a number of human tumour cell lines | particularly prostate PC3M and bladder BXF 1218 L cells
CMNPD19809	radical-scavenging activities against DPPH
CMNPD19810	radical-scavenging activities against DPPH
CMNPD19814	inhibitor of L-glutamate toxicity in neuronal hybridoma N18-RE-105 cells
CMNPD19820	activity to HeLa and SW620 cells
CMNPD19830	inhibitor of the enzyme human leukocyte elastase (HLE)
CMNPD19834	radical scavenging activity against DPPH
CMNPD19835	radical scavenging activity against DPPH
CMNPD19838	cytotoxicity against P388, HL-60, and BEL-7420 cells
CMNPD19842	cytotoxic against a panel of six cancer cell lines but had little effect on the normal human lung fibroblastHLF cells
CMNPD19848	anti-mycobacterial activity against Mycobacterium smegmatis, M. bovisBCG and M. tuberculosisH37Rv under aerobic and dormancy-inducing hypoxic growth conditions
CMNPD19849	anti-mycobacterial activity against Mycobacterium smegmatis, M. bovisBCG and M. tuberculosisH38Rv under aerobic and dormancy-inducing hypoxic growth conditions
CMNPD19850	anti-mycobacterial activity against Mycobacterium smegmatis, M. bovisBCG and M. tuberculosisH39Rv under aerobic and dormancy-inducing hypoxic growth conditions
CMNPD19851	cytotoxic to HeLa and ACC-MESO-1 cells
CMNPD19852	cytotoxic to HeLa and ACC-MESO-1 cells
CMNPD19853	cytotoxic to HeLa and ACC-MESO-1 cells
CMNPD19863	inhibitor of Hep-2 and HepG2 cells
CMNPD19865	inhibitor of several human tumour cell lines | inhibit breast cancer xenograft growth in mice
CMNPD19866	cytotoxic against HepG2 cells
CMNPD19869	cytotoxic to HL-60 cells
CMNPD19870	inhibit proliferation of both A549 and HL-60 cells
CMNPD19873	cytotoxic towards 95-D and HepG2 cells | insecticidal activity against Aphis gossypii
CMNPD19882	promote angiogenesis
CMNPD19884	inhibit angiogenesis
CMNPD19886	antimicrobial to a range of organisms | moderately cytotoxic to KB and KBv200 cells
CMNPD19887	antimicrobial to a range of organisms | moderately cytotoxic to KB and KBv200 cells
CMNPD19888	inhibitor of multi-drug resistant human oral floor carcinoma (KV/MDR) cells
CMNPD19889	inhibitor of multi-drug resistant human oral floor carcinoma (KV/MDR) cells
CMNPD19894	protease-inhibitory activity against both elastase and chymotrypsin at levels
CMNPD19896	MRSA activity | brine shrimp toxicity
CMNPD19899	sodium channel blocker in neuro-2a cells without appreciable cytotoxicity
CMNPD19907	high potency to H-460 cells | solid tumour selectivity for HCT-116 and H125 cells
CMNPD19908	high potency to H-460 cells | solid tumour selectivity for HCT-116 and H125 cells
CMNPD19909	cytotoxic to HT29 and HeLa cells
CMNPD19910	cytotoxic to HT29 and HeLa cells
CMNPD19911	serine protease inhibitor
CMNPD19915	significant antimalarial activity against Plasmodium falciparum | potent cytotoxicity to P388 cells | moderate antiswarming activities against Pseudomonas aeruginosa
CMNPD19916	significant antimalarial activity against Plasmodium falciparum | potent cytotoxicity to P389 cells | moderate antiswarming activities against Pseudomonas aeruginosa
CMNPD19917	antileishmanial activity
CMNPD19918	antileishmanial activity
CMNPD19919	moderate in vitroantimalarial activity against chloroquine-resistant Plasmodium falciparum (W2) | toxic to H-460 human lung cells at similar levels
CMNPD19923	in vitro activity against Leishmania donovani
CMNPD19924	in vitro activity against Leishmania donovani
CMNPD19925	sodium channel blocking activity in neuro-2a cells | modest cytotoxicity to H-460 cells
CMNPD19937	significant inhibitor of expression in HUVEC models
CMNPD19938	haemolytic activity
CMNPD19939	haemolytic activity
CMNPD19940	haemolytic activity
CMNPD19941	haemolytic activity
CMNPD19942	haemolytic activity
CMNPD19944	cytotoxic to P388, L1210 and KB cells
CMNPD19946	compete with a brevetoxin-3 binding site on rat brain synaptosomes but without the accompanying toxicity associated with brevetoxins
CMNPD19947	compete with a brevetoxin-3 binding site on rat brain synaptosomes but without the accompanying toxicity associated with brevetoxins
CMNPD19963	radical scavenger
CMNPD19973	cancer chemoprevention
CMNPD19974	cancer chemoprevention
CMNPD19979	moderate cytotoxicity, but with no selectivity
CMNPD19982	moderate cytotoxicity, but with no selectivity
CMNPD19985	weak activity on NO production
CMNPD19986	weak activity on NO production
CMNPD19987	weak activity on NO production
CMNPD19988	weak activity on NO production
CMNPD19990	inhibitthe growth of the marine algal bacterial pathogen Pseudoalteromonas bacteriolytica at ecologically realistic concentrations
CMNPD19991	inhibitthe growth of the marine algal bacterial pathogen Pseudoalteromonas bacteriolytica at ecologically realistic concentrations
CMNPD19992	modest but non-selective cytotoxicity
CMNPD19993	modest but non-selective cytotoxicity
CMNPD19995	modest but non-selective cytotoxicity
CMNPD20005	modest activity against MDRSA and MRSA
CMNPD20006	modest activity against MDRSA and MRSA
CMNPD20007	modest activity against MDRSA and MRSA
CMNPD20008	modest activity against MDRSA and MRSA
CMNPD20009	weak activity against a range of six human tumour cell lines
CMNPD20010	weak activity against a range of six human tumour cell lines
CMNPD20011	weak activity against a range of six human tumour cell lines
CMNPD20012	modest activity against a range of clinically relevant bacteria
CMNPD20013	modest activity against a range of human cancer cell lines
CMNPD20014	modest activity against a range of human cancer cell lines | moderate activity against Plasmodium falciparum
CMNPD20015	modest activity against a range of human cancer cell lines
CMNPD20016	modest activity against a range of human cancer cell lines
CMNPD20017	little activity against breast cancer cell lines
CMNPD20019	little activity against breast cancer cell lines
CMNPD20020	little activity against breast cancer cell lines
CMNPD20025	moderate activity against MRSA and vancomycin-resistant Enterococcus faecium, and against 11 human cancer cell lines
CMNPD20026	moderate activity against MRSA and vancomycin-resistant Enterococcus faecium, and against 11 human cancer cell lines
CMNPD20028	modest activity against protein tyrosine phosphatase 1B
CMNPD20032	modest activity against protein tyrosine phosphatase 1B
CMNPD20035	potent inhibitor of LPS-induced nitric oxide production
CMNPD20046	inhibit lipid droplet formation at 10 μM yet not cytotoxic at similar concentrations
CMNPD20049	inhibit lipid droplet formation at 10 μM yet not cytotoxic at similar concentrations
CMNPD20052	cytotoxic
CMNPD20053	cytotoxic
CMNPD20054	cytotoxic
CMNPD20059	antifungal
CMNPD20060	antifungal
CMNPD20073	antifungal
CMNPD20074	antifungal
CMNPD20075	potent (nM) inhibitors of Trypanosoma brucei brucei
CMNPD20076	potent (nM) inhibitors of Trypanosoma brucei brucei
CMNPD20081	moderate inhibitor of the BACE1 aspartic protease
CMNPD20082	moderate inhibitor of the BACE1 aspartic protease
CMNPD20083	moderate inhibitor of the BACE1 aspartic protease
CMNPD20084	moderate inhibitor of the BACE1 aspartic protease
CMNPD20085	moderate inhibitor of the BACE1 aspartic protease
CMNPD20086	moderate inhibitor of the BACE1 aspartic protease
CMNPD20087	moderate inhibitor of the BACE1 aspartic protease
CMNPD20088	moderate inhibitor of the BACE1 aspartic protease
CMNPD20094	moderately potent against HCT-116 cells
CMNPD20095	moderately potent against HCT-116 cells
CMNPD20115	inactive vs M. tuberculosis and 2 HTCL
CMNPD20118	moderate inhibitor of cellular HIV-1 entry
CMNPD20120	moderate inhibitor of cellular HIV-1 entry
CMNPD20124	cytotoxic
CMNPD20125	cytotoxic
CMNPD20126	significant cytotoxicity in the NCI-60 cell line screen (mean GI50 of 1.7 μM)
CMNPD20150	active against Mycobacterium tuberculosis and Plasmodium falciparum without significant cytotoxicity against VERO cells
CMNPD20154	inhibit BACE1 in a dose dependent manner
CMNPD20159	active against two strains of Plasmodium falciparum but non-toxic to HEK293 cells
CMNPD20160	selectively antiproliferative against 13 cell lines
CMNPD20163	apoptotic
CMNPD20164	apoptotic
CMNPD20165	apoptotic
CMNPD20176	inhibit sortase A, an enzyme pivotal for bacterial adhesion
CMNPD20177	inhibit sortase A, an enzyme pivotal for bacterial adhesion
CMNPD20183	apoptotic
CMNPD20202	toxic to brine shrimp
CMNPD20203	anti-HIV active
CMNPD20204	anti-HIV active
CMNPD20205	anti-HIV active
CMNPD20206	anti-HIV active
CMNPD20207	anti-HIV active
CMNPD20208	anti-HIV active
CMNPD20209	anti-HIV active
CMNPD20210	anti-HIV active
CMNPD20211	anti-HIV active
CMNPD20212	anti-HIV active
CMNPD20213	anti-HIV active
CMNPD20214	anti-HIV active
CMNPD20215	anti-HIV active
CMNPD20216	anti-HIV active
CMNPD20221	antimalarial
CMNPD20231	potent and selective δ-opioid receptor binder
CMNPD20260	antimalarial
CMNPD20277	inhibit settling | toxic to the larvae of the model fouling organism Balanus improvises
CMNPD20278	inhibit settling | toxic to the larvae of the model fouling organism Balanus improvises
CMNPD20283	isoform-selective glycine-gated chloride channel receptor modulators | have potential roles as neuronal pharmacological agents
CMNPD20284	isoform-selective glycine-gated chloride channel receptor modulators | have potential roles as neuronal pharmacological agents
CMNPD20285	isoform-selective glycine-gated chloride channel receptor modulators | have potential roles as neuronal pharmacological agents
CMNPD20286	isoform-selective glycine-gated chloride channel receptor modulators | have potential roles as neuronal pharmacological agents
CMNPD20287	isoform-selective glycine-gated chloride channel receptor modulators | have potential roles as neuronal pharmacological agents
CMNPD20288	isoform-selective glycine-gated chloride channel receptor modulators | have potential roles as neuronal pharmacological agents
CMNPD20294	anti-inflammatory
CMNPD20295	moderate inhibitor of Plasmodium falciparum
CMNPD20296	moderate inhibitor of Plasmodium falciparum
CMNPD20297	moderate inhibitor of Plasmodium falciparum
CMNPD20298	moderate inhibitor of Plasmodium falciparum
CMNPD20305	nonspecific inhibitor of BACE1
CMNPD20314	antiprotozoal activity
CMNPD20315	antiprotozoal activity
CMNPD20316	antiprotozoal activity
CMNPD20318	antiprotozoal activity
CMNPD20319	antiprotozoal activity
CMNPD20320	antiprotozoal activity
CMNPD20321	antiprotozoal activity
CMNPD20322	antiprotozoal activity
CMNPD20323	antiprotozoal activity
CMNPD20324	antiprotozoal activity
CMNPD20325	antiprotozoal activity
CMNPD20326	activity versus four cancer cell lines
CMNPD20327	activity versus four cancer cell lines
CMNPD20329	neuroprotective effects in a human dopaminergic neuron assay model of Parkinson's disease
CMNPD20333	antibacterial
CMNPD20341	cytotoxicity
CMNPD20342	cytotoxicity
CMNPD20347	inhibit the up-regulation of pro-inflammatory iNOS protein in macrophages
CMNPD20353	enhance iNOS expression in stimulated macrophages
CMNPD20354	cytotoxicity towards a panel of tumour cell lines
CMNPD20355	cytotoxicity towards a panel of tumour cell lines
CMNPD20356	cytotoxicity towards a panel of tumour cell lines
CMNPD20357	cytotoxicity towards a panel of tumour cell lines
CMNPD20367	cytotoxic
CMNPD20377	antiviral activity towards human cytomegalovirus and to suppress COX-2 protein expression in macrophages
CMNPD20378	antiviral activity towards human cytomegalovirus and to suppress COX-2 protein expression in macrophages
CMNPD20382	weak cytotoxicity | inhibit iNOS protein expression
CMNPD20383	weak cytotoxicity | inhibit iNOS protein expression
CMNPD20384	antiviral activity
CMNPD20386	cytotoxicity towards two tumour cell lines
CMNPD20387	active and selective tumour cell line growth inhibitor
CMNPD20397	potent (IC50 9.4 μM) of the series as a growth inhibitor of Plasmodium falciparum
CMNPD20399	cytotoxic
CMNPD20400	cytotoxic
CMNPD20401	cytotoxic | inhibit the expression of iNOS in macrophages
CMNPD20402	cytotoxic | inhibit the expression of iNOS in macrophages
CMNPD20403	cytotoxic | inhibit the expression of iNOS in macrophages
CMNPD20404	cytotoxic | inhibit the expression of iNOS in macrophages
CMNPD20405	cytotoxic | inhibit the expression of iNOS in macrophages
CMNPD20406	inhibit acetylcholinesterase in a TLC bioautographic test
CMNPD20407	antiviral
CMNPD20408	antiviral
CMNPD20409	antiviral
CMNPD20410	antiviral
CMNPD20411	antiviral
CMNPD20412	antiviral
CMNPD20417	inhibitor of iNOS protein expression in macrophages
CMNPD20432	nitric oxide production inhibitor | cytotoxicity
CMNPD20433	nitric oxide production inhibitor
CMNPD20434	nitric oxide production inhibitor
CMNPD20435	nitric oxide production inhibitor
CMNPD20440	brine shrimp toxicity
CMNPD20442	anti-inflammatory and neuroprotective properties
CMNPD20463	cytotoxic | anti-inflammatory
CMNPD20464	cytotoxic | anti-inflammatory
CMNPD20465	cytotoxic | anti-inflammatory
CMNPD20466	cytotoxic | anti-inflammatory
CMNPD20467	cytotoxic | anti-inflammatory
CMNPD20468	cytotoxic | anti-inflammatory
CMNPD20469	cytotoxic | anti-inflammatory
CMNPD20470	cytotoxic | anti-inflammatory
CMNPD20471	potent cytotoxicity | inhibition of both superoxide and elastase
CMNPD20472	potent cytotoxicity | inhibition of both superoxide and elastase
CMNPD20473	inhibit the expression of iNOS protein expression in macrophages
CMNPD20474	inhibit the expression of iNOS protein expression in macrophages
CMNPD20475	inhibit the expression of iNOS protein expression in macrophages | inhibit the expression of COX-2
CMNPD20476	potent activity in an in vitro model of cancer cell migration and invasion
CMNPD20481	activate the inositol 5-phosphatase enzyme SHIP1
CMNPD20486	Gemmacolide H
CMNPD20514	modest toxicity in the brine shrimp assay
CMNPD20517	cytotoxic | anti-inflammatory
CMNPD20523	cytotoxic
CMNPD20538	low micromolar cytotoxicity towards human tumour cell lines
CMNPD20539	low micromolar cytotoxicity towards human tumour cell lines
CMNPD20548	cytotoxic (L1210)
CMNPD20549	cytotoxic (L1210)
CMNPD20551	inhibitethe growth of Trypanosoma brucei brucei (IC50 30–77 nM)
CMNPD20552	antimicrobial
CMNPD20553	antimicrobial
CMNPD20554	cytotoxic
CMNPD20578	biological activity towards a number of tumour cell lines, microorganisms and HDAC-1
CMNPD20579	biological activity towards a number of tumour cell lines, microorganisms and HDAC-1
CMNPD20581	inactive in an urchin embryo sperm-test and embryo development assay
CMNPD20582	inactive in an urchin embryo sperm-test and embryo development assay
CMNPD20583	inactive in an urchin embryo sperm-test and embryo development assay
CMNPD20584	inactive in an urchin embryo sperm-test and embryo development assay
CMNPD20585	inactive in an urchin embryo sperm-test and embryo development assay
CMNPD20592	cytotoxicity towards human tumour cell lines
CMNPD20594	cytotoxicity towards human tumour cell lines
CMNPD20595	cytotoxicity towards human tumour cell lines
CMNPD20596	cytotoxicity towards human tumour cell lines
CMNPD20597	cytotoxicity towards human tumour cell lines
CMNPD20598	cytotoxicity towards human tumour cell lines
CMNPD20599	cytotoxicity
CMNPD20600	cytotoxicity | induce p53- and AP-1-dependent transcription
CMNPD20604	moderate cytotoxicity towards a panel of human tumour cell lines
CMNPD20605	cytotoxic
CMNPD20606	cytotoxic
CMNPD20607	cytotoxic
CMNPD20610	cytotoxic
CMNPD20611	cytotoxic
CMNPD20615	significant antioxidant activity | moderate inhibitor of human kinases FLT3 and SAK
CMNPD20618	inhibit TNF-α production, interleukin-6 release, NF-κB activation and regulation of the activator protein-1 signaling pathway
CMNPD20622	inhibit TNF-α production, interleukin-6 release, NF-κB activation and regulation of the activator protein-1 signaling pathway
CMNPD20624	inhibit TNF-α production, interleukin-6 release, NF-κB activation and regulation of the activator protein-1 signaling pathway
CMNPD20630	cytotoxic
CMNPD20632	moderate antifeedant activity towards Brontispa longissima, an insect pest of coconut palms
CMNPD20633	moderate antifeedant activity towards Brontispa longissima, an insect pest of coconut palms
CMNPD20636	moderate antifeedant activity towards Brontispa longissima, an insect pest of coconut palms
CMNPD20637	cytotoxic
CMNPD20656	modest antifeedant but poor insecticidal activities towards the coconut pest Brontispa longissima
CMNPD20659	modest antifeedant but poor insecticidal activities towards the coconut pest Brontispa longissima
CMNPD20668	in vitro cytotoxicity towards B16 melanoma cells
CMNPD20669	cytotoxic to four human tumour cell lines (HTCLs)
CMNPD20670	cytotoxic to four human tumour cell lines (HTCLs)
CMNPD20671	cytotoxic to four human tumour cell lines (HTCLs)
CMNPD20672	cytotoxic to four human tumour cell lines (HTCLs)
CMNPD20673	cytotoxic to four human tumour cell lines (HTCLs)
CMNPD20675	cytotoxic to three HTCLs
CMNPD20676	cytotoxic to three HTCLs | multidrug resistance (MDR) reversing activity in MDR cell lines
CMNPD20677	cytotoxic to three HTCLs
CMNPD20679	active against NF-κB and glucocorticoid receptors
CMNPD20680	activity against Candida albicans (C. albicans)
CMNPD20681	activity against Candida albicans (C. albicans)
CMNPD20682	activity against Candida albicans (C. albicans)
CMNPD20683	antibacterial
CMNPD20684	antibacterial
CMNPD20685	antibacterial
CMNPD20686	inhibitor of Aspergillus niger (A. niger)
CMNPD20688	broad spectrum antimicrobial activity
CMNPD20689	broad spectrum antimicrobial activity
CMNPD20690	broad spectrum antimicrobial activity
CMNPD20691	broad spectrum antimicrobial activity
CMNPD20693	activate the inositol 5-phosphatase SHIP1
CMNPD20694	activity against both Gram-positive and Gram-negative bacteria
CMNPD20695	active against Plasmodium falciparum (P. falciparum) lines 3D7 and Dd2
CMNPD20696	active against Plasmodium falciparum (P. falciparum) lines 3D7 and Dd2
CMNPD20697	active against Plasmodium falciparum (P. falciparum) lines 3D7 and Dd2
CMNPD20698	active against Plasmodium falciparum (P. falciparum) lines 3D7 and Dd2
CMNPD20699	active against Plasmodium falciparum (P. falciparum) lines 3D7 and Dd2
CMNPD20700	active against Plasmodium falciparum (P. falciparum) lines 3D7 and Dd2
CMNPD20701	cytotoxic to some HTCLs
CMNPD20702	cytotoxic to some HTCLs | inhibitor of topoisomerase II
CMNPD20703	antiproliferative against several tumour cell lines
CMNPD20705	activity against Bacillus subtilis (B. subtilis)
CMNPD20706	activity against Bacillus subtilis (B. subtilis)
CMNPD20707	activity against Bacillus subtilis (B. subtilis)
CMNPD20714	noncytotoxic MDR reversing agent
CMNPD20716	interfere with the agr quorum sensing system that controls virulence gene expression in Staphylococcus aureus (S. aureus)
CMNPD20717	interfere with the agr quorum sensing system that controls virulence gene expression in Staphylococcus aureus (S. aureus)
CMNPD20718	inhibitor of S. aureus, Enterococcus faecalis (E. faecalis) and Bacillus thuringensis
CMNPD20719	cytotoxin to three HTCLs, inhibitor of S. aureus, Enterococcus faecalis (E. faecalis) and Bacillus thuringensis
CMNPD20720	cytotoxin to three HTCLs, inhibitor of S. aureus, Enterococcus faecalis (E. faecalis) and Bacillus thuringensis
CMNPD20721	20S proteasome (chymotrypsin-like) inhibition
CMNPD20722	cytotoxicity against three HTCLs
CMNPD20723	sub-nanomolar active as an inhibitor of mitogenic signalling
CMNPD20725	cytotoxicity against three HTCLs
CMNPD20726	activity against C. albicans
CMNPD20727	activity against C. albicans
CMNPD20728	active against Trypanosoma brucei
CMNPD20729	active against Trypanosoma brucei | active against Leishmania
CMNPD20730	active against Trypanosoma brucei
CMNPD20731	active against Trypanosoma brucei
CMNPD20732	selective inhibitor of HTCLs
CMNPD20733	selective inhibitor of HTCLs
CMNPD20736	potent and long-acting antagonists of mouse and human transient receptor potential vanilloid-1 (TRPV1) channels (pain and inflammation mediators)
CMNPD20743	inhibitor in the biosynthesis of sulfur-containing amino acids
CMNPD20746	cytotoxic to Jurkat T lymphocyte cells
CMNPD20747	iron chelating activity
CMNPD20748	iron chelating activity
CMNPD20750	activity against three methicillin-resistant S. aureus (MRSA) strains
CMNPD20751	activity against three methicillin-resistant S. aureus (MRSA) strains
CMNPD20752	activity against three methicillin-resistant S. aureus (MRSA) strains
CMNPD20754	inhibitor of glycogen synthase kinase 3β, antiproliferative activity against mouse fibroblast cells
CMNPD20755	active against the fungus Mucor miehei | cytotoxicity towards a number of HTCLs
CMNPD20763	cytotoxic to the HL-60 cell line
CMNPD20764	cytotoxic to the HL-60 cell line
CMNPD20765	inhibitory of HeLa cell growth | selective inhibitor of serotonin uptake (5-HT2B)
CMNPD20766	inhibitory of HeLa cell growth | selective inhibitor of serotonin uptake (5-HT2B)
CMNPD20767	inhibitory of HeLa cell growth | selective inhibitor of serotonin uptake (5-HT2B)
CMNPD20768	cytotoxic to the A549 cell line
CMNPD20769	cytotoxic (A549)
CMNPD20772	cytotoxic (A549)
CMNPD20773	cytotoxic (A549)
CMNPD20779	cytotoxic to three HTCLs
CMNPD20780	moderate activity against C. albicans and the HCT-116 cell line
CMNPD20781	moderate activity against C. albicans and the HCT-116 cell line
CMNPD20782	activity against several bacteria, including MRSA and vancomycin-resistant E. faecalis (VREF)
CMNPD20783	activity against several bacteria, including MRSA and vancomycin-resistant E. faecalis (VREF)
CMNPD20784	activity against several bacteria, including MRSA and vancomycin-resistant E. faecalis (VREF)
CMNPD20785	cytotoxic | antibacterial
CMNPD20786	cytotoxic | antibacterial
CMNPD20787	cytotoxic | antibacterial
CMNPD20788	cytotoxic | antibacterial
CMNPD20795	antioxidant activity in a DPPH radical-scavenging assay | inhibit hydrogen peroxide-induced death of human keratinocyte HaCaT cells
CMNPD20796	antiproliferative against four HTCLs
CMNPD20797	antiproliferative against four HTCLs
CMNPD20798	antiproliferative against four HTCLs
CMNPD20799	antiproliferative against four HTCLs
CMNPD20800	antiproliferative against four HTCLs
CMNPD20804	antiangiogenic activity
CMNPD20809	inhibitor of S. aureus, MRSA, and methicillin-resistant S. aureus
CMNPD20810	inhibitor of S. aureus, MRSA, and methicillin-resistant S. aureus
CMNPD20815	antifungal (Neurospora crassa)
CMNPD20817	cytotoxic towards MOLT-4 human leukaemia cells
CMNPD20818	cytotoxic towards MOLT-4 human leukaemia cells
CMNPD20825	cytotoxic | induce apoptotic activity against HCT-116
CMNPD20830	cytotoxic to several HTCLs | inhibitor of settlement of the barnacle Balanus amphitrite (B. amphitrite)
CMNPD20837	active against P. aeruginosa and Enterobacter aerogenes (E. aerogenes)
CMNPD20838	active against P. aeruginosa and Enterobacter aerogenes (E. aerogenes)
CMNPD20851	radical scavenger (DPPH)
CMNPD20855	antifungal activity against C. albicans
CMNPD20860	cytotoxic against a panel of HTCLs
CMNPD20861	inhibitory against several cancer cell lines
CMNPD20862	inhibitory against several cancer cell lines
CMNPD20863	inhibitory against several cancer cell lines
CMNPD20864	inhibitory against several cancer cell lines
CMNPD20866	ntifouling activity (B. amphitrite larvae) | growth inhibition of S. aureus, cytotoxic to two HTCLs
CMNPD20867	cytotoxic to two HTCLs
CMNPD20868	cytotoxic to two HTCLs
CMNPD20869	inhibit growth of Mycobacterium phlei (M. phlei)
CMNPD20871	inhibit growth of Mycobacterium phlei (M. phlei)
CMNPD20872	inhibit growth of S. aureus | inhibitor of human leukocyte elastase (HLE)
CMNPD20874	inhibit growth of Mycobacterium phlei (M. phlei)
CMNPD20875	selectively inhibit human leukocyte elastase
CMNPD20876	inhibitor of M. phlei, S. aureus and E. coli | cytotoxic to mouse fibroblast cells
CMNPD20877	selectively inhibit human leukocyte elastase
CMNPD20882	inhibitor of A549 and BEL-7402 cell lines
CMNPD20888	inhibitor of MRSA and multi-drug-resistant Vibrio parahemolyticus
CMNPD20889	inhibitor of MRSA and multi-drug-resistant Vibrio parahemolyticus
CMNPD20891	inhibitory/cytotoxic to HepG2
CMNPD20894	inhibitor of Aspergillus brassicae
CMNPD20897	antifungal | selectively cytotoxic to three HTCLs
CMNPD20899	activity against Xanthomonas campestris and Septoria tritici
CMNPD20900	cytotoxic to HL-60 cells
CMNPD20902	cytotoxic to HL-60 cells
CMNPD20909	growth inhibitor of several bacteria
CMNPD20910	growth inhibitor of several bacteria | cytotoxic to the human pancreatic tumour cell line SW1990
CMNPD20911	growth inhibitor of several bacteria | cytotoxic to the human pancreatic tumour cell line SW1990
CMNPD20912	cytotoxic to the human pancreatic tumour cell line SW1990
CMNPD20914	cytotoxic to the SMMC-7721 cell line
CMNPD20916	inhibitor of tobacco mosaic virus (TMV) and the human gastric cancer cell line SGC-7901
CMNPD20917	cytotoxic to both HL-60 and A549 cells
CMNPD20918	cytotoxic to both HL-60 cells
CMNPD20921	inhibitor of glycogen synthase kinase-3β
CMNPD20922	inhibitor of glycogen synthase kinase-3β
CMNPD20923	inhibitor of glycogen synthase kinase-3β
CMNPD20924	inhibitor of glycogen synthase kinase-3β
CMNPD20925	inhibitor of the pro-inflammatory mediator interleukin-1β in murine macrophage cells
CMNPD20928	cytotoxic to P388 and K562 cell lines
CMNPD20929	cytotoxic to P388 and K562 cell lines
CMNPD20930	cytotoxic to P388 and K562 cell lines
CMNPD20939	active against Plasmodium berghei liver stages | antiproliferative against three HTCLs
CMNPD20940	selective antagonist of the serotonin receptor 5-HT2B
CMNPD20941	antiproliferative against three HTCLs
CMNPD20943	cytotoxic against three HTCLs
CMNPD20944	anti-HSV-1 active
CMNPD20945	cytotoxic against two HTCLs
CMNPD20946	cytotoxic against two HTCLs
CMNPD20949	cytotoxic to several HTCLs
CMNPD20951	cytotoxic to several HTCLs
CMNPD20952	cytotoxic to several HTCLs
CMNPD20957	cytotoxic to several HTCLs
CMNPD20960	activity against cancer cell lines
CMNPD20961	activity against cancer cell lines
CMNPD20962	activity against cancer cell lines
CMNPD20963	activity against cancer cell lines
CMNPD20964	activity against cancer cell lines
CMNPD20965	activity against cancer cell lines
CMNPD20966	activity against cancer cell lines
CMNPD20976	antiviral effects against H1N1
CMNPD20977	antiviral effects against H1N1
CMNPD20986	inhibitor of α-glucosidase
CMNPD20987	inhibitor of α-glucosidase
CMNPD20988	inhibitor of acetylcholinesterase
CMNPD20990	active against E. aerogenes
CMNPD21013	cytotoxic to hepG2 cells
CMNPD21015	cytotoxic to HTCLs
CMNPD21017	cytotoxic to HTCLs
CMNPD21020	antifungal
CMNPD21021	cytotoxic to HeLa and mouse neuro-2a blastoma cells
CMNPD21022	cytotoxic to HeLa and mouse neuro-2a blastoma cells
CMNPD21024	inhibition of the transcription factor AP-1
CMNPD21025	inhibition of the transcription factor AP-2
CMNPD21026	anti-inflammatory activity in lipopolysaccharide (LPS)-induced RAW macrophage cells with only modest cytotoxicity to the cell line
CMNPD21027	suppress cancer cell migration in vitro
CMNPD21029	cytotoxic against two HTCLs | antibacterial against M. tuberculosis and B. cereus
CMNPD21030	weak cytotoxicity against two HTCLs | more active against M. tuberculosis
CMNPD21031	weak cytotoxicity against two HTCLs | more active against M. tuberculosis
CMNPD21032	weak cytotoxicity against two HTCLs | more active against M. tuberculosis
CMNPD21033	weak cytotoxicity against two HTCLs | more active against M. tuberculosis
CMNPD21034	cytotoxic to HTCLs | significant antimalarial activity against P. falciparum | weak antiswarming activity against P. aeruginosa
CMNPD21035	toxic to brine shrimp
CMNPD21036	toxic to brine shrimp | cytotoxic to a mouse neuroblastoma cell line
CMNPD21037	cytotoxic to HCT-116 and osteosarcoma U2OS cells
CMNPD21038	cytotoxic to HCT-116 and osteosarcoma U2OS cells
CMNPD21039	antiproliferative
CMNPD21040	agonist effect and selectivity for the CB1 cannabinoid receptor
CMNPD21042	disruptor of quorum sensing pathways mediated by acylhomoserine lactones (AHLs) in Gram-negative bacteria
CMNPD21043	anti-inflammatory in the RAW264.6 murine microphage cell based assay and inhibitory to calcium oscillations in neocortical neurons
CMNPD21044	molluscicide against the snail Biomphalaria glabrata
CMNPD21045	molluscicide against the snail Biomphalaria glabrata
CMNPD21046	cytotoxic to two HTCLs | inhibitor of the H-460 human lung cancer cell line
CMNPD21047	cytotoxic to two HTCLs
CMNPD21048	cytotoxic to two HTCLs
CMNPD21049	cytotoxic to two HTCLs
CMNPD21050	cytotoxic to two HTCLs
CMNPD21051	cytotoxic to two HTCLs
CMNPD21052	cytotoxic to two HTCLs
CMNPD21053	cytotoxic to two HTCLs
CMNPD21059	cytotoxic to P388 cells | active against the diatom Nitzschia sp.
CMNPD21091	protective against bleomycin-induced DNA damage | cytotoxic against a variety of cell lines
CMNPD21096	active against a range of HTCLs
CMNPD21100	inhibit intracellular radical oxygen species | increase intracellular GSH levels
CMNPD21101	inhibit intracellular radical oxygen species | increase intracellular GSH levels
CMNPD21102	inhibit intracellular radical oxygen species | increase intracellular GSH levels
CMNPD21103	activation effects on peroxisome proliferator-activated receptor gamma (PPARγ)
CMNPD21104	activation effects on peroxisome proliferator-activated receptor gamma (PPARγ)
CMNPD21105	activation effects on peroxisome proliferator-activated receptor gamma (PPARγ)
CMNPD21106	activation effects on peroxisome proliferator-activated receptor gamma (PPARγ)
CMNPD21108	allelopathic effects on the growth of Skeletonema costatum
CMNPD21109	antifungal
CMNPD21125	cytotoxic effects on an esophageal cell line
CMNPD21126	cytotoxic effects on an esophageal cell line
CMNPD21127	NT
CMNPD21128	NT
CMNPD21132	cytotoxic
CMNPD21133	cytotoxic
CMNPD21134	cytotoxic
CMNPD21135	cytotoxic
CMNPD21137	cytotoxic
CMNPD21139	cytotoxic | inhibit expression of the pro-inflammatory proteins iNOS and COX-2 in stimulated macrophages
CMNPD21141	antioxidant
CMNPD21142	antioxidant
CMNPD21143	antioxidant
CMNPD21144	antioxidant
CMNPD21145	antioxidant
CMNPD21146	antioxidant
CMNPD21147	cytoxic
CMNPD21148	anticancer agent
CMNPD21202	AChE inhibitor
CMNPD21213	active against HeLa cells
CMNPD21214	active against HeLa cells
CMNPD21215	active against HeLa cells
CMNPD21216	active against HeLa cells
CMNPD21217	active against HeLa cells
CMNPD21218	active against HeLa cells
CMNPD21219	active against HeLa cells
CMNPD21220	active against HeLa cells
CMNPD21221	active against HeLa cells
CMNPD21222	active against HeLa cells
CMNPD21223	active against HeLa cells
CMNPD21224	active against HeLa cells
CMNPD21226	toxic to sensitised yeast cells
CMNPD21227	toxic to sensitised yeast cells
CMNPD21228	toxic to sensitised yeast cells
CMNPD21229	toxic to sensitised yeast cells
CMNPD21230	toxic to sensitised yeast cells
CMNPD21231	toxic to sensitised yeast cells
CMNPD21232	toxic to sensitised yeast cells
CMNPD21254	anti-inflammatory activity
CMNPD21274	potent (nM) and selective melanoma inhibitor
CMNPD21275	potent (nM) and selective melanoma inhibitor
CMNPD21276	potent (nM) and selective melanoma inhibitor
CMNPD21277	potent (nM) and selective melanoma inhibitor
CMNPD21278	antimitotic
CMNPD21283	antiproliferative against KB cells
CMNPD21301	inducer of erythroid differentiation in human leukaemia cells
CMNPD21302	inducer of erythroid differentiation in human leukaemia cells
CMNPD21303	antibiotics
CMNPD21304	antibiotics
CMNPD21305	antibiotics
CMNPD21306	antibiotics
CMNPD21307	antibiotics
CMNPD21308	antibiotics
CMNPD21316	antileukaemia agent
CMNPD21317	antileukaemia agent
CMNPD21318	antileukaemia agent
CMNPD21319	antileukaemia agent
CMNPD21340	inhibit secretion of the virulence factor Yersinia Outer Protein E
CMNPD21345	active against a variety of human tumour and mammalian cell lines
CMNPD21346	active against a variety of human tumour and mammalian cell lines
CMNPD21348	antitumour
CMNPD21349	antitumour
CMNPD21350	activity versus five HTCLs
CMNPD21351	activity versus five HTCLs
CMNPD21355	antioxidant | Mod. activ. vs 3 HTCLs
CMNPD21356	activity against Gram-positive bacteria
CMNPD21357	activity against Gram-positive bacteria
CMNPD21383	inhibitor of protein tyrosine phosphatase 1B activity
CMNPD21391	enhance Ca2+ deposition in osteoblasts
CMNPD21407	selective cannabinoid CB2-receptor ligand
CMNPD21408	PXR-agonist/farnesoid-X-receptor antagonist activity
CMNPD21409	PXR-agonist/farnesoid-X-receptor antagonist activity
CMNPD21410	PXR-agonist/farnesoid-X-receptor antagonist activity
CMNPD21411	PXR-agonist/farnesoid-X-receptor antagonist activity
CMNPD21412	PXR-agonist/farnesoid-X-receptor antagonist activity
CMNPD21413	PXR-agonist/farnesoid-X-receptor antagonist activity
CMNPD21414	PXR-agonist/farnesoid-X-receptor antagonist activity
CMNPD21415	PXR-agonist/farnesoid-X-receptor antagonist activity
CMNPD21416	PXR-agonist/farnesoid-X-receptor antagonist activity
CMNPD21417	PXR-agonist/farnesoid-X-receptor antagonist activity
CMNPD21418	PXR-agonist
CMNPD21419	antiprotozoal activity
CMNPD21420	antiprotozoal activity
CMNPD21421	antiprotozoal activity
CMNPD21422	antiprotozoal activity
CMNPD21423	antiprotozoal activity
CMNPD21424	antiprotozoal activity
CMNPD21425	antiprotozoal activity
CMNPD21426	antiprotozoal activity
CMNPD21427	antiprotozoal activity
CMNPD21428	antiprotozoal activity
CMNPD21429	antiprotozoal activity
CMNPD21430	antiprotozoal activity
CMNPD21431	antiprotozoal activity
CMNPD21432	inhibit cathepsin B
CMNPD21433	inhibit cathepsin B
CMNPD21456	bacterial anti-adhesion constituent
CMNPD21457	bacterial anti-adhesion constituent
CMNPD21458	bacterial anti-adhesion constituent
CMNPD21461	antilarval activity towards B. amphitrite
CMNPD21462	antilarval activity towards B. amphitrite
CMNPD21463	toxicity towards Artemia salina
CMNPD21464	toxicity towards Artemia salina
CMNPD21465	inhibit settlement of B. amphitrite cyprids
CMNPD21466	inhibit settlement of B. amphitrite cyprids
CMNPD21467	suppressor of superoxide anion generation by human neutrophils
CMNPD21468	suppressor of superoxide anion generation by human neutrophils
CMNPD21469	inhibit LPS-induced iNOS and COX-2 protein expression | protect cells from 6-hydroxydopamine-induced neurotoxicity
CMNPD21470	protect cells from 6-hydroxydopamine-induced neurotoxicity
CMNPD21480	neuroprotective effects
CMNPD21482	neuroprotective effects
CMNPD21493	cytotoxicity towards the P388 cell line
CMNPD21494	inhibit biofilm formation by P. aeruginosa, Vibrio harveyi and S. aureus | interfere with quorum sensing in Chromobacterium violaceum without affecting organism growth
CMNPD21495	inhibit biofilm formation by P. aeruginosa, Vibrio harveyi and S. aureus | interfere with quorum sensing in Chromobacterium violaceum without affecting organism growth
CMNPD21496	inhibit biofilm formation by P. aeruginosa, Vibrio harveyi and S. aureus | interfere with quorum sensing in Chromobacterium violaceum without affecting organism growth
CMNPD21497	inhibit biofilm formation by P. aeruginosa, Vibrio harveyi and S. aureus | interfere with quorum sensing in Chromobacterium violaceum without affecting organism growth
CMNPD21498	inhibit biofilm formation by P. aeruginosa, Vibrio harveyi and S. aureus | interfere with quorum sensing in Chromobacterium violaceum without affecting organism growth
CMNPD21499	inhibit biofilm formation by P. aeruginosa, Vibrio harveyi and S. aureus | interfere with quorum sensing in Chromobacterium violaceum without affecting organism growth
CMNPD21500	inhibit biofilm formation by P. aeruginosa, Vibrio harveyi and S. aureus | interfere with quorum sensing in Chromobacterium violaceum without affecting organism growth
CMNPD21503	inhibit LPS-induced up-regulation of the pro-inflammatory protein iNOS
CMNPD21504	inhibit LPS-induced up-regulation of the pro-inflammatory protein iNOS
CMNPD21505	inhibit LPS-induced up-regulation of the pro-inflammatory protein iNOS
CMNPD21506	inhibit LPS-induced up-regulation of the pro-inflammatory protein iNOS
CMNPD21507	inhibit LPS-induced up-regulation of the pro-inflammatory protein iNOS
CMNPD21508	inhibit LPS-induced up-regulation of the pro-inflammatory protein iNOS
CMNPD21509	inhibit LPS-induced up-regulation of the pro-inflammatory protein iNOS
CMNPD21510	cytotoxicity
CMNPD21511	cytotoxicity
CMNPD21514	inhibit the accumulation of pro-inflammatory inducible NO synthase protein in LPS-stimulated macrophages
CMNPD21524	antifouling activity towards B. amphitrite
CMNPD21530	antifouling activity towards Bugula neritina
CMNPD21546	gene expression and tumour cell growth inhibitor
CMNPD21547	gene expression and tumour cell growth inhibitor
CMNPD21548	inhibit the accumulation of pro-inflammatory proteins iNOS and COX-2 in stimulated macrophages
CMNPD21549	inhibit the accumulation of pro-inflammatory proteins iNOS and COX-2 in stimulated macrophages
CMNPD21550	inhibit the accumulation of iNOS in simulated macrophages
CMNPD21551	inhibit the accumulation of iNOS in simulated macrophages
CMNPD21552	inhibit the accumulation of iNOS in simulated macrophages
CMNPD21556	cytotoxicity
CMNPD21557	cytotoxicity
CMNPD21558	cytotoxicity
CMNPD21559	cytotoxicity
CMNPD21560	cytotoxicity
CMNPD21561	cytotoxicity
CMNPD21574	antiviral activity
CMNPD21579	inhibitor of NO production by LPS-stimulated mouse macrophages
CMNPD21580	inhibitor of NO production by LPS-stimulated mouse macrophages
CMNPD21581	inhibitor of NO production by LPS-stimulated mouse macrophages
CMNPD21582	inhibitor of NO production by LPS-stimulated mouse macrophages
CMNPD21583	inhibitor of NO production by LPS-stimulated mouse macrophages
CMNPD21584	inhibitor of NO production by LPS-stimulated mouse macrophages
CMNPD21585	inhibitor of NO production by LPS-stimulated mouse macrophages
CMNPD21586	cytotoxic
CMNPD21587	cytotoxic
CMNPD21594	anti-inflammatory (TPA-induced mouse ear edema) constituent
CMNPD21601	cytotoxicity towards a panel of HTCLs
CMNPD21604	inhibit the LPS-induced up-regulation of the pro-inflammatory protein iNOS
CMNPD21605	inhibit the LPS-induced up-regulation of the pro-inflammatory protein iNOS
CMNPD21606	inhibit the LPS-induced up-regulation of the pro-inflammatory protein iNOS
CMNPD21607	inhibit the LPS-induced up-regulation of the pro-inflammatory protein iNOS
CMNPD21608	inhibit the LPS-induced up-regulation of the pro-inflammatory protein iNOS
CMNPD21611	cytotoxicity
CMNPD21612	inhibit the LPS-induced up-regulation of the pro-inflammatory protein iNOS
CMNPD21613	inhibit the LPS-induced up-regulation of the pro-inflammatory protein iNOS
CMNPD21614	cytotoxicity
CMNPD21619	antifouling
CMNPD21620	cytotoxicity
CMNPD21621	cytotoxicity
CMNPD21622	cytotoxicity | inhibitor of superoxide anion generation by stimulated neutrophils
CMNPD21624	cytotoxicity
CMNPD21625	inhibitor of superoxide anion generation by stimulated neutrophils
CMNPD21631	inhibit the accumulation of iNOS in stimulated macrophages
CMNPD21635	inhibit the accumulation of iNOS in stimulated macrophages
CMNPD21636	inhibit the accumulation of iNOS in stimulated macrophages
CMNPD21637	inhibit the accumulation of iNOS in stimulated macrophages
CMNPD21638	inhibit the accumulation of iNOS in stimulated macrophages
CMNPD21639	inhibit the accumulation of iNOS in stimulated macrophages
CMNPD21640	inhibit the accumulation of iNOS in stimulated macrophages
CMNPD21641	inhibit the accumulation of iNOS in stimulated macrophages
CMNPD21642	inhibit the accumulation of iNOS in stimulated macrophages
CMNPD21643	cytotoxicity towards the HL-60 cell line
CMNPD21644	cytotoxicity towards the HL-60 cell line
CMNPD21645	cytotoxicity towards the HL-60 cell line
CMNPD21646	cytotoxicity towards the HL-60 cell line
CMNPD21647	cytotoxicity towards the HL-60 cell line
CMNPD21651	inhibit the accumulation of iNOS in stimulated macrophages
CMNPD21652	inhibit the accumulation of iNOS in stimulated macrophages
CMNPD21653	inhibit the accumulation of iNOS in stimulated macrophages
CMNPD21654	cytotoxicity towards Caco-2 cells
CMNPD21655	cytotoxicity towards Caco-2 cells | decrease the expression of COX-2 in RAW 264.7 murine macrophages
CMNPD21656	cytotoxicity towards Caco-2 cells | decrease the expression of COX-2 in RAW 264.7 murine macrophages
CMNPD21662	cytotoxicity
CMNPD21663	cytotoxicity
CMNPD21664	cytotoxicity
CMNPD21665	cytotoxicity
CMNPD21671	cytotoxicity
CMNPD21672	cytotoxicity
CMNPD21673	cytotoxicity
CMNPD21678	inhibit the growth of fungi but was inactive towards bacteria
CMNPD21682	inhibition of four kinases (ALK, SRC, VEGF-R2, IGF-1R)
CMNPD21683	inhibition of four kinases (ALK, SRC, VEGF-R2, IGF-1R)
CMNPD21684	inhibition of four kinases (ALK, SRC, VEGF-R2, IGF-1R)
CMNPD21685	inhibition of four kinases (ALK, SRC, VEGF-R2, IGF-1R)
CMNPD21686	inhibition of four kinases (ALK, SRC, VEGF-R2, IGF-1R)
CMNPD21687	inhibition of four kinases (ALK, SRC, VEGF-R2, IGF-1R)
CMNPD21688	inhibition of four kinases (ALK, SRC, VEGF-R2, IGF-1R)
CMNPD21689	inhibition of four kinases (ALK, SRC, VEGF-R2, IGF-1R)
CMNPD21690	inhibition of four kinases (ALK, SRC, VEGF-R2, IGF-1R)
CMNPD21691	inhibition of four kinases (ALK, SRC, VEGF-R2, IGF-1R)
CMNPD21692	inhibition of four kinases (ALK, SRC, VEGF-R2, IGF-1R)
CMNPD21693	inhibition of four kinases (ALK, SRC, VEGF-R2, IGF-1R)
CMNPD21694	inhibition of four kinases (ALK, SRC, VEGF-R2, IGF-1R)
CMNPD21695	inhibition of four kinases (ALK, SRC, VEGF-R2, IGF-1R)
CMNPD21697	cytotoxicity towards the P388 cell line
CMNPD21708	cytotoxicity
CMNPD21709	cytotoxicity
CMNPD21710	cytotoxicity
CMNPD21711	cytotoxicity
CMNPD21712	cytotoxicity
CMNPD21713	cytotoxicity
CMNPD21714	cytotoxicity
CMNPD21715	cytotoxicity
CMNPD21716	cytotoxicity
CMNPD21717	cytotoxicity
CMNPD21718	cytotoxicity
CMNPD21719	cytotoxicity
CMNPD21720	cytotoxicity
CMNPD21729	antiviral activity (human cytomegalovirus)
CMNPD21733	cytotoxicity by induction of apoptosis
CMNPD21734	cytotoxic
CMNPD21735	cytotoxic
CMNPD21736	cytotoxic
CMNPD21737	cytotoxic
CMNPD21740	antiviral activity (human cytomegalovirus)
CMNPD21753	analgesic effect
CMNPD21754	activity against the parasite T. brucei brucei | cytotoxic against HEK293 cells
CMNPD21755	activity against the parasite T. brucei brucei
CMNPD21758	growth inhibitor of chloroquine sensitive and resistant strains of P. falciparum
CMNPD21759	growth inhibitor of chloroquine sensitive and resistant strains of P. falciparum
CMNPD21763	growth inhibitior of S. aureus | active against the melanoma cell line A-2058
CMNPD21764	growth inhibitior of S. aureus | inhibitor of C. albicans growth | active against the melanoma cell line A-2058
CMNPD21765	growth inhibitior of S. aureus
CMNPD21766	cytotoxic (weak) to two HTCLs
CMNPD21767	cytotoxic (weak) to two HTCLs
CMNPD21772	inhibit tumour cell growth
CMNPD21773	inhibit tumour cell growth
CMNPD21780	cytotoxic
CMNPD21793	inhibitor of cell division in a fertilised sea urchin egg assay
CMNPD21795	cytotoxic
CMNPD21798	inhibitor of V-ATPase and only mildly cytotoxic
CMNPD21801	antagonists of farnesoid X receptor
CMNPD21802	antagonists of farnesoid X receptor
CMNPD21803	antagonists of farnesoid X receptor
CMNPD21806	activity towards a drug resistant strain of P. falciparum
CMNPD21809	cytotoxic
CMNPD21812	anti-inflammatory properties including the ability to inhibit the production of pro-inflammatory cytokines
CMNPD21813	anti-inflammatory properties including the ability to inhibit the production of pro-inflammatory cytokines
CMNPD21816	antimalarial activity
CMNPD21817	antibacterial | antitumour
CMNPD21819	antimalarial activity
CMNPD21820	antimalarial activity
CMNPD21821	antimalarial activity
CMNPD21824	cytotoxicity towards tumour cell lines
CMNPD21827	growth inhibitor of all life stages of a multiple drug resistant strain of P. falciparum
CMNPD21830	cytotoxic
CMNPD21831	reduce hepatic triglyceride and total cholesterol levels in fatty liver mice by down regulation of stearoyl-CoA desaturase
CMNPD21832	reduce hepatic triglyceride and total cholesterol levels in fatty liver mice by down regulation of stearoyl-CoA desaturase
CMNPD21833	reduce hepatic triglyceride and total cholesterol levels in fatty liver mice by down regulation of stearoyl-CoA desaturase
CMNPD21844	inhibit colony formation of human breast and melanoma cells in a soft agar clonogenic assay
CMNPD21845	cytotoxic to a human melanoma cell line
CMNPD21846	cytotoxic to a human melanoma cell line
CMNPD21847	cytotoxic to the RAW 264.7 assay cells
CMNPD21848	cytotoxic to the RAW 264.7 assay cells
CMNPD21849	cytotoxic to the RAW 264.7 assay cells
CMNPD21853	active in inhibiting colony formation of human HT-29 colon cancer cells
CMNPD21856	antifungal activity towards Cladosporium cucumerinum
CMNPD21857	antifungal activity towards Cladosporium cucumerinum
CMNPD21858	cytotoxic | haemolytic
CMNPD21859	cytotoxic | haemolytic
CMNPD21860	cytotoxic | haemolytic
CMNPD21861	cytotoxic | haemolytic
CMNPD21863	cytotoxicity | induce early apoptosis against a gastric adenocarcinoma cell line
CMNPD21865	inhibit the production of NO by stimulated macrophages
CMNPD21867	inhibit the production of NO by stimulated macrophages
CMNPD21869	antifeedant activity towards second-instar larvae of the diamondback moth Plutella xylostella
CMNPD21870	antifeedant activity towards second-instar larvae of the diamondback moth Plutella xylostella
CMNPD21871	antifeedant activity towards second-instar larvae of the diamondback moth Plutella xylostella
CMNPD21872	antifeedant activity towards second-instar larvae of the diamondback moth Plutella xylostella
CMNPD21873	activity against Trichophyton mentagrophytes (T. mentagrophytes)
CMNPD21874	activity against Trichophyton mentagrophytes (T. mentagrophytes)
CMNPD21875	activity against Trichophyton mentagrophytes (T. mentagrophytes)
CMNPD21876	activity against Trichophyton mentagrophytes (T. mentagrophytes)
CMNPD21877	activity against Trichophyton mentagrophytes (T. mentagrophytes)
CMNPD21878	activity against Trichophyton mentagrophytes (T. mentagrophytes)
CMNPD21879	activity against Trichophyton mentagrophytes (T. mentagrophytes)
CMNPD21880	activity against Trichophyton mentagrophytes (T. mentagrophytes)
CMNPD21881	activity against Trichophyton mentagrophytes (T. mentagrophytes)
CMNPD21882	active antimicrobial agent
CMNPD21883	active antimicrobial agent | cytotoxic to lung and stomach cancer cells
CMNPD21884	antifungal
CMNPD21893	activity towards non-small cell lung cancer cells
CMNPD21897	active against a panel of Gram-positive bacteria | strongly cytotoxic towards a panel of human tumour cell lines (HTCLs)
CMNPD21901	cytotoxic to HCT-8 cells
CMNPD21902	cytotoxic to HCT-8 cells
CMNPD21903	cytotoxic to HCT-8 cells
CMNPD21904	cytotoxic to HCT-8 cells
CMNPD21905	activity against methicillin-resistant Staphylococcus aureus (MRSA) and methicillin-sensitive Staphylococcus aureus (MSSA)
CMNPD21908	activity against methicillin-resistant Staphylococcus aureus (MRSA) and methicillin-sensitive Staphylococcus aureus (MSSA)
CMNPD21915	cytotoxic to MOLT-4 (human acute lymphoblastic leukaemia) cells
CMNPD21916	cytotoxic to MOLT-4 (human acute lymphoblastic leukaemia) cells
CMNPD21917	growth inhibitor of several cancer cell lines
CMNPD21918	growth inhibitor of several cancer cell lines
CMNPD21919	growth inhibitor of several cancer cell lines
CMNPD21920	growth inhibitor of several cancer cell lines
CMNPD21923	broad spectrum antibacterial activity | inhibit MRSA | cytotoxic to HeLa cells
CMNPD21924	broad spectrum antibacterial activity | inhibit MRSA | cytotoxic to HeLa cells
CMNPD21925	broad spectrum antibacterial activity | inhibit MRSA
CMNPD21926	broad spectrum antibacterial activity
CMNPD21927	inhibit Staphylococcus aureus (S. aureus) growth | inhibit growth of several cancer cell lines
CMNPD21928	inhibit Staphylococcus aureus (S. aureus) growth | inhibit growth of several cancer cell lines
CMNPD21929	inhibit growth of several cancer cell lines
CMNPD21930	inhibit growth of several cancer cell lines
CMNPD21931	cytotoxicity against several HTCLs | inhibition of the kinase PKC-α
CMNPD21932	cytotoxicity against several HTCLs | inhibition of the kinase PKC-α
CMNPD21933	cytotoxicity against several HTCLs | inhibition of the kinase PKC-α
CMNPD21934	cytotoxic to a panel of HTCLs
CMNPD21935	cytotoxic to a panel of HTCLs
CMNPD21936	cytotoxic to several HTCLs and to B16 cells
CMNPD21937	cytotoxic to several HTCLs and to B16 cells
CMNPD21938	cytotoxic to several HTCLs and to B16 cells
CMNPD21939	cytotoxic to several HTCLs and to B16 cells
CMNPD21942	cytotoxicity against non-small-cell lung cancer (NSCLC) cells Calu-3 and H2887
CMNPD21944	cytotoxic to P388 cells
CMNPD21948	inhibit TNF-α-induced NFκB activity and LPS-induced nitric oxide (NO) production | Potent cytotox. vs. HCT-116 (IC50 = 0.049 μM). Mod. AM vs. S. aureus (MIC = 2.37 μM) and C. albicans (MIC = 0.95 μM).
CMNPD21949	inhibit TNF-α-induced NFκB activity and LPS-induced nitric oxide (NO) production | Potent cytotox. vs. HCT-116 (IC50 = 0.049 μM). Mod. AM vs. S. aureus (MIC = 2.37 μM) and C. albicans (MIC = 0.95 μM).
CMNPD21957	inhibitor of Candida albicans isocitrate lyase
CMNPD21959	cytotoxicity to a number of cancer cell lines
CMNPD21960	cytotoxicity to a number of cancer cell lines
CMNPD21961	cytotoxicity to a number of cancer cell lines
CMNPD21962	cytotoxicity to a number of cancer cell lines
CMNPD21963	inhibitor of acetylcholinesterase
CMNPD21964	inhibitor of several HTCLs
CMNPD21965	inhibitor of MRSA
CMNPD21966	inhibitor of MRSA
CMNPD21973	inhibitor of the P. falciparum K1 strain | inhibitor of Mycobacterium tuberculosis
CMNPD21974	cytotoxicity to the MIA PaCa-2 pancreatic cancer cell line
CMNPD21976	inhibitor of the proliferation of WI26 (human lung fibroblast) cells
CMNPD21977	induce apoptosis in a cell-based screen
CMNPD21978	induce apoptosis in a cell-based screen
CMNPD21979	modulator of S. aureus virulence gene expression
CMNPD21981	activity against the dinoflagellate Prorocentrum micans
CMNPD21983	activity against S. aureus and Laribacter hongkongensis
CMNPD21984	cytotoxic to HTCLs | arrest the cell cycle of HeLa cells at the G2/M phase
CMNPD21986	inhibitor of B. subtilis and Mycobacterium vaccae growth
CMNPD21987	inhibitor of B. subtilis and Mycobacterium vaccae growth
CMNPD21988	inhibitor of B. subtilis and Mycobacterium vaccae growth
CMNPD21989	inhibitor of B. subtilis and Mycobacterium vaccae growth
CMNPD21990	inhibitor of B. subtilis and Mycobacterium vaccae growth
CMNPD21991	cytotoxicity against HTCLs
CMNPD21993	cytotoxicity against HTCLs
CMNPD21995	cytotoxin against several HTCLs
CMNPD21996	cytotoxin against several HTCLs
CMNPD21997	inhibitory to S. aureus
CMNPD21998	active against the porcine reproductive and respiratory syndrome virus
CMNPD22005	cytotoxic to HTCLs
CMNPD22006	active against the porcine reproductive and respiratory syndrome virus
CMNPD22017	stimulatory phytoregulatory activity
CMNPD22020	inhibitor of human leukaemic monocyte lymphoma (U937) cells
CMNPD22022	inhibitor of human leukaemic monocyte lymphoma (U937) cells
CMNPD22027	cytotoxicity to P388 cells
CMNPD22033	cytotoxic to HTCLs
CMNPD22035	cytotoxic to HTCLs
CMNPD22042	inhibit growth of several HTCLs
CMNPD22059	cytotoxin to P388 cells
CMNPD22060	cytotoxin to P388 cells
CMNPD22061	cytotoxin against SK-MEL-5 human melanoma cells
CMNPD22062	aromatase inhibition
CMNPD22063	aromatase inhibition
CMNPD22064	aromatase inhibition
CMNPD22070	selective activity against the Bacille Calmette-Guérin (BCG) strain of Mycobacterium bovis
CMNPD22074	activity against B. subtilis, B. cereus and S. aureus
CMNPD22082	growth inhibitor of HTCLs and P388 cells
CMNPD22085	cytotoxic to several cancer cell lines
CMNPD22090	selective inhibition of human leukocyte elastase
CMNPD22092	fungistatic against the phytopathogenic fungus Cladosporium cucumerinum
CMNPD22094	inhibit growth of the H1N1 virus along with weak NF-κB inhibition
CMNPD22095	active against E. coli and S. aureus
CMNPD22096	toxic to brine shrimp
CMNPD22100	cytotoxic to MCF-7 cells
CMNPD22101	cytotoxic to both SF-268 and MCF-7 cells
CMNPD22113	active against B. cereus and A549 cells
CMNPD22121	activity against S. aureus and MRSA
CMNPD22128	active against E. coli and Enterobacter aerogenes (E. aerogenes)
CMNPD22133	active against E. coli and Enterobacter aerogenes (E. aerogenes)
CMNPD22134	active against E. coli and Enterobacter aerogenes (E. aerogenes)
CMNPD22137	cytotoxic to HTCLs
CMNPD22140	inhibit the activities of mammalian DNA polymerases (pols), A (pol γ), B (pols α, δ, and ε), and Y (pols η, ι, and κ) families and the growth and proliferation of several HTCLs
CMNPD22141	inhibit the activities of mammalian DNA polymerases (pols), A (pol γ), B (pols α, δ, and ε), and Y (pols η, ι, and κ) families and the growth and proliferation of several HTCLs
CMNPD22144	radical scavenging activities against DPPH
CMNPD22145	radical scavenging activities against DPPH
CMNPD22146	cytotoxic to A549 and MCF-7 cells
CMNPD22147	radical scavenging activities against DPPH
CMNPD22151	cytotoxic (MCF-7 cells)
CMNPD22154	cytotoxic to P388 cells
CMNPD22163	antifouling activity toward Bugula neritina larvae
CMNPD22165	acetylcholinesterase (AChE) inhibition
CMNPD22168	suppressor of NO production in RAW264.7 cells without notable cytotoxicity
CMNPD22169	cytotoxic to several HTCLs
CMNPD22171	cytotoxic to several HTCLs
CMNPD22173	active in a wide range of bioassays
CMNPD22174	active in a wide range of bioassays
CMNPD22175	active in a wide range of bioassays
CMNPD22176	active in a wide range of bioassays
CMNPD22183	cytotoxic to several HTCLs
CMNPD22184	cytotoxic to several HTCLs
CMNPD22197	inhibit growth of P388 cells
CMNPD22198	active against E. coli, B. subtilis and E. aerogenes
CMNPD22236	antibacterial
CMNPD22261	active against C. albicans and Cryptococcus neoformans
CMNPD22262	cytotoxicity against MCF-7 cells | antibacterial activity against S. aureus and MRSA
CMNPD22263	cytotoxic to human malignant pleural mesothelioma (MPM) ACC-MESO-1 cells
CMNPD22273	inhibitory properties against S. aureus and MRSA
CMNPD22278	inhibitor of bacterial quorum-sensing (inhibited bioluminescence in Vibrio harveyi) | inhibit NO production and expression of several pro-inflammatory cytokines in RAW264.7 cells
CMNPD22279	inhibitor of bacterial quorum-sensing (inhibited bioluminescence in Vibrio harveyi) | inhibit NO production and expression of several pro-inflammatory cytokines in RAW264.7 cells
CMNPD22280	inhibitor of bacterial quorum-sensing (inhibited bioluminescence in Vibrio harveyi) | inhibit NO production and expression of several pro-inflammatory cytokines in RAW264.7 cells
CMNPD22281	apoptosis-inducing activity against HeLa S3 and HL-60 cells
CMNPD22282	inhibit growth and induced apoptosis in HeLa S3 and HL-60 cells with increased cytosolic Ca2+ concentration in the HeLa S3 cells
CMNPD22285	cannabinomimetic, decreasing forskolin-induced cAMP accumulation
CMNPD22289	cytotoxic to HCT116 cells
CMNPD22291	molluscicide against the marine snail Biomphalaria glabrata
CMNPD22292	selective antileishmanial activity | potent anti-inflammatory activity
CMNPD22293	selective antileishmanial activity | potent anti-inflammatory activity
CMNPD22294	selective antileishmanial activity | potent anti-inflammatory activity
CMNPD22295	selective antileishmanial activity | potent anti-inflammatory activity
CMNPD22296	toxic to H460 human lung cancer cells
CMNPD22300	inhibit p53/MDM2 protein binding
CMNPD22301	inhibitor of the protease enzyme cathepsin E
CMNPD22302	peptidic proteasome inhibitor
CMNPD22303	peptidic proteasome inhibitor
CMNPD22304	sodium channel blocking activity in murine Neuro-2a cells | antagonist of veratridine-induced sodium influx in murine cerebrocortical neurons
CMNPD22305	sodium channel blocking activity in murine Neuro-2a cells
CMNPD22310	mouse lethality and toxicity to P388 cells
CMNPD22311	activity of ovatoxin-a in mice
CMNPD22328	activity against prostate cancer cells
CMNPD22340	antibacterial
CMNPD22341	antibacterial
CMNPD22342	antibacterial
CMNPD22343	antibacterial
CMNPD22344	antibacterial
CMNPD22345	antibacterial
CMNPD22346	antibacterial
CMNPD22347	antibacterial
CMNPD22348	antibacterial
CMNPD22358	antidiabetic
CMNPD22359	antioxidant
CMNPD22370	antibacterial
CMNPD22375	antifungal
CMNPD22379	antibacterial
CMNPD22380	antibacterial | antifungal | antitumour
CMNPD22381	antibacterial
CMNPD22387	antitumour | antimalarial | antibacterial
CMNPD22388	antitumour | antimalarial | antibacterial
CMNPD22389	antitumour | antimalarial | antibacterial
CMNPD22390	antitumour | antimalarial | antibacterial
CMNPD22391	antitumour | antimalarial | antibacterial
CMNPD22407	antifungal activity
CMNPD22408	androgen receptor inhibitor
CMNPD22409	androgen receptor inhibitor
CMNPD22414	potency against lung tumour cells
CMNPD22415	activity against Pseudomonas aeruginosa (P. aeruginosa)
CMNPD22416	activity against Pseudomonas aeruginosa (P. aeruginosa)
CMNPD22417	activity against Pseudomonas aeruginosa (P. aeruginosa)
CMNPD22456	antifungal
CMNPD22457	antifungal
CMNPD22458	antifungal
CMNPD22459	antifungal
CMNPD22460	antifungal
CMNPD22461	antifungal
CMNPD22462	antifungal
CMNPD22463	antifungal
CMNPD22464	antifungal
CMNPD22467	antidiabetic | anti-arthrosclerosis agent
CMNPD22475	antimalarial (P. falciparum)
CMNPD22478	inhibit NO-production in LPS-induced macrophages
CMNPD22480	activate the hypoxia-inducible factor-1 (HIF-1)
CMNPD22481	activate the hypoxia-inducible factor-1 (HIF-1)
CMNPD22482	activate the hypoxia-inducible factor-1 (HIF-1)
CMNPD22484	antifungal
CMNPD22485	selective against Trypanosoma brucei
CMNPD22486	selective against Trypanosoma brucei
CMNPD22487	carboxypeptidase A inhibitor
CMNPD22488	antiproliferative
CMNPD22489	antiproliferative
CMNPD22490	inhibit HeLa cell migration at sub-inhibitory concentrations
CMNPD22491	anti-inflammatory
CMNPD22492	anti-inflammatory
CMNPD22493	anti-inflammatory
CMNPD22494	anti-inflammatory
CMNPD22495	anti-inflammatory
CMNPD22496	non-selective cytotoxin
CMNPD22497	non-selective cytotoxin
CMNPD22498	non-selective cytotoxin
CMNPD22499	inhibit the growth of Mycobacterium smegmatis
CMNPD22503	radical scavenging antioxidant
CMNPD22516	activities in the low ng mL-1 range against various strains of P. falciparum
CMNPD22517	activities in the low ng mL-1 range against various strains of P. falciparum
CMNPD22519	inhibit NO production in LPS-stimulated BV2 monoglial cells
CMNPD22520	inhibit NO production in LPS-stimulated BV2 monoglial cells
CMNPD22551	inhibit the formation of the E1-ubiquitin
CMNPD22552	inhibit the formation of the E1-ubiquitin
CMNPD22566	inhibitor of P388 cells
CMNPD22567	inhibitor of P388 cells
CMNPD22568	inhibitor of P388 cells
CMNPD22569	inhibitor of P388 cells
CMNPD22571	anti-oxidant
CMNPD22572	anti-oxidant
CMNPD22573	anti-oxidant
CMNPD22578	antimalarial | inhibiting both chloroquine sensitive and resistant P. falciparum at the very low nM level
CMNPD22579	cytotoxic
CMNPD22580	cytotoxic
CMNPD22581	cytotoxic
CMNPD22582	cytotoxic
CMNPD22583	cytotoxic
CMNPD22584	cytotoxic
CMNPD22585	cytotoxic
CMNPD22586	cytotoxic
CMNPD22587	cytotoxic
CMNPD22588	cytotoxic
CMNPD22607	β-secretase (BACE) inhibitor
CMNPD22609	β-secretase (BACE) inhibitor
CMNPD22610	β-secretase (BACE) inhibitor
CMNPD22611	β-secretase (BACE) inhibitor
CMNPD22623	selective inhibitor of kynurenine-3-hydroxylase
CMNPD22628	selective inhibitor of P. aeruginosa
CMNPD22629	selective inhibitor of P. aeruginosa
CMNPD22630	selective inhibitor of P. aeruginosa
CMNPD22641	antimalarial
CMNPD22642	antimalarial
CMNPD22646	activity against P. falciparum
CMNPD22668	antioxidant
CMNPD22669	antioxidant
CMNPD22670	antioxidant
CMNPD22671	cytotoxic
CMNPD22672	cytotoxic
CMNPD22673	cytotoxic
CMNPD22674	cytotoxic
CMNPD22680	inhibit indoleamine 2,3-dioxygenase
CMNPD22681	inhibit indoleamine 2,3-dioxygenase
CMNPD22693	antifouling
CMNPD22694	antifouling
CMNPD22695	antifouling
CMNPD22696	antifouling
CMNPD22697	antifouling
CMNPD22698	antifouling
CMNPD22699	antifouling
CMNPD22700	antifouling
CMNPD22715	antifungal
CMNPD22716	antifungal
CMNPD22718	broadly active
CMNPD22719	broadly active
CMNPD22720	broadly active
CMNPD22721	broadly active
CMNPD22722	broadly active
CMNPD22723	broadly active
CMNPD22724	broadly active
CMNPD22726	cytotoxic
CMNPD22729	inhibitor of NO production in LPS-stimulated RAW 264.7 cells
CMNPD22730	inhibitor of NO production in LPS-stimulated RAW 264.7 cells
CMNPD22731	growth inhibition against human colon cancer cell lines
CMNPD22732	growth inhibition against human colon cancer cell lines
CMNPD22736	inhibit human epidermoid carcinoma cells
CMNPD22737	inhibit human epidermoid carcinoma cells
CMNPD22738	inhibit human epidermoid carcinoma cells
CMNPD22748	active against a panel of cancer cell lines
CMNPD22751	antioxidant
CMNPD22755	inhibitor of the ubiquitin Ubc13-Uev1a complex
CMNPD22756	inhibitor of the ubiquitin Ubc13-Uev1a complex
CMNPD22772	inhibitor of NO release from LPS-stimulated macrophages
CMNPD22773	inhibitor of NO release from LPS-stimulated macrophages
CMNPD22775	cytotoxicity
CMNPD22776	cytotoxicity
CMNPD22778	antifouling activity in vitro towards Balanus amphitrite (B. amphitrite)
CMNPD22779	antifouling activity in vitro towards Balanus amphitrite (B. amphitrite)
CMNPD22783	antifouling activity in vitro towards Balanus amphitrite (B. amphitrite)
CMNPD22784	antifouling activity in vitro towards Balanus amphitrite (B. amphitrite)
CMNPD22793	antifouling activity (B. amphitrite) and antimicrobial properties
CMNPD22808	antitumour activity and to reduce levels of iNOS protein in LPS-stimulated macrophages
CMNPD22810	reduce levels of COX-2 protein in LPS-stimulated macrophages
CMNPD22817	cytotoxicity
CMNPD22818	cytotoxicity
CMNPD22819	cytotoxicity
CMNPD22820	cytoprotective effects towards cells injured with H2O2
CMNPD22823	inhibit quorum sensing in Chromobacterium violaceum
CMNPD22824	inhibit quorum sensing in Chromobacterium violaceum
CMNPD22825	non-cytotoxic
CMNPD22826	non-cytotoxic
CMNPD22827	inhibitor of elastase release from human neutrophils
CMNPD22828	cytotoxicity (P388 cells) | antiviral activity (human cytomegalovirus (CMG))
CMNPD22829	cytotoxicity (P388 cells) | antiviral activity (human cytomegalovirus (CMG))
CMNPD22830	cytotoxicity (P388 cells) | antiviral activity (human cytomegalovirus (CMG))
CMNPD22833	cytotoxic
CMNPD22839	cytotoxicity | reduce the accumulation of iNOS and COX-2 pro-inflammatory proteins
CMNPD22847	inhibit IL-12, IL-6 and TNF-α production in LPS-stimulated bone marrow dendritic cells
CMNPD22848	inhibit IL-12, IL-6 and TNF-α production in LPS-stimulated bone marrow dendritic cells
CMNPD22856	inhibit CYP450 1A and induce glutathione-S-transferase and quinone reductase activity
CMNPD22857	cytotoxicity
CMNPD22858	cytotoxicity
CMNPD22859	cytotoxicity
CMNPD22860	cytotoxicity
CMNPD22861	cytotoxicity
CMNPD22862	cytotoxicity
CMNPD22863	cytotoxicity towards tumour cell lines | inhibit the induction of iNOS protein
CMNPD22864	cytotoxicity towards tumour cell lines
CMNPD22865	cytotoxicity towards tumour cell lines | inhibit the induction of iNOS protein
CMNPD22868	cytotoxic
CMNPD22869	cytotoxic | inhibit settlement of B. amphitrite
CMNPD22870	inhibit settlement of B. amphitrite
CMNPD22874	inhibitor of elastase release and superoxide production by stimulated human neutrophils
CMNPD22877	cytotoxicity towards three HTCLs
CMNPD22878	cytotoxicity towards three HTCLs
CMNPD22879	topical anti-inflammatory metabolites
CMNPD22880	cytotoxicity towards a tumour cell line
CMNPD22883	no cytotoxicity towards a panel of tumour cell lines
CMNPD22910	inhibit the production of NO by LPS-stimulated macrophages
CMNPD22911	inhibit the production of NO by LPS-stimulated macrophages
CMNPD22912	sub-micromolar activity towards the human protozoal targets Leishmania amazonesis (modest selectivity) and Trypanosoma congolense, but less active towards P. falciparum.
CMNPD22913	inhibit the release of elastase from stimulated human neutrophils
CMNPD22924	inhibitor of superoxide generation by stimulated neutrophils
CMNPD22930	inhibitor of CMG
CMNPD22933	inhibitor of CMG
CMNPD22936	exhibit the most pronounced cytotoxicity towards two tumour cell lines
CMNPD22938	poorly cytotoxic with some examples exhibiting strong antifouling activity
CMNPD22939	exhibit the most pronounced cytotoxicity towards two tumour cell lines
CMNPD22943	growth inhibitor of human embryonic stem cells
CMNPD22945	inhibit the expression of iNOS protein in stimulated macrophages
CMNPD22952	cytotoxic
CMNPD22953	cytotoxic
CMNPD22954	inhibit FXR transactivation induced by chenodeoxycholic acid
CMNPD22961	inhibit the generation of superoxide and the release of elastase from stimulated human neutrophils
CMNPD22962	cytotoxic towards a range of tumour cell lines
CMNPD22963	cytotoxic towards a range of tumour cell lines
CMNPD22964	cytotoxic towards a range of tumour cell lines
CMNPD22969	cytotoxicity and inhibited expression of iNOS and COX-2 proteins in stimulated macrophages
CMNPD22970	growth inhibition properties towards two fungi, a microalga and a Gram-positive bacterium, but not a Gram-negative bacterium
CMNPD22971	growth inhibition properties towards two fungi, a microalga and a Gram-positive bacterium, but not a Gram-negative bacterium
CMNPD22972	inhibit expression of the pro-inflammatory proteins iNOS and COX-2 in stimulated macrophages
CMNPD22975	inhibit expression of the pro-inflammatory proteins iNOS and COX-2 in stimulated macrophages
CMNPD22985	active against chloroquine-sensitive and resistant strains of P. falciparum
CMNPD23012	inhibit Jak2-STAT5 and Erk1/2 activation pathways
CMNPD23023	growth inhibitory to a panel of HTCLs
CMNPD23024	growth inhibitory to a panel of HTCLs
CMNPD23026	cytotoxicity towards murine macrophage cells
CMNPD23027	cytotoxicity towards murine macrophage cells
CMNPD23031	antibacterial activity
CMNPD23032	antibacterial activity
CMNPD23033	antibacterial activity
CMNPD23037	antibacterial activity towards MSSA and MRSA strains
CMNPD23038	antibacterial activity towards MSSA and MRSA strains
CMNPD23039	antibacterial activity towards MSSA and MRSA strains
CMNPD23040	antibacterial activity towards MSSA and MRSA strains
CMNPD23041	antibacterial activity towards MSSA and MRSA strains
CMNPD23071	cytotoxicity towards a human carcinoma cell line
CMNPD23072	cytotoxicity towards a human carcinoma cell line
CMNPD23073	cytotoxicity towards a human carcinoma cell line
CMNPD23074	cytotoxicity towards a human carcinoma cell line
CMNPD23075	cytotoxicity towards a human carcinoma cell line
CMNPD23078	inhibitor of CK1δ, CDK5 and GSK3β kinases
CMNPD23085	non-cytotoxic
CMNPD23089	cytotoxic, inhibit colony formation of tumour cells in a soft agar clonogenic assay
CMNPD23092	cytotoxicity and haemolytic activity
CMNPD23112	antifungal
CMNPD23113	antifungal
CMNPD23114	antifungal
CMNPD23115	antifungal
CMNPD23128	inhibit NS3-4A protease | anti-hepatitis C virus (HCV) activity in two assays
CMNPD23143	activate the nuclear factor E2-related antioxidant response element
CMNPD23144	activate the nuclear factor E2-related antioxidant response element
CMNPD23145	activate the nuclear factor E2-related antioxidant response element
CMNPD23146	activate the nuclear factor E2-related antioxidant response element
CMNPD23147	inhibit the signaling pathway of the tyrosine kinase, discoidin domain receptor 2
CMNPD23148	inhibit the signaling pathway of the tyrosine kinase, discoidin domain receptor 2
CMNPD23149	inhibit the signaling pathway of the tyrosine kinase, discoidin domain receptor 2
CMNPD23150	inhibit the signaling pathway of the tyrosine kinase, discoidin domain receptor 2
CMNPD23151	inhibition of Gram-positive and Gram-negative bacterial strains
CMNPD23152	inhibition of Gram-positive and Gram-negative bacterial strains
CMNPD23153	inhibition of Gram-positive and Gram-negative bacterial strains
CMNPD23154	antibacterial | antifungal
CMNPD23155	antibacterial | antifungal
CMNPD23156	antibacterial | antifungal
CMNPD23157	antibacterial | antifungal
CMNPD23158	antibacterial | antifungal
CMNPD23159	antibiotics
CMNPD23160	inhibitors of the Gram-positive bacterium Arthrobacter cristallopoietes
CMNPD23161	inhibitors of the Gram-positive bacterium Arthrobacter cristallopoietes
CMNPD23162	antibiotics
CMNPD23163	inhibitor of Arthrobacter cristallopoietes
CMNPD23164	antibacterial
CMNPD23165	enhance the activity of the enzymes quinone reductase I, glutathione reductase and glutathione peroxidase
CMNPD23166	antiproliferative activity against human tumour cancer cell lines (HTCLs)
CMNPD23168	active against HTCLs
CMNPD23169	active against HTCLs
CMNPD23170	cytotoxic to cancer cell lines
CMNPD23182	inhibit pro-inflammatory factors
CMNPD23185	inhibition of quorum sensing (QS) controlled gene expression in Chromobacterium violaceum CV026 and Pseudomonas aeruginosa QSIS-lasI biosensors
CMNPD23188	inhibition of quorum sensing (QS) controlled gene expression in Chromobacterium violaceum CV026 and Pseudomonas aeruginosa QSIS-lasI biosensors
CMNPD23195	antibacterial inhibition | moderate inhibition of SK-MEL-28 cells
CMNPD23196	inhibit quorum sensing in Staphylococcus aureus
CMNPD23197	inhibit quorum sensing in Staphylococcus aureus
CMNPD23198	inhibit quorum sensing in Staphylococcus aureus
CMNPD23199	inhibit quorum sensing in Staphylococcus aureus
CMNPD23208	activity against Staphylococcus aureus (S. aureus)
CMNPD23211	moderate growth inhibitors of S. aureus.
CMNPD23212	moderate growth inhibitors of S. aureus.
CMNPD23213	moderate growth inhibitors of S. aureus.
CMNPD23214	inhibit the H1N1 virus in infected MDCK cells
CMNPD23215	inhibit the H1N1 virus in infected MDCK cells
CMNPD23216	growth inhibitors of NCI–H460 cancer cells
CMNPD23218	growth inhibitors of NCI–H460 cancer cells
CMNPD23219	growth inhibitors of S. aureus
CMNPD23222	binding affinity for the metal ions Fe3+, Cu2+ and Zn2+
CMNPD23223	binding affinity for the metal ions Fe3+, Cu2+ and Zn2+
CMNPD23224	neuraminidase inhibitors
CMNPD23225	neuraminidase inhibitors
CMNPD23226	modest but selective activity against MRSA
CMNPD23229	cytotoxic towards a panel of HTCLs
CMNPD23235	inhibit proliferation of human lung fibroblasts (WI26)
CMNPD23236	inhibit proliferation of human lung fibroblasts (WI26)
CMNPD23237	cytotoxic against MCF-7 cells (modest)
CMNPD23238	cytotoxic against MCF-7 cells (modest)
CMNPD23239	cytotoxic to a panel of HTCLs
CMNPD23242	modest activity against the influenza A (H1N1) virus
CMNPD23245	inhibitor of both Mycobacterium bovis Bacillus Calmette-Guerin (BCG) and B. subtilis  | a moderate inhibitor of Mycobacterium tuberculosis(M. tuberculosis)
CMNPD23246	inhibit A549 cells
CMNPD23247	cytotoxic (moderate) to HCT-116 cells
CMNPD23248	inhibit MRSA (moderate)
CMNPD23250	cytotoxic (moderate) to HCT-116 cells
CMNPD23251	cytotoxic (moderate) to HCT-116 cells
CMNPD23252	cytotoxic (moderate) to HCT-116 cells
CMNPD23253	active against several HTCLs
CMNPD23254	inhibition of several Gram-positive bacteria
CMNPD23255	inhibition of several Gram-positive bacteria
CMNPD23256	active against Bacillus anthracis
CMNPD23257	modest inhibitors of the protease enzyme bovine cathepsin B
CMNPD23258	modest inhibitors of the protease enzyme bovine cathepsin B
CMNPD23259	modest inhibitors of the protease enzyme bovine cathepsin B
CMNPD23260	modest inhibitors of the protease enzyme bovine cathepsin B
CMNPD23261	modest inhibitors of the protease enzyme bovine cathepsin B
CMNPD23262	inhibitor of the bacterium Erwinia amylovora
CMNPD23264	selective SAM-competitive inhibitor of the histone methyltransferase enzyme SETD8 | No cytotox. vs 7 HTCL | no AChE no AB activ. | weak biofilm formation inhib.
CMNPD23265	moderate cytotoxin of HCT-116
CMNPD23266	cytotoxic to several HTCLs
CMNPD23267	active against Plasmodium falciparum (P. falciparum)
CMNPD23268	active against Plasmodium falciparum (P. falciparum)
CMNPD23269	inhibitor of MRSA and vancomycin-resistant Enterococci pathogens
CMNPD23271	inhibit growth of several HTCLs
CMNPD23272	inhibit growth of several HTCLs
CMNPD23273	modest inhibitor of Candida albicans (C. albicans) isocitrate lyase and two HTCLs
CMNPD23277	significant inhibition of B. subtilis | moderate inhibition of S. aureus
CMNPD23278	inhibition of B. subtilis | inhibition of S. aureus
CMNPD23279	cytotoxin to 3Y1 rat fibroblasts
CMNPD23280	inhibitor of lipopolysaccharide-induced TNFα production in RAW264.7 macrophages
CMNPD23282	activity against calpain 1
CMNPD23287	activity against calpain 1
CMNPD23290	activity against calpain 1
CMNPD23291	inhibitor of the cysteine protease calpain 1
CMNPD23294	inhibitor of the cysteine protease calpain 1
CMNPD23296	inhibitor of NO production in lipopolysaccharide (LPS)-stimulated mouse macrophage RAW 264.7 cells
CMNPD23298	act as a prodrug upon oxidative activation | anti-TB antibiotic
CMNPD23302	inhibition of Salmonella enterica
CMNPD23304	broad-spectrum antimicrobials | inhibitors of HCT-116 cells
CMNPD23305	broad-spectrum antimicrobials | inhibitors of HCT-116 cells
CMNPD23306	broad-spectrum antimicrobials | inhibitors of HCT-116 cells
CMNPD23307	broad-spectrum antimicrobials | inhibitors of HCT-116 cells
CMNPD23308	broad-spectrum antimicrobials | inhibitors of HCT-116 cells
CMNPD23309	broad-spectrum antimicrobials | inhibitors of HCT-116 cells
CMNPD23310	broad-spectrum antimicrobials | inhibitors of HCT-116 cells
CMNPD23311	inhibitor of the plant pathogenic fungi, Colletotrichum musae, Gibberella zeae and Penicillium citrinum
CMNPD23319	inhibitor of NF-κB in RAW264.7 cells
CMNPD23320	inhibitor of NF-κB in RAW264.7 cells
CMNPD23321	inhibitor of NF-κB in RAW264.7 cells
CMNPD23322	inhibitor of NF-κB in RAW264.7 cells
CMNPD23323	inhibitor of NF-κB in RAW264.7 cells
CMNPD23326	inhibitor of NF-κB in RAW264.7 cells
CMNPD23327	inhibitor of NF-κB in RAW264.7 cells
CMNPD23328	inhibitor of NF-κB in RAW264.7 cells
CMNPD23329	inhibitor of NF-κB in RAW264.7 cells
CMNPD23330	inhibitor of NF-κB in RAW264.7 cells
CMNPD23331	inhibitor of NF-κB in RAW264.7 cells
CMNPD23334	cytotoxic to several HTCLs
CMNPD23336	cytotoxic to several HTCLs
CMNPD23340	proliferation of HTCLs
CMNPD23341	proliferation of HTCLs
CMNPD23342	active against Staphylococcus epidermidis
CMNPD23345	inhibit M. tuberculosis protein tyrosine phosphatase A (PTPA)
CMNPD23347	inhibit M. tuberculosis protein tyrosine phosphatase A (PTPA) | weak AO vs TEAC
CMNPD23348	inhibitor of the enzyme β-glucuronidase
CMNPD23349	inhibit influenza virus strains H1N1 and H3N2 | cytotoxic to HTCLs
CMNPD23352	inhibit aromatase, a therapeutic target for breast cancer treatment
CMNPD23353	inhibit aromatase, a therapeutic target for breast cancer treatment
CMNPD23354	inhibit aromatase, a therapeutic target for breast cancer treatment
CMNPD23361	inhibit growth of E. coli
CMNPD23366	growth inhibition (P388)
CMNPD23367	growth inhibition (P388)
CMNPD23368	growth inhibition (P388)
CMNPD23369	growth inhibition (P388)
CMNPD23370	growth inhibition (P388)
CMNPD23371	growth inhibition (P388)
CMNPD23372	growth inhibitor of the phytoplankton Heterosima akashiwo
CMNPD23375	toxic to HTCLs | mod. inhib. vs HL-60 HTCL
CMNPD23376	toxic to HTCLs
CMNPD23379	antimicrobial
CMNPD23380	antimicrobial
CMNPD23391	antifouling activity against Bugula neritina (B. neritina) larvae settlement
CMNPD23404	inhibitor of H1N1
CMNPD23405	toxic to brine shrimp (Artemia salina)
CMNPD23406	toxic to brine shrimp (Artemia salina)
CMNPD23407	toxicity to brine shrimp
CMNPD23408	antimicrobial activities
CMNPD23409	antimicrobial activities
CMNPD23410	inhibit growth of Staphylococcus epidermidis and Xanthomonas campestris
CMNPD23411	inhibit growth of Staphylococcus epidermidis and Xanthomonas campestris
CMNPD23412	inhibit growth of Staphylococcus epidermidis and Xanthomonas campestris
CMNPD23422	active against the bacterial transpeptidase enzyme sortase A
CMNPD23423	inhibitory activity against two HTCLs
CMNPD23424	inhibitory activity against two HTCLs
CMNPD23425	inhibitory activity against two HTCLs
CMNPD23426	inhibitory activity against two HTCLs
CMNPD23427	inhibitory activity against two HTCLs
CMNPD23429	inhibitory activity against two HTCLs
CMNPD23430	inhibitory activity against two HTCLs
CMNPD23431	inhibitory activity against two HTCLs
CMNPD23433	inhibitory activity against two HTCLs
CMNPD23434	inhibitory activity against two HTCLs
CMNPD23438	growth inhibition of P388 cells
CMNPD23439	anti-inflammatory activity (inhibition of NO production)
CMNPD23440	anti-inflammatory activity (inhibition of NO production)
CMNPD23441	growth stimulant of corn (Zea mays L.) and barley (Hordeum vulgare L.) rootlets
CMNPD23442	inhibition of Mycobacterium phlei
CMNPD23443	inhibition of Mycobacterium phlei
CMNPD23444	inhibitor of HTCLs
CMNPD23453	inhibit human colon cancer RKO cells
CMNPD23456	inhibit human colon cancer RKO cells
CMNPD23458	inhibition of E. coli growth
CMNPD23459	cytotoxicity to brine shrimp
CMNPD23460	inhibit the osteosarcoma cell line POS1
CMNPD23465	cytotoxic to A549 cells | inhibitory against sortase A
CMNPD23467	inhibitor of protein tyrosine phosphatase 1B (PTP1B) activity
CMNPD23468	antifouling activity against B. amphitrite larvae settlement
CMNPD23476	cytotoxic to Staphylococcus albus
CMNPD23482	cytotoxic to HTCLs
CMNPD23487	antibacterial activity against several Gram-positive strains
CMNPD23488	inhibitor of tyrosinase
CMNPD23489	inhibitor of tyrosinase
CMNPD23491	inhibition of the Vero cell line
CMNPD23494	inhibition of the Vero cell line
CMNPD23499	cytotoxic to brine shrimp
CMNPD23500	inhibit replication of HIV-1
CMNPD23514	inhibit growth of several pathogenic fungi including azole-resistant C. albicans
CMNPD23538	strong radical-scavengers (DPPH)
CMNPD23539	strong radical-scavengers (DPPH)
CMNPD23542	toxic to brine shrimp
CMNPD23543	toxic to brine shrimp
CMNPD23546	cytotoxic to brine shrimp
CMNPD23547	cytotoxic to brine shrimp
CMNPD23548	cytotoxic to brine shrimp
CMNPD23549	inhibitor of the HTCLs HL60 and A549
CMNPD23550	inhibitor of the HTCLs HL60 and A549
CMNPD23551	H1N1 virus inhibition
CMNPD23553	cytotoxic to two HTCLs
CMNPD23554	cytotoxic to two HTCLs
CMNPD23555	inhibit growth of HTCLs
CMNPD23557	inhibitory activity against M. tuberculosis protein tyrosine phosphatase B (mPTPB)
CMNPD23558	acetylcholinesterase inhibitor
CMNPD23559	acetylcholinesterase inhibitor
CMNPD23562	activities against H1N1
CMNPD23565	activities against H1N1
CMNPD23571	activity against P. falciparum with relatively low toxicity to A549 cells
CMNPD23577	activity against brine shrimp
CMNPD23578	activity against brine shrimp
CMNPD23580	activity against H1N1
CMNPD23581	activity against H1N1
CMNPD23582	activity against H1N1
CMNPD23584	activity against H1N1
CMNPD23585	activity against H1N1
CMNPD23586	cytotoxic to several HTCLs
CMNPD23587	cytotoxic to several HTCLs
CMNPD23588	cytotoxic to several HTCLs
CMNPD23593	inhibitor of acetylcholinesterase
CMNPD23594	cytotoxic to KB and KBV200 cells
CMNPD23595	inhibition of E. faecalis
CMNPD23603	inhibitor of HEp-2 and HepG2 cells
CMNPD23607	inhibition of several Gram-positive bacteria
CMNPD23609	inhibitor of several HTCLs
CMNPD23612	cytotoxicity to NCI-H460 lung cancer cells
CMNPD23613	cytotoxicity to NCI-H460 lung cancer cells
CMNPD23614	toxicity to neuron 2a mouse neuroblastoma cells
CMNPD23615	inhibit quorum sensing in Pseudomonas aeruginosa
CMNPD23616	anti-inflammatory activity | inhibiting production of pro-inflammatory cytokine expression
CMNPD23617	inhibitor of histone deacetylase 4 and cytotoxic to several HTCLs
CMNPD23618	cytotoxicity against human B lymphocyte DG-75 cells
CMNPD23619	cytotoxicity against human B lymphocyte DG-75 cells
CMNPD23621	cytotoxin to P388 cells
CMNPD23622	cytotoxic to brine shrimp
CMNPD23626	toxicity to P388 cells
CMNPD23628	NO inhibitory activity against LPS-induced NO production in RAW264.7 macrophage cells suggesting potential as anti-inflammatory agents
CMNPD23629	NO inhibitory activity against LPS-induced NO production in RAW264.7 macrophage cells suggesting potential as anti-inflammatory agents
CMNPD23630	NO inhibitory activity against LPS-induced NO production in RAW264.7 macrophage cells suggesting potential as anti-inflammatory agents
CMNPD23631	NO inhibitory activity against LPS-induced NO production in RAW264.7 macrophage cells suggesting potential as anti-inflammatory agents
CMNPD23632	NO inhibitory activity against LPS-induced NO production in RAW264.7 macrophage cells suggesting potential as anti-inflammatory agents
CMNPD23633	NO inhibitory activity against LPS-induced NO production in RAW264.7 macrophage cells suggesting potential as anti-inflammatory agents
CMNPD23634	NO inhibitory activity against LPS-induced NO production in RAW264.7 macrophage cells suggesting potential as anti-inflammatory agents
CMNPD23645	antifungal
CMNPD23646	antifungal
CMNPD23647	activator of the ARE response
CMNPD23648	activator of the ARE response
CMNPD23649	activator of the ARE response
CMNPD23660	antioxidant properties in the ABTS assay
CMNPD23661	antioxidant properties in the ABTS assay
CMNPD23662	antioxidant properties in the ABTS assay
CMNPD23663	antioxidant properties in the ABTS assay
CMNPD23664	antioxidant properties in the ABTS assay
CMNPD23665	antioxidant properties in the ABTS assay
CMNPD23682	antifungal
CMNPD23683	cellular antioxidant activities
CMNPD23687	inhibit chloroquine-resistant P. falciparum
CMNPD23688	inhibit chloroquine-resistant P. falciparum
CMNPD23689	inhibit chloroquine-resistant P. falciparum
CMNPD23690	anti-inflammatory by inhibition of PGE2
CMNPD23691	inhibitor of human anaplastic thyroid carcinomas
CMNPD23694	inducer of nerve growth factor-like neuronal differentiation in PC12 cells
CMNPD23695	inducer of nerve growth factor-like neuronal differentiation in PC12 cells
CMNPD23696	inducer of nerve growth factor-like neuronal differentiation in PC12 cells
CMNPD23697	inducer of nerve growth factor-like neuronal differentiation in PC12 cells
CMNPD23698	inducer of nerve growth factor-like neuronal differentiation in PC12 cells
CMNPD23700	active against HeLa
CMNPD23701	inhibitor of multiple HTCLs
CMNPD23702	activity versus various HTCLs and non-proliferative human fibroblasts
CMNPD23703	activity versus various HTCLs and non-proliferative human fibroblasts
CMNPD23704	activity versus various HTCLs and non-proliferative human fibroblasts
CMNPD23705	activity versus various HTCLs and non-proliferative human fibroblasts
CMNPD23707	inhibit starfish embryo blastulation
CMNPD23708	stimulation of the differentiation of preadipocytes to adipocytes
CMNPD23709	stimulation of the differentiation of preadipocytes to adipocytes
CMNPD23710	stimulation of the differentiation of preadipocytes to adipocytes
CMNPD23711	stimulation of the differentiation of preadipocytes to adipocytes
CMNPD23712	stimulation of the differentiation of preadipocytes to adipocytes
CMNPD23713	inhibitor of starfish egg maturation
CMNPD23717	inhibitor of human peroxisome proliferator-activated receptor delta (hPPARδ) with 200-fold selectivity over other PPARs
CMNPD23718	Anti-inflammatory
CMNPD23719	Anti-inflammatory
CMNPD23720	Anti-inflammatory
CMNPD23721	Anti-inflammatory
CMNPD23722	activity against HL-60 cells
CMNPD23726	antitrypanocidal activity against T. b. rhodesiense
CMNPD23727	antitrypanocidal activity against T. b. rhodesiense
CMNPD23728	cytotoxic activity against RAW264.7 cells
CMNPD23729	cytotoxic activity against RAW264.7 cells
CMNPD23730	cytotoxic activity against RAW264.7 cells
CMNPD23731	cytotoxic activity against RAW264.7 cells
CMNPD23732	cytotoxic activity against RAW264.7 cells
CMNPD23733	cytotoxic activity against RAW264.7 cells
CMNPD23745	antimalarial agent against chloroquine-resistant P. falciparum
CMNPD23746	Pregnane X-Receptor (PXR) agonist
CMNPD23747	antifungal
CMNPD23749	antimicrobial activity against E. coli, S. aureus and Cryptococcus neoformans (C. neoformans)
CMNPD23750	antimicrobial activity against E. coli, S. aureus and Cryptococcus neoformans (C. neoformans)
CMNPD23754	active at sub-nanomolar levels against several cancer cell lines
CMNPD23755	active at sub-nanomolar levels against several cancer cell lines
CMNPD23757	inhibit NO production in LPS-stimulated macrophages
CMNPD23761	GI50 = 440–515 nM vs. three cell lines
CMNPD23762	activities against HepG2 hepatic carcinoma cells
CMNPD23763	activities against HepG2 hepatic carcinoma cells
CMNPD23771	potency against HepG2 cells
CMNPD23772	antibacterial (S. aureus)
CMNPD23790	antimicrobial | radical scavenging activity
CMNPD23791	antimicrobial | radical scavenging activity
CMNPD23792	antimicrobial | radical scavenging activity
CMNPD23793	antimicrobial activity (C. albicans and MRSA)
CMNPD23795	activity against tumour cells
CMNPD23798	activity against C. albicans, C. neoformans, S. aureus and Trichophyton mentagrophytes
CMNPD23799	activity against C. albicans, C. neoformans, S. aureus and Trichophyton mentagrophytes
CMNPD23800	inhibitor of P. falciparum
CMNPD23801	inhibitor of P. falciparum
CMNPD23802	inhibitor of P. falciparum
CMNPD23803	inhibitor of P. falciparum
CMNPD23807	activity against murine lymphoma
CMNPD23809	active inhibitor of the transient receptor potential cationic channel subfamily V (capsaicin receptor)
CMNPD23810	active inhibitor of the transient receptor potential cationic channel subfamily V (capsaicin receptor)
CMNPD23811	active inhibitor of the transient receptor potential cationic channel subfamily V (capsaicin receptor)
CMNPD23812	inhibitor of MDA-MB-231 breast cancer cells
CMNPD23813	a variety of biological activities, especially the inhibition of the growth of C. albicans
CMNPD23814	a variety of biological activities, especially the inhibition of the growth of C. albicans
CMNPD23815	a variety of biological activities, especially the inhibition of the growth of C. albicans
CMNPD23816	a variety of biological activities, especially the inhibition of the growth of C. albicans
CMNPD23817	a variety of biological activities, especially the inhibition of the growth of C. albicans
CMNPD23818	a variety of biological activities, especially the inhibition of the growth of C. albicans
CMNPD23823	inhibit the growth of PC3 prostate adenocarcinoma cells
CMNPD23824	activity against six HTCLs
CMNPD23825	activity against six HTCLs
CMNPD23832	inhibit a variety of protein kinases from a panel of 24 enzymes
CMNPD23838	antiproliferative effects at high concentrations
CMNPD23839	antiproliferative effects at high concentrations
CMNPD23840	antiproliferative effects at high concentrations
CMNPD23841	antiproliferative effects at high concentrations
CMNPD23842	antiproliferative effects at high concentrations
CMNPD23843	inhibitor of HT-29 cancer cells
CMNPD23844	inhibitor of HT-29 cancer cells
CMNPD23847	abrogate activity
CMNPD23848	abrogate activity
CMNPD23849	abrogate activity
CMNPD23850	inhibitor of various human and murine cancer cell lines | potent broad-spectrum antibiotic against several Gram-positive and negative bacteria
CMNPD23851	inhibitor of various human and murine cancer cell lines | potent broad-spectrum antibiotic against several Gram-positive and negative bacteria
CMNPD23852	inhibitor of various human and murine cancer cell lines | potent broad-spectrum antibiotic against several Gram-positive and negative bacteria
CMNPD23853	inhibit the growth of HL-60 cells
CMNPD23854	inhibit the growth of HL-60 cells
CMNPD23855	inhibit the growth of HL-60 cells
CMNPD23856	inhibit the growth of HL-60 cells
CMNPD23857	inhibit the growth of HL-60 cells
CMNPD23858	inhibit the growth of HL-60 cells
CMNPD23859	inhibit the growth of HL-60 cells
CMNPD23860	inhibit the growth of HL-60 cells
CMNPD23861	inhibit the growth of HL-60 cells
CMNPD23862	inhibit the growth of HL-60 cells
CMNPD23863	inhibit the growth of HL-60 cells
CMNPD23865	inhibit the growth of Mycobacterium
CMNPD23866	inhibit the growth of Mycobacterium
CMNPD23867	ctivity against HTCLs
CMNPD23868	cytotoxic against K562 and A549 cancer cell lines
CMNPD23869	cytotoxic against K562 and A549 cancer cell lines
CMNPD23870	cytotoxic against K562 and A549 cancer cell lines
CMNPD23871	cytotoxic against K562 and A549 cancer cell lines
CMNPD23872	micromolar inhibitor of various HTCLs
CMNPD23873	micromolar inhibitor of various HTCLs
CMNPD23878	inhibit HIF-1
CMNPD23879	inhibit HIF-1
CMNPD23880	inhibit HIF-1
CMNPD23887	activation of cAMP signalling to the standard probe, forskolin
CMNPD23888	potentiator of α3-GlyR and α1-GlyR
CMNPD23889	potentiator of α3-GlyR and α1-GlyR
CMNPD23890	potentiator of α3-GlyR and α1-GlyR
CMNPD23891	potentiator of α3-GlyR and α1-GlyR
CMNPD23892	potentiator of α3-GlyR and α1-GlyR
CMNPD23897	active against A498 cancer cells
CMNPD23898	active against A498 cancer cells
CMNPD23902	activity against four HTCLs
CMNPD23912	activity against various microbial pathogens
CMNPD23913	activity against various microbial pathogens
CMNPD23914	activity against various microbial pathogens
CMNPD23915	activity against various microbial pathogens
CMNPD23916	growth inhibition of Pseudoalteromonas and Polaribacter bacterial species
CMNPD23917	growth inhibition of Pseudoalteromonas and Polaribacter bacterial species
CMNPD23919	antitubercular activity
CMNPD23926	activity against HL-60 cells
CMNPD23931	anti-H5N1 virus agent
CMNPD23937	antibacterial and antioxidant properties
CMNPD23941	inhibit superoxide generation and elastase release by stimulated human neutrophils
CMNPD23945	antifouling activity against B. amphitrite
CMNPD23969	inhibitor of NF-κB activation
CMNPD23970	inhibitor of NF-κB activation
CMNPD23971	inhibitor of NF-κB activation
CMNPD23972	inhibitor of NF-κB activation
CMNPD23976	inhibitor of expression of iNOS and COX-2 in stimulated macrophages
CMNPD23983	cytotoxicity as anticipated for an exomethylene-conjugated lactone
CMNPD23989	effect against the model fouling organisms B. amphitrite and B. neritina
CMNPD23990	effect against the model fouling organisms B. amphitrite and B. neritina
CMNPD23991	effect against the model fouling organisms B. amphitrite and B. neritina
CMNPD23992	effect against the model fouling organisms B. amphitrite and B. neritina
CMNPD23993	effect against the model fouling organisms B. amphitrite and B. neritina
CMNPD23994	effect against the model fouling organisms B. amphitrite and B. neritina
CMNPD23995	effect against the model fouling organisms B. amphitrite and B. neritina
CMNPD23996	effect against the model fouling organisms B. amphitrite and B. neritina
CMNPD23997	effect against the model fouling organisms B. amphitrite and B. neritina
CMNPD23998	effect against the model fouling organisms B. amphitrite and B. neritina
CMNPD23999	effect against the model fouling organisms B. amphitrite and B. neritina
CMNPD24000	effect against the model fouling organisms B. amphitrite and B. neritina
CMNPD24002	inhibit NO production by stimulated macrophages
CMNPD24005	inhibit NO production by stimulated macrophages
CMNPD24009	inhibitor of NO production by stimulated macrophages
CMNPD24012	cytotoxic towards a range of human and murine tumour cell lines
CMNPD24013	cytotoxic towards a range of human and murine tumour cell lines
CMNPD24014	cytotoxic towards a range of human and murine tumour cell lines
CMNPD24016	cytotoxicity (P388)
CMNPD24017	cytotoxicity (P388)
CMNPD24022	cytotoxic towards a melanoma and a mouse kidney cell line
CMNPD24023	cytotoxic towards a melanoma and a mouse kidney cell line
CMNPD24042	inhibit human PTP1B
CMNPD24044	inhibit human PTP1B
CMNPD24057	cytotoxicity
CMNPD24058	cytotoxicity
CMNPD24059	cytotoxicity
CMNPD24060	cytotoxicity
CMNPD24061	cytotoxicity
CMNPD24062	cytotoxicity
CMNPD24063	cytotoxicity
CMNPD24064	cytotoxicity
CMNPD24065	cytotoxicity
CMNPD24066	poorly cytotoxic with some examples exhibiting strong antifouling activity
CMNPD24067	cytotoxicity
CMNPD24068	poorly cytotoxic with some examples exhibiting strong antifouling activity
CMNPD24069	cytotoxicity
CMNPD24070	cytotoxicity
CMNPD24071	cytotoxicity
CMNPD24072	cytotoxicity
CMNPD24073	cytotoxicity
CMNPD24074	cytotoxicity
CMNPD24075	poorly cytotoxic with some examples exhibiting strong antifouling activity
CMNPD24076	poorly cytotoxic with some examples exhibiting strong antifouling activity
CMNPD24077	poorly cytotoxic with some examples exhibiting strong antifouling activity
CMNPD24078	poorly cytotoxic with some examples exhibiting strong antifouling activity
CMNPD24079	poorly cytotoxic with some examples exhibiting strong antifouling activity
CMNPD24080	poorly cytotoxic with some examples exhibiting strong antifouling activity
CMNPD24081	poorly cytotoxic with some examples exhibiting strong antifouling activity
CMNPD24082	poorly cytotoxic with some examples exhibiting strong antifouling activity
CMNPD24083	poorly cytotoxic with some examples exhibiting strong antifouling activity
CMNPD24084	poorly cytotoxic with some examples exhibiting strong antifouling activity
CMNPD24085	poorly cytotoxic with some examples exhibiting strong antifouling activity
CMNPD24086	poorly cytotoxic with some examples exhibiting strong antifouling activity
CMNPD24087	poorly cytotoxic with some examples exhibiting strong antifouling activity
CMNPD24093	inhibition of NO production by stimulated macrophages
CMNPD24107	cytotoxicity and the ability to inhibit superoxide generation and elastase release from stimulated human neutrophils
CMNPD24109	activity towards an HTCL
CMNPD24111	activity towards an HTCL
CMNPD24113	cytotoxicity and the ability to inhibit superoxide generation and elastase release from stimulated human neutrophils
CMNPD24114	cytotoxicity and the ability to inhibit superoxide generation and elastase release from stimulated human neutrophils
CMNPD24115	cytotoxicity and the ability to inhibit superoxide generation and elastase release from stimulated human neutrophils
CMNPD24116	cytotoxicity and the ability to inhibit superoxide generation and elastase release from stimulated human neutrophils
CMNPD24117	cytotoxicity and the ability to inhibit superoxide generation and elastase release from stimulated human neutrophils
CMNPD24118	cytotoxicity and the ability to inhibit superoxide generation and elastase release from stimulated human neutrophils
CMNPD24119	cytotoxicity and the ability to inhibit superoxide generation and elastase release from stimulated human neutrophils
CMNPD24120	cytotoxicity and the ability to inhibit superoxide generation and elastase release from stimulated human neutrophils
CMNPD24121	cytotoxicity and the ability to inhibit superoxide generation and elastase release from stimulated human neutrophils
CMNPD24122	cytotoxicity and the ability to inhibit superoxide generation and elastase release from stimulated human neutrophils
CMNPD24138	cytotoxic
CMNPD24141	inhibit expression of iNOS and COX-2 in stimulated macrophages
CMNPD24142	inhibit expression of iNOS and COX-2 in stimulated macrophages
CMNPD24143	inhibit expression of iNOS and COX-2 in stimulated macrophages
CMNPD24144	inhibit expression of iNOS and COX-2 in stimulated macrophages
CMNPD24145	inhibit expression of iNOS and COX-2 in stimulated macrophages
CMNPD24146	antimicrobial
CMNPD24154	antibacterial
CMNPD24155	cytotoxic
CMNPD24156	cytotoxic
CMNPD24157	cytotoxic
CMNPD24158	cytotoxic
CMNPD24159	cytotoxic
CMNPD24160	cytotoxic
CMNPD24161	cytotoxic
CMNPD24162	cytotoxic
CMNPD24163	cytotoxic
CMNPD24164	cytotoxic
CMNPD24165	cytotoxic
CMNPD24166	cytotoxic
CMNPD24167	cytotoxic
CMNPD24168	cytotoxic
CMNPD24169	cytotoxic
CMNPD24170	cytotoxin
CMNPD24171	cytotoxin
CMNPD24172	cytotoxin
CMNPD24175	cytotoxicity
CMNPD24176	cytotoxicity
CMNPD24177	cytotoxicity
CMNPD24178	antimicrobial
CMNPD24179	antimicrobial
CMNPD24180	antimicrobial
CMNPD24181	antimicrobial
CMNPD24182	antimicrobial
CMNPD24183	antimicrobial
CMNPD24184	antimicrobial
CMNPD24185	inhibitor of IL-12 p40 cytokine production by stimulated bone marrow-derived dendritic cells
CMNPD24187	cytotoxic
CMNPD24188	antiviral (H5N1)
CMNPD24189	cytotoxicity towards a panel of HTCLs
CMNPD24190	cytotoxicity towards a panel of HTCLs
CMNPD24191	cytotoxicity towards a panel of HTCLs
CMNPD24192	cytotoxicity towards a panel of HTCLs
CMNPD24193	cytotoxicity towards a panel of HTCLs
CMNPD24194	cytotoxicity
CMNPD24195	cytotoxicity
CMNPD24196	cytotoxicity
CMNPD24197	cytotoxicity
CMNPD24198	cytotoxicity
CMNPD24201	cytotoxicity
CMNPD24204	inhibit the settlement of B. neritina larvae
CMNPD24210	cytotoxicity
CMNPD24211	cytotoxicity
CMNPD24212	cytotoxicity
CMNPD24213	cytotoxicity
CMNPD24214	cytotoxicity
CMNPD24215	cytotoxicity
CMNPD24216	cytotoxicity
CMNPD24217	cytotoxicity
CMNPD24218	cytotoxicity
CMNPD24219	cytotoxicity
CMNPD24220	cytotoxicity towards tumour cell lines
CMNPD24221	cytotoxicity towards tumour cell lines
CMNPD24223	active against the amastigote form with nearly sixty-fold selectivity versus Vero cells
CMNPD24224	inhibit the interaction of tumour suppressor p53 with Hdm2, potentially leading to reactivation of p53 and induction of apoptosis in cancer cells
CMNPD24225	inhibit the interaction of tumour suppressor p53 with Hdm2, potentially leading to reactivation of p53 and induction of apoptosis in cancer cells
CMNPD24226	inhibit the interaction of tumour suppressor p53 with Hdm2, potentially leading to reactivation of p53 and induction of apoptosis in cancer cells
CMNPD24227	inhibit the interaction of tumour suppressor p53 with Hdm2, potentially leading to reactivation of p53 and induction of apoptosis in cancer cells
CMNPD24228	inhibit the interaction of tumour suppressor p53 with Hdm2, potentially leading to reactivation of p53 and induction of apoptosis in cancer cells
CMNPD24229	inhibit the interaction of tumour suppressor p53 with Hdm2, potentially leading to reactivation of p53 and induction of apoptosis in cancer cells
CMNPD24230	inhibit the interaction of tumour suppressor p53 with Hdm2, potentially leading to reactivation of p53 and induction of apoptosis in cancer cells
CMNPD24231	inhibit the interaction of tumour suppressor p53 with Hdm2, potentially leading to reactivation of p53 and induction of apoptosis in cancer cells
CMNPD24232	inhibit the interaction of tumour suppressor p53 with Hdm2, potentially leading to reactivation of p53 and induction of apoptosis in cancer cells
CMNPD24233	inhibit the interaction of tumour suppressor p53 with Hdm2, potentially leading to reactivation of p53 and induction of apoptosis in cancer cells
CMNPD24234	inhibit the interaction of tumour suppressor p53 with Hdm2, potentially leading to reactivation of p53 and induction of apoptosis in cancer cells
CMNPD24235	inhibit the interaction of tumour suppressor p53 with Hdm2, potentially leading to reactivation of p53 and induction of apoptosis in cancer cells
CMNPD24236	sub-micromolar cytotoxicity (L5178Y)
CMNPD24255	cytotoxicity towards a panel of HTCLs
CMNPD24256	cytotoxicity towards a panel of HTCLs
CMNPD24257	cytotoxicity towards a panel of HTCLs
CMNPD24258	cytotoxicity towards a panel of HTCLs
CMNPD24262	inhibit the expression of pro-inflammatory cytokines in bone marrow-derived dendritic cells
CMNPD24263	inhibit the expression of pro-inflammatory cytokines in bone marrow-derived dendritic cells
CMNPD24264	inhibit the expression of pro-inflammatory cytokines in bone marrow-derived dendritic cells
CMNPD24265	inhibit the expression of pro-inflammatory cytokines in bone marrow-derived dendritic cells
CMNPD24270	antifungal | haemolytic | cytotoxic
CMNPD24271	antifungal | haemolytic | cytotoxic
CMNPD24272	antifungal | haemolytic | cytotoxic
CMNPD24273	antifungal | haemolytic | cytotoxic
CMNPD24274	antifungal | haemolytic | cytotoxic
CMNPD24276	cytotoxicity (weak) | haemolytic activity (strong)
CMNPD24279	cytotoxicity | haemolytic
CMNPD24280	cytotoxicity | haemolytic
CMNPD24281	cytotoxicity | haemolytic
CMNPD24282	cytotoxicity | haemolytic
CMNPD24283	cytotoxicity | haemolytic
CMNPD24284	cytotoxicity | haemolytic
CMNPD24285	inhibition of IL-6 production by stimulated bone marrow-derived dendritic cells
CMNPD24286	inhibition of IL-6 production by stimulated bone marrow-derived dendritic cells
CMNPD24288	inhibition of production of IL-6, IL-12 p40 and TNF-α
CMNPD24290	inhibition of IL-12 p40 production, and to a lesser extent of IL-6 production, in LPS-stimulated bone marrow-derived dendritic cells
CMNPD24291	inhibition of IL-12 p40 production, and to a lesser extent of IL-6 production, in LPS-stimulated bone marrow-derived dendritic cells
CMNPD24292	inhibition of IL-12 p40 production, and to a lesser extent of IL-6 production, in LPS-stimulated bone marrow-derived dendritic cells
CMNPD24293	antioxidant activity (DPPH assay)
CMNPD24294	antioxidant activity (DPPH assay)
CMNPD24315	cytotoxicity towards a breast tumour cell line
CMNPD24318	inhibitor of the Wnt signalling pathway | sub-micromolar cytotoxicity towards two human colorectal tumour cell lines
CMNPD24327	very potent (low nM) vs HTCL, 5000x less toxic than calyculin C
CMNPD24328	MDR-reversing
CMNPD24329	mod. antitrypanosomal activity
CMNPD24331	inhib. and lytic activity against P. capsici (0.02 uM) | broad spectrum AB
CMNPD24332	lytic activity against P. capsici (not as potent as 1) | broad spectrum AB
CMNPD24333	broad spectrum AB
CMNPD24334	broad spectrum AB
CMNPD24335	good AF | mod. AB activity | mod. cytotox. to HTCLs
CMNPD24336	good AF | mod. AB activity | mod. cytotox. to HTCLs
CMNPD24337	good AF | mod. AB activity | mod. cytotox. to HTCLs
CMNPD24338	inhib. of P. capsici (0.02 uM) | good AB activity
CMNPD24339	inhib. of P. capsici (0.02 uM) | good AB activity
CMNPD24340	inhib. of P. capsici (0.02 uM) | good AB activity
CMNPD24341	mod. AB activity (Ca conc. dependent)
CMNPD24342	weak-mod. MRSA and MSSA activity
CMNPD24343	weak-mod. MRSA and MSSA activity
CMNPD24344	broad spectrum AB (Gram-positive)
CMNPD24345	potent (10-50 nM) and selective growth inhib. of certain Gram-(+) and Gram-(-) strains, potent (7-9 nM) inhib. of drug-sensitive and MDR P. falciparum
CMNPD24347	mod. cytotox. HTCL (MCF-7)
CMNPD24357	mod. cytotox. HTCLs
CMNPD24358	mod. cytotox. HTCLs
CMNPD24359	mod. cytotox. HTCLs
CMNPD24360	mod. cytotox. HTCLs
CMNPD24363	potent antimalarial activity (nM) against several strain | mod. inhib. HepG2
CMNPD24369	potent and selective antitumor activity
CMNPD24370	mod. cytotox. HTCLs
CMNPD24371	mod. cytotox. HTCLs
CMNPD24372	mod. cytotox. HTCLs
CMNPD24373	mod. cytotox. HTCLs
CMNPD24374	in vivo activity against Candida in mice | mod. activity against C. albicans
CMNPD24375	mod. activity against C. albicans
CMNPD24376	mod. antioxidant activity
CMNPD24377	mod. antioxidant activity
CMNPD24381	cytotox HTCLs
CMNPD24382	mod. AF activity against plant pathogens
CMNPD24383	weak cytotox. to HTCLs
CMNPD24384	weak cytotox. to HTCLs | mod.-high inhib. vs 4 crop threatening fungi
CMNPD24385	mod. AF actvity (Fusarium oxysporum)
CMNPD24386	mod. AF actvity (Fusarium oxysporum)
CMNPD24387	mod. AF actvity (Fusarium oxysporum)
CMNPD24388	broad spectrum AB activity
CMNPD24389	mod. AB activity
CMNPD24390	mod. AB activity
CMNPD24391	mod. AB activity
CMNPD24398	potent inhib. of lipopolysaccharide induced NO production.
CMNPD24399	mod. radical scavenging activity (DPPH)
CMNPD24400	mod. radical scavenging activity (DPPH)
CMNPD24401	mod. radical scavenging activity (DPPH)
CMNPD24402	weak-mod. cytotox. to HTCLs
CMNPD24403	weak-mod. cytotox. to HTCLs
CMNPD24405	mod. AB activity
CMNPD24406	modest activity against HTCL (SKOV-3)
CMNPD24408	downregulates MMP-1 production
CMNPD24409	downregulates MMP-1 production
CMNPD24418	mod. AB act.
CMNPD24419	mod. AB act.
CMNPD24420	mod. AB act.
CMNPD24421	mod. AB act.
CMNPD24422	mod. AB act.
CMNPD24423	mod. AB act.
CMNPD24424	mod. but selective activity against VRE
CMNPD24428	mod. cytotox. to HTCLs
CMNPD24429	mod. inhib. phophodiesterase type 4B
CMNPD24430	mod. inhib. phophodiesterase type 4B
CMNPD24431	mod. inhib. phophodiesterase type 4B | mod. AB activity
CMNPD24437	mod. COX-2 inhib.
CMNPD24438	mod.-good selective inhib. of Micrococcus luteus
CMNPD24439	mod.-good selective inhib. of M. luteus.
CMNPD24442	mod.-good selective inhib. of M. luteus
CMNPD24443	mod.-good selective inhib. of M. luteus
CMNPD24451	antihyperlipidemic activity
CMNPD24452	mod. AB activity
CMNPD24455	inhib. siderophore biosynthetic enzymes | broad spectrum AB
CMNPD24456	inhib. siderophore biosynthetic enzymes | broad spectrum AB
CMNPD24457	mod. AB activity
CMNPD24459	topoisomerase I inhib. (good) | topoisomerase II inhib. (mod.) | modest AB
CMNPD24460	topoisomerase II inhib. (mod.)
CMNPD24461	topoisomerase II inhib. (good) | modest AB
CMNPD24465	AB. strongly cytotox. to HTCLs.
CMNPD24466	Binds to cell membranes.
CMNPD24467	induces apoptosis in HCT-116 cells
CMNPD24468	induces apoptosis in HCT-116 cells
CMNPD24469	induces apoptosis in HCT-116 cells
CMNPD24470	induces apoptosis in HCT-116 cells
CMNPD24471	inhib. hyaluronidase
CMNPD24472	potent pepsin inhib. mod. cathepsin B inhib.
CMNPD24473	potent pepsin inhib. mod. cathepsin B inhib.
CMNPD24474	mod. cytotox. to HTCLs
CMNPD24476	mod. cytotox. to HTCLs
CMNPD24477	mod. inhib. of NO production
CMNPD24478	mod. inhib. of NO production
CMNPD24479	good inhib. of isocitrate lyase in Candida
CMNPD24480	weak inhib. of isocitrate lyase in Candida | strong cytotox. to HTCLS
CMNPD24481	weak-mod. cytotox. to HTCLs
CMNPD24485	mod. inhib. of isocitrate lyase in Candida
CMNPD24486	mod. inhib. of isocitrate lyase in Candida
CMNPD24487	mod. inhib. of isocitrate lyase in Candida
CMNPD24488	mod. inhib. of isocitrate lyase in Candida
CMNPD24489	mod. inhib. of acetylcholinesterase | no significant cytotox. against 4 HTCL
CMNPD24490	mod. inhib. of acetylcholinesterase
CMNPD24491	mod. inhib. of acetylcholinesterase | no significant cytotox. against 4 HTCL
CMNPD24492	mod. inhib. of M. smegmatis. | mod. AB activ. vs 3 microb. strains; MIC range 4 - 16 μg/mL
CMNPD24497	inhib. type III secretion system (virulence causing) in Yersinia tuberculosis.
CMNPD24498	mod. cytotox. to HTCLs.
CMNPD24506	good antitrypanosomal activity
CMNPD24507	mod. antitrypanosomal activity.
CMNPD24508	radical scavenging activity vs DPPH and NO
CMNPD24509	radical scavenging activity vs DPPH and NO
CMNPD24510	radical scavenging activity vs DPPH and NO
CMNPD24511	radical scavenging activity vs DPPH and NO
CMNPD24512	radical scavenging activity vs DPPH and NO
CMNPD24513	radical scavenging activity vs DPPH and NO
CMNPD24531	exhibits synergism with antibiotic against MRSA
CMNPD24537	mod. AB activity
CMNPD24539	potent inhib. of human respiratory synctial virus (RSV)
CMNPD24541	potent activity vs 2 HTCLs
CMNPD24555	antimycobacterial activity (good) | antagnoist of TRP channels (modest)
CMNPD24564	potent inhib. of Fusarium graminearum | mod.-good AB activity
CMNPD24569	induction of quinone reductase in murine cancer cells.
CMNPD24572	good cytotox. vs 2 HTCLs
CMNPD24573	good cytotox. vs 2 HTCLs
CMNPD24580	arrest of cell cycle in A549 cells | mod. PKC-beta inhib | mod. S. aureus inhib.
CMNPD24581	arrest of cell cycle in A549 cells
CMNPD24589	mod. activity vs 10 HTCLs and two viruses
CMNPD24607	modest AB activity
CMNPD24610	mod. AB activity
CMNPD24611	mod. inhib. vs HL-60 HTCL
CMNPD24612	mod. inhib. vs HL-60 HTCL
CMNPD24615	potent lipid lowering effects
CMNPD24627	good cytotox. vs two phytoplankton
CMNPD24628	mod. cytotox. vs 1 zooplankton and 1 phytoplankton
CMNPD24629	mod. cytotox. vs 1 phytoplankton
CMNPD24630	selective inhib. of Vibrio species
CMNPD24631	broad spectrum AB
CMNPD24632	mod. AB activity
CMNPD24633	mod. activity vs Gram-positive bacteria
CMNPD24634	P-glycoprotein inhib. (MDR reversing)
CMNPD24636	mod. cytotox. vs 2 HTCLs
CMNPD24641	weak inhib. vs HTCLs
CMNPD24642	weak inhib. vs HTCLs
CMNPD24643	weak inhib. vs HTCLs
CMNPD24644	weak inhib. vs HTCLs
CMNPD24645	weak inhib. vs HTCLs
CMNPD24646	weak inhib. vs HTCLs
CMNPD24648	weak inhib. vs HTCLs
CMNPD24649	weak inhib. vs HTCLs
CMNPD24653	mod. inhib. of E. coli
CMNPD24654	mod. cytotox. to A. salina
CMNPD24655	weak cytotox. to A. salina
CMNPD24656	weak cytotox. to A. salina
CMNPD24662	potent activity vs B. amphitrite larvae
CMNPD24664	potent activity vs B. amphitrite larvae
CMNPD24665	potent and selective AB activity
CMNPD24666	modest AF activity
CMNPD24668	modest AF activity
CMNPD24670	significant AB activity vs S. aureus and MRSA
CMNPD24672	antagonist of cannabinoid receptor (subtype CB2)
CMNPD24673	antagonist of G protein-coupled receptor (GPR18)
CMNPD24678	inhib. of production of pro-inflammatory cytokines
CMNPD24681	potent competitive α-glucosidase inhibiton
CMNPD24682	potent competitive α-glucosidase inhibiton
CMNPD24683	potent broad spectrum AB activity
CMNPD24684	potent broad spectrum AB activity
CMNPD24685	strong antifouling activity vs B. amphitrite larval settlement | broad spectrum AB activity
CMNPD24686	strong antifouling activity vs B. amphitrite larval settlement | broad spectrum AB activity
CMNPD24687	broad spectrum AB activity
CMNPD24688	broad spectrum AB activity.
CMNPD24689	strong antifouling activity vs B. amphitrite larval settlement | broad spectrum AB activity
CMNPD24690	strong antifouling activity vs B. amphitrite larval settlement | broad spectrum AB activity
CMNPD24693	broad spectrum AB activity
CMNPD24694	broad spectrum AB activity
CMNPD24697	good lipid lowering activity
CMNPD24710	mod. cytotox. vs HTCL (HL-60)
CMNPD24715	weak AF activity
CMNPD24716	weak AF activity
CMNPD24718	specific inhib. of mammalian DNA polymerase b (pol b)
CMNPD24720	potent angiogenesis inhib.
CMNPD24722	mod. inhib. of V. harveyi
CMNPD24725	mod. cytotox. to A. salina
CMNPD24726	antiinflammatory | analgesic effects with no ulcerogenic effect
CMNPD24727	modest antiviral activity vs H1N1
CMNPD24728	modest antiviral activity vs H1N1
CMNPD24729	mod. radical scavenging activity (DPPH)
CMNPD24735	mod. inhib. of E. coli, weak AchE inhib.
CMNPD24737	modest cytotox. to A. salina
CMNPD24738	inhib. AP-1 dependent transcription without cytotox. | inhib. mollusk enzyme.
CMNPD24739	inhib. AP-1 dependent transcription without cytotox. | inhib. mollusk enzyme.
CMNPD24740	inhib. mollusk enzyme
CMNPD24741	inhib. mollusk enzyme
CMNPD24742	inhib. mollusk enzyme
CMNPD24745	inhib. AP-1 dependent transcription without cytotox. | inhib. mollusk enzyme
CMNPD24746	inhib. AP-1 dependent transcription without cytotox. | inhib. mollusk enzyme
CMNPD24748	mod. inibition of radical scavenging (DPPH)
CMNPD24750	inhib. transcription of oncogenic nuclear factor AP-1
CMNPD24751	modest inhib. of macrophage adhesion
CMNPD24752	mod. inibition of radical scavenging (DPPH) | mod. cytotox. to mammalian cell line
CMNPD24753	modest inhib. of macrophage adhesion
CMNPD24755	mod.-selective activity vs HTCLs
CMNPD24756	good-mod. activity vs HTCLs
CMNPD24765	modest cytotox. vs 2 HTCLs
CMNPD24766	modest cytotox. vs 2 HTCLs
CMNPD24767	weak cytotox. to HTCLs
CMNPD24768	weak cytotox. to HTCLs
CMNPD24769	weak cytotox. to HTCLs
CMNPD24770	mod. cytotox. vs HTCLs
CMNPD24771	mod. cytotox. vs HTCLs
CMNPD24772	mod. cytotox. vs HTCLs
CMNPD24773	mod. cytotox. vs HTCLs
CMNPD24774	mod. cytotox. vs HTCLs
CMNPD24775	weak cytotox. vs HTCLs
CMNPD24776	weak cytotox. vs HTCLs
CMNPD24777	weak cytotox. vs HTCLs
CMNPD24778	weak cytotox. vs HTCLs
CMNPD24779	weak cytotox. vs HTCLs
CMNPD24782	inhib. of NO production
CMNPD24783	mod. cytotox. vs HTCLs
CMNPD24788	mod.-good inhib. of Gram-positive bacteria
CMNPD24789	mod.-good inhib. of Gram-positive bacteria
CMNPD24790	mod.-good inhib. of Gram-positive bacteria
CMNPD24791	mod.-good inhib. of Gram-positive bacteria
CMNPD24792	mod.-good inhib. of Gram-positive bacteria
CMNPD24793	mod.-good inhib. of Gram-positive bacteria | potent inhib. of MRSA and MRSE
CMNPD24794	mod.-good inhib. of Gram-positive bacteria | potent inhib. of MRSA and MRSE
CMNPD24795	mod.-good inhib. of Gram-positive bacteria | potent inhib. of MRSA and MRSE
CMNPD24796	mod.-good inhib. of Gram-positive bacteria | potent inhib. of MRSA and MRSE
CMNPD24797	mod.-good inhib. of Gram-positive bacteria | potent inhib. of MRSA and MRSE | inhib. of VRE
CMNPD24798	mod.-good inhib. of Gram-positive bacteria
CMNPD24799	mod.-good inhib. of Gram-positive bacteria
CMNPD24800	mod.-good inhib. of Gram-positive bacteria
CMNPD24801	mod.-good inhib. of Gram-positive bacteria
CMNPD24802	mod.-good inhib. of Gram-positive bacteria
CMNPD24806	antihyperlipidemic activity
CMNPD24807	antihyperlipidemic activity
CMNPD24808	antihyperlipidemic activity
CMNPD24813	antihyperlipidemic activity
CMNPD24814	antihyperlipidemic activity
CMNPD24816	antihyperlipidemic activity
CMNPD24817	antihyperlipidemic activity
CMNPD24820	mod. inhib. of HIV-1
CMNPD24825	mod. inhib. of HIV-1
CMNPD24826	mod. inhib. of HIV-1
CMNPD24827	good AB activity | modest cytotox. vs 2 HTCLs
CMNPD24834	weak cytotox. vs HTCL (A-375)
CMNPD24835	weak cytotox. vs HTCL (A-375)
CMNPD24836	weak cytotox. vs 3 HTCLs
CMNPD24837	modest inhib. of S. epidermidis
CMNPD24842	Activation of p21 promoter activity.
CMNPD24849	mod.-high inhib. vs 4 crop threatening fungi
CMNPD24850	mod.-high inhib. vs 4 crop threatening fungi
CMNPD24851	weak cytotox. vs 4 HTCLs
CMNPD24852	good AB activity
CMNPD24856	polarise tumour associated macrophages (TABs)
CMNPD24861	strong inhib. of M. tuberculosis protein tyrosine phosphatase B (MptpB)
CMNPD24864	mod. cytotox. vs HTCL (H1975)
CMNPD24865	mod. cytotox. vs 2 HTCLs
CMNPD24866	modest cytotox. vs two HTCLs
CMNPD24867	inhib. tum. growth human xenograft osteosarcoma | potent cytotox. vs HTCLs (especially MG-63)
CMNPD24875	potent COX-2 inhib. | modest inhib. of anti-enterovirus (EV71)
CMNPD24881	cytotox. vs 3 HTCLs | mod. radical scavenging activity (DPPH)
CMNPD24882	cytotox. vs 3 HTCLs
CMNPD24883	cytotox. vs 3 HTCLs | mod. radical scavenging activity (DPPH)
CMNPD24891	mod. inhib. of S. aureus
CMNPD24892	inhib. of human protein tyrosine phosphatase 1B and silent information regulator T1 (SIRT1) | mod. inhib. of S. aureus
CMNPD24894	cytotox. vs 10 HTCLs
CMNPD24895	cytotox. vs 10 HTCLs
CMNPD24896	potent inhib. of plant pathogenic fungus C. gloeosporoides
CMNPD24897	potent inhib. of plant pathogenic fungus C. gloeosporoides
CMNPD24899	modest cytotox. vs A. salina
CMNPD24901	good cytotox. vs 9 HTCLs
CMNPD24902	good cytotox. vs 9 HTCLs
CMNPD24905	good cytotox. vs 9 HTCLs
CMNPD24906	good cytotox. vs 9 HTCLs
CMNPD24913	weak cytotox. vs 4 HTCLs
CMNPD24914	weak cytotox. vs 4 HTCLs
CMNPD24915	weak cytotox. vs 4 HTCLs
CMNPD24918	mod. activity vs A. hydrophilia | weak cytotox. vs A. salina
CMNPD24919	weak cytotox. vs A. salina
CMNPD24920	weak cytotox. vs A. salina
CMNPD24922	weak inhib. vs 2 viruses
CMNPD24923	inhib. of tuberculosis. weak cytotox. vs 10 HTCLs | weak inhib. vs 2 viruses
CMNPD24924	weak cytotox. vs 10 HTCLs
CMNPD24925	weak inhib. vs 2 viruses
CMNPD24926	weak inhib. vs 2 viruses
CMNPD24928	weak cytotox. vs HTCL (MGC-803)
CMNPD24935	good cytotox. vs 8 HTCLs
CMNPD24938	weak cytotox. vs 2 HTCLs
CMNPD24941	good antiinflammatory activity (NO production inhib.)
CMNPD24942	modest antiinflammatory activity (NO production inhib.)
CMNPD24945	mod. broad spectrum AB activity
CMNPD24946	mod. broad spectrum AB activity
CMNPD24948	modest cytotox. vs A. salina
CMNPD24956	inhib. of differentiation of 3T3-4 cells to adipocytes
CMNPD24958	potent protease inhib. (elastase and chymotrypsin) | mod. cytotox. (2 HTCLs)
CMNPD24959	cytotox. (2 HTCLs)
CMNPD24960	cannabinoid recptor (CB1) binding ligand
CMNPD24962	good inhibition of Chikungunya virus (CHIKV)
CMNPD24963	inhib. of Candida
CMNPD24964	inhib. of Candida
CMNPD24965	inhib. of Candida
CMNPD24966	inhib. of Candida
CMNPD24967	potent inhib. (2 HTCLs) | ER stress induction
CMNPD24968	Selective inhib. of chymotrypsin | Strong cytotox. (2 HTCLs)
CMNPD24969	weak but acute cytotox. vs A. salina
CMNPD24970	weak but acute cytotox. vs A. salina
CMNPD24971	mod. cytotox. ( 2 HTCLs) | cytotox. to shrimp, Palaemon paucidens
CMNPD24972	weak cytox (5 HTCLs) | potent cytotox. vs fibroblasts
CMNPD24978	potent growth promoter of ST-2 cells
CMNPD24979	stim. of actomyosin ATPase activity
CMNPD24980	potent lethal effects on neuronal cells
CMNPD24981	modest activity vs C. albicans
CMNPD24983	growth promoter of ST-2 cells
CMNPD24984	potent cytotox. vs HeLa
CMNPD24985	inhib. of N-type Ca channel opening
CMNPD24986	inhib. of N-type Ca channel opening
CMNPD24987	modest ABl activity | modest inhib. of T. mentagrophytes
CMNPD24988	modest inhib. of T. mentagrophytes
CMNPD24989	modest cytox vs P388 cells
CMNPD24990	modest inhib. of T. mentagrophytes
CMNPD24991	potent cytox to Jurkat T lymphocytes
CMNPD24992	potent cytox to Jurkat T lymphocytes
CMNPD24993	cytotox. vs neuro-2a cells
CMNPD24994	potent cytotox. vs neuro-2a cells
CMNPD24995	high acute toxicity to mice
CMNPD24998	neuroprotective against Ab25-35-induced SH-SY5Y cell damage
CMNPD24999	weakly neuroprotective against Ab25-35-induced SH-SY5Y cell damage
CMNPD25000	inhib. of hPTP1B. IC50 5.86 mM
CMNPD25001	bioactivity against a range of microorganisms evaluated
CMNPD25002	evaluated against HIV-1, H5N1and LPS-induced NO production
CMNPD25003	evaluated against HIV-1, H5N1and LPS-induced NO production
CMNPD25004	evaluated against HIV-1, H5N1and LPS-induced NO production
CMNPD25005	evaluated against HIV-1, H5N1and LPS-induced NO production
CMNPD25006	evaluated against HIV-1, H5N1and LPS-induced NO production
CMNPD25007	evaluated against HIV-1, H5N1and LPS-induced NO production
CMNPD25008	evaluated against HIV-1, H5N1and LPS-induced NO production
CMNPD25012	evaluated in anti-HIV-1 assay system
CMNPD25013	evaluated in anti-HIV-1 assay system
CMNPD25014	evaluated in anti-HIV-1 assay system
CMNPD25015	tested agaisnt 4 HTCLs
CMNPD25016	active agaisnt 3 HTCLs. IC50
CMNPD25017	IC50 against PTP1B 2.24 μg/mL
CMNPD25019	inhib. of LPS-i-NO in RAW264.7 cells
CMNPD25020	inhib. of LPS-i-NO in RAW264.7 cells
CMNPD25021	inhib. of LPS-i-NO in RAW264.7 cells
CMNPD25022	potent antifouling activity
CMNPD25023	potent antifouling activity
CMNPD25040	strong AF activity
CMNPD25041	strong AF activity | mod. cytox. A549 cells
CMNPD25042	strong AF activity
CMNPD25048	mod. cytotox. KB and MCF-7 cells
CMNPD25049	mod. cytotox. KB cells
CMNPD25058	modest AB activity
CMNPD25059	modest AB activity
CMNPD25060	IC50 40 μg/mL DNA binding using methyl green displacement
CMNPD25062	mod. to weak AB activity and vs HTCL, ATPase
CMNPD25063	mod. to weak AB activity and vs HTCL, ATPase
CMNPD25065	weak AB activity
CMNPD25066	low μM activity vs 7 HTCL
CMNPD25067	low μM activity vs 7 HTCL
CMNPD25068	mod. activity vs HTCL
CMNPD25069	weak activity vs HTCL
CMNPD25074	weak inhib. of 5 HTCLs
CMNPD25075	weak inhib. of 3 HTCLs
CMNPD25076	suppresses RANKL-induced osteoclast differentiation at > 1 μM | inhibit NFATTc1 translation
CMNPD25078	23.8% inhib. of pancreatic lipase at 50 μM
CMNPD25079	40.1% inhib. of pancreatic lipase at 50 μM
CMNPD25080	11.9% inhib. of pancreatic lipase at 50 μM
CMNPD25081	43.9% inhib. of pancreatic lipase at 50 μM
CMNPD25082	32.8% inhib. of pancreatic lipase at 50 μM
CMNPD25087	mod. antimalarial activity
CMNPD25088	mod. antimalarial activity
CMNPD25090	mod. antimalarial activity
CMNPD25091	mod. antimalarial activity
CMNPD25092	mod. antimalarial activity
CMNPD25093	weak activity vs HTCL
CMNPD25094	weak activity vs HTCL
CMNPD25097	potent activity vs 3 HTCLs
CMNPD25098	potent activity vs 3 HTCLs
CMNPD25099	potent activity vs 3 HTCLs
CMNPD25100	potent activity vs 3 HTCLs
CMNPD25101	potent activity vs 3 HTCLs
CMNPD25102	potent activity vs 3 HTCLs
CMNPD25103	potent activity vs 3 HTCLs
CMNPD25104	potent activity vs 3 HTCLs
CMNPD25105	potent activity vs 3 HTCLs
CMNPD25106	potent activity vs HTCLs
CMNPD25107	mod. activity vs HTCLs
CMNPD25108	mod. activity vs HTCLs | 39% inhib. of NFF cells at 10 μM
CMNPD25109	potent activity vs HTCLs
CMNPD25110	mod. activity vs HTCLs
CMNPD25111	mod. activity vs HTCLs
CMNPD25112	mod. activity vs HTCLs
CMNPD25119	weak activity vs HTCLs
CMNPD25120	weak activity vs HTCLs | mod. vs Na+/K+ ATPase
CMNPD25121	mod. AB activity and vs HTCL
CMNPD25122	very potent (nM) activity vs three HTCLs
CMNPD25125	mod. cytoxicity vs HTCL and inhib. of proteasome action | modest inhib. of cholesterol accumulation at 20 μM
CMNPD25126	mod. cytoxicity vs HTCL and inhib. of proteasome action | potent inhib. of cholesterol accumulation at 20 μM
CMNPD25128	weak cytoxicity vs HTCL and potent inhib. of proteasome action | strong inhib. of cholesterol accumulation at 20 μM
CMNPD25129	weak cytoxicity vs HTCL and mod. inhib. of proteasome action | strong inhib. of cholesterol accumulation at 20 μM
CMNPD25130	weak activity vs HTCL | weak proteasome inhib. | no inhib. of cholesterol ester accumulation at 20 μM
CMNPD25131	mod. activity vs HTCL | potent proteasome inhib. | 91% inhib. of cholesterol ester accumulation at 20 μM
CMNPD25133	87.1% inhib. of delayed rectifier K+ currents in rat dissociated hippocampal neurons at 100 μM
CMNPD25135	76.2% inhib. of delayed rectifier K+ currents in rat dissociated hippocampal neurons at 100 μM
CMNPD25140	weak cytotox. vs 1 HTCL
CMNPD25141	weak cytotox. vs 1 HTCL
CMNPD25142	weak AB activity
CMNPD25143	weak AB activity
CMNPD25145	weak AB activity
CMNPD25146	weak AB activity
CMNPD25149	mod. inhib. of chymotrypsin-like activity of proteasome and Ubc13-Uev-1A
CMNPD25150	weak activity vs HTCL
CMNPD25151	weak activity vs HTCL
CMNPD25152	mod. antimycobacterial activity against both active and dormant M. smegmatis
CMNPD25155	weak AF activity
CMNPD25156	weak AF activity
CMNPD25157	weak AF activity
CMNPD25159	potent inhib. of 6 HTCLs
CMNPD25165	potent inhib. of 6 HTCLs
CMNPD25167	weak activity against HTCLs
CMNPD25168	increased iNOS expression and hence NO production in RAW 264.7 cells at 10 μM
CMNPD25174	mod. antimalarial activity
CMNPD25176	mod. activity vs HTCL
CMNPD25183	weak AB activity
CMNPD25186	mod. AB activity
CMNPD25187	mod. AB activity
CMNPD25188	mod. AB activity
CMNPD25189	weak AB activity vs Cryptococcus neoformans
CMNPD25190	weak AB activity vs C. neoformans
CMNPD25191	weak AB activity vs C. neoformans
CMNPD25199	increased ApoE secretion at 40 μM
CMNPD25205	mod. to weak AB activity
CMNPD25206	mod. to weak AB activity
CMNPD25207	mod. to weak AB activity
CMNPD25210	IC50 68 μg/mL DNA binding using methyl green displacement
CMNPD25211	weak nemotocidal activ. vs Haemonchus contortus
CMNPD25215	mod. AB activity
CMNPD25216	low activity versus HTCL
CMNPD25217	mod. AB and low activity vs HTCL
CMNPD25220	mod. antibacterial (MIC 8 μg/mL vs MRSA)
CMNPD25221	mod. activity vs HTCLs and NF-κB
CMNPD25222	mod. activity vs HTCLs and NF-κB
CMNPD25223	mod. activity vs HTCLs and NF-κB
CMNPD25224	mod. activity vs HTCLs and NF-κB
CMNPD25225	mod. activity vs HTCLs and NF-κB
CMNPD25226	mod. activity vs HTCLs and NF-κB
CMNPD25227	mod. activity vs HTCLs and NF-κB
CMNPD25228	mod. activity vs HTCLs and NF-κB
CMNPD25229	mod. activity vs HTCLs and NF-κB
CMNPD25230	mod. activity vs HTCLs and NF-κB
CMNPD25231	mod. activity vs HTCLs and NF-κB
CMNPD25232	mod. activity vs HTCLs and NF-κB
CMNPD25233	mod. activity vs HTCLs and NF-κB
CMNPD25235	low μM activity against HTCL and various microbial species
CMNPD25237	low μM activity HTCL | no inhib. of protein kinases
CMNPD25238	low μM activity HTCL | no inhib. of protein kinases
CMNPD25239	low μM activity HTCL | no inhib. of protein kinases
CMNPD25240	low μM activity HTCL | no inhib. of protein kinases
CMNPD25241	low μM activity HTCL | no inhib. of protein kinases
CMNPD25242	inactive vs HTCL | potent low μM inhib. of 16 protein kinases
CMNPD25243	inactive vs HTCL | potent low μM inhib. of 16 protein kinases
CMNPD25244	potent inhib. of chymotrypsin-like activity of proteasome
CMNPD25245	weak inhib. of IDO
CMNPD25246	mod. inhib. of IDO
CMNPD25247	effect neurotransmission by enhancing Ca2+-dependent glutamate release in nerve synaptosomes
CMNPD25250	weak AB activity
CMNPD25253	weak AB activity
CMNPD25254	weak AB activity
CMNPD25255	weak AB activity
CMNPD25259	weak AB activity
CMNPD25261	mod. agonist of hPPARδ
CMNPD25264	mod. agonist of hPPARδ
CMNPD25268	mod. activity vs 2 HTCL
CMNPD25278	mod. to weak activity against P. falciparum (W2)
CMNPD25279	mod. activity against P. falciparum (W2 and D6)
CMNPD25280	mod. activity against P. falciparum (W2 and D6)
CMNPD25285	mod. aromatase inhib. and weak QR1 inducer
CMNPD25296	mod. cytoxicity against HTCL
CMNPD25298	low cytoxicity against HTCL
CMNPD25299	low cytoxicity against HTCL
CMNPD25300	mod. cytoxicity against HTCL
CMNPD25301	mod. to weak AB activity and vs HTCL, ATPase
CMNPD25302	mod. to weak AB activity and vs HTCL, ATPase
CMNPD25303	mod. to weak AB activity and vs HTCL, ATPase
CMNPD25304	mod. to weak AB activity and vs HTCL, ATPase
CMNPD25305	mod. to weak AB activity and vs HTCL, ATPase
CMNPD25306	mod. to weak AB activity and vs HTCL, ATPase
CMNPD25307	low affinity binding to TDP-43
CMNPD25308	high affinity binding to TDP-43
CMNPD25309	high affinity binding to TDP-43
CMNPD25310	low affinity binding to TDP-43
CMNPD25311	low affinity binding to TDP-43
CMNPD25313	weak inihibito of 6 HTCLs
CMNPD25314	weak inihibito of 6 HTCLs
CMNPD25315	weak inihibito of 6 HTCLs
CMNPD25318	weak antileishmanial activity
CMNPD25319	potent activity vs HTCLs | weak AB and mod. ATPase activity
CMNPD25320	potent activity vs HTCLs | weak AB and ATPase activity
CMNPD25321	potent activity vs HTCLs | weak AB and ATPase activity
CMNPD25322	mod. to weak activity vs HTCLs
CMNPD25323	mod. to weak activity vs HTCLs
CMNPD25324	mod. to weak activity vs HTCLs
CMNPD25325	mod. to weak AB activity and weak activity vs HTCL
CMNPD25326	mod. to weak AB activity and weak activity vs HTCL
CMNPD25327	IC50 78 μg/mL DNA binding using methyl green displacement
CMNPD25328	weakly active vs 3 HTCLs
CMNPD25330	mod. PXR agonist (EC50 = 21 μM)
CMNPD25333	weak activity against 60 HTCLs
CMNPD25334	mod. activity against 60 HTCLs
CMNPD25335	modest AB activity
CMNPD25336	agonist of PXR transactivation at 10 μM in HepG2 cells
CMNPD25337	agonist of PXR transactivation at 10 μM in HepG2 cells
CMNPD25338	mod. activity vs HTCLs and (h)p300 histone deacetylase
CMNPD25339	mod. activity vs HTCLs and (h)p300 histone deacetylase
CMNPD25340	potent (nM) activity vs HTCLs | competitive binding vs estradiol against estrogen receptor
CMNPD25345	weakly active vs 3 HTCLs
CMNPD25350	PDE4D IC50 8.5 μM
CMNPD25355	PDE4D IC50 20.3 μM
CMNPD25367	cytotox.
CMNPD25368	cytotox.
CMNPD25369	B. amphitrite settlement inhib.
CMNPD25374	weak NF-kB inhib.
CMNPD25378	inactive antifouling | AB
CMNPD25379	inactive antifouling | AB
CMNPD25380	inactive antifouling | AB
CMNPD25399	weak inhib. superoxide formation and elastase release
CMNPD25400	weak inhib. superoxide formation and elastase release
CMNPD25401	weak inhib. elastase release
CMNPD25403	weak inhib. superoxide formation and elastase release
CMNPD25404	not cytotox. (3 HTCL)
CMNPD25405	not cytotox. (3 HTCL)
CMNPD25406	not cytotox. (3 HTCL)
CMNPD25407	toxic to brine shrimp
CMNPD25408	moderate cytotox. (2 cell lines)
CMNPD25410	antileishmanial activity
CMNPD25411	inactive
CMNPD25412	modest cytotox. (L5187Y)
CMNPD25414	modest cytotox. (L5187Y)
CMNPD25415	mild AB activity
CMNPD25417	inactive in range of assays
CMNPD25418	inactive in range of assays
CMNPD25419	B. amphitrite settlement inhib.
CMNPD25420	B. amphitrite settlement inhib.
CMNPD25421	antiviral (HCMV)
CMNPD25422	modest cytotox. (P388)
CMNPD25423	NF-kB inhib.
CMNPD25424	NF-kB inhib.
CMNPD25427	weakly cytotox. (NCI)
CMNPD25430	weakly cytotox. | potent inhib. of iNOS expression
CMNPD25431	weakly cytotox. | potent inhib. of iNOS expression
CMNPD25432	weakly cytotox. | potent inhib. of iNOS expression
CMNPD25433	weakly cytotox. (4 HTCL)
CMNPD25434	weakly cytotox. (4 HTCL)
CMNPD25435	weakly cytotox. (4 HTCL)
CMNPD25436	weakly cytotox. (MCF7)
CMNPD25437	weakly cytotox. (MCF7)
CMNPD25438	weakly cytotox. (MCF7)
CMNPD25439	inactive (MCF-7)
CMNPD25440	inactive (MCF-7)
CMNPD25441	inactive (MCF-7)
CMNPD25442	inactive (MCF-7)
CMNPD25443	weakly cytotox. (2 HTCL)
CMNPD25444	weakly cytotox. (2 HTCL)
CMNPD25445	cytotox. (4 HTCL) including 2 resistant lines
CMNPD25446	inactive
CMNPD25447	inactive
CMNPD25448	inactive
CMNPD25454	inhibit superoxide formation
CMNPD25455	inhibit elastase release
CMNPD25456	weak inhib. superoxide formation and elastase release
CMNPD25457	weak inhib. superoxide formation and elastase release
CMNPD25458	COX-1/2 inhib.
CMNPD25462	weakly cytotox. (A549)
CMNPD25463	mod. cytotox. (MG63)
CMNPD25466	mild inhib. superoxide generation and elastase release
CMNPD25473	B. amphitrite settlement inhib.
CMNPD25474	B. amphitrite settlement inhib.
CMNPD25477	B. amphitrite settlement inhib.
CMNPD25479	Í
CMNPD25486	weak inhib. superoxide formation and elastase release
CMNPD25490	weak inhib. superoxide formation and elastase release
CMNPD25492	B. amphitrite settlement inhib.
CMNPD25493	B. amphitrite settlement inhib.
CMNPD25501	reduced inducton of IL-6
CMNPD25502	weakly cytotox. (Molt 4)
CMNPD25503	weakly cytotox. (Molt 4)
CMNPD25505	weakly cytotox. (Molt 4)
CMNPD25506	strong inhib. of elastase release
CMNPD25515	mod. cytotox. (2 cell lines)
CMNPD25516	cytotox. (HCT116)
CMNPD25520	cytotox. (2 HTCL)
CMNPD25524	inhibit PTP1B
CMNPD25528	phosphodiesterase-4 inhib.
CMNPD25530	phosphodiesterase-4 inhib.
CMNPD25532	phosphodiesterase-4 inhib.
CMNPD25534	phosphodiesterase-4 inhib.
CMNPD25536	phosphodiesterase-4 inhib.
CMNPD25537	phosphodiesterase-4 inhib.
CMNPD25538	phosphodiesterase-4 inhib.
CMNPD25539	phosphodiesterase-4 inhib.
CMNPD25543	K562 15 uM, zebrafish embryo cytotox. (mixture with 1241)
CMNPD25544	K562 8 uM, zebrafish embryo cytotox..
CMNPD25545	K562 13 uM, zebrafish embryo cytotox.
CMNPD25546	weakly cytotox.
CMNPD25547	weakly cytotox. and PTP1B inhib.
CMNPD25548	weakly cytotox.
CMNPD25549	moderately cytotox. to 5 HTCLs
CMNPD25551	antiviral (RSV)
CMNPD25552	antiviral (RSV)
CMNPD25553	antiviral (RSV)
CMNPD25554	antiviral (RSV)
CMNPD25555	NF-kB inhib.
CMNPD25558	antiinflammatory inhib. of LTC4 generation
CMNPD25559	cytotox. to A549 HTCL
CMNPD25560	cytotox. to A549 HTCL
CMNPD25561	weakly cytotox. to A549 HTCL
CMNPD25562	weakly cytotox. to A549 HTCL
CMNPD25563	weakly cytotox. to A549 HTCL
CMNPD25564	barnacle cyprid settlement inhib.
CMNPD25565	barnacle cyprid settlement inhib.
CMNPD25568	cytotox. rat glioma cell line
CMNPD25569	cytotox. rat glioma cell line
CMNPD25570	cytotox. rat glioma cell line
CMNPD25572	cytotox. rat glioma cell line
CMNPD25593	cytotox.
CMNPD25597	cytotox. (6 HTCL)
CMNPD25600	cytotox. (6 HTCL)
CMNPD25601	cytotox. (6 HTCL)
CMNPD25609	cytotox. (5 HTCL)
CMNPD25610	cytotox. (5 HTCL)
CMNPD25611	anti-neuroinflammatory
CMNPD25614	mildly cytotox. and AB
CMNPD25615	mildly cytotox.
CMNPD25619	mildly AB
CMNPD25620	mildly AB
CMNPD25621	mildly cytotox.
CMNPD25622	mildly cytotox.
CMNPD25623	mild AChE inhib.
CMNPD25624	mild AChE inhib.
CMNPD25626	moderate cytotox. PC3.
CMNPD25627	PXR agonist
CMNPD25631	strongly cytotox. HTCL
CMNPD25632	mod. cytotox. HTCL
CMNPD25635	anti-inflammatory
CMNPD25636	Antioxidant (DPPH)
CMNPD25639	cytotox. and hemolytic
CMNPD25640	cytotox. and hemolytic
CMNPD25641	cytotox. and hemolytic
CMNPD25642	cytotox. and hemolytic
CMNPD25644	cytotox. and hemolytic
CMNPD25647	mild cytotox. (2 HTCLs)
CMNPD25648	AF
CMNPD25649	AF
CMNPD25650	AF
CMNPD25651	AF
CMNPD25652	cytotox., inhib. colony formation of 2 HTCLs
CMNPD25653	cytotox., inhib. colony formation of 2 HTCLs
CMNPD25654	cytotox., inhib. colony formation of 2 HTCLs
CMNPD25658	AF
CMNPD25659	AF
CMNPD25660	AF
CMNPD25661	AF
CMNPD25662	AF
CMNPD25663	AF
CMNPD25664	AF
CMNPD25665	AF
CMNPD25666	AF
CMNPD25667	AF
CMNPD25672	antioxidant
CMNPD25673	antioxidant
CMNPD25674	antioxidant
CMNPD25688	weakly cytotox.
CMNPD25692	inhibit NO production
CMNPD25695	inhibit NO production
CMNPD25697	mild PTP1B inhibition
CMNPD25701	mildly cytotox.
CMNPD25719	mod. AB activity
CMNPD25720	mild anti-influenza activity.
CMNPD25721	weakly cytotox.
CMNPD25723	NaV channel blocker.
CMNPD25724	no AB activity
CMNPD25725	AB activity against Pontibacillus sp.
CMNPD25726	no AB activity
CMNPD25727	no AB activity
CMNPD25728	no AB activity
CMNPD25729	no AB activity
CMNPD25730	AB activity against Pontibacillus sp.
CMNPD25731	no AB activity
CMNPD25732	AB activity against Pontibacillus sp. and Vibrio shiloi
CMNPD25733	sig. activity against HTCL
CMNPD25734	sig. activity against HTCL
CMNPD25735	sig. active against T. brucei
CMNPD25736	sig. active against T. brucei
CMNPD25737	not active against T. brucei
CMNPD25738	not active against T. brucei
CMNPD25739	not active against T. brucei
CMNPD25740	no AB activity
CMNPD25741	AB activity against K. pneumonia, A. hydrophila, S. aureus
CMNPD25743	weak bioactivity
CMNPD25744	weak bioactivity
CMNPD25745	selective inhib. of sterol O-acyltransferase-2
CMNPD25746	not a selective inhib. of sterol O-acyltransferase-2
CMNPD25747	inhib. AchE activity IC 50 11.8 μM. not cytotox. against 4 HTCL
CMNPD25748	inhib. AchE activity IC 50 13.5 μM. not cytotox. against 4 HTCL
CMNPD25749	not cytotox.
CMNPD25750	not cytotox.
CMNPD25751	not cytotox.
CMNPD25752	mod. cyt. against HepG2 | inactive MCF-7 & K562
CMNPD25753	no testing reported
CMNPD25754	no testing reported
CMNPD25755	EC 50 against P. falciparum 0.05μM
CMNPD25756	EC 50 against P. falciparum 0.139μM
CMNPD25757	EC 50 against P. falciparum 0.415μM
CMNPD25758	EC 50 against P. falciparum 0.082μM
CMNPD25759	EC 50 against P. falciparum 3.22μM
CMNPD25760	EC 50 against P. falciparum 0.266 μM
CMNPD25761	EC 50 against P. falciparum 1.52 μM
CMNPD25762	EC 50 against P. falciparum 8.70 μM
CMNPD25763	EC 50 against P. falciparum 1.26 μM
CMNPD25764	EC 50 against P. falciparum 49.6μM
CMNPD25765	EC 50 against P. falciparum 32 μM
CMNPD25766	6-20x less active against 5 parasite strains than actinoramide A
CMNPD25767	~2x less active against 5 parasite strains than actinoramide D
CMNPD25769	potent inducers of CHOP gene expression. mod. splicers XBP1
CMNPD25770	potent inducers of CHOP gene expression. mod. splicers XBP1
CMNPD25771	potent inducers of CHOP gene expression. mod. splicers XBP1
CMNPD25772	no notable AB activity against S. pneumoniae, S. aureus
CMNPD25773	potent inhib, of Gram-(-ve) and (+ve) bacterial RNAP and AB activity
CMNPD25774	no AB activity
CMNPD25775	AB activity against MRSA, E. coli, B. subtilis. active in murine thigh model
CMNPD25776	cyt. to HepG2 & MCF-7. tested for LPS-induced IL-6 production
CMNPD25777	cyt. to HepG2 & MCF-7. tested for LPS-induced IL-6 production
CMNPD25778	cyt. to HepG2 & MCF-7. tested for LPS-induced IL-6 production
CMNPD25779	MIC 2-8 μg/mL against MRSA, C. albicans, A. fumigatus. NA against E. coli
CMNPD25780	MIC 1-8 μg/mL against MRSA, C. albicans, A. fumigatus. NA against E. coli
CMNPD25782	mod. AB activity against 15 drug-sensitive/resistant MO and 12 HTCL
CMNPD25784	inhibits CE syn. in CHO cells and mice macrophages.IC 50 0.83 and 6.1 nM.
CMNPD25785	no testing reported
CMNPD25786	no testing reported
CMNPD25787	no testing reported
CMNPD25788	no bioactivity against HCT-116 or S.aureus
CMNPD25789	no bioactivity against HCT-116 or S.aureus
CMNPD25790	no bioactivity against HCT-116 or S.aureus
CMNPD25791	no bioactivity against HCT-116 or S.aureus
CMNPD25792	not cytotox. to 4 HTCL or AB activity against P. aeruginosa and B. subtilis
CMNPD25793	not cytotox. to 4 HTCL or AB activity against P. aeruginosa and B. subtilis
CMNPD25794	no activity against A549
CMNPD25795	activity against A549 down to 10 -4 to 10 -6 M
CMNPD25796	no cytotox., weak AB against E. faecalis
CMNPD25797	selective IC 50 values 0.45-3.67 μM against 4 tumour cell lines. weak AB against E. faecalis
CMNPD25798	weak to no bioactivity against Gram-(+) bacteria. EC 50 SJCRH30 5.2 μM
CMNPD25799	weak to no bioactivity against Gram-(+) bacteria and SJCRH30 cells
CMNPD25800	weak to no bioactivity against Gram-(+) bacteria and SJCRH30 cells
CMNPD25801	weak to no bioactivity against Gram-(+) bacteria and SJCRH30 cells
CMNPD25802	weak to no bioactivity against Gram-(+) bacteria and SJCRH30 cells
CMNPD25803	weak to no bioactivity against Gram-(+) bacteria and SJCRH30 cells
CMNPD25804	weak to no bioactivity against Gram-(+) bacteria and SJCRH30 cells
CMNPD25805	strong bioactivity against Gram-(+) bacteria. EC 50 SJCRH30 0.73 μM
CMNPD25806	MIC M. bovis 10, B. subtilis 3.7 μM. inactive S. aureus, E. coli, P. aeruginosa, C. albicans. Cyt. to SW620, HepG2
CMNPD25807	similar bioactivities to aranciamycin I 83
CMNPD25808	affects growth cycle of Chlamydia trachomatis and Schistosoma mansoni
CMNPD25809	nano to sub-nanomolar activty against a panel of HTCL, also murine.
CMNPD25811	reactivation of 56%; EC 50 13.9 μM
CMNPD25812	marginal activity
CMNPD25813	marginal activity
CMNPD25815	induced PPARa and g transcription in a conc. dependent manner at 1-10 μM
CMNPD25816	induced PPARa and g transcription in a conc. dependent manner at 1-10 μM
CMNPD25827	bioactive against 5 Vibrio sp.
CMNPD25828	algicidal properties against Alexandrium tamarense
CMNPD25830	AF activity against C. albicans reported
CMNPD25831	antimalarial activity. IC 50 50 μM
CMNPD25832	MIC 0.01- 0.05 μM against 6 bacteria and 5 fungi
CMNPD25833	MIC 0.01- 0.05 μM against 6 bacteria and 5 fungi
CMNPD25834	inhib. of zoospore motility IC 50 1 μg/mL | good AF | mod. AB activity
CMNPD25835	inhib. of zoospore motility IC 50 400 μg/mL | good AF | mod. AB activity
CMNPD25836	Not bioactive against a range of 6 Gram-(-ve) & (+ve) bacteria
CMNPD25837	MIC Acinetobacter baumanni <8 μg/mL
CMNPD25838	MIC Acinetobacter baumanni <32 μg/mL
CMNPD25839	MIC Acinetobacter baumanni <16 μg/mL
CMNPD25840	MIC Acinetobacter baumanni 32-64 μg/mL
CMNPD25841	MIC Acinetobacter baumanni 32-64 μg/mL
CMNPD25842	MIC Acinetobacter baumanni 32-64 μg/mL
CMNPD25843	MIC Acinetobacter baumanni 32-64 μg/mL
CMNPD25844	MIC Acinetobacter baumanni 32-64 μg/mL
CMNPD25845	MIC Acinetobacter baumanni 32-64 μg/mL
CMNPD25846	MIC Acinetobacter baumanni 32-64 μg/mL
CMNPD25847	minimal bioactivity against solid tumours
CMNPD25848	minimal bioactivity against solid tumours
CMNPD25849	minimal bioactivity against solid tumours
CMNPD25850	minimal bioactivity against solid tumours
CMNPD25851	minimal bioactivity against solid tumours
CMNPD25852	minimal bioactivity against solid tumours
CMNPD25853	minimal bioactivity against solid tumours
CMNPD25854	minimal bioactivity against solid tumours
CMNPD25855	inactive in bioassays
CMNPD25856	inactive in bioassays
CMNPD25857	MIC 25 μg/mL as anti-mycobacterial | non cytotox. | MIC 3-6 μg/mL against bacteria
CMNPD25858	MIC 25 μg/mL as anti-mycobacterial | non cytotox.
CMNPD25859	MIC 25 μg/mL as anti-mycobacterial | non cytotox.
CMNPD25861	weak activity against B. subtilis
CMNPD25863	not active against C. albicans, P. notatum | active against range of Gram-(+ve) bacteria
CMNPD25864	not active against C. albicans, P. notatum | no AB activity
CMNPD25865	not active against C. albicans, P. notatum | no AB activity
CMNPD25866	not active against C. albicans, P. notatum
CMNPD25867	not active against C. albicans, P. notatum
CMNPD25868	not active against C. albicans, P. notatum
CMNPD25869	IC 50 5.4 μg/mL against H2122 | inactive against HCC366, A549 & HCC44
CMNPD25870	potent scavenging activity
CMNPD25871	mod. cytotox. against HeLa | weak a-glucosidase activity
CMNPD25872	tested against 5 HTCL. IC50's in range 0.18 - 4.9 μM. weak AB activity
CMNPD25873	not cytotox. | weak AB activity
CMNPD25874	not cytotox. | weak AB activity
CMNPD25875	~4-32 less active than hormaomycin against 4 Gram- (+) bacteria
CMNPD25876	~4-32 less active than hormaomycin against 4 Gram- (+) bacteria
CMNPD25877	IC 50 4.4 μM against isocitrate lyase | no AB, AF activities or cytotox.
CMNPD25878	IC 50 20.5 μM against isocitrate lyase | no AB, AF activities or cytotox.
CMNPD25879	IC 50 0.8-1.9μM against 5 HTCL. inactive K562. very active against S. enterica. good sortase A activity
CMNPD25880	mod. activity against K562, but not 5 other HTCL | no AB activity
CMNPD25881	IC 50 in range 0.96-36 μM against 6 HTCL | weak Na + /K + ATPase inhib.
CMNPD25882	IC 50 in range 27->1006 μM against 6 HTCL
CMNPD25883	IC 50 >100μM against 6 HTCL
CMNPD25884	IC 50 in range 15->100 μM against 6 HTCL | weak Na + /K + ATPase inhib.
CMNPD25885	IC 50 in range 0.57-14 μM against 6 HTCL
CMNPD25886	no inhib. NO production in BV-2 cells. | no cytotox. vs 4 HTCL | no AB activ. vs 2 strains.
CMNPD25887	inhib. NO production in BV-2 cells. IC 50 17.7 μM | no cytotox. vs 4 HTCL | no AB activ. vs 2 strains.
CMNPD25890	inhib. of voltage-dependent K + channel
CMNPD25891	inhib. of voltage-dependent K + channel
CMNPD25893	inactive AB vs 3 strains
CMNPD25894	inactive AB vs 3 strains
CMNPD25895	weak activity vs 1 HTCL and 1 mammalian CL
CMNPD25896	strong activity vs 10 HTCL | mod. vs AchE
CMNPD25898	strong activity vs 10 HTCL | potent vs AchE
CMNPD25899	inactive vs 10 HTCL
CMNPD25900	inactive vs 10 HTCL
CMNPD25901	inactive vs 10 HTCL
CMNPD25902	inactive vs 10 HTCL
CMNPD25903	inactive vs 10 HTCL
CMNPD25904	inactive AB vs 5 strains
CMNPD25916	mod. AB vs 2 strains
CMNPD25917	mod. AB vs 2 strains
CMNPD25923	inactive vs murine cell line and radical scavenging
CMNPD25924	inactive vs murine cell line and radical scavenging
CMNPD25930	potent brine shrimp cytotox. | mod. AB vs 4 strains
CMNPD25931	potent brine shrimp cytotox. | mod. AB vs 4 strains
CMNPD25933	weak activity vs 2 HTCL
CMNPD25935	causes mod. increase in insulin sensitivity in adipogenesis model | DNA binding agent
CMNPD25936	causes mod. increase in insulin sensitivity in adipogenesis model
CMNPD25939	mod. inhib. of Na + /K + -ATPase | weak antiplasmodial activity | no activity vs 4 HTCL
CMNPD25940	mod. inhib. of Na + /K + -ATPase
CMNPD25941	mod. inhib. of Na + /K + -ATPase
CMNPD25942	mod. inhib. of Na + /K + -ATPase
CMNPD25943	mod. inhib. of Na + /K + -ATPase
CMNPD25944	mod. antifouling (B. amphitrite larval settlement)
CMNPD25945	AB vs S. aureus
CMNPD25946	mod. antifouling (B. amphitrite larval settlement) | AB vs S. aureus
CMNPD25947	mod. inhib. of pro-inflammatory cytokines
CMNPD25948	weak inhib. of pro-inflammatory cytokines
CMNPD25949	weak inhib. of pro-inflammatory cytokines
CMNPD25950	good inhib. of pro-inflammatory cytokines
CMNPD25951	mod. α-glucosidase inhib.
CMNPD25952	mod. α-glucosidase inhib.
CMNPD25953	mod. α-glucosidase inhib.
CMNPD25954	mod. α-glucosidase inhib.
CMNPD25955	mod. α-glucosidase inhib.
CMNPD25956	mod. α-glucosidase inhib.
CMNPD25957	mod. α-glucosidase inhib.
CMNPD25958	mod. α-glucosidase inhib.
CMNPD25959	mod. α-glucosidase inhib.
CMNPD25960	mod. α-glucosidase inhib.
CMNPD25961	mod. α-glucosidase inhib.
CMNPD25962	mod. α-glucosidase inhib.
CMNPD25963	mod. α-glucosidase inhib.
CMNPD25964	mod. α-glucosidase inhib.
CMNPD25965	mod. α-glucosidase inhib.
CMNPD25966	mod. α-glucosidase inhib.
CMNPD25967	mod. α-glucosidase inhib.
CMNPD25968	potent α-glucosidase inhib. | mod. inhib. H1N1
CMNPD25972	anti-neuroinflammatory (inhibits NF-kB and p38 signalling pathways
CMNPD25973	suppresses production of pro-inflammatory mediators
CMNPD25975	weak AB vs 2 strains
CMNPD25976	weak AB vs 2 strains
CMNPD25977	mod., non-selective metal ion chelataion
CMNPD25978	mod., non-selective metal ion chelataion
CMNPD25979	mod., non-selective metal ion chelataion | mod. AB vs 3 Gram-(+) strains
CMNPD25980	potent inhib. of NCI-H460
CMNPD25981	mod., non-selective metal ion chelataion
CMNPD25984	weak activity vs 1 HTCL
CMNPD25985	weak activity vs 1 HTCL
CMNPD25986	good inhib. (IC 50 0.76 μM) of 1 HTCL
CMNPD25987	potent lipid-lowering activity
CMNPD25988	potent lipid-lowering activity
CMNPD26001	anti-inflammatory via NF-kB inhib.
CMNPD26002	anti-inflammatory via NF-kB inhib.
CMNPD26005	mod. AB-42 lowering activity
CMNPD26007	weak lipid lowering effect
CMNPD26015	mod. activity vs 3 HTCL
CMNPD26016	mod. activity vs 3 HTCL
CMNPD26017	mod. activity vs 3 HTCL
CMNPD26018	mod. activity vs 3 HTCL
CMNPD26019	good α-glucosidase inhib.
CMNPD26020	weak activity vs H1N1 virus
CMNPD26021	weak activity vs H1N1 virus
CMNPD26022	weak activity vs H1N1 virus
CMNPD26023	weak activity vs H1N1 virus
CMNPD26024	weak activity vs H1N1 virus
CMNPD26025	weak activity vs H1N1 virus
CMNPD26026	weak activity vs H1N1 virus
CMNPD26027	weak activity vs H1N1 virus
CMNPD26028	weak activity vs H1N1 virus
CMNPD26029	weak activity vs H1N1 virus
CMNPD26030	weak activity vs H1N1 virus
CMNPD26031	weak activity vs H1N1 virus
CMNPD26032	weak activity vs H1N1 virus
CMNPD26033	weak activity vs H1N1 virus
CMNPD26034	weak activity vs H1N1 virus
CMNPD26035	mod. activity vs 1 HTCL
CMNPD26040	mod. inhib. of pigment production in MRSA
CMNPD26043	mod. inhib. of pigment production in MRSA
CMNPD26044	mod. inhib. of pigment production in MRSA
CMNPD26046	mod. inhib. of pigment production in MRSA
CMNPD26047	mod. inhib. of pigment production in MRSA
CMNPD26048	good inhib. of pigment production in MRSA
CMNPD26049	good inhib. of pigment production in MRSA
CMNPD26050	mod. AB vs S. aureus | mod. radical scavenging (DPPH)
CMNPD26055	mod. AB vs S. aureus | mod. radical scavenging (DPPH)
CMNPD26057	mod. inhib. of IL-6 production in murine macrophages
CMNPD26058	mod. AB vs 4 strains
CMNPD26061	mod. activity vs HL-60
CMNPD26062	mod. activity vs HL-60
CMNPD26066	mod. radical scavenging activity (DPPH)
CMNPD26067	potent radical scavenging activity (DPPH)
CMNPD26068	mod. AB vs 7 strains | good activity vs plant pathogenic fungus Fusarium graminearum
CMNPD26069	mod. AB vs 7 strains | good activity vs plant pathogenic fungus Fusarium graminearum
CMNPD26070	v. weak activity vs NCI-H460
CMNPD26071	v. weak activity vs NCI-H460 | Mod. inhib. NO prod. and iNOS. IA vs. NCL.
CMNPD26072	mod. AB vs Vibrio ichthyoenteri (as racemate)
CMNPD26073	mod. AB vs Vibrio ichthyoenteri (as racemate)
CMNPD26076	mod. AB vs 5 strains | good cytotox. vs brine shrimp
CMNPD26077	weak AB vs S. aureus only
CMNPD26079	mod., selective activity vs NCI-H446
CMNPD26080	good AB vs 3 strains
CMNPD26081	mod. AB vs 2 strains
CMNPD26083	mod. AB vs 2 strains
CMNPD26084	good anti-inflammatory and analgesic activity
CMNPD26085	weak activity vs 1 HTCL
CMNPD26086	weak activity vs 1 HTCL
CMNPD26089	weak activity vs 2 HTCL
CMNPD26090	weak activity vs 2 HTCL
CMNPD26091	mod. inhib. of plant pathogenic fungus Alternaria brassicae
CMNPD26092	mod. inhib. of plant pathogenic fungus Alternaria brassicae
CMNPD26093	anti-proliferative vs multiple HTCL via apoptosis induction. suppresses metastasis
CMNPD26097	weak toxicity to brine shrimp. inactive vs 2 HTCL and H1N1 virus
CMNPD26098	weak toxicity to brine shrimp. inactive vs 2 HTCL and H1N1 virus
CMNPD26099	weak toxicity to brine shrimp. inactive vs 2 HTCL and H1N1 virus
CMNPD26100	weak toxicity to brine shrimp. inactive vs 2 HTCL and H1N1 virus
CMNPD26101	weak toxicity to brine shrimp. inactive vs 2 HTCL and H1N1 virus
CMNPD26102	weak toxicity to brine shrimp. inactive vs 2 HTCL and H1N1 virus
CMNPD26103	weak toxicity to brine shrimp. inactive vs 2 HTCL and H1N1 virus
CMNPD26104	weak toxicity to brine shrimp. inactive vs 2 HTCL and H1N1 virus
CMNPD26105	weak toxicity to brine shrimp. inactive vs 2 HTCL and H1N1 virus
CMNPD26109	mod. activity vs 1 HTCL | inactive vs 2 other HTCL
CMNPD26110	mod. activity vs 1 HTCL | inactive vs 2 other HTCL
CMNPD26112	mod. vasculogenetic activity | significant mitigation of bradycardia in zebrafish
CMNPD26113	potent vasculogenetic activity | significant mitigation of bradycardia in zebrafish
CMNPD26114	potent vasculogenetic activity | significant mitigation of bradycardia in zebrafish
CMNPD26115	mod. inhib. topoisomerase I
CMNPD26116	potent AB vs S. aureus | inhib. HAB causing Nitzschia closterium
CMNPD26121	good inhib. of settlement of B. amphitrite larvae
CMNPD26122	good inhib. of settlement of B. amphitrite larvae
CMNPD26123	weak activity vs 4 HTCL
CMNPD26124	weak activity vs 4 HTCL
CMNPD26125	weak activity vs 4 HTCL
CMNPD26126	weak activity vs 4 HTCL
CMNPD26127	weak activity vs 4 HTCL
CMNPD26128	inhib. of NO production in LPS-induce murine macrophages
CMNPD26129	inhib. of NO production in LPS-induce murine macrophages
CMNPD26131	inhib. of NO production in LPS-induce murine macrophages
CMNPD26132	good inhib. PTP1B
CMNPD26133	weak inhib. PTP1B
CMNPD26134	good antimigratory activity vs 1 HTCL, mod. inhib. of C. albicans
CMNPD26135	weak activity vs 4 HTCL
CMNPD26136	weak activity vs 4 HTCL
CMNPD26137	weak activity vs 4 HTCL
CMNPD26138	weak activity vs 4 HTCL
CMNPD26140	good AB vs S. aureus
CMNPD26141	good AB vs S. aureus
CMNPD26142	good AB vs S. aureus
CMNPD26143	good AB vs S. aureus
CMNPD26144	good AB vs S. aureus
CMNPD26145	mod. inhib. PTP1B
CMNPD26149	potent antimigratory activity vs 1 HTCL
CMNPD26151	mod. activity vs L5178Y
CMNPD26152	potent AV vs EV71 virus
CMNPD26153	potent AV vs EV71 virus
CMNPD26158	sig. AV vs EV71 virus
CMNPD26160	weak AB vs large panel | weak activity vs 4 HTCL
CMNPD26161	weak AB vs large panel | weak activity vs 4 HTCL
CMNPD26162	weak AB vs large panel | weak activity vs 4 HTCL
CMNPD26165	weak-mod. activity vs 3 HTCL
CMNPD26166	weak-mod. activity vs 3 HTCL
CMNPD26167	weak-mod. activity vs 3 HTCL
CMNPD26168	weak-mod. activity vs 3 HTCL
CMNPD26169	mod. inhib. of IL-6 production in murine macrophages
CMNPD26170	mod. inhib. of IL-6 production in murine macrophages
CMNPD26171	mod. AB vs 1 strain
CMNPD26172	mod. inhib. of C. albicans
CMNPD26189	weak inhib. NO production
CMNPD26190	weak inhib. NO production
CMNPD26191	potent AB vs 7 strains
CMNPD26192	potent AB vs 7 strains
CMNPD26193	potent AB vs 7 strains
CMNPD26199	mod. AB vs 7 strains
CMNPD26200	mod. AB vs 7 strains
CMNPD26201	mod. AB vs 7 strains
CMNPD26204	mod. COX-2 inhib.
CMNPD26205	mod. COX-2 inhib. | mod. AV vs EV71 virus
CMNPD26206	weak activity vs HepG2
CMNPD26209	weak activity vs HepG2
CMNPD26212	potent inhib. of settlement of B. amphitrite larvae
CMNPD26213	potent activity vs 5 HTCL
CMNPD26214	mod. AB vs S. aureus | potent AchE inhib.
CMNPD26216	mod. AB vs S. aureus | potent AchE inhib. | good inhib. PDE-4B2
CMNPD26217	mod., selective activity vs KG-1a | mod. AV vs HSV-1
CMNPD26218	mod., selective activity vs KG-1a | mod. AV vs HSV-2
CMNPD26220	mod., selective activity vs KG-1a | mod. AV vs HSV-1
CMNPD26227	very weak activity vs 1 HTCL
CMNPD26228	very weak activity vs 1 HTCL
CMNPD26229	very weak activity vs 1 HTCL
CMNPD26238	mod. inhib. of PTP1B
CMNPD26239	mod. inhib. of PTP1B
CMNPD26242	mod. inhib. of H1N1 virus
CMNPD26243	inactive, IA vs. H1N1 and HIV.
CMNPD26244	mod. inhib. of H1N1 virus
CMNPD26249	inactive, IA vs. H1N1 and HIV.
CMNPD26252	potent inhib. of H1N1 virus
CMNPD26254	mod. activity vs 6 bacteria and 2 fungal strains
CMNPD26255	mod. activity vs 6 bacteria and 2 fungal strains
CMNPD26259	mod. inhib. of MCF-7
CMNPD26263	potent radical scavenger (ABTS)
CMNPD26264	potent radical scavenger (ABTS) | good AF activity vs 1 strain
CMNPD26265	good AF activity vs 2 strains
CMNPD26271	mod. AB vs 3 aquatic strains
CMNPD26274	very good, selective activity vs HL-60
CMNPD26277	mod. α-glucosidase inhib.
CMNPD26278	mod. radical scavenging activity (DPPH)
CMNPD26281	mod. but selective activity vs 2 HTCL
CMNPD26282	mod. but selective activity vs 2 HTCL
CMNPD26283	mod. but selective activity vs 2 HTCL
CMNPD26284	good activity vs 7 HTCL
CMNPD26285	good activity vs 7 HTCL | topoisomerase I inhib.
CMNPD26286	good activity vs 7 HTCL
CMNPD26287	potent inhib. of M. tuberculosis protein tyrosine phosphatase (MptpB)
CMNPD26288	potent inhib. of M. tuberculosis PTPB1
CMNPD26292	very good inhib. of α-glucosidase
CMNPD26293	good inhib. of α-glucosidase
CMNPD26296	good inhib. of α-glucosidase
CMNPD26298	sig. COX-2 inhib.
CMNPD26299	mod. cytotox. vs 10 HTCL and COX-2 inhib.
CMNPD26300	very weak AB vs 2 strains
CMNPD26301	mod. brine shrimp toxicity
CMNPD26303	good cytotox. vs 4 HTCL
CMNPD26306	inhib. of Ca 2+ signal transduction
CMNPD26309	weak AB vs B. cereus | very weak activity vs 2 HTCL
CMNPD26310	very weak activity vs 4 HTCL
CMNPD26311	weak AB vs B. cereus | very weak activity vs 4 HTCL
CMNPD26313	very weak activity vs 4 HTCL
CMNPD26314	very weak activity vs 1 HTCL
CMNPD26315	very weak activity vs 4 HTCL
CMNPD26316	very weak activity vs 2 HTCL
CMNPD26317	very weak activity vs 1 HTCL
CMNPD26319	strong α-glucosidase inhib.
CMNPD26320	strong α-glucosidase inhib.
CMNPD26321	strong α-glucosidase inhib.
CMNPD26322	good α-glucosidase inhib.
CMNPD26324	mod. activity vs 2 HTCL
CMNPD26326	weak activity vs 4 HTCL
CMNPD26327	mod. activity vs 4 HTCL
CMNPD26328	weak inhib. of human aldose reductase
CMNPD26329	weak inhib. of human aldose reductase
CMNPD26330	weak inhib. of human aldose reductase
CMNPD26331	weak inhib. of human aldose reductase
CMNPD26332	weak inhib. of human aldose reductase
CMNPD26333	weak inhib. of human aldose reductase
CMNPD26335	weak AB vs 2 strains
CMNPD26336	good AB vs 3 strains
CMNPD26337	mod. AB vs 2 strains
CMNPD26338	good AB vs 2 strains
CMNPD26339	good AB vs 5 strains
CMNPD26345	mod. activity vs 4 HTCL
CMNPD26346	mod. activity vs 4 HTCL
CMNPD26347	weak activity vs 4 HTCL
CMNPD26348	potent neuroprotective activity in PC12 cells | weak chemoreversal on Kbvin
CMNPD26349	weak neuroprotective activity in PC12 cells
CMNPD26350	potent chemoreversal on KBvin | inhib. of P-gp efflux
CMNPD26352	potent cytotox. vs brine shrimp
CMNPD26353	good radical scavenging activity (DPPH)
CMNPD26354	good radical scavenging activity (DPPH)
CMNPD26355	good radical scavenging activity (DPPH)
CMNPD26356	good radical scavenging activity (DPPH)
CMNPD26357	good radical scavenging activity (DPPH)
CMNPD26358	good radical scavenging activity (DPPH)
CMNPD26359	mod. α-glucosidase inhib.
CMNPD26361	mod. α-glucosidase inhib.
CMNPD26365	potent COX-2 inhib.
CMNPD26366	mod. activity vs 4 HTCL
CMNPD26368	potent activity vs 2 HTCL | weak AB vs 2 strains
CMNPD26369	mod. activity vs 2 HTCL | weak AB vs 2 strains
CMNPD26373	mod. activity vs 2 HTCL | weak AB vs 2 strains
CMNPD26375	weak AB vs 6 strains
CMNPD26376	mod. AB vs 6 strains
CMNPD26377	mod. AB vs 6 strains
CMNPD26381	mod. anti-malarial | anti-TB | weak AB vs 1 strain | good activity vs Vero
CMNPD26382	good activity vs Vero
CMNPD26383	weak anti-TB | mod. activity vs Vero
CMNPD26386	potent activity vs 5 HTCL
CMNPD26387	mod. activity vs 3 HTCL | AB vs S. aureus
CMNPD26388	mod. activity vs 3 HTCL
CMNPD26391	mod. antiplasmodial activity | no activity vs 4 HTCL
CMNPD26392	mod. activity vs 2 HTCL
CMNPD26393	strong activity vs 2 HTCL
CMNPD26394	very good activity vs 2 HTCL
CMNPD26395	good activity vs 2 HTCL
CMNPD26396	mod. activity vs CB1 and CB2 cannabinoid recpetors
CMNPD26397	mod. activity vs CB1 and CB2 cannabinoid recpetors
CMNPD26405	antagonism of voltage gated sodium channels
CMNPD26411	potent trypsin inhibitior
CMNPD26413	potent antimalarial activity vs 4 strains | mod. toxicity to Vero cells
CMNPD26414	mod. antichemotactic activity vs Jurkat cells
CMNPD26415	mod. activity vs 2 HTCL
CMNPD26416	mod. activity vs H-460
CMNPD26417	broad spectrum AB | activity vs 11 strains | AF activity vs 3 strains
CMNPD26418	potent activity vs 2 HTCL | mod. AB vs 2 strains | mod. AF vs 3 strains
CMNPD26419	weak activity vs 2 HTCL
CMNPD26421	strong activity vs HL-60 cells (but already known)
CMNPD26426	potent activity vs 2 HTCL
CMNPD26427	potent activity vs 2 HTCL | in vivo activity vs P388
CMNPD26428	mod. AF vs T. mentagrophytes
CMNPD26429	mod. toxicity to the Jurkat E6-1
CMNPD26430	mod. toxicity to the Jurkat E6-1
CMNPD26431	mod. effects on cytostolic calcium currents
CMNPD26432	weak inhib. of voltage-gated sodium channels
CMNPD26433	MOA investigated
CMNPD26434	activity already known
CMNPD26435	activity already known
CMNPD26436	mixture lethal to another dinoflagellate
CMNPD26437	mixture lethal to another dinoflagellate
CMNPD26441	weak activity against HeLa and HL60
CMNPD26442	not active but differentiation of HL60 cells at 100μM
CMNPD26445	active against PTP1B. IC 50 2.3 μM
CMNPD26447	active against PTP1B. IC 50 3.8 μM
CMNPD26448	active against α-glucosidase
CMNPD26449	synthetic material is inactive
CMNPD26451	inhibits feeding by the sea urchin Lytechinus variegatus
CMNPD26452	weakly active against wild-type HIV-1
CMNPD26453	inactive against wild-type HIV-1
CMNPD26454	inactive against wild-type HIV-1
CMNPD26455	activity against LPS-induced NO production
CMNPD26456	mod. cytotox. (7-33 μM) agaisnt 4 HTCL
CMNPD26457	mod. cytotox. (7-33 μM) against 4 HTCL
CMNPD26458	various levels of cytotox. | AB and anti-inflamm. activity
CMNPD26459	AM/AF evaluation against 5 bacteria and 1 fungus
CMNPD26460	AM/AF evaluation against 5 bacteria and 1 fungus
CMNPD26461	AM/AF evaluation against 5 bacteria and 1 fungus
CMNPD26462	AM/AF evaluation against 5 bacteria and 1 fungus
CMNPD26463	crude extracts evaluated against 6 bacteria and 3 fungi
CMNPD26464	assayed for gastroprotective activity
CMNPD26468	tested for antifouling properties
CMNPD26469	tested for antifouling properties
CMNPD26470	tested for antifouling properties
CMNPD26471	tested for antifouling properties
CMNPD26472	tested for antifouling properties
CMNPD26473	MIC against S. aureus was 25 μg/mL
CMNPD26474	tested against E. faecalis, E. coli and S. aureues
CMNPD26475	tested against E. faecalis, E. coli and S. aureues
CMNPD26477	tested against E. faecalis, E. coli and S. aureues
CMNPD26478	tested against E. faecalis, E. coli and S. aureues
CMNPD26479	tested against E. faecalis, E. coli and S. aureues
CMNPD26482	tested against E. faecalis, E. coli and S. aureues
CMNPD26484	mod. AF activity
CMNPD26485	weak AF activity
CMNPD26488	mod. inhibit. of diatom growth and zoospore germination
CMNPD26489	mod. inhibit. of diatom growth, inactive vs zoospore germination
CMNPD26490	inactive vs diatom growth and zoospore germination
CMNPD26494	inactive as AM
CMNPD26495	mod. AB activity
CMNPD26496	inactive vs PTP1B
CMNPD26497	PTP1B inhibit. IC 50 13.0 μg/mL
CMNPD26498	mod./weak activity vs HTCLs
CMNPD26499	mod./weak activity vs HTCLs
CMNPD26500	mod./weak activity vs HTCLs
CMNPD26501	antiproliferative vs HepG-2 cells | IC 50 280 μM
CMNPD26502	UV protection
CMNPD26515	weak activity vs 3 HTCL
CMNPD26516	weak activity vs 3 HTCL
CMNPD26517	weak activity vs 3 HTCL
CMNPD26545	Some AF activity vs Cryptococcus neoformans
CMNPD26546	Some AF activity vs Cryptococcus neoformans
CMNPD26548	inactive vs NO production in RAW264.7 cells
CMNPD26549	inactive vs NO production in RAW264.7 cells
CMNPD26551	mod. AF and cytotox. to 1 HTCL
CMNPD26552	inactive as PTP1B inhib.
CMNPD26553	inactive vs 1 HTCL
CMNPD26554	inactive vs 1 HTCL
CMNPD26555	mod. activity vs 1 HTCL
CMNPD26556	mod. activity vs 1 HTCL
CMNPD26557	mod. activity vs 1 HTCL
CMNPD26558	mod. activity vs 1 HTCL
CMNPD26559	inactive vs Chlamdydia trachomatis infection in HeLa cells.
CMNPD26560	mod. activity vs 2 HTCL
CMNPD26561	mod. activity vs 2 HTCL
CMNPD26562	potent activity vs 2 HTCL
CMNPD26563	mod. activity vs 2 HTCL
CMNPD26565	mod. activity vs 2 HTCL
CMNPD26566	weak activity vs 1 HTCL
CMNPD26567	weak activity vs 1 HTCL
CMNPD26568	weak activity vs 1 HTCL
CMNPD26569	weak activity vs 1 HTCL
CMNPD26570	weak activity vs 1 HTCL
CMNPD26571	inactive vs 1 HTCL
CMNPD26572	weak activity vs 1 HTCL
CMNPD26573	strong AM activity vs 6 strains | weak activity vs 2 HTCL
CMNPD26574	strong AM activity vs 6 strains | weak activity vs 2 HTCL
CMNPD26582	mod. active vs 4 HTCL | arrests cell cycle at G2/M phase
CMNPD26583	mod. active vs 4 HTCL
CMNPD26584	mod. activity vs 3 HTCL
CMNPD26585	mod. activity vs 3 HTCL
CMNPD26586	mod. activity vs 3 HTCL
CMNPD26590	inactive vs 4 microbial strains
CMNPD26591	weak AB vs 2 microbial strains | inactive vs 2 others
CMNPD26592	mod. activity vs L5178Y cells.
CMNPD26593	inactive vs 1 HTCL
CMNPD26594	inactive vs 1 HTCL
CMNPD26595	inactive as soluble Epoxide Hydrolase (sEH) inhib..
CMNPD26596	inactive as PTP1B inhib. and vs. 3 HTCL
CMNPD26598	pot. cytotox. activity vs. 4 HTCL | selective induction apoptosis
CMNPD26599	pot. cytotox. activity vs. 4 HTCL | selective induction apoptosis
CMNPD26600	mixture potent (IC 50 0.83 µM) vs. 1 HTCL
CMNPD26601	mixture potent (IC 50 0.83 µM) vs. 1 HTCL
CMNPD26602	mixture potent (IC 50 0.83 µM) vs. 1 HTCL
CMNPD26603	inactive vs M. tuberculosis and 2 HTCL
CMNPD26604	inactive vs M. tuberculosis and 2 HTCL
CMNPD26605	inactive vs M. tuberculosis and 2 HTCL
CMNPD26606	inactive vs M. tuberculosis and 2 HTCL
CMNPD26607	inactive vs M. tuberculosis and 2 HTCL
CMNPD26608	inactive vs M. tuberculosis and 2 HTCL
CMNPD26609	potent HIV inhibit. (EC 50 23 nM in HIV-1RF infected CEM-SS T-cells) | less potent cytotox. (IC 50 367 nM) vs host cells.
CMNPD26610	potent HIV inhibit. (EC 50 27 nM in HIV-1RF infected CEM-SS T-cells) | less potent cytotox. (IC 50 373 nM) vs host cells.
CMNPD26611	mod. activity vs 3 HTCL
CMNPD26612	mod. activity vs 3 HTCL
CMNPD26613	weak activity vs 1 HTCL and 3 microbial strains
CMNPD26614	weak activity vs 1 HTCL and 3 microbial strains
CMNPD26617	not cytotox., inhibit. IL2 secretion at 15 µM
CMNPD26618	not cytotox., inhibit. IL2 secretion but less active than (+) enantiomer
CMNPD26619	inactive vs 3 HTCL
CMNPD26620	inactive vs 3 HTCL
CMNPD26621	weak activity vs 1 HTCL
CMNPD26622	non toxic to C2C12 cells up to 100 µM | upregulates mitochondrial functions at 10 µM
CMNPD26624	inactive vs M. smegmatis
CMNPD26625	inactive vs M. smegmatis
CMNPD26626	inactive vs 2 HTCL
CMNPD26627	weak activity vs 2 HTCL
CMNPD26628	inactive vs the Farnesoid X-activated Receptor (FXR) and 1 monkey kidney cell line
CMNPD26629	inactive vs the Farnesoid X-activated Receptor (FXR) and 1 monkey kidney cell line
CMNPD26630	mod. activity vs 2 HTCL
CMNPD26633	induced 36% neuronal cell differentiation at 5 ng/mL
CMNPD26634	induced 53% neuronal cell differentiation at 50 ng/mL
CMNPD26635	weak activity vs 1 HTCL and P. falciparum
CMNPD26636	weak activity vs 1 HTCL and P. falciparum
CMNPD26637	weak activity vs 1 HTCL and mod. vs P. falciparum
CMNPD26640	AF vs 4 strains
CMNPD26641	AF vs 4 strains
CMNPD26642	AF vs 4 strains
CMNPD26643	AF vs 4 strains
CMNPD26644	mod. anti-leishmanial (IC 50 8 µM) | anti-trypanosomal (IC 50 2 µM) | cytotox. vs 1 HTCL
CMNPD26650	mod. activity vs 2 HTCL
CMNPD26651	mod. activity vs 2 HTCL in 1:1 mix with A28880/3
CMNPD26652	mod. activity vs 2 HTCL in 1:1 mix with A28880/2
CMNPD26653	inactive vs L5178Y | inactive to potent inhibit. of nine protein kinases
CMNPD26656	inactive vs 2 HTCL
CMNPD26657	inactive vs 2 HTCL
CMNPD26658	weak AM activity
CMNPD26659	weak AM activity
CMNPD26660	weak AM activity
CMNPD26661	inactive against 5 microbial strains and 1 mouse cancer cell line
CMNPD26662	some AM activity in disk diffusion assay (zone not listed) | inactive vs. 1 mouse cancer cell line
CMNPD26663	some AM activity in disk diffusion assay (zone not listed) | inactive vs. 1 mouse cancer cell line
CMNPD26664	some AM activity in disk diffusion assay (zone not listed) | inactive vs. 1 mouse cancer cell line
CMNPD26665	inactive against 5 microbial strains and 1 mouse cancer cell line
CMNPD26666	weak AF activity
CMNPD26667	weak AF activity
CMNPD26668	weak inhbit. cell migration in wound healing assay at 10 µM | weak cytotox. vs HTCL
CMNPD26669	weak inhbit. cell migration in wound healing assay at 10 µM | weak cytotox. vs HTCL
CMNPD26671	inactive vs 2 microbial strains
CMNPD26672	weak AM activity
CMNPD26674	inactive vs 2 HTCL
CMNPD26675	inactive vs 2 HTCL
CMNPD26676	mod. activity vs 1 HTCL
CMNPD26677	weak activity vs 1 HTCL
CMNPD26678	weak activity vs 3 HTCL
CMNPD26680	mod. activity vs 2 HTCL | strong AB vs 6 strains
CMNPD26681	mod. activity vs 2 HTCL | weak AB vs 6 strains
CMNPD26682	mod. activity vs 2 HTCL | weak AB vs 6 strains
CMNPD26683	mod. activity vs 2 HTCL | weak AB vs 6 strains
CMNPD26684	strong activity vs 2 HTCL | weak AB vs 6 strains
CMNPD26685	weak activity vs 1 HTCL
CMNPD26686	weak activity vs 1 HTCL
CMNPD26687	mod. activity vs 1 HTCL
CMNPD26688	mod. activity vs 1 HTCL | strong inhibit. of NF-kB
CMNPD26689	mod. activity vs 1 HTCL
CMNPD26690	weak activity vs 1 HTCL
CMNPD26691	weak activity vs 1 HTCL
CMNPD26692	weak activity vs 1 HTCL
CMNPD26693	mod. inhibit. of NO production in RAW264.7 cells
CMNPD26694	mod. inhibit. of NO production in RAW264.7 cells
CMNPD26695	mod. inhibit. of NO production in RAW264.7 cells
CMNPD26697	mod. activity vs 2 HTCL | inhib. β-catenin as MOA
CMNPD26698	mod. activity vs 2 HTCL | inhib. β-catenin as MOA
CMNPD26699	mod. activity vs 2 HTCL | inhib. β-catenin as MOA
CMNPD26703	mod. activity vs 2 HTCL, inhib. β-catenin
CMNPD26704	potent antioxidant | mod. AM vs S. aureus and B. cereus
CMNPD26708	weak inhib. of ubiquitin-specific protease-7 (USP-7, IC50 > 5 μM)
CMNPD26711	inactive as PTP1B inhib. and vs 2 HTCL
CMNPD26712	inactive as PTP1B inhib. and vs 2 HTCL
CMNPD26713	inactive as PTP1B inhib. and vs 2 HTCL
CMNPD26714	inhibit. PTP1B; IC 50 8.7 µM)
CMNPD26715	mod. (IC 50 6.6 µM) inhibit. of chymotrypsin-like activity of proteasome
CMNPD26716	mod. (IC 50 9.3 µM) inhibit. of chymotrypsin-like activity of proteasome
CMNPD26717	inactive vs 2 HTCL
CMNPD26718	inactive vs 2 HTCL
CMNPD26722	inactive vs 3 microbial strains
CMNPD26724	low µg/mL activity vs 3 microbial strains
CMNPD26727	inactive vs 5 HTCL
CMNPD26728	inactive vs 5 HTCL
CMNPD26729	weak activity vs 5 HTCL
CMNPD26730	inhib. p53-Mdm2 interaction (IC 50 16 µM)
CMNPD26731	weak activity vs 1 HTCL
CMNPD26732	weak activity vs 1 HTCL
CMNPD26734	potent antimalarial (IC 50 44.5 nM vs non-resistant P. falciparum)
CMNPD26735	potent antimalarial (IC 50 43.3 nM vs non-resistant P. falciparum)
CMNPD26736	mod. cytotox. vs HL-60
CMNPD26737	mod. cytotox. vs HL-60
CMNPD26738	mod. cytotox. vs HL-60
CMNPD26739	mod. cytotox. vs HL-60
CMNPD26740	mod. cytotox. vs HL-60
CMNPD26741	mod. cytotox. vs HL-60
CMNPD26742	mod. cytotox. vs HL-60
CMNPD26743	mod. cytotox. vs HL-60
CMNPD26745	weak activity vs 2 HTCL
CMNPD26746	mod. activity vs 1 HTCL
CMNPD26747	inactive vs 5 HTCL
CMNPD26748	inactive vs 5 HTCL
CMNPD26749	inactive vs 5 HTCL
CMNPD26750	inactive vs 5 HTCL
CMNPD26751	mod. activity vs 2 HTCL
CMNPD26752	inactive vs 5 HTCL
CMNPD26753	weak activity vs 2 HTCL, inactive vs 4 HTCL
CMNPD26754	inactive vs 6 HTCL
CMNPD26755	weak activity vs 6 HTCL
CMNPD26756	weak activity vs 6 HTCL
CMNPD26757	weak activity vs 6 HTCL
CMNPD26758	weak activity vs 6 HTCL
CMNPD26759	weak activity vs 6 HTCL
CMNPD26760	mod. activity vs 6 HTCL
CMNPD26761	weak activity vs 6 HTCL
CMNPD26762	mod. activity vs. 3 HTCL and 3 of 4 bacterial strains
CMNPD26763	mod. activity vs. 3 HTCL and 3 of 4 bacterial strains
CMNPD26764	mod. activity vs. 2 HTCL and 3 of 4 bacterial strains
CMNPD26765	mod. activity vs. 3 HTCL and 3 of 4 bacterial strains
CMNPD26766	mod. activity vs. 3 HTCL and 3 of 4 bacterial strains
CMNPD26767	inactive as Farnesoid X-activated Receptor (FXR) agonist
CMNPD26768	inactive as Farnesoid X-activated Receptor (FXR) agonist
CMNPD26769	mixed with 1062 and 1063 | mod. activity vs. 3 HTCL
CMNPD26770	mixed with 1061 and 1063 | mod. activity vs. 3 HTCL
CMNPD26771	mixed with 1061 and 1062 | mod. activity vs. 3 HTCL
CMNPD26772	mod. activity vs. 3 HTCL
CMNPD26773	mod. activity vs. 3 HTCL
CMNPD26774	mod. activity vs. 3 HTCL
CMNPD26775	mod. activity vs. 3 HTCL
CMNPD26776	mod. activity vs. 3 HTCL
CMNPD26777	mod. activity vs. 3 HTCL
CMNPD26778	mod. activity vs. 3 HTCL
CMNPD26779	mod. activity vs. 3 HTCL
CMNPD26780	mod. inhibit. of PTP1B (diabetes type II target)
CMNPD26781	weak inhibit. of PTP1B (diabetes type II target)
CMNPD26782	mod. activity vs 2 HTCL, inactive vs 6 microbial strains
CMNPD26783	mod. activity vs 2 HTCL, inactive vs 6 microbial strains
CMNPD26784	weak inhibit. of NO production in LPS-stimulated RAW264.7 cells.
CMNPD26785	mod. AB and cytotox. to 1 HTCL
CMNPD26786	weak activity vs 4 HTCL
CMNPD26787	weak activity vs 4 HTCL
CMNPD26788	weak activity vs 4 HTCL
CMNPD26790	mod. AF activity in disk diffusion assay
CMNPD26791	mod. AF activity in disk diffusion assay
CMNPD26792	mod. to inactive vs 7 microbial strains
CMNPD26793	toxic to RAW264.7 cells (IC 50 65 µM)
CMNPD26794	anti-inflammatory (inhibits LPS-induced IL-6 mRNA expression, IC 50 5.0 µM)
CMNPD26795	anti-inflammatory (inhibits LPS-induced IL-6 mRNA expression, IC 50 5.2 µM)
CMNPD26796	mod. activity vs 2 HTCL, inactive vs 6 microbial strains
CMNPD26806	weak activity vs 3 HTCL
CMNPD26807	weak activity vs 3 HTCL
CMNPD26808	weak activity vs 3 HTCL
CMNPD26809	inactive as PTP1B inhib. and vs 3 HTCL
CMNPD26821	antiepileptic
CMNPD26823	inactive in number of assays
CMNPD26825	weak cytotox. (B16)
CMNPD26826	inactive in number of assays
CMNPD26828	inactive in number of assays
CMNPD26829	inactive in number of assays
CMNPD26830	weakly cytotox. (3 HTCL)
CMNPD26831	unspecified cytotox.
CMNPD26832	modest cytotox. (2 HTCL)
CMNPD26835	mild anti-inflammatory
CMNPD26836	inactive AB
CMNPD26837	mild cytotox. to HTCL
CMNPD26838	inhibits iNOS expression
CMNPD26840	weak inhib. elastase release
CMNPD26841	weak enhancement superoxide production
CMNPD26849	inhib. superoxide prod and elastase release
CMNPD26853	mild cytotox. to HTCL
CMNPD26854	not cytotox. to TCL
CMNPD26855	not cytotox. to TCL
CMNPD26856	not cytotox. to TCL
CMNPD26857	weak inhib. iNOS and COX-2 expression
CMNPD26859	not cytotox. to TCL
CMNPD26860	not cytotox. to TCL
CMNPD26861	not cytotox. to TCL
CMNPD26862	mildly cytotox. P388
CMNPD26863	mildly cytotox. P389
CMNPD26864	not cytotox. to HTCL
CMNPD26865	not cytotox. to HTCL
CMNPD26866	not cytotox. to HTCL
CMNPD26867	not cytotox. to HTCL
CMNPD26868	not cytotox. to HTCL
CMNPD26869	not cytotox. to HTCL
CMNPD26871	inhib. MDA-MB-231 cell migration
CMNPD26875	inactive AB
CMNPD26876	inactive AB
CMNPD26877	modest cytotox. (3 HTCL)
CMNPD26878	not cytotox. (4 HTCL)
CMNPD26879	weak inhib. iNOS expression
CMNPD26880	weak inhib. iNOS expression
CMNPD26881	weak inhib. iNOS and COX-2 expression
CMNPD26882	weak inhib. iNOS and COX-2 expression
CMNPD26883	not cytotox.
CMNPD26884	not cytotox.
CMNPD26885	weak cytotox. (4 HTCL)
CMNPD26886	not cytotox.
CMNPD26887	weak cytotox. (4 HTCL)
CMNPD26888	weak cytotox. (4 HTCL)
CMNPD26889	not cytotox.
CMNPD26890	not cytotox.
CMNPD26891	not cytotox.
CMNPD26892	not cytotox.
CMNPD26893	weakly anti-inflammatory
CMNPD26894	strong inhib. of iNOS expression
CMNPD26895	inhib. iNOS expression
CMNPD26896	mild cytotox. (5 HTCL)
CMNPD26897	not cytotox.
CMNPD26898	not cytotox.
CMNPD26899	not cytotox.
CMNPD26900	not cytotox.
CMNPD26901	not cytotox.
CMNPD26902	not cytotox.
CMNPD26903	not cytotox.
CMNPD26904	not cytotox.
CMNPD26905	mild cytoxicity and inhib superoxide formation and elastase release
CMNPD26906	mild cytoxicity and inhib superoxide formation and elastase release
CMNPD26907	mild cytotox. (8 TCL)
CMNPD26908	not cytotox.
CMNPD26909	inhib iNOS expression
CMNPD26910	inhib iNOS expression
CMNPD26911	inhib iNOS and COX-2 expression
CMNPD26912	inhib iNOS and COX-2 expression
CMNPD26913	inhib iNOS and COX-2 expression
CMNPD26914	inhib iNOS and COX-2 expression
CMNPD26915	inhib iNOS and COX-2 expression
CMNPD26916	not cytotox.
CMNPD26917	non-cytotox. weakly anti-inflammatory
CMNPD26918	non-cytotox. weakly anti- inflammatory
CMNPD26919	non-cytotox. weakly anti- inflammatory
CMNPD26920	not cytotox. (4 HTCL)
CMNPD26921	not cytotox. (4 HTCL)
CMNPD26922	non cytotox. and weak superoxide production and elastase releaase
CMNPD26923	non cytotox. and weak superoxide production and elastase releaase
CMNPD26924	non cytotox. and weak superoxide production and elastase releaase
CMNPD26925	non cytotox. and weak superoxide production and elastase releaase
CMNPD26926	inhib. elastase release
CMNPD26928	not cytotox. to HeLa
CMNPD26929	not cytotox. to HeLa
CMNPD26930	mildly cytotox. to HeLa
CMNPD26931	not cytotox. to HeLa
CMNPD26932	not cytotox. to HeLa
CMNPD26933	not cytotox. to HeLa
CMNPD26934	unspecified cytotox.
CMNPD26935	mild to mod. AB
CMNPD26936	mild to mod. AB
CMNPD26937	mild to mod. AB
CMNPD26938	weakly cytotox.
CMNPD26939	weakly cytotox.
CMNPD26940	weakly cytotox.
CMNPD26942	weakly cytotox.
CMNPD26943	not cytotox.
CMNPD26944	not cytotox.
CMNPD26945	not cytotox.
CMNPD26946	not cytotox.
CMNPD26947	weakly cytotox.
CMNPD26948	mildly cytotox. to HTCL
CMNPD26949	not cytotox.
CMNPD26950	mildly cytotox. to HTCL
CMNPD26951	mildly cytotox. to HTCL
CMNPD26952	mildly cytotox. to HTCL
CMNPD26953	mildly cytotox. to HTCL
CMNPD26954	mildly cytotox. to HTCL
CMNPD26955	inhib. production of superoxide by stimulated macrophages
CMNPD26956	increased production of superoxide by stimulated macrophages
CMNPD26957	increased production of superoxide by stimulated macrophages
CMNPD26958	inhib. production of superoxide by stimulated macrophages
CMNPD26959	toxic to brine shrimp
CMNPD26966	induces phenotypic signature on Parkinson's disease cells indicative of vesicular trafficking
CMNPD26968	mod. activity vs 2 HTCL
CMNPD26970	mod. activity vs 2 HTCL (as a 3: 2 mixture with 1270)
CMNPD26971	mod. activity vs 2 HTCL (as a 2: 3 mixture with 1269)
CMNPD26975	cytotox. towards Jurkat cell line
CMNPD26976	cytotox. towards Jurkat cell line
CMNPD26977	cytotox. towards Jurkat cell line
CMNPD26979	mod. antimalarial activity
CMNPD26980	mod. antimalarial activity
CMNPD26981	mod. antimalarial activity
CMNPD26982	mod. antimalarial activity
CMNPD26983	inactive (malaria)
CMNPD27006	not cytotox. (5 HTCL)
CMNPD27007	not cytotox. (5 HTCL)
CMNPD27008	not cytotox. (5 HTCL)
CMNPD27009	not cytotox. (5 HTCL)
CMNPD27010	not cytotox. (5 HTCL)
CMNPD27011	not cytotox. (5 HTCL)
CMNPD27012	not cytotox. (5 HTCL)
CMNPD27013	not cytotox. (5 HTCL)
CMNPD27014	mild cytotox. (HL-60)
CMNPD27016	causes paralysis (mice)
CMNPD27018	weak to mod. activity against normal cell line | 2HTCL and Na + /K + -ATPase enzyme. No AB activity.
CMNPD27019	weak to mod. activity against normal cell line | 2HTCL and Na + /K + -ATPase enzyme. No AB activity.
CMNPD27020	weak to mod. activity against normal cell line | 2HTCL and Na + /K + -ATPase enzyme. No AB activity.
CMNPD27021	weak to mod. activity against normal cell line | 2HTCL and Na + /K + -ATPase enzyme. No AB activity.
CMNPD27022	weak to mod. activity against normal cell line | 2HTCL and Na + /K + -ATPase enzyme. No AB activity.
CMNPD27023	weak to mod. activity against normal cell line | 2HTCL and Na + /K + -ATPase enzyme. No AB activity.
CMNPD27024	no AB or farnesoid-X receptor activity.
CMNPD27025	inactive PC3 HTCL (20 μM) but induced cellular effects in high-content assay.
CMNPD27026	inactive PC3 HTCL
CMNPD27027	inactive PC3 HTCL (20 μM) but induced cellular effects in high-content assay.
CMNPD27028	inactive towards 4 kinases.
CMNPD27029	inactive towards 4 kinases.
CMNPD27030	inactive towards 4 kinases.
CMNPD27031	inactive towards 4 kinases.
CMNPD27032	antioxidant (weak)
CMNPD27033	p300-HIF-1α inhib.
CMNPD27037	mod. α-glucosidase inhib.
CMNPD27038	inhibits colony formation of T-47D cells. weak inhib. of MAP kinases.
CMNPD27042	activity against glioma cell lines.
CMNPD27045	ineffective ROS and NO generator in murine macrophage cell line.
CMNPD27048	mod. cytotox. towards 5 HTCL
CMNPD27049	mod. cytotox. towards 5 HTCL
CMNPD27050	mod. cytotox. towards 5 HTCL
CMNPD27051	mod. cytotox. towards 5 HTCL
CMNPD27052	mod. cytotox. towards 5 HTCL
CMNPD27053	inactive (HTCL)
CMNPD27055	cytotox. and haemolytic
CMNPD27056	cytotox. and haemolytic
CMNPD27057	cytotox. and haemolytic
CMNPD27058	cytotox. and haemolytic
CMNPD27059	cytotox. and haemolytic
CMNPD27060	cytotox. and haemolytic
CMNPD27061	cytotox. and haemolytic
CMNPD27062	cytotox. and haemolytic
CMNPD27063	mild anti-hepatitis B virus activity.
CMNPD27064	mild anti-hepatitis B virus activity.
CMNPD27065	mild anti-hepatitis B virus activity.
CMNPD27066	mild anti-hepatitis B virus activity.
CMNPD27067	mild anti-oxidant
CMNPD27071	mildly cytotox. to MCF-7
CMNPD27077	mild cytotox. to 4 HTCL panel
CMNPD27078	mild cytotox. to 4 HTCL panel
CMNPD27079	mild cytotox. to 4 HTCL panel
CMNPD27080	mild cytotox. to 4 HTCL panel
CMNPD27081	inactive towards panel of 5 HTCL
CMNPD27082	mildly cytotox. to HCT-8
CMNPD27083	inactive towards panel of 5 HTCL
CMNPD27084	inactive towards panel of 5 HTCL
CMNPD27085	inactive towards panel of 5 HTCL
CMNPD27086	inactive towards panel of 5 HTCL
CMNPD27089	mild AV activity towards H1N1
CMNPD27091	mild AV activity towards H1N1
CMNPD27093	mild AV activity towards H1N1
CMNPD27103	mod. cytotox. towards panel of HTCL
CMNPD27104	mod. cytotox. HTCL (IC50 = 31.54 uM (HL-60)
CMNPD27105	no cytotox. vs 6 HTCL (IC50 > 10 μM)
CMNPD27106	no cytotox. vs 6 HTCL (IC50 > 10 μM)
CMNPD27107	no cytotox. vs 6 HTCL (IC50 > 10 μM)
CMNPD27108	no cytotox. vs 6 HTCL (IC50 > 10 μM)
CMNPD27109	potent quinone reductase inhib. Activ. | no cytotox. vs 6 HTCL (IC50 > 10 μM)
CMNPD27110	mod. MRSA activ., MIC = 31.2 μg/mL | no cytotox. Vs 1 HTCL (HCT-116)
CMNPD27111	mod. MRSA activ., MIC = 31.2 μg/mL | no cytotox. vs 1 HTCL (HCT-116)
CMNPD27112	mod. MRSA activ., MIC = 62.5 μg/mL | no cytotox. vs 1 HTCL (HCT-116)
CMNPD27113	no cytotox. vs 4 HTCL | no AB activ. vs 2 strains.
CMNPD27114	no cytotox. vs 4 HTCL | no AB activ. vs 2 strains.
CMNPD27115	no cytotox. vs 4 HTCL | no AB activ. vs 2 strains.
CMNPD27116	no cytotox. vs 4 HTCL | no AB activ. vs 2 strains.
CMNPD27117	no cytotox. vs 4 HTCL | no AB activ. vs 2 strains.
CMNPD27118	no cytotox. vs 4 HTCL | no AB activ. vs 2 strains.
CMNPD27119	No cytotox. vs 4 HTCL (IC50 > 24 μM)
CMNPD27120	cytotox. vs 4 HTCL | best activ. vs A549 (IC50 = 0.14 μM)
CMNPD27121	cytotox. vs 4 HTCL | best activ. vs A549 (IC50 = 0.145 μM)
CMNPD27122	mod. inhib. of SETD8
CMNPD27123	mod. inhib. of SETD8
CMNPD27124	No cytotox. vs 7 HTCL | no AChE no AB activ. | weak biofilm formation inhib.
CMNPD27125	mod. inhib. of SETD8
CMNPD27126	mod. inhib. of SETD8
CMNPD27127	No cytotox. vs 7 HTCL | no AChE no AB activ. | weak biofilm formation inhib
CMNPD27128	potent AB activ. vs B. subtilis (MIC = 2 μg/mL
CMNPD27129	potent AB activ. vs B. subtilis (MIC = 64 μg/mL)
CMNPD27130	weak MRSA activ., MIC >200 μg/mL
CMNPD27131	mod. MRSA activ., MIC = 40 μg/mL
CMNPD27132	Inhibit migration of A431 cells with IC50 = 6.4 μM | IA vs 3 microb. strains at 50 μg/mL
CMNPD27133	Inhibit migration of A431 cells with IC50 = 6.1 μM | IA vs 3 microb. strains at 50 μg/mL
CMNPD27134	mod. cytotox. Vs 11 HTCL | some AM activ. vs 7 strains
CMNPD27135	mod. cytotox. Vs 11 HTCL | some AM activ. vs 7 strains
CMNPD27136	mod. cytotox. Vs 11 HTCL | some AM activ. vs 7 strains
CMNPD27137	mod. cytotox. Vs 11 HTCL | some AM activ. vs 7 strains
CMNPD27138	mod. cytotox. Vs 11 HTCL | some AM activ. vs 7 strains
CMNPD27139	mod. cytotox. Vs 11 HTCL | some AM activ. vs 7 strains
CMNPD27140	mod. cytotox. Vs 11 HTCL | some AM activ. vs 7 strains
CMNPD27141	potent calpain inhib. | IC50=37.4 nM
CMNPD27142	potent calpain inhib. | IC50=~108 nM
CMNPD27143	potent calpain inhib. | IC50=53.8 nM
CMNPD27147	potent calpain inhib. | IC50=~58 nM
CMNPD27148	potent calpain inhib. | IC50=~39 nM
CMNPD27150	potent calpain inhib. | IC50=1.2 nM
CMNPD27152	potent calpain inhib. | IC50=41.3 nM
CMNPD27154	potent calpain inhib. | IC50=~60 nM
CMNPD27155	potent calpain inhib. | IC50=36.8 nM
CMNPD27156	potent calpain inhib. | IC50=36.8 nM
CMNPD27158	potent calpain inhib. | IC50=~95 nM
CMNPD27159	potent calpain inhib. | IC50=~120 nM
CMNPD27161	potent calpain inhib. | IC50=~50 nM
CMNPD27162	No cytotox. vs 5 HTCL panel at 100 μM
CMNPD27163	mod. PEDV activ. | low cytotox. activ. vs Vero cells
CMNPD27164	mod. PEDV activ. | low cytotox. activ. vs Vero cells
CMNPD27165	mod. PEDV activ. | low cytotox. activ. vs Vero cells
CMNPD27166	Strong inhib. of α-glucosidase | low cytotox. vs murine cell line (IEC-6)
CMNPD27167	Strong inhib. of α-glucosidase | low cytotox. vs murine cell line (IEC-6)
CMNPD27168	Good AI activ. | HO-1 induction
CMNPD27169	mod. cytotox. vs 4 HTCL | IC50 range 0.5-3.9 μM
CMNPD27170	mod. cytotox. vs 4 HTCL | IC50 range 3.3-7.3 μM
CMNPD27171	mod. AB activ. vs 3 microb. strains | MIC range 8 - 16 μg/mL
CMNPD27172	mod. AB activ. vs 22 microb. strains | MIC range 4 - 128 μg/mL | mod. cytotox. vs 4 HTCL
CMNPD27173	mod. AB activ. vs 22 microb. strains | MIC range 16 - >512 μg/mL
CMNPD27176	Low or no cytotox. vs 3 HTCL | no activ. vs 5 microb.
CMNPD27177	Low or no cytotox. vs 3 HTCL | no activ. vs 5 microb.
CMNPD27178	Low or no cytotox. vs 3 HTCL | no activ. vs 5 microb.
CMNPD27179	potent cytotox. vs 3 HTCL | slight antifung. activ.
CMNPD27180	potent cytotox. vs 3 HTCL | slight antifung. activ.
CMNPD27181	mod. AO and AF activ. | no cytotox. vs HL-60 cells
CMNPD27182	mod. siderphore activ.
CMNPD27183	mod. siderphore activ.
CMNPD27184	mod. siderphore activ.
CMNPD27185	weak cytotox. activ. vs 3 HTCL | IC50 >28 μg/mL
CMNPD27186	weak cytotox. activ. vs 3 HTCL | IC50 >28 μg/mL
CMNPD27187	weak cytotox. activ. vs 3 HTCL | IC50 >28 μg/mL
CMNPD27188	weak cytotox. activ. vs 2 HTCL | IC50= 16.73 μM (HeLa)
CMNPD27189	No cytotox. vs 7 HTCL | IC50 > 10 μM
CMNPD27190	No cytotox. vs 7 HTCL | IC50 > 10 μM
CMNPD27191	potent COX-1 and COX-2 inhib.
CMNPD27192	potent COX-1 and COX-2 inhib.
CMNPD27193	mod. cytotox. vs 1 HTCL | IC50 = 8 μg/mL (HL-60)
CMNPD27194	mod. cytotox. vs 2 HTCL | IC50 range 0.19 to 2.12 μM (HeLa, MCF-7)
CMNPD27196	mod. cytotox. vs 2 HTCL | no AF activ.
CMNPD27197	Low cytotox. vs 3 HTCL
CMNPD27198	Low cytotox. vs 3 HTCL
CMNPD27199	Low cytotox. vs 3 HTCL
CMNPD27200	Low cytotox. vs 3 HTCL
CMNPD27203	No AM activ. vs 7 strains | no cytotox. vs 3 HTCL
CMNPD27204	Sign. cytotox. vs 4 HTCL | IC50 range, 0.060 - 0.389 μg/mL
CMNPD27205	No AM activ. vs 3 strains | no cytotox. vs 3 HTCL
CMNPD27206	No AM activ. vs 3 strains | no cytotox. vs 3 HTCL
CMNPD27207	No cytotox. vs 1 HTCL
CMNPD27208	mod. AM activ. vs 4 microb. strains | MIC range >64 μg/mL
CMNPD27209	mod. AM activ. vs 4 microb. strains | MIC range 16 - >1000 μg/mL
CMNPD27210	mod. AM activ. vs 4 microb. strains | MIC range 16 - >1000 μg/mL
CMNPD27211	mod. AM activ. vs 4 microb. strains | MIC range 16 - >1000 μg/mL
CMNPD27212	mod. AM activ. vs 4 microb. strains | MIC range 16 - >1000 μg/mL
CMNPD27213	mod. AM activ. vs 4 microb. strains | MIC range 16 - >1000 μg/mL
CMNPD27214	mod. AM activ. vs 4 microb. strains | MIC range 16 - >1000 μg/mL
CMNPD27215	VaPDF inhib. (IC50 = 6.94 μM) | Vibrio anguillarum IC50 = 2.85 μM
CMNPD27216	no VaPDF or Vibrio anguillarum activ.
CMNPD27217	weak AM activ. vs 4 microb. strains | MIC = or >100 μM
CMNPD27218	No cytoxo. vs 3 HTCL
CMNPD27222	IA vs 2 microb. strains | MIC >100 μg/mL
CMNPD27223	potent tox. vs brine shrimp | LD50 = 0.07 μg/mL
CMNPD27224	AM activ. vs 7 microb. strains (MIC range 3.125 - 12.5 μg/mL) | mod. cytotox. Vs 2 HTCL (IC50 range 4.6 - 9.0 μM)
CMNPD27225	AM activ. vs 7 microb. strains | MIC range 3.125 - 12.5 μg/mL
CMNPD27226	AM activ. vs 7 microb. strains | MIC range 3.125 - 12.5 μg/mL
CMNPD27227	weak AF activ. vs 2 strains | MICs >500 μg/disc
CMNPD27228	inhib. LPS-induced iNOS, IL-1β and IL-6 mRNA Expression
CMNPD27229	HIF-1 inhib.
CMNPD27230	IA vs melanin syn. in melan-A cells
CMNPD27231	inhib. of melanin syn. in melan-A cells
CMNPD27232	mod. cytotox. vs 1 HTCL | IC50 = 12 μM (HeLa-S3) | no AM activ. vs 4 strains
CMNPD27233	Inhib. tyrosinase (IC50 130 μM)
CMNPD27234	Inhib. tyrosinase (IC50 470 μM)
CMNPD27235	Inhib. tyrosinase (IC50 280 μM)
CMNPD27236	IA vs tyrosinase at 1 mM
CMNPD27237	IA vs tyrosinase at 1 mM
CMNPD27238	mod. AM activ. vs >10 strains | IC50 range <1 - >200 μM
CMNPD27239	mod. AM activ. vs >10 strains | IC50 range <1 - >200 μM
CMNPD27240	mod. AM activ. vs 2 strains | IC50 range 41.2 - 54.9 μM
CMNPD27241	mod. AM activ. vs 12 strains
CMNPD27248	no NO prod. inhib. | no AM activ. vs 7 strains, no cytotox. vs 2 HTCL
CMNPD27249	no NO prod. inhib. | no AM activ. vs 7 strains, no cytotox. vs 2 HTCL
CMNPD27250	no NO prod. inhib. | no AM activ. vs 7 strains, no cytotox. vs 2 HTCL
CMNPD27251	NO prod. inhib. (IC50 13 uM) | no AM activ. vs 7 strains, no cytotox. vs 2 HTCL
CMNPD27252	mod. AM activ. vs 7 strains | IC50 range 12.5 - >100 μg/mL
CMNPD27253	mod. AB activ. vs 7 strains.
CMNPD27254	mod. AB activ. vs 7 strains.
CMNPD27255	No AB activ. vs 1 strain | no cytotox. vs 2 HTCL
CMNPD27256	No AB activ. vs 1 strain | no cytotox. vs 2 HTCL
CMNPD27257	No AB activ. vs 1 strain | no cytotox. vs 2 HTCL
CMNPD27258	No AB activ. vs 1 strain | no cytotox. vs 2 HTCL
CMNPD27259	No AB activ. vs 1 strain | no cytotox. vs 2 HTCL
CMNPD27260	No AB activ. vs 1 strain | no cytotox. vs 2 HTCL
CMNPD27261	No AB activ. vs 1 strain | no cytotox. vs 2 HTCL
CMNPD27262	Low cytotox. vs 6 HTCL | IC50 range 20.8 - 81.0 μM
CMNPD27263	Some AB activ. vs 6 strains
CMNPD27264	Some AB activ. vs 6 strains
CMNPD27265	Some AB activ. vs 6 strains
CMNPD27266	Some AB activ. vs 6 strains
CMNPD27267	Some AB activ. vs 6 strains
CMNPD27268	Some AB activ. vs 6 strains
CMNPD27269	Some AB activ. vs 6 strains
CMNPD27270	Some AB activ. vs 6 strains
CMNPD27271	Some AB activ. vs 6 strains
CMNPD27272	Some AB activ. vs 6 strains
CMNPD27273	mod AB activ. vs 7 strains | no cytotox. activ. vs 4 HTCL.
CMNPD27274	No AB activ. vs 7 strains | no cytotox. activ. vs 4 HTCL.
CMNPD27275	No AB activ. vs 7 strains | mod. cytotox. activ. vs 4 HTCL.
CMNPD27277	mod. cytotox. Vs 5 HTCL | IC50 range 15.3-32.5 μg/mL
CMNPD27278	No cytotox. Vs 5 HTCL
CMNPD27284	mod. activ. vs 4 HTCLs
CMNPD27285	IA vs 4 HTCLs
CMNPD27286	mod. activ. vs 1 HTCL
CMNPD27287	weak activ. vs 1 HTCL
CMNPD27288	weak non-specific esterase activ.
CMNPD27289	weak non-specific esterase activ.
CMNPD27290	weak non-specific esterase activ.
CMNPD27293	mod. inhib. NO prod.
CMNPD27294	mod. inhib. NO prod.
CMNPD27295	mod. inhib. NO prod.
CMNPD27296	mod. inhib. NO prod.
CMNPD27297	mod. inhib. NO prod.
CMNPD27305	mod. inhib. NO prod.
CMNPD27307	antiosteoclastogenic activ.
CMNPD27308	IA vs 2 HTCLs and 12 aquatic bact.
CMNPD27309	mod. cytotox . vs brine shrimp
CMNPD27310	mod. activ. vs 2 HTCLs
CMNPD27311	mod. activ. vs 2 HTCLs
CMNPD27312	mod. activ. vs 2 HTCLs | weak AB vs B. subtilis
CMNPD27313	mod. activ. vs 2 HTCLs | weak AB vs B. subtilis
CMNPD27316	weak AO vs TEAC
CMNPD27317	weak AO vs TEAC
CMNPD27319	weak AO vs TEAC
CMNPD27320	weak AO vs TEAC
CMNPD27324	potent inhib. of H1N1
CMNPD27325	potent inhib. of α-glucosidase
CMNPD27326	potent inhib. of α-glucosidase
CMNPD27327	potent inhib. of α-glucosidase
CMNPD27328	IA vs 3 bact., 1 fung.
CMNPD27329	IA vs 2 HTCLs
CMNPD27330	IA vs 2 HTCLs
CMNPD27331	mod. inhib. HIV-1
CMNPD27333	mod. activ. vs 2 HTCLs
CMNPD27334	potent radical scavenging (DPPH)
CMNPD27335	haemolytic vs murine erythrocytes
CMNPD27337	mod. inhib. vs sterol O-acyltransferase (SOAT)
CMNPD27340	weak inhib. of fertilisation sea urchin eggs
CMNPD27341	weak inhib. of fertilisation sea urchin eggs
CMNPD27342	mod. inhib. thioredoxin reductase
CMNPD27343	mod. inhib. thioredoxin reductase
CMNPD27348	mod. inhib. thioredoxin reductase
CMNPD27352	mod. inhib. thioredoxin reductase
CMNPD27356	mod. inhib. vs 5 aquatic bact.
CMNPD27357	potent inhib. Fusarium graminearum
CMNPD27358	mod. inhib. vs 5 aquatic bact.
CMNPD27359	mod. inhib. vs 5 aquatic bact.
CMNPD27360	mod. inhib. vs 5 aquatic bact. | potent inhib. Fusarium graminearum
CMNPD27361	mod. AB vs 1 strain
CMNPD27362	mod. cytotox. vs 3 HTCLs
CMNPD27363	weak inhib. NO prod.
CMNPD27364	AV vs H1N1, H3N2
CMNPD27365	AV vs H3N2
CMNPD27367	mod. inhib. NO prod.
CMNPD27368	mod. inhib. NO prod.
CMNPD27369	mod. inhib. NO prod.
CMNPD27370	mod. inhib. NO prod.
CMNPD27374	mod. inhib. vs Vibrio anguillarum
CMNPD27376	weak inhib. GSK 3β
CMNPD27377	weak inhib. AchE
CMNPD27378	potent cytotox. vs 1 HTCL | potent radical scavenging (DPPH)
CMNPD27379	IA vs 3 HTCLs (> 10 mM)
CMNPD27380	IA vs 3 HTCLs (> 10 mM)
CMNPD27381	weak cytotox. vs 3 HTCLs
CMNPD27382	weak cytotox. vs 3 HTCLs
CMNPD27383	weak cytotox. vs 3 HTCLs
CMNPD27384	IA vs 3 HTCLs
CMNPD27385	IA vs 4 HTCLs
CMNPD27386	IA vs 4 HTCLs
CMNPD27387	IA vs 4 HTCLs
CMNPD27388	IA vs 4 HTCLs
CMNPD27389	IA vs murine cell line | IA vs. 5 HTCLs, α-glucosidase and MptpB.
CMNPD27390	IA vs 5 HTCLs, 10 bact. strains, 2 viruses and barnacle larvae
CMNPD27391	IA vs 5 HTCLs, 10 bact. strains, 2 viruses and barnacle larvae
CMNPD27392	IA vs 5 HTCLs, 10 bact. strains, 2 viruses and barnacle larvae
CMNPD27393	IA vs 5 HTCLs, 10 bact. strains, 2 viruses and barnacle larvae
CMNPD27394	IA vs 5 HTCLs, 10 bact. strains, 2 viruses and barnacle larvae
CMNPD27395	IA vs 5 HTCLs, 10 bact. strains, 2 viruses and barnacle larvae
CMNPD27396	IA vs 5 HTCLs, 10 bact. strains, 2 viruses and barnacle larvae
CMNPD27400	weak-mod. cytotox. vs 3 HTCLs
CMNPD27401	IA vs 4 HTCLs and barnacle larvae
CMNPD27402	IA vs 4 HTCLs and barnacle larvae
CMNPD27403	IA vs 4 HTCLs and barnacle larvae
CMNPD27404	strongα-glucosidase inhib. | weak cytotox. vs 3 HTCLs
CMNPD27407	potent thioredoxin reductase inhib. | weak cytotox. vs 2 HTCLs
CMNPD27408	potent thioredoxin reductase inhib. | weak cytotox. vs 2 HTCLs
CMNPD27409	potent thioredoxin reductase inhib. | weak cytotox. vs 2 HTCLs
CMNPD27410	IA vs 8 bact. strains
CMNPD27411	broad spectrum activ. mod.-strong vs 3 bact. | mod. vs 2 fungi | weak vs 1 HTCL
CMNPD27412	broad spectrum activ. mod.-strong vs 3 bact. | mod. vs 2 fungi | weak vs 1 HTCL
CMNPD27413	weak activ. vs 2 bact. strains
CMNPD27414	weak activ. vs 2 bact. strains
CMNPD27415	weak activ. vs 2 bact. strains
CMNPD27416	weak activ. vs 2 bact. strains
CMNPD27417	broad spectrum activ. mod.-strong vs 3 bact. | mod. vs 2 fungi | weak vs 1 HTCL
CMNPD27418	broad spectrum activ. mod.-strong vs 3 bact. | mod. vs 2 fungi | weak vs 1 HTCL
CMNPD27419	mod. radical scavenging (DPPH) | weak activ. vs 2 bact. strains
CMNPD27420	weak AF activ.
CMNPD27426	mod. activ. vs Candida
CMNPD27427	mod. radical scavenging (DPPH)
CMNPD27428	mod. radical scavenging (DPPH)
CMNPD27432	cytotox. vs pest insect cell line
CMNPD27433	cytotox. vs pest insect cell line
CMNPD27434	cytotox. vs pest insect cell line
CMNPD27435	cytotox. vs pest insect cell line
CMNPD27436	cytotox. vs pest insect cell line
CMNPD27437	cytotox. vs pest insect cell line
CMNPD27438	cytotox. vs pest insect cell line
CMNPD27439	IA vs bact., fung. and HTCLs
CMNPD27440	IA vs bact., fung. and HTCLs
CMNPD27441	IA vs bact., fung. and HTCLs
CMNPD27442	IA vs bact., fung. and HTCLs
CMNPD27443	IA vs bact., fung. and HTCLs
CMNPD27444	IA vs bact., fung. and HTCLs
CMNPD27445	IA vs bact., fung. and HTCLs
CMNPD27446	IA vs bact., fung. and HTCLs
CMNPD27447	IA vs bact., fung. and HTCLs
CMNPD27448	IA vs 1 HTCL, 1 parasite and 3 bact. strains.
CMNPD27449	IA vs 1 HTCL, 1 parasite and 3 bact. strains.
CMNPD27450	IA vs 1 HTCL, 1 parasite and 3 bact. strains.
CMNPD27452	IA vs 2 viruses and 9 bact. strains
CMNPD27453	potent radical scavenging (DPPH)
CMNPD27456	mod. cytotox. vs 3 HTCLs
CMNPD27457	mod. cytotox. vs 3 HTCLs
CMNPD27460	mod. AB vs 4 strains
CMNPD27461	mod. AB vs 4 strains
CMNPD27463	weak AB vs 1 strain
CMNPD27464	mod. but selective activ. vs 2 HTCLs
CMNPD27465	IA vs 2 HTCLs
CMNPD27466	synergistic activ. with fluconazole vs C. albicans
CMNPD27467	synergistic activ. with fluconazole vs C. albicans
CMNPD27471	AI via suppression of interleukin-17 prod.
CMNPD27472	weak cytotox. vs 5 HTCLs
CMNPD27473	mod. but selective cytotox. vs 1 HTCL
CMNPD27474	weak cytotox. vs 4 HTCLs
CMNPD27477	weak cytotox. vs 4 HTCLs
CMNPD27480	AI via suppression NO prod.
CMNPD27481	inhib. endo-1,3-β-D-glucanase
CMNPD27486	growth inhib. vs 1 HTCL
CMNPD27488	down regulation of ROS prod. in macrophages
CMNPD27492	down regulation of ROS prod. in macrophages
CMNPD27494	down regulation of ROS prod. in macrophages
CMNPD27498	activ. vs 1 fung. strain
CMNPD27499	activ. vs 2 bact. strains
CMNPD27500	IA vs 3 HTCLs
CMNPD27501	IA vs 3 HTCLs
CMNPD27503	IA vs 3 HTCLs
CMNPD27504	IA vs 3 HTCLs
CMNPD27507	IA vs 1 HTCL and 1 mammalian cell line
CMNPD27508	IA vs 1 HTCL and 1 mammalian cell line
CMNPD27509	IA vs 1 HTCL and 1 mammalian cell line
CMNPD27510	weak AB vs 1 strain
CMNPD27511	IA vs 1 virus
CMNPD27512	IA vs 1 virus
CMNPD27513	IA vs 1 virus
CMNPD27514	IA vs 1 virus
CMNPD27515	IA vs 2 HTCLS and 12 bact. strains
CMNPD27516	IA vs 2 HTCLS and 12 bact. strains
CMNPD27517	IA vs 2 HTCLS and 12 bact. strains
CMNPD27518	IA vs 2 HTCLS and 12 bact. strains
CMNPD27519	IA vs AchE
CMNPD27520	IA vs AchE
CMNPD27521	IA vs AchE
CMNPD27522	IA vs AchE
CMNPD27523	IA vs AchE
CMNPD27530	potent antifoul. vs barnacle larvae (as racemic mixt)
CMNPD27531	potent antifoul. vs barnacle larvae (as racemic mixt)
CMNPD27532	potent antifoul. vs barnacle larvae (as racemic mixt)
CMNPD27533	potent antifoul. vs barnacle larvae (as racemic mixt)
CMNPD27534	potent AO activ. (AO response element (ARE) reporter assay)
CMNPD27535	potent AO activ. (AO response element (ARE) reporter assay)
CMNPD27537	potent AO activ. (AO response element (ARE) reporter assay)
CMNPD27540	IA in wide range of assays
CMNPD27541	good antiangiogenic activ. vs hum. endothelial progenitor cells (EPCs)
CMNPD27542	mod. antiangiogenic activ. vs hum. endothelial progenitor cells (EPCs)
CMNPD27543	potent AI (inhib. NO prod.), mod antiangiogenic activ. vs hum. endothelial progenitor cells (EPCs)
CMNPD27544	mod. antiangiogenic activ. vs hum. endothelial progenitor cells (EPCs)
CMNPD27545	mod. antiangiogenic activ. vs hum. endothelial progenitor cells (EPCs)
CMNPD27546	mod. antiangiogenic activ. vs hum. endothelial progenitor cells (EPCs)
CMNPD27547	mod. antiangiogenic activ. vs hum. endothelial progenitor cells (EPCs)
CMNPD27548	potent AF vs 3 plant pathogenic strains
CMNPD27549	mod. insecticidal activ. vs Fall armyworm cells
CMNPD27552	good insecticidal activ. vs Fall armyworm cells | signif. AV vs 1 strain | no cytotox. to norm. hum. cell line
CMNPD27566	good cytotox. vs murine cell line (but already known)
CMNPD27574	potent antifoul. activ. vs Bugula neritina larvae
CMNPD27580	strong activ. vs WSN influenza virus
CMNPD27582	strong activ. vs WSN influenza virus
CMNPD27583	strong activ. vs WSN influenza virus
CMNPD27584	mod. activ. vs WSN influenza virus
CMNPD27585	mod. activ. vs WSN influenza virus
CMNPD27587	weak activ. vs WSN influenza virus
CMNPD27588	mod. activ. vs WSN influenza virus
CMNPD27590	mod. activ. vs WSN influenza virus
CMNPD27592	IA AB, AF, cytotox., QS assays
CMNPD27593	mod. fibrinolytic activ.
CMNPD27594	inhib. of osteoclast differentiation
CMNPD27596	affinity vasopressin receptor
CMNPD27597	affinity serotonin receptor
CMNPD27600	IA AB, AF, cytotox., QS assays
CMNPD27601	potent AO activ. (DPPH, ABTS) | mod. AB vs 6 strains
CMNPD27602	potent AO activ. (DPPH, ABTS) | IA AB vs 6 strains
CMNPD27603	potent AO activ. (DPPH, ABTS) | weak AB vs 5 strains
CMNPD27604	potent AO activ. (DPPH, ABTS) | mod. AB vs 6 strains
CMNPD27605	IA vs 4 bact. and 1 fung. strain and 3 HTCLs
CMNPD27606	IA vs 4 bact. and 1 fung. strain and 3 HTCLs
CMNPD27607	potent antifoul. vs Bugula neritina and Bugula amphitrite larvae
CMNPD27608	mod. antifoul. vs Bugula neritina larvae
CMNPD27609	weak antifoul. vs Bugula amphitrite larvae
CMNPD27610	mod. cytotox. vs 2 HTCLs
CMNPD27611	mod. AB vs 1 strain | weak antimicroalgal activ. vs 1 strain
CMNPD27612	mod. AB vs 1 strain
CMNPD27613	mod. cytotox. vs 1 murine , 2 HTCLs
CMNPD27614	mod. cytotox. vs 1 murine , 2 HTCLs
CMNPD27623	good inhib. GSK 3β
CMNPD27624	weak α-glucosidase inhib.
CMNPD27625	mod. α-glucosidase inhib.
CMNPD27626	mod. α-glucosidase inhib.
CMNPD27627	weak α-glucosidase inhib.
CMNPD27628	weak α-glucosidase inhib.
CMNPD27629	good radical scavenging (DPPH) (FRAP)
CMNPD27630	mod. radical scavenging (DPPH) (FRAP)
CMNPD27631	mod. radical scavenging (DPPH) (FRAP)
CMNPD27632	mod. radical scavenging (DPPH) (FRAP)
CMNPD27633	mod. radical scavenging (DPPH) (FRAP)
CMNPD27634	IA AB (6 strains) and 2 HTCLs
CMNPD27635	IA AB (6 strains) and 2 HTCLs
CMNPD27636	weak radical scavenging (DPPH). | IA α-glucosidase inhib. | AB (5 strains).
CMNPD27637	mod. α-glucosidase inhib. | IA AB (5 strains) and radical scavenging (DPPH)
CMNPD27638	weak radical scavenging (DPPH) | IA α-glucosidase inhib. | AB (5 strains).
CMNPD27640	mod. α-glucosidase inhib. | IA AB (5 strains) and radical scavenging (DPPH)
CMNPD27641	mod. α-glucosidase inhib. | IA AB (5 strains) and radical scavenging (DPPH)
CMNPD27643	weak anti-TB vs M. tuberculosis | weak cytotox. vs mammalian cell line
CMNPD27645	IA AB (5 strains), vs 10 HTCLs and COX-2 inhib.
CMNPD27646	specific COX-2 inhib. IA AB (5 strains) and vs 10 HTCLs
CMNPD27647	IA AB (5 strains), vs 10 HTCLs and COX-2 inhib.
CMNPD27648	IA AB (5 strains), vs 10 HTCLs and COX-2 inhib.
CMNPD27649	IA AF (1 strain)
CMNPD27650	mod. inhib. GSK 3β | mod. AB (3 strains) and AF (1 strain)
CMNPD27651	mod. inhib. GSK 3β | increases osteoclast formation | IA AB (3 strains) | AF (1 strain)
CMNPD27652	mod. AB (3 strains) | AF (1 strain) | GSK 3β inhib. NT
CMNPD27653	potent radical scavenging as racemate (DPPH)
CMNPD27654	potent radical scavenging as racemate (DPPH)
CMNPD27655	IA vs 5 HTCLs.
CMNPD27656	IA vs 5 HTCLs.
CMNPD27657	IA vs 5 HTCLs.
CMNPD27658	weak cytotox. vs 5 HTCLs
CMNPD27659	mod. cytotox. vs 5 HTCLs | mod. AB vs S. aureus
CMNPD27660	mod. cytotox. vs 5 HTCLs | mod. AB vs S. aureus
CMNPD27662	mod. cytotox. vs 5 HTCLs | IA vs S. aureus
CMNPD27663	mod. cytotox. vs 5 HTCLs | mod. AB vs S. aureus
CMNPD27664	mod. cytotox. vs 5 HTCLs | weak AB vs S. aureus
CMNPD27665	mod. cytotox. vs 5 HTCLs | AB vs S. aureus
CMNPD27666	mod. cytotox. vs 5 HTCLs | AB NT
CMNPD27668	weak cytotox. vs 2 HTCLs | AB NT
CMNPD27669	weak cytotox. vs 2 HTCLs
CMNPD27670	weak cytotox. vs 2 HTCLs
CMNPD27675	mod. inhib. α-glucosidase
CMNPD27676	potent inhib. α-glucosidase
CMNPD27677	potent inhib. α-glucosidase
CMNPD27678	mod. inhib. α-glucosidase
CMNPD27679	potent AV (H1N1) | IA vs 1 HTCL
CMNPD27680	potent AV (H1N1) | IA vs 1 HTCL
CMNPD27683	IA vs 2 HTCLs and weak AB (3 strains)
CMNPD27685	mod. cytotox. vs 1 HTCL | weak AB (3 strains)
CMNPD27686	potent cytotox. vs 2 HTCLs potent AB (S. aureus)
CMNPD27687	mod. cytotox vs 3 HTCLs | IA AF (4 strains)
CMNPD27688	weak cytotox vs 3 HTCLs | weak AF (4 strains)
CMNPD27689	IA AB (6 strains)
CMNPD27690	mod. AB (5 strains) | IA vs 3 HTCLs
CMNPD27691	mod. AB (4 strains) | IA vs 3 HTCLs
CMNPD27693	mod. AB (6 strains) | AF (1 strain)
CMNPD27694	weak-mod. AB (7 strains) | AF (2 strains)
CMNPD27695	mod. AB (7 strains) | AF (1 strain)
CMNPD27697	mod. immunosuppressive activ.
CMNPD27698	weak immunosuppressive activ.
CMNPD27699	potent and selective cytotox. vs 2 HTCLs | potent AB (4 strains)
CMNPD27700	mod. cytotox. vs murine cell line
CMNPD27707	cytotox. vs murine cancer cell line | weak cytotox. vs 1 HTCL
CMNPD27708	cytotox. vs murine cancer cell line | IA vs 1 HTCL
CMNPD27709	cytotox. vs murine cancer cell line | potent cytotox. vs 1 HTCL
CMNPD27710	cytotox. vs murine cancer cell line | weak cytotox. vs 1 HTCL
CMNPD27711	IA vs murine cancer cell line | weak cytotox. vs 1 HTCL
CMNPD27712	cytotox. vs murine cancer cell line | IA vs 1 HTCL
CMNPD27713	Range of weak activ. | radical scavenging (DPPH), AchE, | AB (13 strains)
CMNPD27714	Range of weak activ. | radical scavenging (DPPH), AchE | AB (13 strains) | IA vs 3 HTCLs, 5 bact. and COX-2.
CMNPD27715	Range of weak activ. | radical scavenging (DPPH), AchE | AB (13 strains)
CMNPD27716	Range of weak activ. | radical scavenging (DPPH), AchE | AB (13 strains)
CMNPD27718	weak cytotox. vs 7 HTCLs
CMNPD27719	mod. cytotox. vs 7 HTCLs
CMNPD27720	mod. cytotox. vs 7 HTCLs
CMNPD27725	weak cytotox. vs 2 HTCLs
CMNPD27738	potent cytotox. vs 7 HTCLs | 1 normal hum. cell line
CMNPD27739	mod. cytotox. vs 7 HTCLs | 1 normal hum. cell line
CMNPD27741	weak cytotox. vs 2 HTCLs
CMNPD27742	weak cytotox. vs 1 HTCL
CMNPD27744	weak cytotox. vs 1 HTCL
CMNPD27745	weak cytotox. vs 2 HTCLs
CMNPD27746	IA vs murine tumour cell line
CMNPD27747	IA vs murine tumour cell line
CMNPD27748	IA vs murine tumour cell line
CMNPD27749	mod. α-glucosidase inhib. | IA AB (5 strains).
CMNPD27750	potent α-glucosidase inhib. | IA AB (5 strains).
CMNPD27751	weak α-glucosidase inhib. | IA AB (5 strains).
CMNPD27752	weak α-glucosidase inhib. | IA AB (5 strains).
CMNPD27753	mod. α-glucosidase inhib. | IA AB (5 strains).
CMNPD27754	mod. α-glucosidase inhib. | IA AB (5 strains).
CMNPD27755	α-glucosidase inhib. NT | weak AB (4 strains).
CMNPD27756	α-glucosidase inhib. NT | weak AB (4 strains).
CMNPD27757	weak cytotox. vs 2 HTCLs
CMNPD27759	IA vs 3 HTCLs
CMNPD27760	IA vs 3 HTCLs
CMNPD27761	weak cytotox. vs 1 HTCL
CMNPD27762	weak cytotox. vs 1 HTCL
CMNPD27763	IA vs 3 HTCLs
CMNPD27764	IA vs 3 HTCLs
CMNPD27768	Antitrypanosomal activ. | IC50 = 47 nM (T. b. brucei) | no cytotox. vs 3 HTCL at 10 μM
CMNPD27769	cytotox. HTCL | IC50 = 0.58 μM (MCF-7) | IC50 = 1.0 μM (H460).
CMNPD27770	cytotox. HTCL | IC50 = 26.3 nM (HeLa S3).
CMNPD27771	cytotox. HTCL | IC50 = 1-5 μM
CMNPD27772	cytotox. HTCL | IC50 = 1-5 μM
CMNPD27773	cytotox. HTCL | EC50 = 9.0 μM (H-460) | mod. AF activ. | EC50 = 13.4 uM (S. cerevisiae)
CMNPD27774	Antiproteolytic activ. (cathepsin D, IC50 = 57 nM; cathespin E, IC50 = 23 nM; BACE1, IC50 = 0.69 μM)
CMNPD27775	mod. cytotox. HTCL | IC50 = 20.5 to >50 μg/mL (MCF-7, HCT-116, HepG2)
CMNPD27776	mod. cytotox. HTCL | IC50 = 18.2 to >50 μg/mL (MCF-7, HCT-116, HepG2)
CMNPD27777	mod. cytotox. HTCL | IC50 = 22.8 to >50 μg/mL (MCF-7, HCT-116, HepG2)
CMNPD27778	cytotox. HTCL | IC50 = 2.5 μM (HeLa) | induced apoptosis.
CMNPD27779	mod. carboxypeptidase A | protein phosphatase inhib.
CMNPD27780	mod. carboxypeptidase A | protein phosphatase inhib.
CMNPD27781	mod. carboxypeptidase A | protein phosphatase inhib.
CMNPD27782	mod. carboxypeptidase A | protein phosphatase inhib.
CMNPD27783	mod. carboxypeptidase A | protein phosphatase inhib.
CMNPD27784	IA vs HTCL | IC50 > 10 μM
CMNPD27785	IA vs HTCL | IC50 > 10 μM
CMNPD27786	IA vs HTCL | IC50 > 10 μM
CMNPD27787	IA vs HTCL | IC50 > 10 μM
CMNPD27788	IA vs HTCL | IC50 > 10 μM
CMNPD27789	IA vs HTCL | IC50 > 10 μM
CMNPD27790	IA vs HTCL | IC50 > 10 μM
CMNPD27791	weak activ. vs marine picocyanobacterium Synechococcus cf. nidulans (IC50 = 108 μM)
CMNPD27792	mod. cytotox. HTCL
CMNPD27793	mod. cytotox. HTCL.
CMNPD27794	Inhib. growth of anti-CD3 stimulated T-cells
CMNPD27799	mod. cytotox. vs 1 murine and 2 HTCLs
CMNPD27800	weak cytotox. vs 1 HTCL
CMNPD27802	cytotox. vs 1 HTCL
CMNPD27804	strong haemolytic activ vs erythrocytes
CMNPD27805	strong haemolytic activ vs erythrocytes
CMNPD27806	cytotox. vs 1 cell line
CMNPD27811	AO activ. 81% Trolox equiv. | AI activ. 81% inhib. of TNFα @ 10 μM
CMNPD27812	AO activ. 77% Trolox equiv. | AI activ. 21-35% inhib. of TNFα @ 10 μM
CMNPD27813	AO activ. 53% Trolox equiv. | AI activ. 21-35% inhib. of TNFα @ 8 μM
CMNPD27814	AO activ. 62% Trolox equiv.
CMNPD27815	AO activ. 50% Trolox equiv.
CMNPD27816	AO activ. 67% Trolox equiv. | AI activ. 79% inhib. of TNFα@ 8 μM
CMNPD27818	AO activ. 45% Trolox equiv. | AI activ. 21-35% inhib. of TNFα @ 8 μM
CMNPD27819	AO activ. 66% Trolox equiv. | AI activ. 59% inhib. of TNFα @ 5 μM
CMNPD27820	AO activ. 65% Trolox equiv. | AI activ. 21-35% inhib. of TNFα @ 8 μM
CMNPD27821	AO activ. 37% Trolox equiv. | AI activ. 21-35% inhib. of TNFα @ 10 μM
CMNPD27823	IA in AF and brine shrimp assays
CMNPD27825	Settlement inhibtion EC50 = 21.9 μM ( A. amphitrite) | 16.6 μM (B. perforatus) | LC50 range from 30.9-66.9 (A. amphitrite), 24.5-41.3 μM (B. perforatus)
CMNPD27826	no AI activ.
CMNPD27827	no A Iactiv.
CMNPD27828	IA in AB and AI assays
CMNPD27830	IA in AB and AI assays
CMNPD27831	IA in AB assays | IC50 3.5 μM in AI assay
CMNPD27832	IA in AB and AI assays
CMNPD27834	40-80% suppression of coral (Acropora muricata) photosynth. efficiency
CMNPD27835	40-80% suppression of coral (Acropora muricata) photosynth. efficiency
CMNPD27836	40-80% suppression of coral (Acropora muricata) photosynth. efficiency
CMNPD27837	IC50 0.44 μM vs PC3 cells
CMNPD27839	IC50 10 μM vs PC3 cells
CMNPD27842	>70% induction of apoptosis of HepG2 cells at 50 μM
CMNPD27846	IA in AB, cytotox. | AI assays
CMNPD27847	IA in AB, cytotox. | AI assays
CMNPD27848	mod. AB | AI activ.
CMNPD27849	IA in AB, cytotox. | AI assays
CMNPD27850	IA in AB, cytotox. | AI assays
CMNPD27851	IA in AB, cytotox. | AI assays
CMNPD27852	IA in AB, cytotox. | AI assays
CMNPD27853	IA in AB, cytotox. | AI assays
CMNPD27854	IA in AB, cytotox. | AI assays
CMNPD27855	MIC 2-6 μM vs some fungi and yeasts | IC50 39.5 μM on MCF-7.
CMNPD27860	DPPH radical scavenging IC50 25 μM
CMNPD27861	DPPH radical scavenging IC50 322 μM
CMNPD27862	DPPH radical scavenging IC50 231 μM
CMNPD27863	IC50 vs HL-60 38 μM | IC50 vs S. cerevisiae 69 μM
CMNPD27865	IC50 vs HL-60 78 μM | IC50 vs S. cerevisiae >83 μM
CMNPD27866	IC50 vs HL-60 61 μM | IC50 vs S. cerevisiae 63 μM
CMNPD27867	IC50 vs HL-60 49 μM | IC50 vs S. cerevisiae 39 μM
CMNPD27874	MIC 2-8 μg/mL vs a range of Gram-positive and -negative bact.
CMNPD27875	MIC 12.5-50 μg/mL vs a range of Gram-positive and -negative bact.
CMNPD27878	weak activ. vs Leuconostoc mesenteroides G6P dehydrogenase
CMNPD27879	weak activ. vs 1 HTCL
CMNPD27880	weak activ. vs 1 HTCL
CMNPD27881	mixt. of all four cpds weak inhib. IDO
CMNPD27882	mixt. of all four cpds weak inhib. IDO
CMNPD27883	mixt. of all four cpds weak inhib. IDO
CMNPD27884	mixt. of all four cpds weak inhib. IDO
CMNPD27885	mod. cytotox. vs 2 HTCLs and Leishmania infantum cell lines
CMNPD27886	mod. cytotox. vs 2 HTCLs and Leishmania infantum cell lines
CMNPD27887	mod. inhib. of 6 histone deacetylases (IC50 = 25 - >200 μM)
CMNPD27888	mod. inhib. of 6 histone deacetylases (IC50 = 29 - 150 μM)
CMNPD27889	Immunomodulatory (decreased IL-12p40 secretion at 10 μg/mL) from dendritic cells
CMNPD27890	Immunomodulatory (decreased IL-10 secretion at 10 μg/mL) from dendritic cells
CMNPD27891	Immunomodulatory (decreased IL-10 secretion at 10 μg/mL) from dendritic cells
CMNPD27892	inhib. autophagy in cisplatin-resistant NCCIT-R cancer cells at 10 μM
CMNPD27893	weak inhib. of PTP1B (IC50 = 8.2 μM)
CMNPD27894	IA in AF testing
CMNPD27895	IA in AF testing
CMNPD27896	IA in AF testing
CMNPD27897	IA in AF testing
CMNPD27898	IA in AF testing
CMNPD27899	Selective inducer of PPAR-γ at 12.5 μM
CMNPD27902	Selective inducer of PPAR-γ at 50 μM
CMNPD27907	inhib. ubiquitin-specific protease-7 (USP-7, IC50 = 0.75 μM)
CMNPD27908	inhib. ubiquitin-specific protease-7 (USP-7, IC50 = 0.36 μM)
CMNPD27909	inhib. ubiquitin-specific protease-7 (USP-7, IC50 = 2.0 μM)
CMNPD27910	weak inhib. of ubiquitin-specific protease-7 (USP-7, IC50 > 5 μM)
CMNPD27911	inhib. ubiquitin-specific protease-7 (USP-7, IC50 = 1.2 μM)
CMNPD27912	inhib. ubiquitin-specific protease-7 (USP-7, IC50 = 0.35 μM)
CMNPD27913	inhib. ubiquitin-specific protease-7 (USP-7, IC50 = 0.47 μM)
CMNPD27914	inhib. ubiquitin-specific protease-7 (USP-7, IC50 = 0.49 μM)
CMNPD27915	weak inhib. of ubiquitin-specific protease-7 (USP-7, IC50 > 5 μM)
CMNPD27916	weak inhib. of ubiquitin-specific protease-7 (USP-7, IC50 > 5 μM)
CMNPD27917	weak inhib. of ubiquitin-specific protease-7 (USP-7, IC50 > 5 μM)
CMNPD27918	inhib. ubiquitin-specific protease-7 (USP-7, IC50 = 1.4 μM)
CMNPD27924	IA vs P388 | inhib. chymotrypsin (IC50 = 2 μM)
CMNPD27925	IA vs P388 | inhib. chymotrypsin (IC50 = 3 μM)
CMNPD27926	IA vs P388 | inhib. chymotrypsin (IC50 = 10 μM)
CMNPD27927	mod. activ. vs 2 HTCLs and RAW264 cells (IC50 = 0.7 - 1.5 μM)
CMNPD27929	mod. activ. vs 6 HTCLs
CMNPD27932	mod. activ. vs 3 HTCLs
CMNPD27933	mod. activ. vs 3 HTCLs
CMNPD27934	potent activ. vs 4 HTCLs
CMNPD27935	potent activ. vs 4 HTCLs
CMNPD27936	IA vs 4 HTCLs
CMNPD27937	IA vs 4 HTCLs
CMNPD27938	inhib. hum. farnesoid X receptor (IC50 = 6.0 μM), IA vs 1 HTCL
CMNPD27939	IA vs hum. farnesoid X receptor and 1 HTCL
CMNPD27940	IA vs hum. farnesoid X receptor and 1 HTCL
CMNPD27941	mod. activ. vs P388 | IA vs 1 HTCL
CMNPD27942	weak activ. vs P388 | IA vs 1 HTCL
CMNPD27943	weak activ. vs P388 | IA vs 1 HTCL
CMNPD27946	mod. activ. vs 2 HTCLs | IA vs various Gram positive and negative bact.
CMNPD27947	mod. activ. vs 2 HTCLs | IA vs various Gram positive and negative bact.
CMNPD27948	12 mm zone vs M. smegmatis (10 μg/disk) | IA vs 1 HTCL
CMNPD27949	7 mm zone vs M. smegmatis (10 μg/disk) | weak activ. vs 1 HTCL
CMNPD27950	8 mm zone vs M. smegmatis (10 μg/disk) | weak activ. vs 1 HTCL
CMNPD27951	7 mm zone vs M. smegmatis (10 μg/disk) | weak activ. vs 1 HTCL
CMNPD27952	Selective inhib. of CK1 kinase (IC50 = 6 μM) while IA vs 8 other kinases. Cl atom enhances binding compared with IA parent halicyclamine B
CMNPD27953	Selective inhib. of PANC-1 cells under nutrient deficient conditions
CMNPD27954	weak activ. vs 3 HTCLs
CMNPD27955	weak active vs 3 HTCLs
CMNPD27956	weak active vs 3 HTCLs
CMNPD27957	IA as AChE inhib.
CMNPD27958	mod. activ. vs 1 HTCL
CMNPD27959	mod. activ. vs 1 HTCL
CMNPD27960	weak AF (IC50 = 32 μg/mL vs A. niger)
CMNPD27961	weak AB (MIC = 16 μg/mL vs E. coli, B. subtilis)
CMNPD27962	IC50 = 4.3 - 6.1 μM vs 2 HTCLs
CMNPD27963	IC50 = 2.9 - 3.4 μM vs 2 HTCLs
CMNPD27965	IC50 = 9.7 μM vs NF-kB, IA vs 2 HTCLs
CMNPD27966	IC50 = 5.7 μM vs NF-kB, IA vs 2 HTCLs
CMNPD27967	IA vs M. smegmatis and 1 HTCL
CMNPD27968	mod. activ. vs 1 HTCL
CMNPD27970	mod. activ. vs 1 HTCL
CMNPD27971	potent activ. vs 1 HTCL
CMNPD27972	potent activ. vs 1 HTCL
CMNPD27973	potent activ. vs 1 HTCL
CMNPD27974	potent activ. vs 1 HTCL
CMNPD27975	potent activ. vs 2 HTCLs
CMNPD27976	potent activ. vs 2 HTCLs
CMNPD27977	weak AF (Candida elegans)
CMNPD27980	weak AF (Candida elegans)
CMNPD27981	weak AF (Candida elegans)
CMNPD27986	weak activ. vs 1 HTCL | IA vs 3 others.
CMNPD27987	IA vs L5178Y cells
CMNPD27988	IA vs L5178Y cells
CMNPD27989	IA as AM
CMNPD27990	IA as AM
CMNPD27991	cytotox. to 3 HTCLs (IC50 = 20-50 μM) | 36% inhib. of BACE1 (at 42 μM)
CMNPD27993	40% inhib. of BACE1 (at 40 μM)
CMNPD27995	35% inhib. of BACE1 (at 42 μM)
CMNPD27996	70% inhib. of BACE1 (at 31 μM)
CMNPD27997	60% inhib. of BACE1 (at 31 μM)
CMNPD27998	weak activ. vs 1 HTCL and 1 non-cancerous hum. cell line
CMNPD27999	mod. activ. vs 1 of 4 HTCLs tested
CMNPD28000	Profiled vs phenotypic screen of PD
CMNPD28001	Profiled vs phenotypic screen of PD
CMNPD28002	Profiled vs phenotypic screen of PD
CMNPD28003	Profiled vs phenotypic screen of PD | potent lead to probe mechanisms of PD
CMNPD28004	Profiled vs phenotypic screen of PD
CMNPD28005	MIC 12.5 μM vs B. subtilis and S. aureus | IA vs K. pneumoniae and E. coli., mod. AB (MIC = 3.1 μg/mL vs E. coli, B. subtilis, S. aureus)
CMNPD28006	MIC 12.5 μM vs B. subtilis and S. aureus | IA vs K. pneumoniae and E. coli.
CMNPD28007	inhib. PTP1B (IC50 = 11.0 μM)
CMNPD28008	inhib. PTP1B (IC50 = 9.5 μM)
CMNPD28009	inhib. PTP1B (IC50 = 6.5 μM)
CMNPD28010	weak AB (MIC = 100 μg/mL vs E. coli, B. subtilis, S. aureus)
CMNPD28012	weak AB (MIC = 50 μg/mL vs E. coli, B. subtilis, S. aureus)
CMNPD28013	potent NF-κB inhib. | cytotox. vs 1 HTCL
CMNPD28014	mod. NF-κB inhib. | cytotox. vs 1 HTCL
CMNPD28015	mod. NF-κB inhib. | cytotox. vs 1 HTCL
CMNPD28017	IA vs Jurkat cells and 2 microb.
CMNPD28018	weak inhib. of Jurkat cells | IA vs 2 microb. strains
CMNPD28023	weak activ. vs 6 HTCLs
CMNPD28024	weak activ. vs 6 HTCLs
CMNPD28025	weak activ. vs 5 HTCLs | IA vs 1 HTCL
CMNPD28028	weak activ. vs 5 HTCLs | IA vs 1 HTCL
CMNPD28029	weak activ. vs 2 HTCLs | IA vs 4 HTCLs
CMNPD28030	weak activ. vs 6 HTCLs
CMNPD28031	IA vs 8 HTCLs
CMNPD28032	IA vs 8 HTCLs
CMNPD28033	IA vs 8 HTCLs
CMNPD28034	weak activ. vs 1 HTCL | no AB activ. vs 5 strains
CMNPD28037	mod. activ. vs 1 HTCL
CMNPD28038	mod. activ. vs 1 HTCL
CMNPD28039	mod. activ. vs 1 HTCL
CMNPD28040	mod. activ. vs 1 HTCL
CMNPD28041	inhib. differentiation of RAW264.7 cells into osteoclasts via RANKL-TRAP (IC50 = 13 μM) | non-toxic
CMNPD28042	inhib. differentiation of RAW264.7 cells into osteoclasts via RANKL-TRAP (IC50 = 18 μM) | non-toxic
CMNPD28048	MIC 133 μM vs MRSA, inhib. biofilm prod. (IC50 = 33 μM) yet non-cytotox. (J774 macrophage IC50 = 73 μM)
CMNPD28049	weak activ. vs 2 of 4 HTCLs
CMNPD28050	Antimalarial (IC50 = 4.2, 5.6 μM vs P. falciparum strain W2 and D6), selectivity = 2.6, 2.0
CMNPD28051	Antimalarial (IC50 = 3.0, 6.6 μM vs P. falciparum strain W2 and D6), selectivity = 3.7, 1.7
CMNPD28052	Antimalarial (IC50 = 4.9, 7.3 μM vs P. falciparum strain W2 and D6), selectivity = 2.4, 1.6
CMNPD28053	weak activ. vs 3 HTCLs
CMNPD28054	weak activ. vs 3 HTCLs
CMNPD28055	weak activ. vs 3 HTCLs
CMNPD28056	Very potent activ. vs 2 HTCLs. Activates apopt. via dual inhib. of Hsp-90 and topoisomerase II
CMNPD28057	potent activ. vs 2 HTCLs. Activates apoptosis via dual inhib. of Hsp-90 and topoisomeraseII
CMNPD28058	Similar level of induction of latent HIV-proviral gene expression as positive control, prostratin
CMNPD28059	Similar level of induction of latent HIV-proviral gene expression as positive control, prostratin
CMNPD28062	Similar level of induction of latent HIV-proviral gene expression as positive control, prostratin
CMNPD28063	Similar level of induction of latent HIV-proviral gene expression as positive control, prostratin
CMNPD28066	weak inhib. of BACE1 (IC50 = 82 μM)
CMNPD28069	inhib. PTP1B (IC50 = 4.3 μM), IA vs 2 HTCLs
CMNPD28070	weak activ. vs 1 HTCL
CMNPD28073	weak activ. vs 1 HTCL
CMNPD28074	weak activ. vs 1 HTCL
CMNPD28075	weak activ. vs 1 HTCL
CMNPD28076	weak activ. vs 1 HTCL
CMNPD28077	weak activ. vs 1 HTCL
CMNPD28078	weak activ. vs 1 HTCL
CMNPD28080	IA vs 2 HTCLs and 3 microb. strains
CMNPD28081	weak activ. vs 2 HTCLs | IA vs 3 microb. strains
CMNPD28082	weak activ. vs 2 HTCLs | IA vs 3 microb. strains
CMNPD28083	weak activ. vs 2 HTCLs
CMNPD28086	weak activ. vs 4 HTCLs
CMNPD28091	potent cytotox. vs Jurkat cells (IC50 = 11 nM), 7 HTCLs (IC50 = 0.23 - 3.56 μM)
CMNPD28095	weakly cytotox Hep-G2 cells
CMNPD28096	activate NF-kB dependent transcription
CMNPD28097	activate NF-kB dependent transcription
CMNPD28098	weak inhib. of superoxide generation and elastase release
CMNPD28099	weak inhib. of superoxide generation and elastase release
CMNPD28100	weak inhib. of superoxide generation and elastase release
CMNPD28101	weak inhib. of superoxide generation and elastase release
CMNPD28102	weak inhib. of superoxide generation and elastase release
CMNPD28103	weak inhib. of superoxide generation and elastase release
CMNPD28104	mod. cytotox HCT116
CMNPD28105	mod. cytotox HCT116
CMNPD28107	weakly cytotox 3 tumor cell lines
CMNPD28108	weakly cytotox 3 tumor cell lines
CMNPD28109	IA to bact.
CMNPD28110	weakly cytotox | AB | AI
CMNPD28111	weakly cytotox | AB | AI
CMNPD28112	weakly cytotox | AB | AI
CMNPD28113	IA antiviral | cytotox | NO prod.
CMNPD28114	IA antiviral | cytotox | NO prod.
CMNPD28115	IA antiviral | cytotox | NO prod.
CMNPD28116	weak antiviral | weak cytotox | mod inhib. of NO prod.
CMNPD28117	mod antiviral | mod cytotox
CMNPD28118	mod. inhib. CDC25 phosphatases
CMNPD28119	mod. inhib. CDC25 phosphatases
CMNPD28120	mod. inhib. CDC25 phosphatases
CMNPD28123	mod. inhib. CDC25 phosphatases
CMNPD28124	mod. inhib. CDC25 phosphatases
CMNPD28125	mod. inhib. CDC25 phosphatases
CMNPD28127	mod. inhib. CDC25 phosphatases
CMNPD28128	mod. inhib. CDC25 phosphatases
CMNPD28129	mod. inhib. CDC25 phosphatases
CMNPD28130	strong inhib. CDC25 phosphatases
CMNPD28131	mod. inhib. CDC25 phosphatases
CMNPD28134	mildly cytotox 2 TCLs
CMNPD28135	mildly cytotox HeLa cells
CMNPD28143	toxic to brine shrimp | not AB
CMNPD28144	AB vs S. aureus | non-cytotox
CMNPD28145	non-cytotox
CMNPD28149	Active vs MRSA
CMNPD28150	weakly AB | weakly cytotox
CMNPD28151	weakly AB | weakly cytotox
CMNPD28154	mildly AB S. aureus
CMNPD28156	non-cytotox
CMNPD28157	non-cytotox
CMNPD28158	non-cytotox
CMNPD28159	non-cytotox
CMNPD28160	non-cytotox
CMNPD28161	potent inhib. of both superoxide generation and elastase release
CMNPD28162	potent inhib. of both superoxide generation and elastase release
CMNPD28163	potent inhib. of both superoxide generation and elastase release
CMNPD28164	potent inhib. of both superoxide generation and elastase release
CMNPD28165	potent inhib. of both superoxide generation and elastase release
CMNPD28169	Inhibits prod. of TNF-α and IL-6
CMNPD28170	Inhibits prod. of TNF-α and IL-7
CMNPD28171	Inhibits prod. of TNF-α and IL-8
CMNPD28172	non-cytotox and IA vs NO prod.
CMNPD28173	non-cytotox and IA vs NO prod.
CMNPD28174	non-cytotox and IA vs NO prod.
CMNPD28175	non-cytotox and IA vs NO prod.
CMNPD28176	non-cytotox
CMNPD28177	Inhibits NO prod.
CMNPD28183	Inhibits NO prod.
CMNPD28187	AB | weak cytotox
CMNPD28188	AB | weak cytotox
CMNPD28189	AB | weak cytotox
CMNPD28190	weak cytotox to 4 HTCLs
CMNPD28191	weak cytotox to 4 HTCLs
CMNPD28192	weak cytotox to 4 HTCLs
CMNPD28193	weak cytotox to 4 HTCLs
CMNPD28195	potent AB
CMNPD28196	mod. AB
CMNPD28197	mod. AB
CMNPD28198	Non-cytotox
CMNPD28199	Non-cytotox
CMNPD28200	Reduced iNOS expression
CMNPD28201	Reduced iNOS expression
CMNPD28203	Reduced iNOS and COX-2 expression
CMNPD28206	Reduced iNOS expression
CMNPD28207	Reduced iNOS and COX-2 expression
CMNPD28209	Reduced iNOS expression
CMNPD28213	Reduced iNOS expression
CMNPD28214	weak cytotox 2HTCLs | weak AB
CMNPD28215	weak cytotox 2HTCLs | weak AB
CMNPD28216	weak cytotox 2HTCLs
CMNPD28217	weak cytotox 2HTCLs | weak AB
CMNPD28218	Non-cytotox | weak AB
CMNPD28219	weak cytotox 2HTCLs
CMNPD28221	weak cytotox CCRF-CEM
CMNPD28224	mild reduction in TNF-α levels
CMNPD28225	weak cytotox CCRF-CEM
CMNPD28226	non-cytotox
CMNPD28227	mod. cytotox to 3 HTCLs
CMNPD28228	cytotox to rat hepatic stellate cells | inhib. prod. of superoxide and elastase release.
CMNPD28229	cytotox to rat hepatic stellate cells | inhib. prod. of superoxide and elastase release.
CMNPD28230	inhib. prod. of superoxide and elastase release.
CMNPD28231	cytotox to rat hepatic stellate cells | inhib. prod. of superoxide and elastase release.
CMNPD28232	cytotox to rat hepatic stellate cells | inhib. prod. of superoxide and elastase release.
CMNPD28233	cytotox to rat hepatic stellate cells | inhib. prod. of superoxide and elastase release.
CMNPD28235	inhib. prod. of superoxide and elastase release.
CMNPD28236	mod cytotox to HeLa cell line.
CMNPD28237	Reduced iNOS and COX-2 expression
CMNPD28238	Reduced iNOS and COX-2 expression
CMNPD28239	weak cytotox to 4 TLC's
CMNPD28240	weak cytotox to 4 TLC's
CMNPD28241	weak cytotox to 4 TLC's
CMNPD28242	weak antiviral activ
CMNPD28243	weak antiviral activ
CMNPD28247	mod cytotox
CMNPD28248	mod cytotox | mod inhib. of superoxide prod.
CMNPD28249	mod cytotox | mod inhib. of superoxide prod.
CMNPD28250	mod antiviral activ
CMNPD28251	weak antiviral activ
CMNPD28252	weak cytotox MCF-7
CMNPD28253	mod cytotox to 5 HTCLs
CMNPD28254	IA vs hepatic stellate cells
CMNPD28255	IA vs hepatic stellate cells
CMNPD28256	IA vs hepatic stellate cells
CMNPD28257	IA vs hepatic stellate cells
CMNPD28259	non-cytotox
CMNPD28260	weak cytotox P388
CMNPD28261	non-cytotox
CMNPD28262	mild cytotox to 3 TCLs | inhib. superoxide formation and elastase release
CMNPD28263	non-cytotox
CMNPD28264	non-cytotox
CMNPD28265	mod cytotox to 2 HTCLs
CMNPD28266	non-cytotox
CMNPD28267	non-cytotox
CMNPD28268	mod cytotox to 2 HTCLs
CMNPD28269	mod cytotoxty vs K562 cell line
CMNPD28270	non-cytotox
CMNPD28272	weak anti-Leishmanial
CMNPD28285	weak AB | weak anti-Leishmanial
CMNPD28286	weak AB
CMNPD28290	weak cytotox to MOLT-4 and SUP-T1 cell lines
CMNPD28291	weak cytotox to 2 HTCLs
CMNPD28292	non-cytotox (4 HTCLs)
CMNPD28293	non-cytotox (4 HTCLs)
CMNPD28294	non-cytotox | Weak activ. vs 1 HTCL
CMNPD28295	mild to weak cytotox (3 HTCLs)
CMNPD28296	weak cytotox
CMNPD28297	weak cytotox
CMNPD28298	weak cytotox
CMNPD28302	AF | AB | cytotox. (4HTCL)
CMNPD28303	AF | AB | cytotox. (4HTCL)
CMNPD28314	cytotox. (HeLa S3)
CMNPD28315	cytotox. (HeLa S3)
CMNPD28316	cytotox. (HeLa S3)
CMNPD28319	Feeding deterent vs fish
CMNPD28325	mod. inhib. PTP1B | non-cytotox. | IA to panel of PTKs
CMNPD28326	mod. cytotox. (2HTCLs)
CMNPD28327	mod. AB activ.
CMNPD28328	mod. antiplasmodial activ.
CMNPD28329	Bound to variety of synaptic receptors | activ. upon intracerebroventricular injection
CMNPD28330	Bound to variety of synaptic receptors | activ. upon intracerebroventricular injection
CMNPD28331	Bound to variety of synaptic receptors | activ. upon intracerebroventricular injection
CMNPD28333	Antiplasmodial | mod. inhib. of HIF-1a / p300 binding
CMNPD28334	IA as PXR agonist.
CMNPD28335	mod. AO
CMNPD28336	cytotox. (P388), no HDAC inhib..
CMNPD28339	mod. inhib. of NO prod.
CMNPD28340	mod. inhib. of NO prod.
CMNPD28344	inhib. formation of ROS in stimulated macrophages
CMNPD28345	inhib. formation of ROS in stimulated macrophages | Not cytotox. to panel of 5 HTCLs.
CMNPD28346	inhib. formation of ROS in stimulated macrophages
CMNPD28347	inhib. formation of ROS in stimulated macrophages
CMNPD28348	IA cytotox./haemolysis/ROS inhib.
CMNPD28349	IA cytotox./haemolysis/ROS inhib.
CMNPD28350	IA cytotox./haemolysis/ROS inhib.
CMNPD28351	inhib. formation of ROS in stimulated macrophages
CMNPD28352	IA cytotox./haemolysis/ROS inhib.
CMNPD28353	IA cytotox./haemolysis/ROS inhib.
CMNPD28354	IA cytotox./haemolysis/ROS inhib.
CMNPD28355	IA cytotox./haemolysis/ROS inhib.
CMNPD28356	mixt. haemolytic
CMNPD28357	mixt. haemolytic
CMNPD28360	Increased ROS prod. in macrophages
CMNPD28361	Increased ROS prod. in macrophages | Not cytotox. to panel of 5 HTCLs.
CMNPD28363	mod. cytotox. (3HTCL)
CMNPD28364	mod. cytotox. (3HTCL)
CMNPD28365	mod. cytotox. (3HTCL)
CMNPD28366	Not cytotox. | weak haemolytic
CMNPD28367	weak cytotox. | inhib. tumour colony formation
CMNPD28368	Strongly cytotox. (1TCL) | haemolytic
CMNPD28369	mod. cytotox. (1TCL) | haemolytic
CMNPD28370	Strongly cytotox. (1TCL) | haemolytic
CMNPD28371	Strongly cytotox. (1TCL) | haemolytic
CMNPD28372	Not cytotox. | not haemolytic
CMNPD28373	Not cytotox. | not haemolytic
CMNPD28374	Not cytotox. | not haemolytic
CMNPD28375	Not cytotox. | not haemolytic
CMNPD28376	Not cytotox. | not haemolytic
CMNPD28377	Not cytotox. | not haemolytic
CMNPD28378	Not cytotox. | not haemolytic
CMNPD28379	Not cytotox. | not haemolytic
CMNPD28380	mod. cytotox. (2 HTCL, Vero)
CMNPD28381	mod. antimalarial activ.
CMNPD28387	IA in neuroprotective assay
CMNPD28388	IA in neuroprotective assay
CMNPD28389	IA in neuroprotective assay
CMNPD28390	IA in neuroprotective assay
CMNPD28391	IA in neuroprotective assay
CMNPD28392	IA in neuroprotective assay
CMNPD28393	IA in neuroprotective assay
CMNPD28394	IA in neuroprotective assay
CMNPD28395	IA to 7 HTCLs
CMNPD28396	weak cytotox. to two ovarian lines
CMNPD28397	IA to 7 HTCLs
CMNPD28398	IA to 7 HTCLs
CMNPD28405	weak to mod. cytotox. vs. 8 HTCLs, IC50 between 18.4 - 67.4 μM.
CMNPD28406	weak to mod. cytotox. vs. 8 HTCLs, IC50 between 18.4 - 67.4 μM.
CMNPD28407	weak cytotox. vs. 8 HTCLs.
CMNPD28408	weak cytotox. vs. 8 HTCLs.
CMNPD28409	weak cytotox. vs. 8 HTCLs.
CMNPD28410	weak cytotox. vs. 8 HTCLs.
CMNPD28411	Potent cytotox. vs. 4 HTCL, IC50 between 0.24 - 0.51 μM.
CMNPD28412	Low cytotox. vs. 4 HTCL, IC50 between 21.9 - 26.1 μM.
CMNPD28413	Mod. cytotox. vs. 4 HTCL, IC50 between 0.71 - 2.42 μM.
CMNPD28414	Low cytotox. vs. 4 HTCL, IC50 between 14.5 - 19.3 μM.
CMNPD28415	Mod. cytotox. vs. 4 HTCL, IC50 between 5.1 - 8.7 μM.
CMNPD28416	Mod. cytotox. vs. 4 HTCL, IC50 between 2.6 - 2.9 μM.
CMNPD28417	No AB or cytotox. activ.
CMNPD28418	Mod. cytotox. vs. 4 glioma HTCLs, IC50s between 0.3 to 0.4 μM | Mod. tox. vs. hum. Astrocytes, IC50 = 9.1 μM | cpd downregulates expression of metabolic regulators such as HK2, PFKFB3, PKM2, GLS, and FASN in glioma U87-MG cells.
CMNPD28419	Mod. cytotox. vs. 4 glioma HTCLs, IC50s between 0.1 to 1.4 μM | Mod. tox. vs. hum. Astrocytes, IC50 = 9.1 μM.
CMNPD28420	Mod. AM vs. 28 strains, MICs between 1 to >160 μg/mL.
CMNPD28421	Mod. AM vs. 28 strains, MICs between 16 to >128 μg/mL.
CMNPD28431	Potent in vitro and in vivo AB activ. vs. Clostridium difficile NAP1/B1/027 (MIC = 59 ng/μL) MOA is ionophoric, with K+ transport dysregulation.
CMNPD28432	Mod. activ. vs. Emiliania huxleyi (alga) with IC50 = 51 μM | No signif. AB activ. Binds to Fe.
CMNPD28433	Mod. activ. vs. Emiliania huxleyi (alga) with IC50 = 51 μM | No signif. AB activ. Binds to Fe.
CMNPD28434	No AB vs. 3 strains.
CMNPD28435	Low AB vs. 2 strains (MIC = 64 μg/ml).
CMNPD28436	Low cytotox. vs. SNU638 (IC50 = 11.2 μg/mL) | weak inhib. vs LPS-induced NO prod at 20 and 40 μM.
CMNPD28437	No cytotox. vs. SNU638 | weak inhib. effects vs LPS-induced NO prod at 20 and 40 μM.
CMNPD28438	No cytotox. vs. SNU638 | weak inhib. effects vs LPS-induced NO prod at 20 and 40 μM.
CMNPD28439	No cytotox. vs. SNU638 | No inhib. effects vs LPS-induced NO prod at 20 and 40 μM.
CMNPD28440	No cytotox. vs. 4 HTCLs | No AB vs. 2 strains.
CMNPD28441	No cytotox. vs. 4 HTCLs | No AB vs. 2 strains.
CMNPD28442	No cytotox. vs. 4 HTCLs | No AB vs. 2 strains.
CMNPD28443	No cytotox. vs. 2 HTCLs | No AM vs. 3 strains up to 100 μM.
CMNPD28444	weak cytotox. vs. HeLa, 25% growth inhib. at 33 μM.
CMNPD28445	weak cytotox. vs. HeLa, 32% growth inhib. at 33 μM.
CMNPD28446	weak cytotox. vs. 3 HTCLs, IC50 = 33.6 to >50 μM | No AF activ. vs. C. albicans.
CMNPD28447	weak cytotox. vs. 3 HTCLs, IC50 = 41.6 to >50 μM | No AF activ. vs. C. albicans.
CMNPD28448	Mod. AM vs. 8 Clostridium strains with MICs between 32 to >128 μg/mL.
CMNPD28449	Mod. AM vs. 8 Clostridium strains with MICs between 8 to >128 μg/mL.
CMNPD28450	Potent cytotox. vs. HCT-116 (IC50 = 0.078 μM) | Mod. AM vs. S. aureus (MIC = 30.71 μM) and C. albicans (MIC = 3.90 μM).
CMNPD28451	Mod. cytotox. vs. HCT-116 (IC50 = 10.56 μM) | Mod. AM vs. S. aureus (MIC = 36.62 μM) and C. albicans (MIC = 14.67 μM).
CMNPD28452	Mod. cytotox. vs. HCT-116 (IC50 = 7.28 μM) | Mod. AM vs. S. aureus (MIC = 36.62 μM) and C. albicans (MIC = 14.67 μM).
CMNPD28453	Low cytotox. vs. HCT-116 (IC50 = 17.14 μM) | Mod. AM vs. S. aureus (MIC = 36.62 μM) and C. albicans (MIC = 14.67 μM).
CMNPD28454	No cytotox. vs. 4 HTCLs, GI50 >10 μM.
CMNPD28455	No cytotox. vs. 4 HTCLs, GI50 >10 μM.
CMNPD28456	No cytotox. vs. 4 HTCLs, GI50 >10 μM.
CMNPD28457	No cytotox. vs. 4 HTCLs, GI50 >10 μM.
CMNPD28458	No cytotox. vs. 4 lung HTCLs | No antibac vs. 2 strains.
CMNPD28459	No cytotox. vs. 4 lung HTCLs | No antibac vs. 2 strains.
CMNPD28460	No cytotox. vs. 4 lung HTCLs | No antibac vs. 2 strains.
CMNPD28461	No cytotox. vs. 4 lung HTCLs | No antibac vs. 2 strains.
CMNPD28462	No cytotox. vs. 4 lung HTCLs | No antibac vs. 2 strains.
CMNPD28463	weak AB vs. B. subtilis (MIC = 64.0 μM) | weak inhib. activ. vs AchE (IC50 = 50.6 μM).
CMNPD28464	No AB vs. B. subtilis. | No inhib. activ. vs AchE.
CMNPD28465	Low cytotox. vs. 2 HTCLs [Jurkat (IC50= 24.7 μM), HCT-116 (IC50= 33.5 μM). No AM vs. 3 strains (MICs > 100 μM).
CMNPD28466	No cytotox. vs. 1 pancreatic HTCL.
CMNPD28467	No cytotox. vs. 1 pancreatic HTCL.
CMNPD28468	Mod. cytotox. vs. 6 HTCLs (IC50 between 6.3 to >42.6 μM) | Mod. AM vs. 6 strains (MIC90 = 40 to >160 μg/mL).
CMNPD28473	Potent cytotox. vs. several HTCLs (some IC50s nM)
CMNPD28474	Potent cytotox. vs. several HTCLs (some IC50s nM)
CMNPD28475	Potent cytotox. vs. several HTCLs (some IC50s nM)
CMNPD28476	Potent cytotox. vs. several HTCLs (some IC50s nM)
CMNPD28477	Potent cytotox. vs. several HTCLs (some IC50s nM)
CMNPD28478	Potent cytotox. vs. several HTCLs (some IC50s nM)
CMNPD28479	No cytotox. vs. 4 glioma HTCLs | No AM vs. 3 strains.
CMNPD28480	Mod. cytotox. vs. 4 glioma HTCLs (IC50 between 7.3 to 13.3 μM).
CMNPD28481	Mod. cytotox. vs. 4 glioma HTCLs induces apoptosis in U87MG cells | No AM vs. 3 strains
CMNPD28482	No cytotox. vs. 4 glioma HTCLs | No AM vs. 3 strains.
CMNPD28483	No cytotox. vs. 4 glioma HTCLs | No AM vs. 3 strains.
CMNPD28484	No cytotox. vs. 4 glioma HTCLs | No AM vs. 3 strains.
CMNPD28485	No cytotox. vs. HeLa, NB4, A549, and H1975 cell lines (IC50 >30 μM).
CMNPD28486	Potent cytotox.vs. HeLa, NB4, A549, and H1975 cells, IC50 values of 0.003, 0.037, 0.56, and 0.49 μM.
CMNPD28487	Mod. inhib. of hum. MAO-B (IC50 = 1.21 μM) and MAO-A (IC50 = 6.47 μM).
CMNPD28488	weak inhib. of hum. MAO-B (IC50 = 14.50 μM) and MAO-A (IC50 >80 μM).
CMNPD28489	weak AM vs. 3 strains | best activ. towards C. albicans with MIC = 12.5 μg/mL | weak cytotox. vs. 4 glioma HTCLs
CMNPD28490	weak AM vs. 3 strains | best activ. towards C. albicans with MIC = 12.5 μg/mL | weak cytotox. vs. 4 glioma HTCLs.
CMNPD28491	No AM vs. 3 strains | No cytotox. vs. 4 glioma HTCLs.
CMNPD28492	No AM vs. 3 strains | No cytotox. vs. 4 glioma HTCLs.
CMNPD28493	No AM vs. 3 strains | No cytotox. vs. 4 glioma HTCLs.
CMNPD28494	No AM vs. 3 strains | No cytotox. vs. 4 glioma HTCLs.
CMNPD28495	No AM vs. 3 strains | No cytotox. vs. 4 glioma HTCLs.
CMNPD28496	No AM vs. 3 strains | No cytotox. vs. 4 glioma HTCLs.
CMNPD28497	No AM vs. 3 strains | No cytotox. vs. 4 glioma HTCLs.
CMNPD28498	weak AM vs. 4 phytopathogen strains, MIC between 375 - 750 μg/mL.
CMNPD28499	weak AM vs. 4 phytopathogen strains, MIC between 50 - 750 μg/mL.
CMNPD28500	No cytotox. vs. Jurkat T cells, IC50 >20 μM.
CMNPD28501	Mod. cytotox. vs. Jurkat T cells, IC50 = 3.0 μM.
CMNPD28502	No AM vs. 4 strains.
CMNPD28503	Mod. AM vs. 37 strains | Potent cytotox. vs. 2 HTCLs, IC50 = 65.8 nM (A549) and IC50 = 38.7 nM (HCT116).
CMNPD28504	No AM vs. 37 strains, MICs >128 μg/mL | Potent cytotox. vs. 2 HTCLs, IC50 = 38.7 nM (A549) and IC50 = 339.1 nM (HCT116).
CMNPD28505	Low cytotox. vs. hum. umbilical cells, IC50 = 62.6 μM.
CMNPD28506	Mod. AM vs. 10 strains, MICs from 25 to 100 μg/mL | weak AO activ. in DPPH assay, ~52% inhib. at 20 μg/mL.
CMNPD28507	Mod. AM vs. 10 strains, MICs from 12.5 to 125 μg/mL | weak AO activ. in DPPH assay, ~62% inhib. at 20 μg/mL.
CMNPD28508	Mod. AM vs. 10 strains, MICs from 12.5 to 125 μg/mL | weak AO activ. in DPPH assay, ~63% inhib. at 20 μg/mL.
CMNPD28509	Low alpha-glucosidase activ., IC50 = 863 μM | No AV activ. vs. influenza A (H1N1) at 50 μg/mL.
CMNPD28510	No alpha-glucosidase activ., IC50 > 5 mM | No cytotox. vs. HeLa, IC50 >50 μM | Mod. AV activ. vs. influenza A (H1N1)
CMNPD28511	No alpha-glucosidase active | No cytotox. vs. HeLa | Mod. AV activ. vs. influenza A (H1N1) | No cytotox. vs. 2 HTCLs | no AB vs. 5 strains.
CMNPD28512	No alpha-glucosidase activ. | Mod. cytotox. vs. HeLa, IC50 = 8.2 μM | No AV activ. vs. influenza A (H1N1)
CMNPD28513	No alpha-glucosidase activ., IC50 > 5 mM | No cytotox. vs. HeLa | No AV activ. vs. influenza A (H1N1)
CMNPD28514	No AB vs. 12 strains | No anti-HIV-1 replication activ. (0.016 to 50 μg/mL), however some promotion of viral replication (10 to 50 μg/mL).
CMNPD28515	No AB vs. 12 strains | No anti-HIV-1 replication activ. (0.016 to 50 μg/mL).
CMNPD28516	No AB vs. 12 strains | No anti-HIV-1 replication activ. (0.016 to 50 μg/mL), however some promotion of viral replication (10 to 50 μg/mL).
CMNPD28517	Potent to mod. cytotox. activ. vs. 4 HTCLs; IC50 values from 0.01 - 31.8 μnM | IA towards 1 HTCL at 2.0 μg/mL.
CMNPD28518	Potent to mod. cytotox. activ. vs. 4 HTCLs; IC50 values from 54.2 - 389.6 μnM | IA towards 1 HTCL at 2.0 μg/mL.
CMNPD28519	Mod. cytotox. vs. H1975 cells, IC50 = 1 μM. | Mod. AM vs. 4 strains, MIC = 64 to >128 μM.
CMNPD28520	No cytotox. vs. H1975 cells at 10 μM | Low. AM vs. 4 strains, MIC >128 μM.
CMNPD28521	No cytotox. vs. H1975 cells at 10 μM | Low. AM vs. 4 strains, MIC >128 μM.
CMNPD28522	No cytotox. vs. H1975 cells at 10 μM | Low. AM vs. 4 strains, MIC >128 μM.
CMNPD28523	No cytotox. vs. H1975 cells at 10 μM | Low. AM vs. 4 strains, MIC >128 μM.
CMNPD28524	No cytotox. vs. H1975 cells at 10 μM | Low. AM vs. 4 strains, MIC >128 μM.
CMNPD28525	No cytotox. vs. H1975 cells at 10 μM | Low. AM vs. 4 strains, MIC >128 μM.
CMNPD28526	Exhibits anti-Stx (shiga toxin) potentIAl and is able to inhibit Stx prod without influencing bact.l growth.
CMNPD28527	No AM vs. 5 strains | No cytotox. vs. 4 HTCLs | No AV vs. HSV T1.
CMNPD28528	No AM vs. 5 strains | No cytotox. vs. 4 HTCLs | No AV vs. HSV T1.
CMNPD28529	weak AM vs. 5 strains | No cytotox. vs. 4 HTCLs | No AV vs. HSV T1.
CMNPD28530	weak AM vs. 5 strains | No cytotox. vs. 4 HTCLs | No AV vs. HSV T1.
CMNPD28531	weak AM vs. 5 strains | best activ. vs B. subtilis (zone of inhib. = 7 mm at 50 μg per disk) | No cytotox. vs. 4 HTCLs | No AV vs. HSV T1.
CMNPD28532	No cytotox. vs. 8 HTCLs.
CMNPD28533	Mod. cytotox. vs. MCF-7, SF-268, and NCI-H460 with IC50 values of 7.5, 7.9, 7.8 μg/mL, respectively | No AM activ. vs. 5 strains.
CMNPD28534	No cytotox. vs. MCF-7, SF-268, and NCI-H460 at 20 μg/mL | No AM activ. vs. 5 strains.
CMNPD28535	Mod. cytotox. vs. HL-60 (IC50 = 3.9 μg/mL) and HT-29 (IC50 = 5.3 μg/mL).
CMNPD28536	No AB activ. vs. 3 strains | No cytotox. vs. 2 HTCLs.
CMNPD28537	No AB activ. vs. 3 strains | No cytotox. vs. 2 HTCLs.
CMNPD28538	No AB activ. vs. 3 strains | No cytotox. vs. 2 HTCLs.
CMNPD28539	No AB activ. vs. 3 strains | No cytotox. vs. 2 HTCLs.
CMNPD28540	Mod. cytotox. vs. 4 glioma HTCLs, IC50s between 0.44 to 0.98 μM | Mod. AB activ. vs. MRSA, MIC 7.4 μM, MBC 14.8 μM | No activ. towards E.coli.
CMNPD28541	No cytotox. vs. 4 glioma HTCLs. | No AB activ. vs. 2 strains.
CMNPD28542	No AB, cytotox., and AF activ.
CMNPD28543	Mod. AB vs. 4 strains. | No cytotox. vs. 2 HTCLs at 1.25 - 10.0 μM.
CMNPD28544	Mod. AB vs. 4 strains. | No cytotox. vs. 2 HTCLs at 1.25 - 10.0 μM.
CMNPD28545	Mod. AB vs. 4 strains. | Potent to no cytotox. vs. 9 HTCLs.
CMNPD28546	Mod. AB vs. 4 strains. | No cytotox. vs. 2 HTCLs at 1.25 - 10.0 μM.
CMNPD28547	Mod. AB vs. 4 strains. | No cytotox. vs. 2 HTCLs at 1.25 - 10.0 μM.
CMNPD28549	No AM activ. vs. 8 strains.
CMNPD28550	Act. vs TRAIL resistance at 10 μM in hum. gastric adenocarcinoma (AGS) cells.
CMNPD28551	No cytotox. vs. 2 HTCLs. | Mod. AB vs. MRSA, MIC 40 μg/mL.
CMNPD28552	Mod. cytotox. vs. 2 HTCLs [U251 (IC50 = 0.21 μM), C6 (IC50 = 1.08 μM). | Mod. AB vs. MRSA, MIC 12.5 μg/mL.
CMNPD28553	Mod. cytotox. vs. 2 HTCLs [U251 (IC50 = 0.36 μM), C6 (IC50 = 0.12 μM). | Mod. AB vs. MRSA, MIC 12.5 μg/mL.
CMNPD28554	MOA involves rapid attenuation of AKT signaling
CMNPD28555	No AM vs. 6 strains. | No cytotox. vs. 2 HTCLs.
CMNPD28556	No AM vs. 6 strains. | No cytotox. vs. 2 HTCLs.
CMNPD28557	weak AM vs. 7 strains; MICs from 16 to >250 μg/mL. | weak cytotox. vs. 6 HTCLs; IC50 values from 5.5 - 96 μM.
CMNPD28558	weak AM vs. 7 strains; MICs from 63 to >250 μg/mL. | weak cytotox. vs. 6 HTCLs; IC50 values from 6.7 - 71 μM.
CMNPD28559	weak AM vs. 7 strains; MICs from 250 to >250 μg/mL. | No cytotox. vs. 6 HTCLs; IC50 >100 μM.
CMNPD28560	Mod. cytotox. vs. 6 HTCLs (IC50 between 3.86 to 22.5 μM). | No AM vs. 4 strains. inhib. of T3SS, with inhib. on the secretion of the SPI-1 effector SipC.
CMNPD28561	Mod. cytotox. vs. 6 HTCLs (IC50 between 2.60 to >40 μM). | Low AM vs. 4 strains, best MIC = 25.8 μM vs B. subtilis.
CMNPD28563	Mod. cytotox. vs. Jurkat cells with IC50 = 6.98 μM. | Arrested cell cycle of Jurkat cells in G2/M phase (66% at 15 μM).
CMNPD28564	No cytotox. vs. 6 HTCLs.
CMNPD28565	No cytotox. vs. 6 HTCLs at 50 μM.
CMNPD28566	No cytotox. vs. 6 HTCLs at 50 μM.
CMNPD28567	No cytotox. vs. 6 HTCLs at 50 μM.
CMNPD28568	No cytotox. vs. 6 HTCLs at 50 μM.
CMNPD28569	No cytotox. vs. 6 HTCLs at 50 μM.
CMNPD28570	weak AM. vs. 5 strains | no cytotox. vs. 4 HTCL | weak antioxid.( EC50 48.6 μM)
CMNPD28571	weak AM. vs. 5 strains | no cytotox. vs. 4 HTCL
CMNPD28572	weak AM. vs. 5 strains | no cytotox. vs. 4 HTCL
CMNPD28573	Potent AM vs. 10 strains, MIC90 between 0.0003 to >10 μM.
CMNPD28574	Potent AM vs. 10 strains, MIC90 between 0.0001 to >10 μM.
CMNPD28575	Mod. AM vs. 10 strains, MIC90 between 0.8 to >50 μM.
CMNPD28576	Potent AM vs. 10 strains, MIC90 between 0.06 to >50 μM.
CMNPD28577	No AM vs. 7 strains | MICs >64 μg/mL.
CMNPD28578	Mod. AM vs. 7 strains | MICs 1 - 8 μg/mL, to IA
CMNPD28579	Mod. cytotox. vs. 3 HTCLs; IC50 between 1.58 to 4.30 μM.
CMNPD28580	No AB vs. 5 strains.
CMNPD28581	No AB vs. 5 strains.
CMNPD28582	Mod. AB vs. B. thuringiensis BT01 and B. subtilis BS01 with MIC between 0.016 to 8.0 μg/mL.
CMNPD28583	Mod. AB vs. B. thuringiensis BT01 and B. subtilis BS01 with MIC between 0.016 to 8.0 μg/mL.
CMNPD28584	Mod. AB vs. B. thuringiensis BT01 and B. subtilis BS01 with MIC between 0.016 to 8.0 μg/mL.
CMNPD28585	Mod. AB vs. B. thuringiensis BT01 and B. subtilis BS01 with MIC between 0.016 to 8.0 μg/mL.
CMNPD28586	Mod. AB vs. B. thuringiensis BT01 and B. subtilis BS01 with MIC between 0.016 to 8.0 μg/mL.
CMNPD28587	Mod. AB vs. B. thuringiensis BT01 and B. subtilis BS01 with MIC between 0.016 to 8.0 μg/mL.
CMNPD28588	Mod. AB vs. B. thuringiensis BT01 and B. subtilis BS01 with MIC between 0.016 to 8.0 μg/mL.
CMNPD28589	Mod. AB activ. vs. B. subtilis (MIC = 8.0 μg/mL) and MRSA (MIC = 2.0 μg/mL) | MOA appears to affect fatty acid biosynthesis.
CMNPD28590	weak inhibit. vs. BACE1 at > 1 μM. | No PPAR or AchE inhib. or AB (vs. several strains).
CMNPD28591	weak inhibit. vs. BACE1 at > 1 μM. | No PPAR or AchE inhib. or AB (vs. several strains).
CMNPD28592	NA in MAO inhib., AchE inhib., BACE1 inhib., anti-osteoporosis, cytotox., anti-tyrosinase, and AB assays. weak AO activ.; IC50 >140 μM.
CMNPD28593	NA in MAO inhib., AchE inhib., BACE1 inhib., anti-osteoporosis, cytotox., anti-tyrosinase, anti-oxidant and AB assays.
CMNPD28594	NA in MAO inhib., AchE inhib., BACE1 inhib., anti-osteoporosis, cytotox., anti-tyrosinase, AO and AB assays.
CMNPD28595	Antichlamydial activ. vs. 4 strains, IC50 between 46.5 - 96.3 μM.
CMNPD28596	weak anti-allergic activ. on IgE-medIAted rat mast RBL-2H3 cells (9.8% inhib. at 20 μg/mL.
CMNPD28597	No cytotox. vs. 1 HTCL (RBL-2H3) at 20 μg/mL.
CMNPD28598	mod. cytotox. vs. 7 HTCLs, IC50 between 0.1 to 9.7 μM. | No AF activ. vs. Aspergillus fumigatus.
CMNPD28599	weak cytotox. vs. 4 HTCLs, IC50 = 14.3 to 23.7 μM.
CMNPD28600	weak cytotox. vs. 4 HTCLs, IC50 = 13.9 to >30 μM.
CMNPD28601	No cytotox. vs. 4 HTCLs, IC50 >30 μM.
CMNPD28602	No cytotox. vs. 4 HTCLs at 10 μM . | No AM vs. 4 strains at 10 μg/disk.
CMNPD28603	No cytotox. vs. 4 HTCLs at 10 μM . | No AM vs. 4 strains at 10 μg/disk.
CMNPD28604	No siderophoric activ.
CMNPD28605	Potent AB vs. 4 strains; MICs between 3.12 to 6.25 μg/mL.
CMNPD28606	Low AB vs. 4 strains; MICs >25 μg/mL.
CMNPD28607	Mod. AB vs. 4 strains; MICs >7 μg/mL.
CMNPD28608	Low AB vs. 4 strains in disc diffusion assay.
CMNPD28609	Mod. AB activ. vs. 5 MRSA strains, MICs between 8 to 32 No cytotox. vs. 2 HTLCs.
CMNPD28610	Mod. AB activ. vs. 5 MRSA strains, MICs between 16 to 32 to NA μg/mL. No cytotox. vs. 2 HTLCs.
CMNPD28611	weak AF vs Colletotrichum gloeosporoides | IA vs Fusarium oxysporum
CMNPD28613	Mod. AB vs 3 strains, zone of inhib.s ranged from 14 to 18 mm.
CMNPD28614	Mod. AB vs 3 strains, zone of inhib.s ranged from 12 to 16.7 mm.
CMNPD28615	inhib. of Vibrio alginolyticus motility and Induces cell aggregation; inhib. biofilm formation vs pathogenic bact. without inducing cell death.
CMNPD28616	inhib. of Vibrio alginolyticus motility and Induces cell aggregation; inhib. biofilm formation vs pathogenic bact. without inducing cell death.
CMNPD28617	Mod. AF activ. vs. 70 strains; MICs from 3.125 to 6.25 μg/mL.
CMNPD28618	Some cytotox. activ. towqrds breast cancer, gastric cancer, and melanoma, triggers apoptosis via ROS mechanism.
CMNPD28619	Mod. AB activ. vs. S. aureus, MIC = 35 μM. IA vs. 5 other bac. strains at 140 μM.
CMNPD28621	inhib. of LPS (IC50 = 4.8 nM). | AB activ. vs. 4 strains with MICs between 0.25 to 128 μg/ml.
CMNPD28622	inhib. of LPS (IC50 = 6.0 nM). | AB activ. vs. 4 strains with MICs between 0.25 to 64 μg/ml.
CMNPD28623	inhib. of LPS (IC50 = 4.1 nM). | AB activ. vs. 4 strains with MICs between 0.25 to 32 μg/ml.
CMNPD28624	inhib. of LPS (IC50 = 5.6 nM). | AB activ. vs. 4 strains with MICs between 0.5 to 16 μg/ml.
CMNPD28636	Mod. AB vs. Vibrio anguillarum C312 (MIC = 50 μg/mL and IC50 = 39.02 μg/mL).
CMNPD28638	Mod. cytotox. vs. 2 HTCLs; L929 cells (EC50 = 7 μM) and A549 cells (EC50 = 8 μM).
CMNPD28639	signif. antifoul. activ. vs the mussel Perna viridis, the barnacle Balanus albicostatus, and the marine bact. Pseudomonas sp. TB4
CMNPD28640	Siderophoric activ. | Mod. in vitro AB activ.vs P. aeruginosa and E. coli with MICs of 64 μg/mL.
CMNPD28641	weak cytotox. vs. 2HTCLs, IC50 = 46 to >30 μM. | NGF enhancer of PC12 cells. | MIC of 8 ug/ml vs. B. subtilis
CMNPD28642	No cytotox. vs. 2 HTCLs. | No AM vs. 7 strains.
CMNPD28643	No cytotox. vs. 2 HTCLs. | No AM vs. 7 strains.
CMNPD28644	Potent cytotox. vs. 4 HTCLs, GI50 between 2.0 to 2.9 nM.
CMNPD28646	Mod. cytotox. vs. 10 HTCL; IC50 values low uM
CMNPD28648	Mod. tox. vs brine shrimp signif. cytotox. vs 39 HTCL, average GI50 = 28 nM.
CMNPD28649	Potent. activ. vs T. brucei brucei (GUT at 3.1 strain) IC50 3.9 nM | no cytotox. vs hum. fetal lung fibroblast MRC-5 cells (IC50 > 25 μM).
CMNPD28650	Mod. antifoul. activ. vs Amphibalanus amphitrite larvae, inhibited settlement < 1 μg/mL
CMNPD28651	Mod. antifoul. activ. vs Amphibalanus amphitrite larvae, inhibited settlement < 1 μg/mL
CMNPD28652	Strong antifoul. activ. vs Amphibalanus amphitrite larvae (EC50 0.38 μM)
CMNPD28653	Strong antifoul. activ. vs Amphibalanus amphitrite larvae (EC50 0.73 μM) | mod. cytotox. vs MCF-7 (GI50 = 90 μM)
CMNPD28654	Potent activ. vs. cathepsins D (IC50 = 2000 nM) and E (IC50 = 30 nM).
CMNPD28655	Potent activ. vs. cathepsins D (IC50 = 900 nM) and E (IC50 = 5 nM).
CMNPD28656	Potent activ. vs. cathepsins D (IC50 = 50 nM) and E (IC50 = 0.5 nM). | Inhibited cleavage of cystatin C and PAI-1.
CMNPD28657	Mod. cytotox. towards several HTCL, best activ. vs H460 hum | non-small-cell lung cancer cells (IC50 = 1.1 μM).
CMNPD28658	Mod. cytotox. towards HeLa cells, IC50 = 1.8 μM. | IA towards Gram +ve and -ve bact. at 100 μg/mL.
CMNPD28659	Low cytotox. towards HeLa cells, IC50 = 11.6 μM. | IA towards Gram +ve and -ve bact. at 100 μg/mL.
CMNPD28660	Low cytotox. towards 1 HTCL (IC50 = 40 μM) | no activ. towards mammalian voltage gated sodium channel Nav1.4 at 10 μM.
CMNPD28661	Potent cytotox. towards HeLaS3 cells, IC50 = 0.099 μM | F-actin depolymerizing activ., IC50 = 12.6 μM.
CMNPD28662	Potent cytotox. towards HeLaS3 cells, IC50 = 0.16 uM | F-actin depolymerizing activ., IC50 = 11.6 uM
CMNPD28663	Potent cytotox.. towards HeLaS3 cells, IC50 = 0.64 uM | F-actin depolymerizing activ., IC50 = 26.9 uM
CMNPD28664	Potent cytotox. towards HeLaS3 cells, IC50 = 0.15 uM | F-actin depolymerizing activ., IC50 = 21.5 uM
CMNPD28665	In vitro Ca influx and Ca channel oscillation modulatory activ. when tested as low as 10 pM | no tox. towards NCI-H460 cells ( IC50 > 10 μM)
CMNPD28666	No cytotox. vs. 2 HTCLs at 22 μM.
CMNPD28669	Mod. cytotox. vs murine neuroblastoma cell line Neuro-2A (EC50: 6.5 μM) and HCT-116 cells (EC50: 11.7 μM).
CMNPD28670	mod. cytotox. to Neuro-2 A cells (EC50: 13.3 μM).
CMNPD28671	No AB activ. vs. 3 strains. | No cytotox. vs. HCT-116 at 25 μM.
CMNPD28672	No AB activ. vs. 3 strains. | No cytotox. vs. HCT-116 at 25 μM. | Low cytotox. vs. Neuro-2A cells (EC50 = 14.5 μM).
CMNPD28673	No AB activ. vs. 3 strains. | No cytotox. vs. 2 HTCLs.
CMNPD28674	Mod. cytotox. (EC50 = 1.45 × 10-5 μM) to a lung HTCL (NCI-H460) and mouse neuro-2a neuroblastoma cell line.
CMNPD28675	weak cytotox. (EC50 = 1.89 × 10-5 μM) vs lung HTCL (NCI-H460) and mouse neuro-2a neuroblastoma cell line.
CMNPD28676	Mod. antimal. (IC50 = 3.6 μM), anti-Chagas (12% GI at 10 μg/mL.
CMNPD28677	Mod. antimal. (IC50 = 8.0 μM), anti-Chagas (7% GI at 10 μg/mL),
CMNPD28678	Mod. antimal. activ. (IC50 = 10 μM);
CMNPD28679	Mod. antimal. (IC50 = 3.5 μM), anti-Chagas (60% GI at 10 μg/mL), anti-Leishman. (IC50 = 2.6 μM) activ
CMNPD28680	signif. stimulated glucose uptake in cultured L6 myotubes via AMPK pathway.
CMNPD28681	weakly stimulated glucose uptake in cultured L6 myotubes via AMPK pathway.
CMNPD28682	weakly stimulated glucose uptake in cultured L6 myotubes via AMPK pathway.
CMNPD28683	No activ. vs. LI210 cell line or diatom Nitzschia amabilis at 20 μg/mL. | No activ. vs. E. coli at 20 μg/disc.
CMNPD28684	No activ. vs. LI210 cell line or diatom Nitzschia amabilis at 20 μg/mL. | No activ. vs. E. coli at 20 μg/disc.
CMNPD28685	No activ. vs. LI210 cell line or diatom Nitzschia amabilis at 20 μg/mL. | No activ. vs. E. coli at 20 μg/disc.
CMNPD28686	No activ. vs. LI210 cell line or diatom Nitzschia amabilis at 20 μg/mL. | No activ. vs. E. coli at 20 μg/disc.
CMNPD28687	No activ. vs. LI210 cell line or diatom Nitzschia amabilis at 20 μg/mL. | No activ. vs. E. coli at 20 μg/disc.
CMNPD28688	weak cytotox. vs 2 HTCLs | inhib. sterol O-acyltransferases (SOAT1-4), IC50 between 1.8 to 9.6 μM.
CMNPD28689	Low cytotox. vs 2 HTCLs | inhib. sterol O-acyltransferases (SOAT1-4), IC50 between 2.5 to 9.9 μM
CMNPD28690	Low cytotox. vs 2 HTCLs | inhib. sterol O-acyltransferases (SOAT1-4), IC50 between 9.6 to >12 μM
CMNPD28691	Low cytotox. vs 2 HTCLs
CMNPD28692	Low cytotox. vs 2 HTCLs
CMNPD28693	Low cytotox. vs 2 HTCLs
CMNPD28694	mod. AB towards 3 ESBL bact., MIC 100 μg/mL. cpd damages bac. membrane leading to cell lysis.
CMNPD28695	Low cytotox. towards 1 HTCL (IC50 = 11 μM).
CMNPD28696	weak AB vs the Gram-negative Vibrio harveyi and V. parahaemolyticus
CMNPD28697	weak-mod. activ. vs 3 phytoplankton strains, IA vs 1 zooplankton strain and 1 bact.
CMNPD28698	weak-mod. activ. vs 3 phytoplankton and 1 zooplankton strain, IA vs 1 bact.
CMNPD28699	weak-mod. activ. vs 3 phytoplankton and 1 zooplankton strain, IA vs 1 bact.
CMNPD28700	weak-mod. activ. vs 3 phytoplankton and 1 zooplankton strain, IA vs 1 bact.
CMNPD28701	weak-mod. activ. vs 3 phytoplankton and 1 zooplankton strain, IA vs 1 bact.
CMNPD28702	mod. inhib. BRD4 protein
CMNPD28703	potent inhib. BRD4 protein
CMNPD28707	IA vs 1 HTCL.
CMNPD28708	IA vs 1 HTCL.
CMNPD28709	IA vs 10 HTCLs
CMNPD28721	IA vs a-glucosidase, 6 HTCLs, 7 bact. and 1 fungus
CMNPD28722	slight activ. vs a-glucosidase, IA vs 6 HTCLs, 7 bact. and 1 fungus
CMNPD28723	mod. AO (DPPH), weak AV vs 4 strains
CMNPD28724	signif. cytotox. vs 1 HTCL.
CMNPD28725	IA AB vs 12 strains.
CMNPD28726	IA vs 3 HTCLs, brine shrimp, and 5 strains bact.
CMNPD28727	IA vs 3 HTCLs, brine shrimp, and 5 strains bact.
CMNPD28728	IA vs 3 HTCLs, brine shrimp, and 5 strains bact.
CMNPD28729	IA vs 3 HTCLs, brine shrimp, and 5 strains bact.
CMNPD28730	mod. tox. vs brine shrimp | growth promoter in 1 strain bact. | IA vs 4 other strains and 3 HTCLs
CMNPD28731	signif. tox. vs brine shrimp | weak-signif. cytotox. vs 3 HTCLs | growth promoter in 1 strain bact. | IA vs 4 other strains
CMNPD28732	mod. tox. vs brine shrimp | weak cytotox. vs 3 HTCLs | IA vs 5 bact..
CMNPD28733	weak cytotox. vs 3 HTCLs
CMNPD28734	weak cytotox. vs 3 HTCLs
CMNPD28735	strong inhib. protein tyrosine phosphatase 1B (PTP1B) | IA vs 4 bact., 2 fungi, 2 HTCLs | good activ. vs 2 oomycetes | IA vs 2 bact. and 1 fungus
CMNPD28736	IA vs 1 bact. and 1 fungus.
CMNPD28737	weak cytotox. vs 3 HTCLs | weak AB vs 4 strains, IA vs 1 strain
CMNPD28738	good cytotox. vs 3 HTCLs | mod.-good AB vs 5 strains
CMNPD28739	mod.-good cytotox. vs 3 HTCLs | mod. AB vs 5 strains
CMNPD28740	IA vs 3 bact.
CMNPD28741	IA vs 3 bact.
CMNPD28742	IA vs 3 bact.
CMNPD28743	IA vs 3 bact.
CMNPD28744	weak AB vs 1 strain
CMNPD28745	IA vs 3 bact.
CMNPD28746	weak AB vs 1 strain
CMNPD28747	weak AB vs 1 strain
CMNPD28748	IA AV vs 1 strain | IA radical scavenging (DPPH) | NT antifoul.
CMNPD28749	signif. AV vs 1 strain | IA radical scavenging (DPPH) | NT antifoul.
CMNPD28750	signif. AV vs 1 strain | IA radical scavenging (DPPH) | NT antifoul.
CMNPD28752	AV NT, IA radical scavenging (DPPH), signif. antifoul. (bryozoan larvae)
CMNPD28753	AV and antifoul. NT, IA radical scavenging (DPPH)
CMNPD28754	lipid-lowering effect via regulation of cholesterol efflux
CMNPD28755	lipid-lowering effect via regulation of cholesterol efflux
CMNPD28756	lipid-lowering effect via regulation of cholesterol efflux
CMNPD28757	weak cytotox. vs 2 HTCLs | IA vs brine shrimp, 2 strains bact., 2 viruses and 2 enzymes
CMNPD28758	weak-mod. AB vs 3 strains | IA vs 4 pthers and 2 HTCLs
CMNPD28759	weak-mod. AB vs 3 strains | IA vs 4 pthers and 2 HTCLs
CMNPD28760	IA vs 7 strains bact. and 2 HTCLs
CMNPD28761	IA vs 7 strains bact. and 2 HTCLs
CMNPD28762	IA vs 7 strains bact. and 2 HTCLs
CMNPD28763	IA vs 7 strains bact. and 2 HTCLs
CMNPD28764	AV vs 2 strains
CMNPD28765	AV vs 1 strain
CMNPD28768	signif. cytotox. vs 4 HTCLs
CMNPD28769	signif. cytotox. vs 4 HTCLs
CMNPD28770	suppression of iNOS and COX-2 protein expression
CMNPD28771	suppression of iNOS and COX-2 protein expression
CMNPD28772	suppression of iNOS and COX-2 protein expression
CMNPD28773	suppression of iNOS and COX-2 protein expression
CMNPD28774	suppression of iNOS and COX-2 protein expression
CMNPD28775	weak cytotox. vs 1 HTCL
CMNPD28778	inhib. of P-glycoprotein | IA vs 9 HTCLs
CMNPD28780	inhib. of P-glycoprotein | IA vs 9 HTCLs
CMNPD28781	mod. biomembrane protective effect | IA vs. 8 HTCLs
CMNPD28782	IA AF (1 strain) | IA as a siderophore
CMNPD28783	IA AF (1 strain) | NT as siderophore
CMNPD28784	signif. inhib. of NO prod | low tox. to 1 norm. cell line
CMNPD28785	weak inhib. of NO prod | tox. NT
CMNPD28786	weak inhib. of NO prod | tox. NT
CMNPD28787	weak inhib. of NO prod | tox. NT
CMNPD28788	weak inhib. of NO prod | tox. NT
CMNPD28789	weak inhib. of NO prod | tox. NT
CMNPD28790	weak inhib. of NO prod | tox. NT
CMNPD28791	signif. inhib. of NO prod but via cell death | toxic to 1 norm. cell line
CMNPD28799	weak cytotox. vs 1 HTCL | AB NT
CMNPD28804	IA vs 1 HTCL | AB NT
CMNPD28806	mod. AB vs 5 strains | IA vs 15 HTCLs
CMNPD28808	weak inhib. AChE | IA vs 2 fungi.
CMNPD28811	IA AB vs 6 strains | IA AF, vs 9 strains | IA vs brine shrimp and nematodes | AO activ. (DPPH) NT
CMNPD28812	lethal vs brine shrimp | weak activ. vs nematodes | mod. AO activ. (DPPH) | IA AB vs 6 strains | IA AF, vs 9 strains.
CMNPD28813	weak activ. vs brine shrimp | IA vs nematodes | IA AB vs 6 strains | IA AF, vs 9 strains | AO activ. (DPPH) NT
CMNPD28814	IA vs brine shrimp and nematodes | IA AB vs 6 strains | IA AF, vs 9 strains | AO activ. (DPPH) NT
CMNPD28815	weak activ. vs brine shrimp | IA vs nematodes | IA AB vs 6 strains | IA AF, vs 9 strains | AO activ. (DPPH) NT
CMNPD28816	IA vs 3 HTCLs and 1 bact.
CMNPD28817	IA vs 3 HTCLs and 1 bact.
CMNPD28818	IA vs 3 HTCLs and 1 bact.
CMNPD28819	IA vs 3 HTCLs
CMNPD28820	mod. cytotox. vs 3 HTCLs
CMNPD28821	weak-good AB vs 5 strains, signif. AV vs 1 strain
CMNPD28822	signif. AV vs 1 strain | no cytotox. to norm. hum. cell line
CMNPD28823	signif. AV vs 1 strain | no cytotox. to norm. hum. cell line
CMNPD28824	signif. AV vs 1 strain | no cytotox. to norm. hum. cell line
CMNPD28825	signif. AV vs 1 strain | no cytotox. to norm. hum. cell line
CMNPD28826	signif. AV vs 1 strain | no cytotox. to norm. hum. cell line
CMNPD28827	signif. AV vs 1 strain | no cytotox. to norm. hum. cell line
CMNPD28828	signif. AV vs 1 strain | no cytotox. to norm. hum. cell line
CMNPD28829	signif. AV vs 1 strain | no cytotox. to norm. hum. cell line
CMNPD28830	signif. AV vs 1 strain | no cytotox. to norm. hum. cell line
CMNPD28831	signif. AV vs 1 strain and reactivation latent HIV-1 | no cytotox. to norm. hum. cell line
CMNPD28832	signif. AV vs 1 strain | no cytotox. to norm. hum. cell line
CMNPD28834	weak AB vs 2 strains
CMNPD28835	weak AB vs 2 strains
CMNPD28836	mod. AB vs 2 strains
CMNPD28837	mod. AB vs 2 strains
CMNPD28838	mod. AB vs 2 strains
CMNPD28839	mod. AB vs 2 strains
CMNPD28840	IA vs 6 HTCLs
CMNPD28841	IA vs 6 HTCLs
CMNPD28842	IA vs 6 HTCLs
CMNPD28843	signif. inhib. of NO prod.
CMNPD28844	signif. inhib. of NO prod.
CMNPD28845	signif. inhib. of NO prod.
CMNPD28846	strong cytotox. vs murine TCL | IA vs 7 strains bact.
CMNPD28847	IA vs murine TCL and 7 strains bact.
CMNPD28848	mod. anti-TB activ. | IA vs murine TCL and 6 strains bact.
CMNPD28849	IA vs murine TCL and 7 strains bact.
CMNPD28850	IA vs murine TCL and 7 strains bact.
CMNPD28851	IA vs murine TCL and 7 strains bact.
CMNPD28852	IA vs murine TCL and 7 strains bact.
CMNPD28853	IA vs murine TCL and 7 strains bact.
CMNPD28854	weak AI (NO prod inhib.) | IA anti-allergic effect assay.
CMNPD28855	weak AI (NO prod inhib.) | IA anti-allergic effect assay.
CMNPD28856	weak AI (NO prod inhib.) | IA anti-allergic effect assay.
CMNPD28857	signif. AI (NO prod inhib.) | weak anti-allergic effect (RBL-2H3 cells)
CMNPD28858	weak AI (NO prod inhib.) | IA anti-allergic effect assay.
CMNPD28859	weak AI (NO prod inhib.) | IA anti-allergic effect assay.
CMNPD28860	weak AI (NO prod inhib.) | IA anti-allergic effect assay.
CMNPD28861	weak AI (NO prod inhib.) | IA anti-allergic effect assay.
CMNPD28862	weak AI (NO prod inhib.) | IA anti-allergic effect assay.
CMNPD28863	weak AI (NO prod inhib.) | IA anti-allergic effect assay.
CMNPD28864	weak AI (NO prod inhib.) | IA anti-allergic effect assay.
CMNPD28865	IA vs 5 HTCLS and 6 strains bact.
CMNPD28866	IA vs 5 HTCLS and 6 strains bact.
CMNPD28867	IA vs 5 HTCLS and 6 strains bact.
CMNPD28868	IA vs 5 HTCLS and 6 strains bact.
CMNPD28869	IA vs 5 HTCLS and 6 strains bact.
CMNPD28870	IA vs 5 HTCLS and 6 strains bact.
CMNPD28871	IA vs 5 HTCLS and 6 strains bact.
CMNPD28872	IA vs 5 HTCLS and 6 strains bact.
CMNPD28873	IA vs 5 HTCLS and 6 strains bact.
CMNPD28874	IA vs 5 HTCLS and 6 strains bact.
CMNPD28875	weak cytotox. vs 1 HTCL | IA vs 3 strains bact., hyaluronidase and elastase
CMNPD28876	signif. inhib. hyaluronidase | IA vs elastase, 3 strains bact. and 1 HTCL
CMNPD28877	IA vs 3 HTCLs
CMNPD28878	IA vs 3 HTCLs
CMNPD28879	IA vs 3 HTCLs and 3 viruses
CMNPD28880	IA vs 3 HTCLs and 3 viruses
CMNPD28881	IA vs 3 HTCLs and 3 viruses
CMNPD28882	IA vs 3 HTCLs and 3 viruses
CMNPD28883	IA vs 3 HTCLs and 3 viruses
CMNPD28884	IA vs 3 HTCLs and 3 viruses
CMNPD28885	IA vs 3 HTCLs and 3 viruses
CMNPD28886	IA vs 3 HTCLs and 3 viruses
CMNPD28887	IA vs 4 bact., 1 fungus and 2 norm. and 2 HTCLs
CMNPD28888	IA vs 4 bact., 1 fungus and 2 norm. and 2 HTCLs
CMNPD28889	IA vs 4 bact., 1 fungus and 2 norm. and 2 HTCLs
CMNPD28890	IA vs 4 bact., 1 fungus and 2 norm. and 2 HTCLs
CMNPD28891	mod. AB vs 3 Gram-positive strains | IA vs 3 Gram-negative strains
CMNPD28892	IA vs 2 HTCLs.
CMNPD28893	IA vs 2 HTCLs.
CMNPD28894	IA vs 1 HTCL, 2 bact., 2 fungi and bryozoan larvae
CMNPD28895	IA vs 1 HTCL, 2 bact., 2 fungi and bryozoan larvae
CMNPD28896	signif. antofouling activ. (bryozoan larvae) | IA vs 1 HTCL, 2 bact. and 2 fungi
CMNPD28897	IA vs 1 HTCL, 2 bact., 2 fungi and bryozoan larvae
CMNPD28898	IA vs 6 HTCLs and 1 murine TCL.
CMNPD28899	IA vs 6 HTCLs and 1 murine TCL.
CMNPD28900	IA vs 6 HTCLs and 1 murine TCL.
CMNPD28901	IA vs 6 HTCLs and 1 murine TCL.
CMNPD28902	signif. cytotox. vs 3 HTCLs | IA AB vs 3 strains | IA COX-3
CMNPD28903	IA vs 3 HTCLs | 3 strains bact. and COX-2
CMNPD28904	weak-mod. cytotox. vs 1 HTCL | IA vs 2 others, 3 strains bact. and COX-2
CMNPD28907	cytotox. vs 8 HTCLs | IA vs 1 norm. hum. cell line
CMNPD28908	mod. antiallergic effect
CMNPD28909	weak cytotox. vs 3 HTCLs | Weak cytotox. vs. 1 HTCL | NT vs topoisomerase I
CMNPD28910	weak cytotox. vs 3 HTCLs
CMNPD28911	mod. AB vs 1 strain.
CMNPD28912	inactvie vs 4 bact., 2 fungi, brine shrimp and 2 HTCLs
CMNPD28913	weak AB vs 3 strains
CMNPD28914	IA vs 3 HTCLs
CMNPD28915	IA vs 3 HTCLs
CMNPD28916	IA vs 3 HTCLs
CMNPD28917	IA vs 3 HTCLs
CMNPD28918	mod. activ. vs 2 HTCLs
CMNPD28919	IA vs 1 HTCL | IA NO downregulation
CMNPD28920	IA vs 1 HTCL | mod. NO downregulation
CMNPD28921	IA vs 1 HTCL | IA NO downregulation
CMNPD28925	IA vs 1 HTCL | IA NO downregulation
CMNPD28926	IA vs 1 HTCL | mod. NO downregulation
CMNPD28927	NT vs 1 HTCL | IA NO downregulation
CMNPD28928	IA vs 1 HTCL | mod. NO downregulation
CMNPD28929	IA vs 1 HTCL | NT NO downregulation
CMNPD28931	IA AI (NO prod inhib.)
CMNPD28932	IA AI (NO prod inhib.)
CMNPD28933	IA AI (NO prod inhib.)
CMNPD28934	IA AI (NO prod inhib.)
CMNPD28935	mod. AI (NO prod inhib.)
CMNPD28936	mod. AI (NO prod inhib.)
CMNPD28937	mod. AI (NO prod inhib.)
CMNPD28938	AB vs 3 strains (weak vs 2, signif. vs 1)
CMNPD28939	AB vs 3 strains (strong vs 1, mod. vs 1, weak vs 1)
CMNPD28940	AB vs 3 strains (strong vs 1, signif. vs 1, weak vs 1)
CMNPD28941	AB vs 3 strains (strong vs 1, signif. vs 1, weak vs 1)
CMNPD28942	IA AB vs 16 strains
CMNPD28943	weak AB activ. vs 1 strain | IA vs 15 strains
CMNPD28944	IA AB vs 16 strains
CMNPD28945	good immunomod. activ. (inhibit interleukin-2 secretion) | IA vs 3 HTCLs
CMNPD28946	signif. immunomod. activ. (inhibit interleukin-2 secretion) | IA vs 3 HTCLs
CMNPD28947	good immunomod. activ. (inhibit interleukin-2 secretion) | IA vs 3 HTCLs
CMNPD28948	good immunomod. activ. (inhibit interleukin-2 secretion) | IA vs 3 HTCLs
CMNPD28949	good immunomod. activ. (inhibit interleukin-2 secretion) | IA vs 3 HTCLs
CMNPD28950	signif. immunomod. activ. (inhibit interleukin-2 secretion) | IA vs 3 HTCLs
CMNPD28951	signif. immunomod. activ. (inhibit interleukin-2 secretion) | IA vs 3 HTCLs
CMNPD28952	signif. immunomod. activ. (inhibit interleukin-2 secretion) | IA vs 3 HTCLs
CMNPD28953	inhib. of biofilm formation | signif. cytotox. vs 1 HTCL
CMNPD28954	AI via NO and prostaglandin E2 inhib.
CMNPD28955	IA AI (NO and PGE2 prod inhib.)
CMNPD28956	renoprotective via inhib. of kidney fibrogenic action
CMNPD28957	mod. inhib. PTP1B | IA vs 3 HTCLs and 1 norm. hum. cell line
CMNPD28959	IA vs PTP1B, 3 HTCLs and 1 norm. hum. cell line
CMNPD28960	mod. inhib. PTP1B | IA vs 3 HTCLs and 1 norm. hum. cell line
CMNPD28961	mod. inhib. PTP1B | IA vs 3 HTCLs and 1 norm. hum. cell line
CMNPD28963	Quorum sensing inhib. vs 1 strain.
CMNPD28964	Quorum sensing inhib. vs 1 strain.
CMNPD28965	IA vs 2 viruses and 3 HTCLs.
CMNPD28966	V. weak activ. vs 1 virus | IA vs another virus and 3 HTCLs.
CMNPD28967	IA vs 3 strains bact. and 3 HTCLs.
CMNPD28968	weak AB vs 1 strain | IA vs 3 HTCLs.
CMNPD28969	weak AB vs 1 strain | IA vs 3 HTCLs.
CMNPD28970	IA vs 3 strains bact. and 3 HTCLs.
CMNPD28971	weak AB vs 1 strain | IA vs 3 HTCLs.
CMNPD28972	good AV activ. | IA vs AChE, a-glucosidase, 1 strain bact., 1 nematode
CMNPD28973	IA vs AChE, a-glucosidase, 1 strain bact., 1 virus, 1 nematode
CMNPD28974	IA vs AChE, a-glucosidase, 1 strain bact., 1 virus, 1 nematode
CMNPD28975	good AV activ. | IA vs AChE, a-glucosidase, 1 strain bact., 1 nematode
CMNPD28976	weak AB (1 strain) | IA vs AChE, a-glucosidase, 1 virus, 1 nematode
CMNPD28977	IA vs AChE, a-glucosidase, 1 strain bact., 1 virus, 1 nematode
CMNPD28978	IA vs AChE, a-glucosidase, 1 strain bact., 1 nematode, NT AV.
CMNPD28979	IA vs AChE, a-glucosidase, 1 strain bact., 1 nematode, NT AV.
CMNPD28980	mod. AB vs 2 strains | weak AF vs 3 strains | IA vs 4 HTCLs
CMNPD28981	mod. AB vs 2 strains | weak AF vs 1 strain | IA vs 4 HTCLs
CMNPD28984	weak cytotox. vs 4 HTCLs | weak AB vs 2 strains | IA vs 2 fungi.
CMNPD28985	weak cytotox. vs 4 HTCLs | weak AB vs 2 strains | IA vs 2 fungi. | IA vs 3 HTCLs.
CMNPD28986	weak cytotox. vs 4 HTCLs | weak AB vs 2 strains | weak AF vs 2 strains
CMNPD28987	IA vs 4 HTCLs, 2 bact. and 2 fungi.
CMNPD28988	IA vs 4 HTCLs, 2 bact. and 2 fungi.
CMNPD28989	weak cytotox. vs 4 HTCLs | weak AB vs 2 strains | IA vs 2 fungi.
CMNPD28990	weak cytotox. vs 4 HTCLs | weak AB vs 2 strains | weak AF vs 2 strains
CMNPD28991	weak cytotox. vs 4 HTCLs | weak AB vs 2 strains | inactvie vs 2 fungi.
CMNPD28992	IA vs 4 HTCLs, 2 bact. and 2 fungi. | IA vs 3 HTCLs.
CMNPD28993	IA vs 4 HTCLs, 2 bact. and 2 fungi.
CMNPD28994	IA vs 4 HTCLs, 2 bact. and 2 fungi.
CMNPD28995	IA vs 4 HTCLs, 2 bact. and 2 fungi.
CMNPD28996	strong AB vs 4 strains | mod. brine shrimp tox.
CMNPD28997	IA AB vs 5 strains | no brine shrimp tox.
CMNPD28998	strong AB vs 4 strains | mod. brine shrimp tox.
CMNPD28999	IA vs 6 HTCLS and 1 virus
CMNPD29001	signif. AV vs 1 strain | IA vs 6 HTCLs
CMNPD29003	NT vs 6 HTCLS | IA AV.
CMNPD29006	signif. AV vs 1 strain | IA vs 6 HTCLs
CMNPD29007	IA vs 6 HTCLS | AV activ. NT
CMNPD29009	IA vs 6 HTCLS and 1 virus
CMNPD29010	IA vs 6 HTCLS and 1 virus
CMNPD29012	NT vs 6 HTCLS | IA AV.
CMNPD29013	IA vs 4 bact. and 1 murine cancer cell line
CMNPD29014	IA vs 4 bact. and 1 murine cancer cell line
CMNPD29015	IA vs 4 bact. and 1 murine cancer cell line
CMNPD29016	signif. activ. vs 4 HTCLs | IA vs 5 tyrosine kinases
CMNPD29017	signif. activ. vs 1 HTCL and 5 tyrosine kinases
CMNPD29018	signif. activ. vs 4 HTCLs and 5 tyrosine kinases
CMNPD29019	potent activ. vs 5 HTCLs and 5 tyrosine kinases
CMNPD29023	signif. AV vs 1 strain | NT for NO prod inhib..
CMNPD29024	IA vs 1 virus. | NT for NO prod inhib..
CMNPD29025	IA vs 1 virus. | NT for NO prod inhib..
CMNPD29026	IA vs 1 virus and AI (NO prod inhib.)
CMNPD29027	IA vs 1 virus and AI (NO prod inhib.)
CMNPD29028	mod. AI (NO prod inhib.) | IA vs 1 virus
CMNPD29029	IA vs 1 HTCL.
CMNPD29030	IA vs 1 HTCL.
CMNPD29032	IA vs 1 HTCL.
CMNPD29033	IA vs 1 HTCL.
CMNPD29034	IA vs 1 HTCL.
CMNPD29038	good fibrinolytic activ.
CMNPD29039	good fibrinolytic activ.
CMNPD29040	weak cytotox. vs 4 HTCLs | IA vs 2 bact. and 2 fungi
CMNPD29041	very weak cytotox. vs 4 HTCLs | IA vs 2 bact. and 2 fungi
CMNPD29043	No AF vs 4 strains. | NT vs HTCLs
CMNPD29044	No AF vs 4 strains. | NT vs HTCLs
CMNPD29045	good AB vs 1 strain | weak vs another | mod. AO activ. (DPPH and ANTS) | IA vs 2 HTCLs
CMNPD29046	good AB vs 1 strain | weak vs 2 others | mod. AO activ. (DPPH and ANTS) | IA vs 2 HTCLs
CMNPD29047	good AB vs 1 strain | weak vs 2 others | mod. AO activ. (DPPH and ANTS) | IA vs 2 HTCLs
CMNPD29048	good AB vs 1 strain | weak vs 2 others | mod. AO activ. (DPPH and ANTS) | IA vs 2 HTCLs
CMNPD29049	good AB vs 1 strain | mod. AO activ. (DPPH and ANTS) | IA vs 2 HTCLs
CMNPD29050	IA vs 3 strains bact and 1 murine TCL.
CMNPD29051	IA vs 3 strains bact and 1 murine TCL.
CMNPD29052	IA vs 3 strains bact and 1 murine TCL.
CMNPD29053	IA vs 3 strains bact and 1 murine TCL.
CMNPD29054	IA vs 3 strains bact and 1 murine TCL.
CMNPD29055	IA vs 3 strains bact and 1 murine TCL.
CMNPD29056	IA vs 3 strains bact and 1 murine TCL.
CMNPD29057	IA vs 3 strains bact and 1 murine TCL.
CMNPD29058	IA vs 3 strains bact and 1 murine TCL.
CMNPD29059	IA vs 3 strains bact and 1 murine TCL.
CMNPD29060	Good cytotox vs 1 murine TCL. | IA vs 3 strains bact.
CMNPD29061	Good cytotox vs 1 murine TCL. | IA vs 3 strains bact.
CMNPD29062	IA vs 3 strains bact and 1 murine TCL.
CMNPD29063	IA vs 3 strains bact and 1 murine TCL.
CMNPD29066	IA vs 2 HTCLs, 1 fungal and 6 bact.l strains
CMNPD29070	signif. cytotox. vs 6 HTCLs.
CMNPD29071	good antifoul. activ. vs barnacle larvae
CMNPD29072	good antifoul. activ. vs barnacle larvae
CMNPD29073	good antifoul. activ. vs barnacle larvae
CMNPD29076	mod. antifoul. activ. vs barnacle larvae
CMNPD29077	good antifoul. activ. vs barnacle larvae
CMNPD29078	mod. antifoul. activ. vs barnacle larvae
CMNPD29079	mod. antifoul. activ. vs barnacle larvae
CMNPD29080	mod. antifoul. activ. vs barnacle larvae
CMNPD29081	good antifoul. activ. vs barnacle larvae
CMNPD29082	mod. antifoul. activ. vs barnacle larvae
CMNPD29083	mod. antifoul. activ. vs barnacle larvae
CMNPD29086	mod. cytotox. vs 5 HTCLs
CMNPD29087	Good cytotox. vs 18 HTCLs.
CMNPD29089	mod. cytotox. vs 17 HTCLs
CMNPD29090	mod. cytotox. vs 17 HTCLs
CMNPD29091	mod. cytotox. vs 6 HTCLs
CMNPD29092	mod. cytotox. vs 3 leukaemia cell lines
CMNPD29093	weak cytotox. vs 3 leukaemia cell lines
CMNPD29094	weak cytotox. vs 3 leukaemia cell lines
CMNPD29095	mod. AO activ. (DPPH) | anti-abfibrillisation | neuroprotective effects
CMNPD29096	mod. AO activ. (luciferase)
CMNPD29097	mod. AO activ. (luciferase)
CMNPD29098	mod. AO activ. (luciferase)
CMNPD29099	mod. AO activ. (luciferase)
CMNPD29100	mod. AO activ. (luciferase)
CMNPD29101	mod. AO activ. (luciferase)
CMNPD29102	mod. AF vs 7 strains | weak AB vs 10 strains
CMNPD29103	mod. AF vs 7 strains | weak AB vs 10 strains
CMNPD29104	mod. AF vs 7 strains | weak AB vs 10 strains
CMNPD29105	mod. AF vs 7 strains | weak AB vs 10 strains
CMNPD29106	mod. AF vs 7 strains | weak AB vs 10 strains
CMNPD29107	mod. AF vs 7 strains | weak AB vs 10 strains
CMNPD29108	mod. AF vs 7 strains | weak AB vs 10 strains
CMNPD29109	IA vs 8 bact. and 5 HTCLs.
CMNPD29110	IA vs 8 bact. and 5 HTCLs.
CMNPD29111	IA vs 8 bact. and 5 HTCLs.
CMNPD29112	weak cytotox. vs 1 HTCL | IA vs 8 bact..
CMNPD29113	weak cytotox. vs 5 HTCLs | IA vs 8 bact..
CMNPD29114	weak cytotox. vs 1 HTCL | IA vs 8 bact..
CMNPD29115	weak cytotox. vs 5 HTCLs | mod. AB vs 1 strain.
CMNPD29116	weak cytotox. vs 5 HTCLs | IA vs 8 bact..
CMNPD29117	IA vs 8 bact. and 5 HTCLs.
CMNPD29118	good cytotox. vs 2 HTCLs | IA v 2 others
CMNPD29119	IA vs 3 bact. and 4 HTCLs
CMNPD29121	mod. AB vs 1 strain.
CMNPD29124	v weak AB vs 9 strains | IA CK-1 inhib..
CMNPD29125	weak AB vs 9 strains | weak casein kinase 1 (CK-1) inhib..
CMNPD29126	IA vs 1 murine cell line.
CMNPD29127	IA vs 2 murine cell lines.
CMNPD29128	IA vs 2 murine cell lines.
CMNPD29129	good algicidal activ. (as racemate)
CMNPD29130	mod. AB vs 1 strain | good algicidal activ.
CMNPD29131	mod. AB vs 2 strains | no activ. vs 1 alga
CMNPD29134	IA vs NCI60 cell line panel
CMNPD29137	IA vs 3 bact. and 2 HTCLs.
CMNPD29138	signif. a-glucosidase inhib.
CMNPD29139	signif. a-glucosidase inhib.
CMNPD29140	signif. AF vs 3 strains.
CMNPD29142	signif. AF vs 3 strains.
CMNPD29143	Strong AF vs 3 strains.
CMNPD29144	potent insecticidal activ. (Spodoptera litura), IA vs 3 fungi.
CMNPD29146	IA vs 5 HTCLs.
CMNPD29147	IA vs 5 HTCLs.
CMNPD29148	mod. cytotox. vs 3 HTCLs.
CMNPD29149	IA vs 5 HTCLs.
CMNPD29150	mod. cytotox. vs 3 HTCLs.
CMNPD29151	IA vs 4 HTCLs and AchE
CMNPD29152	IA vs 10 HTCLs and COX-2.
CMNPD29153	IA vs 3 HTCLs, 2 bact. and 4 fungi.
CMNPD29155	IA vs 3 HTCLs, 2 bact. and 4 fungi.
CMNPD29156	IA vs 3 HTCLs, 2 bact. and 4 fungi.
CMNPD29157	IA vs 3 HTCLs, 2 bact. and 4 fungi.
CMNPD29158	IA vs 3 HTCLs, 2 bact. and 4 fungi.
CMNPD29159	IA vs 3 HTCLs, 2 bact. and 4 fungi.
CMNPD29160	IA vs 3 HTCLs, 2 bact. and 4 fungi.
CMNPD29161	IA vs 3 HTCLs, 2 bact. and 4 fungi.
CMNPD29162	IA vs 3 HTCLs, 2 bact. and 4 fungi.
CMNPD29163	IA vs 5 HTCLs.
CMNPD29164	IA vs 5 HTCLs.
CMNPD29165	IA vs 5 HTCLs.
CMNPD29166	IA vs 5 HTCLs.
CMNPD29167	IA vs 5 HTCLs.
CMNPD29168	IA vs 5 HTCLs.
CMNPD29169	signif. AB vs Mycobact. tuberculosis protein tyrosine phosphatase B (MptpB) | IA vs PTP1B
CMNPD29172	signif. AB vs Mycobact. tuberculosis protein tyrosine phosphatase B (MptpB) | IA vs PTP1B
CMNPD29173	IA AB vs 7 strains.
CMNPD29174	IA AB vs 7 strains.
CMNPD29175	IA AB vs 7 strains.
CMNPD29176	IA AB vs 7 strains.
CMNPD29177	IA AB vs 7 strains.
CMNPD29178	weak-mod. cytotox. vs 2 HTCLs | mod. AB vs 2 strains.
CMNPD29179	IA vs 2 HTCLs and 2 bact..
CMNPD29180	IA vs 2 HTCLs and 2 bact..
CMNPD29181	IA vs 2 HTCLs and 2 bact..
CMNPD29182	strong inhib. NO prod and a-glucosidase | IA vs 5 HTCLs.
CMNPD29183	weak cytotox. vs 3 HTCLs
CMNPD29184	mod. cytotox. vs 3 HTCLs.
CMNPD29185	weak AB vs 2 strains.
CMNPD29186	weak AB vs 2 strains.
CMNPD29187	Good AB vs 1 strain, inactvie vs 4 oathers and α-glucosidase.
CMNPD29188	Selective AF vs 2 strains | signif. cytotox. vs 3 HTCLs.
CMNPD29189	IA vs 6 strains bact.
CMNPD29190	weak AB vs 2 strains.
CMNPD29192	signif. AB vs 6 strains.
CMNPD29193	signif. AB vs 6 strains.
CMNPD29194	signif. AB vs 6 strains.
CMNPD29195	AO via induction of expression of heme oxygenase-1 (HO-1)
CMNPD29196	weak cytotox. vs 10 HTCLs.
CMNPD29198	strong cytotox. vs 2 HTCLs.
CMNPD29199	strong cytotox. vs 2 HTCLs.
CMNPD29200	strong cytotox. vs 2 HTCLs.
CMNPD29201	IA vs 2 HTCLs.
CMNPD29202	IA vs 2 HTCLs.
CMNPD29203	IA vs 2 HTCLs.
CMNPD29204	IA vs 6 HTCLs and 4 AO enzymes.
CMNPD29205	IA vs 6 HTCLs and 4 AO enzymes.
CMNPD29206	IA vs 6 HTCLs and 4 AO enzymes.
CMNPD29207	signif. AV vs 1 strain | IA vs 3 HTCLs.
CMNPD29208	IA vs 3 HTCLs.
CMNPD29209	IA vs 3 HTCLs.
CMNPD29210	IA vs 3 HTCLs.
CMNPD29211	IA vs 3 HTCLs.
CMNPD29212	IA vs 3 HTCLs.
CMNPD29213	IA vs 3 HTCLs.
CMNPD29214	IA vs 3 HTCLs.
CMNPD29215	weak AF vs 3 strains | IA vs 3 others
CMNPD29216	mod. AB vs 1 strain.
CMNPD29217	IA AB vs 3 strains.
CMNPD29218	IA vs 3 HTCLs, 5 bact. and COX-2.
CMNPD29219	IA vs 3 HTCLs, 5 bact. and COX-2.
CMNPD29220	weak-mod. cytotox. vs 2 HTCLs
CMNPD29221	potent cytotox. vs 2 HTCLs
CMNPD29222	IA vs 2 bact. and a-glucosidase.
CMNPD29223	mod. activ. vs 1 bact. and a-glucosidase.
CMNPD29224	potent mycobact.l protein kinase G (PknG) inhib.
CMNPD29225	IA a-glucosidase inhib. and vs 2 rat TCLs.
CMNPD29226	mod. a-glucosidase inhib. | IA vs 2 rat TCLs.
CMNPD29227	Potent a-glucosidase inhib. | IA vs 2 rat TCLs.
CMNPD29228	Potent a-glucosidase inhib. | IA vs 2 rat TCLs.
CMNPD29229	mod. a-glucosidase inhib. | IA vs 2 rat TCLs.
CMNPD29230	mod. AF vs 2 strains.
CMNPD29233	weak haemolytic activ. (hum. erythrocytes). | IA vs 1 fungus.
CMNPD29234	weak haemolytic activ. (hum. erythrocytes). | IA vs 1 fungus.
CMNPD29235	weak AF vs 1 strain
CMNPD29237	weak cytotox. vs 1 HTCL.
CMNPD29238	mod. cytotox. vs 1 HTCL.
CMNPD29239	potent cytotox. (lethality) vs copepod Acartia tonsa.
CMNPD29240	signif. AI (NO prod inhib.) | IA vs 1 murine and 1 HTCL.
CMNPD29241	signif. AI (NO prod inhib.) | weak cytotox. vs 1 murine and 1 HTCL.
CMNPD29242	mod. cytotox. vs 3 HTCLs
CMNPD29259	PTP1B IC 50 = 38.5 uM,mod. activ. towards two HTCL
CMNPD29260	PTP1B NA, mod. activ. towards two HTCL
CMNPD29265	attentuates TLR-9 mediated inflammatory responses
CMNPD29267	very weak (IC50 > 100 ug/ml) urease, a-glucosidase and lipid peroxidation activ.
CMNPD29268	1.9 uM PTP1B, 93 uM α-amylase, 75 uM α-glucosidase
CMNPD29269	1.7 uM PTP1B, 57 uM α-amylase, 38 uM α-glucosidase
CMNPD29270	1.1 mM PTP1B, 450 uM α-amylase, 38- uM α-glucosidase
CMNPD29271	0.9 mM PTP1B, 340 uM α-amylase, 250 uM α-glucosidase
CMNPD29272	2.0 uM antimal. P. falciparum, 11.8 uM T. brucei rhodesiense, 47.8 uM, T. cruzi, 18.8 uM Leishman. donovani,170 uM cytotox
CMNPD29273	EC50 > 100 uM PC3 and HT29 HTCL
CMNPD29274	NA @ 47.8 uM vs PC3 and HT29 HTCL
CMNPD29275	94.4 uM Lieshmania infantum promastigotes, > 88 uM vs intracellular amastigotes, 84.5 uM vs peritoneal macrophages
CMNPD29276	94.4 uM Lieshmania infantum promastigotes, > 88 uM vs intracellular amastigotes, 84.5 uM vs peritoneal macrophages
CMNPD29278	>1mM AO activ. vs DPPH and ABTS and >1 mM antiinflammatory activ. vs COX-1, COX-2 and 5- LOX
CMNPD29279	>1mM AO activ. vs DPPH and ABTS and >1 mM antiinflammatory activ. vs COX-1, COX-2 and 5-LOX
CMNPD29280	IC50 13 uM vs lung cancer (NCI-H460)
CMNPD29281	>1mM AO activ. vs DPPH and ABTS and >1 mM AI activ. vs COX-1, COX-2 and 5-LOX
CMNPD29282	weak cytotox vs 4 HTCL, 14 uM vs peripheral blood neutrophils
CMNPD29283	weak cytotox vs 4 HTCL, 11 uM vs peripheral blood neutrophils
CMNPD29285	IC50 15.9 uM vs peripheral blood neutrophils
CMNPD29286	IC50 12.4 uM vsvs
CMNPD29287	IC50 35.0 uM vs peripheral blood neutrophils
CMNPD29288	antifoul. act EC50 0.31 uM vs barncle larvae
CMNPD29289	antifoul. act EC50 0.76 uM vs barncle larvae
CMNPD29290	very weak active vs a-glucosidase and dipeptidase IV
CMNPD29291	PTP1B IC50 8.1 uM
CMNPD29292	PTP1B IC50 12.5 uM
CMNPD29293	PTP1B IC50 6.1 uM
CMNPD29295	tested for AF activ. vs 8 strains weak active
CMNPD29296	tested for AF activ. vs 8 strains weak active
CMNPD29297	tested for AF activ. vs 8 strains weak active
CMNPD29300	tested for AF activ. vs 8 strains mod active 4ug/ml vs Microsporum gypseum
CMNPD29302	tested for AF activ. vs 8 strains weak active
CMNPD29303	tested for AF activ. vs 8 strains weak active
CMNPD29304	tested for AF activ. vs 8 strains weak active
CMNPD29321	antifoul. act EC50 4.3 uM vs barncle larvae
CMNPD29322	weak AB toward E coli and Salmonella typhi
CMNPD29323	weak AB toward E coli and Salmonella typhi
CMNPD29324	NA vs E. coli and S. typhi
CMNPD29326	antifoul. act EC50 0.59 uM vs barncle larvae
CMNPD29328	weak active vs 2 HTCL
CMNPD29329	weak active vs 2 HTCL
CMNPD29330	weak active vs 2 HTCL
CMNPD29331	mod. AB act vs MRSA MIC 1.4 ug/mL VREF 2.2 ug/mL
CMNPD29332	NA vs MRSA and VREF
CMNPD29333	NA vs MRSA and VREF
CMNPD29334	NA vs MRSA and VREF
CMNPD29335	NA vs MRSA and VREF
CMNPD29336	mod. AB act vs MRSA MIC 8.0 ug/mL VREF 1.6 ug/mL
CMNPD29337	NA vs MRSA and VREF
CMNPD29339	weak active vs 2 HTCL
CMNPD29340	weak active vs 2 HTCL
CMNPD29341	weak active vs 2 HTCL
CMNPD29342	weak active vs 2 HTCL
CMNPD29343	weak active vs 2 HTCL
CMNPD29344	weak active vs 2 HTCL
CMNPD29361	DPPH EC50 13.5 uM, Tyrosinase activ. 31.0 uM
CMNPD29362	DPPH EC50 24.7 uM, Tyrosinase activ. 17.3 uM
CMNPD29374	Potent activ. vs. L5178Y murine leukaemia cell line
CMNPD29375	Potent activ. vs. L5178Y murine leukaemia cell line
CMNPD29376	Potent activ. vs. L5178Y murine leukaemia cell line
CMNPD29377	mod. activ. vs 1 rat cancer cell line.
CMNPD29378	mod. quorum quenching activ. via total protease inhib.
CMNPD29379	IA vs M. tuberculosis
CMNPD29380	IA vs M. tuberculosis
CMNPD29381	mixt. potent activ. vs 2 HTCLs
CMNPD29382	mixt. potent activ. vs 2 HTCLs
CMNPD29383	mod. activ. vs 1 HTCL under glucose deficient conditions, mode of action via inhib. of complex I in the mitochondrIAl electron transport chain.
CMNPD29384	mod. activ. vs 1 HTCL under glucose deficient conditions, mode of action via inhib. of complex I in the mitochondrIAl electron transport chain.
CMNPD29385	Potent activ. vs 1 HTCL under glucose deficient conditions, mode of action via inhib. of complex I in the mitochondrIAl electron transport chain.
CMNPD29386	Potent activ. vs 1 HTCL under glucose deficient conditions, mode of action via inhib. of complex I in the mitochondrIAl electron transport chain.
CMNPD29387	IA vs 4 HTCLs
CMNPD29388	IA vs 4 HTCLs
CMNPD29389	IA vs 4 HTCLs
CMNPD29391	mod. activ. vs. 5 HTCLs
CMNPD29392	mod. activ. vs 2 HTCLs
CMNPD29393	Potent activ. vs. 4 HTCLs
CMNPD29394	Potent activ. vs. 5 HTCLs
CMNPD29395	Potent activ. vs. 5 HTCLs
CMNPD29400	IA vs. P. falciparum, pM inhib. of chymotrypsin and elastase
CMNPD29401	IA vs. P. falciparum, pM inhib. of chymotrypsin and elastase
CMNPD29402	IA vs. P. falciparum, pM inhib. of chymotrypsin and elastase
CMNPD29403	Potent activ. vs 1 HTCL
CMNPD29404	mod. activ. vs 1 HTCL
CMNPD29408	Not cytotox. to RAW 264.7 cells, IAs JNK, ERK, AP-1 and NF-ΚB and activates ATF-3 immunomod.
CMNPD29412	mod. antimycobact. | l activ. in disk assay
CMNPD29413	mod. antimycobact. | l activ. in disk assay
CMNPD29414	mod. antimycobact. | l activ. in disk assay, weak kinase inhibbition of VHR
CMNPD29415	IA vs. 2 HTCLs | potent inhib. of ROS prod in stimulated Neuro2A cells
CMNPD29416	IA vs. 2 HTCLs | potent inhib. of ROS prod in stimulated Neuro2A cells
CMNPD29417	Potent AB activ. (MIC ng/mL range) vs. 6 strains | mod. activ. vs. 2 HTCLs
CMNPD29418	IA as an AB vs. 6 strains | mod. activ. vs. 2 HTCLs
CMNPD29419	Potent AB activ. (MIC ng/mL range) vs. 6 strains | mod. activ. vs. 2 HTCLs
CMNPD29420	Potent AB activ. (MIC ng/mL range) vs. 6 strains | mod. activ. vs. 2 HTCLs
CMNPD29421	Potent AB activ. (MIC ng/mL range) vs. 6 strains | mod. activ. vs. 2 HTCLs
CMNPD29422	mod. AB and AF activ. vs. 4 strains of each.
CMNPD29423	mod. activ. vs. 3 HTCLs
CMNPD29424	Strong AB activ. vs. Gram (=) | IA vs. Gram (-) | strong anti-HIV activ. vs. 2 strains | mod. activ. vs 1 HTCL
CMNPD29425	Strong AB activ. vs. Gram (+) | IA vs. Gram (-) | strong anti-HIV activ. vs. 2 strains | mod. activ. vs 1 HTCL
CMNPD29427	Inhibited PTP1B (IC50 = 8.6 μM)
CMNPD29428	Inhibited PTP1B (IC50 = 10.0 μM)
CMNPD29430	weak AM
CMNPD29438	IA vs 4 HTCLs
CMNPD29439	IA vs 4 HTCLs
CMNPD29440	IA vs 4 HTCLs
CMNPD29441	IA vs 4 HTCLs
CMNPD29442	IA vs 4 HTCLs
CMNPD29443	IA vs 4 HTCLs
CMNPD29446	mod. AB activ. vs 2 Gram (+) strains
CMNPD29447	weak AB activ. vs 2 Gram (+) strains
CMNPD29448	weak AB activ. vs 2 Gram (+) strains
CMNPD29449	mod. AB activ. vs 2 Gram (+) strains
CMNPD29452	mod. activ. vs. 3 HTCLs
CMNPD29453	weak activ. vs. 3 HTCLs
CMNPD29454	mod. activ. vs. 1 HTCL and P. falciparum, selectivity 0.6
CMNPD29455	Potent activ. vs. 1 HTCL and P. falciparum, selectivity 2.4
CMNPD29456	Potent activ. vs. 1 HTCL and P. falciparum, selectivity 7.0
CMNPD29457	Potent activ. vs. 1 HTCL and P. falciparum, selectivity 2.0
CMNPD29458	Potent activ. vs. 1 HTCL and P. falciparum, selectivity 2.0
CMNPD29461	Inhibits Yersinia pseudotuberculosis TS33 levels, but has no effect on Pseudomonas TS33 and does not inhibit Yersinia growth
CMNPD29462	Inhibits Yersinia pseudotuberculosis TS33 levels, but has no effect on Pseudomonas TS33 and does not inhibit Yersinia growth
CMNPD29463	Inhibits Yersinia pseudotuberculosis TS33 levels, but has no effect on Pseudomonas TS33 and does not inhibit Yersinia growth
CMNPD29464	Inhibits Yersinia pseudotuberculosis TS33 levels, but has no effect on Pseudomonas TS33 and does not inhibit Yersinia growth
CMNPD29465	Inhibits Yersinia pseudotuberculosis TS33 levels, but has no effect on Pseudomonas TS33 and does not inhibit Yersinia growth
CMNPD29466	Inhibits Yersinia pseudotuberculosis TS33 levels, but has no effect on Pseudomonas TS33 and does not inhibit Yersinia growth
CMNPD29467	Inhibits Yersinia pseudotuberculosis TS33 levels, but has no effect on Pseudomonas TS33 and does not inhibit Yersinia growth
CMNPD29468	mod. AB activ. vs various Gram (+) bact.
CMNPD29469	mod. AB activ. vs various Gram (+) bact.
CMNPD29470	mod. AB activ. vs various Gram (+) bact.
CMNPD29471	mod. AB activ. vs various Gram (+) bact.
CMNPD29472	mod. activ. vs 3 HTCLs | MOA via induction of apoptosis but not via generation of ROS or inhib. of histone deacetylase
CMNPD29473	mod. activ. vs 3 HTCLs | MOA via induction of apoptosis but not via generation of ROS or inhib. of histone deacetylase
CMNPD29480	AM vs 12 clinical isolates; P10 enters bact. via the NorA multidrug efflux pump
CMNPD29483	mod. inhib. of Scavenger recept. Class B Type 1 HepG2 stable cell lines, therefore target atherosclerosis disease
CMNPD29484	IA vs. 4 HTCLs and as PTP1B inhib.
CMNPD29485	Not cytotox. to BV-2 microglial cells, but weak inhib. of NO prod in LPS-stimulated BV-2 cells
CMNPD29486	mod. PTP1B inhib., IA vs. 4 HTCLs
CMNPD29487	Not cytotox. to BV-2 microglial cells, but weak inhib. of NO prod in LPS-stimulated BV-2 cells
CMNPD29488	Not cytotox. to BV-2 microglial cells, but weak inhib. of NO prod in LPS-stimulated BV-2 cells
CMNPD29489	Not cytotox. to BV-2 microglial cells, but weak inhib. of NO prod in LPS-stimulated BV-2 cells
CMNPD29490	Not cytotox. to BV-2 microglIAl cells, but weak inhib. of NO prod in LPS-stimulated BV-2 cells
CMNPD29491	mod. activ. vs. 5 HTCLs
CMNPD29492	IA vs 4 HTCLs | mod. activ. vs. 1 bact.l strain
CMNPD29494	mod. activ. vs 4 HTCLs | mod. activ. vs 1 bact.l strain
CMNPD29495	mod. activ. vs 4 HTCLs | mod. activ. vs 2 bact.l strains
CMNPD29496	IA vs 4 HTCLs
CMNPD29497	IA vs 4 HTCLs
CMNPD29498	IA vs 4 HTCLs
CMNPD29499	IA vs 4 HTCLs
CMNPD29500	IA vs 4 HTCLs
CMNPD29501	IA vs 4 HTCLs | mod. kinase inhib. (CDK-2, KD 4.8 μM)
CMNPD29502	IA vs 4 HTCLs
CMNPD29503	IA vs 4 HTCLs
CMNPD29504	IA vs 4 HTCLs
CMNPD29505	IA vs 4 HTCLs
CMNPD29506	IA vs 4 HTCLs
CMNPD29507	IA vs 4 HTCLs
CMNPD29516	No cytotox. vs. RBL-2H3 rat leukemia cells | potent inhib.s of allergic cytokine prod
CMNPD29517	No cytotox. vs. RBL-2H3 rat leukemia cells | potent inhib.s of allergic cytokine prod
CMNPD29518	No cytotox. vs. RBL-2H3 rat leukemia cells | potent inhib.s of allergic cytokine prod
CMNPD29519	No cytotox. vs. RBL-2H3 rat leukemia cells | potent inhib.s of allergic cytokine prod
CMNPD29520	mod. activ. vs 1 HTCL | IA vs 3 HTCLs
CMNPD29521	mod. AF activ. vs C. albicans | weak activ. vs 3 HTCLs
CMNPD29522	mod. AF activ. vs C. albicans | weak activ. vs 2 HTCLs
CMNPD29523	IA vs. 3 HTCLs
CMNPD29524	IA vs. 3 HTCLs
CMNPD29525	IA vs. 3 HTCLs
CMNPD29526	IA vs. 3 HTCLs
CMNPD29532	weak activty vs. 3 microb. strains
CMNPD29533	weak activty vs. 3 microb. strains
CMNPD29534	Potent antifoul. activ. vs Balanus amphitrite (LC50 = 3.6 μg/mL)
CMNPD29535	Inhibited RANKL-induced osteoclastogenesis at 50 μM
CMNPD29538	Inhibited RANKL-induced osteoclastogenesis at 50 μM
CMNPD29539	Inhibited RANKL-induced osteoclastogenesis at 50 μM
CMNPD29540	Inhibited RANKL-induced osteoclastogenesis at 50 μM
CMNPD29545	weak activ. vs. 1 HTCL
CMNPD29547	weak activ. vs 1 HTCL
CMNPD29548	weak activ. vs 1 HTCL
CMNPD29553	No signif. tox. vs RBL-2H3 cells but inhibits IL-4 prod and release of β-hexosamidinase hence anti-allergy cpd
CMNPD29554	No signif. tox. vs RBL-2H3 cells but inhibits IL-4 prod and release of β-hexosamidinase hence anti-allergy cpd
CMNPD29556	weak activ. vs. three parasites
CMNPD29557	weak activ. vs. three parasites
CMNPD29558	weak activ. vs. 1 HTCL
CMNPD29559	mod. activ. vs. 1 HTCL
CMNPD29560	Inhibited USP7 (IC50 = 2.8 μM)
CMNPD29561	Inhibited USP7 (IC50 = 4.6 μM)
CMNPD29563	weak activ. vs. 3 HTCLs
CMNPD29564	Potent AF vs 8 clinically relevant strains, less potent than enantiomer
CMNPD29565	Potent AF vs 8 clinically relevant strains, more potent than enantiomer
CMNPD29566	weak activ. vs 5 of 7 HTCLs
CMNPD29567	weak activ. vs 5 of 7 HTCLs
CMNPD29568	weak activ. vs 5 of 7 HTCLs
CMNPD29569	weak activ. vs 5 of 7 HTCLs
CMNPD29572	weak activ. vs 5 of 7 HTCLs
CMNPD29573	weak activ. vs 5 of 7 HTCLs
CMNPD29574	mod. AB activ. vs 4 strains
CMNPD29575	mod. AB activ. vs 4 strains
CMNPD29577	weak activty vs 1 HTCL
CMNPD29578	weak activty vs 1 HTCL
CMNPD29579	weak activty vs 1 HTCL | mod. AF activty vs Aspergillus fumigatus
CMNPD29580	mod. AF activty vs Aspergillus fumigatus
CMNPD29585	Insulin mimetic, enhances 2-NBDG uptake at 20 μM | IA vs 2 HTCLs | NA vs bact., fungi or two isolated enzymes
CMNPD29586	Insulin mimetic, enhances 2-NBDG uptake at 20 μM | IA vs 2 HTCLs | NA vs bact., fungi or two isolated enzymes
CMNPD29587	Insulin mimetic, enhances 2-NBDG uptake at 20 μM | IA vs 2 HTCLs | NA vs bact., fungi or two isolated enzymes
CMNPD29588	Insulin mimetic, enhances 2-NBDG uptake at 20 μM | IA vs 2 HTCLs | NA vs bact., fungi or two isolated enzymes
CMNPD29589	Insulin mimetic, enhances 2-NBDG uptake at 20 μM | IA vs 2 HTCLs | NA. vs bact., fungi or two isolated enzymes
CMNPD29590	Insulin mimetic, enhances 2-NBDG uptake at 20 μM | IA vs 2 HTCLs | no activ. vs bact., fungi or two isolated enzymes
CMNPD29591	Insulin mimetic, enhances 2-NBDG uptake at 20 μM | IA vs 2 HTCLs | no activ. vs bact., fungi or two isolated enzymes
CMNPD29592	weak activ. vs. 1 HTCL | weak hemolytic activ.
CMNPD29593	weak activ. vs. 1 HTCL | mod. hemolytic activ.
CMNPD29594	mod. activ. vs. 1 HTCL | weak hemolytic activ.
CMNPD29595	mod. activ. vs. 1 HTCL | mod. hemolytic activ.
CMNPD29596	mod. activ. vs. 1 HTCL | weak hemolytic activ.
CMNPD29597	mod. activ. vs. 1 HTCL | mod. hemolytic activ.
CMNPD29598	weak activ. vs. 1 HTCL | weak hemolytic activ.
CMNPD29599	weak activ. vs. Neuro-Sa and HepG2 cells
CMNPD29606	weakly cytotox. to 1 HTCL.
CMNPD29607	Inhibits protein sumoylation
CMNPD29608	No AB or cytotox. activ. detected
CMNPD29609	No AB or cytotox. activ. detected
CMNPD29610	No AB or cytotox. activ. detected
CMNPD29611	IA vs 8 HTCLs
CMNPD29612	IA vs 8 HTCLs
CMNPD29614	weak cytotox. to 1 HTCL.
CMNPD29615	weakly cytotox. to P388 cell line. No AV activ.
CMNPD29616	weakly cytotox. to P388 cell line. No AV activ.
CMNPD29617	weakly cytotox. to P388 cell line. No AV activ.
CMNPD29619	mod cytotox. vs 1 HTCL and antifoul. (Balanus sp.)
CMNPD29620	IA vs 2 HTCLs.
CMNPD29621	IA vs 2 HTCLs.
CMNPD29622	IA vs 2 HTCLs.
CMNPD29623	mod cytotox. to HL-60 cell line.
CMNPD29624	IA vs 2 HTCLs.
CMNPD29625	IA vs 2 HTCLs.
CMNPD29630	IA vs 4 HTCLs.
CMNPD29631	weakly cytotox. to P388 cell line. No AV activ.
CMNPD29632	None or weak cytotox. | promoted conA-induced lymphocyte proliferation
CMNPD29633	None or weak cytotox. | promoted conA-induced lymphocyte proliferation
CMNPD29634	None or weak cytotox. | promoted conA-induced lymphocyte proliferation
CMNPD29635	mod. cytotox. vs 1 HTCL
CMNPD29636	mod. cytotox. vs 1 HTCL
CMNPD29637	mod. cytotox. vs 1 HTCL
CMNPD29638	Not cyto vs 3 HTCLs
CMNPD29639	mod. inhib prodn superoxide. Not cyto vs 3 HTCLs
CMNPD29640	Not cyto vs 3 HTCLs
CMNPD29641	Not cyto vs 3 HTCLs
CMNPD29642	mod. inhib prodn superoxide and inhib release elastase. | Not cyto vs 3 HTCLs
CMNPD29643	mod. inhib prodn superoxide and inhib release elastase. | Not cyto vs 3 HTCLs
CMNPD29644	Not cytotox.
CMNPD29645	Mod cytotox. to 2 HTCLs
CMNPD29646	Not cytotox.
CMNPD29647	Mod cytotox. to 1 HTCL | mod. inhib NO prodn
CMNPD29648	Not cytotox. | mod. inhib NO prodn
CMNPD29649	Mod cytotox. to 1 HTCL | mod. inhib NO prodn
CMNPD29651	mod. cytotox. to 3 TCLs.
CMNPD29652	mod. cytotox. to 2 TCLs | mod. inhib NO prodn.
CMNPD29653	Didn’t inhibit PTP1B.
CMNPD29654	Didn’t inhibit PTP1B.
CMNPD29655	Didn’t inhibit PTP1B.
CMNPD29656	Didn’t inhibit PTP1B.
CMNPD29657	Didn’t inhibit PTP1B.
CMNPD29658	Didn’t inhibit PTP1B.
CMNPD29659	IA vs PTP1B, 2 HTCLs and P. aeruginosa
CMNPD29660	IA vs PTP1B, 2 HTCLs and P. aeruginosa
CMNPD29661	IA vs PTP1B, 2 HTCLs and P. aeruginosa
CMNPD29662	IA vs PTP1B, 2 HTCLs and P. aeruginosa
CMNPD29663	IA vs PTP1B, 2 HTCLs and P. aeruginosa
CMNPD29664	IA vs PTP1B, 2 HTCLs and P. aeruginosa
CMNPD29665	IA vs PTP1B, 2 HTCLs and P. aeruginosa
CMNPD29666	IA vs PTP1B, 2 HTCLs and P. aeruginosa
CMNPD29667	IA vs PTP1B, 2 HTCLs and P. aeruginosa
CMNPD29671	Potent inhib IL-12 release and NO prodn.
CMNPD29672	Potent inhib IL-12 release and NO prodn.
CMNPD29673	mod. cytotox vs A549 and HepG2
CMNPD29674	mod. cytotox vs A549
CMNPD29675	mod. cytotox vs A549 and HepG4
CMNPD29676	mod. inhib NO prodn
CMNPD29682	mod. inhib NO prodn
CMNPD29683	IA vs 3 HTCLs.
CMNPD29684	IA vs 3 HTCLs.
CMNPD29685	IA vs 3 HTCLs.
CMNPD29686	IA vs 3 HTCLs.
CMNPD29687	IA vs 3 HTCLs.
CMNPD29688	Enhances expression of COX-2 and iNOS.
CMNPD29690	Inhib elastase release.
CMNPD29691	Inhib expression iNOS.
CMNPD29692	IA vs 4 HTCLs.
CMNPD29693	IA vs 4 HTCLs.
CMNPD29694	IA vs 4 HTCLs.
CMNPD29695	IA vs 4 HTCLs.
CMNPD29696	IA vs 4 HTCLs.
CMNPD29697	IA vs 4 HTCLs.
CMNPD29698	IA vs 4 HTCLs.
CMNPD29699	IA vs 4 HTCLs.
CMNPD29700	IA vs 4 HTCLs.
CMNPD29701	IA vs 4 HTCLs.
CMNPD29702	IA vs 4 HTCLs.
CMNPD29703	IA vs 4 HTCLs.
CMNPD29704	IA vs 4 HTCLs.
CMNPD29705	IA vs 4 HTCLs.
CMNPD29706	IA vs 4 HTCLs.
CMNPD29707	mod. inhib. of hepatitis B e antigen.
CMNPD29708	weak inhib NO prodn.
CMNPD29709	weak inhib NO prodn.
CMNPD29710	weak inhib NO prodn.
CMNPD29711	weak inhib NO prodn.
CMNPD29712	weak inhib NO prodn.
CMNPD29713	mod. to strongly cytotox. to 3 HTCLs.
CMNPD29714	mod. to strongly cytotox. to 3 HTCLs.
CMNPD29715	mod. AB | AF activities | cytotox.
CMNPD29716	mod. AB | AF activities
CMNPD29717	IA vs 8 HTCLs.
CMNPD29718	mod. cytotox. to 2 HTCLs.
CMNPD29719	IA to 3 HTCLs.
CMNPD29720	Inhib cancer cell migration | reduced mRNA levels of 3 cytokines
CMNPD29721	Inhib viability of hepatic stellate cells.
CMNPD29722	Inhib elastase release.
CMNPD29723	Inhib prodn superoxide.
CMNPD29725	Inhib elastase release and inhib prodn superoxide.
CMNPD29727	Inhib elastase release and inhib prodn superoxide.
CMNPD29728	IA to 3 HTCLs.
CMNPD29729	IA to 3 HTCLs.
CMNPD29730	IA to 3 HTCLs.
CMNPD29731	mod. inhib superoxide prodn and elastase release.
CMNPD29733	mod. cytotox. to HCT-116 cells.
CMNPD29735	weak cytotox. to 4 HTCLs | strong inhib prodn superoxide and elastase release.
CMNPD29737	weak cytotox. to 2 HTCLs | inhib elastase release.
CMNPD29738	IA to 3 HTCLs.
CMNPD29739	IA to 3 HTCLs.
CMNPD29740	IA to 3 HTCLs.
CMNPD29741	IA to 3 HTCLs.
CMNPD29742	IA to 3 HTCLs.
CMNPD29743	mod cytotox. to 8 HTCLs.
CMNPD29745	IA vs 3 HTCLs.
CMNPD29746	IA vs superoxide prodn or elastase release.
CMNPD29747	IA vs superoxide prodn or elastase release.
CMNPD29748	weak cytotox. to 2 TCLs.
CMNPD29749	mod cytotox. to 4 TCLs.
CMNPD29750	mod cytotox. to 4 TCLs | mod. inhib elastase release.
CMNPD29751	mod. cytotox. to 4 TCLs | mod. inhib superoxide prodn and elastase release.
CMNPD29752	mod cytotox. to 3 HTCLs.
CMNPD29754	mod. cytotox. to 4 TCLs.
CMNPD29755	Not cytotox.
CMNPD29756	mod. cytotox. to 4 TCLs.
CMNPD29757	mod. cytotox. to 4 TCLs.
CMNPD29758	Not cytotox.
CMNPD29761	IA in anifeedant assay (fish)
CMNPD29762	weak cytotox. vs 3 HTCLs
CMNPD29763	weak cytotox. vs 3 HTCLs
CMNPD29764	weak cytotox. vs 3 HTCLs
CMNPD29765	strong AO (ABTS assay)
CMNPD29766	strong AO (ABTS assay)
CMNPD29767	mod. AO (ABTS assay)
CMNPD29768	mod. AO (ABTS assay)
CMNPD29771	IA vs 3 HTCLs, 5 strains bact., anti-dIAbetic (PTP-1B ) and biofilm inhib.
CMNPD29772	signif. cytotox. vs 3 HTCLs and 1 norm. hum. cell line
CMNPD29773	signif. cytotox. vs 3 HTCLs and 1 norm. hum. cell line
CMNPD29780	mod. AM activ.
CMNPD29781	Mod. AM activ.
CMNPD29783	IA in wide range of bioassays.
CMNPD29784	IA in a variety of bioassays.
CMNPD29785	IA in a variety of bioassays.
CMNPD29786	Not cytotox. to 3 HTCLs.
CMNPD29787	Mod to weak cytotox. to 2 HTCLs.
CMNPD29788	Not cytotox. to 2 TCLs.
CMNPD29789	mod. antimal. activ.
CMNPD29798	Fish feeding deterrent activ.
CMNPD29801	mod cytotox. to 6 HTCLs.
CMNPD29802	mod cytotox. to 4 HTCLs.
CMNPD29805	Not cytotox. to 3 HTCLs.
CMNPD29806	Not cytotox. to 3 HTCLs.
CMNPD29807	Not cytotox. to 3 HTCLs.
CMNPD29808	Not cytotox. to 3 HTCLs.
CMNPD29809	Not cytotox. to 3 HTCLs.
CMNPD29810	Not cytotox. to 3 HTCLs.
CMNPD29811	Strong cytotox. to K562 cell line.
CMNPD29812	Strong cytotox. to K562 cell line.
CMNPD29813	Strong cytotox. to K562 cell line.
CMNPD29814	weak anti-HIV | no AB activ.
CMNPD29815	weak anti-HIV | no AB activ.
CMNPD29816	weak anti-HIV | no AB activ.
CMNPD29817	weak anti-HIV | no AB activ.
CMNPD29818	weak anti-HIV | no AB activ.
CMNPD29819	weak anti-HIV | no AB activ.
CMNPD29820	weak anti-HIV | no AB activ.
CMNPD29821	weak anti-HIV | no AB activ.
CMNPD29822	No AB activ.
CMNPD29826	Act vs S. aureus, not Gram (-) bact.
CMNPD29827	Act vs S. aureus, not Gram (-) bact.
CMNPD29828	Act vs S. aureus, not Gram (-) bact.
CMNPD29829	Act vs S. aureus, not Gram (-) bact.
CMNPD29830	cytotox. to HTCL panel.
CMNPD29832	cytotox. to HTCL panel.
CMNPD29833	cytotox. to HTCL panel.
CMNPD29834	cytotox. to HTCL panel.
CMNPD29835	weak cytotox.
CMNPD29836	cytotox. to HTCL panel.
CMNPD29837	mod. GI50 to 4 HTCLs.
CMNPD29838	mod. GI50 to 4 HTCLs.
CMNPD29839	IA to CLL cell line.
CMNPD29842	weak inhib. of HCV NS3 helicase.
CMNPD29843	weak inhib. of HCV NS3 helicase.
CMNPD29844	mod. inhib. of HCV NS3 helicase.
CMNPD29845	mod. inhib. of HCV NS3 helicase.
CMNPD29848	weakly cytotox. to RAW 264.7 cell line.
CMNPD29849	Not cytotox.
CMNPD29850	Not cytotox. | reduced ROS levels in LPS stimulated RAW 264.7 cells
CMNPD29851	Not cytotox. | reduced ROS levels in LPS stimulated RAW 264.7 cells
CMNPD29852	Not cytotox. | reduced ROS levels in LPS stimulated RAW 264.7 cells
CMNPD29853	Not cytotox.
CMNPD29854	Not cytotox.
CMNPD29856	cytotox. and apoptotic to HTCLs.
CMNPD29857	Mod cytotox. towards 5 HTCLs.
CMNPD29858	Mod cytotox. towards 5 HTCLs.
CMNPD29859	mod. to mod. cytotox. towards 5 HTCLs.
CMNPD29860	mod. to mod. cytotox. towards 5 HTCLs.
CMNPD29861	weak haemolytic.
CMNPD29862	Haemolytic and cytotox.
CMNPD29863	Haemolytic and cytotox. | enhances radiolytic cytotox.
CMNPD29864	Haemolytic and cytotox.
CMNPD29865	weak haemolytic.
CMNPD29866	weak haemolytic.
CMNPD29867	Haemolytic and cytotox.
CMNPD29868	Haemolytic and cytotox.
CMNPD29869	Haemolytic and cytotox. | enhances radiolytic cytotox.
CMNPD29870	Haemolytic and cytotox. | enhances radiolytic cytotox.
CMNPD29871	Haemolytic and cytotox.
CMNPD29872	Haemolytic and cytotox. | enhances radiolytic cytotox.
CMNPD29876	weak AI
CMNPD29877	weak AI
CMNPD29878	weak AI
CMNPD29879	weak AI
CMNPD29882	Cytotox. to 6 hum. breast cancer cell lines
CMNPD29883	Not cytotox. to 3 HTCLs.
CMNPD29884	AV (H1N1) | not cytotox. to 4 TCLs.
CMNPD29885	weak cytotox. to P388 cell line.
CMNPD29886	weak cytotox. to 3 TCLs.
CMNPD29887	weak to mod. cytotox. to 3 TCLs.
CMNPD29888	weak cytotox. to HeLa cell line.
CMNPD29889	AO and weak AI
CMNPD29890	AO and weak AI
CMNPD29895	mod AV (HIV-1).
CMNPD29899	weak cytotox. to panel of 6 HTCLs.
CMNPD29900	weak cytotox. to panel of 6 HTCLs.
CMNPD29901	weak cytotox. to panel of 6 HTCLs.
CMNPD29902	weak cytotox. to panel of 6 HTCLs.
CMNPD29903	weak cytotox. to panel of 6 HTCLs.
CMNPD29904	weak cytotox. to panel of 6 HTCLs.
CMNPD29905	weak cytotox. to panel of 6 HTCLs.
CMNPD29906	weak cytotox. to panel of 6 HTCLs.
CMNPD29907	Strongly AV (HIV-1).
CMNPD29911	IA to panel of 8 HTCLs.
CMNPD29912	AO
CMNPD29913	AO
CMNPD29914	weak AO
CMNPD29916	AO
CMNPD29917	mod. inhib. of HCV NS3-N54A protease.
CMNPD29929	Mod. AB activ. vs 2 strain.
CMNPD29930	Mod. to low antiallergic activ. | IA vs mast cells.
CMNPD29931	Mod. to low antiallergic activ. | IA vs mast cells.
CMNPD29932	Mod. antiallergic activ. | IA vs mast cells.
CMNPD29933	Mod. to low antiallergic activ. | IA vs mast cells.
CMNPD29934	No antiallergic activ. | IA vs mast cells.
CMNPD29935	No antiallergic activ. | IA vs mast cells.
CMNPD29936	Mod. cytotox. vs 5 HTCLs | Mod. activ. in wound and cell invasion assays.
CMNPD29937	Mod. cytotox. vs 3 HTCLs
CMNPD29938	Mod. to no AB activ. vs 6 strain.
CMNPD29939	IA vs 5 HTCLs and several imicrob. strain. | Mod. antiangiogenic activ.
CMNPD29940	Siderophoric activ. | Mod. AB activ. vs 4 strain.
CMNPD29941	potent AB activ. vs MRSA (3 strain). | Low cytotox. vs 1 HTCL
CMNPD29942	potent AB activ. vs MRSA (3 strain). | Low cytotox. vs 1 HTCL
CMNPD29943	Mod. AB activ. vs MRSA (3 strain). | Low cytotox. vs 1 HTCL
CMNPD29944	Mod. AB activ. vs MRSA (3 strain). | Low cytotox. vs 1 HTCL
CMNPD29945	Inhib. malaria parasite via mitochondrial dysfunction and decreased cytosolic Ca 2+
CMNPD29946	Inhib. malaria parasite via mitochondrial dysfunction and decreased cytosolic Ca 2+
CMNPD29947	Low AB vs 2 strain. No cytotox. vs 1 HTCL
CMNPD29948	potent to mod. cytotox. vs 2 HTCLs | potent to mod. AB activ. vs 5 strain.
CMNPD29949	potent to mod. cytotox. vs 2 HTCLs | potent to mod. AB activ. vs 5 strain.
CMNPD29950	potent to mod. cytotox. vs 2 HTCLs | potent to mod. AB activ. vs 5 strain.
CMNPD29951	Siderophoric activ.
CMNPD29952	IA vs 3 HTCLs
CMNPD29953	IA vs 3 HTCLs
CMNPD29957	TGF-β inhib. EMT induc.
CMNPD29958	TGF-β inhib. EMT induc.
CMNPD29959	TGF-β inhib. EMT induc.
CMNPD29960	TGF-β inhib. EMT induc.
CMNPD29961	TGF-β inhib. EMT induc.
CMNPD29962	Mod. to low AB activ. vs 4 strain.
CMNPD29963	IA vs 4 bact.
CMNPD29965	Low to mod. AM activ. vs 11 strain. | IA vs 1 HTCL
CMNPD29966	Low-mod. AM activ. vs 11 strain. | Low cytotox. vs 1 HTCL
CMNPD29967	IA vs 11 AM strain. | IA vs 1 HTCL
CMNPD29969	Low to mod. AM activ. vs 11 strain. | IA vs 1 HTCL
CMNPD29970	Some cell-to-cell signaling activ.
CMNPD29971	Low AM activ. vs 3 strain. | IA vs 4 HTCLs
CMNPD29972	Low AM activ. vs 3 strain. | IA vs 4 HTCLs
CMNPD29973	Low AM activ. vs 3 strain. | IA vs 4 HTCLs
CMNPD29974	Low AM activ. vs 3 strain. | IA vs 4 HTCLs
CMNPD29975	Low AM activ. vs 3 strain. | IA vs 4 HTCLs
CMNPD29976	No cytotox. vs 1 HTCL | No BRD4 inhib.
CMNPD29977	No cytotox. vs 1 HTCL | No BRD4 inhib.
CMNPD29978	No cytotox. vs 1 HTCL | No BRD4 inhib.
CMNPD29979	No cytotox. vs 1 HTCL | No BRD4 inhib.
CMNPD29980	Weak TB activ. | IA vs panel of bact.
CMNPD29982	Low activ. vs MRSA.
CMNPD29983	Low activ. vs MRSA
CMNPD29984	IA vs MRSA
CMNPD29985	Low to mod. AM activ. vs 44 strain. | Mod. to low cytotox. vs 4 HTCLs
CMNPD29986	Low to mod. AM activ. vs38 strain. | Mod. to no cytotox. vs 4 HTCLs
CMNPD29987	Low to mod. AM activ. vs 38 strain. | Mod. to low cytotox. vs 4 HTCLs
CMNPD29988	Low to mod. AM activ. vs 38 strain. | Mod. cytotox. vs 4 HTCLs
CMNPD29989	Low to mod. AM activ. vs 44 strain. | Mod. to low cytotox. vs 4 HTCLs
CMNPD29990	Low to mod. AM activ. vs 38 strain. | Mod. to low cytotox. vs 4 HTCLs
CMNPD29991	Mod. cytotox. vs 5 HTCLs | Mod. cytotox. vs 2 NMCLs.
CMNPD29992	Mod. cytotox. vs 5 HTCLs | Mod. cytotox. vs 2 NMCLs.
CMNPD29993	potent to mod. cytotox. vs 5 HTCLs | Mod. cytotox. vs 2 NMCLs. | Inhib. cell migration vs 2 HTCLs
CMNPD29994	IA vs 5 HTCLs | IA vs 2 NMCLs.
CMNPD29995	Mod. AB activ. vs 5 strain. | IA vs 1 HTCL
CMNPD29996	Mod. AB activ. vs 10 strain.
CMNPD29997	Mod. to low cytotox. vs 3 HTCLs
CMNPD29998	Mod. to low cytotox. vs 3 HTCLs
CMNPD29999	IA vs 3 HTCLs
CMNPD30000	Weak AB activ. vs 6 strain.
CMNPD30001	potent to no activ. vs 7 micro. strain.
CMNPD30002	Weak cytotox. vs 2 HTCLs | Weak AF activ. vs 1 strain.
CMNPD30003	Weak antimalarial activ. vs 2 P. falciparum strain. | No cytotox. vs 1 cell line.
CMNPD30004	potent to mod. cytotox. vs 3 HTCLs | IA vs 5 microbes
CMNPD30005	Mod. to low AB activ. vs 8 strain. | No cytotox. vs 3 mammalian cell lines.
CMNPD30006	potent to mod. cytotox. vs 4 HTCLs
CMNPD30013	Low cytotox. vs 6 HTCLs
CMNPD30014	Mod. cytotox. vs 5 HTCLs
CMNPD30015	IA vs 6 HTCLs
CMNPD30025	IA vs 8 HTCLs
CMNPD30027	IA vs 4 HTCLs
CMNPD30028	IA vs 4 HTCLs
CMNPD30029	IA vs 4 HTCLs
CMNPD30030	Mod. AB activ. vs MRSA. | IA vs 2 other microb.strain.
CMNPD30031	Mod. AB activ. vs MRSA. | IA vs 2 other microb. strain.
CMNPD30032	Mod. AB activ. vs MRSA. | IA vs 2 other microb. strain.
CMNPD30033	Low AO.
CMNPD30034	Low AO.
CMNPD30035	Mod. AO.
CMNPD30036	Mod. AO.
CMNPD30037	Low AO.
CMNPD30040	Low cytotox. vs 1 HTCL | Low inhib. vs 2 kinases.
CMNPD30041	Low cytotox. vs 1 HTCL | Low inhib. vs 2 kinases.
CMNPD30042	Low cytotox. vs 1 HTCL | Low inhib. vs 2 kinases.
CMNPD30043	Low cytotox. vs 1 HTCL | Low inhib. vs 2 kinases.
CMNPD30044	IA vs 4 bact., NO assay and 1 HTCL
CMNPD30045	IA vs 4 bact., NO assay and 1 HTCL
CMNPD30046	IA vs 4 bact., NO assay and 1 HTCL
CMNPD30047	IA vs 4 bact., NO assay and 1 HTCL
CMNPD30048	IA vs 4 bact., NO assay and 1 HTCL
CMNPD30049	IA vs 2 HTCLs and ROCK2 enzyme. | Mod. AM activ. vs 3 strain.
CMNPD30050	IA vs 2 HTCLs and ROCK2 enzyme. | Mod. AM activ. vs 3 strain.
CMNPD30051	IA vs 2 HTCLs and ROCK2 enzyme. | Mod. AM activ. vs 3 strain.
CMNPD30052	Mod. activ. vs 2 HTCLs and ROCK2 enzyme. | Mod. AM activ. vs 3 strain.
CMNPD30053	IA vs 3 HTCLs
CMNPD30054	IA vs 3 HTCLs
CMNPD30055	IA vs 3 HTCLs
CMNPD30056	IA vs 3 HTCLs
CMNPD30057	IA vs 3 HTCLs
CMNPD30058	IA vs 3 HTCLs
CMNPD30059	Mod. cytotox. vs 2 HTCLs | Mod. inhib. vs ROCK2 and BRD4.
CMNPD30060	Mod. cytotox. vs 2 HTCLs | Mod. inhib. vs ROCK2 | no inhib. of BRD4.
CMNPD30061	No cytotox. vs 2 HTCLs | Mod. inhib. vs ROCK2 | no inhib. of BRD4.
CMNPD30062	No cytotox. vs 2 HTCLs | No inhib. vs ROCK2 and BRD4.
CMNPD30063	No cytotox. vs 2 HTCLs | No inhib. vs ROCK2 and BRD4.
CMNPD30064	No cytotox. vs 2 HTCLs | No inhib. vs ROCK2 and BRD4.
CMNPD30065	No cytotox. vs 2 HTCLs | Mod. inhib. vs ROCK2 and BRD4.
CMNPD30066	No cytotox. vs 2 HTCLs | Mod. inhib. vs ROCK2 and BRD4.
CMNPD30067	IA vs 7 bact. | Weak cytotox. vs 4 HTCLs
CMNPD30068	IA vs 7 bact.
CMNPD30069	IA vs 9 bact. | Low AV vs 1 strain.
CMNPD30070	IA vs 9 bact. and a virus.
CMNPD30071	IA vs 9 bact. and a virus.
CMNPD30072	Mod. to low AB activ. vs 9 strain. | IA vs a virus.
CMNPD30073	Mod. to low AB activ. vs 9 strain. | IA vs a virus.
CMNPD30074	Mod. AB activ. vs 1 strain.
CMNPD30075	Disrupts membrane potential. | Mod. to no AB activ. vs 15 strain.
CMNPD30076	Mod. to low AM activ. vs 5 strain.
CMNPD30077	Mod. to low AM activ. vs 5 strain.
CMNPD30078	Mod. inhib. of cathepsin B. | IA vs 1 HTCL
CMNPD30079	Mod. inhib. of cathepsin B. | IA vs 1 HTCL
CMNPD30080	Mod. inhib. of cathepsin B. | IA vs 1 HTCL
CMNPD30081	Low AB activ. vs 2 strain.
CMNPD30082	Low AB activ. vs 2 strain.
CMNPD30083	Low AB activ. vs 2 strain.
CMNPD30086	Low AB activ. vs 6 strain.
CMNPD30087	Low AB activ. vs 6 strain.
CMNPD30088	Low AB activ. vs 6 strain.
CMNPD30089	Low AB activ. vs 6 strain.
CMNPD30090	Mod. cytotox. vs 3 HTCLs
CMNPD30091	Mod. cytotox. vs 3 HTCLs
CMNPD30092	No cytotox. vs 1 HTCL | No BRD4 inhib.
CMNPD30093	No cytotox. vs 1 HTCL | No BRD4 inhib.
CMNPD30094	IA vs 7 bact.
CMNPD30095	IA vs 15 bact.
CMNPD30096	IA vs 15 bact.
CMNPD30097	IA vs 15 bact.
CMNPD30098	IA vs 15 bact.
CMNPD30099	Low cytotox. vs 1 murine cell line.
CMNPD30100	Mod. AF activ. vs 1 strain. | IA vs 2 bact.
CMNPD30101	Mod. AF activ. vs 1 strain. | IA vs 2 bact.
CMNPD30102	Mod. to no AM activ. vs 15 strain. | Low cytotox. vs 1 HTCL Bact. DNA syn. inhib.
CMNPD30103	Mod. AM activ. vs 14 strain.
CMNPD30107	IA vs 5 bact. and 2 HTCL
CMNPD30108	IA vs 5 bact. and 2 HTCL
CMNPD30109	IA vs 5 bact. and 2 HTCL
CMNPD30110	IA vs 5 bact. and 2 HTCL
CMNPD30111	IA in NO inhib. assay | No cytotox. vs 1 cell line.
CMNPD30112	IA in NO inhib. assay | No cytotox. vs 1 cell line.
CMNPD30113	Weak activ. in NO inhib. assay | Mod. cytotox. vs 1 cell line.
CMNPD30114	Mod. activ. in NO inhib. assay | Strong cytotox. vs 1 cell line.
CMNPD30115	Low AB activ. vs 2 strain. | Low AF activ. vs 2 strain. | IA vs GPR84 enzyme.
CMNPD30116	Low AB activ. vs 6 strain. | Mod. AF activ. vs 3 strain. | potent inhib. of GPR84 enzyme.
CMNPD30117	Activ. vs 5 fish bact.
CMNPD30118	Weak to no AM activ. vs 6 strain. | IA vs 2 HTCLs AO activ.
CMNPD30119	Low AB activ. vs 5 strain. | IA vs 2 HTCLs
CMNPD30120	Weak immunomod. activ.
CMNPD30122	Mod. AB activ. vs 2 of 9 strain tested.
CMNPD30123	Free radical scavenging activ.
CMNPD30124	Free radical scavenging activ.
CMNPD30125	Mod. to no AB activ. vs 5 strain. | IA vs 1 HTCL
CMNPD30126	Mod. to low cytotox. vs 12 HTCLs
CMNPD30127	Low AChE inhib.
CMNPD30128	Low AChE inhib.
CMNPD30129	Mod. cytotox. vs 1 HTCL | Mod. inhib. of 3 protein kinases.
CMNPD30130	Low cytotox. vs 1 HTCL | Mod. to potent inhib. of 3 protein kinases.
CMNPD30131	Low cytotox. vs 1 HTCL | Mod. to no inhib. of 3 protein kinases.
CMNPD30132	Cytotox. vs 1 HTCL | Mod. to no inhib. of 3 protein kinases.
CMNPD30133	Mod. cytotox. vs 1 HTCL | Mod. to potent inhib. of 3 protein kinases.
CMNPD30134	Mod. cytotox. vs 1 HTCL | Mod. to potent inhib. of 3 protein kinases.
CMNPD30135	Mod. cytotox. vs 1 HTCL | Mod. to potent inhib. of 3 protein kinases.
CMNPD30136	Low cytotox. vs 1 HTCL | Mod. to potent inhib. of 3 protein kinases.
CMNPD30137	Mod. cytotox. vs 1 HTCL | Mod. to no inhib. of 3 protein kinases.
CMNPD30138	Low cytotox. vs 1 HTCL | Mod. inhib. Of BTK enzyme | IA vs PKC.
CMNPD30139	Mod. cytotox. vs 1 HTCL | Mod. inhib. of PKC and BTK enzymes.
CMNPD30140	Mod. cytotox. vs 1 HTCL | Mod. inhib. of PKC and BTK enzymes.
CMNPD30141	Mod. cytotox. vs 3 HTCLs
CMNPD30142	Mod. activ. vs 3 kinases.
CMNPD30143	Mod. kinase inhib. vs 3 enzymes. | Mod. cytotox. vs 1 HTCL
CMNPD30144	Mod. kinase inhib. vs 3 enzymes. | Mod. cytotox. vs 1 HTCL
CMNPD30145	Mod. kinase inhib. vs 3 enzymes. | Mod. cytotox. vs 1 HTCL
CMNPD30146	No kinase inhib. vs 3 enzymes. | Mod. cytotox. vs 1 HTCL
CMNPD30147	Mod. kinase inhib. vs 3 enzymes. | Mod. cytotox. vs 1 HTCL
CMNPD30148	Low cytotox. vs P388.
CMNPD30152	IA in an antiallergic assay
CMNPD30153	potent Pim-1 kinase inhib. Mod. cytotox. vs 2 HTCLs
CMNPD30154	No Pim-1 kinase inhib. IA vs 2 HTCLs
CMNPD30155	IA vs 2 HTCLs and ROCK2 enzyme.
CMNPD30156	Mod. cytotox. vs 2 HTCLs | Mod. inhib. of ROCK2 enzyme.
CMNPD30157	Low cytotox. vs 2 HTCLs | IA vs ROCK2 enzyme.
CMNPD30158	IA vs 2 HTCLs and ROCK2 enzyme.
CMNPD30159	IA vs 2 HTCLs | low inhib. vs ROCK2 enzyme.
CMNPD30160	IA vs 2 HTCLs and ROCK2 enzyme.
CMNPD30161	Low to no cytotox. vs 2 HTCLs | Low inhib. of ROCK2 enzyme.
CMNPD30162	IA vs 2 HTCLs | low inhib. vs ROCK2 enzyme.
CMNPD30163	Low cytotox. vs 2 HTCLs | IA vs ROCK2 enzyme.
CMNPD30164	IA vs 3 bact. | Low cytotox. vs 1 HTCL
CMNPD30165	IA vs 3 bact. and 1 HTCL
CMNPD30167	IA vs 3 bact. and 1 HTCL
CMNPD30168	IA in HTCL, virus and NF-κB assays.
CMNPD30169	IA in HTCL, virus and NF-κB assays.
CMNPD30170	IA in HTCL and NF-κB assays. | Low activ. vs 1 virus.
CMNPD30171	IA vs 7 bact.
CMNPD30172	Inhib. of cathepsin D (IC 50 = 380 nM). | IA vs 3 HTCLs
CMNPD30173	Inhib. of cathepsin D (IC 50 = 270 nM). | IA vs 3 HTCLs
CMNPD30174	IA vs cathepsin D and 3 HTCLs
CMNPD30175	potent inhib. of chymotrypsin and elastase enzymes (IC 50 = 240 - 290 nM).
CMNPD30176	potent inhib. of chymotrypsin and elastase enzymes (IC 50 = 220 - 890 nM).
CMNPD30177	potent inhib. of chymotrypsin and elastase enzymes (IC 50 = 350 - 620 nM).
CMNPD30178	Inhib. of serine protease trypsin (IC 50 = 160 nM). | Low tox. vs 2 HTCLs
CMNPD30179	Inhib. of serine protease trypsin (IC 50 = 190 nM). | Low tox. vs 2 HTCLs
CMNPD30180	Inhib. of serine protease trypsin (IC 50 = 72 nM). | Low tox. vs 2 HTCLs
CMNPD30181	Inhib. of serine protease trypsin (IC 50 = 1000 nM). | Low tox. vs 2 HTCLs
CMNPD30182	Inhib. of serine protease trypsin (IC 50 = 150 nM). | Low tox. vs 2 HTCLs
CMNPD30183	IA vs thrombin, elastase, trypsin and protein phosphatase 1. | Activ. vs chymotrypsin, IC 50 = 0.26 μM. | IA vs 1 HTCL
CMNPD30184	IA vs thrombin, elastase, chymotrypsin, and protein phosphatase 1. | Low activ. vs trypsin. | IA vs 1 HTCL
CMNPD30185	Inhib. of chymotrypsin, caspase 14, KLK7, IC 50 = 8.98, 50.3, 22.1 μM, resp.
CMNPD30186	IA vs chymotrypsin and KLK7.
CMNPD30187	IA vs chymotrypsin and KLK7.
CMNPD30188	Inhib. of caspase 14, KLK7, chymase, IC 50 = 10.1, 18.9, 23.2 μM, resp.
CMNPD30189	IA vs chymotrypsin and KLK7.
CMNPD30190	Up-regulated growth factors in HaCaT cells; induced secretion of VEGF-A.
CMNPD30191	IA vs 3 bact. | Mod. inhib. of sea urchin fertilized egg div. | IA vs 1 HTCL
CMNPD30192	IA vs 3 bact. | Mod. inhib. of sea urchin fertilized egg div. | Mod. activ. vs 1 HTCL
CMNPD30193	Mod. AB vs 1 strain. | Mod. inhib. of sea urchin fertilized egg div. | Mod. activ. vs 1 HTCL
CMNPD30194	Induced differentiation of neural stem cells. | Mod. cytotox. vs 1 HTCL
CMNPD30195	Mod. cytox. vs 2 HTCLs
CMNPD30196	Mod. cytox. vs 2 HTCLs
CMNPD30197	Mod. cytotox. vs HCT-116 (IC 50 = 1.7 μM).
CMNPD30198	Low cytotox. vs HCT-116 (IC 50 = 29.0 μM).
CMNPD30199	IA vs 2 HTCLs, malaria, bact. and protease assays. | Weak inhib. against NO prod.
CMNPD30200	IA vs 3 HTCLs
CMNPD30201	Low cytotox. vs HeLa IC 50 14 μM. | Mod. activ. vs P. falciparum IC 50 = 0.52 μM
CMNPD30202	Low cytotox. vs HeLa IC 50 29 μM. | Mod. activ. vs P. falciparum IC 50 = 1.0 μM
CMNPD30203	Induced glucose uptake in rat L6 myotubes.
CMNPD30204	Induced glucose uptake in rat L6 myotubes.
CMNPD30205	IA vs L1210 leukemia cells | Low toxicity vs Palaemon paucidens.
CMNPD30206	Mod. cytotox. vs neuro-2A and HCT-116.
CMNPD30207	No cytotox. vs neuro-2A and HCT-116.
CMNPD30208	Mod. cytotox. vs neuro-2A and HCT-116.
CMNPD30209	Weak SOAT inhib. | Mod. osteoblast differentiation inhib. IA vs 2 HTCLs
CMNPD30210	Low toxicity vs neuro-2A cells.
CMNPD30211	Low toxicity vs neuro-2A cells.
CMNPD30212	Low toxicity vs neuro-2A cells.
CMNPD30213	Low toxicity vs neuro-2A cells.
CMNPD30214	Low toxicity vs neuro-2A cells.
CMNPD30216	Mod. activ. vs Kv1.5 channel, IC 50 = 6.94 μM. IA vs 2 HTCLs
CMNPD30217	potent activ. vs Kv1.5 channel, IC 50 = 0.30 μM. IA vs 2 HTCLs
CMNPD30218	IA vs 1 HTCL, 3 microb. strain and 1 virus.
CMNPD30222	Strong cytotox. vs H-460 (IC 50 = 170 nM).
CMNPD30223	Strong cytotox. vs H-460 (IC 50 = 520 nM).
CMNPD30224	Strong cytotox. vs H-460 (IC 50 = 210 nM).
CMNPD30225	Strong cytotox. vs H-460 (IC 50 = 170 nM).
CMNPD30226	Strong cytotox. vs H-460 (IC 50 = 170 nM).
CMNPD30227	Strong cytotox. vs H-460 (IC 50 = 170 nM).
CMNPD30228	Strong cytotox. vs H-460 (IC 50 = 210 nM).
CMNPD30229	Strong cytotox. vs H-460 (IC 50 = 470 nM).
CMNPD30230	Strong cytotox. vs H-460 (IC 50 = 910 nM).
CMNPD30231	Mod. activ. vs P. falciparum (IC 50 = 5.7 μM).
CMNPD30232	AM vs 5 strain (MICs 11 - >22 μg/mL). | Low cytotox. vs 3 HTCLs (IC 50 26 - 38 μM).
CMNPD30233	AM vs 5 strain (MICs 6.1 - >24 μg/mL). | Low cytotox. vs 3 HTCLs (IC 50 28 - 71 μM).
CMNPD30234	AM vs 5 strain (MICs 22 - >22 μg/mL). | Low cytotox. vs 3 HTCLs (IC 50 42 - >100 μM).
CMNPD30237	Mild lipoxygenase inhib.(IC 50 = 22.8 μM).
CMNPD30240	potentInsecticidalactiv.vs.Helicoverpaarmigera(cottonbollworm).
CMNPD30241	Mod. - strong cytotox. vs. 5 HTCLs
CMNPD30242	Mod. - strong cytotox. vs. 5 HTCLs
CMNPD30243	IA AO (DPPH assay). | No inhib. COX-2.
CMNPD30244	IA AO (DPPH assay). | No inhib. COX-2.
CMNPD30245	IA AO (DPPH assay). | No inhib. COX-2.
CMNPD30246	IA vs 2 bact.
CMNPD30247	IA vs 2 bact.
CMNPD30248	Weak inhib. 4 phytoplankton.
CMNPD30249	Weak inhib. 4 phytoplankton.
CMNPD30250	Weak cytotox. vs. 2 HTCLs
CMNPD30251	Mod. cytotox. vs. 3 HTCLs | IA vs 1 bact.
CMNPD30252	Mod. cytotox. vs. 1 HTCL | IA vs 1 bact.
CMNPD30253	NT vs. 3 HTCLs | IA vs. 1 bact.
CMNPD30254	NT vs. 3 HTCLs | IA vs. 1 bact.
CMNPD30255	NT vs. 3 HTCLs | IA vs. 1 bact.
CMNPD30256	NT vs. 3 HTCLs | IA vs. 1 bact.
CMNPD30257	NT vs. 3 HTCLs | IA vs. 1 bact.
CMNPD30258	Photoprotective (UV-B absorbance) with no phototoxicity.
CMNPD30259	IA vs. 2 HTCLs, 4 bact., 1 fungus and AChE.
CMNPD30260	IA vs. 2 HTCLs, 4 bact., 1 fungus and AChE.
CMNPD30261	Mod. AB vs. 2 strain. | IA vs. 2 HTCLs, 2 further bact., 1 fungus and AChE.
CMNPD30262	Mod. AB vs. 2 strain. | IA vs. 2 HTCLs, 2 further bact., 1 fungus and AChE.
CMNPD30263	Mod. AB vs. 2 strain. | IA vs. 2 HTCLs, 2 further bact., 1 fungus and AChE.
CMNPD30264	Mod. AB vs. 2 strain. | IA vs. 2 HTCLs, 2 further bact., 1 fungus and AChE.
CMNPD30265	IA vs. 2 HTCLs, 4 bact., 1 fungus and AChE.
CMNPD30266	IA vs. 2 HTCLs, 4 bact., 1 fungus and AChE.
CMNPD30267	IA AO in DPPH and ABTS assays | AM vs. 4 bact. | AF vs. 1 fungus | NO prod. inhib.
CMNPD30268	IA AO in DPPH and ABTS assays | AM vs. 4 bact. | AF vs. 1 fungus | NO prod. inhib.
CMNPD30269	potent AO in DPPH assay | mod. AO vs. ABTS assay | IA vs. 4 bact., 1 fungus | NO prod. inhib.
CMNPD30270	IA AO in DPPH and ABTS assays | AM vs. 4 bact. | AF vs. 1 fungus | NO prod. inhib.
CMNPD30271	IA AO in DPPH and ABTS assays | AM vs. 4 bact. | AF vs. 1 fungus an | d NO prod. inhib.
CMNPD30272	Weak cytotox. vs. 2 HTCLs | IA vs.5 bact. and 1 fungus
CMNPD30273	IA vs. 2 HTCLs, 5 strain bact. and 1 fungus
CMNPD30274	IA vs. 2 HTCLs, 5 strain bact. and 1 fungus
CMNPD30275	Weak AB vs. 4 strain.
CMNPD30276	Weak AB vs. 2 strain.
CMNPD30277	Weak AB vs. 3 strain.
CMNPD30278	Weak cytotox. vs. 7 HTCLs
CMNPD30279	Weak cytotox. vs. 7 HTCLs
CMNPD30280	potent cytotox. vs. 1 murine TCL. | IA vs. 11 bact.
CMNPD30281	IA vs. 1 murine TCL and 11 bact.
CMNPD30282	IA vs. 1 murine TCL. Mod. AB vs. 2 strain.
CMNPD30283	IA AO (DPPH assay). | No inhib. NF-κB prod.
CMNPD30284	IA AO (DPPH assay). | potent inhib. NF-κB prod. | Weak inhib. NO prod.
CMNPD30285	potent AO (DPPH assay). | No inhib. NF-κB prod.
CMNPD30286	IA AO (DPPH assay). | potent inhib. NF-κB prod. | Weak inhib. NO prod.
CMNPD30287	IA AO (DPPH assay). | No inhib. NF-κB prod.
CMNPD30288	IA AO (DPPH assay). | No inhib. NF-κB prod.
CMNPD30289	Mod. cytotox.vs. 1 HTCL | sig. cytotox. vs. 1 HTCL | potent cytotox vs. 1 HTCL
CMNPD30290	Mod. cytotox.vs. 1 HTCL | sig. cytotox. vs. 2 HTCLs
CMNPD30291	Mod. AB vs. 3 strain. | Mod. cytotox. vs. 1 HTCL
CMNPD30292	potent Inhib. TNF-α and IL-6 prod. | IA vs. 2 HTCLs and 1 inflammatory model CL.
CMNPD30293	potent Inhib. TNF-α and IL-6 prod. | IA vs. 2 HTCLs and 1 inflammatory model CL.
CMNPD30294	potent Inhib. TNF-α and IL-6 prod. | IA vs. 2 HTCLs and 1 inflammatory model CL.
CMNPD30295	Mod. inhib. IL-6 prod. | IA vs. 3 HTCLs and 3 fungi.
CMNPD30296	Mod. inhib. IL-6 prod. | IA vs. 3 HTCLs and 3 fungi.
CMNPD30297	Mod. inhib. IL-6 prod. | IA vs. 3 HTCLs and 3 fungi.
CMNPD30298	Mod. inhib. IL-6 prod. | IA vs. 3 HTCLs and 3 fungi.
CMNPD30299	potent inhib. IL-6 prod. | IA vs. 3 HTCLs and 3 fungi.
CMNPD30300	Mod. inhib. IL-6 prod. | IA vs. 3 HTCLs and 3 fungi.
CMNPD30301	potent inhib. IL-6 prod. | IA vs. 3 HTCLs and 3 fungi.
CMNPD30302	potent inhib. IL-6 prod. | IA vs. 3 HTCLs and 3 fungi.
CMNPD30303	Mod. inhib. IL-6 prod. | IA vs. 3 HTCLs and 3 fungi.
CMNPD30304	Mod. AB vs. 4 strain. | potent AF vs. 1 strain | mod. AF vs. 1 strain.
CMNPD30305	Mod. AB vs. 1 strain. | IA AF vs. 2 strain.
CMNPD30306	Weak AB vs. 1 strain. | IA AF vs. 2 strain.
CMNPD30307	IA vs. 4 bact.
CMNPD30308	IA vs. 4 bact.
CMNPD30309	IA vs. 4 bact.
CMNPD30310	IA vs. 4 bact.
CMNPD30311	Weak-mod. AB vs. 2 strain.
CMNPD30312	Weak-mod. AB vs. 2 strain.
CMNPD30313	IA vs. 4 bact.
CMNPD30314	IA vs. 4 bact.
CMNPD30315	potent AV vs. 1 strain | weak vs. 2 further strain.
CMNPD30316	potent AV vs. 3 strain.
CMNPD30317	Weak AV vs. 1 strain | IA vs. 2 further strain.
CMNPD30318	Weak AV vs. 2 strain | IA vs. 1 further strain.
CMNPD30319	Weak AV vs. 1 strain | IA vs. 2 further strain.
CMNPD30320	Weak AV vs. 1 strain | IA vs. 2 further strain.
CMNPD30321	Weak-mod. AB vs. 1 bact. | IA vs. 2 HTCLs
CMNPD30322	Weak-mod. AB vs. 1 bact. | IA vs. 2 HTCLs
CMNPD30323	Weak-mod. AB vs. 1 bact. | IA vs. 2 HTCLs
CMNPD30324	Sig. inhib. IL-6 and TNF-α.
CMNPD30325	Sig. inhib. IL-6 and TNF-α.
CMNPD30326	IA vs. 3 HTCLs, 5 bact. and 1 fungus
CMNPD30327	Weak AB vs. 1 strain. | IA vs. 3 HTCLs, 4 further bact. and 1 fungus
CMNPD30328	IA vs. 3 HTCLs, 5 bact. and 1 fungus
CMNPD30329	IA vs. 3 HTCLs, 5 bact. and 1 fungus
CMNPD30330	Weak AB vs. 1 strain. | IA vs. 3 HTCLs, 4 further bact. and 1 fungus
CMNPD30331	Weak cytotox. vs. 3 HTCLs
CMNPD30332	potent cytotox. vs. 3 HTCLs
CMNPD30333	Weak cytotox. vs. 3 HTCLs
CMNPD30335	IA vs. 2 HTCLs and 2 NCLs.
CMNPD30336	Inhib. colony formation in 1 HTCL | IA vs. 1 further HTCL and 2 NCLs.
CMNPD30339	IA vs. 2 HTCLs and 2 NCLs.
CMNPD30340	Weak AB vs. 2 strain. | Weak AV vs. 1 virus.
CMNPD30341	Weak AB vs. 3 strain. | Weak AV vs. 1 virus.
CMNPD30342	Mod. selective cytotox. vs. 2 HTCLs
CMNPD30343	IA vs. 8 HTCLs
CMNPD30344	IA vs. 8 HTCLs
CMNPD30345	Weak selective cytotox. vs. 1 HTCL
CMNPD30346	Weak selective cytotox. vs. 2 HTCLs
CMNPD30347	Weak AB vs. 3 strain | weak AF vs 4 strain.
CMNPD30348	Weak-mod. AB vs. 4 strain | weak-mod. AF vs 6 strain.
CMNPD30349	IA vs. 5 HTCLs | Mod. inhib. NO prod.
CMNPD30350	IA vs. 5 HTCLs | No inhib. NO prod.
CMNPD30351	IA vs. 5 HTCLs | No inhib. NO prod.
CMNPD30352	IA vs. 5 HTCLs | No inhib. NO prod.
CMNPD30353	IA vs. 5 HTCLs | Mod. inhib. NO prod.
CMNPD30354	IA vs. 5 HTCLs | No inhib. NO prod.
CMNPD30355	Weak cytotox. vs. 2 HTCLs | No inhib. NO prod.
CMNPD30356	IA vs. 5 HTCLs | No inhib. NO prod.
CMNPD30357	IA vs. 5 HTCLs | No inhib. NO prod.
CMNPD30358	Mod. inhib. NO prod. | IA vs. 3 bact. and α-glucosidase
CMNPD30359	Mod. inhib. NO prod. | IA vs. 3 bact. and α-glucosidase
CMNPD30360	potent inhib. α-glucosidase. | Mod. inhib. NO prod. | IA vs. 3 bact.
CMNPD30361	No inhib. TNF-α prod. | IA vs. 1 murine NCL.
CMNPD30362	No inhib. TNF-α prod. | IA vs. 1 murine NCL.
CMNPD30363	No inhib. TNF-α prod. | IA vs. 1 murine NCL.
CMNPD30364	IA vs. 5 HTCLs
CMNPD30365	IA vs. 5 HTCLs
CMNPD30366	IA vs. 5 HTCLs
CMNPD30367	No inhib. NO prod.
CMNPD30368	No inhib. NO prod.
CMNPD30369	Mod. inhib. NO prod.
CMNPD30370	No inhib. NO prod.
CMNPD30371	No inhib. NO prod.
CMNPD30372	No inhib. NO prod.
CMNPD30373	No inhib. NO prod.
CMNPD30374	No inhib. NO prod.
CMNPD30375	potent α-glucosidase inhib.
CMNPD30376	IA vs. α-glucosidase and 2 HTCLs
CMNPD30377	potent a-glucosidase inhib. | IA vs. 2 HTCLs
CMNPD30378	IA vs. α-glucosidase and 2 HTCLs
CMNPD30379	potent α-glucosidase inhib.
CMNPD30380	potent α-glucosidase inhib.
CMNPD30381	potent α-glucosidase inhib.
CMNPD30382	potent α-glucosidase inhib.
CMNPD30383	potent α-glucosidase inhib.
CMNPD30384	potent α-glucosidase inhib.
CMNPD30385	potent α-glucosidase inhib.
CMNPD30386	potent α-glucosidase inhib.
CMNPD30387	potent α-glucosidase inhib.
CMNPD30388	No inhib. NO prod. and iNOS. | IA vs. NCL.
CMNPD30389	No inhib. NO prod. and iNOS. | IA vs. NCL.
CMNPD30390	No inhib. NO prod. and iNOS. | IA vs. NCL.
CMNPD30391	No inhib. NO prod. and iNOS. | IA vs. NCL.
CMNPD30392	Mod. inhib. NO prod. and iNOS. | IA vs. NCL.
CMNPD30393	Mod. inhib. NO prod. Sig. inhib. iNOS. | IA vs. NCL.
CMNPD30394	No inhib. NO prod. and iNOS. | IA vs. NCL.
CMNPD30395	No inhib. NO prod. and iNOS. | IA vs. NCL.
CMNPD30396	Mod. AB vs. 3 strain | mod. AF vs. 1 strain.
CMNPD30397	IA vs. 4 HTCLs, 4 bact. and AChE
CMNPD30398	IA vs. 4 HTCLs, 4 bact. and AChE
CMNPD30399	IA vs. 4 HTCLs, 4 bact. and AChE
CMNPD30400	IA vs. 4 HTCLs, 4 bact. and AChE
CMNPD30401	IA vs. 4 HTCLs, 4 bact. and AChE
CMNPD30402	IA vs. 4 HTCLs, 4 bact. and AChE
CMNPD30403	Mod.inhib. AChE. IA vs. 4 HTCLs, and 4 bact.
CMNPD30404	Sig. AO (Trolox equivalents). | IA vs. 5 HTCLs | IA vs. 2 bact.
CMNPD30406	mod. - potent AB vs 5 strain.
CMNPD30407	Signif. inhib. NO prod. and of 3 proinflammatory cytokines.
CMNPD30408	Signif. inhib. NO prod. and of 3 proinflammatory cytokines.
CMNPD30409	Weak cytotox. vs. 1 HTCL | Weak inhib. thioredoxin reductase (TrxR)
CMNPD30410	Weak cytotox. vs. 1 HTCL | Weak inhib. thioredoxin reductase (TrxR)
CMNPD30411	Weak cytotox. vs. 1 HTCL | Weak inhib. thioredoxin reductase (TrxR)
CMNPD30412	Weak cytotox. vs. 1 HTCL | Weak inhib. thioredoxin reductase (TrxR)
CMNPD30413	Weak cytotox. vs. 1 HTCL | potent inhib. thioredoxin reductase (TrxR)
CMNPD30414	Weak cytotox. vs. 1 HTCL | potent inhib. thioredoxin reductase (TrxR)
CMNPD30415	Sig. inhib. interleukin-10 (IL-10). | IA vs. IL-6, monocyte chemoattractant protein 1 (MCP-1) and TNF-α
CMNPD30416	IA vs. IL-6, IL-10, monocyte chemoattractant protein 1 (MCP-1) and TNF-α
CMNPD30417	Sig. inhib. interleukin-10 (IL-10). | IA vs. IL-6, monocyte chemoattractant protein 1 (MCP-1) and TNF-α
CMNPD30418	Selective cytotox. vs. 2 HTCLs | IA vs. 1 NCL and 1 bact.
CMNPD30419	Selective cytotox. vs. 2 HTCLs | IA vs. 1 NCL and 1 bact.
CMNPD30420	IA vs. 3 HTCLs, 1 NCL and 1 bact.
CMNPD30421	IA vs. 3 HTCLs, 1 NCL and 1 bact.
CMNPD30422	Weak cytotox. vs. 1 HTCL | IA vs. 1 NCL and 1 bact.
CMNPD30423	Weak-mod. AB vs. 4 strain.
CMNPD30424	Weak-mod. AB vs. 4 strain.
CMNPD30425	Weak AB vs. 2 strain.
CMNPD30426	Weak AB vs. 2 strain.
CMNPD30427	potent AB vs. 1 | weak AB vs.2 strain.
CMNPD30428	Weak cytotox. vs. 1 HTCL
CMNPD30429	Weak cytotox. vs. 1 HTCL
CMNPD30430	Weak cytotox. vs. 1 HTCL
CMNPD30432	Mod. AB vs 2 strain.
CMNPD30433	potent and selective cytotox. vs. 1 HTCL | IA vs. 4 bact.
CMNPD30434	IA vs. 5 HTCLs and 4 bact.
CMNPD30435	Sig. cytotox. vs. 5 HTCLs | IA vs. 4 bact.
CMNPD30436	IA vs. 5 HTCLs and 4 bact.
CMNPD30437	IA vs. 5 HTCLs and 4 bact.
CMNPD30438	Sig. cytotox. vs. 5 HTCLs | IA vs. 4 bact.
CMNPD30439	potent AB vs. 1 strain, mod. AB vs. 3 strain. | IA vs. 5 HTCLs
CMNPD30440	Mod. AB. vs. 4 strain. | IA vs. 5 HTCLs
CMNPD30441	Weak cytotox. vs. 1 HTCL
CMNPD30442	Weak cytotox. vs. 1 HTCL
CMNPD30443	Weak anti-saprolegniasis activ. | IA vs. 3 bact. and 1 fungus
CMNPD30444	Weak-mod. cytotox. vs. 3 HTCLs
CMNPD30446	IA vs. 3 HTCLs
CMNPD30448	Mod. Cytotox. vs. 2 HTCLs | IA vs. COX-1, COX-2, 1 virus and TB.
CMNPD30449	IA vs. 1 HTCL
CMNPD30450	IA vs. 1 HTCL
CMNPD30451	IA vs. 4 bact., AchE and α-glucosidase. | Weak AO (DPPH assay).
CMNPD30452	IA vs. 4 bact., AchE and α-glucosidase. | No AO (DPPH assay).
CMNPD30453	IA vs. 4 bact., AchE and α-glucosidase. | Weak AO (DPPH assay).
CMNPD30454	IA vs. 4 bact., AchE and α-glucosidase. | Weak AO (DPPH assay).
CMNPD30455	IA vs. 4 bact., AchE and α-glucosidase. | No AO (DPPH assay).
CMNPD30456	Weak AB vs. 2 strain.
CMNPD30457	Weak AB vs. 1 strain. | Mod. AO via DPPH and Ferric Reducing Antioxidant Power (FRAP) assays.
CMNPD30459	potent inhib. platelet activating factor receptor (PAFR). | potent inhib. tumour cell repopulation.
CMNPD30460	potent inhib. platelet activating factor receptor (PAFR). | potent inhib. tumour cell repopulation.
CMNPD30462	Mod. inhib. platelet activating factor receptor (PAFR). | Mod. inhib. tumour cell repopulation.
CMNPD30463	potent inhib. platelet activating factor receptor (PAFR). | Mod. inhib. tumour cell repopulation.
CMNPD30464	Weak cytotox. vs. 3 HTCLs | Signif. AB vs. 2 MRSA strain | weak AB vs. 2 strain.
CMNPD30465	Sig. cytotox. vs. 1 HTCL | weak cytotox. vs. 2 HTCLs | Mod. AB vs. 2 MRSA strain | Sig. AB vs. 1 strain.
CMNPD30466	Weak cytotox. vs. 3 HTCLs | Signif. AB vs. 2 MRSA strain | mod. AB vs. 2 strain.
CMNPD30467	Weak cytotox. vs. 3 HTCLs | Signif. AB vs. 2 MRSA strain | mod. AB vs. 2 strain.
CMNPD30468	IA vs. 6 HTCLs
CMNPD30469	IA vs. 6 HTCLs
CMNPD30470	Mod.-sig. cytotox. vs.6 HTCLs
CMNPD30471	Mod.-sig. cytotox. vs.6 HTCLs
CMNPD30472	Sig. cytotox. vs.2 HTCLs
CMNPD30473	Sig. cytotox. vs.2 HTCLs
CMNPD30474	Mod.-sig. cytotox. vs. 4 HTCLs
CMNPD30475	Mod.-sig. cytotox. vs. 4 HTCLs
CMNPD30476	IA vs. 3 HTCLs and 3 bact.
CMNPD30477	IA vs. 3 HTCLs and 3 bact.
CMNPD30478	IA vs. 3 HTCLs and 3 bact.
CMNPD30479	IA vs. 3 HTCLs and 3 bact.
CMNPD30480	IA vs. 3 HTCLs and 3 bact.
CMNPD30481	IA vs. 3 HTCLs and 3 bact.
CMNPD30482	IA vs. 3 HTCLs and 3 bact.
CMNPD30483	IA vs. 3 HTCLs and 3 bact.
CMNPD30484	IA vs. 3 HTCLs and 3 bact.
CMNPD30485	IA vs. 3 HTCLS, 3 bact., 1 fungus and AChE.
CMNPD30486	IA vs. 3 HTCLS, 3 bact., 1 fungus and AChE.
CMNPD30487	IA vs. 3 HTCLS, 3 bact., 1 fungus and AChE.
CMNPD30488	IA vs. 3 HTCLS, 3 bact., 1 fungus and AChE.
CMNPD30489	IA vs. 3 HTCLS, 3 bact., 1 fungus and AChE.
CMNPD30490	IA vs. 3 HTCLS, 3 bact., 1 fungus and AChE.
CMNPD30491	IA vs. 3 HTCLS, 3 bact., 1 fungus and AChE.
CMNPD30492	IA vs. 3 HTCLS, 3 bact., 1 fungus and AChE.
CMNPD30493	Weak-mod. cytotox. vs. 4 HTCLs | IA vs. 4 bact. and 1 fungus
CMNPD30494	Weak-mod. cytotox. vs. 4 HTCLs | IA vs. 4 bact. and 1 fungus
CMNPD30495	IA vs. 6 HTCLs, 4 bact. and 1 fungus
CMNPD30496	Weak inhib. PTP1B and T-cell PTP.
CMNPD30498	Weak AV vs. 1 strain. | IA vs. 3 HTCLs | Weak AchE inhib. IA vs. 8 bact.
CMNPD30499	IA vs. 1 virus and 3 HTCLs
CMNPD30501	IA vs. 5 HTCLs and 4 bact.
CMNPD30502	Sig. cytotox. vs. 5 HTCLs | potent AB vs. 1 strain | mod. AB vs. 2 strain.
CMNPD30503	Sig. cytotox. vs. 2 HTCLs | mod. cytotox. vs. 2 HTCLs | IA AB vs. 4 strain.
CMNPD30504	IA vs. 5 HTCLs and 4 bact.
CMNPD30505	IA vs. 5 HTCLs and 4 bact.
CMNPD30506	Weak cytotox. vs. 2 HTCLs | IA AB vs. 4 strain.
CMNPD30507	Sig. inhib. 5 strain influenza A (IAV). | IA vs. 5 HTCLs, 4 bact. and germination inhib. 2 plant seeds.
CMNPD30508	Sig. cytotox. vs. 2 HTCLs
CMNPD30509	IA vs. several bact. and fungi
CMNPD30510	Weak AB vs. 1 strain | weak AF vs 1 strain.
CMNPD30511	IA vs. 2 HTCLs, 3 bact. and 1 fungus | No phytotoxicity to seed germination or lettuce radicles.
CMNPD30512	IA vs. 2 HTCLs and 1 fung Mod. AB vs. 1 strain. | No phytotoxicity to seed germination or lettuce radicles
CMNPD30513	IA vs. 2 HTCLs, 3 bact. and 1 fungus | No phytotoxicity to seed germination or lettuce radicles.
CMNPD30514	IA vs. 2 HTCLs, 3 bact. and 1 fungus | No phytotoxicity to seed germination or lettuce radicles.
CMNPD30519	IA vs. 10 HTCLs | No inhib. COX-2.
CMNPD30520	IA vs. 10 HTCLs | No inhib. COX-2.
CMNPD30521	Weak - mod. cytotox. vs. 9 HTCLs | No inhib. COX-2.
CMNPD30522	IA vs. 10 HTCLs | No inhib. COX-2.
CMNPD30523	IA vs. 10 HTCLs | No inhib. COX-2.
CMNPD30524	IA vs. 10 HTCLs | Sig. inhib. COX-2.
CMNPD30525	IA vs. 10 HTCLs | No inhib. COX-2.
CMNPD30526	Signif. TNF-α inhib. | IA vs. 4 HTCLs and 3 bact.
CMNPD30527	Signif. TNF-α inhib. | IA vs. 4 HTCLs and 3 bact.
CMNPD30528	Signif. TNF-α inhib. | IA vs. 4 HTCLs and 3 bact.
CMNPD30529	Signif. TNF-α inhib. | IA vs. 4 HTCLs and 3 bact.
CMNPD30531	Weak cytotox. vs. 2 HTCLs | IA vs 3 bact.
CMNPD30532	Weak cytotox. vs. 2 HTCLs | IA vs 3 bact.
CMNPD30533	Weak cytotox. vs. 2 HTCLs | IA vs 3 bact.
CMNPD30534	Weak cytotox. vs. 2 HTCLs | IA vs 3 bact.
CMNPD30535	Mod. AO activ. in DPPH assay
CMNPD30536	Mod. AO activ. in DPPH assay
CMNPD30537	Signif. AO activ. in DPPH assay
CMNPD30538	IA AO in DPPH assay
CMNPD30539	IA AO in DPPH assay
CMNPD30540	IA vs. 2 HTCLs | Sig. AO in DPPH assay
CMNPD30541	IA. vs. 2 HTCLs | Weak AO in DPPH assay
CMNPD30542	Mod. cytotox. vs. 2 HTCLs | No AO in DPPH assay
CMNPD30543	IA vs. 2 HTCLs | No AO in DPPH assay
CMNPD30544	Weak cytotox. vs. 2 HTCLs | No AO in DPPH assay
CMNPD30545	IA vs. 2 HTCLs | No AO in DPPH assay
CMNPD30546	No inhib. NO prod.
CMNPD30547	Mod. inhib. NO prod.
CMNPD30548	No inhib. NO prod.
CMNPD30549	No inhib. NO prod.
CMNPD30550	No inhib. NO prod.
CMNPD30551	No inhib. NO prod.
CMNPD30552	No inhib. NO prod.
CMNPD30553	No inhib. NO prod.
CMNPD30554	Sig. inhib. NO prod.
CMNPD30555	Sig. inhib. NO prod.
CMNPD30556	No inhib. NO prod.
CMNPD30557	No inhib. NO prod.
CMNPD30558	No inhib. NO prod.
CMNPD30559	No inhib. NO prod.
CMNPD30560	No inhib. NO prod.
CMNPD30561	Weak inhib. NO prod.
CMNPD30562	Weak inhib. NO prod.
CMNPD30563	No inhib. NO prod.
CMNPD30564	Weak inhib. NO prod.
CMNPD30565	No inhib. NO prod.
CMNPD30566	No inhib. NO prod.
CMNPD30567	No inhib. NO prod.
CMNPD30568	Mod. inhib. NO prod.
CMNPD30569	Weak inhib. NO prod.
CMNPD30570	No inhib. NO prod.
CMNPD30571	No inhib. NO prod.
CMNPD30572	Mod. inhib. angiotensin converting enzyme (ACE). | IA vs. α-glucosidase.
CMNPD30573	Mod. inhib. angiotensin converting enzyme (ACE). | IA vs. α-glucosidase.
CMNPD30574	Mod. inhib. angiotensin converting enzyme (ACE). | IA vs. α-glucosidase.
CMNPD30575	Mod. antifoul. vs. barnacle larvae. | IA vs. 1 HTCL
CMNPD30576	IA vs. barnacle larvae and 1 HTCL
CMNPD30577	IA vs. barnacle larvae and 1 HTCL
CMNPD30578	IA vs. barnacle larvae and 1 HTCL
CMNPD30579	IA in RBL-2H3 cell degranulation antiallergy assay
CMNPD30580	IA in RBL-2H3 cell degranulation antiallergy assay
CMNPD30581	IA in RBL-2H3 cell degranulation antiallergy assay
CMNPD30582	IA in RBL-2H3 cell degranulation antiallergy assay
CMNPD30583	IA in RBL-2H3 cell degranulation antiallergy assay
CMNPD30584	IA in RBL-2H3 cell degranulation antiallergy assay
CMNPD30585	IA in RBL-2H3 cell degranulation antiallergy assay
CMNPD30586	IA in RBL-2H3 cell degranulation antiallergy assay
CMNPD30587	IA in RBL-2H3 cell degranulation antiallergy assay
CMNPD30588	Sig. AB vs. 7 strain.
CMNPD30589	Weak AB vs. 7 strain.
CMNPD30590	Weak AB vs. 1 strain.
CMNPD30591	Mod. AB vs. 6 strain | weak AB vs. 1 strain.
CMNPD30592	Weak AB vs. 7 strain.
CMNPD30593	Weak AB vs. 6 strain.
CMNPD30594	Weak AB vs. 1 strain.
CMNPD30602	No inhib. NO prod. | IA vs. 3 HTCLs
CMNPD30603	No inhib. NO prod. | IA vs. 3 HTCLs
CMNPD30604	No inhib. NO prod. | IA vs. 3 HTCLs
CMNPD30605	No inhib. NO prod. | IA vs. 3 HTCLs
CMNPD30606	No inhib. NO prod. | IA vs. 3 HTCLs
CMNPD30607	Mod. inhib. NO prod. | IA vs. 3 HTCLs
CMNPD30608	IA vs. 3 HTCLs and 4 bact. | No inhib. NO prod.
CMNPD30609	IA vs. 3 HTCLs and 4 bact. | No inhib. NO prod.
CMNPD30610	Weak inhib. α-glucosidase.
CMNPD30611	Weak inhib. α-glucosidase.
CMNPD30612	Weak inhib. α-glucosidase.
CMNPD30613	Weak inhib. α-glucosidase.
CMNPD30614	Weak inhib. α-glucosidase.
CMNPD30615	IA vs. α-glucosidase.
CMNPD30616	Weak inhib. α-glucosidase.
CMNPD30617	IA vs. α-glucosidase.
CMNPD30618	No inhib. NO prod.
CMNPD30619	No inhib. NO prod.
CMNPD30620	No inhib. NO prod.
CMNPD30621	No inhib. NO prod.
CMNPD30622	Sig. inhib. NO prod. and other pro-inflammatory cytokines.
CMNPD30623	No inhib. NO prod.
CMNPD30624	potent IMPDH inhib.
CMNPD30625	Sig. IMPDH inhib.
CMNPD30626	Sig. IMPDH inhib.
CMNPD30627	Sig. IMPDH inhib.
CMNPD30628	Sig. IMPDH inhib.
CMNPD30629	Stimulates filaggrin and caspase-14 expression. | IA vs. 3 HTCLs | No inhib. NO prod.
CMNPD30630	Mod. inhib. NO prod. | IA vs. 3 HTCLs
CMNPD30631	Mod. inhib. NO prod. | IA vs. 3 HTCLs
CMNPD30632	IA vs 3 HTCLs | No inhib. NO prod.
CMNPD30633	IA vs 3 HTCLs | No inhib. NO prod.
CMNPD30634	IA vs 3 HTCLs | No inhib. NO prod.
CMNPD30635	AI via peroxidase proliferator-activated receptor (PPAR-γ) agonism.
CMNPD30636	No PPAR-γ activ.
CMNPD30637	IA vs. α-glucosidase.
CMNPD30638	potent inhib. α-glucosidase.
CMNPD30639	potent inhib. α-glucosidase.
CMNPD30640	IA vs. α-glucosidase.
CMNPD30641	potent inhib. α-glucosidase.
CMNPD30642	potent inhib. α-glucosidase.
CMNPD30643	IA vs. α-glucosidase.
CMNPD30644	Mod. AB vs. 1 strain | weak AB. vs. 2 strain.
CMNPD30645	Mod. AB vs. 1 strain.
CMNPD30646	Weak AB vs. 3 strain.
CMNPD30647	Weak AB vs. 1 strain. | IA vs. 5 HTCLs
CMNPD30648	Weak selective cytotox. vs. 2 HTCLs | IA vs. 1 bact.
CMNPD30649	Weak selective cytotox. vs. 2 HTCLs | IA vs. 1 bact.
CMNPD30650	IA in immunoglobulin E (IgE)-mediated mast cell allergy test.
CMNPD30651	IA in immunoglobulin E (IgE)-mediated mast cell allergy test.
CMNPD30652	IA in immunoglobulin E (IgE)-mediated mast cell allergy test.
CMNPD30653	IA in immunoglobulin E (IgE)-mediated mast cell allergy test.
CMNPD30654	potent AB vs. 1 bact. | IA vs. 3 further bact.
CMNPD30656	potent AB vs. 1 bact. | IA vs. 3 further bact.
CMNPD30659	Weak cytotox. vs. 1 HTCL
CMNPD30660	No activation latent HIV. | No inhib. bromodomain-containing protein (BRD4).
CMNPD30661	No activation latent HIV. | No inhib. bromodomain-containing protein (BRD4).
CMNPD30662	No activation latent HIV. | No inhib. bromodomain-containing protein (BRD4).
CMNPD30663	No activation latent HIV. | No inhib. bromodomain-containing protein (BRD4).
CMNPD30664	Mod. AO in DPPH assay
CMNPD30665	Mod. AO in DPPH assay
CMNPD30666	Mod. AO in DPPH assay
CMNPD30667	Mod. AO in DPPH assay
CMNPD30668	Mod. AO in DPPH assay
CMNPD30669	IA vs. 6 bact. and 4 viruses.
CMNPD30670	IA vs. 6 bact. and 4 viruses.
CMNPD30671	IA vs. 2 norm. HCLs.
CMNPD30672	IA vs. 2 HTCLs
CMNPD30673	IA vs. 2 HTCLs
CMNPD30674	Weak cytotox. vs. 4 HTCLs | Signif. AB vs. 2 strain.
CMNPD30675	Weak cytotox. vs. 4 HTCLs | Signif. AB vs. 1 strain, weak AB vs. 1 strain.
CMNPD30676	Weak cytotox. vs. 4 HTCLs | Weak AB vs. 2 strain.
CMNPD30677	Weak cytotox. vs. 4 HTCLs | Signif. AB vs. 2 strain.
CMNPD30678	potent cytotox. vs. 4 HTCLs | IA vs. 2 bact.
CMNPD30679	Weak cytotox. vs. 4 HTCLs | Signif. AB vs. 1 strain | weak AB vs. 1 strain.
CMNPD30680	Weak cytotox. vs. 4 HTCLs | Signif. AB vs. 2 strain.
CMNPD30681	Sig. AB vs. MRSA | weak AB. vs. 1 further strain. | Mod. cytotox. vs. 3 HTCLs and 1 murine TCL.
CMNPD30682	IA vs. 6 HTCLs and isocitrate dehydrogenase.
CMNPD30683	IA vs. 2 bact.
CMNPD30684	Weak AB vs. 2 strain.
CMNPD30685	Weak AB vs. 1 strain.
CMNPD30686	Weak AB vs. 2 strain.
CMNPD30688	Weak AB vs. 1 strain.
CMNPD30689	Weak AB vs. 1 strain.
CMNPD30690	Weak AB vs. 1 strain.
CMNPD30691	potent cytotox. vs. 3 HTCLs
CMNPD30692	IA vs. 5 HTCLs
CMNPD30694	Signif. AB vs. 2 strain | mod. AF vs. 1 strain. | Weak cytotox. vs. 1 HTCL
CMNPD30695	IA vs. 2 HTCLs and 2 bact.
CMNPD30696	IA vs. 2 HTCLs and 2 bact.
CMNPD30697	IA vs. 2 HTCLs and 2 bact.
CMNPD30698	IA vs. 2 HTCLs and 2 bact.
CMNPD30699	IA vs. 2 HTCLs and 2 bact.
CMNPD30700	IA vs. 2 HTCLs and 2 bact.
CMNPD30701	Mod. AO in DPPH assay Neuroprotective in 6-hydroxydopamine and paraquat-induced Parkinson's disesase models. IA vs. 1 murine TCL.
CMNPD30702	Mod. inhib. PTP1B.
CMNPD30703	No inhib. PTP1B.
CMNPD30704	Weak PTP1B inhib. | No inhib. NO prod.
CMNPD30705	Weak inhib. NO prod. | No inhib. PTP1B.
CMNPD30706	IA vs. various HTCLs, bact. and fungi. | No inhib. isocitrate lyase, Na + /K + ATPase or sortase A.
CMNPD30707	IA vs. various HTCLs, bact. and fungi. | No inhib. isocitrate lyase, Na + /K + ATPase or sortase A.
CMNPD30708	No AO in DPPH assay | IA vs. 2 HTCLs
CMNPD30709	No AO in DPPH assay | IA vs. 2 HTCLs
CMNPD30710	Weak AO in DPPH assay | IA vs. 2 HTCLs
CMNPD30711	Mod. AB vs. 4 strain. | No cytotox. to brine shrimp.
CMNPD30712	Mod. AB vs. 4 strain. | No cytotox. to brine shrimp.
CMNPD30713	Mod. AB vs. 4 strain. | No cytotox. to brine shrimp.
CMNPD30714	IA vs. 3 HTCLs, 3 NCLs, 6 bact. and 1 fungus
CMNPD30715	Weak cytotox. vs. 1 HTCL
CMNPD30716	IA vs. 1 bact., 5 fung and various viruses. | IA in DPPH assay No MptpB inhib.
CMNPD30717	IA vs. 1 bact., 5 fung and various viruses. | IA in DPPH assay No MptpB inhib.
CMNPD30718	IA vs. 1 bact., 5 fung and various viruses. | IA in DPPH assay No MptpB inhib.
CMNPD30719	IA vs. 1 bact., 5 fung and various viruses. | IA in DPPH assay No MptpB inhib.
CMNPD30720	IA vs. 1 bact., 5 fung and various viruses. | IA in DPPH assay No MptpB inhib.
CMNPD30721	IA vs. 1 bact., 5 fung and various viruses. | IA in DPPH assay No MptpB inhib.
CMNPD30722	IA vs. 1 bact., 5 fung and various viruses. | IA in DPPH assay No MptpB inhib.
CMNPD30723	IA vs. 1 bact., 5 fung and various viruses. | IA in DPPH assay No MptpB inhib.
CMNPD30724	IA vs. 1 bact., 5 fung and various viruses. | IA in DPPH assay No MptpB inhib.
CMNPD30725	IA vs. 1 bact., 5 fung and various viruses. | IA in DPPH assay No MptpB inhib.
CMNPD30726	IA vs. 1 bact., 5 fung and various viruses. | IA in DPPH assay No MptpB inhib.
CMNPD30727	IA vs. 1 bact., 5 fung and various viruses. | IA in DPPH assay No MptpB inhib.
CMNPD30728	IA vs. 1 bact., 5 fung and various viruses. | IA in DPPH assay No MptpB inhib.
CMNPD30729	IA vs. 1 bact., 5 fungus and viruses. | IA in DPPH assay | No MptpB inhib.
CMNPD30730	Mod. AF vs. 2 strain. | IA vs. 1 bact. and various viruses. | IA in DPPH assay | No MptpB inhib.
CMNPD30731	Mod. AF vs. 2 strain. | IA vs. 1 bact. and various viruses. | IA in DPPH assay | No MptpB inhib.
CMNPD30732	Sig. AF vs. 1 strain. | IA vs. protein tyrosine phosphatase MptpB.
CMNPD30736	IA vs.5 fungi and protein tyrosine phosphatase MptpB.
CMNPD30737	IA vs. 2 murine cell lines and 1 HTCL
CMNPD30738	IA vs. 2 murine cell lines and 1 HTCL
CMNPD30739	IA vs. 2 murine cell lines and 1 HTCL
CMNPD30740	IA vs. 2 murine cell lines and 1 HTCL
CMNPD30741	Mod. AB vs. 1 strain. | IA vs. 2 HTCLs and 1 fungus
CMNPD30742	Mod. AB vs. 1 strain. | IA vs. 2 HTCLs and 1 fungus
CMNPD30743	IA vs. 2 HTCLs, 5 bact. and 1 fungus
CMNPD30744	IA vs. 2 HTCLs, 5 bact. and 1 fungus
CMNPD30745	Weak cytotox. vs. 2 HTCLs
CMNPD30746	Weak cytotox. vs. 3 HTCLs | mod. cytotox. vs. 1 HTCL
CMNPD30747	Weak AB vs. 4 strain. | Weak. inhib. 2 phytoplankton.
CMNPD30748	Weak AB vs. 4 strain. | Mod. inhib. 4 phytoplankton.
CMNPD30751	Weak AB vs. 4 strain. | Mod. inhib. 4 phytoplankton.
CMNPD30752	Weak AB vs. 4 strain. | Weak inhib. 4 phytoplankton.
CMNPD30755	IA vs. 5 bact. | Weak-mod. cytotox. brine shrimp.
CMNPD30756	potent AB vs. 4 bact. | Weak-mod. cytotox. brine shrimp.
CMNPD30757	potent AB vs. 4 bact. | Weak-mod. cytotox. brine shrimp.
CMNPD30758	IA vs. 5 bact. | Weak-mod. cytotox. brine shrimp.
CMNPD30759	IA vs. 2 bact. | Weak-mod. cytotox. brine shrimp.
CMNPD30760	potent AB vs. 1 strain. | Weak-mod. cytotox. brine shrimp.
CMNPD30761	potent AB vs. 1 strain. | Weak-mod. cytotox. brine shrimp.
CMNPD30762	potent inhib. 4 phytoplankton. | Weak AB vs. 3 strain. Mod. AF vs. 1 strain.
CMNPD30763	IA vs. 3 bact., topoisomerase I and AChE.
CMNPD30764	IA vs. 3 bact., topoisomerase I and AChE.
CMNPD30765	potent AB vs. 2 strain, | IA vs. 2 further strain. | Weak-mod. inhib. 4 phytoplankton.
CMNPD30766	potent AB vs. 1 strain, | IA vs. 3 further strain. | potent inhib. 4 phytoplankton.
CMNPD30767	potent AB vs. 1 strain, | IA vs. 3 further strain. | potent inhib. 3 phytoplankton | weak inhib. 1 further phytoplankton.
CMNPD30768	potent AB vs. 1 strain, | IA vs. 3 further strain. | Weak-mod. inhib. 4 phytoplankton.
CMNPD30769	potent AB vs. 1 strain, | IA vs. 3 further strain. | Weak-mod. inhib. 4 phytoplankton.
CMNPD30770	potent AB vs. 2 strain, | IA vs. 2 further strain. | potent inhib. 1 phytoplankton | weak inhib. 3 further phytoplankton.
CMNPD30771	IA vs. 5 bact.
CMNPD30772	IA vs. 5 bact.
CMNPD30773	IA vs. 5 bact.
CMNPD30774	IA vs. 5 bact.
CMNPD30775	IA vs. 5 bact.
CMNPD30776	Sig. AB vs. 1 bact. | mod. AB vs. 3 strain.
CMNPD30777	IA vs. 5 bact.
CMNPD30778	Mod. AB vs. 1 bact. | weak. AB vs. 1 strain.
CMNPD30779	potent inhib. vs. 2 phytoplankton strain. | IA vs. 2 further phytoplankton, 1 zooplankton and 5 bact.
CMNPD30780	potent inhib. vs. 2 phytoplankton strain. | IA vs. 2 further phytoplankton, 1 zooplankton and 5 bact.
CMNPD30781	potent inhib. vs. 2 phytoplankton strain. | IA vs. 2 further phytoplankton, 1 zooplankton and 5 bact.
CMNPD30782	IA vs. 5 bact., 4 phytoplankton and 1 zooplankton.
CMNPD30783	IA vs. 5 bact., 4 phytoplankton and 1 zooplankton.
CMNPD30784	IA vs. 5 bact., 4 phytoplankton and 1 zooplankton.
CMNPD30785	IA vs. 5 bact., 4 phytoplankton and 1 zooplankton.
CMNPD30786	IA vs. 5 bact. | potent inhib. 4 phytoplankton | weak inhib. 1 zooplankton.
CMNPD30787	IA vs. 5 bact. and 1 zooplankton. | potent inhib. 4 phytoplankton.
CMNPD30788	IA vs. 5 bact. and 1 zooplankton. | potent inhib. 4 phytoplankton.
CMNPD30789	IA vs. 5 bact., 4 phytoplankton and 1 zooplankton.
CMNPD30790	IA vs. 5 bact., 4 phytoplankton and 1 zooplankton.
CMNPD30791	IA vs. 5 bact.Mod. | potent inhib. 4 phytoplankton | weak inhib. 1 zooplankton.
CMNPD30792	IA vs. 5 bact. and 4 phytoplankton. | Mod.inhib. 1 zooplankton.
CMNPD30793	IA vs 3 HTCLs and 2 viruses.
CMNPD30794	IA vs. 3 HTCLs and 2 viruses.
CMNPD30798	potent, selective cytotox. vs. 3 HTCLs | Sig. brine shrimp lethality. | Mod. nematocidal inhib.
CMNPD30799	IA vs. 3 HTCLs, brine shrimp and nematodes.
CMNPD30800	IA vs. 3 HTCLs, brine shrimp and nematodes, | IA vs. 2 bact | Weak-mod. cytotox. brine shrimp.
CMNPD30801	potent inhib. H1N1 | weak inhib. HIV.
CMNPD30802	IA vs. H1N1 | weak inhib. HIV.
CMNPD30803	IA vs. H1N1 and HIV.
CMNPD30804	IA vs. H1N1 and HIV.
CMNPD30805	IA vs. H1N1 and HIV.
CMNPD30806	Sig. downregulation osteroclast cell differentiation.
CMNPD30807	No inhib. osteroclast cell differentiation.
CMNPD30808	Weak AB vs. 1 strain | weak cytotox. vs. 1 primate NCL | weak anti-TB vs. 1 strain. | IA antimal. vs. 1 strain.
CMNPD30821	significant α-glucosidase inhib.
CMNPD30823	Sig. inhib. NO prod. with low cytotox.
CMNPD30824	No inhib. NO prod.
CMNPD30825	Weak inhib. NO prod. with no cytotox.
CMNPD30826	Weak inhib. NO prod. with no cytotox. | Weak AB vs. 3 strain.
CMNPD30827	Sig. inhib. NO prod. with no cytotox. | IA vs. 3 bact.
CMNPD30828	No inhib. NO prod. | IA vs 5 bact.
CMNPD30829	potent inhib. NO prod. | Sig. inhib. MptpB.
CMNPD30830	potent inhib. NO prod. | Sig. inhib. MptpB.
CMNPD30831	potent AB vs. 2 strain | weak vs. 4 strain | IA vs. 1 strain
CMNPD30832	Weak AB vs. 1 strain | IA vs. 6 strain.
CMNPD30833	Weak AB vs. 1 strain | IA vs. 6 strain.
CMNPD30834	IA vs. 6 HTCLs | NT vs. 1.
CMNPD30835	IA vs. 4 HTCLs | NT vs. 3.
CMNPD30836	IA vs. 4 HTCLs | NT vs. 3.
CMNPD30837	Mod. cytotox. vs. 1 HTCL | weak cytotox. vs. 2 | IA vs. 2 | NT vs. 2.
CMNPD30838	Sig. cytotox. vs. 1 HTCL | weak cytotox. vs. 3 | IA vs. 1 | NT vs. 2.
CMNPD30839	potent cytotox. vs. 2 HTCLs | NT vs. 5.
CMNPD30840	Weak cytotox. vs. 2 HTCLs | NT vs. 5.
CMNPD30841	Mod. inhib. α-glucosidase. | No inhib. NO prod.
CMNPD30842	Mod. inhib. α-glucosidase. | No inhib. NO prod.
CMNPD30843	Mod. inhib. α-glucosidase. | No inhib. NO prod.
CMNPD30844	Mod. inhib. α-glucosidase. | No inhib. NO prod.
CMNPD30845	Mod-sig. cytotox. vs. 7 HTCLs | Sig. inhib. topoisomerase I (via necrosis).
CMNPD30846	Weak cytotox. vs. 1 HTCL | NT vs topoisomerase I
CMNPD30847	Weak cytotox. vs. 2 HTCLs | Mod. inhib. topoisomerase I.
CMNPD30848	potent cytotox. vs. 6 HTCLs | NT vs. topoisomerase I.
CMNPD30849	potent cytotox. vs. 6 HTCLs | weak cytotox. vs. 1 HTCL | NT vs. topoisomerase I.
CMNPD30850	Weak AB vs. 4 strain.
CMNPD30851	Weak AB vs. 4 strain.
CMNPD30853	IA vs. 4 bact., 1 fungus and AChE. | No AO (DPPH assay).
CMNPD30854	Weak AB vs. 1 strain. | IA vs. 1 fungus and AChE. | No AO (DPPH assay).
CMNPD30855	Weak AB vs. 1 strain. IA vs. 1 fungus and AChE. | No AO (DPPH assay).
CMNPD30856	IA vs. 4 bact., 1 fungus and AChE. | No AO (DPPH assay).
CMNPD30857	Weak AB vs. 1 strain. | IA vs. 1 fungus and AChE. | No AO (DPPH assay).
CMNPD30858	IA vs. 4 bact., 1 fungus and AChE. | No AO (DPPH assay).
CMNPD30859	Weak AB vs. 1 strain. | IA vs. 1 fungus and AChE. | No AO (DPPH assay).
CMNPD30860	IA vs. 10 HTCLs, 2 viruses and mycobact.
CMNPD30861	IA vs. 6 HTCLs, 4 bact. and 1 fungus No AO (DPPH assay).
CMNPD30862	IA vs. 6 HTCLs, 4 bact. and 1 fungus No AO (DPPH assay).
CMNPD30863	Sig. AO (DPPH assay). | IA vs. 6 HTCLs, 4 bact. and 1 fungus
CMNPD30864	IA vs. 6 HTCLs, 4 bact. and 1 fungus | No AO (DPPH assay).
CMNPD30865	Weak cytotox. vs. 1 HTCL | IA vs. 5 HTCLs, 4 bact. and 1 fungus | No AO (DPPH assay).
CMNPD30866	IA vs. 3 HTCLs, 5 bact. and 1 fungus
CMNPD30867	IA vs. 3 HTCLs, 5 bact. and 1 fungus
CMNPD30868	IA vs. 3 HTCLs, 5 bact. and 1 fungus
CMNPD30869	IA vs. 3 HTCLs, 5 bact. and 1 fungus
CMNPD30870	IA vs. 3 HTCLs, 5 bact. and 1 fungus
CMNPD30871	IA vs. 3 HTCLs, 5 bact. and 1 fungus
CMNPD30872	IA vs. 3 HTCLs, 5 bact. and 1 fungus
CMNPD30873	IA vs. 3 HTCLs, 5 bact. and 1 fungus
CMNPD30874	Weak AB vs. 5 strain. | IA vs. 3 HTCLs
CMNPD30875	Sig. inhib. NO prod. | IA vs. MptpB.
CMNPD30876	Sig. inhib. NO prod. | IA vs. MptpB.
CMNPD30877	Sig. inhib. NO prod. | IA vs. MptpB.
CMNPD30878	Sig. inhib. NO prod. | IA vs. MptpB.
CMNPD30879	Sig. inhib. NO prod. | IA vs. MptpB.
CMNPD30880	No inhib. NO prod. or MptpB.
CMNPD30881	No inhib. NO prod. or MptpB.
CMNPD30882	No inhib. NO prod. or MptpB.
CMNPD30883	Weak cytotox. vs. 3 HTCLs
CMNPD30885	Weak cytotox. vs. 2 HTCLs
CMNPD30886	Mod. cytotox. vs. 3 HTCLs
CMNPD30888	Weak-mod. cytotox. vs. 3 HTCLs
CMNPD30889	IA vs. 3 viruses.
CMNPD30890	IA vs. 3 viruses.
CMNPD30891	IA vs. 3 viruses.
CMNPD30892	IA vs. 3 viruses.
CMNPD30893	IA vs. 3 viruses.
CMNPD30894	IA vs. 3 viruses.
CMNPD30895	Sig. cytotox. vs. 2 HTCLs | weak-mod. cytotox. vs. 1 HTCL | IA vs 6 bact.
CMNPD30896	Weak-mod. cytotox. vs. 3 HTCLs | IA vs 6 bact.
CMNPD30898	IA vs. 2 fungi, zebrafish, eggs, embryos and larvae.
CMNPD30899	IA vs. 2 fungi, zebrafish, eggs, embryos and larvae.
CMNPD30900	IA vs. 2 fungi, zebrafish, eggs, embryos and larvae.
CMNPD30901	Mod. inhib. 1 fungus | IA vs. zebrafish, eggs, embryos and larvae.
CMNPD30902	potent AF vs. 3 strain.
CMNPD30903	potent AF vs. 2 strain.
CMNPD30904	potent IDO inhib.
CMNPD30905	Sig. IDO inhib.
CMNPD30906	Sig. IDO inhib.
CMNPD30907	No inhib. quorum sensing.
CMNPD30908	potent QS inhib.
CMNPD30909	Sig. QS inhib.
CMNPD30911	IA vs. 2 fungi.
CMNPD30913	IA vs. 5 HTCLs, α-glucosidase and MptpB.
CMNPD30914	IA vs. 5 HTCLs, α-glucosidase and MptpB.
CMNPD30915	potent inhib. α-glucosidase. | IA vs. 5 HTCLs and MptpB.
CMNPD30916	Mod. inhib. α-glucosidase. | IA vs. 5 HTCLs and MptpB.
CMNPD30917	Mod. inhib. α-glucosidase. | IA vs. 5 HTCLs and MptpB.
CMNPD30918	potent inhib. α-glucosidase. | Sig. inhib. MptpB. | IA vs. 5 HTCLs
CMNPD30919	IA vs. 5 HTCLs, α-glucosidase and MptpB.
CMNPD30920	potent inhib. a-glucosidase. | IA vs. 5 HTCLs and MptpB.
CMNPD30921	potent inhib. a-glucosidase. | IA vs. 5 HTCLs and MptpB.
CMNPD30922	IA vs. 3 HTCLs, 1 bact. and 1 fungus
CMNPD30923	Weak cytotox. vs. 1 HTCL | IA vs. 1 bact. and 1 fungus
CMNPD30924	IA vs. 3 HTCLs, 1 bact. and 1 fungus
CMNPD30925	IA vs. 3 HTCLs, 1 bact. and 1 fungus
CMNPD30926	potent AV vs 1 virus. | IA vs 1 HTCL
CMNPD30928	Sig. AV vs 1 virus. | IA vs 1 HTCL
CMNPD30929	Weak AB vs. 1 strain.
CMNPD30930	IA vs. 1 bact.
CMNPD30931	IA vs. 1 bact.
CMNPD30932	IA vs. 1 bact.
CMNPD30933	IA anti-allergy assay
CMNPD30934	IA anti-allergy assay
CMNPD30935	IA anti-allergy assay
CMNPD30936	IA anti-allergy assay
CMNPD30937	IA anti-allergy assay
CMNPD30938	IA anti-allergy assay
CMNPD30939	IA anti-allergy assay
CMNPD30940	IA anti-allergy assay
CMNPD30942	No inhib. NO prod. | IA vs. 1 HTCL | No AI (DPPH assay).
CMNPD30943	No inhib. NO prod. | IA vs. 1 HTCL | No AI (DPPH assay).
CMNPD30944	Mod. inhib. NO prod. | IA vs. 1 HTCL | No AI (DPPH assay).
CMNPD30945	Mod. inhib. NO prod. | Mod. AI (DPPH assay). | IA vs. 1 HTCL
CMNPD30946	Weak inhib, HIV-1. | IA vs. 8 HTCLs
CMNPD30947	IA vs. 8 HTCLs and HIV-1.
CMNPD30948	IA vs. 8 HTCLs and HIV-1.
CMNPD30949	IA vs. 8 HTCLs | NT vs. HIV-1.
CMNPD30950	IA vs. 8 HTCLs | NT vs. HIV-1.
CMNPD30951	IA vs. 8 HTCLs and HIV-1.
CMNPD30952	IA vs. 8 HTCLs
CMNPD30953	IA vs. 8 HTCLs
CMNPD30954	IA vs. 8 HTCLs
CMNPD30955	Sig. lipid lowering (oleic acid-induced lipid accumulation asssay). | IA vs. 5 HTCLs, 3 bact. and 1 fungus
CMNPD30956	IA vs. 5 HTCLs, 3 bact. and 1 fungus | No lipid lowering activ. or NT (unspecified).
CMNPD30957	IA vs. 1 HTCL
CMNPD30958	Mod. cytotox. vs. 1 HTCL
CMNPD30959	IA vs. 1 HTCL
CMNPD30960	Weak inhib. NO prod.
CMNPD30961	potent inhib. NO prod.
CMNPD30962	No inhib. NO prod.
CMNPD30963	No inhib. NO prod.
CMNPD30964	potent inhib. α-glucosidase. | potent cytotox. vs. 2 murine TCLs. | IA vs. 4 bact.
CMNPD30965	IA vs. α-glucosidase and AChE.
CMNPD30971	potent activ. vs murine P388 cells
CMNPD30972	potent activ. vs murine P388 cells
CMNPD30973	potent activ. vs murine P388 cells
CMNPD30974	Mod. activ. vs 3 HTCLs
CMNPD30986	NA in DPPH assay
CMNPD30996	α-glucosidase inhib. activ. IC 50 = 54 μM
CMNPD30997	20 μM preincubation of eckmaxol with Aβ oligomer prevented cell toxicty in SH-SY5Y cells.
CMNPD30998	PTP1B IC 50 =7.92 μM
CMNPD30999	PTP1B IC 50 = 7.78 μM
CMNPD31000	PTP1B IC 50 = 3.03 μM
CMNPD31001	PTP1B NA, NA to two HTCL
CMNPD31002	PTP1B NA, NA to two HTCL
CMNPD31003	PTP1B IC 50 = 35 μM, NA to two HTCL
CMNPD31004	PTP1B IC 50 = 1.88 μM | mod. activ. towards two HTCL
CMNPD31005	PTP1B IC 50 = 1.88 μM | mod. activ. towards two HTCL
CMNPD31006	PTP1B IC 50 = 48.2 μM | mod. activ. towards two HTCL
CMNPD31007	PTP1B IC 50 = 3.47 μM | mod. activ. towards two HTCL
CMNPD31008	PTP1B IC 50 = 16.3 μM | mod. activ. towards two HTCL
CMNPD31009	very weak antiox activ.
CMNPD31019	mod. radical scavenger in DPPH and ABTS assays
CMNPD31020	inhibits LPS induced inflamm. by inhib. ROS-mediated ERK signaling pathway at 2 μM
CMNPD31027	IA against K. pneumoniae
CMNPD31028	IA against K. pneumoniae
CMNPD31029	IA against K. pneumoniae
CMNPD31030	IA against K. pneumoniae
CMNPD31038	weak B-glucosidase activ. 57 μM
CMNPD31043	mod. Cytotox to HL-60 IC50 5.1 μM
CMNPD31044	non-cytotox to HL-60 cells
CMNPD31047	PP2A inhib. IC 50 11.3 μM
CMNPD31049	IA @ 100 μM to PP2A
CMNPD31050	Antimalarial, IC50 = 3 μM against 3D7 Plasmodium flaciparum
CMNPD31051	low DPPH radical scav. activ. IC 50 = 810 μM
CMNPD31052	low DPPH radical scav. activ. IC 50 = 2 μM
CMNPD31059	Mod. activ. vs 3HTCLs
CMNPD31060	Weak activ. vs 3HTCLs
CMNPD31061	Weak activ. vs 3HTCLs
CMNPD31062	Weak activ. vs 3HTCLs
CMNPD31064	Inhibited oncogenic AP-1 and NF-κB transciptional activ. at non-toxic concentrations (IC 50 25-37 µM)
CMNPD31065	Inhib. oncogenic AP-1/NF-κB transcript. activ. at non-tox. conc (IC 50 6-12 µM)
CMNPD31066	IA vs 6 bact., 2 fungi and 7 HTCLs
CMNPD31067	Mod. activ. vs 1 HTCL | IA vs 6 bact., 2 fungi and 6 HTCLs
CMNPD31068	IA vs 6 bact., 2 fungi and 7 HTCLs
CMNPD31069	IA vs 6 bact., 2 fungi and 7 HTCLs
CMNPD31070	Mod. activ. vs 3 HTCLs
CMNPD31075	Weak activ. vs 6 HTCLs
CMNPD31080	Mod. activ. vs 1 of 3 HTCLs
CMNPD31081	potent AB and AF activ.
CMNPD31082	potent AB and AF activ.
CMNPD31083	Weak activ. vs 3 HTCLs | weak antiglycation (anti-diabetic) activ.
CMNPD31084	Weak activ. vs 3 HTCLs | IA in antiglycation assay
CMNPD31087	potent inhib. of sterol-O-acyltransferases 1 and 2 in cell and enzyme assays
CMNPD31088	Mod. inhib. of sterol-O-acyltransferases 1 and 2 in cell and enzyme assays
CMNPD31090	Mod. AI, inhbiting IL-12p40 secretion from dendritic cells
CMNPD31091	Mod. AI, inhbiting IL-12p40 secretion from dendritic cells
CMNPD31093	Mod. activ. vs 6 HTCLs
CMNPD31094	potent activ. vs 6 HTCLs
CMNPD31095	potent activ. vs 6 HTCLs
CMNPD31096	potent activ. vs 1 HTCL
CMNPD31097	Mod. activ. vs P388 murine leukaemia cells
CMNPD31098	potent activ. vs 1 HTCL, causes tubulin polymerization
CMNPD31099	Extremely potent activ. vs 1 HTCL
CMNPD31100	Extremely potent activ. vs 1 HTCL
CMNPD31101	Extremely potent activ. vs 1 HTCL
CMNPD31102	Extremely potent activ. vs 1 HTCL
CMNPD31103	Extrem. potent activ. vs 1 HTCL, via actin polymerization
CMNPD31104	Extremely potent activ. vs 1 HTCL, causes actin polymerization
CMNPD31105	Extremely potent activ. vs 1 HTCL, causes tubulin polymerization
CMNPD31106	Extremely potent activ. vs 1 HTCL, causes tubulin polymerization
CMNPD31107	Extremely potent activ. vs 1 HTCL, causes tubulin polymerization
CMNPD31108	potent activ. vs 1 HTCL, causes tubulin polymerization
CMNPD31109	potent activ. vs 1 HTCL, causes tubulin polymerization
CMNPD31110	Very weak activ. vs Staphylococcus aureus
CMNPD31111	Moderare antimycobact. activ. vs four species
CMNPD31112	Moderare antimycobact. activ. vs four species
CMNPD31113	Very weak activ. vs 1 HTCL
CMNPD31114	Very weak activ. vs 1 HTCL
CMNPD31115	Very weak activ. vs 1 HTCL
CMNPD31116	Mod. activ. vs 3 HTCLs
CMNPD31117	Mod. antitrypanosomal activ. | IA vs J774.1 macrophages.
CMNPD31118	Mod. activ. vs 5 HTCLs
CMNPD31119	Weak antinbact. activ.
CMNPD31120	Mod. activ. vs 3 of 5 HTCLs
CMNPD31121	Inhibits isocitrate lyase
CMNPD31122	Mod. cytostatic activ. vs 3 HTCLs, mode of action via inhib. of protein phosphatase 1
CMNPD31123	Mod. cytostatic activ. vs 3 HTCLs, mode of action via inhib. of protein phosphatase 1
CMNPD31124	Mod. activ. vs 1 of 2 HTCLs
CMNPD31132	Mol. docking study suggests potential topoisomerase activ.
CMNPD31135	Weak inhib. of yeast 20S proteasome (IC 50 = 27 µM)
CMNPD31136	Weak inhib. of yeast 20S proteasome (IC 50 = 23 µM)
CMNPD31137	IA
CMNPD31138	Mod. inhib. of yeast 20S proteasome (IC 50 = 9.2 µM)
CMNPD31148	Mod. activ. vs. 6 HTCLs | IA vs. imicrob.s
CMNPD31149	Weak activ. vs. 6 HTCLs | IA vs. imicrob.s
CMNPD31151	potent activ. against 3 of 4 HTCLs
CMNPD31152	potent activ. against 3 of 4 HTCLs
CMNPD31155	IA vs 3 HTCLs | weakly inhibits TNF-α and IL-6 prod in LPS-stimulated THP-1 cells
CMNPD31157	Mod. activ. vs 1 HTCL | active as anti-oomycete agent vs. Phytophthora capsici
CMNPD31158	Mod. activ. vs 1 HTCL | active as anti-oomycete agent vs. Phytophthora capsici
CMNPD31159	potent activ. vs 1 HTCL | active as anti-oomycete agent vs. Phytophthora capsici
CMNPD31163	Mod activ. vs 1 HTCL
CMNPD31164	Mod activ. vs 1 HTCL
CMNPD31166	Weak activ. vs 1 HTCL
CMNPD31167	Weak activ. vs 1 HTCL
CMNPD31168	Weak activ. vs 1 HTCL
CMNPD31169	Weak activ. vs 1 HTCL
CMNPD31171	potent antimalarial activ. against two P. falciparum strain | mod. cyotoxicity, selectivity index 15.5
CMNPD31172	Mod. antimalarial activ. against one P. falciparum strain | weak cyotoxicity, selectivity index >4
CMNPD31174	Moderatve activ. vs. Gram positive bact. | mod. activ. vs 4 HTCLs
CMNPD31177	Mod. inhibiton of cytokine prod in LPS stimulated THP-1 cells
CMNPD31178	Mod. inhibiton of cytokine prod in LPS stimulated THP-1 cells
CMNPD31180	Mod. inhibiton of cytokine prod in LPS stimulated THP-1 cells
CMNPD31181	Mod. inhibiton of cytokine prod in LPS stimulated THP-1 cells
CMNPD31185	Mod. inhibiton of cytokine prod in LPS stimulated THP-1 cells
CMNPD31186	Weak activ. vs 1 of 5 HTCLs | mod. inhibiton of cytokine prod in LPS stimulated THP-1 cells
CMNPD31187	IA vs 5 HTCLs
CMNPD31188	IA vs 5 HTCLs | inhibited IL-6 prod in LPS-stimulated THP-1 cells
CMNPD31189	IA vs 5 HTCLs
CMNPD31192	Inhibits COX-2 expression in LPS-stimulated RAW264.7 macrophages in dose dependent manner; 10x more active than avarol
CMNPD31193	Mod. activ. vs 3 HTCLs
CMNPD31194	Mod. activ. vs 3 HTCLs
CMNPD31208	IA vs 2 bact., 1 fungus and 1 HTCL
CMNPD31209	IA vs 2 bact., 1 fungus and 1 HTCL
CMNPD31210	IA vs 2 bact., 1 fungus and 1 HTCL
CMNPD31211	IA vs 2 bact., 1 fungus and 1 HTCL
CMNPD31212	IA vs 2 bact., 1 fungus and 1 HTCL
CMNPD31213	IA vs 2 bact., 1 fungus and 1 HTCL
CMNPD31214	IA vs 2 bact., 1 fungus and 1 HTCL
CMNPD31215	IA vs 2 bact., 1 fungus and 1 HTCL
CMNPD31216	IA vs 2 bact., 1 fungus and 1 HTCL
CMNPD31217	IA vs 2 bact., 1 fungus and 1 HTCL
CMNPD31218	IA vs 2 bact., 1 fungus and 1 HTCL
CMNPD31219	IA vs 2 bact., 1 fungus and 1 HTCL
CMNPD31220	IA vs 2 bact., 1 fungus and 1 HTCL
CMNPD31221	IA vs 2 bact., 1 fungus and 1 HTCL
CMNPD31222	IA vs 2 bact., 1 fungus and 1 HTCL
CMNPD31226	Weak activ. vs. 6 HTCLs
CMNPD31228	Weak activ. vs. 6 HTCLs
CMNPD31231	Weak activ. vs 6 HTCLs
CMNPD31239	Mod. activ. vs 5 HTCLs
CMNPD31240	Mod. activ. vs 5 HTCLs
CMNPD31241	Weak activ. vs 5 HTCLs
CMNPD31243	Weak anti-tubucular activ.
CMNPD31244	Weak activ. vs 1 HTCL
CMNPD31245	Weak activ. vs 1 HTCL
CMNPD31246	Weak activ. vs 1 HTCL
CMNPD31249	Weak activ. vs 3 HTCLs
CMNPD31250	Weak activ. vs 3 HTCLs
CMNPD31259	Mod. activ. vs 3 HTCls, causes ROS-induced apoptosis
CMNPD31260	Inhibited histone acetyltransferase (H)p300 (IC 50 = 8.8 µM)
CMNPD31264	Weak activ. vs 2 HTCLs | IA vs various bact. and fungi
CMNPD31265	Weak inhib. of NO prod in LPS stimulated BV2 cells
CMNPD31266	Weak inhib. of NO prod in LPS stimulated BV2 cells
CMNPD31267	Weak inhib. of NO prod in LPS stimulated BV2 cells
CMNPD31272	Weak activ. vs 5 HTCLs
CMNPD31273	Mod. activ. vs 5 HTCLs
CMNPD31274	Weak activ. vs 5 HTCLs
CMNPD31279	Inhibited RANKL-induced differentiation of RAW264 cells into osteoclasts (IC 50 = 12.8 µM)
CMNPD31291	Anti-lymphangiogenic
CMNPD31292	Anti-lymphangiogenic
CMNPD31293	Anti-lymphangiogenic
CMNPD31294	Not cytotox.
CMNPD31295	Mod. in vitro cytotox. and induces slow death in vivo.
CMNPD31296	AI in various assays
CMNPD31297	AI in various assays
CMNPD31298	Not AM or cytotox.
CMNPD31299	Not AM or cytotox.
CMNPD31300	Not AM or cytotox.
CMNPD31301	Not AM or cytotox.
CMNPD31302	Inhib. protein sumoylation
CMNPD31303	Inhib. protein sumoylation | cytotox.
CMNPD31304	Inhib. protein sumoylation | cytotox.
CMNPD31305	Inhib. protein sumoylation
CMNPD31306	Inhib. protein sumoylation
CMNPD31307	Inhib. protein sumoylation
CMNPD31309	Mod. cytotox. to A549 cell line
CMNPD31310	Weak AF | cytotox. to T-cell leukemia
CMNPD31311	Fungistatic
CMNPD31312	Weakly fungistatic
CMNPD31313	Weak cytotox. to T-cell leukemia
CMNPD31314	Mod. AB to Bacillus cereus
CMNPD31315	Not cytotox.
CMNPD31316	Not cytotox.
CMNPD31317	Not cytotox.
CMNPD31318	Weak inhib. PTP1B
CMNPD31319	Weak inhib. PTP1B
CMNPD31321	Weakly antimalarial and cytotox.
CMNPD31324	Repellent to maize weevil
CMNPD31325	Weak inhib. PTP1B
CMNPD31326	Weak inhib. PTP1B
CMNPD31327	Weak promoter of concanavalin A-induced T lymphocyte prolif.
CMNPD31328	Weak promoter of concanavalin A-induced T lymphocyte prolif.
CMNPD31329	Mod. inhib. settlement of Balanus cyprids
CMNPD31330	Mod. cytotox. to 2 HTCL
CMNPD31331	Weak or not cytotox. To 2 HTCL
CMNPD31332	Inhibit. NO prod. in stimulated macrophages, induces apoptosis in HL60 cells
CMNPD31334	Mild inhib. PTP1B
CMNPD31335	Not cytotox. or AI
CMNPD31336	Not cytotox. or AI
CMNPD31337	Not cytotox. or AI
CMNPD31339	Not cytotox. or AI
CMNPD31340	Weak inhib. NO prod. and TNF-a in macrophages
CMNPD31341	Weak inhib. NO prod. and TNF-a in macrophages
CMNPD31342	Weak inhib. NO prod. and TNF-a in macrophages
CMNPD31343	Weak inhib. NO prod. and TNF-a in macrophages
CMNPD31344	Weak inhib. NO prod. and TNF-a in macrophages
CMNPD31345	IA PTP1B
CMNPD31346	IA PTP1B
CMNPD31347	Mod. inhib. PTP1B
CMNPD31348	IA PTP1B
CMNPD31349	IA PTP1B
CMNPD31350	Not cytotox. to 3 HTCLs
CMNPD31351	Not cytotox. to 3 HTCLs
CMNPD31352	Not cytotox. to 3 HTCLs
CMNPD31353	Not cytotox. to 3 HTCLs
CMNPD31354	Not cytotox. to 3 HTCLs
CMNPD31355	Not cytotox. to 3 HTCLs
CMNPD31356	Not cytotox. to 3 HTCLs
CMNPD31357	Not cytotox. to 3 HTCLs
CMNPD31358	Weak to low activ. for superoxide and elastase release
CMNPD31359	Weak to low activ. for superoxide and elastase release
CMNPD31360	Weak to low activ. for superoxide and elastase release
CMNPD31361	Weak to low activ. for superoxide and elastase release
CMNPD31362	Weak to low activ. for superoxide and elastase release
CMNPD31363	Mod. inhib. release superoxide and elastase in stim. neutrophils
CMNPD31364	Not cytotox. to 2 HTCLs
CMNPD31365	Not cytotox. to 2 HTCLs
CMNPD31366	Not cytotox. to 2 HTCLs
CMNPD31367	Not cytotox. to 2 HTCLs
CMNPD31368	Not cytotox. to 2 HTCLs
CMNPD31369	Not cytotox. to 2 HTCLs
CMNPD31371	Mod. anti-leishmanial activ.
CMNPD31372	Mod. anti-leishmanial activ.
CMNPD31373	Mod. anti-leishmanial activ.
CMNPD31374	Mod. anti-leishmanial activ.
CMNPD31375	Mod. cytotox. to 2 HTCL
CMNPD31376	Enhanced beta-cell prolif.
CMNPD31377	Enhanced beta-cell prolif.
CMNPD31382	Enhanced beta-cell prolif.
CMNPD31391	Inhib. expression iNOS and COX-2
CMNPD31394	Inhib. expression iNOS, but not COX-2
CMNPD31396	Inhib. expression iNOS, but not COX-2
CMNPD31397	Inhib. Express. iNOS, but not COX-2
CMNPD31398	Inhib. expression iNOS, but not COX-2 or β-actin
CMNPD31399	Inhib. expression iNOS, but not COX-2 or β-actin
CMNPD31400	Mod. inhib. TNF-α
CMNPD31401	Mod. inhib. TNF-α
CMNPD31402	Mod. inhib. TNF-α
CMNPD31403	Not cytotox. or AB
CMNPD31404	Not cytotox. or AV
CMNPD31405	Not cytotox. or AV
CMNPD31406	Cytotox. to 1 HTCL | inhib. superoxide generation and elastase release
CMNPD31408	Inhib. elastase release
CMNPD31409	Cytoprotective of oxidative damage to PC12 cells
CMNPD31413	Mod. cytotox. to HL-60 CL
CMNPD31414	Mod. cytotox. to HL-60 CL
CMNPD31415	Weakly cytotox. to 8 HTCL
CMNPD31416	Not cytotox.
CMNPD31417	Weakly cytotox. to 8 HTCL
CMNPD31418	Not cytotox.
CMNPD31419	Weakly cytotox. to 8 HTCL
CMNPD31420	Weakly cytotox. to 8 HTCL
CMNPD31421	Modest cytotox. to 8 HTCL
CMNPD31422	Weakly cytotox. to 8 HTCL
CMNPD31423	Weakly cytotox. to 8 HTCL
CMNPD31424	Weakly cytotox. to 8 HTCL
CMNPD31425	Antifoul. activ. to Balanus cyprids confirmed
CMNPD31427	Sig.inhib. vs. 2 strain P. falciparum. | Mod. cytotox. small subset NCI-60 panel HTCLs
CMNPD31428	Sig.inhib. vs. 2 strain P. falciparum.
CMNPD31429	IA vs. 1 HTCL, 1 norm. HCL and 5 bact.
CMNPD31430	Weakly cytotox. T lymphocytes.
CMNPD31431	Weakly antioxid. and COX-1/2 inhib.
CMNPD31432	Weakly antioxid. and COX-1/2 inhib.
CMNPD31433	Weakly antioxid. and COX-1/2 inhib.
CMNPD31434	Weakly antioxid. and COX-1/2 inhib.
CMNPD31435	Weakly antioxid. and COX-1/2 inhib.
CMNPD31436	Weakly antioxid. and COX-1/2 inhib.
CMNPD31437	Weakly antioxid. and COX-1/2 inhib.
CMNPD31438	Weakly antioxid. and 5-LOX inhib.
CMNPD31439	Weakly antioxid. and 5-LOX inhib.
CMNPD31447	Anti-HIV-1 IC 50 0.225 μM, cytotox. CC 50 2.63 μM
CMNPD31451	Inhib. BuChE (IC50 3.1 μM), IA to AChE.
CMNPD31454	IA p53-Hdm2 (50 μM)
CMNPD31455	IA p53-Hdm2 (50 μM)
CMNPD31456	IA p53-Hdm2 (50 μM)
CMNPD31457	IA p53-Hdm2 (50 μM)
CMNPD31458	Maintains colony formation of murine embryonic stem cells
CMNPD31461	Fluorescent, endosomal/lysosomal accum.
CMNPD31462	Fluorescent, endosomal/lysosomal accum.
CMNPD31463	Fluorescent, endosomal/lysosomal accum.
CMNPD31464	Inhib. NO prodn in RAW264.7 cells | inhib. expression of iNOS and COX-2.
CMNPD31465	Inhib. NO prodn in RAW264.7 cells
CMNPD31468	Inhib. colony formn breast tumor T-47D cells.
CMNPD31470	Not cytotox. 5 HTCLs
CMNPD31471	Cytotox. 3 HTCLs
CMNPD31472	mod. cytotox. 3 HTCLs
CMNPD31473	mod. cytotox. 3 HTCLs
CMNPD31474	mod. cytotox. 3 HTCLs
CMNPD31475	Not cytotox. or tumour colony inhib.
CMNPD31476	Not cytotox. or tumour colony inhib.
CMNPD31478	Not cytotox. or tumour colony inhib.
CMNPD31481	Cytotox. 5 HTCLs
CMNPD31485	Cytotox. Ehrlich, haemolytic, synergist with radiation against HT-29.
CMNPD31486	Cytotox. Ehrlich, haemolytic, synergist with radiation against HT-29.
CMNPD31487	Cytotox. Ehrlich, haemolytic, synergist with radiation against HT-29.
CMNPD31488	Cytotox. Ehrlich, haemolytic, synergist with radiation against HT-29.
CMNPD31489	Cytotox. Ehrlich, haemolytic, synergist with radiation against HT-29.
CMNPD31490	Cytotox. Ehrlich, haemolytic, synergist with radiation against HT-29.
CMNPD31491	Cytotox. Ehrlich, haemolytic, synergist with radiation against HT-29.
CMNPD31492	Cytotox. Ehrlich, haemolytic, synergist with radiation against HT-29.
CMNPD31493	Cytotox. Ehrlich, haemolytic, synergist with radiation against HT-29.
CMNPD31494	Cytotox. Ehrlich, haemolytic, synergist with radiation against HT-29.
CMNPD31495	Cytotox. Ehrlich, haemolytic, synergist with radiation against HT-29.
CMNPD31496	Cytotox. Ehrlich, haemolytic, synergist with radiation against HT-29.
CMNPD31497	Cytotox. Ehrlich, haemolytic, synergist with radiation against HT-29.
CMNPD31498	Cytotox. Ehrlich, haemolytic, synergist with radiation against HT-29.
CMNPD31502	Not cytotox. to 2 HTCL
CMNPD31503	MRSA MIC 6.25 μg/mL
CMNPD31504	MRSA MIC 6.25 μg/mL
CMNPD31505	Not cytotox. to 2 HTCL
CMNPD31506	Not cytotox. to 2 HTCL
CMNPD31507	S. aureus MIC 64 μg/mL
CMNPD31508	Anti-angiogenic | inhib. superoxide prod. by stim. neutrophils
CMNPD31512	IA in activation of NF-κβ by LPS
CMNPD31513	Inhib. activation NF-κβ by LPS
CMNPD31515	Inhib. activation NF-κβ by LPS
CMNPD31520	Not cytotox. to 2 HTCL
CMNPD31521	Not cytotox. to 2 HTCL
CMNPD31522	Cytotox. to 6 HTCL
CMNPD31523	Not cytotox.
CMNPD31524	Not cytotox. to 5 HTCLs
CMNPD31525	Not cytotox. to 5 HTCLs
CMNPD31526	Cytotox. to 6 hum. breast cancer cell lines
CMNPD31527	Cytotox. to 6 hum. breast cancer cell lines
CMNPD31531	Not cytotox.
CMNPD31538	Inhib. activation NF-κβ by LPS
CMNPD31539	Inhib. activation NF-κβ by LPS
CMNPD31540	Inhib. activation NF-κβ by LPS
CMNPD31546	Cytotox. to triple-negative breast cancer cell line
CMNPD31547	Anti-HIV-1 activ. | weakly cytotox.
CMNPD31548	Cytotox. to triple-negative breast cancer cell line
CMNPD31549	Anti-HIV-1 activ. | weakly cytotox.
CMNPD31550	FXR agonist
CMNPD31554	FXR agonist
CMNPD31555	FXR agonist
CMNPD31556	FXR agonist
CMNPD31558	FXR agonist
CMNPD31559	PXR agonist
CMNPD31561	Non-cytotox. (CCRF-CEM) at 100 mM
